Clustering O 0 0.11460577696561813
of O 0 0.031218450516462326
missense O 1 0.967517077922821
mutations O 1 0.943035364151001
in O 0 0.01757517084479332
the O 0 0.02157355472445488
ataxia B-Disease 1 0.9994877576828003
- I-Disease 1 0.98604416847229
telangiectasia I-Disease 1 0.9991520643234253
gene O 1 0.9606916904449463
in O 0 0.01662737876176834
a O 0 0.023009222000837326
sporadic B-Disease 1 0.84108966588974
T I-Disease 1 0.9900147914886475
- I-Disease 1 0.8833128213882446
cell I-Disease 1 0.9387572407722473
leukaemia I-Disease 1 0.9975870847702026
. O 0 0.06144139915704727

Ataxia B-Disease 1 0.9982348680496216
- I-Disease 1 0.9520872235298157
telangiectasia I-Disease 1 0.9978625178337097
( O 0 0.036647945642471313
A B-Disease 0 0.03340351954102516
- I-Disease 0 0.40502026677131653
T I-Disease 1 0.8869014978408813
) O 0 0.013178316876292229
is O 0 0.010346396826207638
a O 0 0.017311464995145798
recessive B-Disease 1 0.9981988072395325
multi I-Disease 1 0.8421531319618225
- I-Disease 1 0.8028136491775513
system I-Disease 1 0.5298128128051758
disorder I-Disease 1 0.9997418522834778
caused O 1 0.966582179069519
by O 0 0.015593218617141247
mutations O 1 0.9746997356414795
in O 0 0.007866974920034409
the O 0 0.010015031322836876
ATM O 0 0.22162067890167236
gene O 1 0.5216079950332642
at O 0 0.01854722760617733
11q22 O 1 0.7887826561927795
- O 0 0.34450313448905945
q23 O 1 0.7230810523033142
( O 0 0.029408514499664307
ref O 0 0.3473180830478668
. O 0 0.013528672978281975
3 O 0 0.01979183778166771
) O 0 0.01967090368270874
. O 0 0.024543840438127518

The O 0 0.02915029786527157
risk O 1 0.5059342384338379
of O 0 0.02153065614402294
cancer B-Disease 1 0.9987542629241943
, O 0 0.017061429098248482
especially O 0 0.052373070269823074
lymphoid B-Disease 1 0.99565190076828
neoplasias I-Disease 1 0.9075156450271606
, O 0 0.010219862684607506
is O 0 0.009174099192023277
substantially O 0 0.028215141966938972
elevated O 0 0.048817068338394165
in O 0 0.007090517319738865
A B-Disease 0 0.02109113149344921
- I-Disease 1 0.9149379134178162
T I-Disease 1 0.9979999661445618
patients O 1 0.9962605834007263
and O 0 0.005913333036005497
has O 0 0.007181915454566479
long O 0 0.011550470255315304
been O 0 0.0077702803537249565
associated O 0 0.018369806930422783
with O 0 0.01736307330429554
chromosomal O 1 0.9962778687477112
instability O 1 0.9835957288742065
. O 0 0.05399082601070404

By O 0 0.038468874990940094
analysing O 1 0.6219028830528259
tumour B-Disease 1 0.9979978203773499
DNA O 0 0.4480961561203003
from O 0 0.021712658926844597
patients O 1 0.9772459864616394
with O 0 0.017341095954179764
sporadic B-Disease 1 0.8826255202293396
T I-Disease 1 0.9922453761100769
- I-Disease 1 0.8304556012153625
cell I-Disease 1 0.9516631364822388
prolymphocytic I-Disease 1 0.9948741793632507
leukaemia I-Disease 1 0.999342143535614
( O 0 0.23474250733852386
T B-Disease 1 0.9838377833366394
- I-Disease 0 0.4607287049293518
PLL I-Disease 1 0.9430248737335205
) O 0 0.014167796820402145
, O 0 0.008692044764757156
a O 0 0.011694904416799545
rare O 0 0.10575239360332489
clonal B-Disease 1 0.9719944000244141
malignancy I-Disease 1 0.9948260188102722
with O 0 0.010055586695671082
similarities O 0 0.015884624794125557
to O 0 0.006258637178689241
a O 0 0.013447004370391369
mature B-Disease 1 0.6909125447273254
T I-Disease 1 0.9841747879981995
- I-Disease 1 0.7665679454803467
cell I-Disease 1 0.873390257358551
leukaemia I-Disease 1 0.9985906481742859
seen O 0 0.017837313935160637
in O 0 0.008274419233202934
A B-Disease 0 0.015715816989541054
- I-Disease 0 0.25264793634414673
T I-Disease 1 0.8353103399276733
, O 0 0.005574950482696295
we O 0 0.004260210786014795
demonstrate O 0 0.007285724394023418
a O 0 0.005730298347771168
high O 0 0.008438537828624249
frequency O 0 0.013943162746727467
of O 0 0.008055535145103931
ATM O 0 0.4263496398925781
mutations O 1 0.9656737446784973
in O 0 0.020717132836580276
T B-Disease 1 0.947097897529602
- I-Disease 1 0.6213350296020508
PLL I-Disease 1 0.9615272283554077
. O 0 0.04915187507867813

In O 0 0.02001148648560047
marked O 0 0.023745013400912285
contrast O 0 0.016591964289546013
to O 0 0.0057873292826116085
the O 0 0.009419172070920467
ATM O 0 0.1307753473520279
mutation O 1 0.9557034969329834
pattern O 0 0.029737820848822594
in O 0 0.0072470856830477715
A B-Disease 0 0.013055458664894104
- I-Disease 0 0.1123003214597702
T I-Disease 1 0.5322567224502563
, O 0 0.0055434624664485455
the O 0 0.004991828463971615
most O 0 0.0063475859351456165
frequent O 0 0.024725226685404778
nucleotide O 0 0.034521959722042084
changes O 0 0.01340806670486927
in O 0 0.00663880305364728
this O 0 0.010486329905688763
leukaemia B-Disease 1 0.9949076771736145
were O 0 0.019189663231372833
missense O 1 0.983185887336731
mutations O 1 0.9836367964744568
. O 0 0.044321801513433456

These O 0 0.01693608984351158
clustered O 0 0.027718033641576767
in O 0 0.00830486137419939
the O 0 0.007128124125301838
region O 0 0.012551432475447655
corresponding O 0 0.009590275585651398
to O 0 0.0047903587110340595
the O 0 0.006662799045443535
kinase O 0 0.2675850987434387
domain O 0 0.01239450741559267
, O 0 0.004243660252541304
which O 0 0.004153787158429623
is O 0 0.005138630513101816
highly O 0 0.009578501805663109
conserved O 0 0.014885987155139446
in O 0 0.007419634144753218
ATM O 0 0.05645913630723953
- O 0 0.027261266484856606
related O 0 0.020117295905947685
proteins O 0 0.02455856278538704
in O 0 0.010932856239378452
mouse O 0 0.22388741374015808
, O 0 0.015743203461170197
yeast O 0 0.3956378400325775
and O 0 0.01956176571547985
Drosophila O 0 0.30310383439064026
. O 0 0.03324611857533455

The O 0 0.028514036908745766
resulting O 0 0.05806806683540344
amino O 0 0.04471524804830551
- O 0 0.05845111235976219
acid O 0 0.07454892992973328
substitutions O 0 0.024161528795957565
are O 0 0.007426442112773657
predicted O 0 0.013100331649184227
to O 0 0.0059487284161150455
interfere O 0 0.018619658425450325
with O 0 0.008715317584574223
ATP O 0 0.04887863248586655
binding O 0 0.02891562134027481
or O 0 0.018092388287186623
substrate O 0 0.0649210512638092
recognition O 0 0.04878674075007439
. O 0 0.03538043051958084

Two O 0 0.018409326672554016
of O 0 0.016324840486049652
seventeen O 0 0.04967235401272774
mutated O 1 0.9924572706222534
T B-Disease 1 0.9803870320320129
- I-Disease 0 0.37130892276763916
PLL I-Disease 1 0.9348689317703247
samples O 0 0.024721011519432068
had O 0 0.009285648353397846
a O 0 0.008572656661272049
previously O 0 0.011194122023880482
reported O 0 0.0196821428835392
A B-Disease 0 0.022387182340025902
- I-Disease 1 0.6114389300346375
T I-Disease 1 0.9824192523956299
allele O 1 0.8861292600631714
. O 0 0.05530574172735214

In O 0 0.018740179017186165
contrast O 0 0.022945059463381767
, O 0 0.009614890441298485
no O 0 0.009460008703172207
mutations O 1 0.8806818127632141
were O 0 0.006568519864231348
detected O 0 0.038957495242357254
in O 0 0.007234921213239431
the O 0 0.009745350107550621
p53 O 1 0.9799396991729736
gene O 1 0.7913381457328796
, O 0 0.0070004998706281185
suggesting O 0 0.016028838232159615
that O 0 0.006409154273569584
this O 0 0.010884406045079231
tumour B-Disease 1 0.9993019104003906
suppressor O 1 0.9962026476860046
is O 0 0.010107418522238731
not O 0 0.007136130705475807
frequently O 0 0.014853989705443382
altered O 0 0.02184566855430603
in O 0 0.009892864152789116
this O 0 0.014611282385885715
leukaemia B-Disease 1 0.9962562322616577
. O 0 0.03941516950726509

Occasional O 0 0.2628348767757416
missense O 1 0.972061038017273
mutations O 1 0.9501193761825562
in O 0 0.01348242536187172
ATM O 0 0.033423181623220444
were O 0 0.004997691605240107
also O 0 0.005567076150327921
found O 0 0.0073844064027071
in O 0 0.009117048233747482
tumour B-Disease 1 0.9988144636154175
DNA O 0 0.2809126377105713
from O 0 0.012776973657310009
patients O 1 0.986983060836792
with O 0 0.013219866901636124
B B-Disease 0 0.2859533131122589
- I-Disease 0 0.2112451195716858
cell I-Disease 1 0.5428677201271057
non I-Disease 0 0.16883620619773865
- I-Disease 1 0.980647623538971
Hodgkins I-Disease 1 0.9998252987861633
lymphomas I-Disease 1 0.9991378784179688
( O 0 0.0790296122431755
B B-Disease 0 0.20930755138397217
- I-Disease 0 0.049602072685956955
NHL I-Disease 0 0.02780483476817608
) O 0 0.009344498626887798
and O 0 0.005540915764868259
a O 0 0.010649510659277439
B B-Disease 0 0.06259329617023468
- I-Disease 0 0.04890861362218857
NHL I-Disease 0 0.055071134120225906
cell O 0 0.06553862988948822
line O 0 0.03239215165376663
. O 0 0.03260623663663864

The O 0 0.013312947005033493
evidence O 0 0.009846717119216919
of O 0 0.005642957519739866
a O 0 0.007572766859084368
significant O 0 0.009867077693343163
proportion O 0 0.013539738953113556
of O 0 0.005756353493779898
loss O 0 0.020348846912384033
- O 0 0.01680074818432331
of O 0 0.006425045430660248
- O 0 0.1484462022781372
function O 0 0.06014179810881615
mutations O 1 0.8769454956054688
and O 0 0.004632577765733004
a O 0 0.005760300904512405
complete O 0 0.007143891882151365
absence O 0 0.008122903294861317
of O 0 0.0038260642904788256
the O 0 0.00531401252374053
normal O 0 0.012341718189418316
copy O 0 0.009865004569292068
of O 0 0.005596542730927467
ATM O 0 0.018563954159617424
in O 0 0.005523690488189459
the O 0 0.006045645102858543
majority O 0 0.015764573588967323
of O 0 0.013513969257473946
mutated O 1 0.9966852068901062
tumours B-Disease 1 0.9989243149757385
establishes O 1 0.8453654646873474
somatic O 1 0.9793263673782349
inactivation O 1 0.6907381415367126
of O 0 0.008392317220568657
this O 0 0.00774588156491518
gene O 0 0.0687524825334549
in O 0 0.006154569797217846
the O 0 0.007877354510128498
pathogenesis O 1 0.9729113578796387
of O 0 0.012030838057398796
sporadic B-Disease 1 0.876953125
T I-Disease 1 0.9901453256607056
- I-Disease 1 0.694823682308197
PLL I-Disease 1 0.973063588142395
and O 0 0.010083135217428207
suggests O 0 0.019125137478113174
that O 0 0.007824750617146492
ATM O 0 0.03331563249230385
acts O 0 0.018085608258843422
as O 0 0.014363373629748821
a O 0 0.028011830523610115
tumour B-Disease 1 0.9973666071891785
suppressor O 1 0.9888655543327332
. O 0 0.05565093085169792

As O 0 0.020808830857276917
constitutional O 0 0.021347159519791603
DNA O 0 0.025128144770860672
was O 0 0.00803153496235609
not O 0 0.004731630906462669
available O 0 0.005917505361139774
, O 0 0.0052453638054430485
a O 0 0.010105711407959461
putative O 1 0.6739231944084167
hereditary O 1 0.9946106672286987
predisposition O 1 0.9977694749832153
to O 0 0.016254227608442307
T B-Disease 1 0.979852020740509
- I-Disease 0 0.4724971652030945
PLL I-Disease 1 0.9623414278030396
will O 0 0.011508668772876263
require O 0 0.01937735266983509
further O 0 0.014296145178377628
investigation O 0 0.023200850933790207
. O 0 0.017350712791085243
. O 0 0.023644672706723213

Myotonic B-Disease 1 0.9987742304801941
dystrophy I-Disease 1 0.999398946762085
protein O 1 0.9144863486289978
kinase O 1 0.8994185328483582
is O 0 0.014553539454936981
involved O 0 0.013322953134775162
in O 0 0.00811755657196045
the O 0 0.009020037017762661
modulation O 0 0.03581984341144562
of O 0 0.010794323869049549
the O 0 0.018560534343123436
Ca2 O 1 0.9847623109817505
+ O 1 0.7493975758552551
homeostasis O 1 0.9751631617546082
in O 0 0.032937027513980865
skeletal O 1 0.9962363839149475
muscle O 1 0.9954344630241394
cells O 1 0.8755617141723633
. O 0 0.04732854664325714

Myotonic B-Disease 1 0.9987163543701172
dystrophy I-Disease 1 0.9995999932289124
( O 1 0.6746107935905457
DM B-Disease 1 0.9972203969955444
) O 0 0.019354838877916336
, O 0 0.00843676645308733
the O 0 0.00842770840972662
most O 0 0.016937248408794403
prevalent O 1 0.9914714694023132
muscular B-Disease 1 0.9997732043266296
disorder I-Disease 1 0.9997982382774353
in O 0 0.021042970940470695
adults O 1 0.7425990104675293
, O 0 0.008145874366164207
is O 0 0.008688635192811489
caused O 0 0.26695865392684937
by O 0 0.010192218236625195
( O 0 0.01635296456515789
CTG O 1 0.6575228571891785
) O 0 0.014301803894340992
n O 0 0.02144097164273262
- O 0 0.023826653137803078
repeat O 0 0.02731407806277275
expansion O 0 0.015172410756349564
in O 0 0.0070731486193835735
a O 0 0.011768911965191364
gene O 0 0.07971807569265366
encoding O 0 0.03432277962565422
a O 0 0.018875963985919952
protein O 0 0.17265771329402924
kinase O 1 0.938220202922821
( O 0 0.06143071874976158
DM B-Disease 1 0.996218740940094
protein O 1 0.8112711906433105
kinase O 1 0.9368810653686523
; O 0 0.020611412823200226
DMPK O 0 0.48366495966911316
) O 0 0.013655447401106358
and O 0 0.00784443598240614
involves O 0 0.022073810920119286
changes O 0 0.01614939421415329
in O 0 0.013635128736495972
cytoarchitecture O 0 0.37728166580200195
and O 0 0.02149449661374092
ion O 0 0.23053433001041412
homeostasis O 1 0.827995240688324
. O 0 0.04417123645544052

To O 0 0.01658025197684765
obtain O 0 0.01671898551285267
clues O 0 0.01627443917095661
to O 0 0.005618860945105553
the O 0 0.005426556803286076
normal O 0 0.013369745574891567
biological O 0 0.011753265745937824
role O 0 0.008311454206705093
of O 0 0.006287118885666132
DMPK O 0 0.48793745040893555
in O 0 0.010185327380895615
cellular O 0 0.23381595313549042
ion O 0 0.4219692647457123
homeostasis O 1 0.8859848976135254
, O 0 0.006420088466256857
we O 0 0.004163131583482027
have O 0 0.004738682880997658
compared O 0 0.010454933159053326
the O 0 0.007865438237786293
resting O 0 0.2997935116291046
[ O 0 0.2858371436595917
Ca2 O 1 0.9812901616096497
+ O 0 0.2574288249015808
] O 0 0.02339089848101139
i O 0 0.0072136325761675835
, O 0 0.00447773328050971
the O 0 0.005018583033233881
amplitude O 0 0.016017494723200798
and O 0 0.005982164293527603
shape O 0 0.01871776580810547
of O 0 0.012346591800451279
depolarization O 1 0.9911708235740662
- O 1 0.9710978269577026
induced O 1 0.9983130693435669
Ca2 O 1 0.996566891670227
+ O 1 0.8830938339233398
transients O 1 0.7269338965415955
, O 0 0.007065825164318085
and O 0 0.003866983577609062
the O 0 0.004096733406186104
content O 0 0.007056872360408306
of O 0 0.0052461400628089905
ATP O 0 0.04041407257318497
- O 0 0.0371856614947319
driven O 0 0.03256652504205704
ion O 0 0.08935817331075668
pumps O 0 0.068913035094738
in O 0 0.01685320772230625
cultured O 1 0.8599004149436951
skeletal O 1 0.9945270419120789
muscle O 1 0.9960885047912598
cells O 0 0.49705246090888977
of O 0 0.011025689542293549
wild O 0 0.02786855772137642
- O 0 0.057047124952077866
type O 0 0.029354332014918327
and O 0 0.011383770033717155
DMPK O 1 0.9073147773742676
[ O 0 0.12930317223072052
- O 0 0.22747834026813507
/ O 1 0.6239405870437622
- O 0 0.31852850317955017
] O 0 0.18915247917175293
knockout O 1 0.7061987519264221
mice O 1 0.9283437728881836
. O 0 0.038859911262989044

In O 0 0.03257611021399498
vitro O 1 0.6016890406608582
- O 0 0.2999002933502197
differentiated O 1 0.7753775119781494
DMPK O 1 0.9639341235160828
[ O 0 0.2819637358188629
- O 0 0.3373091518878937
/ O 1 0.648770272731781
- O 0 0.20345447957515717
] O 0 0.10630936175584793
myotubes O 0 0.42542171478271484
exhibit O 0 0.025947026908397675
a O 0 0.013968326151371002
higher O 0 0.021246057003736496
resting O 0 0.19528545439243317
[ O 0 0.26853227615356445
Ca2 O 1 0.9864696264266968
+ O 0 0.2944210171699524
] O 0 0.023771777749061584
i O 0 0.00693409563973546
than O 0 0.0057678730227053165
do O 0 0.006744222715497017
wild O 0 0.015347208827733994
- O 0 0.031929753720760345
type O 0 0.037296246737241745
myotubes O 0 0.09522176533937454
because O 0 0.006646317895501852
of O 0 0.004370649345219135
an O 0 0.005521072074770927
altered O 0 0.01635541208088398
open O 0 0.010196120478212833
probability O 0 0.012483554892241955
of O 0 0.0067490763030946255
voltage O 0 0.02814461477100849
- O 0 0.03744649887084961
dependent O 0 0.10554330050945282
l O 1 0.570399820804596
- O 0 0.26414844393730164
type O 0 0.40774068236351013
Ca2 O 1 0.9584944248199463
+ O 0 0.12544092535972595
and O 0 0.020085489377379417
Na O 1 0.8115589618682861
+ O 0 0.1700960248708725
channels O 0 0.049092698842287064
. O 0 0.032422956079244614

The O 0 0.038444843143224716
mutant O 1 0.635294497013092
myotubes O 1 0.6127855777740479
exhibit O 0 0.038927339017391205
smaller O 0 0.020768897607922554
and O 0 0.011236404068768024
slower O 0 0.049962155520915985
Ca2 O 1 0.981404185295105
+ O 0 0.18564102053642273
responses O 0 0.04299267381429672
upon O 0 0.017012208700180054
triggering O 1 0.5270195603370667
by O 0 0.014682605862617493
acetylcholine O 1 0.6060085892677307
or O 0 0.014960036613047123
high O 0 0.020235102623701096
external O 0 0.03424366936087608
K O 0 0.09818870574235916
+ O 0 0.08628827333450317
. O 0 0.038041695952415466

In O 0 0.015505139715969563
addition O 0 0.013473224826157093
, O 0 0.006669850554317236
we O 0 0.004919176455587149
observed O 0 0.011188956908881664
that O 0 0.005510096903890371
these O 0 0.009001356549561024
Ca2 O 1 0.9830615520477295
+ O 1 0.5651675462722778
transients O 1 0.897803008556366
partially O 0 0.05070716142654419
result O 0 0.013437620364129543
from O 0 0.008184301666915417
an O 0 0.007002140395343304
influx O 0 0.031144212931394577
of O 0 0.010388609021902084
extracellular O 1 0.6278868913650513
Ca2 O 1 0.9808322191238403
+ O 0 0.06859614700078964
through O 0 0.014524231664836407
the O 0 0.01313572097569704
l O 0 0.2629300057888031
- O 0 0.24891184270381927
type O 0 0.4446735978126526
Ca2 O 1 0.9576667547225952
+ O 0 0.13814175128936768
channel O 0 0.06218336522579193
. O 0 0.03291972726583481

Neither O 0 0.02848859131336212
the O 0 0.0117125753313303
content O 0 0.015363351441919804
nor O 0 0.01236284151673317
the O 0 0.007938257418572903
activity O 0 0.015425523743033409
of O 0 0.011693218722939491
Na O 1 0.8507933616638184
+ O 1 0.5485737919807434
/ O 0 0.49358630180358887
K O 0 0.17073656618595123
+ O 0 0.44844740629196167
ATPase O 1 0.9028608202934265
and O 0 0.03293231502175331
sarcoplasmic O 1 0.9953639507293701
reticulum O 1 0.9890012741088867
Ca2 O 1 0.9864616990089417
+ O 1 0.7586045861244202
- O 0 0.23391710221767426
ATPase O 1 0.8802337050437927
are O 0 0.01529654674232006
affected O 0 0.049591392278671265
by O 0 0.020974474027752876
DMPK O 1 0.6634091138839722
absence O 0 0.0693427100777626
. O 0 0.04434749856591225

In O 0 0.01665211282670498
conclusion O 0 0.01705336384475231
, O 0 0.007492258679121733
our O 0 0.0071853469125926495
data O 0 0.008960111066699028
suggest O 0 0.01356587465852499
that O 0 0.007131834048777819
DMPK O 0 0.12765976786613464
is O 0 0.007563283666968346
involved O 0 0.010244263336062431
in O 0 0.007821489125490189
modulating O 0 0.09514129906892776
the O 0 0.007193378638476133
initial O 0 0.013497678562998772
events O 0 0.010670366697013378
of O 0 0.008733847178518772
excitation O 1 0.5375047326087952
- O 0 0.48212477564811707
contraction O 1 0.9319635033607483
coupling O 0 0.38911736011505127
in O 0 0.021152829751372337
skeletal O 1 0.9945348501205444
muscle O 1 0.9915717840194702
. O 0 0.02564403973519802
. O 0 0.03271147981286049

Constitutional O 0 0.17209948599338531
RB1 O 1 0.9857712984085083
- O 1 0.8103359937667847
gene O 1 0.9752535223960876
mutations O 1 0.9901683330535889
in O 0 0.02777695097029209
patients O 1 0.9913895726203918
with O 0 0.023754769936203957
isolated O 1 0.749893307685852
unilateral B-Disease 1 0.8688714504241943
retinoblastoma I-Disease 1 0.9907817244529724
. O 0 0.05250528082251549

In O 0 0.024729575961828232
most O 0 0.023311229422688484
patients O 1 0.9678493738174438
with O 0 0.01650557480752468
isolated O 1 0.7222082614898682
unilateral B-Disease 1 0.9486598372459412
retinoblastoma I-Disease 1 0.9986186027526855
, O 0 0.03209647908806801
tumor B-Disease 1 0.9972449541091919
development O 0 0.013631090521812439
is O 0 0.008671615272760391
initiated O 0 0.023402664810419083
by O 0 0.011951003223657608
somatic O 1 0.6697613596916199
inactivation O 0 0.48569759726524353
of O 0 0.01019772794097662
both O 0 0.01144377700984478
alleles O 0 0.4769693911075592
of O 0 0.013596951961517334
the O 0 0.022374635562300682
RB1 O 1 0.9890145659446716
gene O 1 0.8861634731292725
. O 0 0.05018239840865135

However O 0 0.017086144536733627
, O 0 0.0072559150867164135
some O 0 0.005575096700340509
of O 0 0.0060087088495492935
these O 0 0.009879776276648045
patients O 1 0.9935628175735474
can O 0 0.027265066280961037
transmit O 1 0.9600439667701721
retinoblastoma B-Disease 1 0.9982206225395203
predisposition O 1 0.9922806024551392
to O 0 0.01446943823248148
their O 0 0.019371826201677322
offspring O 0 0.4836876392364502
. O 0 0.035236671566963196

To O 0 0.01373974233865738
determine O 0 0.013709088787436485
the O 0 0.006628610193729401
frequency O 0 0.012849018909037113
and O 0 0.004844650160521269
nature O 0 0.008908133953809738
of O 0 0.007134981453418732
constitutional O 0 0.028309207409620285
RB1 O 1 0.9953956007957458
- O 1 0.8320093750953674
gene O 1 0.9904879927635193
mutations O 1 0.9897174835205078
in O 0 0.013701535761356354
patients O 1 0.9953171014785767
with O 0 0.012066562660038471
isolated O 1 0.8675646781921387
unilateral B-Disease 1 0.949039876461029
retinoblastoma I-Disease 1 0.9965863227844238
, O 0 0.008031963370740414
we O 0 0.005914440844208002
analyzed O 0 0.017330601811408997
DNA O 0 0.02931896783411503
from O 0 0.01395275816321373
peripheral O 1 0.986352801322937
blood O 1 0.9619314670562744
and O 0 0.012616326101124287
from O 0 0.03491096943616867
tumor B-Disease 1 0.9983629584312439
tissue O 1 0.9897393584251404
. O 0 0.05103302001953125

The O 0 0.02048562653362751
analysis O 0 0.02585778385400772
of O 0 0.01755586639046669
tumors B-Disease 1 0.9904492497444153
from O 0 0.013459229841828346
54 O 0 0.01880180463194847
( O 0 0.011958680115640163
71 O 0 0.01648285612463951
% O 0 0.010034731589257717
) O 0 0.007602058816701174
of O 0 0.006951157469302416
76 O 0 0.031085330992937088
informative O 0 0.06710752844810486
patients O 1 0.9845011234283447
showed O 0 0.021094901487231255
loss O 0 0.027241136878728867
of O 0 0.011004210449755192
constitutional O 0 0.04636009782552719
heterozygosity O 1 0.9927629828453064
( O 0 0.11902035772800446
LOH O 1 0.9921936988830566
) O 0 0.02453252114355564
at O 0 0.02621312625706196
intragenic O 1 0.7439984679222107
loci O 1 0.8328717947006226
. O 0 0.04622308537364006

Three O 0 0.021040145307779312
of O 0 0.017609288915991783
13 O 0 0.034461021423339844
uninformative O 1 0.9275022745132446
patients O 1 0.9773069620132446
had O 0 0.023639464750885963
constitutional O 0 0.04496238753199577
deletions O 0 0.4619477093219757
. O 0 0.046874117106199265

For O 0 0.020698146894574165
39 O 0 0.031671516597270966
randomly O 0 0.03729753941297531
selected O 0 0.026871809735894203
tumors B-Disease 1 0.9957793951034546
, O 0 0.013960225507616997
SSCP O 1 0.8816496133804321
, O 0 0.017636843025684357
hetero O 1 0.9798957109451294
- O 0 0.19103260338306427
duplex O 0 0.2483607679605484
analysis O 0 0.01880105584859848
, O 0 0.00923622865229845
sequencing O 0 0.021763358265161514
, O 0 0.00566446129232645
and O 0 0.004782318603247404
Southern O 0 0.011889634653925896
blot O 0 0.11545941233634949
analysis O 0 0.01232694648206234
were O 0 0.005155556835234165
used O 0 0.007167259231209755
to O 0 0.008886193856596947
identify O 0 0.03397765010595322
mutations O 1 0.8533434271812439
. O 0 0.0333215706050396

Mutations O 1 0.9434158205986023
were O 0 0.01758199743926525
detected O 0 0.04184458404779434
in O 0 0.009412660263478756
21 O 0 0.01446028333157301
( O 0 0.01238206960260868
91 O 0 0.019380098208785057
% O 0 0.011817117221653461
) O 0 0.010693923570215702
of O 0 0.009642313234508038
23 O 0 0.02864951640367508
tumors B-Disease 1 0.9932004809379578
with O 0 0.028023842722177505
LOH O 1 0.9878330230712891
. O 0 0.04907548055052757

In O 0 0.020402150228619576
6 O 0 0.020770363509655
( O 0 0.013283958658576012
38 O 0 0.01604476012289524
% O 0 0.009877112694084644
) O 0 0.0071589103899896145
of O 0 0.0063767931424081326
16 O 0 0.019741732627153397
tumors B-Disease 1 0.9974169731140137
without O 0 0.021345196291804314
LOH O 1 0.9930199980735779
, O 0 0.007872652262449265
one O 0 0.008836505934596062
mutation O 1 0.9049474596977234
was O 0 0.007220687344670296
detected O 0 0.030963681638240814
, O 0 0.003948710393160582
and O 0 0.0037125120870769024
in O 0 0.0047090849839150906
9 O 0 0.008371075615286827
( O 0 0.007497994229197502
56 O 0 0.010589087381958961
% O 0 0.007649156264960766
) O 0 0.006187106017023325
of O 0 0.0052400017157197
the O 0 0.009551654569804668
tumors B-Disease 1 0.997078537940979
without O 0 0.021665656939148903
LOH O 1 0.9943174719810486
, O 0 0.00959007628262043
both O 0 0.012066556140780449
mutations O 1 0.9074047207832336
were O 0 0.010973033495247364
found O 0 0.02072889544069767
. O 0 0.025820119306445122

Thus O 0 0.022554244846105576
, O 0 0.008055359125137329
a O 0 0.007099049165844917
total O 0 0.006792984437197447
of O 0 0.0063182283192873
45 O 0 0.013028360903263092
mutations O 1 0.7499570250511169
were O 0 0.006499756593257189
identified O 0 0.014278644695878029
in O 0 0.011300907470285892
tumors B-Disease 1 0.9972354769706726
of O 0 0.014304143376648426
36 O 0 0.08177543431520462
patients O 1 0.972873866558075
. O 0 0.03732001781463623

Thirty O 0 0.04033089429140091
- O 0 0.02520832233130932
nine O 0 0.01128016971051693
of O 0 0.0078091612085700035
the O 0 0.009378309361636639
mutations O 1 0.95790696144104
- O 0 0.027849577367305756
including O 0 0.008993903174996376
34 O 0 0.0145264295861125
small O 0 0.011869658716022968
mutations O 1 0.8539510369300842
, O 0 0.006501893978565931
2 O 0 0.009802387095987797
large O 0 0.009381446987390518
structural O 0 0.045469529926776886
alterations O 0 0.02498355507850647
, O 0 0.005263158585876226
and O 0 0.006371351890265942
hypermethylation O 1 0.9374686479568481
in O 0 0.009520470164716244
3 O 0 0.021827587857842445
tumors O 1 0.9976159334182739
- O 0 0.033312633633613586
were O 0 0.005595764610916376
not O 0 0.006230825092643499
detected O 0 0.021194880828261375
in O 0 0.006115974858403206
the O 0 0.007653293665498495
corresponding O 0 0.026350833475589752
peripheral O 1 0.9811828136444092
blood O 1 0.975104808807373
DNA O 0 0.28969690203666687
. O 0 0.03857798874378204

In O 0 0.0202566459774971
6 O 0 0.020348750054836273
( O 0 0.011896354146301746
17 O 0 0.011652444489300251
% O 0 0.007274152245372534
) O 0 0.0051642172038555145
of O 0 0.0038378776516765356
the O 0 0.005249522626399994
36 O 0 0.015263342298567295
patients O 1 0.91154545545578
, O 0 0.005953884683549404
a O 0 0.009777613915503025
mutation O 1 0.9498171210289001
was O 0 0.007433310616761446
detected O 0 0.02733103185892105
in O 0 0.005486316047608852
constitutional O 0 0.01007070578634739
DNA O 0 0.015872957184910774
, O 0 0.004336775746196508
and O 0 0.003312935819849372
1 O 0 0.005058200564235449
of O 0 0.0037584134843200445
these O 0 0.00563115393742919
mutations O 1 0.725999653339386
is O 0 0.00533543573692441
known O 0 0.006660334765911102
to O 0 0.0038870421703904867
be O 0 0.0043927328661084175
associated O 0 0.012101981788873672
with O 0 0.010614536702632904
reduced O 0 0.05001302435994148
expressivity O 1 0.9264786243438721
. O 0 0.038740139454603195

The O 0 0.01749725639820099
presence O 0 0.0184165071696043
of O 0 0.00822873692959547
a O 0 0.009658272378146648
constitutional O 0 0.017401915043592453
mutation O 1 0.9177463054656982
was O 0 0.006751394364982843
not O 0 0.0039413501508533955
associated O 0 0.007963161915540695
with O 0 0.004103310406208038
an O 0 0.005193611606955528
early O 0 0.009982689283788204
age O 0 0.014052404090762138
at O 0 0.013836639001965523
treatment O 1 0.6655063629150391
. O 0 0.028270622715353966

In O 0 0.028066912665963173
1 O 0 0.030822960659861565
patient O 1 0.8632966876029968
, O 0 0.019280051812529564
somatic O 1 0.9256377816200256
mosaicism O 1 0.9814715385437012
was O 0 0.01281440258026123
demonstrated O 0 0.0174401942640543
by O 0 0.008252214640378952
molecular O 0 0.01800432801246643
analysis O 0 0.009940631687641144
of O 0 0.006213014014065266
DNA O 0 0.02327708713710308
and O 0 0.008077999576926231
RNA O 0 0.057414792478084564
from O 0 0.01572427898645401
peripheral O 1 0.968048632144928
blood O 1 0.9271740317344666
. O 0 0.04161988943815231

In O 0 0.026142284274101257
2 O 0 0.02855200693011284
patients O 1 0.9171205163002014
without O 0 0.015072041191160679
a O 0 0.017060399055480957
detectable O 1 0.9543778300285339
mutation O 1 0.9922755360603333
in O 0 0.01813347637653351
peripheral O 1 0.9958447813987732
blood O 1 0.9841750264167786
, O 0 0.015568154864013195
mosaicism O 1 0.9866313338279724
was O 0 0.009443904273211956
suggested O 0 0.011682593263685703
because O 0 0.008175837807357311
1 O 0 0.007060682866722345
of O 0 0.006165598519146442
the O 0 0.01068936474621296
patients O 1 0.9968425035476685
showed O 1 0.8544577360153198
multifocal O 1 0.9997996687889099
tumors B-Disease 1 0.9993909597396851
and O 0 0.007537310477346182
the O 0 0.006438307464122772
other O 0 0.0064895544201135635
later O 0 0.009495717473328114
developed O 0 0.028256993740797043
bilateral B-Disease 0 0.055814873427152634
retinoblastoma I-Disease 1 0.9856633543968201
. O 0 0.04337339475750923

In O 0 0.014629458077251911
conclusion O 0 0.016604065895080566
, O 0 0.006579606793820858
our O 0 0.007405162323266268
results O 0 0.010367333889007568
emphasize O 0 0.012197981588542461
that O 0 0.004575480241328478
the O 0 0.005756435450166464
manifestation O 0 0.16362479329109192
and O 0 0.007436280604451895
transmissibility O 1 0.8945191502571106
of O 0 0.01046376209706068
retinoblastoma B-Disease 1 0.9826241135597229
depend O 0 0.01037931814789772
on O 0 0.0038204598240554333
the O 0 0.00399588281288743
nature O 0 0.005668214987963438
of O 0 0.0032159858383238316
the O 0 0.004060704726725817
first O 0 0.005796510726213455
mutation O 1 0.616328239440918
, O 0 0.004071454517543316
its O 0 0.0032053187023848295
time O 0 0.0033134915865957737
in O 0 0.0031737415120005608
development O 0 0.0041903103701770306
, O 0 0.002632940886542201
and O 0 0.002241668989881873
the O 0 0.0025312916841357946
number O 0 0.003385320771485567
and O 0 0.0033265179954469204
types O 0 0.007880952209234238
of O 0 0.0047575319185853004
cells O 0 0.2472797930240631
that O 0 0.0058297403156757355
are O 0 0.006417346186935902
affected O 0 0.02948516607284546
. O 0 0.012912800535559654
. O 0 0.02444327436387539

Hereditary B-Disease 1 0.992954671382904
deficiency I-Disease 1 0.9981074333190918
of I-Disease 0 0.014046618714928627
the I-Disease 0 0.011219639331102371
fifth I-Disease 0 0.018491283059120178
component I-Disease 0 0.021589500829577446
of I-Disease 0 0.010125215165317059
complement I-Disease 0 0.021251050755381584
in O 0 0.015031415037810802
man O 0 0.03332740440964699
. O 0 0.031214624643325806

I O 0 0.08034786581993103
. O 0 0.06140962988138199

Clinical O 1 0.8046916127204895
, O 0 0.023172996938228607
immunochemical O 0 0.32605743408203125
, O 0 0.012651939876377583
and O 0 0.01225732546299696
family O 0 0.02859409712255001
studies O 0 0.034674569964408875
. O 0 0.03304658085107803

The O 0 0.01840297318994999
first O 0 0.014496480114758015
recognized O 0 0.022341713309288025
human O 0 0.02767694741487503
kindred O 1 0.9215514063835144
with O 0 0.017849557101726532
hereditary B-Disease 1 0.9967408776283264
deficiency I-Disease 1 0.9992744326591492
of I-Disease 0 0.007530130445957184
the I-Disease 0 0.007095306646078825
fifth I-Disease 0 0.012371077202260494
component I-Disease 0 0.017093265429139137
of I-Disease 0 0.007454784587025642
complement I-Disease 0 0.023757528513669968
( O 0 0.018471434712409973
C5 O 0 0.42697960138320923
) O 0 0.014810740947723389
is O 0 0.013033922761678696
described O 0 0.027678731828927994
. O 0 0.028889555484056473

The O 0 0.02027508243918419
proband O 0 0.10019448399543762
, O 0 0.007432669401168823
a O 0 0.008106783032417297
20 O 0 0.00981700886040926
- O 0 0.01682039350271225
year O 0 0.0105537548661232
- O 0 0.02767852507531643
old O 0 0.018827082589268684
black O 0 0.037691593170166016
female O 0 0.11983032524585724
with O 0 0.1136634424328804
systemic B-Disease 1 0.9998980760574341
lupus I-Disease 1 0.9999830722808838
erythematosus I-Disease 1 0.9999374151229858
since O 0 0.18298062682151794
age O 0 0.08986343443393707
11 O 0 0.021109241992235184
, O 0 0.014422141015529633
lacked O 0 0.2291271984577179
serum O 1 0.9948076605796814
hemolytic O 1 0.9995433688163757
complement O 0 0.1516711264848709
activity O 0 0.026229700073599815
, O 0 0.011266169138252735
even O 0 0.014654816128313541
during O 0 0.02574251778423786
remission O 1 0.9797331094741821
. O 0 0.03969233110547066

C5 O 1 0.765727162361145
was O 0 0.02686230093240738
undetectable O 0 0.21110899746418
in O 0 0.012895282357931137
her O 0 0.016096793115139008
serum O 0 0.4132327735424042
by O 0 0.012057408690452576
both O 0 0.01637881062924862
immunodiffusion O 1 0.6987034678459167
and O 0 0.03275173902511597
hemolytic O 1 0.9988453388214111
assays O 1 0.6862069964408875
. O 0 0.05388328433036804

Other O 0 0.01711760088801384
complement O 0 0.02148984931409359
components O 0 0.014532643370330334
were O 0 0.0078436816111207
normal O 0 0.02171708084642887
during O 0 0.01732168160378933
remission O 1 0.991174042224884
of O 0 0.021137172356247902
lupus O 1 0.9997578263282776
, O 0 0.014248019084334373
but O 0 0.013038266450166702
C1 O 1 0.9442110657691956
, O 0 0.012802024371922016
C4 O 0 0.12339712679386139
, O 0 0.011724980548024178
C2 O 1 0.7114070653915405
, O 0 0.009848126210272312
and O 0 0.01119648851454258
C3 O 1 0.7458614706993103
levels O 0 0.0344405435025692
fell O 0 0.037805307656526566
during O 0 0.04018477350473404
exacerbations O 1 0.9657688140869141
. O 0 0.05371708795428276

A O 0 0.028766654431819916
younger O 0 0.0380888506770134
half O 0 0.018850168213248253
- O 0 0.029416430741548538
sister O 0 0.019621262326836586
, O 0 0.006258937530219555
who O 0 0.006118436343967915
had O 0 0.006282955873757601
no O 0 0.0078096273355185986
underlying O 1 0.6049329042434692
disease O 1 0.9994345307350159
, O 0 0.007060207426548004
was O 0 0.006189885549247265
also O 0 0.005205423105508089
found O 0 0.00790815893560648
to O 0 0.008384441025555134
lack O 0 0.03349025920033455
immunochemically O 1 0.9241374135017395
detectable O 1 0.9625320434570312
C5 O 1 0.9481810331344604
. O 0 0.041438449174165726

By O 0 0.05382834002375603
hemolytic O 1 0.9984488487243652
assay O 0 0.2425534874200821
, O 0 0.011852260679006577
she O 0 0.009359404444694519
exhibited O 0 0.015201120637357235
1 O 0 0.009596590884029865
- O 0 0.014649453572928905
2 O 0 0.008199981413781643
% O 0 0.006168729159981012
of O 0 0.004770803265273571
the O 0 0.006650411523878574
normal O 0 0.027274463325738907
serum O 1 0.7636610865592957
C5 O 1 0.601262092590332
level O 0 0.009915818460285664
and O 0 0.005940517410635948
normal O 0 0.014162976294755936
concentrations O 0 0.016186924651265144
of O 0 0.0059206364676356316
other O 0 0.006810530088841915
complement O 0 0.023017024621367455
components O 0 0.023007705807685852
. O 0 0.02458815649151802

C5 O 1 0.5574197173118591
levels O 0 0.030186275020241737
of O 0 0.008248411118984222
other O 0 0.005308505147695541
family O 0 0.0089921485632658
members O 0 0.0052283331751823425
were O 0 0.003289889544248581
either O 0 0.005716093350201845
normal O 0 0.009338480420410633
or O 0 0.004765833728015423
approximately O 0 0.006718277931213379
half O 0 0.00790918804705143
- O 0 0.018377255648374557
normal O 0 0.015191901475191116
, O 0 0.006402662023901939
consistent O 0 0.015300828032195568
with O 0 0.013726268894970417
autosomal O 1 0.9984820485115051
codominant O 1 0.9746300578117371
inheritance O 0 0.31804341077804565
of O 0 0.012626400217413902
the O 0 0.017848294228315353
gene O 1 0.9382733106613159
determining O 1 0.5165209770202637
C5 B-Disease 1 0.990484356880188
deficiency I-Disease 1 0.9987689852714539
. O 0 0.07359515875577927

Normal O 1 0.9205166101455688
hemolytic O 1 0.998775064945221
titers O 1 0.9128961563110352
were O 0 0.014357199892401695
restored O 0 0.017016179859638214
to O 0 0.00886222068220377
both O 0 0.012824817560613155
homozygous O 1 0.9272592067718506
C5 B-Disease 1 0.9847884178161621
- I-Disease 1 0.8067615628242493
deficient I-Disease 1 0.9840975403785706
( O 0 0.027784176170825958
C5D B-Disease 1 0.8883396983146667
) O 0 0.015676062554121017
sera O 0 0.025286894291639328
by O 0 0.007809050381183624
addition O 0 0.00968137476593256
of O 0 0.008638417348265648
highly O 0 0.024643486365675926
purified O 0 0.17801620066165924
human O 0 0.08863894641399384
C5 O 1 0.8937579393386841
. O 0 0.03599110618233681

In O 0 0.02734951116144657
specific O 0 0.03675326704978943
C5 O 1 0.967406153678894
titrations O 1 0.9648781418800354
, O 0 0.010326026007533073
however O 0 0.007958045229315758
, O 0 0.004276025574654341
it O 0 0.003414464183151722
was O 0 0.003866238286718726
noted O 0 0.005092347972095013
that O 0 0.0033639015164226294
when O 0 0.004765664227306843
limited O 0 0.006783895194530487
amounts O 0 0.00913194753229618
of O 0 0.005852135829627514
C5 O 0 0.17770171165466309
were O 0 0.005678734742105007
assayed O 0 0.021812232211232185
in O 0 0.005458598956465721
the O 0 0.005807331297546625
presence O 0 0.011511805467307568
of O 0 0.007574315648525953
low O 0 0.022372785955667496
dilutions O 0 0.3823200762271881
of O 0 0.011061283759772778
either O 0 0.018060924485325813
C5D B-Disease 1 0.968340277671814
serum O 1 0.8397701978683472
, O 0 0.01037156768143177
curving O 0 0.037910886108875275
rather O 0 0.011344818398356438
than O 0 0.01134668942540884
linear O 0 0.04114177078008652
dose O 1 0.8377454280853271
- O 0 0.053232789039611816
response O 0 0.023190056905150414
plots O 0 0.017571771517395973
were O 0 0.0067022149451076984
consistently O 0 0.012104501016438007
obtained O 0 0.009730193763971329
, O 0 0.008012675680220127
suggesting O 0 0.023143984377384186
some O 0 0.01496340986341238
inhibitory O 0 0.1481979936361313
effect O 0 0.052765924483537674
. O 0 0.03622106835246086

Further O 0 0.028970418497920036
studies O 0 0.021575933322310448
suggested O 0 0.017075711861252785
that O 0 0.009077373892068863
low O 0 0.024642400443553925
dilutions O 1 0.6292889714241028
of O 0 0.01539447158575058
C5D B-Disease 1 0.9907463788986206
serum O 1 0.9035881757736206
contain O 0 0.019618505612015724
a O 0 0.010750927962362766
factor O 0 0.02638090029358864
( O 0 0.010249433107674122
or O 0 0.007688658777624369
factors O 0 0.013084113597869873
) O 0 0.007898923940956593
interfering O 0 0.014717381447553635
at O 0 0.005882303696125746
some O 0 0.005312139634042978
step O 0 0.010625855065882206
in O 0 0.007644542958587408
the O 0 0.011014355346560478
hemolytic O 1 0.999262273311615
assay O 0 0.1276085376739502
of O 0 0.012148967012763023
C5 O 1 0.6277071237564087
, O 0 0.007682519964873791
rather O 0 0.008889531716704369
than O 0 0.00806020013988018
a O 0 0.01098897960036993
true O 0 0.027406511828303337
C5 O 1 0.9524564743041992
inhibitor O 1 0.9380844235420227
or O 0 0.03244616463780403
inactivator O 1 0.6979275345802307
. O 0 0.041079260408878326

Of O 0 0.0199067834764719
clinical O 0 0.11662105470895767
interest O 0 0.01285728719085455
are O 0 0.006591291632503271
( O 0 0.008523613214492798
a O 0 0.006565857212990522
) O 0 0.007314689457416534
the O 0 0.006068648304790258
documentation O 0 0.015066809952259064
of O 0 0.013871674425899982
membranous O 1 0.9982889294624329
glomerulonephritis B-Disease 1 0.9994882345199585
, O 0 0.08064381033182144
vasculitis B-Disease 1 0.999225378036499
, O 0 0.01617206260561943
and O 0 0.01712953671813011
arthritis B-Disease 1 0.9998252987861633
in O 0 0.008014854043722153
an O 0 0.0066761719062924385
individual O 0 0.013550965115427971
lacking O 0 0.08628497272729874
C5 O 1 0.802007794380188
( O 0 0.011560654267668724
and O 0 0.005075243301689625
its O 0 0.007031936664134264
biologic O 0 0.2540402412414551
functions O 0 0.009663465432822704
) O 0 0.007116440683603287
, O 0 0.004406308755278587
and O 0 0.0046704551205039024
( O 0 0.009484724141657352
b O 0 0.015122488141059875
) O 0 0.00765279121696949
a O 0 0.0075357696041464806
remarkable O 0 0.018357131630182266
propensity O 1 0.7258820533752441
to O 0 0.014388649724423885
bacterial B-Disease 1 0.9992145299911499
infections I-Disease 1 0.9997214674949646
in O 0 0.00885735359042883
the O 0 0.00912919919937849
proband O 0 0.3788304030895233
, O 0 0.006553825456649065
even O 0 0.0061802249401807785
during O 0 0.00828507635742426
periods O 0 0.011926226317882538
of O 0 0.007337944582104683
low O 0 0.02046630159020424
- O 0 0.06107710301876068
dose O 1 0.6627453565597534
or O 0 0.011715900152921677
alternate O 0 0.020887119695544243
- O 0 0.05834907665848732
day O 0 0.03504258766770363
corticosteroid O 1 0.9829782843589783
therapy O 1 0.9696128964424133
. O 0 0.04671148955821991

Other O 0 0.015605995431542397
observations O 0 0.019107500091195107
indicate O 0 0.0134154437109828
that O 0 0.005163400433957577
the O 0 0.007156876847147942
C5D B-Disease 0 0.4933299124240875
state O 0 0.007474745158106089
is O 0 0.006108805071562529
compatible O 0 0.011132647283375263
with O 0 0.007074522785842419
normal O 0 0.04133690521121025
coagulation O 1 0.9266436100006104
function O 0 0.01265622302889824
and O 0 0.0043109566904604435
the O 0 0.004455116577446461
capacity O 0 0.007476089987903833
to O 0 0.005678172223269939
mount O 0 0.02120339870452881
a O 0 0.02336583472788334
neutrophilic O 1 0.995329737663269
leukocytosis O 1 0.9958904981613159
during O 1 0.5519100427627563
pyogenic B-Disease 1 0.9982581734657288
infection I-Disease 1 0.999110996723175
. O 0 0.03614111989736557
. O 0 0.04190095514059067

Susceptibility O 1 0.98634934425354
to O 0 0.062295738607645035
ankylosing B-Disease 1 0.9993626475334167
spondylitis I-Disease 1 0.9992006421089172
in O 0 0.021259939298033714
twins O 0 0.47790807485580444
: O 0 0.012342091649770737
the O 0 0.00729369604960084
role O 0 0.011656410060822964
of O 0 0.008772273547947407
genes O 0 0.4029090404510498
, O 0 0.01145356148481369
HLA O 1 0.9857088327407837
, O 0 0.008167014457285404
and O 0 0.007371151354163885
the O 0 0.010940148495137691
environment O 0 0.02616887167096138
. O 0 0.025349989533424377

OBJECTIVE O 0 0.03198911249637604
To O 0 0.010630602017045021
determine O 0 0.012689060531556606
the O 0 0.008423158898949623
relative O 0 0.015845295041799545
effects O 0 0.03229081630706787
of O 0 0.006752312183380127
genetic O 1 0.5906558036804199
and O 0 0.008537503890693188
environmental O 0 0.02133163809776306
factors O 0 0.021495215594768524
in O 0 0.012639245949685574
susceptibility O 1 0.9932627081871033
to O 0 0.06465951353311539
ankylosing B-Disease 1 0.999767005443573
spondylitis I-Disease 1 0.9997896552085876
( O 0 0.04957076534628868
AS B-Disease 0 0.02058263309299946
) O 0 0.02078736014664173
. O 0 0.024760065600275993

METHODS O 0 0.0368838794529438
Twins O 0 0.06268310546875
with O 0 0.00753058772534132
AS B-Disease 0 0.007208589930087328
were O 0 0.0042778002098202705
identified O 0 0.008605741895735264
from O 0 0.005458161700516939
the O 0 0.006452976725995541
Royal O 0 0.017253577709197998
National O 0 0.026316622272133827
Hospital O 1 0.9799525141716003
for O 0 0.04506342113018036
Rheumatic B-Disease 1 0.9997697472572327
Diseases I-Disease 1 0.9996228218078613
database O 1 0.6111407279968262
. O 0 0.05223189294338226

Clinical O 1 0.5159453749656677
and O 0 0.020372234284877777
radiographic O 1 0.7908889055252075
examinations O 0 0.03255482763051987
were O 0 0.007292621769011021
performed O 0 0.01006891019642353
to O 0 0.006208646576851606
establish O 0 0.015768922865390778
diagnoses O 1 0.984327495098114
, O 0 0.01063035149127245
and O 0 0.01574644073843956
disease O 1 0.999832272529602
severity O 1 0.9868978261947632
was O 0 0.010144985280930996
assessed O 0 0.015881286934018135
using O 0 0.007921185344457626
a O 0 0.007464415393769741
combination O 0 0.015959899872541428
of O 0 0.008079956285655499
validated O 0 0.025874348357319832
scoring O 0 0.022829020395874977
systems O 0 0.034809622913599014
. O 0 0.029883388429880142

HLA O 1 0.9751020669937134
typing O 0 0.19926495850086212
for O 0 0.027656087651848793
HLA O 1 0.9929293990135193
- O 0 0.40609171986579895
B27 O 1 0.8012750744819641
, O 0 0.02299952693283558
HLA O 1 0.993166983127594
- O 0 0.2527864873409271
B60 O 1 0.5295668840408325
, O 0 0.013061941601336002
and O 0 0.013338225893676281
HLA O 1 0.9934430122375488
- O 0 0.4956493675708771
DR1 O 1 0.9461019039154053
was O 0 0.013003550469875336
performed O 0 0.015719657763838768
by O 0 0.013688873499631882
polymerase O 0 0.21431908011436462
chain O 0 0.040160171687603
reaction O 0 0.021076897159218788
with O 0 0.007620968855917454
sequence O 0 0.016301047056913376
- O 0 0.019034385681152344
specific O 0 0.01187513954937458
primers O 0 0.04074246436357498
, O 0 0.007325818762183189
and O 0 0.007440734189003706
zygosity O 0 0.08185631036758423
was O 0 0.010923732072114944
assessed O 0 0.025594165548682213
using O 0 0.0234183631837368
microsatellite O 1 0.8728532195091248
markers O 0 0.12884919345378876
. O 0 0.043419159948825836

Genetic O 0 0.4102376699447632
and O 0 0.012650146149098873
environmental O 0 0.02027321793138981
variance O 0 0.02166295051574707
components O 0 0.011124074459075928
were O 0 0.00439048558473587
assessed O 0 0.00939097162336111
with O 0 0.004190374165773392
the O 0 0.004376253578811884
program O 0 0.008829910308122635
Mx O 0 0.1828162521123886
, O 0 0.004021849948912859
using O 0 0.004432549234479666
data O 0 0.004132934380322695
from O 0 0.003238092642277479
this O 0 0.0032034728210419416
and O 0 0.0027565208729356527
previous O 0 0.006073556840419769
studies O 0 0.008346355520188808
of O 0 0.006588594522327185
twins O 0 0.0419631265103817
with O 0 0.008964714594185352
AS B-Disease 0 0.016013549640774727
. O 0 0.0266171395778656

RESULTS O 0 0.03813581168651581
Six O 0 0.01680608093738556
of O 0 0.012288075871765614
8 O 0 0.023231707513332367
monozygotic O 1 0.9261903762817383
( O 0 0.032195791602134705
MZ O 1 0.9855270385742188
) O 0 0.02083485759794712
twin O 0 0.14196519553661346
pairs O 0 0.03059045597910881
were O 0 0.012585535645484924
disease O 1 0.9993294477462769
concordant O 1 0.8316768407821655
, O 0 0.009053416550159454
compared O 0 0.012914562597870827
with O 0 0.006015561055392027
4 O 0 0.0088124331086874
of O 0 0.00587012805044651
15 O 0 0.01432557962834835
B27 O 0 0.3861091732978821
- O 0 0.07349897176027298
positive O 0 0.049318935722112656
dizygotic O 1 0.9761966466903687
( O 0 0.03313124552369118
DZ O 1 0.9463604092597961
) O 0 0.019412580877542496
twin O 0 0.0510648712515831
pairs O 0 0.022643737494945526
( O 0 0.013032137416303158
27 O 0 0.011460410431027412
% O 0 0.007953871041536331
) O 0 0.005768769886344671
and O 0 0.003739579813554883
4 O 0 0.006027423311024904
of O 0 0.005273729097098112
32 O 0 0.016931412741541862
DZ O 1 0.8858046531677246
twin O 0 0.10807116329669952
pairs O 0 0.022342942655086517
overall O 0 0.013901046477258205
( O 0 0.010239966213703156
12 O 0 0.00817531906068325
. O 0 0.005827457644045353
5 O 0 0.011815013363957405
% O 0 0.013184941373765469
) O 0 0.016242602840065956
. O 0 0.02138740010559559

Nonsignificant O 1 0.8183304667472839
increases O 0 0.03908983990550041
in O 0 0.010844063945114613
similarity O 0 0.017502158880233765
with O 0 0.0059392498806118965
regard O 0 0.009705236181616783
to O 0 0.0058738719671964645
age O 0 0.016811732202768326
at O 0 0.01967701129615307
disease O 1 0.9998158812522888
onset O 1 0.9980302453041077
and O 0 0.0052730608731508255
all O 0 0.003981203772127628
of O 0 0.005138779524713755
the O 0 0.014643282629549503
disease O 1 0.9998588562011719
severity O 1 0.9957396984100342
scores O 0 0.030845055356621742
assessed O 0 0.02247627079486847
were O 0 0.007391904015094042
noted O 0 0.012721911072731018
in O 0 0.015497935935854912
disease O 1 0.9995935559272766
- O 1 0.9059990644454956
concordant O 1 0.9886366724967957
MZ O 1 0.9971917271614075
twins O 1 0.8225576281547546
compared O 0 0.04074745252728462
with O 0 0.03003619983792305
concordant O 1 0.9434903860092163
DZ O 1 0.9774873852729797
twins O 1 0.6888914704322815
. O 0 0.06003984808921814

HLA O 1 0.9858304858207703
- O 0 0.1835586428642273
B27 O 0 0.29513826966285706
and O 0 0.0138558279722929
B60 O 0 0.11573590338230133
were O 0 0.007016697432845831
associated O 0 0.010890872217714787
with O 0 0.00619678245857358
the O 0 0.008522424846887589
disease O 1 0.9994246959686279
in O 0 0.00860048271715641
probands O 1 0.5463994741439819
, O 0 0.004839366301894188
and O 0 0.003807097440585494
the O 0 0.004906562622636557
rate O 0 0.011183344759047031
of O 0 0.008375088684260845
disease O 1 0.9996461868286133
concordance O 1 0.5551711916923523
was O 0 0.010190943256020546
significantly O 0 0.0473383367061615
increased O 0 0.017774686217308044
among O 0 0.015413721092045307
DZ O 1 0.9290663599967957
twin O 0 0.11066355556249619
pairs O 0 0.016080226749181747
in O 0 0.005479518789798021
which O 0 0.005010793451219797
the O 0 0.005310345906764269
co O 0 0.019775720313191414
- O 0 0.04226277768611908
twin O 0 0.038009680807590485
was O 0 0.00785009004175663
positive O 0 0.012818909250199795
for O 0 0.007102619856595993
both O 0 0.011518296785652637
B27 O 0 0.21465003490447998
and O 0 0.020639963448047638
DR1 O 1 0.931871771812439
. O 0 0.0437525138258934

Additive O 1 0.5366421937942505
genetic O 1 0.7749904990196228
effects O 0 0.11706189811229706
were O 0 0.008160303346812725
estimated O 0 0.013411038555204868
to O 0 0.005986029747873545
contribute O 0 0.015840692445635796
97 O 0 0.017195554450154305
% O 0 0.010688673704862595
of O 0 0.0062009659595787525
the O 0 0.010033168829977512
population O 0 0.024116946384310722
variance O 0 0.05142514035105705
. O 0 0.03181609883904457

CONCLUSION O 0 0.05853961780667305
Susceptibility O 1 0.9170790910720825
to O 0 0.009121396578848362
AS B-Disease 0 0.00860811397433281
is O 0 0.007439145818352699
largely O 0 0.012947836890816689
genetically O 0 0.1085481271147728
determined O 0 0.010705467313528061
, O 0 0.00499067734926939
and O 0 0.003931950777769089
the O 0 0.005466803442686796
environmental O 0 0.015129626728594303
trigger O 0 0.4686926603317261
for O 0 0.007317716255784035
the O 0 0.012635604478418827
disease O 1 0.9991769194602966
is O 0 0.016099298372864723
probably O 0 0.029776886105537415
ubiquitous O 0 0.15965139865875244
. O 0 0.034193240106105804

HLA O 1 0.978023111820221
- O 0 0.13524016737937927
B27 O 0 0.1374150514602661
accounts O 0 0.019418012350797653
for O 0 0.008152835071086884
a O 0 0.009723543189466
minority O 0 0.01615702547132969
of O 0 0.006893293000757694
the O 0 0.008694296702742577
overall O 0 0.025582602247595787
genetic O 1 0.9628003835678101
susceptibility O 1 0.9866329431533813
to O 0 0.011705772951245308
AS B-Disease 0 0.019060321152210236
. O 0 0.026384269818663597

Cell O 0 0.33290407061576843
cycle O 0 0.08885873109102249
- O 0 0.06986253708600998
dependent O 0 0.06003805994987488
colocalization O 0 0.35413658618927
of O 0 0.017390700057148933
BARD1 O 1 0.8030146956443787
and O 0 0.017504192888736725
BRCA1 O 1 0.992382824420929
proteins O 0 0.045740410685539246
in O 0 0.015454546548426151
discrete O 0 0.03860018774867058
nuclear O 0 0.03139869496226311
domains O 0 0.05516936257481575
. O 0 0.03232714906334877

Germ O 1 0.8151721358299255
- O 0 0.07535360753536224
line O 0 0.03787674754858017
mutations O 0 0.4933606684207916
of O 0 0.012646139599382877
the O 0 0.02016916126012802
BRCA1 O 1 0.9988470077514648
gene O 1 0.9904183745384216
predispose O 1 0.9929949641227722
women O 0 0.028962168842554092
to O 0 0.010754148475825787
early O 0 0.024155128747224808
- O 1 0.937794029712677
onset O 1 0.9996789693832397
breast B-Disease 1 0.9999006986618042
and I-Disease 1 0.8402358293533325
ovarian I-Disease 1 0.9999765157699585
cancer I-Disease 1 0.9998121857643127
by O 0 0.017950644716620445
compromising O 0 0.2939607501029968
the O 0 0.015515522100031376
genes O 1 0.9502176642417908
presumptive O 1 0.9485332369804382
function O 0 0.035139136016368866
as O 0 0.013356650248169899
a O 0 0.037415511906147
tumor B-Disease 1 0.9984209537506104
suppressor O 1 0.9936949610710144
. O 0 0.0535820797085762

Although O 0 0.023771727457642555
the O 0 0.013868570327758789
biochemical O 0 0.04593480005860329
properties O 0 0.016745904460549355
of O 0 0.0117950439453125
BRCA1 O 1 0.9976632595062256
polypeptides O 0 0.28859391808509827
are O 0 0.005795730277895927
not O 0 0.0048241401091217995
understood O 0 0.009625301696360111
, O 0 0.004068951588124037
their O 0 0.0047677140682935715
expression O 0 0.01762833632528782
pattern O 0 0.019388968124985695
and O 0 0.006868086289614439
subcellular O 0 0.042244523763656616
localization O 0 0.027930062264204025
suggest O 0 0.01240535732358694
a O 0 0.007778357248753309
role O 0 0.012108903378248215
in O 0 0.010054636746644974
cell O 0 0.18923205137252808
- O 0 0.10201770812273026
cycle O 0 0.08117666095495224
regulation O 0 0.054785702377557755
. O 0 0.03734372928738594

When O 0 0.04204392805695534
resting O 0 0.3186177611351013
cells O 0 0.4683157205581665
are O 0 0.009412300772964954
induced O 1 0.9175747632980347
to O 0 0.006475341506302357
proliferate O 0 0.03676578402519226
, O 0 0.0043120235204696655
the O 0 0.0045939283445477486
steady O 0 0.011532910168170929
- O 0 0.013713745400309563
state O 0 0.006918722297996283
levels O 0 0.011699370108544827
of O 0 0.007609127555042505
BRCA1 O 1 0.9940339922904968
increase O 0 0.014269278384745121
in O 0 0.007144916336983442
late O 0 0.01487200241535902
G1 O 0 0.42709314823150635
and O 0 0.00691330898553133
reach O 0 0.012438501231372356
a O 0 0.00958014465868473
maximum O 0 0.017129752784967422
during O 0 0.02204306051135063
S O 0 0.066293865442276
phase O 0 0.05450473725795746
. O 0 0.03821722790598869

Moreover O 0 0.046001285314559937
, O 0 0.013047848828136921
in O 0 0.014387223869562149
S O 0 0.1630699783563614
phase O 0 0.05851619318127632
cells O 1 0.6658735871315002
, O 0 0.018485506996512413
BRCA1 O 1 0.9950705766677856
polypeptides O 0 0.34329551458358765
are O 0 0.011781505309045315
hyperphosphorylated O 0 0.35792016983032227
and O 0 0.010391829535365105
accumulate O 0 0.03582575544714928
into O 0 0.015488450415432453
discrete O 0 0.04101569578051567
subnuclear O 1 0.6893839240074158
foci O 1 0.7477471232414246
termed O 0 0.3798072040081024
" O 0 0.0332346111536026
BRCA1 O 1 0.994186282157898
nuclear O 0 0.04511629417538643
dots O 0 0.20637477934360504
. O 0 0.04030260816216469

" O 0 0.053393181413412094
BRCA1 O 1 0.9928470253944397
associates O 0 0.045895956456661224
in O 0 0.015721498057246208
vivo O 0 0.05085710808634758
with O 0 0.010912940837442875
a O 0 0.014867286197841167
structurally O 0 0.13795647025108337
related O 0 0.04828376695513725
protein O 0 0.3181515336036682
termed O 0 0.3313775062561035
BARD1 O 1 0.9285866022109985
. O 0 0.04130985215306282

Here O 0 0.013888226822018623
we O 0 0.007049094419926405
show O 0 0.007909109815955162
that O 0 0.004405185580253601
the O 0 0.004819003399461508
steady O 0 0.01304900273680687
- O 0 0.015444515272974968
state O 0 0.007953023537993431
levels O 0 0.011400509625673294
of O 0 0.006877930834889412
BARD1 O 0 0.3132570683956146
, O 0 0.005948479752987623
unlike O 0 0.010251518338918686
those O 0 0.005400169640779495
of O 0 0.007821658626198769
BRCA1 O 1 0.9969480633735657
, O 0 0.008165898732841015
remain O 0 0.01346662174910307
relatively O 0 0.018902253359556198
constant O 0 0.028956042602658272
during O 0 0.028943877667188644
cell O 0 0.1665596067905426
cycle O 0 0.3766370117664337
progression O 1 0.9341988563537598
. O 0 0.04759930819272995

However O 0 0.030415747314691544
, O 0 0.019840480759739876
immunostaining O 0 0.37926045060157776
revealed O 0 0.027160203084349632
that O 0 0.01225731335580349
BARD1 O 1 0.7881166934967041
resides O 0 0.04081801325082779
within O 0 0.020287612453103065
BRCA1 O 1 0.9922183752059937
nuclear O 0 0.025134457275271416
dots O 0 0.09611248224973679
during O 0 0.015028661116957664
S O 0 0.04118378460407257
phase O 0 0.0148171903565526
of O 0 0.005076834931969643
the O 0 0.006346458103507757
cell O 0 0.037911899387836456
cycle O 0 0.020917406305670738
, O 0 0.005337212700396776
but O 0 0.00430336594581604
not O 0 0.004444921854883432
during O 0 0.009695465676486492
the O 0 0.012674990110099316
G1 O 1 0.8475772142410278
phase O 0 0.05810488760471344
. O 0 0.040010690689086914

Nevertheless O 0 0.0503457635641098
, O 0 0.01978745125234127
BARD1 O 1 0.6965948939323425
polypeptides O 0 0.10994237661361694
are O 0 0.007081693969666958
found O 0 0.007620117161422968
exclusively O 0 0.007915817201137543
in O 0 0.003724619746208191
the O 0 0.003930714912712574
nuclear O 0 0.00702045951038599
fractions O 0 0.009392949752509594
of O 0 0.004806628450751305
both O 0 0.007317698560655117
G1 O 1 0.6388985514640808
- O 0 0.02582836151123047
and O 0 0.010074053891003132
S O 0 0.24478939175605774
- O 0 0.14939124882221222
phase O 0 0.09771725535392761
cells O 0 0.3637765049934387
. O 0 0.04244266450405121

Therefore O 0 0.03339041396975517
, O 0 0.017585884779691696
progression O 0 0.4809841215610504
to O 0 0.010442967526614666
S O 0 0.04791618883609772
phase O 0 0.022117270156741142
is O 0 0.00812913291156292
accompanied O 0 0.011939679272472858
by O 0 0.007154465187340975
the O 0 0.007888467982411385
aggregation O 0 0.028907058760523796
of O 0 0.009715300984680653
nuclear O 0 0.024674542248249054
BARD1 O 1 0.5915282964706421
polypeptides O 0 0.25781765580177307
into O 0 0.03856159746646881
BRCA1 O 1 0.9867202639579773
nuclear O 0 0.05440348759293556
dots O 0 0.15742704272270203
. O 0 0.04291153699159622

This O 0 0.02455879934132099
cell O 0 0.09421652555465698
cycle O 0 0.0826861634850502
- O 0 0.06922832131385803
dependent O 0 0.050898369401693344
colocalization O 0 0.1407112181186676
of O 0 0.015371921472251415
BARD1 O 1 0.8226203918457031
and O 0 0.01333305612206459
BRCA1 O 1 0.9945875406265259
indicates O 0 0.026001831516623497
a O 0 0.009186617098748684
role O 0 0.012196407653391361
for O 0 0.008949777111411095
BARD1 O 1 0.8750941753387451
in O 0 0.02512897364795208
BRCA1 O 1 0.9990612864494324
- O 1 0.9730761051177979
mediated O 1 0.9902992248535156
tumor B-Disease 1 0.9988850951194763
suppression O 1 0.9000303745269775
. O 0 0.056724537163972855

Ethnic O 0 0.049749474972486496
differences O 0 0.029409945011138916
in O 0 0.014463190920650959
the O 0 0.01764925941824913
HFE O 1 0.9742587208747864
codon O 1 0.609164834022522
282 O 0 0.36161985993385315
( O 0 0.06919831782579422
Cys O 1 0.9788020849227905
/ O 1 0.8556625843048096
Tyr O 1 0.9578275680541992
) O 0 0.04948695749044418
polymorphism O 0 0.14792947471141815
. O 0 0.04986640065908432

Recent O 0 0.04521971568465233
studies O 0 0.028474418446421623
have O 0 0.011607133783400059
shown O 0 0.01767159439623356
that O 0 0.013940599747002125
hereditary B-Disease 1 0.9986897110939026
hemochromatosis I-Disease 1 0.9998931884765625
( O 0 0.3766801357269287
HH B-Disease 1 0.9970266222953796
) O 0 0.01229230035096407
is O 0 0.006725582294166088
likely O 0 0.009424770250916481
to O 0 0.004170682281255722
be O 0 0.004906178452074528
caused O 0 0.02723633125424385
by O 0 0.0074396212585270405
homozygosity O 0 0.11875329911708832
for O 0 0.0072749024257063866
a O 0 0.012684844434261322
Cys282Tyr O 1 0.8810115456581116
mutation O 1 0.9382582902908325
in O 0 0.012185095809400082
the O 0 0.016116002574563026
HFE O 1 0.9879249334335327
gene O 1 0.8212366700172424
located O 0 0.026941774412989616
4 O 0 0.026762187480926514
. O 0 0.028002003207802773

5 O 0 0.08685671538114548
Mb O 1 0.6203311681747437
telomeric O 1 0.8229186534881592
to O 0 0.035539500415325165
HLA O 1 0.9629644751548767
- O 0 0.07028867304325104
A O 0 0.04157485067844391
. O 0 0.043432123959064484

Population O 0 0.03449838608503342
studies O 0 0.017569415271282196
of O 0 0.007905488833785057
this O 0 0.00779758021235466
polymorphism O 0 0.06479040533304214
are O 0 0.0047134943306446075
facilitated O 0 0.01169858779758215
by O 0 0.004599477630108595
the O 0 0.003956455737352371
fact O 0 0.00618617981672287
that O 0 0.004362574778497219
the O 0 0.007232434581965208
Cys282Tyr O 1 0.9520105719566345
mutation O 1 0.9888013601303101
creates O 0 0.08668071031570435
a O 0 0.020937684923410416
Rsal O 1 0.5951611399650574
restriction O 0 0.05200016498565674
site O 0 0.03765052184462547
. O 0 0.03869527205824852

We O 0 0.01695549488067627
have O 0 0.011578459292650223
studied O 0 0.016268279403448105
the O 0 0.01252219919115305
codon O 0 0.08019011467695236
282 O 0 0.15047001838684082
( O 0 0.04451741278171539
Cys O 1 0.9883701801300049
/ O 1 0.8256804347038269
Tyr O 1 0.955306351184845
) O 0 0.021048765629529953
polymorphism O 0 0.05623556300997734
in O 0 0.008947044610977173
different O 0 0.009911779314279556
ethnic O 0 0.024494724348187447
groups O 0 0.027410682290792465
. O 0 0.029598165303468704

In O 0 0.017331762239336967
agreement O 0 0.01271964143961668
with O 0 0.007946725934743881
previous O 0 0.011670592240989208
observations O 0 0.014233547262847424
the O 0 0.010769753716886044
Tyr O 1 0.9746851325035095
allele O 1 0.8468600511550903
appeared O 0 0.013823105953633785
to O 0 0.0057220072485506535
be O 0 0.005387487355619669
rare O 0 0.012653810903429985
or O 0 0.008502494543790817
absent O 0 0.018657729029655457
in O 0 0.007336937356740236
Asiatic O 0 0.2634948194026947
( O 0 0.01224373746663332
Indian O 0 0.011450701393187046
, O 0 0.00789472833275795
Chinese O 0 0.014601756818592548
) O 0 0.019817613065242767
populations O 0 0.05776941776275635
. O 0 0.02894039824604988

The O 0 0.027349239215254784
highest O 0 0.04255983978509903
allele O 1 0.7422295212745667
frequency O 0 0.03576777130365372
( O 0 0.014019133523106575
7 O 0 0.011700527742505074
. O 0 0.006341787986457348
5 O 0 0.008090228773653507
% O 0 0.00875908974558115
) O 0 0.006505744997411966
was O 0 0.0067900316789746284
found O 0 0.009971003979444504
in O 0 0.011918952688574791
Swedes O 0 0.044771190732717514
. O 0 0.029522482305765152

Saamis O 1 0.5359075665473938
( O 0 0.028893442824482918
2 O 0 0.018574846908450127
% O 0 0.014679079875349998
) O 0 0.011376019567251205
and O 0 0.007175006903707981
Mordvinians O 0 0.144027441740036
( O 0 0.01130054984241724
1 O 0 0.010152027942240238
. O 0 0.006074676755815744
8 O 0 0.009685718454420567
% O 0 0.008561377413570881
) O 0 0.007235896773636341
had O 0 0.007147965021431446
significantly O 0 0.018366465345025063
lower O 0 0.014937428757548332
frequencies O 0 0.01877453178167343
of O 0 0.00834839791059494
the O 0 0.015376743860542774
Tyr O 1 0.9775397777557373
allele O 1 0.9535905122756958
. O 0 0.040193602442741394

Comparisons O 0 0.052907977253198624
with O 0 0.02090444788336754
allele O 1 0.5087478756904602
frequencies O 0 0.024567823857069016
based O 0 0.010001221671700478
on O 0 0.009511930868029594
prevalence O 1 0.8299033045768738
estimates O 0 0.01682206057012081
of O 0 0.009999975562095642
HH B-Disease 1 0.9845253825187683
showed O 0 0.016053127124905586
some O 0 0.007192146964371204
disagreements O 0 0.014925307594239712
with O 0 0.006042952183634043
the O 0 0.008681964129209518
RFLP O 0 0.349615216255188
data O 0 0.011207034811377525
, O 0 0.008285678923130035
particularly O 0 0.016313033178448677
in O 0 0.013846800662577152
Finns O 0 0.06159039959311485
. O 0 0.03390689939260483

The O 0 0.023679625242948532
newly O 0 0.029428325593471527
described O 0 0.03618650883436203
HFE O 1 0.9805899858474731
marker O 0 0.05271076038479805
provides O 0 0.01327344961464405
a O 0 0.007574018556624651
new O 0 0.0060422676615417
approach O 0 0.008246359415352345
to O 0 0.00380754959769547
the O 0 0.005135680083185434
screening O 0 0.017308350652456284
of O 0 0.006322819739580154
HH B-Disease 1 0.9698728919029236
as O 0 0.005547769833356142
well O 0 0.004446013364940882
as O 0 0.00404830789193511
studies O 0 0.006392583716660738
of O 0 0.0037935152649879456
the O 0 0.005522860214114189
relationship O 0 0.014297671616077423
between O 0 0.01055823266506195
the O 0 0.01485938299447298
HFE O 1 0.9940587282180786
Tyr O 1 0.9952397346496582
allele O 1 0.9758383631706238
and O 0 0.01533499825745821
different O 0 0.02717784233391285
disorders O 1 0.9989123344421387
including O 0 0.19608844816684723
cancer B-Disease 1 0.9987456798553467

Autosomal B-Disease 1 0.9967993497848511
dominant I-Disease 1 0.9746366739273071
neurohypophyseal I-Disease 1 0.9965223073959351
diabetes I-Disease 1 0.9998400211334229
insipidus I-Disease 1 0.998184859752655
associated O 0 0.060194890946149826
with O 0 0.01783757470548153
a O 0 0.02548271045088768
missense O 1 0.9622654914855957
mutation O 1 0.9836329817771912
encoding O 0 0.3571567237377167
Gly23 O 1 0.9578183889389038
- O 1 0.5546229481697083
- O 1 0.6469506025314331
> O 1 0.8679512143135071
Val O 1 0.8590571284294128
in O 0 0.028758523985743523
neurophysin O 1 0.814143180847168
II O 0 0.13375934958457947
. O 0 0.04212797060608864

Autosomal B-Disease 1 0.9979292154312134
dominant I-Disease 1 0.973274827003479
neurohypophyseal I-Disease 1 0.9953805208206177
diabetes I-Disease 1 0.9998188614845276
insipidus I-Disease 1 0.9986851811408997
( O 0 0.2547667920589447
ADNDI B-Disease 1 0.9525877833366394
) O 0 0.02020791359245777
is O 0 0.012913182377815247
an O 0 0.016718680039048195
inherited B-Disease 1 0.9984375834465027
disease I-Disease 1 0.9999264478683472
caused O 1 0.9879118204116821
by O 0 0.024685652926564217
progressive O 1 0.9869905114173889
degeneration O 1 0.9984464049339294
of O 0 0.011118725873529911
the O 0 0.012888511642813683
magnocellular O 1 0.9784140586853027
neurons O 1 0.535112738609314
of O 0 0.009141634218394756
the O 0 0.011578787118196487
hypothalamus O 1 0.913973331451416
leading O 0 0.014929949305951595
to O 0 0.007975305430591106
decreased O 0 0.05199483409523964
ability O 0 0.015034923329949379
to O 0 0.006793222390115261
produce O 0 0.014594299718737602
the O 0 0.013876469805836678
hormone O 1 0.9618520736694336
arginine O 1 0.709864616394043
vasopressin O 1 0.9736700057983398
( O 0 0.04800400510430336
AVP O 1 0.8033813238143921
) O 0 0.0338791161775589
. O 0 0.03560344874858856

Affected O 0 0.38244184851646423
individuals O 0 0.022586453706026077
are O 0 0.00783755723387003
not O 0 0.008446194231510162
symptomatic O 1 0.9848877191543579
at O 0 0.0100502148270607
birth O 0 0.1865006685256958
, O 0 0.00682106614112854
but O 0 0.007480751257389784
usually O 0 0.021482540294528008
develop O 1 0.802902340888977
diabetes B-Disease 1 0.9998331069946289
insipidus I-Disease 1 0.9986287355422974
at O 0 0.017491241917014122
1 O 0 0.019243840128183365
- O 0 0.037272077053785324
6 O 0 0.026545008644461632
yr O 1 0.7628017067909241
of O 0 0.015885155647993088
age O 0 0.03242208808660507
. O 0 0.03126911073923111

The O 0 0.030123934149742126
genetic O 1 0.6690594553947449
locus O 1 0.6983344554901123
of O 0 0.014250450767576694
the O 0 0.015750601887702942
disease O 1 0.9985557198524475
is O 0 0.011263327673077583
the O 0 0.013013935647904873
AVP O 1 0.9666031002998352
- O 0 0.3988761603832245
neurophysin O 1 0.9018740057945251
II O 0 0.266403466463089
( O 0 0.025567205622792244
NPII O 1 0.8002510666847229
) O 0 0.014401429332792759
gene O 0 0.41815340518951416
, O 0 0.007130686193704605
and O 0 0.006577951367944479
mutations O 1 0.9376676082611084
that O 0 0.007599713746458292
cause O 1 0.7994201183319092
ADNDI B-Disease 1 0.9086252450942993
have O 0 0.005100638139992952
been O 0 0.00460520526394248
found O 0 0.004699757322669029
in O 0 0.003254625480622053
both O 0 0.003928484860807657
the O 0 0.004592995624989271
signal O 0 0.013040929101407528
peptide O 0 0.02251221239566803
of O 0 0.0059922863729298115
the O 0 0.008467942476272583
prepro O 1 0.7990384697914124
- O 0 0.480429470539093
AVP O 1 0.9629443883895874
- O 0 0.327748566865921
NPII O 1 0.8328088521957397
precursor O 0 0.05851822718977928
and O 0 0.014249050058424473
within O 0 0.02230069227516651
NPII O 0 0.4738694131374359
itself O 0 0.04588991031050682
. O 0 0.036332547664642334

An O 0 0.024962281808257103
affected O 0 0.14939412474632263
girl O 0 0.0395820289850235
who O 0 0.009102895855903625
presented O 0 0.008762212470173836
at O 0 0.0061791203916072845
9 O 0 0.00778456823900342
months O 0 0.007158690597862005
of O 0 0.004151527304202318
age O 0 0.008231114596128464
and O 0 0.004288333933800459
her O 0 0.008726563304662704
similarly O 0 0.019015207886695862
affected O 0 0.1293896585702896
younger O 0 0.04440716654062271
brother O 0 0.013431774452328682
and O 0 0.004194403532892466
father O 0 0.006800580304116011
were O 0 0.0030497752595692873
all O 0 0.0028188989963382483
found O 0 0.004596166778355837
to O 0 0.0033708836417645216
have O 0 0.004714438691735268
a O 0 0.00793519988656044
novel O 0 0.03150913491845131
missense O 1 0.9762232303619385
mutation O 1 0.991361677646637
( O 0 0.02972007915377617
G1758 O 1 0.7465302348136902
- O 0 0.261343777179718
- O 0 0.4365493357181549
> O 1 0.8122650384902954
T O 1 0.5240698456764221
) O 0 0.014794467948377132
encoding O 0 0.026170693337917328
the O 0 0.011418301612138748
amino O 0 0.031610045582056046
acid O 0 0.06530775129795074
substitution O 0 0.046272579580545425
Gly23 O 1 0.7883763313293457
- O 0 0.3157557547092438
- O 0 0.48187255859375
> O 1 0.8651415705680847
Val O 1 0.8907910585403442
within O 0 0.038565147668123245
NPII O 1 0.6592650413513184
. O 0 0.04655110836029053

The O 0 0.031230652704834938
mutation O 1 0.9242667555809021
was O 0 0.016383685171604156
confirmed O 0 0.023924557492136955
by O 0 0.01693335920572281
restriction O 0 0.060079190880060196
endonuclease O 1 0.8293610215187073
analysis O 0 0.043987199664115906
. O 0 0.04006987810134888

A O 0 0.04950236529111862
T1 O 1 0.551781415939331
- O 0 0.060556814074516296
weighted O 0 0.04903915524482727
magnetic O 0 0.043720465153455734
resonance O 0 0.052429165691137314
imaging O 0 0.03825641795992851
of O 0 0.010662214830517769
the O 0 0.01501530408859253
fathers O 0 0.39555761218070984
pituitary O 1 0.9948025941848755
gland O 1 0.9910897016525269
demonstrates O 0 0.34419873356819153
an O 0 0.03355077654123306
attenuated O 1 0.9884899258613586
posterior O 1 0.9907770156860352
pituitary O 1 0.9933140873908997
bright O 0 0.2926037609577179
spot O 0 0.055916015058755875
. O 0 0.03519421070814133

This O 0 0.025121230632066727
mutation O 1 0.9252582788467407
may O 0 0.013459661975502968
be O 0 0.005004112608730793
valuable O 0 0.007455846294760704
for O 0 0.006022711284458637
developing O 0 0.015451411716639996
models O 0 0.013317031785845757
of O 0 0.008904371410608292
dominantly B-Disease 1 0.9891515970230103
inherited I-Disease 1 0.9974871873855591
neurodegeneration I-Disease 1 0.9991551637649536
, O 0 0.009237999096512794
as O 0 0.005350742023438215
the O 0 0.005119403824210167
early O 0 0.007811380084604025
age O 0 0.011334682814776897
of O 0 0.008280986919999123
onset O 1 0.9985837936401367
of O 0 0.021458059549331665
symptoms O 1 0.9996447563171387
suggests O 0 0.1139301061630249
that O 0 0.006150994449853897
this O 0 0.007614163216203451
mutation O 1 0.9803204536437988
may O 0 0.014226083643734455
be O 0 0.005951729137450457
particularly O 0 0.016932278871536255
deleterious O 1 0.8737345337867737
to O 0 0.009315401315689087
the O 0 0.016133137047290802
magnocellular O 1 0.9646766185760498
neuron O 1 0.8975300788879395
. O 0 0.028642678633332253
. O 0 0.03538910299539566

Frequent O 0 0.2385132759809494
inactivation O 1 0.8011434674263
of O 0 0.0400216281414032
PTEN O 1 0.9949163198471069
/ O 1 0.9413023591041565
MMAC1 O 1 0.9674940705299377
in O 0 0.04118010401725769
primary O 1 0.8761347532272339
prostate B-Disease 1 0.9996398687362671
cancer I-Disease 1 0.9991912245750427
. O 0 0.07965429127216339

Sporadic B-Disease 1 0.9933220744132996
prostate I-Disease 1 0.99982088804245
carcinoma I-Disease 1 0.9994786381721497
is O 0 0.015004871413111687
the O 0 0.009206973016262054
most O 0 0.009399048052728176
common O 0 0.15729250013828278
male B-Disease 1 0.9096331000328064
cancer I-Disease 1 0.9990901947021484
in O 0 0.006005109753459692
the O 0 0.0046546547673642635
Western O 0 0.008256478235125542
world O 0 0.005447426810860634
, O 0 0.003501882078126073
yet O 0 0.004218635614961386
many O 0 0.0036386738065630198
of O 0 0.003367276396602392
the O 0 0.004253476392477751
major O 0 0.009646588936448097
genetic O 0 0.25544387102127075
events O 0 0.009133816696703434
involved O 0 0.007746873889118433
in O 0 0.004405034705996513
the O 0 0.005917454604059458
progression O 0 0.37945616245269775
of O 0 0.0068845730274915695
this O 0 0.009219055995345116
often O 0 0.0837671309709549
fatal O 1 0.9994844198226929
cancer B-Disease 1 0.999688982963562
remain O 0 0.0160444974899292
to O 0 0.00897841714322567
be O 0 0.01191898062825203
elucidated O 0 0.14591896533966064
. O 0 0.03392917662858963

Numerous O 0 0.0633496344089508
cytogenetic O 1 0.8313320875167847
and O 0 0.020743688568472862
allelotype O 0 0.4007665514945984
studies O 0 0.024042820557951927
have O 0 0.010577762499451637
reported O 0 0.021522533148527145
frequent O 0 0.03149332106113434
loss O 0 0.031047789379954338
of O 0 0.012088277377188206
heterozygosity O 1 0.9756304025650024
on O 0 0.017825674265623093
chromosomal O 1 0.9934831261634827
arm O 1 0.9288018941879272
10q O 1 0.9554272294044495
in O 0 0.044507015496492386
sporadic B-Disease 1 0.9926590323448181
prostate I-Disease 1 0.9998382329940796
cancer I-Disease 1 0.9994818568229675
. O 0 0.0804039016366005

Deletion O 1 0.5274534821510315
mapping O 0 0.050848934799432755
studies O 0 0.024829018861055374
have O 0 0.010422488674521446
unambiguously O 0 0.02214447222650051
identified O 0 0.012733684852719307
a O 0 0.009018574841320515
region O 0 0.014972774311900139
of O 0 0.009956037625670433
chromosome O 1 0.9512185454368591
10q23 O 0 0.13798101246356964
to O 0 0.005961668211966753
be O 0 0.005058186128735542
the O 0 0.005728342104703188
minimal O 0 0.016574643552303314
area O 0 0.010931875556707382
of O 0 0.01000877283513546
loss O 0 0.0466909222304821
. O 0 0.029597008600831032

A O 0 0.04785672947764397
new O 0 0.0478837788105011
tumor B-Disease 1 0.9974833130836487
suppressor O 1 0.9931995272636414
gene O 1 0.9641370177268982
, O 0 0.03894418105483055
PTEN O 1 0.9949539303779602
/ O 1 0.8822600245475769
MMAC1 O 1 0.8162375688552856
, O 0 0.008990236558020115
was O 0 0.007674712222069502
isolated O 0 0.02434471622109413
recently O 0 0.010518698021769524
at O 0 0.0056391083635389805
this O 0 0.005120451096445322
region O 0 0.012474588118493557
of O 0 0.008276657201349735
chromosome O 1 0.9853726029396057
10q23 O 0 0.4949335753917694
and O 0 0.005428951233625412
found O 0 0.006007985677570105
to O 0 0.004617946222424507
be O 0 0.005942057818174362
inactivated O 0 0.05789671465754509
by O 0 0.010475732386112213
mutation O 1 0.8802838921546936
in O 0 0.013803424313664436
three O 0 0.03733338415622711
prostate B-Disease 1 0.9999016523361206
cancer I-Disease 1 0.9997484087944031
cell O 1 0.9265720844268799
lines O 0 0.06625919789075851
. O 0 0.038605641573667526

We O 0 0.037524498999118805
screened O 0 0.22095952928066254
80 O 0 0.3450630009174347
prostate B-Disease 1 0.9995119571685791
tumors I-Disease 1 0.9982996582984924
by O 0 0.023574350401759148
microsatellite O 1 0.7789561152458191
analysis O 0 0.02193833701312542
and O 0 0.009589605033397675
found O 0 0.01636410504579544
chromosome O 1 0.887795090675354
10q23 O 0 0.11851627379655838
to O 0 0.007379224523901939
be O 0 0.006899700500071049
deleted O 0 0.020175717771053314
in O 0 0.009313562884926796
23 O 0 0.02192464843392372
cases O 0 0.03421079367399216
. O 0 0.03000190667808056

We O 0 0.01301991380751133
then O 0 0.008666587062180042
proceeded O 0 0.011411380022764206
with O 0 0.006683748681098223
sequence O 0 0.013857828453183174
analysis O 0 0.010226970538496971
of O 0 0.006419225595891476
the O 0 0.01018958818167448
entire O 0 0.03222939744591713
PTEN O 1 0.9894753694534302
/ O 1 0.6382412314414978
MMAC1 O 1 0.9096201658248901
coding O 0 0.17694562673568726
region O 0 0.025532519444823265
and O 0 0.008815273642539978
tested O 0 0.022795092314481735
for O 0 0.009107568301260471
homozygous O 1 0.7568615078926086
deletion O 0 0.48459485173225403
with O 0 0.007922493852674961
new O 0 0.011065891943871975
intragenic O 1 0.5886245965957642
markers O 0 0.02837880700826645
in O 0 0.006580488756299019
these O 0 0.005799883510917425
23 O 0 0.01151253841817379
cases O 0 0.015265263617038727
with O 0 0.010064912028610706
10q23 O 1 0.5226961374282837
loss O 0 0.06249329447746277
of O 0 0.022729501128196716
heterozygosity O 1 0.9190203547477722
. O 0 0.0479608029127121

The O 0 0.01549618225544691
identification O 0 0.015194506384432316
of O 0 0.006331999320536852
the O 0 0.00605693319812417
second O 0 0.0111078517511487
mutational O 1 0.5639505982398987
event O 0 0.016008373349905014
in O 0 0.009030066430568695
10 O 0 0.010563328862190247
( O 0 0.011143436655402184
43 O 0 0.01657417230308056
% O 0 0.015264187939465046
) O 0 0.02374683879315853
tumors B-Disease 1 0.9971739053726196
establishes O 1 0.8160632848739624
PTEN O 1 0.9973317384719849
/ O 1 0.7444647550582886
MMAC1 O 1 0.7238870859146118
as O 0 0.008246402256190777
a O 0 0.009821523912250996
main O 0 0.014904290437698364
inactivation O 0 0.3815591335296631
target O 0 0.014500445686280727
of O 0 0.0108943497762084
10q O 1 0.5944278836250305
loss O 0 0.1326567828655243
in O 0 0.02960493043065071
sporadic B-Disease 1 0.9909830093383789
prostate I-Disease 1 0.9999384880065918
cancer I-Disease 1 0.999778687953949
. O 0 0.040653686970472336
. O 0 0.03857698664069176

Risk O 1 0.8792641162872314
reversals O 0 0.3870221972465515
in O 0 0.02917114831507206
predictive O 0 0.3876146972179413
testing O 0 0.08125904202461243
for O 0 0.034342069178819656
Huntington B-Disease 1 0.9952551126480103
disease I-Disease 1 0.9993664622306824
. O 0 0.0665181577205658

The O 0 0.021472424268722534
first O 0 0.01793583109974861
predictive O 0 0.09835595637559891
testing O 0 0.03776394948363304
for O 0 0.02028554119169712
Huntington B-Disease 1 0.9993213415145874
disease I-Disease 1 0.9999041557312012
( O 0 0.10027245432138443
HD B-Disease 0 0.3701772689819336
) O 0 0.00819101557135582
was O 0 0.00469254469498992
based O 0 0.004513763356953859
on O 0 0.0036995362024754286
analysis O 0 0.00820884294807911
of O 0 0.00592321902513504
linked O 0 0.18187788128852844
polymorphic O 1 0.9629974365234375
DNA O 0 0.23453502357006073
markers O 0 0.02808328904211521
to O 0 0.006729162763804197
estimate O 0 0.01272853184491396
the O 0 0.008222196251153946
likelihood O 0 0.02201240137219429
of O 0 0.010783854871988297
inheriting O 0 0.21423305571079254
the O 0 0.017344331368803978
mutation O 1 0.9372870922088623
for O 0 0.020428603515028954
HD B-Disease 0 0.1765104979276657
. O 0 0.032689835876226425

Limits O 0 0.02664012648165226
to O 0 0.009911601431667805
accuracy O 0 0.01505052950233221
included O 0 0.009518671780824661
recombination O 0 0.03530140966176987
between O 0 0.008725643157958984
the O 0 0.006393117364495993
DNA O 0 0.029255475848913193
markers O 0 0.019357401877641678
and O 0 0.0050299642607569695
the O 0 0.0070468890480697155
mutation O 1 0.925791323184967
, O 0 0.00753720011562109
pedigree O 0 0.10600362718105316
structure O 0 0.0102308951318264
, O 0 0.00490734213963151
and O 0 0.003976860549300909
whether O 0 0.0069094011560082436
DNA O 0 0.016429409384727478
samples O 0 0.011549538932740688
were O 0 0.003979375585913658
available O 0 0.005505693145096302
from O 0 0.007571469992399216
family O 0 0.015850909054279327
members O 0 0.017302123829722404
. O 0 0.023390740156173706

With O 0 0.01618092693388462
direct O 0 0.016736602410674095
tests O 0 0.013552672229707241
for O 0 0.006960722617805004
the O 0 0.009157694876194
HD B-Disease 0 0.4165067672729492
mutation O 1 0.8325175046920776
, O 0 0.005305720958858728
we O 0 0.0035248163621872663
have O 0 0.0035016159527003765
assessed O 0 0.007577062118798494
the O 0 0.0038925090339034796
accuracy O 0 0.006841674912720919
of O 0 0.003638372989371419
results O 0 0.008351094089448452
obtained O 0 0.00685402937233448
by O 0 0.0068326727487146854
linkage O 0 0.03170473501086235
approaches O 0 0.014664930291473866
when O 0 0.006673737894743681
requested O 0 0.007595982402563095
to O 0 0.003787799272686243
do O 0 0.004720308352261782
so O 0 0.004372311756014824
by O 0 0.004816010594367981
the O 0 0.0063781109638512135
test O 0 0.016750488430261612
individuals O 0 0.022228529676795006
. O 0 0.025003258138895035

For O 0 0.011785836890339851
six O 0 0.010149536654353142
such O 0 0.007387431338429451
individuals O 0 0.01030933577567339
, O 0 0.005580899305641651
there O 0 0.005222691688686609
was O 0 0.0057413275353610516
significant O 0 0.011784426867961884
disparity O 0 0.06336812674999237
between O 0 0.010011509992182255
the O 0 0.009325351566076279
tests O 0 0.02637551724910736
. O 0 0.02528201788663864

Three O 0 0.0171895120292902
went O 0 0.015506725758314133
from O 0 0.010134706273674965
a O 0 0.011070636101067066
decreased O 0 0.1720058172941208
risk O 0 0.24696536362171173
to O 0 0.005627150647342205
an O 0 0.005831180140376091
increased O 0 0.014598428271710873
risk O 0 0.2513827383518219
, O 0 0.0040941606275737286
while O 0 0.00423047412186861
in O 0 0.003633092390373349
another O 0 0.00574857834726572
three O 0 0.00450130645185709
the O 0 0.00674337288364768
risk O 0 0.2198966145515442
was O 0 0.014819851145148277
decreased O 0 0.11511736363172531
. O 0 0.030752824619412422

Knowledge O 0 0.021417446434497833
of O 0 0.008066561073064804
the O 0 0.006900379899889231
potential O 0 0.011881431564688683
reasons O 0 0.007867712527513504
for O 0 0.0040181102231144905
these O 0 0.00346385152079165
changes O 0 0.00601565046235919
in O 0 0.0038681156001985073
results O 0 0.006736669223755598
and O 0 0.0038091668393462896
impact O 0 0.007977481931447983
of O 0 0.004056487698107958
these O 0 0.005341629032045603
risk O 1 0.6394585967063904
reversals O 0 0.1727849692106247
on O 0 0.006073324009776115
both O 0 0.006247952580451965
patients O 1 0.955527663230896
and O 0 0.0043660057708621025
the O 0 0.005487179383635521
counseling O 0 0.12085683643817902
team O 0 0.006990532390773296
can O 0 0.005435706116259098
assist O 0 0.008097609505057335
in O 0 0.0037282882258296013
the O 0 0.0039564501494169235
development O 0 0.005725483875721693
of O 0 0.0042302836664021015
strategies O 0 0.013150268234312534
for O 0 0.0047364565543830395
the O 0 0.00572437047958374
prevention O 0 0.42952507734298706
and O 0 0.004766917787492275
, O 0 0.0038813650608062744
where O 0 0.004513380117714405
necessary O 0 0.004843257833272219
, O 0 0.0038544442504644394
management O 0 0.00817381963133812
of O 0 0.0047792126424610615
a O 0 0.008674480020999908
risk O 1 0.7438952922821045
reversal O 0 0.10733038187026978
in O 0 0.007403742987662554
any O 0 0.009595371782779694
predictive O 0 0.17228387296199799
testing O 0 0.02464553900063038
program O 0 0.018693650141358376
. O 0 0.013765606097877026
. O 0 0.02381070889532566

A O 0 0.041580185294151306
novel O 0 0.055876992642879486
common O 0 0.07422404736280441
missense O 1 0.970752477645874
mutation O 1 0.9810490608215332
G301C O 0 0.31757673621177673
in O 0 0.010512977838516235
the O 0 0.01107001956552267
N O 0 0.040431249886751175
- O 0 0.05661850422620773
acetylgalactosamine O 1 0.5349504947662354
- O 0 0.06578198075294495
6 O 0 0.034018974751234055
- O 0 0.33221325278282166
sulfate O 1 0.9790335297584534
sulfatase O 1 0.9926388263702393
gene O 1 0.8323562145233154
in O 0 0.03037242963910103
mucopolysaccharidosis B-Disease 1 0.8739714026451111
IVA I-Disease 1 0.9503872394561768
. O 0 0.05418506637215614

Mucopolysaccharidosis B-Disease 1 0.9278369545936584
IVA I-Disease 1 0.9387471675872803
( O 0 0.05769241601228714
MPS B-Disease 0 0.19668011367321014
IVA I-Disease 1 0.9437849521636963
) O 0 0.02446570433676243
is O 0 0.014058226719498634
an O 0 0.02567134238779545
autosomal B-Disease 1 0.9994250535964966
recessive I-Disease 1 0.9998329877853394
lysosomal I-Disease 1 0.99905925989151
storage I-Disease 1 0.9755842685699463
disorder I-Disease 1 0.9998514652252197
caused O 1 0.9743330478668213
by O 0 0.013240838423371315
a O 0 0.01936490461230278
genetic B-Disease 1 0.9939140677452087
defect I-Disease 1 0.9897233247756958
in O 0 0.012647068127989769
N O 0 0.12216097861528397
- O 0 0.2984715402126312
acetylgalactosamine O 1 0.9078130125999451
- O 0 0.2299608290195465
6 O 0 0.04198005795478821
- O 0 0.39539486169815063
sulfate O 1 0.9788967967033386
sulfatase O 1 0.987404465675354
( O 0 0.05451732501387596
GALNS O 1 0.7329159379005432
) O 0 0.03588493540883064
. O 0 0.037272658199071884

In O 0 0.015087287873029709
previous O 0 0.012432779185473919
studies O 0 0.012155983597040176
, O 0 0.005007527768611908
we O 0 0.0039513627998530865
have O 0 0.0037920591421425343
found O 0 0.005493760574609041
two O 0 0.004803377203643322
common O 0 0.01744445227086544
mutations O 1 0.9727938771247864
in O 0 0.007837881334125996
Caucasians O 1 0.5948846936225891
and O 0 0.009071066044270992
Japanese O 0 0.015475544147193432
, O 0 0.01121828518807888
respectively O 0 0.02357681840658188
. O 0 0.027461079880595207

To O 0 0.021601097658276558
characterize O 0 0.04592832922935486
the O 0 0.014655348844826221
mutational O 1 0.8271333575248718
spectrum O 0 0.031039614230394363
in O 0 0.007037619594484568
various O 0 0.007035673130303621
ethnic O 0 0.011727123521268368
groups O 0 0.010401577688753605
, O 0 0.00730538135394454
mutations O 1 0.8480401635169983
in O 0 0.007627725135535002
the O 0 0.009134394116699696
GALNS O 1 0.8242480158805847
gene O 1 0.6164088249206543
in O 0 0.011351479217410088
Colombian O 0 0.057458776980638504
MPS B-Disease 1 0.9000381827354431
IVA I-Disease 1 0.9981635212898254
patients O 1 0.9956328272819519
were O 0 0.00783299095928669
investigated O 0 0.019714603200554848
, O 0 0.0062582604587078094
and O 0 0.0057026781141757965
genetic O 0 0.1755269169807434
backgrounds O 0 0.014052755199372768
were O 0 0.004861175548285246
extensively O 0 0.01096258033066988
analyzed O 0 0.011319451034069061
to O 0 0.004519822541624308
identify O 0 0.010353860445320606
racial O 0 0.012324288487434387
origin O 0 0.009410143829882145
, O 0 0.004936722107231617
based O 0 0.0065264953300356865
on O 0 0.007324445992708206
mitochondrial O 0 0.41719675064086914
DNA O 0 0.11234740912914276
( O 0 0.02407231368124485
mtDNA O 0 0.22399546205997467
) O 0 0.02605113759636879
lineages O 0 0.11692149192094803
. O 0 0.03809627518057823

Three O 0 0.03261479735374451
novel O 0 0.0819818452000618
missense O 1 0.9847618341445923
mutations O 1 0.9803802371025085
never O 0 0.01692723110318184
identified O 0 0.01594238542020321
previously O 0 0.009660033509135246
in O 0 0.005530371330678463
other O 0 0.004955652169883251
populations O 0 0.01460964698344469
and O 0 0.0037034612614661455
found O 0 0.005702259484678507
in O 0 0.0039088004268705845
16 O 0 0.0053820195607841015
out O 0 0.00424815621227026
of O 0 0.005998590029776096
19 O 0 0.014259543269872665
Colombian O 0 0.03217468783259392
MPS B-Disease 0 0.1857328861951828
IVA I-Disease 1 0.987322986125946
unrelated O 0 0.4695928394794464
alleles O 1 0.9497650265693665
account O 0 0.02757791057229042
for O 0 0.019123079255223274
84 O 0 0.05004489794373512
. O 0 0.03880416974425316

2 O 0 0.02942495420575142
% O 0 0.015787599608302116
of O 0 0.008001568727195263
the O 0 0.009857815690338612
alleles O 0 0.4787653088569641
in O 0 0.008918373845517635
this O 0 0.009888521395623684
study O 0 0.02446783520281315
. O 0 0.02706737630069256

The O 0 0.034473225474357605
G301C O 0 0.3420141339302063
and O 0 0.022436825558543205
S162F O 1 0.8759357333183289
mutations O 1 0.9535492062568665
account O 0 0.022237351164221764
for O 0 0.015604084357619286
68 O 0 0.04030868038535118
. O 0 0.037593141198158264

4 O 0 0.033216699957847595
% O 0 0.022117001935839653
and O 0 0.013073897920548916
10 O 0 0.02302638255059719
. O 0 0.028878407552838326

5 O 0 0.03178961202502251
% O 0 0.01993483304977417
of O 0 0.01096661202609539
mutations O 1 0.9190812706947327
, O 0 0.00737911369651556
respectively O 0 0.008963347412645817
, O 0 0.005514292046427727
whereas O 0 0.009825128130614758
the O 0 0.005214587319642305
remaining O 0 0.009009028784930706
F69V O 0 0.1450926959514618
is O 0 0.007060023490339518
limited O 0 0.009557674638926983
to O 0 0.006231099367141724
a O 0 0.011869344860315323
single O 0 0.026096684858202934
allele O 0 0.4872662425041199
. O 0 0.04456288740038872

The O 0 0.03287174180150032
skewed O 0 0.26522213220596313
prevalence O 1 0.8885231018066406
of O 0 0.01269303448498249
G301C O 0 0.19130399823188782
in O 0 0.008988477289676666
only O 0 0.009059329517185688
Colombian O 0 0.042372096329927444
patients O 1 0.964840292930603
and O 0 0.011216898448765278
haplotype O 1 0.7927379012107849
analysis O 0 0.01648614928126335
by O 0 0.011304968036711216
restriction O 0 0.027839232236146927
fragment O 0 0.05950349196791649
length O 0 0.023200588300824165
polymorphisms O 0 0.34905922412872314
in O 0 0.009915677830576897
the O 0 0.01230535190552473
GALNS O 1 0.8351936936378479
gene O 1 0.5295687913894653
suggest O 0 0.01897657848894596
that O 0 0.010364796034991741
G301C O 0 0.10270853340625763
originated O 0 0.021998651325702667
from O 0 0.01144033670425415
a O 0 0.01435914821922779
common O 0 0.02999223582446575
ancestor O 0 0.1649596393108368
. O 0 0.03397064283490181

Investigation O 0 0.031610388308763504
of O 0 0.011281545273959637
the O 0 0.010213267058134079
genetic O 0 0.14206211268901825
background O 0 0.013060836121439934
by O 0 0.007107437122613192
means O 0 0.008309928700327873
of O 0 0.00706581911072135
mtDNA O 0 0.4864281713962555
lineages O 0 0.3676419258117676
indicate O 0 0.011937811970710754
that O 0 0.004383032210171223
all O 0 0.004045548383146524
our O 0 0.0077631366439163685
patients O 1 0.921265721321106
are O 0 0.005990322213619947
probably O 0 0.01145524624735117
of O 0 0.008855010382831097
native O 0 0.017240289598703384
American O 0 0.029153138399124146
descent O 0 0.08227109163999557

Low O 0 0.07594811916351318
frequency O 0 0.06027577444911003
of O 0 0.028852561488747597
BRCA1 O 1 0.998404324054718
germline O 1 0.9970736503601074
mutations O 1 0.9916480779647827
in O 0 0.01744488812983036
45 O 0 0.0469878651201725
German O 1 0.7870064973831177
breast B-Disease 1 0.9998534917831421
/ I-Disease 1 0.9987521171569824
ovarian I-Disease 1 0.9999330043792725
cancer I-Disease 1 0.999738872051239
families O 0 0.31425371766090393
. O 0 0.048874177038669586

In O 0 0.01657683029770851
this O 0 0.010399614460766315
study O 0 0.014884580858051777
we O 0 0.008533995598554611
investigated O 0 0.023414280265569687
45 O 0 0.025375068187713623
German O 0 0.46876755356788635
breast B-Disease 1 0.9997695088386536
/ I-Disease 1 0.9986095428466797
ovarian I-Disease 1 0.9999605417251587
cancer I-Disease 1 0.9998815059661865
families O 0 0.29014718532562256
for O 0 0.02667410485446453
germline O 1 0.9976974129676819
mutations O 1 0.987919807434082
in O 0 0.019310690462589264
the O 0 0.030562350526452065
BRCA1 O 1 0.9973108768463135
gene O 1 0.9686718583106995
. O 0 0.05056329071521759

We O 0 0.017856528982520103
identified O 0 0.026461642235517502
four O 0 0.01762736216187477
germline O 1 0.9881762266159058
mutations O 1 0.9903774857521057
in O 0 0.014456973411142826
three O 0 0.025045517832040787
breast B-Disease 1 0.9998007416725159
cancer I-Disease 1 0.9996691942214966
families O 0 0.023096442222595215
and O 0 0.0064528021030128
in O 0 0.007925795391201973
one O 0 0.05712392181158066
breast B-Disease 1 0.999927282333374
- I-Disease 1 0.9987427592277527
ovarian I-Disease 1 0.9999862909317017
cancer I-Disease 1 0.9999223947525024
family O 0 0.12396428734064102
. O 0 0.006860359571874142
among O 0 0.00696248933672905
these O 0 0.0042782430537045
were O 0 0.0043306839652359486
one O 0 0.0084654800593853
frameshift O 1 0.990915834903717
mutation O 1 0.9713852405548096
, O 0 0.008665947243571281
one O 0 0.00845198705792427
nonsense O 0 0.053104352205991745
mutation O 1 0.9507467746734619
, O 0 0.007164440583437681
one O 0 0.007266501896083355
novel O 0 0.021708054468035698
splice O 1 0.6856662034988403
site O 0 0.022365787997841835
mutation O 1 0.8628866076469421
, O 0 0.008866936899721622
and O 0 0.009072626009583473
one O 0 0.01808725856244564
missense O 1 0.9542905688285828
mutation O 1 0.9824537038803101
. O 0 0.044522859156131744

The O 0 0.039780501276254654
missense O 1 0.9637773036956787
mutation O 1 0.9373397827148438
was O 0 0.012135091237723827
also O 0 0.008156556636095047
found O 0 0.010134849697351456
in O 0 0.00946315098553896
2 O 0 0.020407695323228836
. O 0 0.024514589458703995

8 O 0 0.02590072900056839
% O 0 0.012880106456577778
of O 0 0.005505188833922148
the O 0 0.005020695272833109
general O 0 0.007259543519467115
population O 0 0.009284967556595802
, O 0 0.00503953592851758
suggesting O 0 0.011007916182279587
that O 0 0.004063872620463371
it O 0 0.004972266033291817
is O 0 0.007709747180342674
not O 0 0.010835764929652214
disease O 1 0.9978293776512146
associated O 0 0.046565499156713486
. O 0 0.03188960626721382

The O 0 0.021579649299383163
average O 0 0.028440603986382484
age O 0 0.026724817231297493
of O 0 0.018843891099095345
disease O 1 0.9998387098312378
onset O 1 0.9986147880554199
in O 0 0.011050283908843994
those O 0 0.011528702452778816
families O 0 0.11362745612859726
harbouring O 1 0.9936941266059875
causative O 1 0.9946459531784058
mutations O 1 0.9930902123451233
was O 0 0.015045284293591976
between O 0 0.01903560385107994
32 O 0 0.03176732733845711
. O 0 0.028664158657193184

3 O 0 0.051750291138887405
and O 0 0.02418339066207409
37 O 0 0.05291558802127838
. O 0 0.0433732308447361

4 O 0 0.02851153165102005
years O 0 0.014140795916318893
, O 0 0.009133358485996723
whereas O 0 0.014015942811965942
the O 0 0.00716444430872798
family O 0 0.0178513266146183
harbouring O 1 0.6655439734458923
the O 0 0.014423360116779804
missense O 1 0.9881424307823181
mutation O 1 0.9788404703140259
had O 0 0.008803179487586021
an O 0 0.007255238480865955
average O 0 0.014364467933773994
age O 0 0.014669634401798248
of O 0 0.01259115431457758
onset O 1 0.9851447343826294
of O 0 0.016465287655591965
51 O 0 0.04495599865913391
. O 0 0.03060874342918396

2 O 0 0.05944740027189255
years O 0 0.04404919221997261
. O 0 0.04303169250488281

These O 0 0.02001342363655567
findings O 0 0.02613004483282566
show O 0 0.013904856517910957
that O 0 0.0098962327465415
BRCA1 O 1 0.9916577935218811
is O 0 0.008618700318038464
implicated O 0 0.044860221445560455
in O 0 0.006478256545960903
a O 0 0.008806849829852581
small O 0 0.010694826953113079
fraction O 0 0.03630837798118591
of O 0 0.0286631491035223
breast B-Disease 1 0.9999281167984009
/ I-Disease 1 0.999332845211029
ovarian I-Disease 1 0.9999772310256958
cancer I-Disease 1 0.9998807907104492
families O 0 0.13797427713871002
suggesting O 0 0.03369816392660141
the O 0 0.009809410199522972
involvement O 0 0.024683421477675438
of O 0 0.011668865568935871
another O 0 0.02703096903860569
susceptibility O 1 0.9915285110473633
gene O 1 0.9771395325660706
( O 0 0.04885907098650932
s O 0 0.12405624985694885
) O 0 0.05529845878481865

Paternal O 1 0.960296630859375
transmission O 1 0.9157381057739258
of O 0 0.2731665074825287
congenital B-Disease 1 0.9998111128807068
myotonic I-Disease 1 0.9995827078819275
dystrophy I-Disease 1 0.9996906518936157
. O 0 0.17082828283309937

We O 0 0.01785040833055973
report O 0 0.018787382170557976
a O 0 0.014431755058467388
rare O 0 0.02630055509507656
case O 0 0.02143494039773941
of O 0 0.024739084765315056
paternally O 1 0.9957566857337952
transmitted O 1 0.9982079267501831
congenital B-Disease 1 0.9999641180038452
myotonic I-Disease 1 0.9999213218688965
dystrophy I-Disease 1 0.9999039173126221
( O 1 0.9607307314872742
DM B-Disease 1 0.9977801442146301
) O 0 0.06290031969547272
. O 0 0.050391316413879395

The O 0 0.02607904002070427
proband O 0 0.107081837952137
is O 0 0.01168869435787201
a O 0 0.010506471619009972
23 O 0 0.015693511813879013
year O 0 0.012206499464809895
old O 0 0.018030185252428055
, O 0 0.015388024039566517
mentally B-Disease 1 0.9652140736579895
retarded I-Disease 1 0.9855660796165466
male O 1 0.9259721636772156
who O 1 0.5787574052810669
suffers O 1 0.9996684789657593
severe O 1 0.999656081199646
muscular B-Disease 1 0.9991969466209412
weakness I-Disease 1 0.9908761382102966
. O 0 0.06393414735794067

He O 0 0.02035064436495304
presented O 0 0.020487356930971146
with O 0 0.016012009233236313
respiratory O 1 0.9986827969551086
and O 0 0.015118617564439774
feeding O 0 0.41667458415031433
difficulties O 0 0.25510287284851074
at O 0 0.0263410285115242
birth O 0 0.22159631550312042
. O 0 0.03878793120384216

His O 0 0.0317586325109005
two O 0 0.026387786492705345
sibs O 1 0.9873952865600586
suffer O 1 0.9788920879364014
from O 0 0.04701597988605499
childhood O 1 0.9911401867866516
onset O 1 0.9986369013786316
DM B-Disease 1 0.9977926015853882
. O 0 0.08522549271583557

Their O 0 0.01765744574368
late O 0 0.02000376582145691
father O 0 0.01690567657351494
had O 0 0.009260826744139194
the O 0 0.008834518492221832
adult O 0 0.02997545339167118
type O 0 0.02677188813686371
of O 0 0.011029022745788097
DM B-Disease 1 0.995795488357544
, O 0 0.010800276882946491
with O 0 0.012267298996448517
onset O 1 0.9944961667060852
around O 0 0.015364425256848335
30 O 0 0.020687241107225418
years O 0 0.022967828437685966
. O 0 0.028324373066425323

Only O 0 0.014342475682497025
six O 0 0.011330941691994667
other O 0 0.007027756422758102
cases O 0 0.014389576390385628
of O 0 0.009493700228631496
paternal O 1 0.8685932755470276
transmission O 1 0.8549894690513611
of O 0 0.06025040149688721
congenital B-Disease 1 0.999940037727356
DM I-Disease 1 0.9992166757583618
have O 0 0.016481341794133186
been O 0 0.016352256760001183
reported O 0 0.032797060906887054
recently O 0 0.03539841249585152
. O 0 0.027969840914011

We O 0 0.01689920388162136
review O 0 0.019130764529109
the O 0 0.010537832975387573
sex O 0 0.027313603088259697
related O 0 0.023083960637450218
effects O 0 0.07476229965686798
on O 0 0.012654376216232777
transmission O 0 0.3130106031894684
of O 0 0.03381221368908882
congenital B-Disease 1 0.999743640422821
DM I-Disease 1 0.9977421760559082
. O 0 0.07551974058151245

Decreased O 1 0.6960916519165039
fertility O 1 0.6752405166625977
of O 0 0.01909506879746914
males O 1 0.5615989565849304
with O 0 0.019995277747511864
adult O 1 0.8361759185791016
onset O 1 0.9991974234580994
DM B-Disease 1 0.9985026121139526
and O 0 0.013836724683642387
contraction O 0 0.30200281739234924
of O 0 0.007415301166474819
the O 0 0.008601426146924496
repeat O 0 0.029330870136618614
upon O 0 0.010501738637685776
male O 0 0.12953248620033264
transmission O 0 0.17756129801273346
contribute O 0 0.015371178276836872
to O 0 0.005402004346251488
the O 0 0.0065721673890948296
almost O 0 0.011831698939204216
absent O 0 0.08645462989807129
occurrence O 0 0.15983925759792328
of O 0 0.012307316064834595
paternal O 1 0.9540145397186279
transmission O 1 0.8418053388595581
of O 0 0.05561061576008797
congenital B-Disease 1 0.9997292160987854
DM I-Disease 1 0.9971643090248108
. O 0 0.07854977250099182

Also O 0 0.015492051839828491
the O 0 0.010445392690598965
fathers O 0 0.018173184245824814
of O 0 0.006807202473282814
the O 0 0.008007575757801533
reported O 0 0.031759340316057205
congenitally O 1 0.9926332831382751
affected O 1 0.5901250839233398
children O 0 0.02188693732023239
showed O 0 0.011296240612864494
, O 0 0.005219514016062021
on O 0 0.004950264003127813
average O 0 0.01095444057136774
, O 0 0.008643262088298798
shorter O 0 0.035015057772397995
CTG O 1 0.7317185401916504
repeat O 0 0.04889309033751488
lengths O 0 0.02531382068991661
and O 0 0.010092764161527157
hence O 0 0.02669517882168293
less O 0 0.0518963448703289
severe O 1 0.9990044236183167
clinical O 1 0.9969539642333984
symptoms O 1 0.9996500015258789
than O 0 0.010941439308226109
the O 0 0.010294916108250618
mothers O 1 0.5075690746307373
of O 0 0.010422986000776291
children O 0 0.19038642942905426
with O 0 0.0771312490105629
congenital B-Disease 1 0.9997921586036682
DM I-Disease 1 0.9982353448867798
. O 0 0.0818244218826294

We O 0 0.01926366426050663
conclude O 0 0.02748659998178482
that O 0 0.012641889043152332
paternal O 1 0.7061938047409058
transmission O 1 0.5796827673912048
of O 0 0.03988255560398102
congenital B-Disease 1 0.9999431371688843
DM I-Disease 1 0.9993256330490112
is O 0 0.025385627523064613
rare O 0 0.14780087769031525
and O 0 0.011410810984671116
preferentially O 0 0.4105462431907654
occurs O 0 0.19678477942943573
with O 0 0.01380421593785286
onset O 1 0.9963047504425049
of O 0 0.0159562099725008
DM B-Disease 1 0.9972196817398071
past O 0 0.016687167808413506
30 O 0 0.01181184034794569
years O 0 0.007686811499297619
in O 0 0.0062224953435361385
the O 0 0.00793848279863596
father O 0 0.019042575731873512
. O 0 0.014074282720685005
. O 0 0.02164383791387081

The O 0 0.057217542082071304
RB1 O 1 0.986040472984314
gene O 1 0.9476723670959473
mutation O 1 0.9604503512382507
in O 0 0.013174057938158512
a O 0 0.016137519851326942
child O 0 0.1903352439403534
with O 0 0.03753706440329552
ectopic B-Disease 1 0.9985504746437073
intracranial I-Disease 1 0.9990376234054565
retinoblastoma I-Disease 1 0.9943019151687622
. O 0 0.0670081377029419

The O 0 0.05433739349246025
RB1 O 1 0.9924397468566895
gene O 1 0.9713459610939026
mutation O 1 0.9741876125335693
was O 0 0.014577077701687813
investigated O 0 0.021603142842650414
in O 0 0.00852406769990921
a O 0 0.012351691722869873
child O 0 0.06310313194990158
with O 0 0.02191336639225483
ectopic B-Disease 1 0.998331606388092
intracranial I-Disease 1 0.9991434812545776
retinoblastoma I-Disease 1 0.9955955147743225
using O 0 0.020019643008708954
DNA O 0 0.029251625761389732
obtained O 0 0.010240750387310982
from O 0 0.007463857531547546
both O 0 0.006970119196921587
the O 0 0.010851135477423668
pineal B-Disease 1 0.9744957089424133
and I-Disease 0 0.021075207740068436
retinal I-Disease 1 0.99868243932724
tumours I-Disease 1 0.9974563717842102
of O 0 0.015385576523840427
the O 0 0.019642764702439308
patient O 1 0.950055718421936
. O 0 0.03568235784769058

A O 0 0.05073307082056999
nonsense O 0 0.0832749530673027
mutation O 1 0.7904295921325684
in O 0 0.019544532522559166
exon O 0 0.1257900446653366
17 O 0 0.028025036677718163
( O 0 0.022229325026273727
codon O 0 0.0693710446357727
556 O 0 0.041640691459178925
) O 0 0.01031882781535387
of O 0 0.007549209054559469
the O 0 0.011228387244045734
RB1 O 1 0.9929131865501404
gene O 0 0.4410567879676819
was O 0 0.0070173479616642
found O 0 0.005471204873174429
to O 0 0.003486105240881443
be O 0 0.0035394211299717426
present O 0 0.006097220815718174
homozygously O 0 0.0823591873049736
in O 0 0.006528004538267851
both O 0 0.007143262308090925
the O 0 0.009686989709734917
retinal B-Disease 1 0.9735119938850403
and I-Disease 0 0.012876753695309162
the I-Disease 0 0.021846603602170944
pineal I-Disease 1 0.9932882189750671
tumours I-Disease 1 0.9971895813941956
. O 0 0.054314952343702316

The O 0 0.01840836927294731
same O 0 0.018496235832571983
mutation O 1 0.8810103535652161
was O 0 0.01001195888966322
present O 0 0.009523061104118824
heterozygously O 0 0.06635493040084839
in O 0 0.005417505279183388
the O 0 0.005014555994421244
DNA O 0 0.01366785541176796
from O 0 0.005143162328749895
the O 0 0.004988692235201597
constitutional O 0 0.009100726805627346
cells O 0 0.02997443825006485
of O 0 0.004491325933486223
the O 0 0.005744576454162598
patient O 1 0.859076738357544
, O 0 0.004920086823403835
proving O 0 0.010626380331814289
it O 0 0.003788350149989128
to O 0 0.003754366422072053
be O 0 0.004821569658815861
of O 0 0.009918886236846447
germline O 1 0.9047222137451172
origin O 0 0.04062134772539139
. O 0 0.03483479842543602

The O 0 0.025442739948630333
initial O 0 0.048818450421094894
mutation O 1 0.895784854888916
was O 0 0.010636587627232075
shown O 0 0.011487819254398346
to O 0 0.005327768623828888
have O 0 0.006176378112286329
occurred O 0 0.015797531232237816
in O 0 0.008777912706136703
the O 0 0.014154389500617981
paternally O 1 0.8359547853469849
derived O 0 0.18690608441829681
RB1 O 1 0.989608108997345
allele O 1 0.9452090263366699
. O 0 0.05865919589996338

The O 0 0.02473977394402027
mutation O 1 0.7195626497268677
is O 0 0.00779443746432662
in O 0 0.00542981643229723
an O 0 0.004538409877568483
area O 0 0.006630921270698309
of O 0 0.0039242287166416645
the O 0 0.005863948259502649
gene O 0 0.09671857953071594
that O 0 0.005732295569032431
encodes O 0 0.019663572311401367
the O 0 0.006967202760279179
protein O 0 0.03183835744857788
- O 0 0.026765616610646248
binding O 0 0.016106726601719856
region O 0 0.012387044727802277
known O 0 0.007950677536427975
as O 0 0.004822464659810066
the O 0 0.005904067773371935
pocket O 0 0.03670254349708557
region O 0 0.011792503297328949
and O 0 0.004505516029894352
has O 0 0.005186703521758318
been O 0 0.006078625097870827
detected O 0 0.02238265797495842
in O 0 0.0051206983625888824
other O 0 0.005738021340221167
cases O 0 0.016316233202815056
of O 0 0.012270974926650524
retinoblastoma B-Disease 1 0.9924378991127014
. O 0 0.019620174542069435
. O 0 0.026321833953261375

Low O 0 0.047763969749212265
levels O 0 0.026955148205161095
of O 0 0.012298972345888615
beta O 0 0.049555711448192596
hexosaminidase O 0 0.17961546778678894
A O 0 0.01195439975708723
in O 0 0.009265080094337463
healthy O 0 0.24135516583919525
individuals O 0 0.014741268008947372
with O 0 0.013020727783441544
apparent O 1 0.6261112689971924
deficiency O 1 0.9984538555145264
of O 0 0.011951318010687828
this O 0 0.014643673785030842
enzyme O 0 0.2790730595588684
. O 0 0.030101178213953972

Appreciable O 0 0.37476110458374023
beta O 0 0.11750108003616333
hexosaminidase O 0 0.17516356706619263
A O 0 0.020999491214752197
( O 0 0.017512017861008644
hex O 0 0.025650016963481903
A O 0 0.010996687225997448
) O 0 0.00903488602489233
activity O 0 0.012144691310822964
has O 0 0.006488352548331022
been O 0 0.008026153780519962
detected O 0 0.07386087626218796
in O 0 0.01323537528514862
cultured O 1 0.9466317892074585
skin O 1 0.9994193315505981
fibroblasts O 1 0.9966331124305725
and O 0 0.2247057855129242
melanoma B-Disease 1 0.9998791217803955
tissue O 1 0.9981196522712708
from O 0 0.019836904481053352
healthy O 1 0.8069999814033508
individuals O 0 0.022107401862740517
previously O 0 0.012505236081779003
reported O 0 0.015744680538773537
as O 0 0.007028701715171337
having O 0 0.01622575893998146
deficiency B-Disease 1 0.998129665851593
of I-Disease 0 0.008251115679740906
hex I-Disease 0 0.034051213413476944
A I-Disease 0 0.009646003134548664
activity O 0 0.012997341342270374
indistinguishable O 0 0.02050427347421646
from O 0 0.005973794497549534
that O 0 0.004487732425332069
of O 0 0.007386276964098215
patients O 1 0.9935129284858704
with O 0 0.04464638605713844
Tay B-Disease 1 0.9996951818466187
- I-Disease 1 0.9933106899261475
Sachs I-Disease 1 0.9982971549034119
disease I-Disease 1 0.9996747970581055
( O 0 0.4715224802494049
TSD B-Disease 1 0.9898815751075745
) O 0 0.04428765922784805
. O 0 0.04009408876299858

Identification O 0 0.03820168972015381
and O 0 0.01495580654591322
quantitation O 0 0.1343069225549698
of O 0 0.011052489280700684
hex O 0 0.03017420507967472
A O 0 0.012369423173367977
, O 0 0.00861397199332714
amounting O 0 0.024396052584052086
to O 0 0.011369231157004833
3 O 0 0.02458864077925682
. O 0 0.02627546712756157

5 O 0 0.054426293820142746
% O 0 0.04188929870724678
- O 0 0.06751048564910889
6 O 0 0.053265638649463654
. O 0 0.04165847972035408

9 O 0 0.030623354017734528
% O 0 0.016164524480700493
of O 0 0.00881240889430046
total O 0 0.014958413317799568
beta O 0 0.03889187425374985
hexosaminidase O 0 0.16070674359798431
activity O 0 0.014950939454138279
, O 0 0.0055794804356992245
has O 0 0.005552183371037245
been O 0 0.005541250109672546
obtained O 0 0.009046505205333233
by O 0 0.010450261645019054
cellulose O 0 0.13840442895889282
acetate O 1 0.5427014827728271
gel O 1 0.9312248826026917
electrophoresis O 1 0.5760536789894104
, O 0 0.01712433621287346
DEAE O 1 0.7435638308525085
- O 0 0.09246654063463211
cellulose O 0 0.2548483908176422
ion O 0 0.11160018295049667
- O 0 0.050976261496543884
exchange O 0 0.030901353806257248
chromatography O 0 0.07247841358184814
, O 0 0.01692608743906021
radial O 1 0.648906946182251
immunodiffusion O 0 0.3766959011554718
, O 0 0.015024468302726746
and O 0 0.018010489642620087
radioimmunoassay O 0 0.3632841110229492
. O 0 0.04171429201960564

Previous O 0 0.03427556902170181
family O 0 0.028701139613986015
studies O 0 0.019658289849758148
suggested O 0 0.013281233608722687
that O 0 0.005405035801231861
these O 0 0.004834949504584074
individuals O 0 0.009360920637845993
may O 0 0.008562041446566582
be O 0 0.004972842056304216
compound O 0 0.015377949923276901
heterozygotes O 0 0.2999767065048218
for O 0 0.0061558266170322895
the O 0 0.007766148541122675
common O 0 0.031695134937763214
mutant O 1 0.9802427887916565
TSD B-Disease 1 0.996370792388916
gene O 1 0.8815232515335083
and O 0 0.009610605426132679
a O 0 0.014655913226306438
rare O 0 0.1385979950428009
( O 0 0.03277904540300369
allelic O 1 0.9451772570610046
) O 0 0.03739248216152191
mutant O 1 0.8206334114074707
gene O 1 0.6471608877182007
. O 0 0.0486774742603302

Thus O 0 0.02893086150288582
, O 0 0.013395212590694427
the O 0 0.010735105723142624
postulated O 0 0.05707918480038643
rate O 0 0.03405068814754486
mutant O 1 0.8371672034263611
gene O 0 0.4346756339073181
appears O 0 0.015684040263295174
to O 0 0.004729089792817831
code O 0 0.006932316813617945
for O 0 0.0037088277749717236
the O 0 0.004600566811859608
expression O 0 0.012464969418942928
of O 0 0.005667056422680616
low O 0 0.015330895781517029
amounts O 0 0.014003664255142212
of O 0 0.010350996628403664
hex O 0 0.040786027908325195
A O 0 0.024499354884028435
. O 0 0.029099533334374428

Heterozygotes O 1 0.6361813545227051
for O 0 0.014430813491344452
the O 0 0.012014412321150303
rare O 0 0.14134614169597626
mutant O 1 0.8281245827674866
may O 0 0.014048678800463676
be O 0 0.006487919017672539
indistinguishable O 0 0.027688780799508095
from O 0 0.011985004879534245
heterozygotes O 1 0.5007050633430481
for O 0 0.009625202976167202
the O 0 0.01222940906882286
common O 0 0.0684482604265213
TSD B-Disease 1 0.9920473098754883
mutant O 1 0.9332106113433838
. O 0 0.04635601118206978

However O 0 0.023039422929286957
, O 0 0.012870725244283676
direct O 0 0.01842477172613144
visualization O 0 0.024933330714702606
and O 0 0.008347398601472378
quantitation O 0 0.12688037753105164
of O 0 0.008026938885450363
hex O 0 0.019378570839762688
A O 0 0.007473994977772236
by O 0 0.004584144800901413
the O 0 0.00450920220464468
methods O 0 0.008653335273265839
described O 0 0.01037568412721157
may O 0 0.008831392042338848
prevent O 0 0.057435233145952225
false O 0 0.017165852710604668
- O 0 0.48792850971221924
positive O 0 0.4130881726741791
prenatal O 1 0.99673992395401
diagnosis O 1 0.9940749406814575
of O 0 0.017430458217859268
TSD B-Disease 1 0.9895804524421692
in O 0 0.014319512993097305
fetuses O 1 0.8864010572433472
having O 0 0.01144696120172739
the O 0 0.00783418770879507
incomplete O 0 0.01980404183268547
hex B-Disease 0 0.05809352919459343
A I-Disease 0 0.01609460450708866
deficiency I-Disease 1 0.9961642026901245
of O 0 0.006397746503353119
the O 0 0.007498627062886953
type O 0 0.02178797498345375
described O 0 0.0113346166908741
in O 0 0.005854710005223751
the O 0 0.007659793831408024
four O 0 0.0130467489361763
healthy O 0 0.2878631055355072
individuals O 0 0.06094294413924217

The O 0 0.07020721584558487
tumor B-Disease 1 0.9979259967803955
suppressor O 1 0.996817946434021
gene O 1 0.9922385811805725
Smad4 O 1 0.9862067103385925
/ O 1 0.7836945056915283
Dpc4 O 1 0.574735164642334
is O 0 0.010602992959320545
required O 0 0.009474224410951138
for O 0 0.0073294746689498425
gastrulation O 1 0.5196534991264343
and O 0 0.006388253998011351
later O 0 0.00835119653493166
for O 0 0.007670587860047817
anterior O 1 0.7115594744682312
development O 0 0.011719992384314537
of O 0 0.009138944558799267
the O 0 0.01635739579796791
mouse O 1 0.7417288422584534
embryo O 1 0.695381224155426
. O 0 0.0397992841899395

Mutations O 1 0.8603960871696472
in O 0 0.02110240049660206
the O 0 0.024345463141798973
SMAD4 O 1 0.9710894823074341
/ O 1 0.9651493430137634
DPC4 O 1 0.9955434203147888
tumor B-Disease 1 0.9993209838867188
suppressor O 1 0.9969123601913452
gene O 1 0.660857081413269
, O 0 0.008216623216867447
a O 0 0.00889813993126154
key O 0 0.012191364541649818
signal O 0 0.01811143197119236
transducer O 0 0.042901597917079926
in O 0 0.006882736925035715
most O 0 0.008743098936975002
TGFbeta O 1 0.6245370507240295
- O 0 0.05239827558398247
related O 0 0.0225859172642231
pathways O 0 0.265385240316391
, O 0 0.005136388819664717
are O 0 0.003925817087292671
involved O 0 0.007063169497996569
in O 0 0.005155309569090605
50 O 0 0.010257035493850708
% O 0 0.013081436045467854
of O 0 0.01842810958623886
pancreatic B-Disease 1 0.9995138645172119
cancers I-Disease 1 0.9993023872375488
. O 0 0.04434296116232872

Homozygous O 1 0.9782172441482544
Smad4 O 1 0.9836434721946716
mutant O 1 0.9817230105400085
mice O 1 0.9883623719215393
die O 1 0.703047513961792
before O 0 0.017527136951684952
day O 0 0.01832198165357113
7 O 0 0.02590588852763176
. O 0 0.02523716911673546

5 O 0 0.04768557846546173
of O 0 0.03286130726337433
embryogenesis O 0 0.37244102358818054
. O 0 0.050358571112155914

Mutant O 1 0.9069527983665466
embryos O 0 0.0748407393693924
have O 0 0.014713854528963566
reduced O 0 0.023140158504247665
size O 0 0.013512658886611462
, O 0 0.007765285670757294
fail O 0 0.02102656662464142
to O 0 0.008031971752643585
gastrulate O 0 0.11389606446027756
or O 0 0.009668205864727497
express O 0 0.0162469781935215
a O 0 0.01462768018245697
mesodermal O 1 0.7963658571243286
marker O 0 0.05083687976002693
, O 0 0.009598883800208569
and O 0 0.009453674778342247
show O 0 0.025568323209881783
abnormal O 1 0.9804415702819824
visceral O 1 0.9876809120178223
endoderm O 1 0.9751623868942261
development O 0 0.044151607900857925
. O 0 0.03784743696451187

Growth B-Disease 0 0.23942111432552338
retardation I-Disease 1 0.9729521870613098
of O 0 0.01292355079203844
the O 0 0.01579054817557335
Smad4 O 1 0.9269806146621704
- O 0 0.4703703224658966
deficient O 1 0.9509394764900208
embryos O 0 0.1643095463514328
results O 0 0.021454492583870888
from O 0 0.013088278472423553
reduced O 0 0.04885870963335037
cell O 0 0.17122305929660797
proliferation O 0 0.07549934834241867
rather O 0 0.017100971192121506
than O 0 0.018078522756695747
increased O 0 0.04507885500788689
apoptosis O 1 0.8256049156188965
. O 0 0.04295346513390541

Aggregation O 0 0.11877162754535675
of O 0 0.029350338503718376
mutant O 1 0.9389137029647827
Smad4 O 1 0.9592702388763428
ES O 1 0.8958504796028137
cells O 1 0.526724636554718
with O 0 0.01652783527970314
wild O 0 0.04361354559659958
- O 0 0.25486016273498535
type O 0 0.35741642117500305
tetraploid O 1 0.9643866419792175
morulae O 1 0.9295881390571594
rescues O 1 0.5197137594223022
the O 0 0.04108397290110588
gastrulation B-Disease 1 0.9726261496543884
defect I-Disease 1 0.9590827822685242
. O 0 0.05523991212248802

These O 0 0.015322210267186165
results O 0 0.01916307955980301
indicate O 0 0.01747092232108116
that O 0 0.007956411689519882
Smad4 O 0 0.11323344707489014
is O 0 0.0074695320799946785
initially O 0 0.008864188566803932
required O 0 0.005466650240123272
for O 0 0.003557829884812236
the O 0 0.005239465739578009
differentiation O 0 0.01777730882167816
of O 0 0.004958639852702618
the O 0 0.008694806136190891
visceral O 1 0.8937656283378601
endoderm O 1 0.8024306893348694
and O 0 0.006658562924712896
that O 0 0.006819570437073708
the O 0 0.010536525398492813
gastrulation B-Disease 1 0.9835439324378967
defect I-Disease 1 0.8552822470664978
in O 0 0.009786934591829777
the O 0 0.011030000634491444
epiblast O 1 0.9352574944496155
is O 0 0.011523195542395115
secondary O 0 0.018914345651865005
and O 0 0.00799128320068121
non O 0 0.020816488191485405
- O 0 0.06089348718523979
cell O 0 0.06368934363126755
autonomous O 0 0.040536101907491684
. O 0 0.03515112027525902

Rescued O 0 0.33599892258644104
embryos O 0 0.4890880882740021
show O 0 0.07467999309301376
severe O 1 0.9953978657722473
anterior O 1 0.9935846924781799
truncations O 1 0.873913586139679
, O 0 0.012995303608477116
indicating O 0 0.019535325467586517
a O 0 0.008487734012305737
second O 0 0.00875677540898323
important O 0 0.008160647004842758
role O 0 0.012408009730279446
for O 0 0.01074787974357605
Smad4 O 1 0.6462470889091492
in O 0 0.02273976430296898
anterior O 1 0.9859654903411865
patterning O 1 0.958159327507019
during O 0 0.06383322924375534
embryogenesis O 1 0.8095288276672363
. O 0 0.05239417031407356

Prevalence O 1 0.958854079246521
of O 0 0.0358160138130188
p16 O 1 0.968207836151123
and O 0 0.029580537229776382
CDK4 O 1 0.9883291721343994
germline O 1 0.9959214925765991
mutations O 1 0.9914355874061584
in O 0 0.02098788134753704
48 O 1 0.6116483807563782
melanoma B-Disease 1 0.9997764229774475
- O 1 0.9207779169082642
prone O 1 0.9677785634994507
families O 0 0.02697444148361683
in O 0 0.01776251196861267
France O 0 0.040406204760074615
. O 0 0.03370565548539162

The O 0 0.04371974617242813
French O 1 0.5436986684799194
Familial B-Disease 1 0.9986190795898438
Melanoma I-Disease 1 0.99928879737854
Study O 0 0.11850682646036148
Group O 0 0.05363456532359123
. O 0 0.040529537945985794

Germline O 1 0.9898951649665833
mutations O 1 0.971916675567627
in O 0 0.01406757440418005
the O 0 0.014425951987504959
p16 O 1 0.9578853249549866
and O 0 0.013094168156385422
CDK4 O 1 0.9350448250770569
genes O 1 0.5163528919219971
have O 0 0.007806310895830393
been O 0 0.006160776596516371
reported O 0 0.010663779452443123
in O 0 0.005411548539996147
a O 0 0.008235428482294083
subset O 0 0.02380448207259178
of O 0 0.009868452325463295
melanoma B-Disease 1 0.9996979236602783
pedigrees O 1 0.7281797528266907
, O 0 0.007867477834224701
but O 0 0.00688260979950428
their O 0 0.007805864326655865
prevalence O 1 0.944905698299408
is O 0 0.00783650390803814
not O 0 0.006566650699824095
well O 0 0.010314562357962132
known O 0 0.02203524485230446
. O 0 0.023656023666262627

We O 0 0.018636422231793404
searched O 0 0.02354287914931774
for O 0 0.010278231464326382
such O 0 0.014650081284344196
germline O 1 0.9893141984939575
mutations O 1 0.9741611480712891
in O 0 0.012626239098608494
48 O 0 0.03180530294775963
French O 1 0.536913275718689
melanoma B-Disease 1 0.9996932744979858
- O 1 0.843368411064148
prone O 1 0.9019708037376404
families O 0 0.014336829073727131
selected O 0 0.006998103577643633
according O 0 0.005086553283035755
to O 0 0.0035426903050392866
two O 0 0.0037636307533830404
major O 0 0.0066663166508078575
criteria O 0 0.007306508254259825
families O 0 0.007003891281783581
with O 0 0.004086984321475029
at O 0 0.0042058732360601425
least O 0 0.005770836025476456
three O 0 0.004630311392247677
affected O 0 0.01850186474621296
members O 0 0.006728583015501499
( O 0 0.009861634112894535
n O 0 0.016545789316296577
= O 0 0.01832607015967369
20 O 0 0.00594137841835618
) O 0 0.005083364434540272
or O 0 0.004080720711499453
families O 0 0.004816179629415274
with O 0 0.0028458067681640387
two O 0 0.0034415835980325937
affected O 0 0.012464594095945358
members O 0 0.0042021144181489944
, O 0 0.003023772966116667
one O 0 0.002483706921339035
of O 0 0.0026676126290112734
them O 0 0.003241840749979019
affected O 0 0.010597323067486286
before O 0 0.004144649021327496
the O 0 0.00373696256428957
age O 0 0.006937915459275246
of O 0 0.004765300080180168
50 O 0 0.010357769206166267
( O 0 0.01182230282574892
n O 0 0.02318362146615982
= O 0 0.023648060858249664
28 O 0 0.011329082772135735
) O 0 0.0070142620243132114
, O 0 0.004318446386605501
and O 0 0.0037347511388361454
one O 0 0.006116867531090975
additional O 0 0.013876066543161869
minor O 0 0.03415911644697189
criterion O 0 0.042916737496852875
. O 0 0.032202549278736115

Sixteen O 0 0.060500502586364746
different O 0 0.03444155305624008
p16 O 1 0.9843839406967163
germline O 1 0.991740345954895
mutations O 1 0.9546241760253906
were O 0 0.007525801658630371
found O 0 0.009075087495148182
in O 0 0.005827551707625389
21 O 0 0.010735881514847279
families O 0 0.010517983697354794
, O 0 0.00559073593467474
while O 0 0.006781376898288727
one O 0 0.01270044595003128
germline O 1 0.9944139719009399
mutation O 1 0.993062436580658
, O 0 0.012836098670959473
Arg24His O 1 0.6689466238021851
, O 0 0.008629986084997654
was O 0 0.009290382266044617
detected O 0 0.029724150896072388
in O 0 0.009160096757113934
the O 0 0.014716820791363716
CDK4 O 1 0.9176144003868103
gene O 1 0.8021978139877319
. O 0 0.04013717174530029

The O 0 0.023306403309106827
frequency O 0 0.03853936493396759
of O 0 0.01813414692878723
p16 O 1 0.9792030453681946
gene O 1 0.9626433253288269
mutation O 1 0.9376298785209656
in O 0 0.008501449599862099
our O 0 0.00871491339057684
sample O 0 0.013977386988699436
( O 0 0.008247104473412037
44 O 0 0.009433918632566929
% O 0 0.006921248976141214
) O 0 0.0050605530850589275
is O 0 0.0034268132876604795
among O 0 0.004416338168084621
the O 0 0.003779892809689045
highest O 0 0.008058118633925915
rates O 0 0.011217412538826466
yet O 0 0.007877634838223457
reported O 0 0.009899330325424671
and O 0 0.005356033332645893
the O 0 0.00868091732263565
CDK4 O 1 0.8726403713226318
mutation O 1 0.8850935101509094
is O 0 0.008204981684684753
the O 0 0.007937269285321236
second O 0 0.01499133836477995
mutation O 1 0.9697185158729553
detected O 0 0.1025775894522667
in O 0 0.010337612591683865
this O 0 0.012779325246810913
gene O 0 0.412895530462265
worldwide O 0 0.05534955859184265
. O 0 0.03344816341996193

In O 0 0.016899997368454933
summary O 0 0.02133956179022789
, O 0 0.0075296214781701565
our O 0 0.00814029760658741
results O 0 0.012452725321054459
show O 0 0.01219012401998043
frequent O 0 0.021385686472058296
involvement O 0 0.01818864792585373
of O 0 0.00898120366036892
the O 0 0.013379169628024101
p16 O 1 0.9905917048454285
gene O 1 0.9710448384284973
in O 0 0.025547116994857788
familial B-Disease 1 0.9994340538978577
melanoma I-Disease 1 0.9997194409370422
and O 0 0.010742750950157642
confirm O 0 0.012830976396799088
the O 0 0.005861541721969843
role O 0 0.009385481476783752
of O 0 0.005650829058140516
the O 0 0.00863767508417368
CDK4 O 1 0.9301586747169495
gene O 1 0.6753317713737488
as O 0 0.011388042941689491
a O 0 0.025065533816814423
melanoma B-Disease 1 0.999395489692688
- O 1 0.8853300213813782
predisposing O 1 0.9862465858459473
gene O 1 0.8992534279823303
. O 0 0.024134648963809013
. O 0 0.02922148071229458

Progression O 1 0.7399575710296631
of O 0 0.033723555505275726
somatic O 1 0.9436101913452148
CTG O 1 0.9478785991668701
repeat O 0 0.18382415175437927
length O 0 0.032793279737234116
heterogeneity O 0 0.12764163315296173
in O 0 0.011395126581192017
the O 0 0.014205227605998516
blood O 1 0.9813002347946167
cells O 1 0.9508118629455566
of O 0 0.2659987211227417
myotonic B-Disease 1 0.9998408555984497
dystrophy I-Disease 1 0.9999375343322754
patients O 1 0.9983554482460022
. O 0 0.10066240280866623

The O 0 0.02780921757221222
genetic O 0 0.18645727634429932
basis O 0 0.025146441534161568
of O 0 0.03614996001124382
myotonic B-Disease 1 0.9997240900993347
dystrophy I-Disease 1 0.9999022483825684
( O 1 0.766722559928894
DM B-Disease 1 0.9975231289863586
) O 0 0.015173336490988731
is O 0 0.0073201339691877365
the O 0 0.005251333583146334
expansion O 0 0.01020388025790453
of O 0 0.00616594310849905
an O 0 0.008736786432564259
unstable O 0 0.46947944164276123
CTG O 1 0.7640811800956726
repeat O 0 0.034299805760383606
in O 0 0.007994787767529488
the O 0 0.00802198238670826
34 O 0 0.018064113333821297
UTR O 0 0.0906440019607544
of O 0 0.009924604557454586
the O 0 0.01825295202434063
DM B-Disease 1 0.995879054069519
protein O 1 0.7258259654045105
kinase O 1 0.9435908198356628
gene O 1 0.7293634414672852
on O 0 0.024341261014342308
chromosome O 1 0.9303576350212097
19 O 0 0.04189732298254967
. O 0 0.036997560411691666

One O 0 0.013660348951816559
of O 0 0.00759882852435112
the O 0 0.0062412419356405735
principal O 0 0.008491294458508492
features O 0 0.007882175035774708
of O 0 0.0058920541778206825
the O 0 0.010252036154270172
DM B-Disease 1 0.9981740713119507
mutation O 1 0.9863622188568115
is O 0 0.008799327537417412
an O 0 0.007774255704134703
extraordinarily O 0 0.026766572147607803
high O 0 0.009770265780389309
level O 0 0.008534899912774563
of O 0 0.00787291768938303
somatic O 1 0.9583613872528076
mosaicism O 1 0.9907222986221313
, O 0 0.008515770547091961
due O 0 0.009001603350043297
to O 0 0.004605045076459646
an O 0 0.005300592631101608
extremely O 0 0.01304903905838728
high O 0 0.00869053602218628
degree O 0 0.008207076229155064
of O 0 0.006356498226523399
somatic O 1 0.872493326663971
instability O 1 0.6486547589302063
both O 0 0.0067127724178135395
within O 0 0.006596405059099197
and O 0 0.005267783999443054
between O 0 0.009659736417233944
different O 0 0.014236398041248322
tissues O 1 0.923311173915863
. O 0 0.03003121353685856

This O 0 0.024455685168504715
instability O 0 0.43381139636039734
appears O 0 0.02275034785270691
to O 0 0.006879211403429508
be O 0 0.00561628257855773
biased O 0 0.013570559211075306
towards O 0 0.009206412360072136
further O 0 0.007697985507547855
expansion O 0 0.009162585251033306
and O 0 0.004486876539885998
continuous O 0 0.011480903252959251
throughout O 0 0.0062765940092504025
the O 0 0.0038133016787469387
life O 0 0.005110539961606264
of O 0 0.003236133838072419
an O 0 0.0036559016443789005
individual O 0 0.005401125643402338
, O 0 0.003640515496954322
features O 0 0.004897019825875759
that O 0 0.003100647358223796
could O 0 0.0038314585108309984
be O 0 0.003094556974247098
associated O 0 0.0060744755901396275
with O 0 0.003966095857322216
the O 0 0.0053319549188017845
progressive O 0 0.061474528163671494
nature O 0 0.01195770688354969
of O 0 0.008854500949382782
the O 0 0.01723400503396988
disease O 1 0.9986937642097473
. O 0 0.03880097717046738

Although O 0 0.03281689062714577
increasing O 0 0.0416291318833828
measured O 0 0.04098721593618393
allele O 1 0.7778448462486267
size O 0 0.025589264929294586
between O 0 0.017492912709712982
patients O 1 0.9704585671424866
clearly O 0 0.015696827322244644
correlates O 0 0.077829509973526
with O 0 0.00591960409656167
an O 0 0.0061992472037673
increased O 0 0.019992345944046974
severity O 1 0.9304672479629517
of O 0 0.009017500095069408
symptoms O 1 0.999498724937439
and O 0 0.0055974447168409824
an O 0 0.005060188006609678
earlier O 0 0.00829025823622942
age O 0 0.011422515846788883
of O 0 0.007493149023503065
onset O 1 0.9942139983177185
, O 0 0.005419052205979824
this O 0 0.0042415945790708065
correlation O 0 0.011427908204495907
is O 0 0.0038238915149122477
not O 0 0.0031808712519705296
precise O 0 0.007419921923428774
and O 0 0.0040089222602546215
measured O 0 0.013044238090515137
allele O 1 0.6048281192779541
length O 0 0.009340942837297916
cannot O 0 0.005905613303184509
be O 0 0.0026817391626536846
used O 0 0.0035305372439324856
as O 0 0.0031576077453792095
an O 0 0.004460788797587156
accurate O 0 0.009855229407548904
predictor O 0 0.09228379279375076
of O 0 0.007654221262782812
age O 0 0.0189170204102993
of O 0 0.015208874829113483
onset O 1 0.9948998093605042
. O 0 0.033852461725473404

In O 0 0.01591108739376068
order O 0 0.011059824377298355
to O 0 0.00685152830556035
further O 0 0.010034490376710892
characterize O 0 0.02342771366238594
the O 0 0.00946218054741621
dynamics O 0 0.02958727441728115
of O 0 0.014747945591807365
DM B-Disease 1 0.9980366826057434
CTG O 1 0.9850900173187256
repeat O 1 0.8828999400138855
somatic O 1 0.9564012885093689
instability O 1 0.6186439990997314
, O 0 0.008477010764181614
we O 0 0.005161454435437918
have O 0 0.005584091413766146
studied O 0 0.010175840929150581
repeat O 0 0.022175416350364685
length O 0 0.012054040096700191
changes O 0 0.009247413836419582
over O 0 0.006757213268429041
time O 0 0.008754690177738667
in O 0 0.012371833436191082
111 O 1 0.9162586331367493
myotonic B-Disease 1 0.9998084902763367
dystrophy I-Disease 1 0.9999475479125977
patients O 1 0.9984727501869202
with O 0 0.022757263854146004
varying O 0 0.28221702575683594
clinical O 1 0.9854922890663147
severity O 1 0.9876235723495483
and O 0 0.01240695733577013
CTG O 1 0.9334231019020081
repeat O 0 0.05089254304766655
size O 0 0.012247866950929165
over O 0 0.005860280245542526
time O 0 0.005898864474147558
intervals O 0 0.011381102725863457
of O 0 0.006508076563477516
1 O 0 0.012814518064260483
- O 0 0.023361222818493843
7 O 0 0.02164626494050026
years O 0 0.01895265467464924
. O 0 0.026680804789066315

We O 0 0.014187884517014027
have O 0 0.009551596827805042
found O 0 0.009653800167143345
a O 0 0.008922652341425419
direct O 0 0.014187977649271488
progression O 0 0.23449644446372986
of O 0 0.005974029190838337
the O 0 0.0059013087302446365
size O 0 0.010530213825404644
heterogeneity O 0 0.060786835849285126
over O 0 0.00601485138759017
time O 0 0.0059281038120388985
related O 0 0.010211295448243618
to O 0 0.005540571175515652
initial O 0 0.017218537628650665
CTG O 1 0.6454441547393799
repeat O 0 0.03312906250357628
size O 0 0.009398408234119415
and O 0 0.003531616646796465
the O 0 0.0035956245847046375
time O 0 0.005456621292978525
interval O 0 0.012677430175244808
and O 0 0.005487591028213501
always O 0 0.00948081724345684
biased O 0 0.018279818817973137
towards O 0 0.015111157670617104
further O 0 0.01817232370376587
expansion O 0 0.03214861825108528
. O 0 0.03045695088803768

Attempts O 0 0.03138355910778046
to O 0 0.01189522072672844
mathematically O 0 0.019732648506760597
model O 0 0.01318781916052103
the O 0 0.006847349461168051
dynamics O 0 0.017767006531357765
have O 0 0.00579478032886982
proved O 0 0.010521786287426949
only O 0 0.005357834510505199
partially O 0 0.015160643495619297
successful O 0 0.010885542258620262
suggesting O 0 0.012356335297226906
that O 0 0.004976328462362289
individual O 0 0.008252418600022793
specific O 0 0.009268267080187798
genetic O 1 0.5039021968841553
and O 0 0.006003513466566801
/ O 0 0.12602351605892181
or O 0 0.007271284703165293
environmental O 0 0.013484962284564972
factors O 0 0.01124870590865612
also O 0 0.005551882553845644
play O 0 0.005647437646985054
a O 0 0.007589112035930157
role O 0 0.013486629351973534
in O 0 0.014152898453176022
somatic O 1 0.9572477340698242
mosaicism O 1 0.9858653545379639
. O 0 0.026218879967927933
. O 0 0.03403165936470032

Aspartylglucosaminuria B-Disease 1 0.7873130440711975
among O 0 0.0474829226732254
Palestinian O 0 0.06299061328172684
Arabs O 0 0.07329734414815903
. O 0 0.044189490377902985

Aspartylglucosaminuria B-Disease 1 0.957622766494751
( O 0 0.07240863889455795
AGU B-Disease 1 0.9808540344238281
) O 0 0.021229276433587074
is O 0 0.01118430495262146
a O 0 0.014722914434969425
rare O 0 0.4124006927013397
disorder B-Disease 1 0.998945415019989
of I-Disease 0 0.01889743097126484
glycoprotein I-Disease 1 0.9936291575431824
metabolism I-Disease 1 0.9895022511482239
caused O 1 0.7342537045478821
by O 0 0.01091706845909357
the O 0 0.013209065422415733
deficiency B-Disease 1 0.9982176423072815
of I-Disease 0 0.012358603999018669
the I-Disease 0 0.017551153898239136
lysosomal I-Disease 1 0.9927883744239807
enzyme I-Disease 1 0.9668073058128357
aspartylglucosaminidase I-Disease 1 0.9564843773841858
( O 0 0.043804995715618134
AGA O 0 0.22108758985996246
) O 0 0.0384615883231163
. O 0 0.03899620845913887

AGU B-Disease 1 0.9881772398948669
is O 0 0.029969623312354088
inherited O 1 0.6922885179519653
as O 0 0.01588393934071064
an O 0 0.026219630613923073
autosomal O 1 0.9997804760932922
recessive O 1 0.9997962117195129
trait O 1 0.990884006023407
and O 0 0.010239807888865471
occurs O 0 0.12103132158517838
with O 0 0.0055255587212741375
a O 0 0.00675837229937315
high O 0 0.00876951590180397
frequency O 0 0.01378406211733818
in O 0 0.005260652396827936
Finland O 0 0.012005971744656563
because O 0 0.007273350842297077
of O 0 0.0064369309693574905
a O 0 0.01097962912172079
founder O 0 0.033499084413051605
effect O 0 0.0408964641392231
. O 0 0.03054099716246128

While O 0 0.0234413743019104
very O 0 0.01888270489871502
few O 0 0.016745315864682198
patients O 1 0.9700515270233154
with O 0 0.0136973662301898
AGU B-Disease 1 0.9914790987968445
have O 0 0.007476914674043655
been O 0 0.006785617675632238
reported O 0 0.010512253269553185
from O 0 0.006880485452711582
non O 0 0.013909367844462395
- O 0 0.02170420251786709
Finnish O 0 0.02164875715970993
origin O 0 0.012698628008365631
, O 0 0.007300507742911577
we O 0 0.0098097063601017
diagnosed O 1 0.9990420937538147
the O 0 0.014944670721888542
disorder O 1 0.9987552165985107
in O 0 0.011218215338885784
8 O 0 0.04330964386463165
patients O 1 0.9864548444747925
originating O 0 0.02674165926873684
from O 0 0.008771617896854877
3 O 0 0.01016267016530037
unrelated O 0 0.022455304861068726
families O 0 0.009506694972515106
, O 0 0.004723358899354935
all O 0 0.0041680606082081795
Palestinian O 0 0.011874333955347538
Arabs O 0 0.013009108603000641
from O 0 0.0067134336568415165
the O 0 0.006490950472652912
region O 0 0.015474309213459492
of O 0 0.009817471727728844
Jerusalem O 0 0.030618345364928246
. O 0 0.027085941284894943

The O 0 0.03624589741230011
clinical O 1 0.9280560612678528
diagnosis O 1 0.9958761930465698
of O 0 0.020383048802614212
AGU B-Disease 1 0.9973856806755066
is O 0 0.010546750389039516
often O 0 0.009511512704193592
difficult O 0 0.006883011199533939
, O 0 0.0032797923777252436
in O 0 0.0030707812402397394
particular O 0 0.005008589942008257
early O 0 0.004362235311418772
in O 0 0.0025925692170858383
the O 0 0.002938713412731886
course O 0 0.004983650520443916
of O 0 0.0034188590943813324
the O 0 0.005370453465729952
disease O 1 0.9983808994293213
, O 0 0.004429059103131294
and O 0 0.003031038213521242
most O 0 0.003779298160225153
of O 0 0.003884810721501708
the O 0 0.00656640762463212
patients O 1 0.9968177080154419
are O 0 0.012429004535079002
diagnosed O 1 0.9991193413734436
after O 0 0.011981001123785973
the O 0 0.006980080157518387
age O 0 0.012420234270393848
of O 0 0.007847984321415424
5 O 0 0.014301145449280739
years O 0 0.0166977196931839
. O 0 0.021801983937621117

However O 0 0.02070934884250164
, O 0 0.010722191073000431
since O 0 0.013721389696002007
these O 0 0.011248531751334667
patients O 1 0.9901732206344604
excrete O 1 0.7820163369178772
early O 0 0.016392264515161514
large O 0 0.012872638180851936
amounts O 0 0.015500199049711227
of O 0 0.008923866786062717
aspartylglucosamine O 0 0.38385745882987976
in O 0 0.012473001144826412
urine O 0 0.2105683982372284
, O 0 0.01232957188040018
biochemical O 0 0.09761790931224823
screening O 0 0.03448380157351494
is O 0 0.009224999696016312
easy O 0 0.01551998220384121
by O 0 0.01398473046720028
urine O 0 0.3068310022354126
chromatography O 0 0.08276019245386124
. O 0 0.0189284086227417
. O 0 0.02725241146981716

Detection O 0 0.06957200169563293
of O 0 0.018533241003751755
heterozygous O 1 0.585010826587677
carriers O 0 0.04272143915295601
of O 0 0.0097671989351511
the O 0 0.015388241969048977
ataxia B-Disease 1 0.9992427825927734
- I-Disease 1 0.9827662706375122
telangiectasia I-Disease 1 0.9993603825569153
( O 0 0.044028885662555695
ATM O 0 0.21090413630008698
) O 0 0.017399974167346954
gene O 0 0.17956648766994476
by O 0 0.01718270592391491
G2 O 1 0.9633110761642456
phase O 0 0.38283371925354004
chromosomal O 1 0.9908598065376282
radiosensitivity O 1 0.9474856853485107
of O 0 0.031019851565361023
peripheral O 1 0.9949226975440979
blood O 1 0.9963926672935486
lymphocytes O 1 0.9958571791648865
. O 0 0.05813000723719597

In O 0 0.047806717455387115
ataxia B-Disease 1 0.9987917542457581
- I-Disease 1 0.9589409232139587
telangiectasia I-Disease 1 0.99904865026474
( O 0 0.0410202220082283
A B-Disease 0 0.033310357481241226
- I-Disease 1 0.7516502737998962
T I-Disease 1 0.9899356961250305
) O 0 0.03278063237667084
patients O 1 0.9908509850502014
, O 0 0.011054056696593761
mutations O 1 0.8449649810791016
in O 0 0.00667336443439126
a O 0 0.007768640760332346
single O 0 0.01260668970644474
gene O 0 0.43018826842308044
, O 0 0.006984603125602007
ATM O 0 0.031508054584264755
, O 0 0.006248136050999165
result O 0 0.011688816361129284
in O 0 0.008933820761740208
an O 0 0.03713757172226906
autosomal B-Disease 1 0.9999206066131592
recessive I-Disease 1 0.9999656677246094
syndrome I-Disease 1 0.999976396560669
that O 0 0.017164960503578186
embraces O 0 0.15914812684059143
a O 0 0.008985819295048714
variety O 0 0.010592454113066196
of O 0 0.007926968857645988
clinical O 0 0.4836719334125519
features O 0 0.01141653023660183
and O 0 0.00795464962720871
manifests O 0 0.4557371139526367
extreme O 0 0.16458822786808014
radiosensitivity O 0 0.2862851917743683
and O 0 0.007678755093365908
a O 0 0.010135811753571033
strong O 0 0.014870326966047287
pre O 0 0.0756494328379631
- O 0 0.08284801989793777
disposition O 0 0.14068156480789185
to O 0 0.02486230805516243
malignancy B-Disease 1 0.9868099689483643
. O 0 0.04594824090600014

Heterozygotes O 1 0.5466001033782959
for O 0 0.012870675884187222
the O 0 0.011777187697589397
ATM O 0 0.1606592833995819
gene O 0 0.46949532628059387
have O 0 0.007639942690730095
no O 0 0.006935008801519871
clinical O 0 0.25283631682395935
expression O 0 0.016346275806427002
of O 0 0.005318686831742525
A B-Disease 0 0.01513152290135622
- I-Disease 1 0.6652140021324158
T I-Disease 1 0.9812427759170532
but O 0 0.007208466995507479
may O 0 0.012950207106769085
be O 0 0.007775597739964724
cancer B-Disease 1 0.9991957545280457
prone O 1 0.8482592701911926
with O 0 0.006186293438076973
a O 0 0.009076768532395363
moderate O 0 0.038594767451286316
increase O 0 0.013788190670311451
in O 0 0.008075371384620667
in O 0 0.01303645595908165
vitro O 1 0.6235032677650452
radiosensitivity O 1 0.6742473244667053
. O 0 0.03981926664710045

We O 0 0.018635060638189316
performed O 0 0.019396204501390457
a O 0 0.017108779400587082
blind O 0 0.4655155539512634
chromosomal O 1 0.9770085215568542
analysis O 0 0.016939083114266396
on O 0 0.009574007242918015
G2 O 1 0.9601691365242004
- O 0 0.15172213315963745
phase O 0 0.1679174154996872
lymphocytes O 1 0.9738117456436157
from O 0 0.012182614766061306
7 O 0 0.0145802553743124
unrelated O 0 0.039617616683244705
A B-Disease 0 0.02786966972053051
- I-Disease 1 0.8192546367645264
T I-Disease 1 0.9954355359077454
patients O 1 0.993977427482605
, O 0 0.010160474106669426
13 O 0 0.014946628361940384
obligate O 0 0.24926547706127167
A B-Disease 0 0.027688711881637573
- I-Disease 1 0.8454041481018066
T I-Disease 1 0.9950706958770752
heterozygotes O 1 0.9830728769302368
( O 0 0.015905942767858505
parents O 0 0.013254078105092049
of O 0 0.006112790200859308
the O 0 0.007959453389048576
patients O 1 0.9604464173316956
) O 0 0.008006356656551361
, O 0 0.005184635985642672
and O 0 0.00503032049164176
14 O 0 0.009971070103347301
normal O 0 0.016589224338531494
controls O 0 0.017783813178539276
following O 0 0.012637175619602203
X O 0 0.05021066591143608
- O 0 0.028387948870658875
irradiation O 0 0.06590209156274796
with O 0 0.007797525729984045
1 O 0 0.012656562961637974
Gy O 1 0.6357383131980896
in O 0 0.006608347874134779
order O 0 0.0070160068571567535
to O 0 0.005377531982958317
evaluate O 0 0.013951648026704788
this O 0 0.006919020786881447
cytogenetic O 0 0.340242475271225
method O 0 0.011717512272298336
as O 0 0.005284924525767565
a O 0 0.006607093382626772
tool O 0 0.013991003856062889
for O 0 0.008029104210436344
detection O 0 0.02775311842560768
of O 0 0.013414938002824783
ATM O 0 0.17077553272247314
carriers O 0 0.12139707803726196
. O 0 0.038883935660123825

Both O 0 0.024932201951742172
A B-Disease 0 0.0358712375164032
- I-Disease 1 0.510115385055542
T I-Disease 1 0.9816988706588745
homozygotes O 1 0.9616854190826416
and O 0 0.019202345982193947
heterozygotes O 1 0.9116235971450806
showed O 0 0.032713230699300766
significantly O 0 0.03716328740119934
increased O 0 0.019590534269809723
levels O 0 0.018565697595477104
of O 0 0.012977915816009045
radiation O 1 0.9820913672447205
- O 1 0.8957882523536682
induced O 1 0.9964667558670044
chromatid O 1 0.9966404438018799
damage O 1 0.8056744337081909
relative O 0 0.017175815999507904
to O 0 0.0063987476751208305
that O 0 0.0062903729267418385
of O 0 0.008538959547877312
normal O 0 0.03129120543599129
controls O 0 0.04195369780063629
. O 0 0.03221004828810692

These O 0 0.018045589327812195
results O 0 0.017704345285892487
show O 0 0.011057368479669094
that O 0 0.005406871438026428
the O 0 0.007877429015934467
G2 O 1 0.90981125831604
- O 0 0.18359704315662384
phase O 0 0.2915870249271393
chromosomal O 1 0.9947131276130676
radiosensitivity O 1 0.8981398940086365
assay O 0 0.06329573690891266
can O 0 0.006743398495018482
be O 0 0.003220916260033846
used O 0 0.0033375651109963655
for O 0 0.0031930566765367985
the O 0 0.004317943938076496
detection O 0 0.01616511680185795
of O 0 0.007640423718839884
A B-Disease 0 0.020727595314383507
- I-Disease 1 0.5616875290870667
T I-Disease 1 0.9794111847877502
heterozygotes O 1 0.9620555639266968
. O 0 0.0560421347618103

In O 0 0.019650571048259735
combination O 0 0.036284226924180984
with O 0 0.01296820119023323
molecular O 0 0.08335667848587036
genetic O 0 0.3713957667350769
analyses O 0 0.01715865358710289
, O 0 0.00501946359872818
this O 0 0.004149863962084055
test O 0 0.006512584630399942
may O 0 0.0045782653614878654
be O 0 0.002177806571125984
of O 0 0.0022787924390286207
value O 0 0.003575284266844392
in O 0 0.0032654686365276575
studies O 0 0.0073583959601819515
of O 0 0.0065190731547772884
familial B-Disease 1 0.9967644214630127
and I-Disease 0 0.012880457565188408
sporadic I-Disease 1 0.9850956797599792
cancers I-Disease 1 0.999271810054779
aimed O 0 0.02225029096007347
at O 0 0.008426972664892673
determination O 0 0.010755162686109543
of O 0 0.005329512059688568
the O 0 0.005507936235517263
potential O 0 0.013412452302873135
involvement O 0 0.021159719675779343
of O 0 0.010222602635622025
ATM O 1 0.8983561396598816
mutations O 1 0.9946475625038147
in O 0 0.036607228219509125
tumor B-Disease 1 0.9993645548820496
risk O 1 0.9604641199111938
or O 0 0.015087799169123173
development O 0 0.016511620953679085
. O 0 0.014823339879512787
. O 0 0.02519705705344677

Ataxia B-Disease 1 0.9989066123962402
- I-Disease 1 0.9619899392127991
telangiectasia I-Disease 1 0.9967831373214722
: O 0 0.02474180981516838
identification O 0 0.019392898306250572
and O 0 0.007372620049864054
detection O 0 0.021232064813375473
of O 0 0.00709173921495676
founder O 0 0.029029540717601776
- O 0 0.31236523389816284
effect O 0 0.11899591982364655
mutations O 1 0.8446140289306641
in O 0 0.008080804720520973
the O 0 0.010033831000328064
ATM O 0 0.20369088649749756
gene O 0 0.24329859018325806
in O 0 0.014492392539978027
ethnic O 0 0.0370110347867012
populations O 0 0.1137724369764328
. O 0 0.033942848443984985

To O 0 0.014380077831447124
facilitate O 0 0.022837208583950996
the O 0 0.008606634102761745
evaluation O 0 0.017168186604976654
of O 0 0.00922244880348444
ATM O 0 0.2933254539966583
heterozygotes O 1 0.8534674048423767
for O 0 0.010503264144062996
susceptibility O 1 0.9872433543205261
to O 0 0.00679771788418293
other O 0 0.008171036839485168
diseases O 1 0.9976508021354675
, O 0 0.007632783614099026
such O 0 0.007563566789031029
as O 0 0.04873655363917351
breast B-Disease 1 0.9999030828475952
cancer I-Disease 1 0.9996724128723145
, O 0 0.005741978529840708
we O 0 0.0034713302738964558
have O 0 0.0031452493276447058
attempted O 0 0.006334666628390551
to O 0 0.003130170749500394
define O 0 0.006919122766703367
the O 0 0.004089058376848698
most O 0 0.0050278315320611
common O 0 0.012682371772825718
mutations O 1 0.8730378746986389
and O 0 0.005120750050991774
their O 0 0.006232186686247587
frequencies O 0 0.01563883386552334
in O 0 0.01121912058442831
ataxia B-Disease 1 0.9989473223686218
- I-Disease 1 0.9638769030570984
telangiectasia I-Disease 1 0.9992979764938354
( O 0 0.040381863713264465
A B-Disease 0 0.031779296696186066
- I-Disease 1 0.5303220748901367
T I-Disease 1 0.9563592076301575
) O 0 0.021997841075062752
homozygotes O 1 0.6808520555496216
from O 0 0.014859314076602459
10 O 0 0.019607683643698692
ethnic O 0 0.035430118441581726
populations O 0 0.0991130918264389
. O 0 0.0350235253572464

Both O 0 0.035455651581287384
genomic O 1 0.867224395275116
mutations O 1 0.9590429663658142
and O 0 0.009844346903264523
their O 0 0.010280675254762173
effects O 0 0.036047954112291336
on O 0 0.010718701407313347
cDNA O 0 0.053890157490968704
were O 0 0.01574544422328472
characterized O 0 0.11398328840732574
. O 0 0.03137388452887535

Protein O 0 0.17601002752780914
- O 0 0.07750972360372543
truncation O 0 0.14642658829689026
testing O 0 0.02419048361480236
of O 0 0.008248110301792622
the O 0 0.008719789795577526
entire O 0 0.02195989526808262
ATM O 0 0.09039954841136932
cDNA O 0 0.10353388637304306
detected O 0 0.11331307142972946
92 O 0 0.02887660451233387
( O 0 0.016753440722823143
66 O 0 0.021926799789071083
% O 0 0.0159296877682209
) O 0 0.017739655449986458
truncating O 1 0.8247817754745483
mutations O 1 0.9404687881469727
in O 0 0.015702897682785988
140 O 0 0.06240984424948692
mutant O 1 0.9463191032409668
alleles O 1 0.9774682521820068
screened O 0 0.12864068150520325
. O 0 0.043173979967832565

The O 0 0.02682931162416935
haplotyping O 0 0.3329790234565735
of O 0 0.01641172543168068
patients O 1 0.9737328290939331
with O 0 0.010416294448077679
identical O 0 0.06722592562437057
mutations O 1 0.9715369939804077
indicates O 0 0.01649031788110733
that O 0 0.004062243737280369
almost O 0 0.004515781998634338
all O 0 0.0026853340677917004
of O 0 0.003211584873497486
these O 0 0.0035825620871037245
represent O 0 0.006681916769593954
common O 0 0.008795388974249363
ancestry O 0 0.020003240555524826
and O 0 0.004358778242021799
that O 0 0.004723244812339544
very O 0 0.0088672349229455
few O 0 0.011807521805167198
spontaneously O 1 0.705598771572113
recurring O 1 0.9730114340782166
ATM O 1 0.9085553288459778
mutations O 1 0.9887874722480774
exist O 0 0.04234156385064125
. O 0 0.03782820329070091

Assays O 0 0.14662808179855347
requiring O 0 0.05280023813247681
minimal O 0 0.04058150574564934
amounts O 0 0.021897878497838974
of O 0 0.01003201398998499
genomic O 0 0.39341339468955994
DNA O 0 0.024768071249127388
were O 0 0.005338795017451048
designed O 0 0.007846313528716564
to O 0 0.004819247405976057
allow O 0 0.009750348515808582
rapid O 0 0.028569893911480904
screening O 0 0.030879566445946693
for O 0 0.00889268796890974
common O 0 0.025193896144628525
ethnic O 0 0.06335479021072388
mutations O 1 0.9809199571609497
. O 0 0.04301762953400612

These O 0 0.025292934849858284
rapid O 0 0.09895221889019012
assays O 0 0.27771440148353577
detected O 1 0.5939419865608215
mutations O 1 0.8637813329696655
in O 0 0.012803470715880394
76 O 0 0.02515234611928463
% O 0 0.011769309639930725
of O 0 0.008278042078018188
Costa O 0 0.028636429458856583
Rican O 0 0.10341811180114746
patients O 1 0.987489640712738
( O 0 0.01206770446151495
3 O 0 0.010627959854900837
) O 0 0.0066764624789357185
, O 0 0.0044309538789093494
50 O 0 0.006419492419809103
% O 0 0.006621465086936951
of O 0 0.005103337578475475
Norwegian O 0 0.01834835298359394
patients O 1 0.967706024646759
( O 0 0.010339431464672089
1 O 0 0.008812999352812767
) O 0 0.006106055341660976
, O 0 0.004250433761626482
25 O 0 0.006909757852554321
% O 0 0.006771370302885771
of O 0 0.005643294658511877
Polish O 0 0.09273219853639603
patients O 1 0.9886423945426941
( O 0 0.010196100920438766
4 O 0 0.009135421365499496
) O 0 0.0048644389025866985
, O 0 0.0031030511017888784
and O 0 0.0031763040460646152
14 O 0 0.0065681529231369495
% O 0 0.006681132595986128
of O 0 0.005951965693384409
Italian O 0 0.039482347667217255
patients O 1 0.9816871285438538
( O 0 0.010597292333841324
1 O 0 0.007581993937492371
) O 0 0.005143572576344013
, O 0 0.0032783052884042263
as O 0 0.002533597405999899
well O 0 0.003262238809838891
as O 0 0.0031887113582342863
in O 0 0.005046529695391655
patients O 1 0.7823629379272461
of O 0 0.007447963580489159
Amish O 0 0.2984738349914551
/ O 0 0.36450397968292236
Mennonite O 0 0.055093005299568176
and O 0 0.012006441131234169
Irish O 0 0.02805222198367119
English O 0 0.026284746825695038
backgrounds O 0 0.048996083438396454
. O 0 0.03469531983137131

Additional O 0 0.04219718649983406
mutations O 1 0.7778110504150391
were O 0 0.01099636685103178
observed O 0 0.016815420240163803
in O 0 0.00650857575237751
Japanese O 0 0.011553090065717697
, O 0 0.006952464580535889
Utah O 0 0.014639394357800484
Mormon O 0 0.016786009073257446
, O 0 0.007139840628951788
and O 0 0.007476981729269028
African O 0 0.026405591517686844
American O 0 0.030628813430666924
patients O 1 0.9738392233848572
. O 0 0.035517845302820206

These O 0 0.02115265466272831
assays O 0 0.044102638959884644
should O 0 0.01108319777995348
facilitate O 0 0.01943700946867466
screening O 0 0.02872975543141365
for O 0 0.008119046688079834
A B-Disease 0 0.016637759283185005
- I-Disease 0 0.399056613445282
T I-Disease 1 0.9807217121124268
heterozygotes O 1 0.768805742263794
in O 0 0.010606885887682438
the O 0 0.011291975155472755
populations O 0 0.05064299330115318
studied O 0 0.02242031879723072
. O 0 0.016695933416485786
. O 0 0.025807322934269905

The O 0 0.05163760855793953
von B-Disease 1 0.8531966209411621
Hippel I-Disease 1 0.9897945523262024
- I-Disease 1 0.9737409353256226
Lindau I-Disease 1 0.9978455305099487
tumor I-Disease 1 0.999413251876831
suppressor O 1 0.9968401193618774
gene O 1 0.900160551071167
is O 0 0.014036801643669605
required O 0 0.011977090500295162
for O 0 0.009740706533193588
cell O 0 0.12828800082206726
cycle O 0 0.06651954352855682
exit O 0 0.050330858677625656
upon O 0 0.02886022999882698
serum O 1 0.8058881163597107
withdrawal O 0 0.10295344144105911
. O 0 0.0433809757232666

The O 0 0.024521399289369583
inactivation O 0 0.1634678691625595
of O 0 0.011381414718925953
the O 0 0.016431229189038277
von B-Disease 1 0.794378399848938
Hippel I-Disease 1 0.9914284348487854
- I-Disease 1 0.9347202777862549
Lindau I-Disease 1 0.9939113855361938
( I-Disease 0 0.4813993573188782
VHL I-Disease 1 0.9982074499130249
) I-Disease 1 0.5149655342102051
tumor I-Disease 1 0.9995112419128418
suppressor O 1 0.9987363219261169
gene O 1 0.9949253797531128
predisposes O 1 0.9971707463264465
affected O 1 0.6711550354957581
individuals O 0 0.020413672551512718
to O 0 0.008593160659074783
the O 0 0.012521857395768166
human O 1 0.9508371949195862
VHL B-Disease 1 0.9998526573181152
cancer I-Disease 1 0.9999568462371826
syndrome I-Disease 1 0.9999665021896362
and O 0 0.013941889628767967
is O 0 0.011162083595991135
associated O 0 0.022898294031620026
with O 0 0.016177890822291374
sporadic B-Disease 1 0.9901793003082275
renal I-Disease 1 0.9999313354492188
cell I-Disease 1 0.9980692267417908
carcinomas I-Disease 1 0.9997020363807678
( O 1 0.5198797583580017
RCC B-Disease 1 0.9874841570854187
) O 0 0.02461487613618374
and O 0 0.020967507734894753
brain B-Disease 1 0.9923110008239746
hemangioblastomas I-Disease 1 0.9203686714172363
. O 0 0.04416368901729584

VHL O 1 0.9822429418563843
- O 0 0.39904075860977173
negative O 0 0.2437073439359665
786 O 1 0.9561874866485596
- O 0 0.37389546632766724
0 O 0 0.1884455531835556
RCC B-Disease 1 0.9802613258361816
cells O 1 0.6471889615058899
are O 0 0.009773967787623405
tumorigenic O 0 0.4447995126247406
in O 0 0.011844846419990063
nude O 1 0.508323609828949
mice O 1 0.818732500076294
which O 0 0.008190710097551346
is O 0 0.008667105808854103
suppressed O 0 0.035387616604566574
by O 0 0.008697280660271645
the O 0 0.01073418464511633
reintroduction O 0 0.08476489037275314
of O 0 0.02303515002131462
VHL B-Disease 1 0.9827881455421448
. O 0 0.04708123579621315

Remarkably O 0 0.06029962748289108
, O 0 0.0118651632219553
this O 0 0.010105930268764496
occurs O 0 0.022692769765853882
without O 0 0.008996118791401386
affecting O 0 0.04342139884829521
the O 0 0.007011243607848883
growth O 0 0.015416023321449757
rate O 0 0.014522034674882889
and O 0 0.00830442551523447
cell O 0 0.05381384491920471
cycle O 0 0.038213182240724564
profile O 0 0.025588246062397957
of O 0 0.007573519833385944
these O 0 0.008095174096524715
cells O 0 0.07612893730401993
in O 0 0.011519704014062881
culture O 0 0.026323674246668816
. O 0 0.02561771683394909

The O 0 0.03112737648189068
786 O 1 0.6556345224380493
- O 0 0.09905975311994553
0 O 0 0.03437190130352974
cell O 0 0.040855489671230316
line O 0 0.012800993397831917
, O 0 0.007513620425015688
like O 0 0.010560886934399605
many O 0 0.013040311634540558
cancer B-Disease 1 0.9989796280860901
cells O 1 0.7587175965309143
, O 0 0.007619860582053661
fails O 0 0.018843574449419975
to O 0 0.005741396453231573
exit O 0 0.015246976166963577
the O 0 0.0080278804525733
cell O 0 0.05546075850725174
cycle O 0 0.05146465077996254
upon O 0 0.02340851165354252
serum O 1 0.8852788209915161
withdrawal O 0 0.13121211528778076
. O 0 0.036204077303409576

Here O 0 0.014195983298122883
, O 0 0.007678450085222721
it O 0 0.004753741901367903
is O 0 0.0051911803893744946
shown O 0 0.007344369310885668
that O 0 0.004648435860872269
reintroduction O 0 0.0215399619191885
of O 0 0.0053605674766004086
the O 0 0.007592054083943367
wild O 0 0.02759142965078354
- O 0 0.2750556170940399
type O 0 0.41801586747169495
VHL B-Disease 1 0.995216965675354
gene O 1 0.954204261302948
restores O 0 0.15285515785217285
the O 0 0.011674211360514164
ability O 0 0.020938154309988022
of O 0 0.015464127995073795
VHL O 1 0.9977549910545349
- O 1 0.9401276707649231
negative O 1 0.9629371762275696
RCC B-Disease 1 0.998611330986023
cancer I-Disease 1 0.9996966123580933
cells O 1 0.8651956915855408
to O 0 0.009128911420702934
exit O 0 0.021177327260375023
the O 0 0.009752737358212471
cell O 0 0.04582267999649048
cycle O 0 0.03593534231185913
and O 0 0.01288028247654438
enter O 0 0.03137311711907387
G0 O 1 0.9771395325660706
/ O 1 0.5806339383125305
quiescence O 1 0.8272197246551514
in O 0 0.027858853340148926
low O 0 0.07103918492794037
serum O 1 0.683409571647644
. O 0 0.04886028170585632

Both O 0 0.04032309725880623
VHL O 1 0.9898684024810791
- O 0 0.13732540607452393
positive O 0 0.04469313099980354
and O 0 0.02306925505399704
VHL O 1 0.9955845475196838
- O 1 0.784784734249115
negative O 1 0.6127398014068604
RCC B-Disease 1 0.9863668084144592
cells O 1 0.7144265174865723
exit O 0 0.039521217346191406
the O 0 0.014609374105930328
cell O 0 0.07334800064563751
cycle O 0 0.05397667735815048
by O 0 0.018631428480148315
contact O 0 0.05396711081266403
inhibition O 1 0.605951726436615
. O 0 0.042741380631923676

The O 0 0.040204714983701706
cyclin O 1 0.9690563082695007
- O 0 0.44302675127983093
dependent O 0 0.3984763026237488
kinase O 1 0.9770869612693787
inhibitor O 1 0.9551011919975281
, O 0 0.021647294983267784
p27 O 1 0.9605933427810669
, O 0 0.017841067165136337
accumulates O 0 0.45053982734680176
upon O 0 0.020216936245560646
serum O 1 0.7518497109413147
withdrawal O 0 0.028245285153388977
, O 0 0.005404530558735132
only O 0 0.003754277713596821
in O 0 0.003723397385329008
the O 0 0.004218707792460918
presence O 0 0.008533438667654991
of O 0 0.006241179537028074
VHL B-Disease 1 0.9722220301628113
, O 0 0.0051705362275242805
as O 0 0.0035550252068787813
a O 0 0.005177990533411503
result O 0 0.006476268172264099
of O 0 0.003926237113773823
the O 0 0.0057037328369915485
stabilization O 0 0.019029097631573677
of O 0 0.007821248844265938
the O 0 0.010664728470146656
protein O 0 0.04793514683842659
. O 0 0.023918932303786278

We O 0 0.014074317179620266
propose O 0 0.019316822290420532
that O 0 0.00592718506231904
the O 0 0.006365823093801737
loss O 0 0.014026807621121407
of O 0 0.006821434944868088
wild O 0 0.029267294332385063
- O 0 0.2919847071170807
type O 0 0.450009822845459
VHL B-Disease 1 0.9958850741386414
gene O 1 0.7109256386756897
results O 0 0.014053217135369778
in O 0 0.006810897961258888
a O 0 0.008652925491333008
specific O 0 0.01360896322876215
cellular O 0 0.1936500370502472
defect O 1 0.7750369906425476
in O 0 0.009901550598442554
serum O 1 0.8963901400566101
- O 0 0.09983707964420319
dependent O 0 0.06794378906488419
growth O 0 0.02462146431207657
control O 0 0.017538027837872505
, O 0 0.007630025502294302
which O 0 0.00918334536254406
may O 0 0.024513188749551773
initiate O 1 0.6380837559700012
tumor B-Disease 1 0.9971184730529785
formation O 0 0.19232885539531708
. O 0 0.039393167942762375

This O 0 0.019127080217003822
is O 0 0.015200921334326267
corrected O 0 0.03262229636311531
by O 0 0.00872538797557354
the O 0 0.0074154529720544815
reintroduction O 0 0.03129157796502113
of O 0 0.008179085329174995
wild O 0 0.05430105701088905
- O 0 0.36551108956336975
type O 1 0.5047951340675354
VHL B-Disease 1 0.994601845741272
, O 0 0.017766930162906647
implicating O 1 0.7744141817092896
VHL B-Disease 1 0.9894309043884277
as O 0 0.01040560845285654
the O 0 0.00901775248348713
first O 0 0.012739045545458794
tumor B-Disease 1 0.998885452747345
suppressor O 1 0.9850718379020691
involved O 0 0.015890471637248993
in O 0 0.005881470162421465
the O 0 0.006127527914941311
regulation O 0 0.015502717345952988
of O 0 0.007745987270027399
cell O 0 0.04876096919178963
cycle O 0 0.03237288072705269
exit O 0 0.018992744386196136
, O 0 0.005434684921056032
which O 0 0.005495124496519566
is O 0 0.0056893909350037575
consistent O 0 0.009168040938675404
with O 0 0.0056573436595499516
its O 0 0.00879749283194542
gatekeeper O 1 0.5823009014129639
function O 0 0.019209951162338257
in O 0 0.009299827739596367
the O 0 0.013114788569509983
kidney O 1 0.998531699180603
. O 0 0.017832377925515175
. O 0 0.029787711799144745

Piebaldism B-Disease 1 0.93778395652771
with O 0 0.04108520597219467
deafness B-Disease 1 0.9978162050247192
: O 0 0.02592414990067482
molecular O 0 0.03780898079276085
evidence O 0 0.012509464286267757
for O 0 0.008357596583664417
an O 0 0.01348965521901846
expanded O 0 0.12392527610063553
syndrome O 1 0.9996212720870972
. O 0 0.04188923537731171

In O 0 0.019559569656848907
a O 0 0.017803972586989403
South O 0 0.017579173669219017
African O 0 0.025169221684336662
girl O 0 0.0343116894364357
of O 0 0.01266905851662159
Xhosa O 1 0.7053046226501465
stock O 0 0.04439834505319595
with O 0 0.023180905729532242
severe O 1 0.9975542426109314
piebaldism B-Disease 1 0.9858686923980713
and O 0 0.04079589992761612
profound O 1 0.9978151321411133
congenital O 1 0.9999722242355347
sensorineural B-Disease 1 0.9997804760932922
deafness I-Disease 1 0.9997727274894714
we O 0 0.014463729225099087
identified O 0 0.02047526277601719
a O 0 0.010934135876595974
novel O 0 0.027568712830543518
missense O 1 0.8904460072517395
substitution O 0 0.02339812181890011
at O 0 0.008228568360209465
a O 0 0.008608699776232243
highly O 0 0.015704696998000145
conserved O 0 0.01956135965883732
residue O 0 0.021442588418722153
in O 0 0.007665816228836775
the O 0 0.010405671782791615
intracellular O 0 0.44996997714042664
kinase O 0 0.46845337748527527
domain O 0 0.020819703117012978
of O 0 0.009050952270627022
the O 0 0.01309247873723507
KIT O 1 0.509392261505127
proto O 1 0.9515331983566284
- O 1 0.7101628184318542
oncogene O 1 0.9842432737350464
, O 0 0.03434177115559578
R796G O 1 0.5795922875404358
. O 0 0.04623282328248024

Though O 0 0.05021729692816734
auditory B-Disease 1 0.9614678621292114
anomalies I-Disease 1 0.6018351316452026
have O 0 0.01146190706640482
been O 0 0.01121643278747797
observed O 0 0.018091117963194847
in O 0 0.009292533621191978
mice O 0 0.49114564061164856
with O 0 0.009366086684167385
dominant O 0 0.16513898968696594
white O 0 0.034528713673353195
spotting O 1 0.8356753587722778
( O 0 0.02990945242345333
W O 1 0.6204939484596252
) O 0 0.011568614281713963
due O 0 0.01266419142484665
to O 0 0.008205423131585121
KIT O 1 0.7161332964897156
mutations O 1 0.9942634701728821
, O 0 0.015966005623340607
deafness B-Disease 1 0.9987953901290894
is O 0 0.00874023512005806
not O 0 0.006266011390835047
typical O 0 0.017950063571333885
in O 0 0.00999116525053978
human O 0 0.06503354012966156
piebaldism B-Disease 1 0.7099140286445618
. O 0 0.03776083514094353

Thus O 0 0.029963629320263863
, O 0 0.012119004502892494
the O 0 0.010636039078235626
occurrence O 0 0.09755030274391174
of O 0 0.017036715522408485
sensorineural B-Disease 1 0.9991427659988403
deafness I-Disease 1 0.9994649291038513
in O 0 0.01238905731588602
this O 0 0.011477897875010967
patient O 1 0.946101188659668
extends O 0 0.07446648180484772
considerably O 0 0.02918081358075142
the O 0 0.010123117826879025
phenotypic O 0 0.3919227123260498
range O 0 0.01210283674299717
of O 0 0.007905294187366962
piebaldism B-Disease 1 0.5922539830207825
due O 0 0.015980029478669167
to O 0 0.0103883296251297
KIT O 1 0.8102694749832153
gene O 1 0.9799129962921143
mutation O 1 0.9858705401420593
in O 0 0.01270225178450346
humans O 0 0.1474376618862152
and O 0 0.008980476297438145
tightens O 1 0.7631528377532959
the O 0 0.010694161057472229
clinical O 0 0.4752684235572815
similarity O 0 0.04955180361866951
between O 0 0.01168906968086958
piebaldism B-Disease 0 0.16075466573238373
and O 0 0.005727329757064581
the O 0 0.006102739833295345
various O 0 0.007672544103115797
forms O 0 0.02048756740987301
of O 0 0.024981027469038963
Waardenburg B-Disease 1 0.9997285008430481
syndrome I-Disease 1 0.9998745918273926
. O 0 0.033655885607004166
. O 0 0.03794476017355919

Cycloheximide O 0 0.4800526797771454
facilitates O 0 0.04764488711953163
the O 0 0.011325356550514698
identification O 0 0.016514990478754044
of O 0 0.00925651378929615
aberrant O 0 0.23520533740520477
transcripts O 0 0.019908104091882706
resulting O 0 0.021535679697990417
from O 0 0.008437653072178364
a O 0 0.010660413652658463
novel O 0 0.023570343852043152
splice O 0 0.43085864186286926
- O 0 0.05421708524227142
site O 0 0.02103467471897602
mutation O 1 0.8834447860717773
in O 0 0.010136313736438751
COL17A1 O 0 0.4225848913192749
in O 0 0.009493548423051834
a O 0 0.01405913196504116
patient O 1 0.950546145439148
with O 0 0.04057137295603752
generalized O 1 0.9969053864479065
atrophic B-Disease 1 0.9992514252662659
benign I-Disease 1 0.9988377690315247
epidermolysis I-Disease 1 0.9984617233276367
bullosa I-Disease 1 0.9950858950614929
. O 0 0.09855449944734573

Patients O 1 0.9823028445243835
with O 0 0.06790686398744583
generalized O 1 0.9957246780395508
atrophic B-Disease 1 0.9993966817855835
benign I-Disease 1 0.9995383024215698
epidermolysis I-Disease 1 0.9994913339614868
bullosa I-Disease 1 0.9987232089042664
often O 0 0.0721798986196518
show O 0 0.030940191820263863
decreased O 0 0.37323689460754395
expression O 0 0.03403150662779808
of O 0 0.01260213740170002
type O 1 0.7477167844772339
XVII O 1 0.9970272183418274
collagen O 1 0.9922139048576355
, O 0 0.01249752938747406
a O 0 0.019342707470059395
transmembrane O 1 0.8655120730400085
hemidesmosomal O 1 0.822752833366394
protein O 0 0.0938609167933464
encoded O 0 0.04078104346990585
by O 0 0.026040304452180862
COL17A1 O 1 0.5579268932342529
. O 0 0.04445376992225647

This O 0 0.015121719799935818
report O 0 0.014333403669297695
documents O 0 0.009316641837358475
a O 0 0.009717089124023914
novel O 0 0.02280857041478157
splice O 1 0.6302313804626465
- O 0 0.05648898705840111
site O 0 0.01860806532204151
mutation O 1 0.8870128393173218
in O 0 0.01106671616435051
COL17A1 O 0 0.19024907052516937
in O 0 0.010680860839784145
a O 0 0.014944649301469326
patient O 1 0.8838606476783752
with O 0 0.023838868364691734
generalized O 1 0.9938642978668213
atrophic B-Disease 1 0.9996134638786316
benign I-Disease 1 0.9994339346885681
epidermolysis I-Disease 1 0.9995280504226685
bullosa I-Disease 1 0.9981641173362732
, O 0 0.01372800674289465
and O 0 0.008091675117611885
applies O 0 0.012871499173343182
a O 0 0.006884452421218157
new O 0 0.00614091707393527
methodology O 0 0.010566544719040394
to O 0 0.004972169641405344
define O 0 0.01060447096824646
and O 0 0.006022091489285231
characterize O 0 0.025257674977183342
the O 0 0.010753199458122253
resulting O 0 0.04749297350645065
mRNA O 0 0.07235397398471832
splice O 0 0.47463372349739075
variants O 0 0.0893435999751091
. O 0 0.036115508526563644

Mutational O 1 0.7243403792381287
analysis O 0 0.04275134950876236
of O 0 0.018455492332577705
COL17A1 O 0 0.49894973635673523
identified O 0 0.03104551136493683
a O 0 0.020045526325702667
maternally O 1 0.9286446571350098
inherited O 1 0.9724665284156799
G O 0 0.45608437061309814
- O 0 0.04156184941530228
to O 0 0.009716318920254707
- O 0 0.13461899757385254
T O 1 0.8501001596450806
transversion O 0 0.2005487084388733
at O 0 0.009172980673611164
the O 0 0.007373384200036526
- O 0 0.018826592713594437
1 O 0 0.010978877544403076
position O 0 0.010675833560526371
of O 0 0.011475042439997196
exon O 0 0.07284890115261078
32 O 0 0.03982071951031685
. O 0 0.032291311770677567

This O 0 0.03569507971405983
acceptor O 0 0.20126371085643768
splice O 0 0.32984113693237305
- O 0 0.04961303249001503
site O 0 0.025245796889066696
mutation O 1 0.7599494457244873
led O 0 0.012300189584493637
to O 0 0.0059982966631650925
the O 0 0.0066744014620780945
formation O 0 0.017256850376725197
of O 0 0.009149269200861454
aberrant O 0 0.13633371889591217
transcripts O 0 0.019835909828543663
present O 0 0.013360527344048023
at O 0 0.012644544243812561
extremely O 0 0.029317781329154968
low O 0 0.03653113916516304
levels O 0 0.03969859331846237
. O 0 0.03112371638417244

Based O 0 0.02033964730799198
on O 0 0.010160814970731735
our O 0 0.00941406562924385
recent O 0 0.016943370923399925
finding O 0 0.018456581979990005
that O 0 0.013622322119772434
cycloheximide O 1 0.8218590021133423
stabilized O 1 0.8985942006111145
mutant O 1 0.9186480641365051
COL17A1 O 1 0.6970241665840149
transcripts O 0 0.034960877150297165
in O 0 0.016917601227760315
keratinocytes O 1 0.9263849854469299
homozygous O 1 0.7616774439811707
for O 0 0.012573771178722382
a O 0 0.019318459555506706
frameshift O 1 0.990278422832489
mutation O 1 0.9844878315925598
, O 0 0.008730193600058556
the O 0 0.007709663826972246
effects O 0 0.022427009418606758
of O 0 0.005746463779360056
the O 0 0.007179396227002144
splice O 0 0.2721511125564575
- O 0 0.0489584319293499
site O 0 0.018785027787089348
mutation O 1 0.5971167087554932
on O 0 0.009742693975567818
splicing O 0 0.03731108456850052
of O 0 0.010548866353929043
COL17A1 O 0 0.3063291311264038
transcripts O 0 0.018365442752838135
were O 0 0.0065491595305502415
determined O 0 0.014772201888263226
using O 0 0.013631928712129593
reverse O 0 0.16364605724811554
transcriptase O 1 0.9554758667945862
polymerase O 1 0.6022853851318359
chain O 0 0.0635782778263092
reaction O 0 0.03107423707842827
of O 0 0.011130553670227528
total O 0 0.01871022954583168
RNA O 0 0.04784249886870384
from O 0 0.0209369920194149
keratinocytes O 1 0.5964579582214355
incubated O 0 0.06097820773720741
for O 0 0.01837310940027237
2 O 0 0.03107963129878044
. O 0 0.029235338792204857

5 O 0 0.03625106438994408
h O 0 0.03534029424190521
in O 0 0.0068180556409060955
the O 0 0.005970710888504982
presence O 0 0.011826259084045887
or O 0 0.0072406502440571785
absence O 0 0.013040701858699322
of O 0 0.00823886413127184
10 O 0 0.017915936186909676
microg O 1 0.6653885245323181
cycloheximide O 1 0.6998433470726013
per O 0 0.03795574605464935
ml O 1 0.7155212163925171
. O 0 0.046464405953884125

Using O 0 0.0217936709523201
this O 0 0.011037176474928856
approach O 0 0.016434619203209877
, O 0 0.007728693075478077
an O 0 0.010845199227333069
abnormally O 1 0.5718863606452942
spliced O 0 0.07668344676494598
transcript O 0 0.026210887357592583
was O 0 0.00832950510084629
identified O 0 0.010247479192912579
that O 0 0.004887822084128857
contains O 0 0.00669215340167284
an O 0 0.005819374695420265
extra O 0 0.01277843490242958
264 O 0 0.02384634129703045
bases O 0 0.01704666018486023
upstream O 0 0.0227192509919405
from O 0 0.010745922103524208
exon O 0 0.05522673577070236
32 O 0 0.01544226799160242
, O 0 0.008481456898152828
resulting O 0 0.019761500880122185
in O 0 0.008644047193229198
a O 0 0.015822481364011765
premature O 1 0.9601185917854309
termination O 1 0.7937958836555481
codon O 0 0.35651037096977234
27 O 0 0.030040249228477478
bp O 0 0.03648332133889198
downstream O 0 0.0333108976483345
from O 0 0.012905623763799667
the O 0 0.016926437616348267
cryptic O 0 0.1511046439409256
splice O 0 0.3648298978805542
site O 0 0.037739478051662445
. O 0 0.03724927455186844

Three O 0 0.017202114686369896
other O 0 0.01221505831927061
splice O 0 0.16675132513046265
variants O 0 0.022617589682340622
, O 0 0.005388088058680296
including O 0 0.004809723235666752
one O 0 0.004835669882595539
derived O 0 0.008761626668274403
from O 0 0.005436423234641552
the O 0 0.004489671904593706
skipping O 0 0.016817903146147728
of O 0 0.007884043268859386
exon O 0 0.07505263388156891
32 O 0 0.012892006896436214
, O 0 0.005999391432851553
were O 0 0.005402424838393927
also O 0 0.008620155043900013
identified O 0 0.024132337421178818
. O 0 0.023921411484479904

These O 0 0.016338931396603584
results O 0 0.01978078857064247
indicate O 0 0.015041039325296879
the O 0 0.009172768332064152
usefulness O 0 0.02867390401661396
of O 0 0.010817591100931168
cycloheximide O 1 0.8460347652435303
treatment O 0 0.447046160697937
in O 0 0.008594521321356297
evaluating O 0 0.01967182382941246
the O 0 0.008819600567221642
abnormal O 1 0.5227080583572388
processing O 0 0.015143025666475296
of O 0 0.007614212576299906
mRNA O 0 0.024797018617391586
due O 0 0.011956293135881424
to O 0 0.007478602230548859
splice O 1 0.542706310749054
- O 0 0.11617746949195862
site O 0 0.022617191076278687
mutations O 1 0.9392349720001221
, O 0 0.008782673627138138
because O 0 0.011103122495114803
( O 0 0.011007547378540039
i O 0 0.010396248660981655
) O 0 0.012782669626176357
aberrant O 0 0.21712259948253632
splicing O 0 0.10163802653551102
often O 0 0.016604363918304443
generates O 0 0.03495055437088013
a O 0 0.020918624475598335
premature O 1 0.9338603615760803
termination O 1 0.6412820816040039
codon O 0 0.25133538246154785
, O 0 0.011775500141084194
( O 0 0.014989507384598255
ii O 0 0.021827520802617073
) O 0 0.009007947519421577
transcripts O 0 0.017137840390205383
with O 0 0.012182834558188915
premature O 1 0.9841321706771851
termination O 1 0.948137104511261
codons O 1 0.5129031538963318
can O 0 0.012421450577676296
occur O 0 0.019043872132897377
at O 0 0.008527616038918495
low O 0 0.017311187461018562
or O 0 0.011352896690368652
undetectable O 1 0.6596727967262268
levels O 0 0.01895170845091343
due O 0 0.010602003894746304
to O 0 0.006794647313654423
nonsense O 0 0.026860907673835754
- O 0 0.06006159633398056
mediated O 1 0.514520525932312
mRNA O 0 0.04524843767285347
decay O 0 0.031734153628349304
, O 0 0.006059010047465563
and O 0 0.004571782890707254
( O 0 0.0070442138239741325
iii O 0 0.013092338107526302
) O 0 0.004730326123535633
the O 0 0.0034319108817726374
levels O 0 0.006955428048968315
of O 0 0.0034350757487118244
these O 0 0.0039137788116931915
transcripts O 0 0.009042629040777683
can O 0 0.006554852705448866
be O 0 0.005518122110515833
increased O 0 0.015248220413923264
by O 0 0.016336509957909584
cycloheximide O 0 0.2203328013420105
. O 0 0.03404751420021057

A O 0 0.051935140043497086
deletion O 1 0.9251030683517456
mutation O 1 0.9628335237503052
in O 0 0.019179146736860275
COL17A1 O 0 0.1713903248310089
in O 0 0.012203365564346313
five O 0 0.013531570322811604
Austrian O 0 0.030701808631420135
families O 0 0.025117702782154083
with O 0 0.025921417400240898
generalized O 1 0.9960659146308899
atrophic B-Disease 1 0.9996427297592163
benign I-Disease 1 0.9988036155700684
epidermolysis I-Disease 1 0.9991708993911743
bullosa I-Disease 1 0.9973859190940857
represents O 0 0.08365502953529358
propagation O 0 0.05564027279615402
of O 0 0.013819921761751175
an O 0 0.020090099424123764
ancestral O 0 0.13873693346977234
allele O 1 0.8598477244377136
. O 0 0.0490802563726902

Patients O 1 0.9881961345672607
with O 0 0.06617569178342819
generalized O 1 0.9946784973144531
atrophic B-Disease 1 0.9996297359466553
benign I-Disease 1 0.998838484287262
epidermolysis I-Disease 1 0.999083399772644
bullosa I-Disease 1 0.9968283772468567
, O 0 0.02166273444890976
a O 0 0.019575374200940132
usually O 0 0.020617911592125893
nonlethal O 0 0.06627321243286133
form O 0 0.02425079233944416
of O 0 0.025662807747721672
junctional B-Disease 1 0.9960129261016846
epidermolysis I-Disease 1 0.9989843964576721
bullosa I-Disease 1 0.9975007176399231
, O 0 0.022103434428572655
have O 0 0.017794335260987282
generalized O 1 0.9293506741523743
blistering B-Disease 1 0.9005330801010132
, O 0 0.0340854786336422
nail B-Disease 1 0.996641993522644
dystrophy I-Disease 1 0.9997493624687195
, O 0 0.17586836218833923
patchy B-Disease 1 0.9951045513153076
alopecia I-Disease 1 0.999273955821991
, O 0 0.029484495520591736
and O 0 0.02976958639919758
dental B-Disease 1 0.995415210723877
abnormalities I-Disease 1 0.9970045685768127
. O 0 0.051737017929553986

Skin B-Disease 1 0.9953120946884155
fragility I-Disease 1 0.8158960342407227
in O 0 0.01462367083877325
most O 0 0.011120429262518883
cases O 0 0.015710290521383286
is O 0 0.007019016891717911
due O 0 0.009855963289737701
to O 0 0.005980213638395071
mutations O 1 0.6132786870002747
in O 0 0.007076076697558165
the O 0 0.01023623626679182
gene O 1 0.7592921257019043
encoding O 0 0.2715423107147217
type O 1 0.8832104802131653
XVII O 1 0.9944948554039001
collagen O 1 0.9954885840415955
( O 0 0.05525873601436615
COL17A1 O 1 0.8293044567108154
) O 0 0.03646177053451538
. O 0 0.03571580350399017

Recently O 0 0.03232242912054062
, O 0 0.010672484524548054
we O 0 0.007204707246273756
reported O 0 0.012491852045059204
five O 0 0.00879181083291769
Austrian O 0 0.029418963938951492
families O 0 0.02225576713681221
with O 0 0.023122521117329597
generalized O 1 0.9947819113731384
atrophic B-Disease 1 0.9996505975723267
benign I-Disease 1 0.9991658926010132
epidermolysis I-Disease 1 0.9991781115531921
bullosa I-Disease 1 0.9981745481491089
who O 0 0.028484605252742767
share O 0 0.02737496607005596
the O 0 0.01647808775305748
same O 0 0.028580285608768463
COL17A1 O 1 0.9493734836578369
mutation O 1 0.9831369519233704
. O 0 0.04582685977220535

Affected O 0 0.13355979323387146
individuals O 0 0.019227387383580208
in O 0 0.007501696702092886
three O 0 0.0066993143409490585
families O 0 0.01050255075097084
are O 0 0.006157102528959513
homozygous O 0 0.20723913609981537
for O 0 0.007300541736185551
4003delTC O 0 0.48283302783966064
, O 0 0.006975808646529913
whereas O 0 0.01062321662902832
those O 0 0.004307521972805262
in O 0 0.004285627044737339
two O 0 0.004775117617100477
others O 0 0.009627626277506351
are O 0 0.010194018483161926
compound O 0 0.041929394006729126
heterozygotes O 1 0.8794010877609253
. O 0 0.045497916638851166

To O 0 0.015631141141057014
determine O 0 0.016629725694656372
if O 0 0.007665170356631279
the O 0 0.0062790741212666035
occurrence O 0 0.027058592066168785
of O 0 0.006864713970571756
4003delTC O 0 0.12203402817249298
in O 0 0.007430166471749544
these O 0 0.006065250374376774
unrelated O 0 0.022215276956558228
families O 0 0.01399946678429842
signifies O 0 0.05222246050834656
propagation O 0 0.020777711644768715
of O 0 0.006131570786237717
an O 0 0.00883856974542141
ancestral O 0 0.05446137115359306
allele O 1 0.7298797369003296
or O 0 0.013471044600009918
a O 0 0.014957030303776264
mutational O 1 0.9409496784210205
hot O 0 0.04497254639863968
spot O 0 0.020059917122125626
, O 0 0.009656097739934921
haplotypes O 1 0.5914496779441833
were O 0 0.0064259800128638744
determined O 0 0.010999084450304508
for O 0 0.007083575241267681
polymorphisms O 0 0.3779066503047943
both O 0 0.009174523875117302
within O 0 0.012327133677899837
and O 0 0.013561121188104153
flanking O 0 0.15216563642024994
COL17A1 O 1 0.6038382649421692
. O 0 0.049143556505441666

Five O 0 0.039960093796253204
intragenic O 1 0.6916570067405701
polymorphisms O 0 0.3026960492134094
were O 0 0.009122761897742748
chosen O 0 0.01139375101774931
based O 0 0.010075998492538929
on O 0 0.009017410688102245
their O 0 0.01457681693136692
informativeness O 0 0.16517296433448792
. O 0 0.03245122358202934

One O 0 0.011211727745831013
of O 0 0.0065016476437449455
these O 0 0.004636761732399464
, O 0 0.004299493506550789
not O 0 0.003970240242779255
previously O 0 0.006321596913039684
reported O 0 0.008365828543901443
, O 0 0.004869233351200819
was O 0 0.005906153470277786
2988 O 0 0.040324337780475616
A O 0 0.007602137979120016
or O 0 0.007215513847768307
C O 0 0.013203124515712261
that O 0 0.004731494002044201
introduces O 0 0.01343205850571394
a O 0 0.006519416347146034
new O 0 0.007430232595652342
restriction O 0 0.015986764803528786
site O 0 0.010600498877465725
for O 0 0.009944869205355644
Eco0109 O 0 0.16218410432338715
I O 0 0.023900248110294342
. O 0 0.02572314813733101

All O 0 0.019488602876663208
the O 0 0.018451610580086708
4003delTC O 1 0.7344316244125366
alleles O 1 0.790296733379364
showed O 0 0.020770007744431496
the O 0 0.008977602235972881
same O 0 0.01167241856455803
haplotype O 0 0.28035521507263184
for O 0 0.0070194159634411335
these O 0 0.00830597709864378
five O 0 0.015156913548707962
polymorphic O 1 0.9406635761260986
markers O 0 0.20938092470169067
. O 0 0.03220147266983986

Fourteen O 0 0.06460148841142654
microsatellite O 1 0.9295171499252319
polymorphisms O 0 0.44171223044395447
were O 0 0.007549301255494356
selected O 0 0.007693247403949499
based O 0 0.0060719652101397514
on O 0 0.004183888901025057
their O 0 0.005126739386469126
high O 0 0.009008828550577164
heterozygosity O 0 0.14813794195652008
and O 0 0.005458417814224958
their O 0 0.00605538347736001
location O 0 0.01014990545809269
within O 0 0.014056343585252762
10q23 O 1 0.6221023797988892
- O 0 0.10107943415641785
q25 O 1 0.6317968368530273
near O 0 0.045999202877283096
COL17A1 O 1 0.7336165904998779
. O 0 0.046694956719875336

Three O 0 0.023177461698651314
families O 0 0.02773228846490383
shared O 0 0.028817450627684593
microsatellite O 1 0.9546394944190979
polymorphisms O 1 0.8664574027061462
covering O 0 0.0236275102943182
at O 0 0.010680070146918297
most O 0 0.00807091873139143
19 O 0 0.013307048007845879
cM O 0 0.022029170766472816
, O 0 0.00535473832860589
whereas O 0 0.008905341848731041
the O 0 0.004426820203661919
others O 0 0.006611508317291737
shared O 0 0.008461822755634785
smaller O 0 0.009998265653848648
regions O 0 0.011550388298928738
consistent O 0 0.009073796682059765
with O 0 0.004806213546544313
cross O 0 0.011426764540374279
- O 0 0.014756208285689354
over O 0 0.006571236997842789
events O 0 0.00829425361007452
during O 0 0.007952200248837471
passage O 0 0.00942146684974432
of O 0 0.005813175812363625
this O 0 0.007903285324573517
mutation O 1 0.6947538256645203
through O 0 0.013985407538712025
several O 0 0.015936192125082016
generations O 0 0.04659703001379967
. O 0 0.034732576459646225

These O 0 0.020230108872056007
results O 0 0.021805157884955406
indicate O 0 0.017861900851130486
that O 0 0.009109998121857643
4003delTC O 0 0.12816277146339417
occurs O 0 0.022280745208263397
on O 0 0.007384927477687597
a O 0 0.00975591130554676
single O 0 0.018354887142777443
ancestral O 0 0.07693233340978622
allele O 1 0.7741917967796326
. O 0 0.025274135172367096
. O 0 0.03428035229444504

The O 0 0.04698728024959564
haptoglobin O 1 0.8650896549224854
- O 0 0.4106162190437317
gene O 1 0.8412775993347168
deletion O 1 0.7911233305931091
responsible O 0 0.04715421423316002
for O 0 0.027683401480317116
anhaptoglobinemia B-Disease 0 0.3768311142921448
. O 0 0.04575195536017418

We O 0 0.016001541167497635
have O 0 0.009993604384362698
found O 0 0.012875462882220745
an O 0 0.010747521184384823
allelic O 0 0.3993160128593445
deletion O 0 0.1536734402179718
of O 0 0.008280904963612556
the O 0 0.01036264467984438
haptoglobin O 1 0.869537353515625
( O 0 0.0170277189463377
Hp O 0 0.03835844248533249
) O 0 0.012037260457873344
gene O 0 0.08185191452503204
from O 0 0.007121496368199587
an O 0 0.005860863719135523
individual O 0 0.011246887966990471
with O 0 0.01321633905172348
anhaptoglobinemia B-Disease 0 0.35965272784233093
. O 0 0.029653174802660942

The O 0 0.031093018129467964
Hp O 0 0.08532435446977615
gene O 0 0.46984410285949707
cluster O 0 0.03843794763088226
consists O 0 0.014446412213146687
of O 0 0.008429729379713535
coding O 0 0.03264043107628822
regions O 0 0.014663061127066612
of O 0 0.005697651766240597
the O 0 0.006554032675921917
alpha O 0 0.02404201030731201
chain O 0 0.024492833763360977
and O 0 0.006975976750254631
beta O 0 0.022435562685132027
chain O 0 0.018073922023177147
of O 0 0.006938503589481115
the O 0 0.010576210916042328
haptoglobin O 1 0.9462750554084778
gene O 1 0.7764118313789368
( O 0 0.01424331869930029
Hp O 0 0.020232919603586197
) O 0 0.006877615116536617
and O 0 0.0034791233483701944
of O 0 0.0035335717257112265
the O 0 0.00524939363822341
alpha O 0 0.018195083364844322
chain O 0 0.020953623577952385
and O 0 0.006282920017838478
beta O 0 0.024087166413664818
chain O 0 0.02069144695997238
of O 0 0.0067777615040540695
the O 0 0.009490691125392914
haptoglobin O 1 0.8689323663711548
- O 0 0.11744916439056396
related O 0 0.12911951541900635
gene O 1 0.9473229050636292
( O 0 0.02662697620689869
Hpr O 1 0.9369044899940491
) O 0 0.011017290875315666
, O 0 0.005454298108816147
in O 0 0.006560835521668196
tandem O 0 0.01716703735291958
from O 0 0.00818428210914135
the O 0 0.007695126347243786
5 O 0 0.014912736602127552
side O 0 0.023985913023352623
. O 0 0.027785325422883034

Southern O 0 0.05051225796341896
blot O 0 0.2551947832107544
and O 0 0.014792689122259617
PCR O 0 0.1618998646736145
analyses O 0 0.018647952005267143
have O 0 0.006854893174022436
indicated O 0 0.009201672859489918
that O 0 0.003733356948941946
the O 0 0.004134383983910084
individual O 0 0.006692476570606232
with O 0 0.005962704308331013
anhaptoglobinemia B-Disease 0 0.18553191423416138
was O 0 0.008092992007732391
homozygous O 0 0.09310659021139145
for O 0 0.006293354090303183
the O 0 0.008346506394445896
gene O 1 0.5050450563430786
deletion O 0 0.4119589328765869
and O 0 0.0049195075407624245
that O 0 0.004501126706600189
the O 0 0.007863533683121204
gene O 0 0.43418970704078674
deletion O 0 0.2620605230331421
was O 0 0.0075450618751347065
included O 0 0.005512169562280178
at O 0 0.005018094554543495
least O 0 0.005920423660427332
from O 0 0.0047654747031629086
the O 0 0.006046728231012821
promoter O 0 0.051037196069955826
region O 0 0.01274890173226595
of O 0 0.007367264945060015
Hp O 0 0.02641792595386505
to O 0 0.010896204970777035
Hpr O 1 0.8623248338699341
alpha O 0 0.02388903871178627
but O 0 0.006878364365547895
not O 0 0.005871513858437538
to O 0 0.010913295671343803
Hpr O 1 0.9511197805404663
beta O 0 0.17494916915893555
( O 0 0.029395146295428276
Hpdel O 1 0.5005553960800171
) O 0 0.029509462416172028
. O 0 0.030333131551742554

In O 0 0.01575775258243084
addition O 0 0.013964373618364334
, O 0 0.005538323428481817
we O 0 0.0037572267465293407
found O 0 0.005008487030863762
seven O 0 0.004943902138620615
individuals O 0 0.006911937613040209
with O 0 0.005798418074846268
hypohaptoglobinemia B-Disease 0 0.08651770651340485
in O 0 0.004445264115929604
three O 0 0.004271463956683874
families O 0 0.00654905429109931
, O 0 0.003764501539990306
and O 0 0.0032068060245364904
the O 0 0.004013275261968374
genotypes O 0 0.2995143234729767
of O 0 0.0036497446708381176
six O 0 0.003899750066921115
of O 0 0.0030353956390172243
the O 0 0.003451692406088114
seven O 0 0.005151400808244944
individuals O 0 0.007402096409350634
were O 0 0.004417988006025553
found O 0 0.006982992868870497
to O 0 0.005523200612515211
be O 0 0.009755781851708889
Hp2 O 1 0.5417094230651855
/ O 0 0.3394277095794678
Hpdel O 1 0.5672244429588318
. O 0 0.04222068563103676

The O 0 0.029239391908049583
phenotypes O 1 0.7931307554244995
and O 0 0.012827993370592594
genotypes O 1 0.5239870548248291
in O 0 0.006573460064828396
one O 0 0.004159649834036827
of O 0 0.003547661006450653
these O 0 0.0031299612019211054
three O 0 0.0033711816649883986
families O 0 0.0061171576380729675
showed O 0 0.007698072120547295
the O 0 0.004374803509563208
father O 0 0.009560645557940006
to O 0 0.005389099474996328
be O 0 0.0065199811942875385
hypohaptoglobinemic B-Disease 0 0.2901037037372589
( O 0 0.01711873523890972
Hp2 O 0 0.20538513362407684
) O 0 0.011480062268674374
and O 0 0.009381390176713467
Hp2 O 1 0.8466781973838806
/ O 0 0.3176361322402954
Hpdel O 0 0.32500335574150085
, O 0 0.007528387941420078
the O 0 0.006759194657206535
mother O 0 0.012885254807770252
to O 0 0.005718739237636328
be O 0 0.006676968187093735
Hp2 O 0 0.24899254739284515
- O 0 0.02467259392142296
1 O 0 0.012331499718129635
and O 0 0.008360853418707848
Hp1 O 1 0.7524040341377258
/ O 0 0.3486805260181427
Hp2 O 0 0.14320863783359528
, O 0 0.005928511265665293
one O 0 0.003593045985326171
of O 0 0.0033459935802966356
the O 0 0.003415603656321764
two O 0 0.00370066799223423
children O 0 0.00783766619861126
to O 0 0.0039863744750618935
be O 0 0.006069882307201624
hypohaptoglobinemic B-Disease 0 0.33651983737945557
( O 0 0.015441419556736946
Hp2 O 0 0.2272839993238449
) O 0 0.010804221034049988
and O 0 0.0075948815792799
Hp2 O 1 0.9071281552314758
/ O 0 0.33402201533317566
Hpdel O 0 0.203042134642601
, O 0 0.005162193905562162
and O 0 0.0030869452748447657
the O 0 0.003538109827786684
other O 0 0.0036769153084605932
child O 0 0.010709821246564388
to O 0 0.004372963681817055
be O 0 0.005276523996144533
Hp1 O 0 0.21174417436122894
and O 0 0.00989941880106926
Hp1 O 1 0.9127892255783081
/ O 1 0.6008673310279846
Hpdel O 0 0.4644239544868469
, O 0 0.010746785439550877
showing O 0 0.016532596200704575
an O 0 0.01019931212067604
anomalous O 0 0.1455846130847931
inheritance O 0 0.13287150859832764
of O 0 0.011491172015666962
Hp O 0 0.07628027349710464
phenotypes O 1 0.8713746666908264
in O 0 0.008629904128611088
the O 0 0.009116139262914658
child O 0 0.03804557025432587
with O 0 0.01884918101131916
Hp1 O 1 0.8055820465087891
. O 0 0.039567433297634125

The O 0 0.03477037698030472
Hp2 O 1 0.9504305124282837
/ O 1 0.6267384886741638
Hpdel O 1 0.8185322284698486
individuals O 0 0.01841099187731743
had O 0 0.009351343847811222
an O 0 0.007246605586260557
extremely O 0 0.014823075383901596
low O 0 0.013234803453087807
level O 0 0.008587782271206379
of O 0 0.006390221416950226
Hp O 0 0.0283851008862257
( O 0 0.01542912982404232
mean O 0 0.02169889584183693
+ O 0 0.16762486100196838
/ O 0 0.12873826920986176
- O 0 0.06658841669559479
SD O 1 0.5223566293716431
= O 0 0.06064798682928085
0 O 0 0.028347566723823547
. O 0 0.01606408879160881
049 O 1 0.9595298171043396
+ O 0 0.33571889996528625
/ O 0 0.15093818306922913
- O 0 0.041697271168231964
0 O 0 0.02758103609085083
. O 0 0.015129022300243378
043 O 1 0.9407826662063599
mg O 1 0.9632608294487
/ O 1 0.6748248934745789
ml O 1 0.8417260646820068
; O 0 0.02231292985379696
n O 0 0.03557642549276352
= O 0 0.02998443692922592
6 O 0 0.012745128944516182
) O 0 0.007782800123095512
, O 0 0.004346360452473164
compared O 0 0.007706505712121725
with O 0 0.0032428763806819916
the O 0 0.0038831315468996763
level O 0 0.006412771996110678
( O 0 0.006781168282032013
1 O 0 0.006527813617140055
. O 0 0.004966089501976967
64 O 0 0.013408169150352478
+ O 0 0.06101033091545105
/ O 0 0.047800589352846146
- O 0 0.022003985941410065
1 O 0 0.01227548997849226
. O 0 0.009426007978618145
07 O 0 0.14296945929527283
mg O 1 0.7278954386711121
/ O 0 0.2619055211544037
ml O 1 0.6335906386375427
) O 0 0.012443916872143745
obtained O 0 0.010799537412822247
from O 0 0.011094539426267147
52 O 0 0.023991484194993973
healthy O 0 0.2947942614555359
volunteers O 0 0.03571503981947899
having O 0 0.02872736193239689
phenotype O 1 0.9902530908584595
Hp2 O 1 0.7066459655761719
, O 0 0.011098024435341358
whereas O 0 0.015429940074682236
the O 0 0.008421092294156551
serum O 0 0.33556067943573
Hp O 0 0.02083321288228035
level O 0 0.008703555911779404
of O 0 0.005054256413131952
an O 0 0.005448204930871725
individual O 0 0.010593983344733715
with O 0 0.012212756089866161
Hp1 O 1 0.9312471151351929
/ O 1 0.7039173245429993
Hpdel O 1 0.7133625149726868
was O 0 0.026915930211544037
0 O 0 0.05393621698021889
. O 0 0.040238190442323685

50 O 0 0.06012527272105217
mg O 1 0.8526048064231873
/ O 0 0.21335555613040924
ml O 0 0.24101895093917847
, O 0 0.009363578632473946
which O 0 0.006333697121590376
was O 0 0.0053671663627028465
approximately O 0 0.007769118528813124
half O 0 0.00570019381120801
the O 0 0.004180782474577427
level O 0 0.0066380989737808704
of O 0 0.005618293769657612
Hp O 0 0.01740364544093609
in O 0 0.006502627395093441
control O 0 0.015826011076569557
sera O 0 0.029429230839014053
from O 0 0.009701941162347794
the O 0 0.010431304574012756
Hp1 O 1 0.9515586495399475
phenotype O 1 0.9912420511245728
( O 0 0.01588262990117073
1 O 0 0.011317946948111057
. O 0 0.00718961376696825
26 O 0 0.016670284792780876
+ O 0 0.0976526141166687
/ O 0 0.061039507389068604
- O 0 0.027418699115514755
0 O 0 0.017544077709317207
. O 0 0.008751966990530491
33 O 0 0.022698841989040375
mg O 1 0.7120602130889893
/ O 0 0.18852992355823517
ml O 1 0.5687927603721619
; O 0 0.01771288737654686
n O 0 0.02822461538016796
= O 0 0.028111755847930908
9 O 0 0.013415385968983173
) O 0 0.008097424171864986
, O 0 0.005974963307380676
showing O 0 0.0139223113656044
a O 0 0.016018914058804512
gene O 1 0.7603651285171509
- O 0 0.22250938415527344
dosage O 1 0.8843725323677063
effect O 0 0.05771690607070923
. O 0 0.041337959468364716

The O 0 0.02099262736737728
other O 0 0.01668636128306389
allele O 1 0.6770620346069336
( O 0 0.01967032253742218
Hp2 O 0 0.13360455632209778
) O 0 0.008380468934774399
of O 0 0.0053163389675319195
individuals O 0 0.00986263994127512
with O 0 0.007263018283993006
Hp2 O 1 0.9585081934928894
/ O 1 0.8082347512245178
Hpdel O 1 0.5694630146026611
was O 0 0.006165551953017712
found O 0 0.005465623456984758
to O 0 0.002640250837430358
have O 0 0.0029567412566393614
, O 0 0.002702770521864295
in O 0 0.0032127639278769493
all O 0 0.0034491901751607656
exons O 0 0.04788784310221672
, O 0 0.005717817228287458
no O 0 0.008040269836783409
mutation O 1 0.7589062452316284
, O 0 0.00873214565217495
by O 0 0.012869683094322681
DNA O 0 0.0491693839430809
sequencing O 0 0.07173267006874084
. O 0 0.03728298842906952

On O 0 0.009973720647394657
the O 0 0.00561561482027173
basis O 0 0.005159349180757999
of O 0 0.003359762253239751
the O 0 0.003865988692268729
present O 0 0.005064590834081173
study O 0 0.005756694823503494
, O 0 0.0034721570555120707
the O 0 0.003604762488976121
mechanism O 0 0.011244837194681168
of O 0 0.005701540503650904
anhaptoglobinemia B-Disease 0 0.16921521723270416
and O 0 0.004666615277528763
the O 0 0.004888884257525206
mechanism O 0 0.015704859048128128
of O 0 0.00792666245251894
anomalous O 1 0.5106804370880127
inheritance O 0 0.27333641052246094
of O 0 0.010496730916202068
Hp O 0 0.25311124324798584
phenotypes O 1 0.9354405403137207
were O 0 0.009156933054327965
well O 0 0.01321395207196474
explained O 0 0.02810894139111042
. O 0 0.02441207505762577

However O 0 0.024253645911812782
, O 0 0.011096292175352573
the O 0 0.011508929543197155
mechanism O 0 0.02886955626308918
of O 0 0.01819711923599243
hypohaptoglobinemia B-Disease 1 0.6010549068450928
remains O 0 0.05556223914027214
unknown O 0 0.08493846654891968

ATM O 1 0.5613259673118591
mutations O 1 0.9390648603439331
and O 0 0.027964884415268898
phenotypes O 1 0.9581850171089172
in O 0 0.02805396541953087
ataxia B-Disease 1 0.9993545413017273
- I-Disease 1 0.984218418598175
telangiectasia I-Disease 1 0.9985653758049011
families O 0 0.02571827918291092
in O 0 0.007835118100047112
the O 0 0.00766725605353713
British O 0 0.014395000413060188
Isles O 0 0.09207739681005478
: O 0 0.010381307452917099
expression O 0 0.015628794208168983
of O 0 0.0073285833932459354
mutant O 0 0.43518203496932983
ATM O 0 0.0330517552793026
and O 0 0.005586637184023857
the O 0 0.008459282107651234
risk O 1 0.8329882621765137
of O 0 0.024991195648908615
leukemia B-Disease 1 0.999934196472168
, O 1 0.784899890422821
lymphoma B-Disease 1 0.9999599456787109
, O 0 0.09988969564437866
and O 0 0.11324498057365417
breast B-Disease 1 0.9995243549346924
cancer I-Disease 1 0.999045193195343
. O 0 0.062196049839258194

We O 0 0.012661837972700596
report O 0 0.01215279009193182
the O 0 0.00799544621258974
spectrum O 0 0.0191810242831707
of O 0 0.008444405160844326
59 O 0 0.028257543221116066
ATM O 1 0.5381384491920471
mutations O 1 0.9779893755912781
observed O 0 0.030664946883916855
in O 0 0.015295613557100296
ataxia B-Disease 1 0.9994452595710754
- I-Disease 1 0.9608995318412781
telangiectasia I-Disease 1 0.9987344145774841
( O 0 0.04243416711688042
A B-Disease 0 0.05560607463121414
- I-Disease 1 0.8131619691848755
T I-Disease 1 0.9889139533042908
) O 0 0.020969711244106293
patients O 1 0.8895513415336609
in O 0 0.008450360037386417
the O 0 0.010210157372057438
British O 0 0.025947555899620056
Isles O 0 0.15129391849040985
. O 0 0.03553376346826553

Of O 0 0.023895354941487312
51 O 0 0.046269550919532776
ATM O 0 0.3469054698944092
mutations O 1 0.9488130807876587
identified O 0 0.015102416276931763
in O 0 0.005811694078147411
families O 0 0.008470769040286541
native O 0 0.0059446184895932674
to O 0 0.003397975116968155
the O 0 0.0042174444533884525
British O 0 0.009150523692369461
Isles O 0 0.039482612162828445
, O 0 0.005568025633692741
11 O 0 0.00803961232304573
were O 0 0.00532064912840724
founder O 0 0.022631973028182983
mutations O 1 0.604507565498352
, O 0 0.004546674899756908
and O 0 0.0034513019490987062
2 O 0 0.004522483330219984
of O 0 0.003384204814210534
these O 0 0.004001439083367586
11 O 0 0.0078666927292943
conferred O 0 0.015802262350916862
a O 0 0.011333312839269638
milder O 1 0.9843281507492065
clinical O 1 0.9537243247032166
phenotype O 1 0.9923087358474731
with O 0 0.007269956637173891
respect O 0 0.007726642768830061
to O 0 0.0058713192120194435
both O 0 0.011947838589549065
cerebellar B-Disease 1 0.9981396198272705
degeneration I-Disease 1 0.9995948672294617
and O 0 0.019834430888295174
cellular O 0 0.3347051441669464
features O 0 0.03408512845635414
. O 0 0.03117828629910946

We O 0 0.0125677939504385
report O 0 0.01098975632339716
, O 0 0.005187182687222958
in O 0 0.004630370531231165
two O 0 0.005108390469104052
A B-Disease 0 0.011029412969946861
- I-Disease 0 0.09490765631198883
T I-Disease 1 0.8194320797920227
families O 0 0.015357732772827148
, O 0 0.00750713748857379
an O 0 0.010012516751885414
ATM O 0 0.1943085938692093
mutation O 1 0.9775845408439636
( O 0 0.021507132798433304
7271T O 1 0.5870903134346008
- O 0 0.22739331424236298
- O 0 0.461835116147995
> O 1 0.8973823189735413
G O 0 0.18082460761070251
) O 0 0.007612008601427078
that O 0 0.00396300433203578
may O 0 0.006167799700051546
be O 0 0.0030386096332222223
associated O 0 0.0059258053079247475
with O 0 0.0036169327795505524
an O 0 0.005604941863566637
increased O 0 0.0233834907412529
risk O 1 0.8349846601486206
of O 0 0.021725311875343323
breast B-Disease 1 0.9998879432678223
cancer I-Disease 1 0.9995965361595154
in O 0 0.01222126092761755
both O 0 0.013887978158891201
homozygotes O 1 0.9787333607673645
and O 0 0.013661512173712254
heterozygotes O 1 0.9731220602989197
( O 0 0.01644941046833992
relative O 0 0.022018346935510635
risk O 0 0.2161569893360138
12 O 0 0.009136910550296307
. O 0 0.006682505365461111
7 O 0 0.012876104563474655
; O 0 0.013718041591346264
P O 0 0.08248286694288254
= O 0 0.037369128316640854
. O 0 0.011643891222774982
0025 O 1 0.9218674898147583
) O 0 0.009142144583165646
, O 0 0.0046935114078223705
although O 0 0.004916656296700239
there O 0 0.0034300179686397314
is O 0 0.0036590243689715862
a O 0 0.005598827265202999
less O 0 0.010729336179792881
severe O 1 0.992032527923584
A B-Disease 0 0.07793854922056198
- I-Disease 1 0.8613303899765015
T I-Disease 1 0.9937445521354675
phenotype O 1 0.9633841514587402
in O 0 0.008149801753461361
terms O 0 0.008626670576632023
of O 0 0.0063240984454751015
the O 0 0.007254757918417454
degree O 0 0.015940546989440918
of O 0 0.019615663215517998
cerebellar B-Disease 1 0.9962144494056702
degeneration I-Disease 1 0.9983646273612976
. O 0 0.06879287213087082

This O 0 0.037831712514162064
mutation O 1 0.9631423950195312
( O 0 0.03177686035633087
7271T O 1 0.5542653799057007
- O 0 0.2344546616077423
- O 0 0.3941277265548706
> O 1 0.6814970970153809
G O 0 0.09977973252534866
) O 0 0.009030408225953579
also O 0 0.004929148592054844
allows O 0 0.008645003661513329
expression O 0 0.010641967877745628
of O 0 0.004909266252070665
full O 0 0.008593453094363213
- O 0 0.02297767996788025
length O 0 0.017318805679678917
ATM O 0 0.035484421998262405
protein O 0 0.01909773051738739
at O 0 0.005763731896877289
a O 0 0.0054669748060405254
level O 0 0.006890022661536932
comparable O 0 0.008563199080526829
with O 0 0.004875417798757553
that O 0 0.004679961130023003
in O 0 0.008301508612930775
unaffected O 0 0.2453429251909256
individuals O 0 0.030695345252752304
. O 0 0.027674047276377678

In O 0 0.015080452896654606
addition O 0 0.012696949765086174
, O 0 0.005775655619800091
we O 0 0.004233567044138908
have O 0 0.004682686645537615
studied O 0 0.0075855073519051075
18 O 0 0.008862065151333809
A B-Disease 0 0.013518412597477436
- I-Disease 1 0.7720122337341309
T I-Disease 1 0.993650496006012
patients O 1 0.985292375087738
, O 0 0.007061598356813192
in O 0 0.005751879885792732
15 O 0 0.008956140838563442
families O 0 0.010509173385798931
, O 0 0.006639872211962938
who O 0 0.013127150945365429
developed O 1 0.7825688123703003
leukemia B-Disease 1 0.9998937845230103
, O 0 0.34684842824935913
lymphoma B-Disease 1 0.9999451637268066
, O 0 0.06405576318502426
preleukemic O 1 0.9942851662635803
T O 1 0.9922109842300415
- O 1 0.7137529253959656
cell O 1 0.7936776280403137
proliferation O 1 0.7028001546859741
, O 0 0.01809545047581196
or O 0 0.29424190521240234
Hodgkin B-Disease 1 0.999932050704956
lymphoma I-Disease 1 0.9999159574508667
, O 0 0.019712619483470917
mostly O 0 0.01965450495481491
in O 0 0.017833763733506203
childhood O 1 0.8100556135177612
. O 0 0.036723170429468155

A O 0 0.027094053104519844
wide O 0 0.023528801277279854
variety O 0 0.01514752022922039
of O 0 0.008924921974539757
ATM O 1 0.5743381381034851
mutation O 1 0.9891505837440491
types O 0 0.020390527322888374
, O 0 0.006980721838772297
including O 0 0.009902887046337128
missense O 1 0.9893382787704468
mutations O 1 0.9824206233024597
and O 0 0.005893556866794825
in O 0 0.007383823394775391
- O 0 0.026934145018458366
frame O 0 0.02000211924314499
deletions O 0 0.1186097264289856
, O 0 0.006635119207203388
were O 0 0.005553894676268101
seen O 0 0.011584359221160412
in O 0 0.008501478470861912
these O 0 0.014653269201517105
patients O 1 0.9390696883201599
. O 0 0.03429362550377846

We O 0 0.013296515680849552
also O 0 0.007210071198642254
show O 0 0.008294601924717426
that O 0 0.0034562128130346537
25 O 0 0.005121017340570688
% O 0 0.004437151364982128
of O 0 0.0031005071941763163
all O 0 0.003462074091657996
A B-Disease 0 0.0109855430200696
- I-Disease 1 0.6506041884422302
T I-Disease 1 0.9962980151176453
patients O 1 0.9909446239471436
carried O 0 0.01115694735199213
in O 0 0.007879523560404778
- O 0 0.039875298738479614
frame O 0 0.027980968356132507
deletions O 0 0.39616644382476807
or O 0 0.020087236538529396
missense O 1 0.9735674858093262
mutations O 1 0.9623559713363647
, O 0 0.006514133885502815
many O 0 0.004446943756192923
of O 0 0.00349521916359663
which O 0 0.0036184070631861687
were O 0 0.0030892188660800457
also O 0 0.003968772012740374
associated O 0 0.007988338358700275
with O 0 0.00607710424810648
expression O 0 0.019088290631771088
of O 0 0.010835720226168633
mutant O 1 0.8197048902511597
ATM O 0 0.3687380850315094
protein O 0 0.0961032435297966
. O 0 0.03368924558162689

The O 0 0.04146871715784073
DMPK O 1 0.8544532060623169
gene O 1 0.7091582417488098
of O 0 0.03964054211974144
severely O 1 0.994045615196228
affected O 1 0.9951255917549133
myotonic B-Disease 1 0.9999005794525146
dystrophy I-Disease 1 0.9999490976333618
patients O 1 0.9988157749176025
is O 0 0.07223077118396759
hypermethylated O 1 0.9819737672805786
proximal O 1 0.9908610582351685
to O 0 0.012674380093812943
the O 0 0.013597771525382996
largely O 0 0.025249747559428215
expanded O 0 0.039702147245407104
CTG O 1 0.8247578740119934
repeat O 0 0.2410815954208374
. O 0 0.04849536344408989

Using O 0 0.03846299648284912
methylation O 0 0.068059042096138
- O 0 0.04940761625766754
sensitive O 0 0.03326554596424103
restriction O 0 0.03208453208208084
enzymes O 0 0.031411681324243546
, O 0 0.007083655335009098
we O 0 0.006201447919011116
characterized O 0 0.01817464642226696
the O 0 0.007077792193740606
methylation O 0 0.029870804399251938
pattern O 0 0.014024202711880207
on O 0 0.00427679717540741
the O 0 0.003992932382971048
5 O 0 0.00605648010969162
side O 0 0.005885056219995022
of O 0 0.00383658311329782
the O 0 0.0063889469020068645
CTG O 1 0.5371414422988892
repeat O 0 0.03101413883268833
in O 0 0.007050716783851385
the O 0 0.009366636164486408
DMPK O 1 0.7711303234100342
gene O 0 0.3518650233745575
of O 0 0.008548872545361519
normal O 0 0.020490363240242004
individuals O 0 0.010288689285516739
and O 0 0.005451616831123829
of O 0 0.00864996574819088
patients O 1 0.9966092109680176
affected O 1 0.9339672327041626
with O 0 0.28296664357185364
myotonic B-Disease 1 0.9998654127120972
dystrophy I-Disease 1 0.9999332427978516
, O 0 0.01988978125154972
showing O 0 0.028446434065699577
expansions O 0 0.02746465429663658
of O 0 0.009809095412492752
the O 0 0.016904892399907112
repetitive O 1 0.9513923525810242
sequence O 0 0.052389174699783325
. O 0 0.033616408705711365

The O 0 0.03566708788275719
gene O 0 0.2653239965438843
segment O 0 0.04894014820456505
analyzed O 0 0.032354794442653656
corresponds O 0 0.024329544976353645
to O 0 0.009571072645485401
the O 0 0.013539370149374008
genomic O 0 0.3549341559410095
SacI O 1 0.9096468687057495
- O 0 0.1425846964120865
HindIII O 1 0.6641318202018738
fragment O 0 0.0645427405834198
carrying O 0 0.024995004758238792
exons O 0 0.14695057272911072
11 O 0 0.024561895057559013
- O 0 0.04342737793922424
15 O 0 0.03333010524511337
. O 0 0.03172409161925316

There O 0 0.02173132263123989
is O 0 0.01739870384335518
constitutive O 0 0.11678861081600189
methylation O 0 0.07020028680562973
in O 0 0.014106336049735546
intron O 0 0.4757543206214905
12 O 0 0.013417104259133339
at O 0 0.008703861385583878
restriction O 0 0.0145652387291193
sites O 0 0.009195691905915737
of O 0 0.007239258848130703
SacII O 0 0.3751552402973175
and O 0 0.007793331053107977
HhaI O 1 0.5739988088607788
, O 0 0.010139252059161663
localized O 0 0.20641213655471802
1 O 0 0.011413910426199436
, O 0 0.007191536948084831
159 O 0 0.02222910150885582
- O 0 0.017560800537467003
1 O 0 0.009994719177484512
, O 0 0.006789176259189844
232 O 0 0.022667385637760162
bp O 0 0.024616612121462822
upstream O 0 0.016736313700675964
of O 0 0.006933976896107197
the O 0 0.008367307484149933
CTG O 1 0.5504589080810547
repeat O 0 0.043758030980825424
, O 0 0.007145630661398172
whereas O 0 0.010657095350325108
most O 0 0.004443335346877575
, O 0 0.0029036824125796556
if O 0 0.0029122892301529646
not O 0 0.0020379547495394945
all O 0 0.0016827606596052647
, O 0 0.001821177895180881
of O 0 0.0020915560889989138
the O 0 0.0028017954900860786
other O 0 0.003449229756370187
sites O 0 0.006699987221509218
of O 0 0.00615735212340951
SacII O 0 0.40779411792755127
, O 0 0.009425700642168522
HhaI O 0 0.31645968556404114
, O 0 0.007397675421088934
and O 0 0.0063231633976101875
HpaII O 0 0.08323721587657928
in O 0 0.006531212478876114
this O 0 0.005445107817649841
region O 0 0.011927715502679348
are O 0 0.006944074761122465
unmethylated O 0 0.3338516652584076
, O 0 0.005810773931443691
in O 0 0.006012132856994867
normal O 0 0.013384800404310226
individuals O 0 0.008411494083702564
and O 0 0.0038347032386809587
most O 0 0.005392733030021191
of O 0 0.006508692167699337
the O 0 0.012289898470044136
patients O 1 0.95513916015625
. O 0 0.032195765525102615

In O 0 0.013816776685416698
a O 0 0.011211855337023735
number O 0 0.007387011311948299
of O 0 0.00639701634645462
young O 0 0.01704847253859043
and O 0 0.009848949499428272
severely O 1 0.9891149997711182
affected O 1 0.8805715441703796
patients O 1 0.9935421943664551
, O 0 0.007148344069719315
however O 0 0.0064057656563818455
, O 0 0.004484129603952169
complete O 0 0.006443875841796398
methylation O 0 0.016789676621556282
of O 0 0.0035818624310195446
these O 0 0.004102143459022045
restriction O 0 0.011355801485478878
sites O 0 0.007120481692254543
was O 0 0.004919955972582102
found O 0 0.007074354682117701
in O 0 0.007161763962358236
the O 0 0.013268331065773964
mutated O 1 0.9360775947570801
allele O 1 0.864355742931366
. O 0 0.04208638519048691

In O 0 0.01382519956678152
most O 0 0.01047684345394373
of O 0 0.00819101557135582
these O 0 0.00973901990801096
patients O 1 0.9695956707000732
, O 0 0.0072155785746872425
the O 0 0.00952268298715353
onset O 1 0.9948288798332214
of O 0 0.012263862416148186
the O 0 0.026286857202649117
disease O 1 0.9997535347938538
was O 0 0.3809191584587097
congenital O 1 0.999566376209259
. O 0 0.06266333162784576

Preliminary O 0 0.040313348174095154
in O 0 0.021769927814602852
vivo O 0 0.43285447359085083
footprinting O 1 0.8946202397346497
data O 0 0.016455722972750664
gave O 0 0.011963291093707085
evidence O 0 0.009342759847640991
for O 0 0.007402558345347643
protein O 0 0.039411623030900955
- O 0 0.042664315551519394
DNA O 0 0.03246461972594261
contact O 0 0.016480838879942894
in O 0 0.007424622308462858
normal O 0 0.02069881185889244
genes O 0 0.07296089828014374
at O 0 0.007481272332370281
an O 0 0.00802908930927515
Sp1 O 1 0.6962432265281677
consensus O 0 0.016909219324588776
binding O 0 0.01666933111846447
site O 0 0.009319094009697437
upstream O 0 0.013373085297644138
of O 0 0.004840158857405186
the O 0 0.006842509843409061
CTG O 0 0.4169282019138336
repeat O 0 0.02205348014831543
and O 0 0.004441526252776384
for O 0 0.004027646966278553
a O 0 0.005785474553704262
significant O 0 0.008783574216067791
reduction O 0 0.012533579021692276
of O 0 0.004612949211150408
this O 0 0.004737935960292816
interaction O 0 0.011164708994328976
in O 0 0.006544632371515036
cells O 0 0.05939032882452011
with O 0 0.009571393020451069
a O 0 0.017515316605567932
hypermethylated O 1 0.9466553926467896
DMPK O 1 0.9816131591796875
gene O 1 0.778311014175415
. O 0 0.026172809302806854
. O 0 0.031861741095781326

The O 0 0.04552021250128746
hemochromatosis B-Disease 1 0.9985467791557312
gene O 1 0.8996150493621826
product O 0 0.033549755811691284
complexes O 0 0.03044462390244007
with O 0 0.00999404862523079
the O 0 0.013308662921190262
transferrin O 1 0.9395912885665894
receptor O 1 0.7111252546310425
and O 0 0.010152900591492653
lowers O 0 0.3729611337184906
its O 0 0.014662152156233788
affinity O 0 0.03752434626221657
for O 0 0.013735451735556126
ligand O 0 0.09252117574214935
binding O 0 0.04537619277834892
. O 0 0.03485235944390297

We O 0 0.015734413638710976
recently O 0 0.02042384073138237
reported O 0 0.016351774334907532
the O 0 0.008835562504827976
positional O 0 0.02861482836306095
cloning O 0 0.027742760255932808
of O 0 0.00778316892683506
a O 0 0.011508350260555744
candidate O 0 0.02597956173121929
gene O 1 0.6747589111328125
for O 0 0.023426979780197144
hereditary B-Disease 1 0.9977318644523621
hemochromatosis I-Disease 1 0.9997264742851257
called O 0 0.4578039050102234
HFE O 1 0.9884329438209534
. O 0 0.06463734060525894

The O 0 0.02203189767897129
gene O 0 0.2643696963787079
product O 0 0.015570126473903656
, O 0 0.005647866055369377
a O 0 0.005498992279171944
member O 0 0.00575868459418416
of O 0 0.004492526408284903
the O 0 0.006952318828552961
major O 0 0.017314165830612183
histocompatibility O 1 0.9925830364227295
complex O 0 0.019130272790789604
class O 0 0.015507811680436134
I O 0 0.008675264194607735
- O 0 0.015674907714128494
like O 0 0.007673498708754778
family O 0 0.0092910286039114
, O 0 0.004069115035235882
was O 0 0.00396663136780262
found O 0 0.004173681605607271
to O 0 0.003056109184399247
have O 0 0.004135994706302881
a O 0 0.00757240504026413
mutation O 1 0.9418672919273376
, O 0 0.013460066169500351
Cys O 1 0.9692408442497253
- O 0 0.20263461768627167
282 O 0 0.18698826432228088
- O 0 0.30861538648605347
- O 1 0.5379290580749512
> O 1 0.9298067688941956
Tyr O 1 0.968771755695343
( O 0 0.02239123359322548
C282Y O 0 0.21794460713863373
) O 0 0.011352596804499626
, O 0 0.0060606892220675945
in O 0 0.006767381448298693
85 O 0 0.015972374007105827
% O 0 0.013722507283091545
of O 0 0.014723307453095913
patient O 1 0.8942828178405762
chromosomes O 0 0.4848841726779938
. O 0 0.04562056064605713

This O 0 0.02782280556857586
mutation O 1 0.9109484553337097
eliminates O 0 0.052460793405771255
the O 0 0.011375272646546364
ability O 0 0.01764243096113205
of O 0 0.009692495688796043
HFE O 1 0.9121412038803101
to O 0 0.008300735615193844
associate O 0 0.016857633367180824
with O 0 0.01207569520920515
beta2 O 1 0.6869350075721741
- O 0 0.4284263849258423
microglobulin O 1 0.9068570137023926
( O 0 0.025319715961813927
beta2m O 1 0.655296802520752
) O 0 0.012615286745131016
and O 0 0.009520596824586391
prevents O 0 0.23183868825435638
cell O 0 0.1759202927350998
- O 0 0.0696837455034256
surface O 0 0.04214387759566307
expression O 0 0.058659978210926056
. O 0 0.03217136487364769

A O 0 0.02588515542447567
second O 0 0.022332431748509407
mutation O 1 0.8364138603210449
that O 0 0.00765640614554286
has O 0 0.007488908711820841
no O 0 0.006118865218013525
effect O 0 0.012617496773600578
on O 0 0.006663781125098467
beta2m O 1 0.5136727094650269
association O 0 0.017541101202368736
, O 0 0.007851867936551571
H63D O 0 0.4681621491909027
, O 0 0.004882589913904667
was O 0 0.004326976370066404
found O 0 0.004546288400888443
in O 0 0.003168881870806217
eight O 0 0.003880109405145049
out O 0 0.003936250228434801
of O 0 0.004688564222306013
nine O 0 0.011201983317732811
patients O 1 0.984870195388794
heterozygous O 1 0.6336027979850769
for O 0 0.010341783985495567
the O 0 0.015548696741461754
C282Y O 1 0.8556146025657654
mutant O 1 0.791248083114624
. O 0 0.04244089871644974

In O 0 0.01444084569811821
this O 0 0.008815349079668522
report O 0 0.00942227803170681
, O 0 0.006164249032735825
we O 0 0.006130751688033342
demonstrate O 0 0.011343618854880333
in O 0 0.008880223147571087
cultured O 0 0.14955732226371765
293 O 1 0.6026544570922852
cells O 1 0.8872489333152771
overexpressing O 1 0.9861934781074524
wild O 0 0.12695838510990143
- O 0 0.18646663427352905
type O 0 0.12470580637454987
or O 0 0.017505301162600517
mutant O 1 0.9465318322181702
HFE O 1 0.9828305244445801
proteins O 0 0.023748373612761497
that O 0 0.0052382079884409904
both O 0 0.00469215726479888
the O 0 0.00556964473798871
wild O 0 0.016838228330016136
- O 0 0.03834608942270279
type O 0 0.0342734232544899
and O 0 0.01354419719427824
H63D O 1 0.9715135097503662
HFE O 1 0.9937498569488525
proteins O 0 0.14024682343006134
form O 0 0.022963158786296844
stable O 0 0.06528609991073608
complexes O 0 0.03293853998184204
with O 0 0.010205586440861225
the O 0 0.016433648765087128
transferrin O 1 0.9737399220466614
receptor O 1 0.957149863243103
( O 0 0.04642541706562042
TfR O 1 0.8647369146347046
) O 0 0.036638982594013214
. O 0 0.0386311337351799

The O 0 0.03611864522099495
C282Y O 1 0.8061168193817139
mutation O 1 0.9532575011253357
nearly O 0 0.033947963267564774
completely O 0 0.02415420487523079
prevents O 0 0.04112797975540161
the O 0 0.009011504240334034
association O 0 0.012910496443510056
of O 0 0.0075144381262362
the O 0 0.011786103248596191
mutant O 1 0.9027798771858215
HFE O 1 0.9842367172241211
protein O 0 0.08396946638822556
with O 0 0.01515459269285202
the O 0 0.021228022873401642
TfR O 1 0.836398720741272
. O 0 0.04146839678287506

Studies O 0 0.03899582475423813
on O 0 0.016361340880393982
cell O 0 0.06952107697725296
- O 0 0.04857967793941498
associated O 0 0.026723336428403854
transferrin O 0 0.22108758985996246
at O 0 0.011083359830081463
37 O 0 0.018485816195607185
degrees O 0 0.01678512617945671
C O 0 0.023137152194976807
suggest O 0 0.011882706545293331
that O 0 0.005560793913900852
the O 0 0.00986670982092619
overexpressed O 1 0.7715307474136353
wild O 0 0.06516380608081818
- O 0 0.21482408046722412
type O 0 0.43922191858291626
HFE O 1 0.9834303855895996
protein O 0 0.19067378342151642
decreases O 0 0.044072266668081284
the O 0 0.00938549917191267
affinity O 0 0.023298976942896843
of O 0 0.007638384122401476
the O 0 0.010988911613821983
TfR O 1 0.8877112865447998
for O 0 0.01799013465642929
transferrin O 1 0.8645110130310059
. O 0 0.04147576540708542

The O 0 0.03895105421543121
overexpressed O 1 0.9664942026138306
H63D O 1 0.9299300312995911
protein O 0 0.06326387822628021
does O 0 0.010554267093539238
not O 0 0.004272321239113808
have O 0 0.0035053216852247715
this O 0 0.003042982192710042
effect O 0 0.006470281630754471
, O 0 0.00286593334749341
providing O 0 0.004503131378442049
the O 0 0.002868909854441881
first O 0 0.003658041823655367
direct O 0 0.006962506100535393
evidence O 0 0.005753204692155123
for O 0 0.004716820549219847
a O 0 0.008041132241487503
functional O 0 0.020513717085123062
consequence O 0 0.020215511322021484
of O 0 0.0094052255153656
the O 0 0.017018072307109833
H63D O 1 0.9551135897636414
mutation O 1 0.9801176190376282
. O 0 0.04629622772336006

Addition O 0 0.025523094460368156
of O 0 0.01793348602950573
soluble O 0 0.2968994677066803
wild O 0 0.07285900413990021
- O 0 0.47348061203956604
type O 1 0.7244434356689453
HFE O 1 0.9970270991325378
/ O 1 0.9079688787460327
beta2m O 1 0.9707151651382446
heterodimers O 1 0.9666908979415894
to O 0 0.01463023480027914
cultured O 1 0.6034218072891235
cells O 1 0.5009267330169678
also O 0 0.008947162888944149
decreased O 0 0.03791196644306183
the O 0 0.00849276315420866
apparent O 0 0.0290388036519289
affinity O 0 0.02274319902062416
of O 0 0.006517226807773113
the O 0 0.007883438840508461
TfR O 1 0.5758306384086609
for O 0 0.005704416893422604
its O 0 0.006372842472046614
ligand O 0 0.02064911089837551
under O 0 0.006468482781201601
steady O 0 0.013528794050216675
- O 0 0.015321583487093449
state O 0 0.00711025670170784
conditions O 0 0.010179459117352962
, O 0 0.004275883082300425
both O 0 0.00522867264226079
in O 0 0.007503471337258816
293 O 0 0.20631365478038788
cells O 0 0.2796621024608612
and O 0 0.011061064898967743
in O 0 0.01790503039956093
HeLa O 1 0.9881481528282166
cells O 1 0.8131178021430969
. O 0 0.04199228808283806

Furthermore O 0 0.03744758293032646
, O 0 0.010705189779400826
at O 0 0.008785184472799301
4 O 0 0.010588562116026878
degrees O 0 0.009951948188245296
C O 0 0.01427413523197174
, O 0 0.004606505855917931
the O 0 0.004595490638166666
added O 0 0.007409428246319294
soluble O 0 0.03614516928792
complex O 0 0.01536453329026699
of O 0 0.0139240063726902
HFE O 1 0.9915792942047119
/ O 1 0.7645544409751892
beta2m O 1 0.9317297339439392
inhibited O 1 0.689696729183197
binding O 0 0.028847694396972656
of O 0 0.011295761913061142
transferrin O 1 0.8251412510871887
to O 0 0.015080948360264301
HeLa O 1 0.9700775742530823
cell O 0 0.3569023311138153
TfR O 1 0.7080740332603455
in O 0 0.012561269104480743
a O 0 0.014682392589747906
concentration O 0 0.04168734699487686
- O 0 0.052722759544849396
dependent O 0 0.04656418412923813
manner O 0 0.03602239117026329
. O 0 0.03157462552189827

Scatchard O 0 0.11381778866052628
plots O 0 0.034548692405223846
of O 0 0.01101693231612444
these O 0 0.006674748845398426
data O 0 0.008537054061889648
indicate O 0 0.010026691481471062
that O 0 0.004484532400965691
the O 0 0.005763098131865263
added O 0 0.01035866979509592
heterodimer O 1 0.566543459892273
substantially O 0 0.03820235654711723
reduced O 0 0.022562090307474136
the O 0 0.010518975555896759
affinity O 0 0.035978011786937714
of O 0 0.016156738623976707
TfR O 1 0.846542239189148
for O 0 0.024510132148861885
transferrin O 1 0.6874160170555115
. O 0 0.048082418739795685

These O 0 0.017213907092809677
results O 0 0.019934222102165222
establish O 0 0.018070317804813385
a O 0 0.012920119799673557
molecular O 0 0.028948623687028885
link O 0 0.02284800074994564
between O 0 0.01357744075357914
HFE O 1 0.8294382095336914
and O 0 0.006390636786818504
a O 0 0.0075451587326824665
key O 0 0.010134276002645493
protein O 0 0.022294245660305023
involved O 0 0.00836054515093565
in O 0 0.005937491077929735
iron O 0 0.01593763753771782
transport O 0 0.009230522438883781
, O 0 0.004879905842244625
the O 0 0.005873412359505892
TfR O 1 0.8191566467285156
, O 0 0.004762908443808556
and O 0 0.0037431633099913597
raise O 0 0.007515538018196821
the O 0 0.00426255539059639
possibility O 0 0.008434867486357689
that O 0 0.004155085422098637
alterations O 0 0.01119264867156744
in O 0 0.004214159213006496
this O 0 0.005067899823188782
regulatory O 0 0.02488306723535061
mechanism O 0 0.02584044076502323
may O 0 0.008352910168468952
play O 0 0.0052234032191336155
a O 0 0.0057869115844368935
role O 0 0.009581529535353184
in O 0 0.0065218014642596245
the O 0 0.010857135988771915
pathogenesis O 1 0.9708041548728943
of O 0 0.02706029824912548
hereditary B-Disease 1 0.9991545677185059
hemochromatosis I-Disease 1 0.9997065663337708
. O 0 0.03962504491209984
. O 0 0.04229915142059326

Genomic O 0 0.2871740162372589
organization O 0 0.02886536903679371
of O 0 0.014922217465937138
the O 0 0.022340048104524612
UBE3A O 1 0.9819278717041016
/ O 1 0.7036916017532349
E6 O 1 0.8143904805183411
- O 0 0.2492264360189438
AP O 0 0.08235723525285721
gene O 0 0.2326606959104538
and O 0 0.01948457770049572
related O 0 0.05077829584479332
pseudogenes O 1 0.7817450165748596
. O 0 0.04218559339642525

The O 0 0.05390571802854538
UBE3A O 1 0.96039879322052
gene O 1 0.6141990423202515
encodes O 0 0.07317429035902023
the O 0 0.018643155694007874
E6 O 0 0.3812103271484375
- O 0 0.07015159726142883
AP O 0 0.05662006884813309
ubiquitin O 0 0.07896833121776581
- O 0 0.04784749448299408
protein O 0 0.04466455057263374
ligase O 0 0.032271016389131546
and O 0 0.005879730451852083
has O 0 0.006601990200579166
recently O 0 0.00941954180598259
been O 0 0.006393201649188995
shown O 0 0.009445610456168652
to O 0 0.005269203335046768
be O 0 0.008752558380365372
mutated O 1 0.9793601036071777
in O 0 0.13612930476665497
Angelman B-Disease 1 0.9999308586120605
syndrome I-Disease 1 0.9999860525131226
patients O 1 0.9990403056144714
who O 0 0.069825179874897
lack O 0 0.4956350028514862
15q11 O 1 0.9853458404541016
- O 1 0.7315099835395813
q13 O 1 0.9663723707199097
deletions O 1 0.9293747544288635
or O 0 0.04727817699313164
chromosome O 1 0.9805585741996765
15 O 0 0.053187042474746704
paternal O 1 0.9460002183914185
uniparental B-Disease 1 0.990591824054718
disomy I-Disease 1 0.9511364698410034
. O 0 0.06488561630249023

Previous O 0 0.06294086575508118
UBE3A O 1 0.937363862991333
cDNA O 0 0.08276522159576416
analysis O 0 0.0209204014390707
has O 0 0.010846151039004326
shown O 0 0.013358592055737972
a O 0 0.011700082570314407
coding O 0 0.03571613132953644
region O 0 0.01656709983944893
of O 0 0.00930611602962017
approximately O 0 0.019616158679127693
2 O 0 0.021757226437330246
. O 0 0.026143621653318405

6 O 0 0.04431644082069397
kb O 0 0.054198604077100754
and O 0 0.010274752974510193
a O 0 0.01340468693524599
3 O 0 0.017185935750603676
- O 0 0.037058670073747635
untranslated O 0 0.15187963843345642
region O 0 0.032088395208120346
( O 0 0.020364880561828613
UTR O 0 0.27747824788093567
) O 0 0.012408338487148285
of O 0 0.008665992878377438
< O 0 0.1262071579694748
50 O 0 0.011113886721432209
bp O 0 0.019143976271152496
, O 0 0.005733403842896223
whereas O 0 0.011989612132310867
Northern O 0 0.01087149791419506
analysis O 0 0.01189300138503313
has O 0 0.007607327774167061
indicated O 0 0.014874901622533798
mRNA O 0 0.024201955646276474
sizes O 0 0.015472842380404472
of O 0 0.007512017153203487
5 O 0 0.014461839571595192
- O 0 0.03179483488202095
8 O 0 0.02717180922627449
kb O 0 0.08311496675014496
. O 0 0.03721088543534279

We O 0 0.015582469291985035
have O 0 0.011518850922584534
analyzed O 0 0.02210923098027706
additional O 0 0.014251663349568844
cDNA O 0 0.0441904179751873
clones O 0 0.043794240802526474
and O 0 0.006665688008069992
provide O 0 0.007851976901292801
evidence O 0 0.007264330983161926
for O 0 0.0055346060544252396
an O 0 0.008673378266394138
additional O 0 0.016313990578055382
0 O 0 0.03626183792948723
. O 0 0.025068970397114754

5 O 0 0.03705989196896553
kb O 0 0.0444519966840744
of O 0 0.010787442326545715
5 O 0 0.016563093289732933
- O 0 0.031047001481056213
UTR O 0 0.2904545068740845
and O 0 0.01077377237379551
> O 0 0.10741102695465088
2 O 0 0.016115320846438408
kb O 0 0.03809119388461113
of O 0 0.014335325919091702
3 O 0 0.027529524639248848
- O 0 0.07101800292730331
UTR O 0 0.46137863397598267
. O 0 0.04455220699310303

We O 0 0.01288908813148737
have O 0 0.008926806040108204
established O 0 0.011002715677022934
the O 0 0.008793044835329056
genomic O 0 0.08644577860832214
organization O 0 0.014730427414178848
of O 0 0.008996373042464256
UBE3A O 1 0.9061161875724792
and O 0 0.006591042038053274
the O 0 0.007083614822477102
sequence O 0 0.016874220222234726
of O 0 0.012421047315001488
intron O 1 0.951322078704834
- O 0 0.31417715549468994
exon O 0 0.462222158908844
borders O 0 0.06414633989334106
. O 0 0.04203527793288231

We O 0 0.011876674368977547
have O 0 0.006636451929807663
also O 0 0.005488774739205837
mapped O 0 0.01398258563131094
two O 0 0.008575920015573502
highly O 0 0.018141191452741623
homologous O 0 0.17624695599079132
processed O 0 0.02725301682949066
pseudogenes O 1 0.7519741654396057
, O 0 0.009630054235458374
UBE3AP1 O 1 0.5249429941177368
and O 0 0.007101389113813639
UBE3AP2 O 1 0.5192572474479675
, O 0 0.005673040635883808
to O 0 0.004998495802283287
chromosomes O 0 0.029667586088180542
2 O 0 0.007371025159955025
and O 0 0.0038482407107949257
21 O 0 0.0065188356675207615
, O 0 0.00391929829493165
respectively O 0 0.005954161752015352
, O 0 0.004411482717841864
and O 0 0.004972311668097973
determined O 0 0.011225061491131783
their O 0 0.010731121525168419
genomic O 0 0.18137136101722717
organization O 0 0.03552623838186264
. O 0 0.029473116621375084

These O 0 0.01294005662202835
results O 0 0.013338602147996426
will O 0 0.0053943851962685585
form O 0 0.00684023555368185
the O 0 0.0037555352319031954
basis O 0 0.004536708816885948
for O 0 0.004267474170774221
studies O 0 0.00886837113648653
of O 0 0.0078352065756917
mutation O 1 0.9289625287055969
and O 0 0.011299990117549896
imprinting O 1 0.8565532565116882
of O 0 0.024260560050606728
UBE3A O 1 0.9794754981994629
. O 0 0.04581734165549278

Mutation O 1 0.9768819212913513
spectrum O 0 0.18181723356246948
and O 0 0.023649699985980988
genotype O 1 0.9887323379516602
- O 1 0.8686373233795166
phenotype O 1 0.9960863590240479
analyses O 0 0.14128461480140686
in O 0 0.02835925854742527
Cowden B-Disease 1 0.9990960359573364
disease I-Disease 1 0.9998557567596436
and O 0 0.07992134243249893
Bannayan B-Disease 1 0.9970747232437134
- I-Disease 1 0.9940415024757385
Zonana I-Disease 1 0.9994221925735474
syndrome I-Disease 1 0.999919056892395
, O 0 0.030980709940195084
two O 0 0.03542338311672211
hamartoma B-Disease 1 0.9984283447265625
syndromes I-Disease 1 0.9990091323852539
with O 0 0.39212289452552795
germline O 1 0.9972370862960815
PTEN O 1 0.9976046085357666
mutation O 1 0.994022786617279
. O 0 0.0650525614619255

The O 0 0.07635285705327988
tumour B-Disease 1 0.9984240531921387
suppressor O 1 0.9963724613189697
gene O 1 0.9901841282844543
PTEN O 1 0.9873446822166443
, O 0 0.01631961576640606
which O 0 0.011068579740822315
maps O 0 0.01768186129629612
to O 0 0.014672448858618736
10q23 O 0 0.23780450224876404
. O 0 0.03714250400662422

3 O 0 0.030400043353438377
and O 0 0.014357839711010456
encodes O 0 0.038604822009801865
a O 0 0.018595336005091667
403 O 0 0.04709137603640556
amino O 0 0.045179735869169235
acid O 0 0.11275668442249298
dual O 0 0.04252764955163002
specificity O 0 0.16970206797122955
phosphatase O 1 0.9638427495956421
( O 0 0.03584403544664383
protein O 0 0.15489614009857178
tyrosine O 1 0.7908661365509033
phosphatase O 1 0.9656079411506653
; O 0 0.020462054759263992
PTPase O 0 0.46616241335868835
) O 0 0.010332456789910793
, O 0 0.005685933865606785
was O 0 0.005463840905576944
shown O 0 0.007586656138300896
recently O 0 0.007225491106510162
to O 0 0.004066061694175005
play O 0 0.005846212152391672
a O 0 0.007113469298928976
broad O 0 0.01647196151316166
role O 0 0.015268618240952492
in O 0 0.01204655785113573
human O 0 0.2415665239095688
malignancy B-Disease 1 0.9955397248268127
. O 0 0.043577201664447784

Somatic O 1 0.9751786589622498
PTEN O 1 0.9875226616859436
deletions O 1 0.7624696493148804
and O 0 0.019045362249016762
mutations O 1 0.9232197403907776
were O 0 0.008481569588184357
observed O 0 0.020439215004444122
in O 0 0.011959785595536232
sporadic B-Disease 1 0.943896472454071
breast I-Disease 1 0.9997205138206482
, I-Disease 0 0.15205256640911102
brain I-Disease 1 0.9994955062866211
, I-Disease 0 0.48161885142326355
prostate I-Disease 1 0.9999290704727173
and I-Disease 1 0.7363676428794861
kidney I-Disease 1 0.9999723434448242
cancer I-Disease 1 0.9999353885650635
cell O 1 0.9473966360092163
lines O 0 0.025716114789247513
and O 0 0.006329941097646952
in O 0 0.006898651365190744
several O 0 0.009259654209017754
primary O 0 0.0765809714794159
tumours B-Disease 1 0.9970224499702454
such O 0 0.01673133671283722
as O 0 0.06891623139381409
endometrial B-Disease 1 0.9997145533561707
carcinomas I-Disease 1 0.9998055100440979
, O 1 0.9637432098388672
malignant B-Disease 1 0.9999619722366333
melanoma I-Disease 1 0.9999665021896362
and O 1 0.8510261178016663
thyroid B-Disease 1 0.9997854828834534
tumours I-Disease 1 0.9982800483703613
. O 0 0.08954399079084396

In O 0 0.02010595053434372
addition O 0 0.02204085700213909
, O 0 0.014969666488468647
PTEN O 1 0.9401036500930786
was O 0 0.00965586956590414
identified O 0 0.014146833680570126
as O 0 0.006619392428547144
the O 0 0.009355844929814339
susceptibility O 1 0.987054169178009
gene O 1 0.5941322445869446
for O 0 0.013506443239748478
two O 0 0.034340791404247284
hamartoma B-Disease 1 0.999617338180542
syndromes I-Disease 1 0.9999223947525024
Cowden B-Disease 1 0.9998389482498169
disease I-Disease 1 0.9998990297317505
( O 0 0.12902890145778656
CD B-Disease 0 0.07085998356342316
; O 0 0.02692105993628502
MIM O 1 0.9477100372314453
158350 O 1 0.5864897966384888
) O 0 0.018544474616646767
and O 0 0.013388576917350292
Bannayan B-Disease 1 0.7546928524971008
- I-Disease 1 0.5121725797653198
Zonana I-Disease 1 0.9861780405044556
( I-Disease 0 0.03352386876940727
BZS I-Disease 1 0.7631670832633972
) I-Disease 0 0.01966424100100994
or I-Disease 0 0.0194843802601099
Ruvalcaba I-Disease 1 0.9677824974060059
- I-Disease 0 0.3116741478443146
Riley I-Disease 0 0.49140727519989014
- I-Disease 1 0.821533203125
Smith I-Disease 1 0.9566563963890076
syndrome I-Disease 1 0.9998419284820557
( O 0 0.2716110348701477
MIM O 1 0.9810886383056641
153480 O 1 0.8041589260101318
) O 0 0.04286768659949303
. O 0 0.03955462574958801

Constitutive O 0 0.19290465116500854
DNA O 0 0.04904874041676521
from O 0 0.016429318115115166
37 O 0 0.021841464564204216
CD B-Disease 0 0.02013595588505268
families O 0 0.013022040016949177
and O 0 0.007420533336699009
seven O 0 0.01430431753396988
BZS B-Disease 1 0.7592470049858093
families O 0 0.020413463935256004
was O 0 0.01477714441716671
screened O 0 0.0485142320394516
for O 0 0.024157483130693436
germline O 1 0.993559718132019
PTEN O 1 0.9960712194442749
mutations O 1 0.9859166741371155
. O 0 0.05597449466586113

PTEN O 1 0.9911760091781616
mutations O 1 0.9556389451026917
were O 0 0.009862378239631653
identified O 0 0.013554803095757961
in O 0 0.00614502839744091
30 O 0 0.007145311217755079
of O 0 0.005125566851347685
37 O 0 0.011953825131058693
( O 0 0.009503960609436035
81 O 0 0.015657108277082443
% O 0 0.008770366199314594
) O 0 0.007523010019212961
CD B-Disease 0 0.011385311372578144
families O 0 0.008958693593740463
, O 0 0.006206139922142029
including O 0 0.007647208869457245
missense O 0 0.27929723262786865
and O 0 0.007232251111418009
nonsense O 0 0.022849157452583313
point O 0 0.013313010334968567
mutations O 1 0.85272216796875
, O 0 0.008901365101337433
deletions O 0 0.04831083118915558
, O 0 0.009338132105767727
insertions O 0 0.06734824180603027
, O 0 0.008296206593513489
a O 0 0.015571551397442818
deletion O 1 0.8369871973991394
/ O 0 0.3832545876502991
insertion O 0 0.24047379195690155
and O 0 0.018692607060074806
splice O 1 0.550460159778595
site O 0 0.04316609725356102
mutations O 1 0.9365592002868652
. O 0 0.041313957422971725

These O 0 0.02229703962802887
mutations O 1 0.6283516883850098
were O 0 0.007891681976616383
scattered O 0 0.01262381300330162
over O 0 0.005825540516525507
the O 0 0.005583683494478464
entire O 0 0.009849539957940578
length O 0 0.010149018839001656
of O 0 0.006445311009883881
PTEN O 1 0.9477812647819519
, O 0 0.00562206981703639
with O 0 0.004729020409286022
the O 0 0.004528652876615524
exception O 0 0.007302149198949337
of O 0 0.003188065718859434
the O 0 0.003987595904618502
first O 0 0.004030115436762571
, O 0 0.004451755899935961
fourth O 0 0.008900146931409836
and O 0 0.00723354471847415
last O 0 0.015551690012216568
exons O 0 0.08970735967159271
. O 0 0.030087044462561607

A O 0 0.028290998190641403
hot O 0 0.036285292357206345
spot O 0 0.029380572959780693
for O 0 0.015183871611952782
PTEN O 1 0.9894779324531555
mutation O 1 0.8738186359405518
in O 0 0.009906703606247902
CD B-Disease 0 0.014614908024668694
was O 0 0.0069358134642243385
identified O 0 0.011570428498089314
in O 0 0.006550411228090525
exon O 0 0.03551844507455826
5 O 0 0.007775362115353346
that O 0 0.00389160867780447
contains O 0 0.006144401617348194
the O 0 0.005222280044108629
PTPase O 0 0.1849999725818634
core O 0 0.013851344585418701
motif O 0 0.019520821049809456
, O 0 0.004443550482392311
with O 0 0.003941068891435862
13 O 0 0.0063071525655686855
of O 0 0.0049370224587619305
30 O 0 0.009218407794833183
( O 0 0.009326418861746788
43 O 0 0.013781008310616016
% O 0 0.011665115132927895
) O 0 0.011154722422361374
CD B-Disease 0 0.02208615094423294
mutations O 1 0.6283143758773804
identified O 0 0.018023837357759476
in O 0 0.011424406431615353
this O 0 0.015263090841472149
exon O 0 0.089802086353302
. O 0 0.03456464782357216

Seven O 0 0.018343783915042877
of O 0 0.01053709164261818
30 O 0 0.012822499498724937
( O 0 0.009067753329873085
23 O 0 0.009243953973054886
% O 0 0.006449421867728233
) O 0 0.00478392094373703
were O 0 0.0026995232328772545
within O 0 0.0042098029516637325
the O 0 0.003883056342601776
core O 0 0.009600489400327206
motif O 0 0.016447728499770164
, O 0 0.003997336141765118
the O 0 0.003973143640905619
majority O 0 0.007990239188075066
( O 0 0.0050938366912305355
five O 0 0.0035683498717844486
of O 0 0.00306753464974463
seven O 0 0.004405670333653688
) O 0 0.004157412331551313
of O 0 0.0032793525606393814
which O 0 0.00521588372066617
were O 0 0.006851962301880121
missense O 1 0.9350219368934631
mutations O 1 0.9799428582191467
, O 0 0.008366326801478863
possibly O 0 0.013462826609611511
pointing O 0 0.011051222681999207
to O 0 0.004489671904593706
the O 0 0.005578359588980675
functional O 0 0.015093205496668816
significance O 0 0.009016304276883602
of O 0 0.005987699143588543
this O 0 0.009522256441414356
region O 0 0.02753639407455921
. O 0 0.028169821947813034

Germline O 1 0.9914159178733826
PTEN O 1 0.9941430687904358
mutations O 1 0.972873866558075
were O 0 0.010132907889783382
identified O 0 0.011159509420394897
in O 0 0.005074202548712492
four O 0 0.0046957130543887615
of O 0 0.0049621365033090115
seven O 0 0.00832361914217472
( O 0 0.013401735574007034
57 O 0 0.02116822637617588
% O 0 0.018218809738755226
) O 0 0.02106511779129505
BZS B-Disease 0 0.3130370080471039
families O 0 0.037256691604852676
studied O 0 0.03620114177465439
. O 0 0.03467382490634918

Interestingly O 0 0.06544055044651031
, O 0 0.011968719772994518
none O 0 0.01112073939293623
of O 0 0.006427825428545475
these O 0 0.007333014626055956
mutations O 1 0.6797566413879395
was O 0 0.007719476241618395
observed O 0 0.014217465184628963
in O 0 0.0071186041459441185
the O 0 0.011378517374396324
PTPase O 1 0.6108816862106323
core O 0 0.04179011657834053
motif O 0 0.11808765679597855
. O 0 0.039029188454151154

It O 0 0.014444376341998577
is O 0 0.010394325479865074
also O 0 0.007273574825376272
worthy O 0 0.014213623479008675
of O 0 0.005703242961317301
note O 0 0.00986805185675621
that O 0 0.004484525881707668
a O 0 0.006235163193196058
single O 0 0.00954350270330906
nonsense O 0 0.01973441056907177
point O 0 0.011876006610691547
mutation O 1 0.8412696123123169
, O 0 0.008497342467308044
R233X O 0 0.08105883002281189
, O 0 0.007018617819994688
was O 0 0.006948988884687424
observed O 0 0.011803700588643551
in O 0 0.005554908886551857
the O 0 0.008482026867568493
germline O 1 0.9136099815368652
DNA O 0 0.02828342653810978
from O 0 0.007807204034179449
two O 0 0.007641064003109932
unrelated O 0 0.02232068032026291
CD B-Disease 0 0.016676828265190125
families O 0 0.012583165429532528
and O 0 0.007617175579071045
one O 0 0.013239804655313492
BZS B-Disease 1 0.7846150994300842
family O 0 0.04332767054438591
. O 0 0.03262785077095032

Genotype O 1 0.9882839918136597
- O 1 0.6963444948196411
phenotype O 1 0.9781277179718018
studies O 0 0.0193556547164917
were O 0 0.005804380401968956
not O 0 0.004256130196154118
performed O 0 0.006302360910922289
on O 0 0.003737303428351879
this O 0 0.00404988881200552
small O 0 0.007850853726267815
group O 0 0.011032355949282646
of O 0 0.012098470702767372
BZS B-Disease 1 0.705458402633667
families O 0 0.03600950911641121
. O 0 0.03223678097128868

However O 0 0.029189854860305786
, O 0 0.022268684580922127
genotype O 1 0.950591504573822
- O 0 0.38866013288497925
phenotype O 1 0.9847709536552429
analysis O 0 0.030418025329709053
inthe O 0 0.21164658665657043
group O 0 0.013609122484922409
of O 0 0.0075060403905808926
CD B-Disease 0 0.01607750914990902
families O 0 0.010250556282699108
revealed O 0 0.010257824324071407
two O 0 0.004893224220722914
possible O 0 0.007959486916661263
associations O 0 0.010582503862679005
worthy O 0 0.011002320796251297
of O 0 0.004728916101157665
follow O 0 0.009490400552749634
- O 0 0.013688487000763416
up O 0 0.008801955729722977
in O 0 0.009219042025506496
independent O 0 0.01816553995013237
analyses O 0 0.036342471837997437
. O 0 0.03176623955368996

The O 0 0.014526210725307465
first O 0 0.00969143770635128
was O 0 0.00748363696038723
an O 0 0.005687287542968988
association O 0 0.010608107782900333
noted O 0 0.006975996773689985
in O 0 0.004090623464435339
the O 0 0.0042563206516206264
group O 0 0.006909423973411322
of O 0 0.006218939553946257
CD B-Disease 0 0.018529845401644707
families O 0 0.025061961263418198
with O 0 0.04633071646094322
breast B-Disease 1 0.9994474053382874
disease I-Disease 1 0.9995786547660828
. O 0 0.06466194987297058

A O 0 0.027006326243281364
correlation O 0 0.03869239240884781
was O 0 0.010928700678050518
observed O 0 0.013466564007103443
between O 0 0.0072972942143678665
the O 0 0.006726594641804695
presence O 0 0.017252977937459946
/ O 0 0.06622233986854553
absence O 0 0.013564158231019974
of O 0 0.006929838564246893
a O 0 0.01579456403851509
PTEN O 1 0.9963217973709106
mutation O 1 0.9771502017974854
and O 0 0.007682138588279486
the O 0 0.007926028221845627
type O 0 0.030044855549931526
of O 0 0.013898738659918308
breast O 1 0.9994912147521973
involvement O 1 0.7405242323875427
( O 0 0.11629083752632141
unaffected O 1 0.9857704639434814
versus O 1 0.9659669995307922
benign O 1 0.9977542757987976
versus O 1 0.9808386564254761
malignant O 1 0.9981403350830078
) O 0 0.04809150844812393
. O 0 0.042378392070531845

Specifically O 0 0.02556120976805687
and O 0 0.008419726975262165
more O 0 0.007079527713358402
directly O 0 0.008304468356072903
, O 0 0.004906481131911278
an O 0 0.004622951149940491
association O 0 0.008625601418316364
was O 0 0.004367162473499775
also O 0 0.004303656052798033
observed O 0 0.007834548130631447
between O 0 0.00459610391408205
the O 0 0.00440834229812026
presence O 0 0.010417030192911625
of O 0 0.006923911161720753
a O 0 0.021511930972337723
PTEN O 1 0.9982510209083557
mutation O 1 0.9985748529434204
and O 1 0.6730028986930847
malignant B-Disease 1 0.9999175071716309
breast I-Disease 1 0.9999244213104248
disease I-Disease 1 0.9997894167900085
. O 0 0.17060503363609314

Secondly O 0 0.04875825718045235
, O 0 0.009607120417058468
there O 0 0.006257523316890001
appeared O 0 0.007225326728075743
to O 0 0.004167625214904547
be O 0 0.00409452011808753
an O 0 0.006525320932269096
interdependent O 0 0.08899939060211182
association O 0 0.015953965485095978
between O 0 0.011904056183993816
mutations O 1 0.9574436545372009
upstream O 0 0.017315447330474854
and O 0 0.004901862237602472
within O 0 0.006984183099120855
the O 0 0.007123883347958326
PTPase O 0 0.26080068945884705
core O 0 0.015298185870051384
motif O 0 0.02120894007384777
, O 0 0.005180821288377047
the O 0 0.005664936266839504
core O 0 0.01196094136685133
motif O 0 0.02039381116628647
containing O 0 0.0095248743891716
the O 0 0.005546496715396643
majority O 0 0.010570134967565536
of O 0 0.008418970741331577
missense O 1 0.9876105785369873
mutations O 1 0.9434325695037842
, O 0 0.0055926027707755566
and O 0 0.0036569389048963785
the O 0 0.004473333712667227
involvement O 0 0.01111968420445919
of O 0 0.0048004877753555775
all O 0 0.004874651785939932
major O 0 0.01159205473959446
organ O 0 0.37183281779289246
systems O 0 0.02244599722325802
( O 0 0.01262348797172308
central O 0 0.011976356618106365
nervous O 1 0.9740550518035889
system O 0 0.0239420123398304
, O 0 0.032116957008838654
thyroid O 1 0.9997901320457458
, O 0 0.12288178503513336
breast O 1 0.9996867179870605
, O 0 0.12627284228801727
skin O 1 0.9995433688163757
and O 0 0.23481270670890808
gastrointestinal O 1 0.9996480941772461
tract O 1 0.9978674650192261
) O 0 0.04697795957326889
. O 0 0.0415177159011364

However O 0 0.019779464229941368
, O 0 0.00814681127667427
these O 0 0.005499435588717461
observations O 0 0.00833017099648714
would O 0 0.002877532271668315
need O 0 0.0037590782158076763
to O 0 0.002637444995343685
be O 0 0.002719663316383958
confirmed O 0 0.006034548860043287
by O 0 0.003504882100969553
studying O 0 0.006079372018575668
a O 0 0.0055064428597688675
larger O 0 0.008799904957413673
number O 0 0.006144550163298845
of O 0 0.007480347063392401
CD B-Disease 0 0.02117302082479
families O 0 0.02523920312523842
. O 0 0.02814837545156479

Molecular O 1 0.5086303949356079
defects O 1 0.9681563377380371
leading O 0 0.023224113509058952
to O 0 0.010804984718561172
human O 0 0.033396489918231964
complement B-Disease 0 0.12466612458229065
component I-Disease 1 0.6935915350914001
C6 I-Disease 1 0.9981366395950317
deficiency I-Disease 1 0.9994921684265137
in O 0 0.01239137351512909
an O 0 0.010705719701945782
African O 0 0.02672424726188183
- O 0 0.04948318377137184
American O 0 0.0255751870572567
family O 0 0.038514476269483566
. O 0 0.03292974457144737

Complement B-Disease 0 0.2149640917778015
component I-Disease 1 0.8006656169891357
C6 I-Disease 1 0.9972426891326904
deficiency I-Disease 1 0.9995477795600891
( O 0 0.08676247298717499
C6D B-Disease 1 0.8982163667678833
) O 0 0.01641669310629368
was O 0 0.01295968983322382
diagnosed O 1 0.9973583817481995
in O 0 0.006170465610921383
a O 0 0.007042232435196638
16 O 0 0.010039607994258404
- O 0 0.015517817810177803
year O 0 0.009239221923053265
- O 0 0.018925847485661507
old O 0 0.014971854165196419
African O 0 0.02298635058104992
- O 0 0.04431809484958649
American O 0 0.02481292374432087
male O 0 0.16352339088916779
with O 0 0.047223031520843506
meningococcal B-Disease 1 0.9993128776550293
meningitis I-Disease 1 0.9994599223136902
. O 0 0.0673150047659874

The O 0 0.026514673605561256
patients O 1 0.9826981425285339
father O 0 0.019526980817317963
and O 0 0.006295785773545504
two O 0 0.005780900828540325
brothers O 0 0.01374281756579876
also O 0 0.005675161257386208
had O 0 0.006803103722631931
C6D B-Disease 0 0.14069923758506775
, O 0 0.005210269708186388
but O 0 0.004616841208189726
gave O 0 0.005974864587187767
no O 0 0.0047409413382411
history O 0 0.00922643207013607
of O 0 0.011308410204946995
meningitis B-Disease 1 0.9994352459907532
or O 0 0.024782145395874977
other O 0 0.022001473233103752
neisserial B-Disease 1 0.9874204993247986
infection I-Disease 1 0.9986734390258789
. O 0 0.05473135784268379

By O 0 0.02150600776076317
using O 0 0.021411588415503502
exon O 0 0.21906305849552155
- O 0 0.04623810574412346
specific O 0 0.03172001615166664
polymerase O 1 0.5659284591674805
chain O 0 0.20388180017471313
reaction O 0 0.050723783671855927
( O 0 0.022306162863969803
PCR O 0 0.12493225932121277
) O 0 0.015509726479649544
/ O 0 0.03237984701991081
single O 0 0.017645422369241714
- O 0 0.03972737118601799
strand O 0 0.07410808652639389
conformation O 0 0.19484108686447144
polymorphism O 0 0.05555596947669983
as O 0 0.007390585262328386
a O 0 0.009706881828606129
screening O 0 0.024166418239474297
step O 0 0.012072349898517132
and O 0 0.007237215526401997
nucleotide O 0 0.025780802592635155
sequencing O 0 0.020035337656736374
of O 0 0.006369172129780054
target O 0 0.01193166058510542
exons O 0 0.02991178072988987
, O 0 0.004845952149480581
we O 0 0.003608275204896927
determined O 0 0.006813711486756802
that O 0 0.003407327691093087
the O 0 0.004906914662569761
proband O 0 0.05563405528664589
was O 0 0.0072250403463840485
a O 0 0.00991206057369709
compound O 0 0.02371509186923504
heterozygote O 0 0.1965828686952591
for O 0 0.01328699104487896
two O 0 0.02023433893918991
C6 O 1 0.9844095706939697
gene O 1 0.9792500138282776
mutations O 1 0.9793134331703186
. O 0 0.04810645803809166

The O 0 0.016662977635860443
first O 0 0.011964750476181507
, O 0 0.010507617145776749
1195delC O 0 0.09097033739089966
located O 0 0.011297439225018024
in O 0 0.007933136075735092
exon O 0 0.04288319870829582
7 O 0 0.010387863032519817
, O 0 0.004644911736249924
is O 0 0.0047119068913161755
a O 0 0.006287702824920416
novel O 0 0.015712056308984756
mutation O 1 0.8936012983322144
, O 0 0.004905245266854763
while O 0 0.004377803299576044
the O 0 0.004513236228376627
second O 0 0.006897452287375927
, O 0 0.006586057599633932
1936delG O 0 0.08705806732177734
in O 0 0.0072342087514698505
exon O 0 0.048553068190813065
12 O 0 0.008747951127588749
, O 0 0.005184048321098089
has O 0 0.0052958023734390736
been O 0 0.0055367001332342625
described O 0 0.008953072130680084
before O 0 0.006959986872971058
to O 0 0.007288218475878239
cause O 0 0.4392628073692322
C6D B-Disease 0 0.42709681391716003
in O 0 0.007051284424960613
an O 0 0.008065813221037388
unrelated O 0 0.02555146999657154
African O 0 0.024711981415748596
- O 0 0.04805310070514679
American O 0 0.02293296530842781
individual O 0 0.025829117745161057
. O 0 0.029238417744636536

Both O 0 0.040536925196647644
mutations O 1 0.9561494588851929
result O 0 0.03644457086920738
in O 0 0.021132376044988632
premature O 1 0.9736030697822571
termination O 1 0.9196859002113342
codons O 1 0.6470436453819275
and O 0 0.02553696744143963
C6 O 1 0.9885162115097046
null O 1 0.6263919472694397
alleles O 1 0.9642242193222046
. O 0 0.046525925397872925

Allele O 1 0.9074292182922363
- O 0 0.07416252046823502
specific O 0 0.030389027670025826
PCR O 0 0.19242970645427704
indicated O 0 0.01564381830394268
that O 0 0.005289049353450537
the O 0 0.006396600976586342
probands O 0 0.09160585701465607
two O 0 0.006701914127916098
brothers O 0 0.015106658451259136
also O 0 0.007286638952791691
inherited O 0 0.47846871614456177
the O 0 0.010587758384644985
1195delC O 1 0.9170762896537781
mutation O 1 0.9569034576416016
from O 0 0.009622607380151749
their O 0 0.00926235318183899
heterozygous O 0 0.4007561504840851
mother O 0 0.0209260992705822
and O 0 0.00631299102678895
the O 0 0.00944713968783617
1936delG O 1 0.8903424739837646
mutation O 1 0.9714500308036804
from O 0 0.012720402330160141
their O 0 0.011713497340679169
homozygous O 1 0.8451700210571289
father O 0 0.033489663153886795
. O 0 0.020094137638807297
. O 0 0.027221040800213814

PAX6 O 1 0.970511794090271
mutations O 1 0.9596681594848633
reviewed O 0 0.10781426727771759
. O 0 0.06664600968360901

Mutations O 1 0.9743098616600037
in O 0 0.022330759093165398
PAX6 O 1 0.9657555818557739
are O 0 0.008558646775782108
responsible O 0 0.012778879143297672
for O 0 0.005621691234409809
human O 0 0.03542639687657356
aniridia B-Disease 1 0.806105375289917
and O 0 0.0043083662167191505
have O 0 0.0034367411863058805
also O 0 0.003335573710501194
been O 0 0.004194188397377729
found O 0 0.006265619769692421
in O 0 0.0071446760557591915
patients O 1 0.9758240580558777
with O 0 0.01037935633212328
Peters B-Disease 1 0.904750645160675
anomaly I-Disease 1 0.9684528708457947
, O 0 0.012437177821993828
with O 0 0.04815796762704849
congenital B-Disease 1 0.9999421834945679
cataracts I-Disease 1 0.9997912049293518
, O 0 0.024584874510765076
with O 0 0.04098434001207352
autosomal B-Disease 1 0.9995107650756836
dominant I-Disease 1 0.9872746467590332
keratitis I-Disease 1 0.9990636706352234
, O 0 0.014193380251526833
and O 0 0.010449212044477463
with O 0 0.01691507361829281
isolated B-Disease 1 0.9215412735939026
foveal I-Disease 1 0.9928065538406372
hypoplasia I-Disease 1 0.9964534044265747
. O 0 0.05858737230300903

No O 0 0.029088132083415985
locus O 0 0.18373112380504608
other O 0 0.012486406601965427
than O 0 0.015526947565376759
chromosome O 1 0.9829428195953369
11p13 O 0 0.47581762075424194
has O 0 0.011429485864937305
been O 0 0.009493977762758732
implicated O 0 0.144449844956398
in O 0 0.009128277190029621
aniridia B-Disease 1 0.7816329002380371
, O 0 0.007749344687908888
and O 0 0.007749154232442379
PAX6 O 1 0.9246931076049805
is O 0 0.00681874668225646
clearly O 0 0.0075803473591804504
the O 0 0.004574522376060486
major O 0 0.00657355273142457
, O 0 0.003793334821239114
if O 0 0.003882766468450427
not O 0 0.0032443872187286615
only O 0 0.004435274749994278
, O 0 0.007609141059219837
gene O 0 0.2480962723493576
responsible O 0 0.0318165197968483
. O 0 0.02694716677069664

Twenty O 0 0.03342265263199806
- O 0 0.029564643278717995
eight O 0 0.012877481989562511
percent O 0 0.015462275594472885
of O 0 0.011439182795584202
identified O 0 0.04470301792025566
PAX6 O 1 0.9951683282852173
mutations O 1 0.985985279083252
are O 0 0.012588894926011562
C O 0 0.1026914194226265
- O 0 0.15362414717674255
T O 1 0.7194773554801941
changes O 0 0.017374645918607712
at O 0 0.012549126520752907
CpG O 1 0.8260039687156677
dinucleotides O 0 0.3054911196231842
, O 0 0.008456418290734291
20 O 0 0.009168327786028385
% O 0 0.008520759642124176
are O 0 0.005642906296998262
splicing O 0 0.036980390548706055
errors O 0 0.011631464585661888
, O 0 0.00405955919995904
and O 0 0.003162920940667391
more O 0 0.003486835630610585
than O 0 0.004785190336406231
30 O 0 0.007610877975821495
% O 0 0.008312162011861801
are O 0 0.00603675190359354
deletion O 0 0.2505846321582794
or O 0 0.016025004908442497
insertion O 0 0.12820276618003845
events O 0 0.029595309868454933
. O 0 0.02790032885968685

There O 0 0.015960529446601868
is O 0 0.011452405713498592
a O 0 0.01418542955070734
noticeably O 0 0.09125896543264389
elevated O 0 0.07171031832695007
level O 0 0.011372094042599201
of O 0 0.007198655512183905
mutation O 1 0.7364323139190674
in O 0 0.0064603122882544994
the O 0 0.005802226718515158
paired O 0 0.020701533183455467
domain O 0 0.015026557259261608
compared O 0 0.009809558279812336
with O 0 0.004636075347661972
the O 0 0.0050767166540026665
rest O 0 0.009202733635902405
of O 0 0.008021344430744648
the O 0 0.013661029748618603
gene O 0 0.22638274729251862
. O 0 0.034154076129198074

Increased O 0 0.07042557746171951
mutation O 1 0.8023711442947388
in O 0 0.01096227578818798
the O 0 0.009836588054895401
homeodomain O 0 0.47758954763412476
is O 0 0.009414056316018105
accounted O 0 0.01597726158797741
for O 0 0.007207163609564304
by O 0 0.010511057451367378
the O 0 0.013644989579916
hypermutable O 1 0.5649499297142029
CpG O 1 0.8666921257972717
dinucleotide O 0 0.4702128767967224
in O 0 0.029520737007260323
codon O 0 0.14766232669353485
240 O 0 0.05970850959420204
. O 0 0.038377467542886734

Very O 0 0.023113789036870003
nearly O 0 0.024727225303649902
all O 0 0.012106942012906075
mutations O 1 0.9015167355537415
appear O 0 0.01446495857089758
to O 0 0.008060680702328682
cause O 0 0.1352887749671936
loss O 0 0.015504026785492897
of O 0 0.005114976316690445
function O 0 0.0090651148930192
of O 0 0.004812690895050764
the O 0 0.00719981174916029
mutant O 1 0.7861833572387695
allele O 1 0.6744874119758606
, O 0 0.006061545107513666
and O 0 0.003962954971939325
more O 0 0.004514457657933235
than O 0 0.005627569276839495
80 O 0 0.009692058898508549
% O 0 0.008573533035814762
of O 0 0.007503557484596968
exonic O 0 0.3982536792755127
substitutions O 0 0.029744496569037437
result O 0 0.022249402478337288
in O 0 0.015965383499860764
nonsense O 0 0.062103401869535446
codons O 0 0.3120116889476776
. O 0 0.038779787719249725

In O 0 0.019724594429135323
a O 0 0.01848817616701126
gene O 0 0.06303104758262634
with O 0 0.007865795865654945
such O 0 0.008061214350163937
extraordinarily O 0 0.02736338973045349
high O 0 0.010572807863354683
sequence O 0 0.014711891300976276
conservation O 0 0.012420509941875935
throughout O 0 0.009227234870195389
evolution O 0 0.012935995124280453
, O 0 0.005048632156103849
there O 0 0.005335984751582146
are O 0 0.0059256115928292274
presumed O 0 0.03589382767677307
undiscovered O 1 0.5760922431945801
missense O 1 0.9898765683174133
mutations O 1 0.97627854347229
, O 0 0.00617696950212121
these O 0 0.00450041564181447
are O 0 0.0037401807494461536
hypothesized O 0 0.024329794570803642
to O 0 0.0035470190923660994
exist O 0 0.005527545232325792
in O 0 0.0041372100822627544
as O 0 0.0053976173512637615
- O 0 0.020664440467953682
yet O 0 0.015175865963101387
unidentified O 0 0.04963000863790512
phenotypes O 1 0.8208522200584412
. O 0 0.020710844546556473
. O 0 0.02781371958553791

Genetic O 1 0.8525907397270203
heterogeneity O 0 0.3977346420288086
and O 0 0.017086368054151535
penetrance O 1 0.73939049243927
analysis O 0 0.018816351890563965
of O 0 0.010287838988006115
the O 0 0.014468438923358917
BRCA1 O 1 0.99791020154953
and O 0 0.03794458135962486
BRCA2 O 1 0.9994329810142517
genes O 1 0.9940949082374573
in O 0 0.4761715531349182
breast B-Disease 1 0.9998561143875122
cancer I-Disease 1 0.9996767044067383
families O 0 0.2847957909107208
. O 0 0.04871588945388794

The O 0 0.24456031620502472
Breast B-Disease 1 0.9996464252471924
Cancer I-Disease 1 0.9993839263916016
Linkage O 1 0.947537899017334
Consortium O 0 0.2604525685310364
. O 0 0.06250899285078049

The O 0 0.023823756724596024
contribution O 0 0.03526190668344498
of O 0 0.018230631947517395
BRCA1 O 1 0.9970633387565613
and O 0 0.027124637737870216
BRCA2 O 1 0.9991193413734436
to O 0 0.07900480926036835
inherited B-Disease 1 0.9994145631790161
breast I-Disease 1 0.999953031539917
cancer I-Disease 1 0.99977046251297
was O 0 0.015224682167172432
assessed O 0 0.0248887836933136
by O 0 0.009174181148409843
linkage O 0 0.06428702920675278
and O 0 0.007853555493056774
mutation O 1 0.930122971534729
analysis O 0 0.011388552375137806
in O 0 0.0061013721860945225
237 O 0 0.019482502713799477
families O 0 0.009206212125718594
, O 0 0.0043162084184587
each O 0 0.0038749175146222115
with O 0 0.003911578096449375
at O 0 0.004688114859163761
least O 0 0.006899625528603792
four O 0 0.006662117782980204
cases O 0 0.018480850383639336
of O 0 0.013682937249541283
breast B-Disease 1 0.9999020099639893
cancer I-Disease 1 0.9995749592781067
, O 0 0.009616103023290634
collected O 0 0.011561374180018902
by O 0 0.012636931613087654
the O 0 0.04678536206483841
Breast B-Disease 1 0.9998447895050049
Cancer I-Disease 1 0.9997630715370178
Linkage O 1 0.9785329699516296
Consortium O 1 0.5126663446426392
. O 0 0.05130044370889664

Families O 0 0.026825031265616417
were O 0 0.009323682636022568
included O 0 0.007954292930662632
without O 0 0.007449578493833542
regard O 0 0.009570855647325516
to O 0 0.0049702757969498634
the O 0 0.007351176347583532
occurrence O 0 0.217352494597435
of O 0 0.015159007161855698
ovarian B-Disease 1 0.9991652965545654
or I-Disease 0 0.026116635650396347
other I-Disease 0 0.02424726076424122
cancers I-Disease 1 0.9972122311592102
. O 0 0.04061123728752136

Overall O 0 0.05432675778865814
, O 0 0.02323758788406849
disease O 1 0.9987611770629883
was O 0 0.011837096884846687
linked O 0 0.05977014824748039
to O 0 0.008405041880905628
BRCA1 O 1 0.990496039390564
in O 0 0.006611251272261143
an O 0 0.005326328333467245
estimated O 0 0.009996185079216957
52 O 0 0.009502883069217205
% O 0 0.005501963663846254
of O 0 0.0038482611998915672
families O 0 0.007446702104061842
, O 0 0.0046547167003154755
to O 0 0.00555976340547204
BRCA2 O 1 0.9883657693862915
in O 0 0.0068237087689340115
32 O 0 0.009734919294714928
% O 0 0.006346969865262508
of O 0 0.003727969480678439
families O 0 0.0066611613146960735
, O 0 0.003452775301411748
and O 0 0.0030580912716686726
to O 0 0.003668583696708083
neither O 0 0.008436367847025394
gene O 0 0.06424877047538757
in O 0 0.005499555729329586
16 O 0 0.007667246274650097
% O 0 0.007558896671980619
( O 0 0.007877354510128498
95 O 0 0.009840396232903004
% O 0 0.00877941120415926
confidence O 0 0.015068573877215385
interval O 0 0.029125025495886803
[ O 0 0.03227094188332558
CI O 1 0.5831897258758545
] O 0 0.027683429419994354
6 O 0 0.012843400239944458
% O 0 0.009911064058542252
- O 0 0.017154159024357796
28 O 0 0.012990925461053848
% O 0 0.009451991878449917
) O 0 0.008525962941348553
, O 0 0.0072632720693945885
suggesting O 0 0.020654918625950813
other O 0 0.014917808584868908
predisposition O 1 0.9852448105812073
genes O 1 0.8650215864181519
. O 0 0.03703375160694122

The O 0 0.020789768546819687
majority O 0 0.022576354444026947
( O 0 0.015873108059167862
81 O 0 0.020278984680771828
% O 0 0.01097825262695551
) O 0 0.008672745898365974
of O 0 0.007493634708225727
the O 0 0.01684175431728363
breast B-Disease 1 0.999697208404541
- I-Disease 1 0.9972000122070312
ovarian I-Disease 1 0.9999725818634033
cancer I-Disease 1 0.9998173117637634
families O 0 0.03823746368288994
were O 0 0.007178237196058035
due O 0 0.011763510294258595
to O 0 0.006767782382667065
BRCA1 O 1 0.9897777438163757
, O 0 0.005523986648768187
with O 0 0.004674801602959633
most O 0 0.005139152519404888
others O 0 0.007250980474054813
( O 0 0.008900146931409836
14 O 0 0.010508489795029163
% O 0 0.010234961286187172
) O 0 0.010693343356251717
due O 0 0.016409242525696754
to O 0 0.01702483743429184
BRCA2 O 1 0.9879453182220459
. O 0 0.045264750719070435

Conversely O 0 0.058403607457876205
, O 0 0.009656097739934921
the O 0 0.006599686574190855
majority O 0 0.009525084868073463
of O 0 0.005864618346095085
families O 0 0.009719843044877052
with O 0 0.0068492828868329525
male B-Disease 0 0.07640779763460159
and I-Disease 0 0.011554194614291191
female I-Disease 1 0.9310595393180847
breast I-Disease 1 0.9998525381088257
cancer I-Disease 1 0.9996343851089478
were O 0 0.009100610390305519
due O 0 0.024891065433621407
to O 0 0.012676003389060497
BRCA2 O 1 0.9972406625747681
( O 0 0.027213994413614273
76 O 0 0.0451989620923996
% O 0 0.02237662486732006
) O 0 0.023217931389808655
. O 0 0.029763689264655113

The O 0 0.01944352313876152
largest O 0 0.025078872218728065
proportion O 0 0.02916528657078743
( O 0 0.01359534077346325
67 O 0 0.015657715499401093
% O 0 0.008496848866343498
) O 0 0.005736884661018848
of O 0 0.004271835088729858
families O 0 0.008179154247045517
due O 0 0.008452266454696655
to O 0 0.004296943079680204
other O 0 0.004181890282779932
genes O 0 0.027708519250154495
was O 0 0.004588332958519459
found O 0 0.004731069318950176
in O 0 0.0033778371289372444
families O 0 0.005471489857882261
with O 0 0.0032249174546450377
four O 0 0.003575291018933058
or O 0 0.00529404915869236
five O 0 0.006120695732533932
cases O 0 0.014161297120153904
of O 0 0.01151374913752079
female O 1 0.8800989985466003
breast B-Disease 1 0.9998006224632263
cancer I-Disease 1 0.9990479350090027
only O 0 0.025154251605272293
. O 0 0.032966841012239456

These O 0 0.018500184640288353
estimates O 0 0.019084487110376358
were O 0 0.006212030537426472
not O 0 0.006586126051843166
substantially O 0 0.02298140898346901
affected O 0 0.019400695338845253
either O 0 0.006651979871094227
by O 0 0.006914422381669283
changing O 0 0.013425360433757305
the O 0 0.008074133656919003
assumed O 0 0.021183805540204048
penetrance O 1 0.7926233410835266
model O 0 0.016209373250603676
for O 0 0.010197232477366924
BRCA1 O 1 0.9920403361320496
or O 0 0.010101542808115482
by O 0 0.007560406811535358
including O 0 0.00797014869749546
or O 0 0.012173622846603394
excluding O 0 0.03711942955851555
BRCA1 O 1 0.9975696206092834
mutation O 1 0.987494170665741
data O 0 0.030891794711351395
. O 0 0.030886391177773476

Among O 0 0.022636916488409042
those O 0 0.01356493029743433
families O 0 0.018941860646009445
with O 0 0.015518459491431713
disease O 1 0.9996334314346313
due O 0 0.06060662493109703
to O 0 0.007614800240844488
BRCA1 O 1 0.9964932799339294
that O 0 0.0048540630377829075
were O 0 0.0035058280918747187
tested O 0 0.008956046774983406
by O 0 0.0032915787305682898
one O 0 0.002875956706702709
of O 0 0.002568983007222414
the O 0 0.0037308374885469675
standard O 0 0.008353491313755512
screening O 0 0.0223125908523798
methods O 0 0.009109358303248882
, O 0 0.0065419794991612434
mutations O 1 0.7427950501441956
were O 0 0.005337189417332411
detected O 0 0.01959979720413685
in O 0 0.0054207900539040565
the O 0 0.006376956589519978
coding O 0 0.030765367671847343
sequence O 0 0.015335027128458023
or O 0 0.007944793440401554
splice O 0 0.10072100162506104
sites O 0 0.0076050953939557076
in O 0 0.004402239806950092
an O 0 0.005024180747568607
estimated O 0 0.011001288890838623
63 O 0 0.012738541699945927
% O 0 0.009253492578864098
( O 0 0.008542424067854881
95 O 0 0.011759004555642605
% O 0 0.012775847688317299
CI O 0 0.42729857563972473
51 O 0 0.025147728621959686
% O 0 0.015964917838573456
- O 0 0.03186335787177086
77 O 0 0.029597001150250435
% O 0 0.020871607586741447
) O 0 0.021854300051927567
. O 0 0.02698877453804016

The O 0 0.024273667484521866
estimated O 0 0.028548957780003548
sensitivity O 0 0.030526071786880493
was O 0 0.008571851067245007
identical O 0 0.013643180020153522
for O 0 0.005931757856160402
direct O 0 0.013074795715510845
sequencing O 0 0.024857094511389732
and O 0 0.008318562060594559
other O 0 0.010207691229879856
techniques O 0 0.0267221350222826
. O 0 0.02468036860227585

The O 0 0.03332250937819481
penetrance O 1 0.6690137982368469
of O 0 0.020687568932771683
BRCA2 O 1 0.9932366013526917
was O 0 0.013855748809874058
estimated O 0 0.016302278265357018
by O 0 0.010386441834270954
maximizing O 0 0.0249568410217762
the O 0 0.009523843415081501
LOD O 0 0.11386927962303162
score O 0 0.013638759031891823
in O 0 0.013186653144657612
BRCA2 O 1 0.9986157417297363
- O 1 0.6469504237174988
mutation O 1 0.9857562184333801
families O 0 0.014242656528949738
, O 0 0.006064062472432852
over O 0 0.006710061337798834
all O 0 0.006915958132594824
possible O 0 0.018266748636960983
penetrance O 1 0.6455531120300293
functions O 0 0.036500558257102966
. O 0 0.0329708531498909

The O 0 0.023162998259067535
estimated O 0 0.04161544889211655
cumulative O 0 0.49053269624710083
risk O 1 0.9291344881057739
of O 0 0.034048039466142654
breast B-Disease 1 0.9998214840888977
cancer I-Disease 1 0.9993533492088318
reached O 0 0.023819109424948692
28 O 0 0.019454287365078926
% O 0 0.01357191987335682
( O 0 0.011335386894643307
95 O 0 0.01482329610735178
% O 0 0.013507167808711529
CI O 0 0.34261390566825867
9 O 0 0.015443139709532261
% O 0 0.012102254666388035
- O 0 0.01740931160748005
44 O 0 0.012723689898848534
% O 0 0.010062918066978455
) O 0 0.006917637772858143
by O 0 0.005442154593765736
age O 0 0.00843121949583292
50 O 0 0.006576238200068474
years O 0 0.005258247256278992
and O 0 0.004549228586256504
84 O 0 0.013780847191810608
% O 0 0.010169201530516148
( O 0 0.009902354329824448
95 O 0 0.013016188517212868
% O 0 0.012952860444784164
CI O 0 0.19570255279541016
43 O 0 0.018451668322086334
% O 0 0.013396435417234898
- O 0 0.02155083231627941
95 O 0 0.016552750021219254
% O 0 0.011246809735894203
) O 0 0.010021411813795567
by O 0 0.009865991771221161
age O 0 0.018826132640242577
70 O 0 0.020698221400380135
years O 0 0.023772049695253372
. O 0 0.02770336903631687

The O 0 0.04151913896203041
corresponding O 1 0.8567367792129517
ovarian B-Disease 1 0.999896764755249
cancer I-Disease 1 0.999810516834259
risks O 1 0.9388189911842346
were O 0 0.02079339697957039
0 O 0 0.04279762879014015
. O 0 0.03150053322315216

4 O 0 0.034814346581697464
% O 0 0.024729525670409203
( O 0 0.017420124262571335
95 O 0 0.019420333206653595
% O 0 0.015427947975695133
CI O 0 0.3597840666770935
0 O 0 0.019662970677018166
% O 0 0.012119118124246597
- O 0 0.016594281420111656
1 O 0 0.010166273452341557
% O 0 0.008494844660162926
) O 0 0.0063974009826779366
by O 0 0.005033466964960098
age O 0 0.008177407085895538
50 O 0 0.006940747611224651
years O 0 0.0061234282329678535
and O 0 0.004608228802680969
27 O 0 0.009964359924197197
% O 0 0.009667144156992435
( O 0 0.008672812022268772
95 O 0 0.012799138203263283
% O 0 0.012277362868189812
CI O 0 0.3049643337726593
0 O 0 0.018425352871418
% O 0 0.011838369071483612
- O 0 0.018391769379377365
47 O 0 0.01741524413228035
% O 0 0.010032283142209053
) O 0 0.007916615344583988
by O 0 0.007302263285964727
age O 0 0.016097450628876686
70 O 0 0.02067033387720585
years O 0 0.020426377654075623
. O 0 0.0285219457000494

The O 0 0.03211090341210365
lifetime O 0 0.2337290197610855
risk O 1 0.9200385808944702
of O 0 0.04909435659646988
breast B-Disease 1 0.9998693466186523
cancer I-Disease 1 0.9997901320457458
appears O 0 0.12015368044376373
similar O 0 0.012011678889393806
to O 0 0.0051075974479317665
the O 0 0.006076341029256582
risk O 1 0.6678397059440613
in O 0 0.010889829136431217
BRCA1 O 1 0.9990552067756653
carriers O 1 0.5560586452484131
, O 0 0.004991691559553146
but O 0 0.003975816536694765
there O 0 0.003445985959842801
was O 0 0.0035638834815472364
some O 0 0.003966841846704483
suggestion O 0 0.008556951768696308
of O 0 0.004881380591541529
a O 0 0.007686228957027197
lower O 0 0.02001018263399601
risk O 1 0.5525004863739014
in O 0 0.016950704157352448
BRCA2 O 1 0.9985973238945007
carriers O 1 0.8512763381004333
< O 1 0.5088120102882385
50 O 0 0.01641794666647911
years O 0 0.012732906267046928
of O 0 0.012062856927514076
age O 0 0.030238712206482887
. O 0 0.02802852727472782

Eye B-Disease 1 0.9719542860984802
movement I-Disease 0 0.48318713903427124
abnormalities I-Disease 1 0.991063117980957
correlate O 0 0.22493094205856323
with O 0 0.025375589728355408
genotype O 1 0.9812394380569458
in O 0 0.03576786443591118
autosomal O 1 0.9994101524353027
dominant O 1 0.9920759201049805
cerebellar B-Disease 1 0.9995391368865967
ataxia I-Disease 1 0.9997308850288391
type I-Disease 1 0.9480249285697937
I I-Disease 0 0.047177523374557495
. O 0 0.03698184713721275

We O 0 0.027028756216168404
compared O 0 0.04573613405227661
horizontal O 0 0.10603614151477814
eye O 1 0.8592422604560852
movements O 0 0.03339340165257454
( O 0 0.017597761005163193
visually O 0 0.043520715087652206
guided O 0 0.025361593812704086
saccades O 1 0.9764857292175293
, O 0 0.009748019278049469
antisaccades O 0 0.22991566359996796
, O 0 0.006040666718035936
and O 0 0.005248825531452894
smooth O 0 0.017481278628110886
pursuit O 0 0.015870120376348495
) O 0 0.007697824388742447
in O 0 0.006513233296573162
control O 0 0.014548276551067829
subjects O 0 0.014889441430568695
( O 0 0.010855465196073055
n O 0 0.019068783149123192
= O 0 0.02183508314192295
14 O 0 0.009377522394061089
) O 0 0.0067516472190618515
and O 0 0.004908772651106119
patients O 1 0.5701746940612793
with O 0 0.005704511888325214
three O 0 0.006604158319532871
forms O 0 0.014599834568798542
of O 0 0.01452008169144392
autosomal O 1 0.9991249442100525
dominant O 1 0.9691327810287476
cerebellar B-Disease 1 0.9986020922660828
ataxias I-Disease 1 0.9929355978965759
type I-Disease 1 0.7571497559547424
I I-Disease 0 0.06751766800880432
spinocerebellar B-Disease 1 0.9970603585243225
ataxias I-Disease 1 0.6862533092498779
1 I-Disease 0 0.013883219100534916
and I-Disease 0 0.00700979633256793
2 I-Disease 0 0.010777056217193604
( O 0 0.011283348314464092
SCA1 B-Disease 0 0.37334758043289185
, O 0 0.009457922540605068
n O 0 0.02002222090959549
= O 0 0.020840942859649658
11 O 0 0.009738614782691002
; O 0 0.010010072961449623
SCA2 B-Disease 0 0.14702902734279633
, O 0 0.00784448254853487
n O 0 0.018773403018712997
= O 0 0.018387824296951294
10 O 0 0.00818503275513649
) O 0 0.007829038426280022
and O 0 0.008022665046155453
SCA3 B-Disease 1 0.9792128205299377
/ O 1 0.7602295279502869
Machado B-Disease 1 0.7308986783027649
- I-Disease 1 0.6749753355979919
Joseph I-Disease 1 0.851162850856781
disease I-Disease 1 0.9995299577713013
( O 0 0.15613752603530884
MJD B-Disease 1 0.9775660634040833
) O 0 0.02012501284480095
( O 0 0.01812060922384262
n O 0 0.03160371631383896
= O 0 0.03857788071036339
16 O 0 0.020653951913118362
) O 0 0.02172435261309147
. O 0 0.029620977118611336

In O 0 0.03781396150588989
SCA1 B-Disease 0 0.47869402170181274
, O 0 0.023805057629942894
saccade O 1 0.7201107740402222
amplitude O 0 0.054380595684051514
was O 0 0.013512455858290195
significantly O 0 0.030784480273723602
increased O 0 0.016482045873999596
, O 0 0.008794612251222134
resulting O 0 0.03231367468833923
in O 0 0.015541021712124348
hypermetria B-Disease 1 0.6056746244430542
. O 0 0.03375821188092232

The O 0 0.028932830318808556
smooth O 0 0.05252460390329361
pursuit O 0 0.04422987252473831
gain O 0 0.03448197990655899
was O 0 0.02595548890531063
decreased O 0 0.08229829370975494
. O 0 0.039117660373449326

In O 0 0.04225087910890579
SCA2 B-Disease 1 0.5726977586746216
, O 0 0.028444325551390648
saccade O 1 0.7285670638084412
velocity O 0 0.06023247539997101
was O 0 0.026553859934210777
markedly O 0 0.21098630130290985
decreased O 0 0.18105527758598328
. O 0 0.041802458465099335

The O 0 0.016475027427077293
percentage O 0 0.02005278691649437
of O 0 0.00955574307590723
errors O 0 0.01930135115981102
in O 0 0.009389054030179977
antisaccades O 0 0.4019109904766083
was O 0 0.008806146681308746
greatly O 0 0.0201322752982378
increased O 0 0.013055913150310516
and O 0 0.005676837172359228
was O 0 0.008013722486793995
significantly O 0 0.030129212886095047
correlated O 0 0.06532956659793854
with O 0 0.0115927429869771
age O 0 0.0599045529961586
at O 0 0.04376858100295067
disease O 1 0.9996108412742615
onset O 1 0.9979185461997986
. O 0 0.05871085450053215

In O 0 0.017752964049577713
addition O 0 0.013135146349668503
, O 0 0.006963222287595272
a O 0 0.008575073443353176
correlation O 0 0.019282929599285126
between O 0 0.009938576258718967
smooth O 0 0.017459867522120476
pursuit O 0 0.01593349315226078
gain O 0 0.010473274625837803
and O 0 0.004135609604418278
the O 0 0.004697367083281279
number O 0 0.0066681187599897385
of O 0 0.009328567422926426
trinucleotide O 1 0.9203878045082092
repeats O 0 0.05303096026182175
was O 0 0.014906026422977448
found O 0 0.021731285378336906
. O 0 0.027986960485577583

In O 0 0.03470875322818756
SCA3 B-Disease 1 0.9334006309509277
, O 0 0.02505440078675747
gaze B-Disease 0 0.45800337195396423
- I-Disease 0 0.33156800270080566
evoked I-Disease 1 0.8709685206413269
nystagmus I-Disease 1 0.9928694367408752
was O 0 0.013220655731856823
often O 0 0.011231605894863605
present O 0 0.00916761253029108
as O 0 0.007850665599107742
was O 0 0.011789324693381786
saccade O 1 0.7885381579399109
hypometria O 0 0.21070030331611633
and O 0 0.012497094459831715
smooth O 0 0.03334599733352661
pursuit O 0 0.032494522631168365
gain O 0 0.02767149545252323
was O 0 0.020839910954236984
markedly O 0 0.2384990006685257
decreased O 0 0.26034507155418396
. O 0 0.037258733063936234

Three O 0 0.021389732137322426
major O 0 0.021885933354496956
criteria O 0 0.02123783342540264
, O 0 0.014588185586035252
saccade O 1 0.8162997961044312
amplitude O 0 0.06342322379350662
, O 0 0.014082039706408978
saccade O 0 0.31961384415626526
velocity O 0 0.023028042167425156
, O 0 0.005837168078869581
and O 0 0.0047615631483495235
presence O 0 0.010464224964380264
of O 0 0.007881112396717072
gaze B-Disease 1 0.5629568696022034
- I-Disease 0 0.4484521150588989
evoked I-Disease 1 0.937047004699707
nystagmus I-Disease 1 0.9940375089645386
, O 0 0.00887294765561819
permitted O 0 0.008421641774475574
the O 0 0.005514111835509539
correct O 0 0.013171780854463577
assignment O 0 0.01153171993792057
of O 0 0.005130573641508818
90 O 0 0.008394881151616573
% O 0 0.0059315720573067665
of O 0 0.004487170372158289
the O 0 0.005544290412217379
SCA1 B-Disease 0 0.11601521074771881
, O 0 0.007289898581802845
90 O 0 0.010354626923799515
% O 0 0.006866700481623411
of O 0 0.004621538333594799
the O 0 0.0059010242111980915
SCA2 B-Disease 0 0.4103539288043976
, O 0 0.006007435265928507
and O 0 0.005089813843369484
93 O 0 0.010598198510706425
% O 0 0.007029533386230469
of O 0 0.00550659466534853
the O 0 0.007650061044842005
patients O 1 0.9292218685150146
with O 0 0.007883844897150993
SCA3 B-Disease 1 0.7099311351776123
to O 0 0.005966515745967627
their O 0 0.007549194619059563
genetically O 0 0.21545179188251495
confirmed O 0 0.047565411776304245
patient O 1 0.839819610118866
group O 0 0.008394571952521801
and O 0 0.0039857784286141396
, O 0 0.004126245155930519
therefore O 0 0.005776142701506615
, O 0 0.004515361972153187
may O 0 0.007130058016628027
help O 0 0.009967483580112457
orient O 0 0.052153438329696655
diagnoses O 1 0.9839116930961609
of O 0 0.010180559009313583
SCA1 B-Disease 1 0.9439604878425598
, O 0 0.010840934701263905
SCA2 B-Disease 1 0.7622504830360413
, O 0 0.00789499469101429
and O 0 0.007606380619108677
SCA3 B-Disease 1 0.6251987814903259
at O 0 0.010255002416670322
early O 0 0.014434191398322582
clinical O 0 0.292210191488266
stages O 0 0.02171575464308262
of O 0 0.009009698405861855
the O 0 0.0135195879265666
diseases O 1 0.997541069984436
. O 0 0.01913902722299099
. O 0 0.029610618948936462

Genetic O 0 0.3984074592590332
basis O 0 0.018608804792165756
and O 0 0.012010026723146439
molecular O 0 0.09194925427436829
mechanism O 0 0.24937358498573303
for O 0 0.04829935356974602
idiopathic B-Disease 1 0.9996609687805176
ventricular I-Disease 1 0.999460756778717
fibrillation I-Disease 1 0.998981773853302
. O 0 0.10692495852708817

Ventricular B-Disease 1 0.9979711174964905
fibrillation I-Disease 1 0.9990803003311157
causes O 1 0.9744565486907959
more O 0 0.014349191449582577
than O 0 0.01074937079101801
300 O 0 0.015657877549529076
, O 0 0.009173301048576832
000 O 0 0.05133100226521492
sudden O 1 0.7772456407546997
deaths O 0 0.2756038010120392
each O 0 0.006370557006448507
year O 0 0.006946435663849115
in O 0 0.006030083168298006
the O 0 0.008473576977849007
USA O 0 0.0275479294359684
alone O 0 0.027672074735164642
. O 0 0.02807273156940937

In O 0 0.016765844076871872
approximately O 0 0.01819494739174843
5 O 0 0.013138347305357456
- O 0 0.01521261129528284
12 O 0 0.00731592858210206
% O 0 0.005622525699436665
of O 0 0.003318001748993993
these O 0 0.0031677072402089834
cases O 0 0.00697254529222846
, O 0 0.00313907815143466
there O 0 0.0031009202357381582
are O 0 0.0037947024684399366
no O 0 0.007019435055553913
demonstrable O 1 0.9806652069091797
cardiac O 1 0.9989781379699707
or O 0 0.018784817308187485
non O 0 0.27873051166534424
- O 1 0.941868007183075
cardiac O 1 0.9993114471435547
causes O 1 0.9628860354423523
to O 0 0.005381716415286064
account O 0 0.006878124084323645
for O 0 0.0038980727549642324
the O 0 0.004573128651827574
episode O 0 0.010162019170820713
, O 0 0.00416588643565774
which O 0 0.00384457572363317
is O 0 0.005381700582802296
therefore O 0 0.0092979921028018
classified O 0 0.02230200543999672
as O 0 0.0270369965583086
idiopathic B-Disease 1 0.9998834133148193
ventricular I-Disease 1 0.9997922778129578
fibrillation I-Disease 1 0.9997327923774719
( O 1 0.6444031596183777
IVF B-Disease 1 0.9897159934043884
) O 0 0.04545193538069725
. O 0 0.04511858895421028

A O 0 0.03082779049873352
distinct O 0 0.027171412482857704
group O 0 0.017105884850025177
of O 0 0.012983554042875767
IVF B-Disease 1 0.996956467628479
patients O 1 0.9938441514968872
has O 0 0.009991821832954884
been O 0 0.006205339916050434
found O 0 0.006847793702036142
to O 0 0.0038626918103545904
present O 0 0.00631679454818368
with O 0 0.00596215995028615
a O 0 0.013307160697877407
characteristic O 0 0.11505551636219025
electrocardiographic O 1 0.8583800792694092
pattern O 0 0.17717888951301575
. O 0 0.038096047937870026

Because O 0 0.018972737714648247
of O 0 0.007838417775928974
the O 0 0.006387182977050543
small O 0 0.008123466745018959
size O 0 0.00748574361205101
of O 0 0.004815315827727318
most O 0 0.005461379885673523
pedigrees O 0 0.028987770900130272
and O 0 0.004427488427609205
the O 0 0.005554023664444685
high O 0 0.012070370838046074
incidence O 1 0.9577034711837769
of O 0 0.008977525867521763
sudden B-Disease 1 0.9523232579231262
death I-Disease 0 0.09274167567491531
, O 0 0.006512979976832867
however O 0 0.006570745259523392
, O 0 0.006166510749608278
molecular O 0 0.06268536299467087
genetic O 0 0.4999963939189911
studies O 0 0.01150480192154646
of O 0 0.006062631495296955
IVF B-Disease 1 0.9707085490226746
have O 0 0.006890173070132732
not O 0 0.004897572565823793
yet O 0 0.008264993317425251
been O 0 0.008961869403719902
done O 0 0.017060117796063423
. O 0 0.020526224747300148

Because O 0 0.13431355357170105
IVF B-Disease 1 0.9944092631340027
causes O 1 0.9968681931495667
cardiac O 1 0.9992438554763794
rhythm O 1 0.9244584441184998
disturbance O 1 0.6986111998558044
, O 0 0.00942857377231121
we O 0 0.007051154505461454
investigated O 0 0.01745426468551159
whether O 0 0.01198496948927641
malfunction O 0 0.3088991045951843
of O 0 0.010319947265088558
ion O 0 0.05723898485302925
channels O 0 0.021819567307829857
could O 0 0.011101980693638325
cause O 0 0.3485721945762634
the O 0 0.01200654823333025
disorder O 1 0.9976014494895935
by O 0 0.012338603846728802
studying O 0 0.022104496136307716
mutations O 1 0.9777576327323914
in O 0 0.015044133178889751
the O 0 0.02026144042611122
cardiac O 1 0.9966933727264404
sodium O 1 0.8613225221633911
channel O 0 0.09009379893541336
gene O 1 0.8013835549354553
SCN5A O 1 0.8447822332382202
. O 0 0.05184801295399666

We O 0 0.013946350663900375
have O 0 0.008901871740818024
now O 0 0.009997427463531494
identified O 0 0.017431505024433136
a O 0 0.015922633931040764
missense O 1 0.9417548775672913
mutation O 1 0.9535520076751709
, O 0 0.011103174649178982
a O 0 0.01604338362812996
splice O 1 0.79886394739151
- O 0 0.41687339544296265
donor O 1 0.9001262784004211
mutation O 1 0.9801458716392517
, O 0 0.008331223390996456
and O 0 0.007325222250074148
a O 0 0.015392070636153221
frameshift O 1 0.9915146827697754
mutation O 1 0.8901842832565308
in O 0 0.008114997297525406
the O 0 0.008199822157621384
coding O 0 0.038983866572380066
region O 0 0.017929935827851295
of O 0 0.009785446338355541
SCN5A O 0 0.4494696855545044
in O 0 0.011968070641160011
three O 0 0.017157431691884995
IVF B-Disease 1 0.9319156408309937
families O 0 0.04501965269446373
. O 0 0.03753624111413956

We O 0 0.018241319805383682
show O 0 0.020495368167757988
that O 0 0.0097722876816988
sodium O 0 0.034672822803258896
channels O 0 0.014825568534433842
with O 0 0.008476883172988892
the O 0 0.011750229634344578
missense O 1 0.970808207988739
mutation O 1 0.9956639409065247
recover O 1 0.7594955563545227
from O 0 0.014601063914597034
inactivation O 1 0.7520356774330139
more O 0 0.009846740402281284
rapidly O 0 0.020684638991951942
than O 0 0.00790455099195242
normal O 0 0.011934978887438774
and O 0 0.0049284095875918865
that O 0 0.005048069171607494
the O 0 0.00974330585449934
frameshift O 1 0.9956541061401367
mutation O 1 0.9974786639213562
causes O 1 0.9798292517662048
the O 0 0.011406965553760529
sodium O 0 0.18081416189670563
channel O 0 0.017040716484189034
to O 0 0.006153770722448826
be O 0 0.007258756086230278
non O 0 0.021100090816617012
- O 0 0.04460601136088371
functional O 0 0.05329485610127449
. O 0 0.030528005212545395

Our O 0 0.02833503857254982
results O 0 0.025276178494095802
indicate O 0 0.02253894694149494
that O 0 0.011031800881028175
mutations O 1 0.9029300808906555
in O 0 0.014410610310733318
cardiac O 1 0.9980629086494446
ion O 0 0.48962628841400146
- O 0 0.18366898596286774
channel O 0 0.03457668796181679
genes O 0 0.2743462324142456
contribute O 0 0.01830504648387432
to O 0 0.006338194478303194
the O 0 0.007991524413228035
risk O 0 0.06343275308609009
of O 0 0.010635241866111755
developing O 0 0.06024169921875
IVF B-Disease 1 0.9769611954689026
. O 0 0.02263021469116211
. O 0 0.028605781495571136

Molecular O 0 0.14653471112251282
heterogeneity O 0 0.34988775849342346
in O 0 0.020418593659996986
mucopolysaccharidosis B-Disease 1 0.7079641819000244
IVA I-Disease 1 0.8184182047843933
in O 0 0.009292923845350742
Australia O 0 0.01073955837637186
and O 0 0.006087739020586014
Northern O 0 0.012071656063199043
Ireland O 0 0.012211600318551064
: O 0 0.00907108373939991
nine O 0 0.01123807393014431
novel O 0 0.025169629603624344
mutations O 1 0.8966863751411438
including O 0 0.011927608400583267
T312S O 0 0.24739788472652435
, O 0 0.007922377437353134
a O 0 0.010854574851691723
common O 0 0.02038382552564144
allele O 1 0.9164147973060608
that O 0 0.011840984225273132
confers O 1 0.6041255593299866
a O 0 0.03517644479870796
mild O 1 0.9877631068229675
phenotype O 1 0.9918777942657471
. O 0 0.04716841131448746

Mucopolysaccharidosis B-Disease 1 0.9475287795066833
IVA I-Disease 1 0.971039354801178
( O 0 0.04543285444378853
MPS B-Disease 0 0.2837326228618622
IVA I-Disease 1 0.9652819633483887
) O 0 0.021383365616202354
is O 0 0.014988522045314312
an O 0 0.024903126060962677
autosomal B-Disease 1 0.9995288848876953
recessive I-Disease 1 0.9998130202293396
lysosomal I-Disease 1 0.9992511868476868
storage I-Disease 1 0.9784014821052551
disorder I-Disease 1 0.9998842477798462
caused O 1 0.9783147573471069
by O 0 0.01464877836406231
a O 0 0.019568191841244698
genetic B-Disease 1 0.9890719652175903
defect I-Disease 1 0.986647367477417
in O 0 0.013740174472332
N O 0 0.12413936853408813
- O 0 0.2819284498691559
acetylgalactosamine O 1 0.8887845277786255
- O 0 0.18700538575649261
6 O 0 0.036646027117967606
- O 1 0.5300691723823547
sulfate O 1 0.9698193669319153
sulfatase O 1 0.9858003854751587
( O 0 0.06051171198487282
GALNS O 1 0.8222925066947937
) O 0 0.03767354413866997
. O 0 0.03452552482485771

Previous O 0 0.03074946068227291
studies O 0 0.023645926266908646
of O 0 0.012297507375478745
patients O 1 0.8647012114524841
from O 0 0.007595967035740614
a O 0 0.007652037777006626
British O 0 0.011733939871191978
- O 0 0.03333936631679535
Irish O 0 0.023018697276711464
population O 0 0.014674033969640732
showed O 0 0.010038048028945923
that O 0 0.004520955495536327
the O 0 0.006306913215667009
I113F O 1 0.6875587105751038
mutation O 1 0.8928894400596619
is O 0 0.005340777803212404
the O 0 0.004695039242506027
most O 0 0.005335562396794558
common O 0 0.011076985858380795
single O 0 0.014064723625779152
mutation O 1 0.9765318632125854
among O 0 0.025985470041632652
MPS B-Disease 1 0.9233855605125427
IVA I-Disease 1 0.998735249042511
patients O 1 0.9972696900367737
and O 0 0.014798249118030071
produces O 0 0.1436818391084671
a O 0 0.03463919460773468
severe O 1 0.9980801343917847
clinical O 1 0.9934159517288208
phenotype O 1 0.9969671368598938
. O 0 0.05695485696196556

We O 0 0.02420821785926819
studied O 0 0.03397195786237717
mutations O 1 0.5864574909210205
in O 0 0.01261887513101101
the O 0 0.014687125571072102
GALNS O 1 0.6570470929145813
gene O 1 0.5048705339431763
from O 0 0.012809854932129383
23 O 0 0.017165103927254677
additional O 0 0.016036653891205788
MPS B-Disease 0 0.4244312644004822
IVA I-Disease 1 0.997144877910614
patients O 1 0.9967711567878723
( O 0 0.012457657605409622
15 O 0 0.00815661158412695
from O 0 0.005802774336189032
Australia O 0 0.005582095123827457
, O 0 0.00407650601118803
8 O 0 0.00699255196377635
from O 0 0.004951802082359791
Northern O 0 0.009232214652001858
Ireland O 0 0.009839290753006935
) O 0 0.006986340042203665
, O 0 0.0042640999890863895
with O 0 0.0046926336362957954
various O 0 0.007200076710432768
clinical O 1 0.9046362638473511
phenotypes O 1 0.9969156980514526
( O 0 0.24574331939220428
severe O 1 0.9961848855018616
, O 0 0.008079292252659798
16 O 0 0.011382472701370716
cases O 0 0.020767824724316597
; O 0 0.00869406946003437
intermediate O 0 0.014824007637798786
, O 0 0.0065205711871385574
4 O 0 0.011497772298753262
cases O 0 0.01949661411345005
; O 0 0.012141574174165726
mild O 1 0.7791808247566223
, O 0 0.009355196729302406
3 O 0 0.014976194128394127
cases O 0 0.024545980617403984
) O 0 0.020052917301654816
. O 0 0.023437267169356346

We O 0 0.014089793898165226
found O 0 0.012896230444312096
two O 0 0.008941064588725567
common O 0 0.01874641329050064
mutations O 1 0.8126873970031738
that O 0 0.004707219544798136
together O 0 0.005476538557559252
accounted O 0 0.011242445558309555
for O 0 0.004708027932792902
32 O 0 0.008907624520361423
% O 0 0.006487783510237932
of O 0 0.00454341946169734
the O 0 0.006204722449183464
44 O 0 0.016334427520632744
unrelated O 0 0.21119704842567444
alleles O 1 0.856618344783783
in O 0 0.014720610342919827
these O 0 0.017112959176301956
patients O 1 0.9770920872688293
. O 0 0.03961901366710663

One O 0 0.016867617145180702
is O 0 0.011122720316052437
the O 0 0.01076234970241785
T312S O 1 0.8503343462944031
mutation O 1 0.9666561484336853
, O 0 0.008871774189174175
a O 0 0.011873260140419006
novel O 0 0.033767033368349075
mutation O 1 0.969610333442688
found O 0 0.016421476379036903
exclusively O 0 0.019800174981355667
in O 0 0.015763506293296814
milder O 1 0.9811428189277649
patients O 1 0.9883114695549011
. O 0 0.043496403843164444

The O 0 0.014642641879618168
other O 0 0.007985067553818226
is O 0 0.007583665661513805
the O 0 0.007029433269053698
previously O 0 0.012038638815283775
described O 0 0.017530355602502823
I113F O 0 0.13149945437908173
that O 0 0.01167240645736456
produces O 0 0.04751178249716759
a O 0 0.03273409232497215
severe O 1 0.9960487484931946
phenotype O 1 0.9919915795326233
. O 0 0.04931062459945679

The O 0 0.024820134043693542
I113F O 0 0.27648982405662537
and O 0 0.016119156032800674
T312S O 1 0.8922461867332458
mutations O 1 0.9659468531608582
accounted O 0 0.02274003066122532
for O 0 0.0074607450515031815
8 O 0 0.011762812733650208
( O 0 0.008226378820836544
18 O 0 0.007421786896884441
% O 0 0.007164978887885809
) O 0 0.0056134420447051525
and O 0 0.0038456516340374947
6 O 0 0.00787567812949419
( O 0 0.008085767738521099
14 O 0 0.008765812031924725
% O 0 0.007591697853058577
) O 0 0.006793580017983913
of O 0 0.006530080456286669
44 O 0 0.017801770940423012
unrelated O 0 0.0813959538936615
alleles O 1 0.9115715026855469
, O 0 0.015431635081768036
respectively O 0 0.027350248768925667
. O 0 0.027319379150867462

The O 0 0.026707421988248825
relatively O 0 0.03345087170600891
high O 0 0.025430569425225258
residual O 0 0.34392502903938293
GALNS O 1 0.6171848773956299
activity O 0 0.02535535767674446
seen O 0 0.018588878214359283
when O 0 0.01110961101949215
the O 0 0.010067245922982693
T312S O 1 0.585422158241272
mutant O 1 0.7346875667572021
cDNA O 0 0.10439097881317139
is O 0 0.014786623418331146
overexpressed O 1 0.5703691244125366
in O 0 0.012402151711285114
mutant O 1 0.8277156949043274
cells O 0 0.3447105586528778
provides O 0 0.012589287012815475
an O 0 0.0072855520993471146
explanation O 0 0.014338836073875427
for O 0 0.006924760062247515
the O 0 0.01176522858440876
mild O 1 0.9945353269577026
phenotype O 1 0.9966422319412231
in O 0 0.01728857308626175
patients O 1 0.9874186515808105
with O 0 0.014276484027504921
this O 0 0.017570380121469498
mutation O 1 0.9562013149261475
. O 0 0.03734859451651573

The O 0 0.013010253198444843
distribution O 0 0.015203149989247322
and O 0 0.006625835783779621
relative O 0 0.012279975228011608
frequencies O 0 0.013490544632077217
of O 0 0.0054073818027973175
the O 0 0.007408369332551956
I113F O 0 0.3033756613731384
and O 0 0.01080702431499958
T312S O 1 0.8166074156761169
mutations O 1 0.9292902946472168
in O 0 0.0074973697774112225
Australia O 0 0.008119414560496807
corresponded O 0 0.012390807271003723
to O 0 0.003935639280825853
those O 0 0.004152205772697926
observed O 0 0.007734406739473343
in O 0 0.0037963164504617453
Northern O 0 0.007329918444156647
Ireland O 0 0.0066225784830749035
and O 0 0.0028814368415623903
are O 0 0.002497396431863308
unique O 0 0.004174541682004929
to O 0 0.002525357063859701
these O 0 0.0025125339161604643
two O 0 0.0031807490158826113
populations O 0 0.016793519258499146
, O 0 0.0038019486237317324
suggesting O 0 0.008169854059815407
that O 0 0.00404116278514266
both O 0 0.005675057880580425
mutations O 1 0.8216856122016907
were O 0 0.003970219753682613
probably O 0 0.007333812769502401
introduced O 0 0.007226815912872553
to O 0 0.004132802598178387
Australia O 0 0.006054459139704704
by O 0 0.006636649835854769
Irish O 0 0.015128439292311668
migrants O 0 0.015254536643624306
during O 0 0.011621239595115185
the O 0 0.0077860597521066666
19th O 0 0.017254594713449478
century O 0 0.021251294761896133
. O 0 0.025347113609313965

Haplotype O 1 0.7834191918373108
analysis O 0 0.03991297632455826
using O 0 0.02087685465812683
6 O 0 0.023882916197180748
RFLPs O 0 0.06182250380516052
provides O 0 0.014039870351552963
additional O 0 0.009759228676557541
data O 0 0.007272025104612112
that O 0 0.0054636853747069836
the O 0 0.009901906363666058
I113F O 1 0.7191954851150513
mutation O 1 0.9620643854141235
originated O 0 0.026759209111332893
from O 0 0.012227953411638737
a O 0 0.015018188394606113
common O 0 0.029269861057400703
ancestor O 0 0.21029238402843475
. O 0 0.03986981138586998

The O 0 0.017370250076055527
other O 0 0.012136600911617279
9 O 0 0.019697394222021103
novel O 0 0.028808336704969406
mutations O 1 0.9304940104484558
identified O 0 0.015187956392765045
in O 0 0.006384925451129675
these O 0 0.006511669140309095
23 O 0 0.012450193986296654
patients O 1 0.6193028688430786
were O 0 0.003411155892536044
each O 0 0.004568300675600767
limited O 0 0.006357627455145121
to O 0 0.0043051233515143394
a O 0 0.009133937768638134
single O 0 0.0167554784566164
family O 0 0.029160290956497192
. O 0 0.03229488432407379

These O 0 0.014843476936221123
data O 0 0.01251404732465744
provide O 0 0.01061651948839426
further O 0 0.00889851525425911
evidence O 0 0.008519741706550121
for O 0 0.008035724982619286
extensive O 0 0.024431850761175156
allelic O 1 0.8447296619415283
heterogeneity O 1 0.5411403775215149
in O 0 0.014744198881089687
MPS B-Disease 0 0.18611320853233337
IVA I-Disease 1 0.9745287299156189
in O 0 0.010342082008719444
British O 0 0.019461654126644135
- O 0 0.16714262962341309
Irish O 0 0.1790374368429184
patients O 1 0.9693371653556824
and O 0 0.004451064392924309
provide O 0 0.005834616720676422
evidence O 0 0.005754159297794104
for O 0 0.003909583669155836
their O 0 0.004794839303940535
transmission O 0 0.01655208133161068
to O 0 0.004496531095355749
Australia O 0 0.006467082537710667
by O 0 0.00666996743530035
British O 0 0.013483800925314426
- O 0 0.034944020211696625
Irish O 0 0.03173721954226494
migrants O 0 0.031376443803310394
. O 0 0.017315911129117012
. O 0 0.03253711760044098

Identification O 0 0.055339910089969635
of O 0 0.025479139760136604
constitutional O 0 0.06005730479955673
WT1 O 1 0.9960556030273438
mutations O 1 0.9893719553947449
, O 0 0.011579959653317928
in O 0 0.013889596797525883
patients O 1 0.9949325919151306
with O 0 0.02483886294066906
isolated O 1 0.9889153838157654
diffuse B-Disease 1 0.9992051720619202
mesangial I-Disease 1 0.9998499155044556
sclerosis I-Disease 1 0.999896764755249
, O 0 0.014850938692688942
and O 0 0.00862230733036995
analysis O 0 0.015340766869485378
of O 0 0.011458361521363258
genotype O 1 0.9971051812171936
/ O 1 0.9607869982719421
phenotype O 1 0.994917631149292
correlations O 0 0.05353378877043724
by O 0 0.008043685927987099
use O 0 0.007654279470443726
of O 0 0.007026278413832188
a O 0 0.014996775425970554
computerized O 0 0.2897464632987976
mutation O 1 0.9639180898666382
database O 0 0.06677522510290146
. O 0 0.04330563172698021

Constitutional O 0 0.05988208204507828
mutations O 1 0.8064416646957397
of O 0 0.014716454781591892
the O 0 0.016553843393921852
WT1 O 1 0.9866489768028259
gene O 1 0.6945207715034485
, O 0 0.011484219692647457
encoding O 0 0.02690209075808525
a O 0 0.014141686260700226
zinc O 1 0.7123035788536072
- O 0 0.32707202434539795
finger O 1 0.759347677230835
transcription O 1 0.5595018863677979
factor O 0 0.12828576564788818
involved O 0 0.018011553213000298
in O 0 0.012659418396651745
renal O 1 0.9992877840995789
and O 0 0.012597979977726936
gonadal O 1 0.9856804609298706
development O 0 0.010730003006756306
, O 0 0.005650097504258156
are O 0 0.004255928099155426
found O 0 0.005878401454538107
in O 0 0.0049547962844371796
most O 0 0.008705897256731987
patients O 1 0.9869440793991089
with O 0 0.018078835681080818
Denys B-Disease 1 0.9954402446746826
- I-Disease 1 0.9858301281929016
Drash I-Disease 1 0.9979832172393799
syndrome I-Disease 1 0.9999487400054932
( O 0 0.30314889550209045
DDS B-Disease 1 0.9939953684806824
) O 0 0.019552001729607582
, O 0 0.014650349505245686
or O 0 0.0546439066529274
diffuse B-Disease 1 0.9978062510490417
mesangial I-Disease 1 0.9996662139892578
sclerosis I-Disease 1 0.9999536275863647
( O 1 0.6025879979133606
DMS B-Disease 1 0.991463840007782
) O 0 0.016870947554707527
associated O 0 0.016770968213677406
with O 0 0.010499534197151661
pseudohermaphroditism B-Disease 1 0.8778698444366455
and O 0 0.013148757629096508
/ O 1 0.7847707867622375
or O 0 0.18330352008342743
Wilms B-Disease 1 0.9991542100906372
tumor I-Disease 1 0.9990780353546143
( O 0 0.24000747501850128
WT B-Disease 1 0.9677340388298035
) O 0 0.041810326278209686
. O 0 0.04105436056852341

Most O 0 0.044795434921979904
mutations O 1 0.9686363935470581
in O 0 0.025720486417412758
DDS B-Disease 1 0.9976129531860352
patients O 1 0.9941211342811584
lie O 0 0.026438547298312187
in O 0 0.012058067135512829
exon O 0 0.15609264373779297
8 O 0 0.015617338940501213
or O 0 0.011693372391164303
exon O 0 0.04742276668548584
9 O 0 0.014167450368404388
, O 0 0.0093183983117342
encoding O 0 0.03171064332127571
zinc O 0 0.2813580632209778
finger O 0 0.18322640657424927
2 O 0 0.014978880062699318
or O 0 0.012557691894471645
zinc O 0 0.18463078141212463
finger O 0 0.14959578216075897
3 O 0 0.01230061799287796
, O 0 0.005872766952961683
respectively O 0 0.007778969127684832
, O 0 0.004557259846478701
with O 0 0.004549718927592039
a O 0 0.007601468823850155
hot O 0 0.01786528155207634
spot O 0 0.016717687249183655
( O 0 0.015228872187435627
R394W O 0 0.09467103332281113
) O 0 0.012808624655008316
in O 0 0.012413708493113518
exon O 0 0.07659117132425308
9 O 0 0.038677431643009186
. O 0 0.03071609139442444

We O 0 0.017138440161943436
analyzed O 0 0.022635655477643013
a O 0 0.009900891222059727
series O 0 0.009787045419216156
of O 0 0.007215660996735096
24 O 0 0.013862630352377892
patients O 1 0.9246533513069153
, O 0 0.006539391819387674
10 O 0 0.008704361505806446
with O 0 0.009485363028943539
isolated B-Disease 1 0.6150950193405151
DMS I-Disease 1 0.9932246804237366
( O 0 0.02933651953935623
IDMS B-Disease 1 0.993420422077179
) O 0 0.010480457916855812
, O 0 0.006252945400774479
10 O 0 0.007986627519130707
with O 0 0.008585307747125626
DDS B-Disease 1 0.8875408172607422
, O 0 0.006953774951398373
and O 0 0.00583072891458869
4 O 0 0.010669752024114132
with O 0 0.01413189060986042
urogenital B-Disease 1 0.9960190653800964
abnormalities I-Disease 1 0.9954694509506226
and O 0 0.015105927363038063
/ O 0 0.3817675709724426
or O 0 0.03239505738019943
WT B-Disease 1 0.9638341069221497
. O 0 0.04123956337571144

We O 0 0.0294395312666893
report O 0 0.04488906264305115
WT1 O 1 0.9890897870063782
heterozygous O 1 0.9550484418869019
mutations O 1 0.9586451649665833
in O 0 0.014705187641084194
16 O 0 0.022451749071478844
patients O 1 0.9525386691093445
, O 0 0.007788402959704399
4 O 0 0.010216757655143738
of O 0 0.006886924151331186
whom O 0 0.016762886196374893
presented O 0 0.01768200844526291
with O 0 0.01945444941520691
IDMS B-Disease 1 0.9830870628356934
. O 0 0.044134676456451416

One O 0 0.021753329783678055
male O 0 0.033014461398124695
and O 0 0.010224586352705956
two O 0 0.012625995092093945
female O 0 0.2913477122783661
IDMS B-Disease 1 0.9972225427627563
patients O 1 0.9966848492622375
with O 0 0.1783103197813034
WT1 O 1 0.9985753297805786
mutations O 1 0.9981437921524048
underwent O 1 0.996371865272522
normal O 1 0.7723414897918701
puberty O 1 0.9833807945251465
. O 0 0.05381559208035469

Two O 0 0.029484523460268974
mutations O 1 0.913970410823822
associated O 0 0.02754841186106205
with O 0 0.012972657568752766
IDMS B-Disease 1 0.9778981804847717
are O 0 0.006891390308737755
different O 0 0.0059831878170371056
from O 0 0.006774533074349165
those O 0 0.00840122252702713
described O 0 0.01795009709894657
in O 0 0.019899491220712662
DDS B-Disease 1 0.9962965846061707
patients O 1 0.995491087436676
. O 0 0.04598921537399292

No O 0 0.046455688774585724
WT1 O 1 0.9855490326881409
mutations O 1 0.9511297941207886
were O 0 0.010814479552209377
detected O 0 0.035370197147130966
in O 0 0.0060241809114813805
the O 0 0.006079590879380703
six O 0 0.008940936997532845
other O 0 0.012326261959969997
IDMS B-Disease 1 0.9988217949867249
patients O 1 0.9968771934509277
, O 0 0.014223801903426647
suggesting O 0 0.08415191620588303
genetic O 1 0.9141671657562256
heterogeneity O 1 0.7187519073486328
of O 0 0.017752347514033318
this O 0 0.024565890431404114
disease O 1 0.999062716960907
. O 0 0.0465046726167202

We O 0 0.032591987401247025
analyzed O 0 0.07479681819677353
genotype O 1 0.9867557287216187
/ O 1 0.9105587601661682
phenotype O 1 0.9911206364631653
correlations O 0 0.0640803873538971
, O 0 0.005195898003876209
on O 0 0.0031418337021023035
the O 0 0.003065345576032996
basis O 0 0.003623024094849825
of O 0 0.0029107220470905304
the O 0 0.0037494171410799026
constitution O 0 0.0066087436862289906
of O 0 0.004999480210244656
a O 0 0.010103507898747921
WT1 O 1 0.9965862035751343
mutation O 1 0.9904047250747681
database O 0 0.022036127746105194
of O 0 0.00899906549602747
84 O 0 0.09625012427568436
germ O 1 0.9591344594955444
- O 0 0.19704023003578186
line O 0 0.019208811223506927
mutations O 1 0.8252348303794861
, O 0 0.004321541637182236
to O 0 0.003446197137236595
compare O 0 0.007999164052307606
the O 0 0.003876893315464258
distribution O 0 0.007259972859174013
and O 0 0.0037369607016444206
type O 0 0.013527489267289639
of O 0 0.0053251562640070915
mutations O 1 0.9495026469230652
, O 0 0.005266801919788122
according O 0 0.005536090582609177
to O 0 0.00498849805444479
the O 0 0.008497990667819977
different O 0 0.01678367890417576
symptoms O 1 0.9971264004707336
. O 0 0.03421572223305702

This O 0 0.020658913999795914
demonstrated O 0 0.025586877018213272
( O 0 0.011988234706223011
1 O 0 0.00971983466297388
) O 0 0.007163561414927244
the O 0 0.005226443521678448
association O 0 0.011679207906126976
between O 0 0.009261269122362137
mutations O 1 0.7919934988021851
in O 0 0.008443869650363922
exons O 0 0.07659836113452911
8 O 0 0.010769824497401714
and O 0 0.005379929207265377
9 O 0 0.008699084632098675
and O 0 0.006653158459812403
DMS B-Disease 1 0.8630227446556091
; O 0 0.009786834008991718
( O 0 0.009257616475224495
2 O 0 0.008763935416936874
) O 0 0.007852629758417606
among O 0 0.00957054365426302
patients O 1 0.9541487693786621
with O 0 0.0078115640208125114
DMS B-Disease 1 0.921700656414032
, O 0 0.006053486373275518
a O 0 0.006784261669963598
higher O 0 0.009583573788404465
frequency O 0 0.015126189216971397
of O 0 0.007175440900027752
exon O 0 0.3140653967857361
8 O 0 0.019323475658893585
mutations O 1 0.9026868343353271
among O 0 0.013366243802011013
46 O 0 0.021620862185955048
, O 0 0.01503461878746748
XY O 1 0.9928988218307495
patients O 1 0.9882921576499939
with O 0 0.011421648785471916
female O 0 0.28221312165260315
phenotype O 1 0.9940906167030334
than O 0 0.010234169661998749
among O 0 0.012697672471404076
46 O 0 0.023490549996495247
, O 0 0.01484776008874178
XY O 1 0.9948922395706177
patients O 1 0.9872936010360718
with O 0 0.011003037914633751
sexual O 0 0.08262374997138977
ambiguity O 0 0.034936338663101196
or O 0 0.014784914441406727
male O 0 0.4696730971336365
phenotype O 1 0.9923317432403564
; O 0 0.01052350364625454
and O 0 0.005824052728712559
( O 0 0.008669794537127018
3 O 0 0.008560895919799805
) O 0 0.008031131699681282
statistically O 0 0.01437044981867075
significant O 0 0.00834682211279869
evidence O 0 0.008018090389668941
that O 0 0.005752097349613905
mutations O 1 0.7442582845687866
in O 0 0.007280098274350166
exons O 0 0.0945681631565094
8 O 0 0.010661042295396328
and O 0 0.0061966595239937305
9 O 0 0.01230249647051096
preferentially O 0 0.048706188797950745
affect O 0 0.025631677359342575
amino O 0 0.025537189096212387
acids O 0 0.019281666725873947
with O 0 0.0065719960257411
different O 0 0.008233912289142609
functions O 0 0.010998275130987167
. O 0 0.009805158711969852
. O 0 0.022014927119016647

The O 0 0.05353118106722832
185delAG O 1 0.9641019701957703
BRCA1 O 1 0.9965730905532837
mutation O 1 0.9827986359596252
originated O 0 0.032471537590026855
before O 0 0.009349842555820942
the O 0 0.007195142563432455
dispersion O 0 0.021144498139619827
of O 0 0.005340783391147852
Jews O 0 0.00813539419323206
in O 0 0.004519199952483177
the O 0 0.0050986227579414845
diaspora O 0 0.014774338342249393
and O 0 0.004507554229348898
is O 0 0.0053841667249798775
not O 0 0.0053810314275324345
limited O 0 0.010553933680057526
to O 0 0.010858019813895226
Ashkenazim O 0 0.36249879002571106
. O 0 0.03248869627714157

The O 0 0.04058871045708656
185delAG O 1 0.8675482869148254
mutation O 1 0.9796549677848816
in O 0 0.02380152978003025
BRCA1 O 1 0.9970909357070923
is O 0 0.017115451395511627
detected O 0 0.27799925208091736
in O 0 0.01045428216457367
Ashkenazi O 0 0.4042985737323761
Jews O 0 0.01568301022052765
both O 0 0.010732783004641533
in O 0 0.021595003083348274
familial B-Disease 1 0.9997085928916931
breast I-Disease 1 0.9999409914016724
and I-Disease 1 0.9226569533348083
ovarian I-Disease 1 0.9999785423278809
cancer I-Disease 1 0.9998593330383301
and O 0 0.010531795211136341
in O 0 0.009024577215313911
the O 0 0.011483104899525642
general O 0 0.018870815634727478
population O 0 0.03269824758172035
. O 0 0.026688825339078903

All O 0 0.028851324692368507
tested O 0 0.23545333743095398
Ashkenazi O 1 0.9476690292358398
mutation O 1 0.9868462681770325
carriers O 0 0.09441863745450974
share O 0 0.015124859288334846
the O 0 0.008657820522785187
same O 0 0.013750498183071613
allelic O 1 0.5379119515419006
pattern O 0 0.03904543071985245
at O 0 0.01396030280739069
the O 0 0.02104891836643219
BRCA1 O 1 0.9927569031715393
locus O 1 0.9478731155395508
. O 0 0.047865573316812515

Our O 0 0.01902613416314125
previous O 0 0.015510549768805504
study O 0 0.013701251707971096
showed O 0 0.01172341126948595
that O 0 0.005219548940658569
this O 0 0.007253267802298069
Ashkenazi O 1 0.8998340964317322
mutation O 1 0.9726495146751404
also O 0 0.00795949436724186
occurs O 0 0.020848238840699196
in O 0 0.006039507687091827
Iraqi O 0 0.013279816135764122
Jews O 0 0.012079039588570595
with O 0 0.007264571730047464
a O 0 0.013540769927203655
similar O 0 0.02445673756301403
allelic O 1 0.9097706079483032
pattern O 0 0.1276915967464447
. O 0 0.04498837888240814

We O 0 0.014455615542829037
extended O 0 0.016439123079180717
our O 0 0.00917070172727108
analysis O 0 0.010878141038119793
to O 0 0.005498518235981464
other O 0 0.00673383055254817
non O 0 0.014300862327218056
- O 0 0.03137160465121269
Ashkenazi O 0 0.337179958820343
subsets O 0 0.029363198205828667
354 O 0 0.025783319026231766
of O 0 0.00912633165717125
Moroccan O 0 0.026170214638113976
origin O 0 0.014735514298081398
, O 0 0.008276548236608505
200 O 0 0.015263034962117672
Yemenites O 0 0.16009218990802765
and O 0 0.010195470415055752
150 O 0 0.02262035943567753
Iranian O 0 0.028406532481312752
Jews O 0 0.03496112674474716
. O 0 0.03495016321539879

Heteroduplex O 0 0.315933495759964
analysis O 0 0.03667030110955238
complemented O 0 0.03598989173769951
by O 0 0.01656978204846382
direct O 0 0.022924643009901047
DNA O 0 0.03741214796900749
sequencing O 0 0.04382842779159546
of O 0 0.01715748757123947
abnormally O 1 0.9143841862678528
migrating O 0 0.23558339476585388
bands O 0 0.03047780692577362
were O 0 0.013628806918859482
employed O 0 0.03149699419736862
. O 0 0.030754519626498222

Four O 0 0.017526349052786827
of O 0 0.010518922470510006
Moroccan O 0 0.028095027431845665
origin O 0 0.01607425883412361
( O 0 0.010232237167656422
1 O 0 0.008542092517018318
. O 0 0.0048363241367042065
1 O 0 0.006784586235880852
% O 0 0.0064026229083538055
) O 0 0.004707357846200466
and O 0 0.0031416546553373337
none O 0 0.005739639978855848
of O 0 0.003760387422516942
the O 0 0.005087085999548435
Yemenites O 0 0.28836789727211
or O 0 0.007817564532160759
Iranians O 0 0.00972655601799488
was O 0 0.005691173952072859
a O 0 0.007894747890532017
carrier O 0 0.019721727818250656
of O 0 0.008878905326128006
the O 0 0.015039965510368347
185delAG O 1 0.8495732545852661
mutation O 1 0.9773398041725159
. O 0 0.04340488091111183

BRCA1 O 1 0.9944532513618469
allelic O 1 0.9194449186325073
patterns O 0 0.03878349810838699
were O 0 0.006852566730231047
determined O 0 0.00852483045309782
for O 0 0.00340517470613122
four O 0 0.0034121579956263304
of O 0 0.0028008949011564255
these O 0 0.0027090758085250854
individuals O 0 0.00444870674982667
and O 0 0.0026247508358210325
for O 0 0.0034590354189276695
12 O 0 0.0073129720985889435
additional O 0 0.009979131631553173
non O 0 0.02170521393418312
- O 0 0.2120213508605957
Ashkenazi O 1 0.9729593992233276
185delAG O 1 0.9922448992729187
mutation O 1 0.9958477020263672
carriers O 1 0.8213000297546387
who O 0 0.03024771623313427
had O 0 0.17924806475639343
breast B-Disease 1 0.9998100399971008
/ I-Disease 1 0.9985883831977844
ovarian I-Disease 1 0.9999366998672485
cancer I-Disease 1 0.9996601343154907
. O 0 0.0904819443821907

Six O 0 0.03551388159394264
non O 0 0.03786522150039673
- O 0 0.09288851171731949
Ashkenazi O 0 0.385944128036499
individuals O 0 0.01604016311466694
shared O 0 0.01300765946507454
the O 0 0.008776072412729263
common O 0 0.030300689861178398
Ashkenazi O 1 0.8781722784042358
haplotype O 1 0.9330623149871826
, O 0 0.00630015367642045
four O 0 0.004985047969967127
had O 0 0.005225323606282473
a O 0 0.005214077420532703
closely O 0 0.007645909674465656
related O 0 0.010761039331555367
pattern O 0 0.015099833719432354
, O 0 0.0038665819447487593
and O 0 0.003301797667518258
the O 0 0.004039794206619263
rest O 0 0.008424206636846066
( O 0 0.009168742224574089
n O 0 0.017722373828291893
= O 0 0.02075330913066864
6 O 0 0.011745735071599483
) O 0 0.007934052497148514
displayed O 0 0.011245355010032654
a O 0 0.013613289222121239
distinct O 0 0.10477606952190399
BRCA1 O 1 0.9978255033493042
allelic O 1 0.9771942496299744
pattern O 1 0.5058536529541016
. O 0 0.04193828999996185

We O 0 0.018231842666864395
conclude O 0 0.028637610375881195
that O 0 0.01099494006484747
the O 0 0.0157131589949131
185delAG O 1 0.9764612913131714
BRCA1 O 1 0.9984069466590881
mutation O 1 0.9947987794876099
occurs O 0 0.0769311711192131
in O 0 0.007801521103829145
some O 0 0.007272947113960981
non O 0 0.01938454806804657
- O 0 0.182308167219162
Ashkenazi O 1 0.8580981492996216
populations O 0 0.17871955037117004
at O 0 0.010993804782629013
rates O 0 0.01889204978942871
comparable O 0 0.01777484454214573
with O 0 0.008041303604841232
that O 0 0.009004573337733746
of O 0 0.014295016415417194
Ashkenazim O 1 0.5317264795303345
. O 0 0.04248666763305664

The O 0 0.017960641533136368
majority O 0 0.021043917164206505
of O 0 0.011133652180433273
Jewish O 0 0.0366995632648468
185delAG O 1 0.9569259285926819
mutation O 1 0.9930518865585327
carriers O 0 0.243662029504776
have O 0 0.00796984788030386
a O 0 0.007967706769704819
common O 0 0.024512480944395065
allelic O 1 0.8916075825691223
pattern O 0 0.06745467334985733
, O 0 0.006032678764313459
supporting O 0 0.010214490815997124
the O 0 0.005651610903441906
founder O 0 0.017795853316783905
effect O 0 0.014903241768479347
notion O 0 0.009744158014655113
, O 0 0.00451294519007206
but O 0 0.004727545194327831
dating O 0 0.01087265182286501
the O 0 0.006849230267107487
mutations O 1 0.6735315322875977
origin O 0 0.008202692493796349
to O 0 0.003920599818229675
an O 0 0.003973483107984066
earlier O 0 0.006250760052353144
date O 0 0.007900119759142399
than O 0 0.006618056911975145
currently O 0 0.010359157808125019
estimated O 0 0.023559855297207832
. O 0 0.02232319489121437

However O 0 0.021281516179442406
, O 0 0.0090516097843647
the O 0 0.008454727940261364
different O 0 0.01132358331233263
allelic O 0 0.41411566734313965
pattern O 0 0.029083633795380592
at O 0 0.010199479758739471
the O 0 0.012098093517124653
BRCA1 O 1 0.9977859258651733
locus O 1 0.8931008577346802
even O 0 0.010393786244094372
in O 0 0.007291009183973074
some O 0 0.008395484648644924
Jewish O 0 0.034977249801158905
mutation O 1 0.9938965439796448
carriers O 0 0.2557494342327118
, O 0 0.00668511725962162
might O 0 0.00925538595765829
suggest O 0 0.01003155019134283
that O 0 0.005454215686768293
the O 0 0.010004016570746899
mutation O 1 0.9544757008552551
arose O 0 0.03872625529766083
independently O 0 0.02712124027311802
. O 0 0.01857597753405571
. O 0 0.02891787514090538

Crystal O 0 0.0598309226334095
structure O 0 0.02759578451514244
of O 0 0.014967584982514381
the O 0 0.02432488091289997
hemochromatosis B-Disease 1 0.9989513158798218
protein O 1 0.7917648553848267
HFE O 1 0.9833167195320129
and O 0 0.010791732929646969
characterization O 0 0.02401757426559925
of O 0 0.0076652574352920055
its O 0 0.010168236680328846
interaction O 0 0.02478468231856823
with O 0 0.01819569431245327
transferrin O 1 0.9476302862167358
receptor O 1 0.8809597492218018
. O 0 0.04096584394574165

HFE O 1 0.9514484405517578
is O 0 0.02255973406136036
an O 0 0.0177872683852911
MHC O 1 0.9441417455673218
- O 0 0.04919634386897087
related O 0 0.023881858214735985
protein O 0 0.027261918410658836
that O 0 0.005783755332231522
is O 0 0.0070584360510110855
mutated O 1 0.5394697785377502
in O 0 0.0077405874617397785
the O 0 0.011181361973285675
iron B-Disease 0 0.43691521883010864
- I-Disease 1 0.9683049917221069
overload I-Disease 1 0.9985600113868713
disease I-Disease 1 0.9999198913574219
hereditary B-Disease 1 0.9994421601295471
hemochromatosis I-Disease 1 0.9995952248573303
. O 0 0.21030208468437195

HFE O 1 0.9750780463218689
binds O 0 0.33300989866256714
to O 0 0.031752604991197586
transferrin O 1 0.9287297129631042
receptor O 1 0.9383257627487183
( O 0 0.02977791428565979
TfR O 1 0.6200059652328491
) O 0 0.013737273402512074
and O 0 0.007783982902765274
reduces O 0 0.029228128492832184
its O 0 0.008582576178014278
affinity O 0 0.021943433210253716
for O 0 0.007270046044141054
iron O 0 0.03457266464829445
- O 0 0.037238575518131256
loaded O 0 0.026497557759284973
transferrin O 1 0.6784737706184387
, O 0 0.014830359257757664
implicating O 1 0.6778557896614075
HFE O 1 0.9853699207305908
in O 0 0.02209782786667347
iron O 0 0.2461523413658142
metabolism O 1 0.7331556677818298
. O 0 0.044943273067474365

The O 0 0.04313419386744499
2 O 0 0.055865176022052765
. O 0 0.04085802286863327

6 O 0 0.03708864375948906
A O 0 0.020992189645767212
crystal O 0 0.0316285602748394
structure O 0 0.02071387693285942
of O 0 0.012884842231869698
HFE O 1 0.9604750871658325
reveals O 0 0.029199136421084404
the O 0 0.009521666914224625
locations O 0 0.01623929850757122
of O 0 0.01364683173596859
hemochromatosis B-Disease 1 0.99959796667099
mutations O 1 0.9925334453582764
and O 0 0.008406631648540497
a O 0 0.01147974468767643
patch O 1 0.7089717388153076
of O 0 0.009064857847988605
histidines O 0 0.3671869933605194
that O 0 0.005171856377273798
could O 0 0.006181853357702494
be O 0 0.004302402026951313
involved O 0 0.010137131437659264
in O 0 0.00897170789539814
pH O 1 0.776339590549469
- O 0 0.1532849669456482
dependent O 0 0.05766599252820015
interactions O 0 0.053352583199739456
. O 0 0.03570897877216339

We O 0 0.01708170771598816
also O 0 0.012238115072250366
demonstrate O 0 0.017686912789940834
that O 0 0.010985585860908031
soluble O 0 0.3355082869529724
TfR O 1 0.9424158334732056
and O 0 0.016713542863726616
HFE O 1 0.986714780330658
bind O 0 0.09281335026025772
tightly O 0 0.02318713627755642
at O 0 0.007920049130916595
the O 0 0.005955810192972422
basic O 0 0.010456901974976063
pH O 0 0.08266305178403854
of O 0 0.004540035035461187
the O 0 0.005202028900384903
cell O 0 0.06550387293100357
surface O 0 0.00927914958447218
, O 0 0.0037424894981086254
but O 0 0.0034866086207330227
not O 0 0.0033531791996210814
at O 0 0.004993695765733719
the O 0 0.0073133809491992
acidic O 1 0.7165773510932922
pH O 1 0.850334107875824
of O 0 0.016606153920292854
intracellular O 1 0.8254346251487732
vesicles O 1 0.6742092370986938
. O 0 0.04406137019395828

TfR O 1 0.9640360474586487
HFE O 1 0.9788303971290588
stoichiometry O 1 0.6035665273666382
( O 0 0.030958347022533417
2 O 0 0.020076218992471695
1 O 0 0.017545480281114578
) O 0 0.014044451527297497
differs O 0 0.025212787091732025
from O 0 0.016104277223348618
TfR O 1 0.9613153338432312
transferrin O 1 0.8790321350097656
stoichiometry O 0 0.26810404658317566
( O 0 0.014346256852149963
2 O 0 0.010242561809718609
2 O 0 0.008374575525522232
) O 0 0.006265400443226099
, O 0 0.00457827327772975
implying O 0 0.011767290532588959
a O 0 0.006319353822618723
different O 0 0.005479705985635519
mode O 0 0.013877447694540024
of O 0 0.006302175112068653
binding O 0 0.015089917927980423
for O 0 0.00893086101859808
HFE O 1 0.9551678895950317
and O 0 0.010000155307352543
transferrin O 1 0.788045346736908
to O 0 0.00926740001887083
TfR O 1 0.5031891465187073
, O 0 0.006715159863233566
consistent O 0 0.009882365353405476
with O 0 0.005415651015937328
our O 0 0.007305491715669632
demonstration O 0 0.014492584392428398
that O 0 0.008195064961910248
HFE O 1 0.957243025302887
, O 0 0.009653366170823574
transferrin O 1 0.6001684069633484
, O 0 0.007655608933418989
and O 0 0.008581459522247314
TfR O 1 0.8868558406829834
form O 0 0.02014394849538803
a O 0 0.02030450850725174
ternary O 0 0.10539788007736206
complex O 0 0.04292882978916168
. O 0 0.033841900527477264

Identification O 0 0.02844858169555664
of O 0 0.010541344061493874
three O 0 0.009526057168841362
novel O 0 0.0227949395775795
mutations O 1 0.7409151792526245
and O 0 0.00563066266477108
a O 0 0.007327109109610319
high O 0 0.00842978060245514
frequency O 0 0.012951805256307125
of O 0 0.00573705555871129
the O 0 0.009470045566558838
Arg778Leu O 1 0.8832067847251892
mutation O 1 0.9860532879829407
in O 0 0.014275705441832542
Korean O 0 0.2817710041999817
patients O 1 0.9967319965362549
with O 0 0.029816070571541786
Wilson B-Disease 1 0.959300696849823
disease I-Disease 1 0.9994009733200073
. O 0 0.05385651811957359

Four O 0 0.03649716079235077
mutations O 1 0.9581006169319153
- O 0 0.17661796510219574
- O 0 0.23253831267356873
R778L O 1 0.5133975148200989
, O 0 0.013687185011804104
A874V O 0 0.3340691328048706
, O 0 0.008865667507052422
L1083F O 0 0.2574496269226074
, O 0 0.0069215670228004456
and O 0 0.006427892483770847
2304delC O 0 0.4495483338832855
- O 0 0.029109273105859756
- O 0 0.01819513738155365
in O 0 0.006962423212826252
the O 0 0.006947100628167391
copper O 0 0.018692804500460625
- O 0 0.024366071447730064
transporting O 0 0.025680145248770714
enzyme O 0 0.08711070567369461
, O 0 0.012245380319654942
P O 0 0.14238648116588593
- O 0 0.0716148242354393
type O 0 0.10776402801275253
ATPase O 1 0.9347360134124756
( O 0 0.020888477563858032
ATP7B O 0 0.39525240659713745
) O 0 0.009222505614161491
, O 0 0.004820583388209343
were O 0 0.004479842726141214
identified O 0 0.010827167890965939
in O 0 0.008098659105598927
Korean O 0 0.05052144080400467
Patients O 1 0.9932689070701599
with O 0 0.02562941610813141
Wilson B-Disease 1 0.9076746106147766
disease I-Disease 1 0.9990185499191284
. O 0 0.05241779237985611

Arg778Leu O 0 0.33914679288864136
, O 0 0.011721367947757244
the O 0 0.007137995678931475
most O 0 0.007911588065326214
frequently O 0 0.014331196434795856
reported O 0 0.020610908046364784
mutation O 1 0.5650900602340698
of O 0 0.005860477685928345
this O 0 0.005536648444831371
enzyme O 0 0.026170792058110237
, O 0 0.004015797283500433
was O 0 0.0036038444377481937
found O 0 0.004052634350955486
in O 0 0.003006251761689782
six O 0 0.003631670493632555
of O 0 0.0038091163150966167
eight O 0 0.007706363219767809
unrelated O 1 0.5383973717689514
patients O 1 0.9876619577407837
studied O 0 0.011764994822442532
, O 0 0.006687631364911795
an O 0 0.010018724016845226
allele O 1 0.7824501395225525
frequency O 0 0.025892464444041252
of O 0 0.012882593087852001
37 O 0 0.03374077007174492
. O 0 0.027000023052096367

5 O 0 0.02842538245022297
% O 0 0.01491648517549038
, O 0 0.006990422960370779
which O 0 0.005515568424016237
is O 0 0.005444524344056845
considerably O 0 0.013273574411869049
higher O 0 0.006999800447374582
than O 0 0.004797570873051882
those O 0 0.004546627402305603
in O 0 0.005344421602785587
other O 0 0.008706275373697281
Asian O 0 0.03145935758948326
populations O 0 0.07172740995883942
. O 0 0.03155010938644409

The O 0 0.027445662766695023
novel O 0 0.038981590420007706
single O 0 0.03254205733537674
nucleotide O 0 0.08515822142362595
deletion O 0 0.4348732829093933
, O 0 0.013391677290201187
2304delC O 0 0.08831857889890671
, O 0 0.006609003059566021
was O 0 0.0056958007626235485
found O 0 0.007284469436854124
in O 0 0.0074537331238389015
one O 0 0.01164594478905201
patient O 1 0.7841594219207764
. O 0 0.030977582558989525

Since O 0 0.046815816313028336
a O 0 0.028623949736356735
mutation O 1 0.8109620213508606
at O 0 0.025562576949596405
cDNA O 0 0.10540293157100677
nucleotide O 0 0.36588525772094727
2302 O 1 0.9760808944702148
( O 0 0.02436247281730175
2302insC O 0 0.1828826516866684
) O 0 0.01036074198782444
had O 0 0.00586782768368721
been O 0 0.004667193163186312
previously O 0 0.006617996841669083
described O 0 0.007439518813043833
, O 0 0.0035970513708889484
this O 0 0.0034579539205878973
region O 0 0.007122419774532318
of O 0 0.004719526972621679
the O 0 0.007238634396344423
ATP7B O 1 0.9354094862937927
gene O 1 0.9178715348243713
may O 0 0.015281591564416885
be O 0 0.007835584692656994
susceptible O 1 0.920322597026825
to O 0 0.012642591260373592
gene O 1 0.9756405353546143
rearrangements O 1 0.9883183240890503
causing O 1 0.9932643175125122
Wilson B-Disease 1 0.9686153531074524
disease I-Disease 1 0.9989960789680481
. O 0 0.05524222180247307

Disruption O 0 0.11548807471990585
of O 0 0.01985640823841095
splicing O 0 0.09724738448858261
regulated O 0 0.029037024825811386
by O 0 0.012568557634949684
a O 0 0.01759609580039978
CUG O 1 0.7678747177124023
- O 0 0.16429060697555542
binding O 0 0.07386106252670288
protein O 0 0.3372054696083069
in O 0 0.03734365105628967
myotonic B-Disease 1 0.9989761114120483
dystrophy I-Disease 1 0.9993366599082947
. O 0 0.07296755909919739

Myotonic B-Disease 1 0.9992889165878296
dystrophy I-Disease 1 0.9995817542076111
( O 1 0.5731406211853027
DM B-Disease 1 0.9958051443099976
) O 0 0.023851120844483376
is O 0 0.012947502546012402
caused O 0 0.045885119587183
by O 0 0.009132172912359238
a O 0 0.011823244392871857
CTG O 0 0.19801640510559082
expansion O 0 0.015268775634467602
in O 0 0.006820345763117075
the O 0 0.006440756842494011
3 O 0 0.012203664518892765
untranslated O 0 0.0656665712594986
region O 0 0.019707392901182175
of O 0 0.013389548286795616
the O 0 0.02590910904109478
DM B-Disease 1 0.993169903755188
gene O 1 0.8823282718658447
. O 0 0.045947566628456116

One O 0 0.02600589022040367
model O 0 0.03412896394729614
of O 0 0.02336614578962326
DM B-Disease 1 0.9948552846908569
pathogenesis O 1 0.9868345856666565
suggests O 0 0.04739196598529816
that O 0 0.012659978121519089
RNAs O 0 0.03656233474612236
from O 0 0.008595800958573818
the O 0 0.007593516726046801
expanded O 0 0.013958694413304329
allele O 0 0.20526044070720673
create O 0 0.0105135478079319
a O 0 0.008617250248789787
gain O 0 0.013470055535435677
- O 0 0.016152789816260338
of O 0 0.007297632750123739
- O 0 0.05349963158369064
function O 0 0.024771207943558693
mutation O 1 0.6933169364929199
by O 0 0.00807488989084959
the O 0 0.006968502886593342
inappropriate O 0 0.018960729241371155
binding O 0 0.014510832726955414
of O 0 0.006699708290398121
proteins O 0 0.018097486346960068
to O 0 0.0075077093206346035
the O 0 0.013832936994731426
CUG O 1 0.6905204057693481
repeats O 0 0.0871594250202179
. O 0 0.0373319536447525

Data O 0 0.022262075915932655
presented O 0 0.013885647989809513
here O 0 0.008670622482895851
indicate O 0 0.011087950319051743
that O 0 0.004453019239008427
the O 0 0.005899597890675068
conserved O 0 0.0227048359811306
heterogeneous O 0 0.08831311017274857
nuclear O 0 0.020379839465022087
ribonucleoprotein O 1 0.7105114459991455
, O 0 0.013092503882944584
CUG O 1 0.6516873240470886
- O 0 0.04882379248738289
binding O 0 0.03849439695477486
protein O 0 0.07871796935796738
( O 0 0.019254319369792938
CUG O 1 0.5795514583587646
- O 0 0.04386526346206665
BP O 0 0.041434481739997864
) O 0 0.010553909465670586
, O 0 0.006046023685485125
may O 0 0.00916304811835289
mediate O 0 0.021448707208037376
the O 0 0.00815183948725462
trans O 0 0.2016143500804901
- O 0 0.06594236195087433
dominant O 0 0.0409928560256958
effect O 0 0.020251143723726273
of O 0 0.00969554390758276
the O 0 0.015611600130796432
RNA O 0 0.06875928491353989
. O 0 0.03264545276761055

CUG O 1 0.9012983441352844
- O 0 0.08522314578294754
BP O 0 0.04461120814085007
was O 0 0.011389121413230896
found O 0 0.010257621295750141
to O 0 0.006704964675009251
bind O 0 0.020487193018198013
to O 0 0.006843239068984985
the O 0 0.011117792688310146
human O 1 0.5418835878372192
cardiac O 1 0.9993995428085327
troponin O 1 0.9980254173278809
T O 1 0.9861959218978882
( O 0 0.030668778344988823
cTNT O 0 0.41558700799942017
) O 0 0.01624857820570469
pre O 0 0.03315449133515358
- O 0 0.04634667560458183
messenger O 0 0.052931733429431915
RNA O 0 0.039723239839076996
and O 0 0.011366230435669422
regulate O 0 0.035099390894174576
its O 0 0.017572304233908653
alternative O 0 0.03451748937368393
splicing O 0 0.1027272492647171
. O 0 0.039702028036117554

Splicing O 0 0.11369916051626205
of O 0 0.024520542472600937
cTNT O 0 0.3639945983886719
was O 0 0.022094108164310455
disrupted O 0 0.31182950735092163
in O 0 0.027234503999352455
DM B-Disease 1 0.9990090131759644
striated O 1 0.9971211552619934
muscle O 1 0.9930375218391418
and O 0 0.01219682116061449
in O 0 0.012565746903419495
normal O 0 0.09725922346115112
cells O 0 0.43626877665519714
expressing O 0 0.04312075302004814
transcripts O 0 0.02504846267402172
that O 0 0.013012506999075413
contain O 0 0.03520553186535835
CUG O 1 0.798442006111145
repeats O 0 0.17312858998775482
. O 0 0.04237611964344978

Altered O 0 0.07344406843185425
expression O 0 0.0427122637629509
of O 0 0.015363241545855999
genes O 1 0.6301591396331787
regulated O 0 0.07990739494562149
posttranscriptionally O 1 0.6417404413223267
by O 0 0.015987489372491837
CUG O 1 0.9223712682723999
- O 0 0.09953424334526062
BP O 0 0.05860224366188049
therefore O 0 0.014442110434174538
may O 0 0.01459547970443964
contribute O 0 0.02881755866110325
to O 0 0.018382519483566284
DM B-Disease 1 0.9968034029006958
pathogenesis O 1 0.9882664084434509
. O 0 0.026413504034280777
. O 0 0.030565530061721802

Identification O 0 0.036444369703531265
of O 0 0.013469993136823177
a O 0 0.01575186662375927
novel O 0 0.03221059963107109
nonsense O 0 0.08844184130430222
mutation O 1 0.913987934589386
and O 0 0.009061701595783234
a O 0 0.012951366603374481
missense O 0 0.4471006989479065
substitution O 0 0.022406531497836113
in O 0 0.009038565680384636
the O 0 0.011216042563319206
vasopressin O 1 0.9528231024742126
- O 0 0.4480192959308624
neurophysin O 1 0.9281769394874573
II O 0 0.3242024779319763
gene O 0 0.23866863548755646
in O 0 0.008758406154811382
two O 0 0.01050847489386797
Spanish O 0 0.032655008137226105
kindreds O 1 0.8776949644088745
with O 0 0.03840186074376106
familial B-Disease 1 0.9981738328933716
neurohypophyseal I-Disease 1 0.9969165325164795
diabetes I-Disease 1 0.9998008608818054
insipidus I-Disease 1 0.9976263642311096
. O 0 0.09091241657733917

Familial B-Disease 1 0.99741530418396
neurohypophyseal I-Disease 1 0.9965798258781433
diabetes I-Disease 1 0.9998672008514404
insipidus I-Disease 1 0.999011754989624
( O 0 0.324185311794281
FNDI B-Disease 1 0.972337543964386
) O 0 0.022667476907372475
is O 0 0.014383112080395222
an O 0 0.022389259189367294
autosomal B-Disease 1 0.9993910789489746
dominant I-Disease 1 0.9953191876411438
disease I-Disease 1 0.999875545501709
caused O 1 0.992135763168335
by O 0 0.053719304502010345
deficiency O 1 0.9993095397949219
in O 0 0.01573427952826023
the O 0 0.02144799754023552
antidiuretic O 1 0.9958617091178894
hormone O 1 0.9955737590789795
arginine O 1 0.9502781629562378
vasopressin O 1 0.9868502616882324
( O 0 0.034098319709300995
AVP O 0 0.4910186231136322
) O 0 0.012038269080221653
encoded O 0 0.015871617943048477
by O 0 0.00826360285282135
the O 0 0.011168559081852436
AVP O 1 0.7918931245803833
- O 0 0.17495019733905792
neurophysin O 1 0.897513210773468
II O 0 0.19709785282611847
( O 0 0.032400328665971756
AVP O 1 0.8551554679870605
- O 0 0.30253922939300537
NPII O 1 0.8214147686958313
) O 0 0.02604183368384838
gene O 0 0.4438474178314209
on O 0 0.02491021528840065
chromosome O 1 0.9539679288864136
20p13 O 1 0.5476962924003601
. O 0 0.04624621942639351

In O 0 0.015035975724458694
this O 0 0.0075034331530332565
study O 0 0.010983141139149666
, O 0 0.004514213185757399
we O 0 0.003763616317883134
analyzed O 0 0.00922546535730362
two O 0 0.004572175908833742
families O 0 0.009445716626942158
with O 0 0.007217638660222292
FNDI B-Disease 1 0.526441216468811
using O 0 0.010301068425178528
direct O 0 0.014417635276913643
automated O 0 0.02255656011402607
fluorescent O 0 0.034380290657281876
, O 0 0.006534371990710497
solid O 0 0.012694367207586765
phase O 0 0.017012018710374832
, O 0 0.0065431841649115086
single O 0 0.012633945792913437
- O 0 0.03201843425631523
stranded O 0 0.04986894130706787
DNA O 0 0.03703559190034866
sequencing O 0 0.03745103254914284
of O 0 0.014378719963133335
PCR O 0 0.27821946144104004
- O 0 0.13614392280578613
amplified O 0 0.4305335581302643
AVP O 1 0.9424657821655273
- O 0 0.4802759885787964
NPII O 1 0.9252386689186096
DNA O 0 0.12755087018013
. O 0 0.048188429325819016

In O 0 0.012992343865334988
one O 0 0.007274159695953131
of O 0 0.005072648636996746
the O 0 0.005130407866090536
families O 0 0.009596562944352627
, O 0 0.006622531451284885
affected O 0 0.0264756940305233
individuals O 0 0.009830950759351254
presented O 0 0.008347962982952595
a O 0 0.00805180799216032
novel O 0 0.01965693198144436
nonsense O 0 0.15116822719573975
mutation O 1 0.9720130562782288
in O 0 0.008547922596335411
exon O 0 0.09380287677049637
3 O 0 0.008637499064207077
of O 0 0.004234751220792532
the O 0 0.005424804985523224
gene O 0 0.2015799731016159
, O 0 0.005027922801673412
consisting O 0 0.0075720506720244884
in O 0 0.005196371115744114
a O 0 0.007937918417155743
G O 0 0.03178177401423454
to O 0 0.007682971656322479
T O 0 0.31548628211021423
transition O 0 0.018120530992746353
at O 0 0.011827568523585796
nucleotide O 0 0.07170221209526062
2101 O 0 0.4562637209892273
, O 0 0.006406992673873901
which O 0 0.0057054259814321995
produces O 0 0.013114634901285172
a O 0 0.007170598953962326
stop O 0 0.012653703801333904
signal O 0 0.015623476356267929
in O 0 0.008730276487767696
codon O 0 0.15094396471977234
82 O 0 0.03906130790710449
( O 0 0.025144554674625397
Glu O 1 0.9494805932044983
) O 0 0.018331190571188927
of O 0 0.01760099269449711
NPII O 0 0.4278438687324524
. O 0 0.043764468282461166

The O 0 0.03581363335251808
premature O 1 0.9519833922386169
termination O 1 0.5608996152877808
eliminates O 0 0.07088149338960648
part O 0 0.009751986712217331
of O 0 0.006211571861058474
the O 0 0.00707643199712038
C O 0 0.03393154963850975
- O 0 0.03580630570650101
terminal O 0 0.038758911192417145
domain O 0 0.01500967051833868
of O 0 0.007277300581336021
NPII O 0 0.2967647612094879
, O 0 0.005879903212189674
including O 0 0.006156751420348883
a O 0 0.008657991886138916
cysteine O 0 0.025248484686017036
residue O 0 0.02149849943816662
in O 0 0.005486500449478626
position O 0 0.0063148909248411655
85 O 0 0.009120464324951172
, O 0 0.0035931039601564407
which O 0 0.0029820974450558424
could O 0 0.0034209671430289745
be O 0 0.002440958982333541
involved O 0 0.005039019975811243
in O 0 0.003830172121524811
the O 0 0.005080817732959986
correct O 0 0.015040791593492031
folding O 0 0.027634132653474808
of O 0 0.011563291773200035
the O 0 0.01917494833469391
prohormone O 1 0.9271264672279358
. O 0 0.03998873755335808

In O 0 0.01400711014866829
the O 0 0.00797903724014759
second O 0 0.01034204289317131
family O 0 0.012369965203106403
, O 0 0.006737169809639454
a O 0 0.00947108305990696
G279A O 0 0.11004553735256195
substitution O 0 0.017215674743056297
at O 0 0.006725867744535208
position O 0 0.007479426451027393
- O 0 0.012215477414429188
1 O 0 0.007147707510739565
of O 0 0.0043779537081718445
the O 0 0.005833433009684086
signal O 0 0.016626514494419098
peptide O 0 0.03415454924106598
was O 0 0.006976492237299681
observed O 0 0.012060066685080528
in O 0 0.006227392237633467
all O 0 0.007323215249925852
affected O 0 0.043529707938432693
individuals O 0 0.027310213074088097
. O 0 0.02605455555021763

This O 0 0.032775696367025375
missense O 1 0.9709250330924988
mutation O 1 0.9741902351379395
, O 0 0.013932934030890465
which O 0 0.011943225748836994
replaces O 0 0.10087583214044571
Ala O 1 0.8362103700637817
with O 0 0.014670331962406635
Thr O 1 0.9908912777900696
, O 0 0.009617887437343597
is O 0 0.008542138151824474
frequent O 0 0.06969490647315979
among O 0 0.03603365644812584
FNDI B-Disease 1 0.9968812465667725
patients O 1 0.9946185350418091
and O 0 0.0061409808695316315
is O 0 0.005876018665730953
thought O 0 0.0078051649034023285
to O 0 0.004390307702124119
reduce O 0 0.0113622872158885
the O 0 0.005858968943357468
efficiency O 0 0.012344150803983212
of O 0 0.008642624132335186
cleavage O 0 0.45855289697647095
by O 0 0.012376462109386921
signal O 0 0.030442602932453156
peptidases O 0 0.23671187460422516
. O 0 0.017926769331097603
. O 0 0.025877641513943672

Genetic O 1 0.7662349939346313
heterogeneity O 0 0.38041800260543823
of O 0 0.03278863802552223
Saethre B-Disease 1 0.9850085973739624
- I-Disease 1 0.9652585983276367
Chotzen I-Disease 1 0.9944182634353638
syndrome I-Disease 1 0.9997380375862122
, O 0 0.017853954806923866
due O 0 0.021348480135202408
to O 0 0.012216622941195965
TWIST O 0 0.19491003453731537
and O 0 0.022290289402008057
FGFR O 1 0.9358792901039124
mutations O 1 0.9702334403991699
. O 0 0.044392380863428116

Thirty O 0 0.04099314659833908
- O 0 0.039224956184625626
two O 0 0.013513904996216297
unrelated O 0 0.2239793837070465
patients O 1 0.9117308855056763
with O 0 0.007879315875470638
features O 0 0.011183693073689938
of O 0 0.009479805827140808
Saethre B-Disease 1 0.9905552268028259
- I-Disease 1 0.960021436214447
Chotzen I-Disease 1 0.997519314289093
syndrome I-Disease 1 0.999890923500061
, O 0 0.013790746219456196
a O 0 0.016836797818541527
common O 1 0.6439561247825623
autosomal B-Disease 1 0.9990561604499817
dominant I-Disease 1 0.9138946533203125
condition I-Disease 1 0.8020597100257874
of O 0 0.01739800162613392
craniosynostosis B-Disease 1 0.9992326498031616
and O 0 0.05519683659076691
limb B-Disease 1 0.9994695782661438
anomalies I-Disease 1 0.921068549156189
, O 0 0.007653319276869297
were O 0 0.005868007894605398
screened O 0 0.01817847229540348
for O 0 0.007033132016658783
mutations O 1 0.8730645179748535
in O 0 0.009682544507086277
TWIST O 0 0.20907609164714813
, O 0 0.01110110804438591
FGFR2 O 1 0.5516546964645386
, O 0 0.012533224187791348
and O 0 0.014898230321705341
FGFR3 O 1 0.5056270956993103
. O 0 0.03679521381855011

Nine O 0 0.027606137096881866
novel O 0 0.027096310630440712
and O 0 0.009148985147476196
three O 0 0.013041635043919086
recurrent O 1 0.9887314438819885
TWIST O 1 0.8659403324127197
mutations O 1 0.9780989289283752
were O 0 0.008373474702239037
found O 0 0.011119523085653782
in O 0 0.010170512832701206
12 O 0 0.0207049623131752
families O 0 0.029471687972545624
. O 0 0.029506564140319824

Seven O 0 0.01967889815568924
families O 0 0.01656675897538662
were O 0 0.00546086672693491
found O 0 0.006492672488093376
to O 0 0.004048819653689861
have O 0 0.004981692880392075
the O 0 0.007768045645207167
FGFR3 O 1 0.967173159122467
P250R O 1 0.976357638835907
mutation O 1 0.9892206788063049
, O 0 0.005904593504965305
and O 0 0.0035016110632568598
one O 0 0.003739357925951481
individual O 0 0.005415425170212984
was O 0 0.003966303076595068
found O 0 0.004908828530460596
to O 0 0.003990339580923319
have O 0 0.0060645053163170815
an O 0 0.009082401171326637
FGFR2 O 1 0.6665732264518738
VV269 O 1 0.7172195911407471
- O 0 0.21573202311992645
270 O 0 0.1433863788843155
deletion O 1 0.8564679026603699
. O 0 0.052725229412317276

To O 0 0.012592528946697712
date O 0 0.013835032470524311
, O 0 0.0070138536393642426
our O 0 0.008779158815741539
detection O 0 0.021126780658960342
rate O 0 0.012802542187273502
for O 0 0.008186736144125462
TWIST O 0 0.060084547847509384
or O 0 0.015574540011584759
FGFR O 1 0.9409800171852112
mutations O 1 0.9499688744544983
is O 0 0.008729388937354088
68 O 0 0.014568893238902092
% O 0 0.008529082871973515
in O 0 0.007000310812145472
our O 0 0.01163214910775423
Saethre B-Disease 1 0.9724568128585815
- I-Disease 1 0.9897350072860718
Chotzen I-Disease 1 0.9989851117134094
syndrome I-Disease 1 0.9999834299087524
patients O 1 0.9989801049232483
, O 0 0.008231612853705883
including O 0 0.0067992922849953175
our O 0 0.007749535143375397
five O 0 0.011067545972764492
patients O 1 0.9906812310218811
elsewhere O 0 0.023380596190690994
reported O 0 0.026448069140315056
with O 0 0.018239516764879227
TWIST O 1 0.8858044743537903
mutations O 1 0.9845709204673767
. O 0 0.037394627928733826

More O 0 0.019074007868766785
than O 0 0.013640825636684895
35 O 0 0.01804414764046669
different O 0 0.012932500801980495
TWIST O 0 0.3912224769592285
mutations O 1 0.8174653053283691
are O 0 0.007363560143858194
now O 0 0.007908623665571213
known O 0 0.00899277813732624
in O 0 0.006740656215697527
the O 0 0.00827951543033123
literature O 0 0.020759787410497665
. O 0 0.022828010842204094

The O 0 0.01991860195994377
most O 0 0.015246066264808178
common O 0 0.02163812331855297
phenotypic O 1 0.7469149827957153
features O 0 0.01091455202549696
, O 0 0.004534912761300802
present O 0 0.0044621373526751995
in O 0 0.003371116006746888
more O 0 0.00291117443703115
than O 0 0.0037022859323769808
a O 0 0.004186699166893959
third O 0 0.005377350375056267
of O 0 0.004348532296717167
our O 0 0.007596039213240147
patients O 1 0.972617506980896
with O 0 0.007951042614877224
TWIST O 1 0.814535915851593
mutations O 1 0.9893201589584351
, O 0 0.007257835473865271
are O 0 0.007565181702375412
coronal B-Disease 1 0.6694576740264893
synostosis I-Disease 1 0.6391835808753967
, O 0 0.011518482118844986
brachycephaly B-Disease 1 0.7240100502967834
, O 0 0.015383943915367126
low B-Disease 0 0.3909538984298706
frontal I-Disease 1 0.997676432132721
hairline I-Disease 1 0.998871386051178
, O 0 0.051958296447992325
facial B-Disease 1 0.9972773194313049
asymmetry I-Disease 1 0.9720087051391602
, O 0 0.036340028047561646
ptosis B-Disease 1 0.9989410042762756
, O 0 0.02701105736196041
hypertelorism B-Disease 1 0.9840770363807678
, O 0 0.014930903911590576
broad B-Disease 0 0.033262163400650024
great I-Disease 0 0.022916629910469055
toes I-Disease 1 0.5117737054824829
, O 0 0.013435091823339462
and O 0 0.016360482200980186
clinodactyly B-Disease 0 0.2881309986114502
. O 0 0.04453744366765022

Significant O 0 0.05075753480195999
intra O 0 0.23034526407718658
- O 0 0.06630555540323257
and O 0 0.019236084073781967
interfamilial O 1 0.8642665147781372
phenotypic O 1 0.9366249442100525
variability O 0 0.23754122853279114
is O 0 0.009469055570662022
present O 0 0.009132866747677326
for O 0 0.007827493362128735
either O 0 0.016636589542031288
TWIST O 1 0.5860787034034729
mutations O 1 0.9911441802978516
or O 0 0.03874923288822174
FGFR O 1 0.9767003655433655
mutations O 1 0.9817363023757935
. O 0 0.05139501765370369

The O 0 0.0227974820882082
overlap O 0 0.033505745232105255
in O 0 0.011287941597402096
clinical O 0 0.05912785232067108
features O 0 0.008487522602081299
and O 0 0.004010102711617947
the O 0 0.004042713437229395
presence O 0 0.007381842005997896
, O 0 0.0032860268838703632
in O 0 0.00316031975671649
the O 0 0.0036284145899116993
same O 0 0.004988251253962517
genes O 0 0.048587262630462646
, O 0 0.004077179357409477
of O 0 0.00506236869841814
mutations O 0 0.43710270524024963
for O 0 0.004013433121144772
more O 0 0.004131581634283066
than O 0 0.00480918912217021
one O 0 0.006414968986064196
craniosynostotic B-Disease 1 0.8200163245201111
condition I-Disease 0 0.3991664946079254
- O 0 0.023716893047094345
such O 0 0.006395610049366951
as O 0 0.006877341773360968
Saethre B-Disease 1 0.8306102752685547
- I-Disease 0 0.2463669329881668
Chotzen I-Disease 1 0.8256126642227173
, I-Disease 0 0.011623737402260303
Crouzon I-Disease 1 0.5615113973617554
, I-Disease 0 0.009297662414610386
and I-Disease 0 0.00947369635105133
Pfeiffer I-Disease 1 0.9898680448532104
syndromes I-Disease 1 0.9989826083183289
- O 0 0.060388028621673584
support O 0 0.010607652366161346
the O 0 0.006793154403567314
hypothesis O 0 0.02036161720752716
that O 0 0.006476504262536764
TWIST O 0 0.03769447281956673
and O 0 0.006830323953181505
FGFRs O 0 0.11693255603313446
are O 0 0.005190867464989424
components O 0 0.007726952899247408
of O 0 0.003933562897145748
the O 0 0.005193012300878763
same O 0 0.0077603599056601524
molecular O 0 0.023741988465189934
pathway O 0 0.033100441098213196
involved O 0 0.01044552493840456
in O 0 0.006198310758918524
the O 0 0.006783291697502136
modulation O 0 0.03386537358164787
of O 0 0.009830216877162457
craniofacial O 1 0.9958353042602539
and O 0 0.014940373599529266
limb O 1 0.9953255653381348
development O 0 0.01994028128683567
in O 0 0.014330150559544563
humans O 0 0.09968021512031555
. O 0 0.0180831216275692
. O 0 0.027171632274985313

Mutation O 1 0.950253963470459
analysis O 0 0.05499672144651413
of O 0 0.03713555634021759
UBE3A O 1 0.992978036403656
in O 1 0.6474288105964661
Angelman B-Disease 1 0.9998868703842163
syndrome I-Disease 1 0.9999796152114868
patients O 1 0.9984037280082703
. O 0 0.08448208123445511

Angelman B-Disease 1 0.9997535347938538
syndrome I-Disease 1 0.9999125003814697
( O 0 0.05136316642165184
AS B-Disease 0 0.016556423157453537
) O 0 0.013292238116264343
is O 0 0.01111824344843626
caused O 0 0.22614753246307373
by O 0 0.017669986933469772
chromosome O 1 0.9872174859046936
15q11 O 1 0.9092462658882141
- O 0 0.40569645166397095
q13 O 1 0.7512317895889282
deletions O 0 0.29075193405151367
of O 0 0.011163709685206413
maternal O 1 0.8883910775184631
origin O 0 0.017962204292416573
, O 0 0.009189090691506863
by O 0 0.013038142584264278
paternal O 1 0.985713005065918
uniparental B-Disease 1 0.997687578201294
disomy I-Disease 1 0.9912944436073303
( O 0 0.07725375890731812
UPD B-Disease 1 0.9881067276000977
) O 0 0.01453616563230753
15 O 0 0.010939303785562515
, O 0 0.006424859631806612
by O 0 0.010242707096040249
imprinting O 1 0.9737412929534912
defects O 1 0.9872252345085144
, O 0 0.0071202791295945644
and O 0 0.006103211548179388
by O 0 0.010112949647009373
mutations O 1 0.6794580817222595
in O 0 0.012550604529678822
the O 0 0.02149456925690174
UBE3A O 1 0.9883838891983032
gene O 1 0.9058537483215332
. O 0 0.04432397335767746

UBE3A O 1 0.9432421326637268
encodes O 0 0.11743702739477158
a O 0 0.03528502956032753
ubiquitin O 0 0.1697453111410141
- O 0 0.09886065870523453
protein O 0 0.07293713837862015
ligase O 0 0.05865275859832764
and O 0 0.013953551650047302
shows O 0 0.028546975925564766
brain O 1 0.9846606850624084
- O 0 0.07489433884620667
specific O 0 0.03532857820391655
imprinting O 1 0.9317724108695984
. O 0 0.03652855381369591

Here O 0 0.02600376307964325
we O 0 0.01583467237651348
describe O 0 0.041460663080215454
UBE3A O 1 0.981378436088562
coding O 1 0.5521173477172852
- O 0 0.16831514239311218
region O 0 0.14098045229911804
mutations O 1 0.9904407262802124
detected O 0 0.36936601996421814
by O 0 0.014072596095502377
SSCP O 1 0.5111132860183716
analysis O 0 0.014439862221479416
in O 0 0.006731247995048761
13 O 0 0.0096950214356184
AS B-Disease 0 0.007900666445493698
individuals O 0 0.010747839696705341
or O 0 0.011542138643562794
families O 0 0.021430766209959984
. O 0 0.026025041937828064

Two O 0 0.02691313996911049
identical O 0 0.04415833577513695
de O 0 0.04579729586839676
novo O 0 0.05793433636426926
5 O 0 0.02295658551156521
- O 0 0.04103041812777519
bp O 0 0.05359401926398277
duplications O 0 0.11403103917837143
in O 0 0.01622632145881653
exon O 0 0.06582337617874146
16 O 0 0.019467206671833992
were O 0 0.011213816702365875
found O 0 0.021805843338370323
. O 0 0.028094440698623657

Among O 0 0.022480053827166557
the O 0 0.008936417289078236
other O 0 0.007365832105278969
11 O 0 0.012584332376718521
unique O 0 0.013689438812434673
mutations O 1 0.9221168160438538
, O 0 0.0060599022544920444
8 O 0 0.008153209462761879
were O 0 0.004293954931199551
small O 0 0.008389124646782875
deletions O 0 0.03874295577406883
or O 0 0.010857242159545422
insertions O 0 0.2445077896118164
predicted O 0 0.0178579930216074
to O 0 0.006903279107064009
cause O 1 0.5551013946533203
frameshifts O 0 0.30190330743789673
, O 0 0.00638054683804512
1 O 0 0.007703851908445358
was O 0 0.0051111262291669846
a O 0 0.0065730479545891285
mutation O 1 0.6343943476676941
to O 0 0.004118313081562519
a O 0 0.006304481532424688
stop O 0 0.012574819847941399
codon O 0 0.03470589220523834
, O 0 0.006032941862940788
1 O 0 0.007622241508215666
was O 0 0.0064255231991410255
a O 0 0.010521085932850838
missense O 1 0.9245352745056152
mutation O 1 0.9471505284309387
, O 0 0.006979174911975861
and O 0 0.004487711936235428
1 O 0 0.006282752845436335
was O 0 0.004644032102078199
predicted O 0 0.011115234345197678
to O 0 0.0057744476944208145
cause O 0 0.1368875950574875
insertion O 0 0.03677592799067497
of O 0 0.005953608080744743
an O 0 0.006624598987400532
isoleucine O 0 0.062265899032354355
in O 0 0.006925029680132866
the O 0 0.008097165264189243
hect O 0 0.13782551884651184
domain O 0 0.01686519756913185
of O 0 0.006483611185103655
the O 0 0.011119958013296127
UBE3A O 1 0.9858369827270508
protein O 0 0.0390707328915596
, O 0 0.007470459211617708
which O 0 0.007027097046375275
functions O 0 0.010182919912040234
in O 0 0.009115028195083141
E2 O 0 0.13048020005226135
binding O 0 0.023646280169487
and O 0 0.010298219509422779
ubiquitin O 0 0.050646938383579254
transfer O 0 0.027105582877993584
. O 0 0.030856361612677574

Eight O 0 0.01693488471210003
of O 0 0.00854866486042738
the O 0 0.007444985676556826
cases O 0 0.015084540471434593
were O 0 0.006206686142832041
familial O 1 0.9708808064460754
, O 0 0.005750778131186962
and O 0 0.005258277524262667
five O 0 0.007068950682878494
were O 0 0.009185265749692917
sporadic O 0 0.08316733688116074
. O 0 0.028952959924936295

In O 0 0.0195065438747406
two O 0 0.01603870280086994
familial O 1 0.9845945835113525
cases O 0 0.0322624035179615
and O 0 0.006954061798751354
one O 0 0.00813758373260498
sporadic O 0 0.13205291330814362
case O 0 0.014642615802586079
, O 0 0.00998537614941597
mosaicism O 1 0.9725127220153809
for O 0 0.018149491399526596
UBE3A O 1 0.9962422847747803
mutations O 1 0.9925981760025024
was O 0 0.011083725839853287
detected O 0 0.034355249255895615
in O 0 0.004660944454371929
the O 0 0.004370939917862415
mother O 0 0.008196611888706684
of O 0 0.003220760030671954
three O 0 0.0035232293885201216
AS B-Disease 0 0.0046463292092084885
sons O 0 0.009589115157723427
, O 0 0.0034676259383559227
in O 0 0.003982748836278915
the O 0 0.004795767832547426
maternal O 0 0.4333278238773346
grandfather O 0 0.015435288660228252
of O 0 0.0037723584100604057
two O 0 0.0033394230995327234
AS B-Disease 0 0.004233565181493759
first O 0 0.0041982210241258144
cousins O 0 0.013816794380545616
, O 0 0.0036008511669933796
and O 0 0.0028274415526539087
in O 0 0.0034361714497208595
the O 0 0.003963975235819817
mother O 0 0.009488755837082863
of O 0 0.005342718213796616
an O 0 0.007898371666669846
AS B-Disease 0 0.012339424341917038
daughter O 0 0.056306593120098114
. O 0 0.02833164483308792

The O 0 0.017286384478211403
frequencies O 0 0.023234808817505836
with O 0 0.00739724887534976
which O 0 0.006359342020004988
we O 0 0.007317594718188047
detected O 0 0.1507696658372879
mutations O 1 0.7582435607910156
were O 0 0.005427658557891846
5 O 0 0.008522073738276958
( O 0 0.006799811497330666
14 O 0 0.00696859136223793
% O 0 0.0055189174599945545
) O 0 0.004674092400819063
of O 0 0.0038537231739610434
35 O 0 0.00843990221619606
in O 0 0.0060378736816346645
sporadic O 0 0.027126172557473183
cases O 0 0.013474645093083382
and O 0 0.005713330116122961
8 O 0 0.010081091895699501
( O 0 0.009113185107707977
80 O 0 0.009007398970425129
% O 0 0.0074074226431548595
) O 0 0.005878000054508448
of O 0 0.005273951683193445
10 O 0 0.009120313450694084
in O 0 0.011335055343806744
familial O 1 0.9911906719207764
cases O 0 0.14527463912963867
. O 0 0.018014509230852127
. O 0 0.02797584794461727

The O 0 0.04923604801297188
hemochromatosis B-Disease 1 0.9977926015853882
845 O 1 0.9712778329849243
G O 1 0.7976987361907959
- O 0 0.1784222573041916
- O 0 0.0851845070719719
> O 0 0.15164007246494293
A O 0 0.011387618258595467
and O 0 0.008081210777163506
187 O 0 0.030844977125525475
C O 0 0.0449407584965229
- O 0 0.07304448634386063
- O 0 0.37686386704444885
> O 1 0.9179311394691467
G O 1 0.767634391784668
mutations O 1 0.9646875262260437
: O 0 0.020859677344560623
prevalence O 1 0.8745970129966736
in O 0 0.013497183099389076
non O 0 0.03532842919230461
- O 0 0.2534094452857971
Caucasian O 1 0.8616118431091309
populations O 0 0.3519994020462036
. O 0 0.043742891401052475

Hemochromatosis B-Disease 1 0.9916398525238037
, O 0 0.0276626069098711
the O 0 0.024598639458417892
inherited B-Disease 1 0.9967605471611023
disorder I-Disease 1 0.9994131326675415
of I-Disease 0 0.018156562000513077
iron I-Disease 1 0.7732241153717041
metabolism I-Disease 1 0.9034897685050964
, O 0 0.00805057492107153
leads O 0 0.02413955144584179
, O 0 0.006500711664557457
if O 0 0.008850378915667534
untreated O 1 0.9221522808074951
, O 0 0.007541011553257704
to O 0 0.008365156129002571
progressive O 1 0.7098386287689209
iron B-Disease 1 0.6751591563224792
overload I-Disease 1 0.9790225625038147
and O 0 0.01925220526754856
premature B-Disease 1 0.9713473320007324
death I-Disease 0 0.20432543754577637
. O 0 0.043993305414915085

The O 0 0.06062602251768112
hemochromatosis B-Disease 1 0.9981645941734314
gene O 1 0.955580472946167
, O 0 0.02351696789264679
HFE O 1 0.9837878942489624
, O 0 0.010663149878382683
recently O 0 0.012631727382540703
has O 0 0.006838072091341019
been O 0 0.005552117247134447
identified O 0 0.00839295331388712
, O 0 0.003545510582625866
and O 0 0.0031323363073170185
characterization O 0 0.009908855892717838
of O 0 0.004063914529979229
this O 0 0.005028306040912867
gene O 0 0.25718510150909424
has O 0 0.004607724025845528
shown O 0 0.006109621841460466
that O 0 0.002716883784160018
it O 0 0.003403628244996071
contains O 0 0.005517478100955486
two O 0 0.004612811375409365
mutations O 1 0.5668935775756836
that O 0 0.00493138050660491
result O 0 0.010303743183612823
in O 0 0.00766045693308115
amino O 0 0.023726942017674446
acid O 0 0.09909339249134064
substitutions O 0 0.029766730964183807
- O 0 0.04944581165909767
cDNA O 0 0.10586762428283691
nucleotides O 0 0.08071232587099075
845 O 1 0.839350700378418
G O 1 0.5520962476730347
- O 0 0.09396886825561523
- O 0 0.10490790754556656
> O 0 0.215369313955307
A O 0 0.014311364851891994
( O 0 0.016636017709970474
C282Y O 0 0.0614980049431324
) O 0 0.011235594749450684
and O 0 0.00763032166287303
187 O 0 0.029726799577474594
C O 0 0.04178578406572342
- O 0 0.05617176741361618
- O 0 0.14889180660247803
> O 1 0.7256234288215637
G O 0 0.21302922070026398
( O 0 0.0343419648706913
H63D O 0 0.3503589332103729
) O 0 0.0387345552444458
. O 0 0.03702683001756668

Although O 0 0.05761057138442993
hemochromatosis B-Disease 1 0.9956205487251282
is O 0 0.018605224788188934
common O 0 0.01924746297299862
in O 0 0.011921940371394157
Caucasians O 1 0.8161815404891968
, O 0 0.014825331047177315
affecting O 1 0.7686643600463867
> O 1 0.8923447132110596
= O 0 0.05149798095226288
1 O 0 0.015279427170753479
/ O 0 0.02682059071958065
300 O 0 0.009671568870544434
individuals O 0 0.007163114380091429
of O 0 0.0047084372490644455
northern O 0 0.008030323311686516
European O 0 0.006708885543048382
origin O 0 0.008321926929056644
, O 0 0.003759354818612337
it O 0 0.0032514987979084253
has O 0 0.0038654159288853407
not O 0 0.0032195174135267735
been O 0 0.004681293852627277
recognized O 0 0.008077209815382957
in O 0 0.006392583716660738
other O 0 0.010565212927758694
populations O 0 0.07469554245471954
. O 0 0.02598826214671135

The O 0 0.018825452774763107
present O 0 0.01672801375389099
study O 0 0.018937233835458755
used O 0 0.013264085166156292
PCR O 0 0.04284687712788582
and O 0 0.009301107376813889
restriction O 0 0.02591651678085327
- O 0 0.04259072616696358
enzyme O 0 0.14655260741710663
digestion O 0 0.24080754816532135
to O 0 0.0069916886277496815
analyze O 0 0.014526531100273132
the O 0 0.005671319086104631
frequency O 0 0.012122442945837975
of O 0 0.005030158441513777
the O 0 0.008748729713261127
845 O 1 0.532383382320404
G O 0 0.2177063524723053
- O 0 0.056422557681798935
- O 0 0.04175560921430588
> O 0 0.0667240172624588
A O 0 0.011488409712910652
and O 0 0.00734114833176136
187 O 0 0.03115842305123806
C O 0 0.06197157874703407
- O 0 0.10359528660774231
- O 0 0.2640731930732727
> O 1 0.8502616882324219
G O 0 0.49717938899993896
mutations O 1 0.930158793926239
in O 0 0.014006358571350574
HLA O 1 0.9827724099159241
- O 0 0.04390367493033409
typed O 0 0.03604024648666382
samples O 0 0.023774629458785057
from O 0 0.011951903812587261
non O 0 0.02459556609392166
- O 0 0.05819762498140335
Caucasian O 1 0.6316519379615784
populations O 0 0.04100784659385681
, O 0 0.0075600058771669865
comprising O 0 0.012452849186956882
Australian O 0 0.013120974414050579
Aboriginal O 0 0.018172116950154305
, O 0 0.006216005887836218
Chinese O 0 0.009612048044800758
, O 0 0.006885064300149679
and O 0 0.0085856718942523
Pacific O 0 0.029631273820996284
Islanders O 0 0.05619611591100693
. O 0 0.03248303011059761

Results O 0 0.035678502172231674
showed O 0 0.01983107440173626
that O 0 0.008652763441205025
the O 0 0.010875832289457321
845 O 1 0.716498851776123
G O 0 0.380344957113266
- O 0 0.1435602456331253
- O 0 0.2266392707824707
> O 0 0.4697509706020355
A O 0 0.01643696241080761
mutation O 1 0.7181786298751831
was O 0 0.007023285608738661
present O 0 0.006374648306518793
in O 0 0.004901990294456482
these O 0 0.006070837378501892
populations O 0 0.04760308563709259
( O 0 0.014272176660597324
allele O 0 0.47584524750709534
frequency O 0 0.020262455567717552
0 O 0 0.012970710173249245
. O 0 0.004854587838053703
32 O 0 0.008687689900398254
% O 0 0.006326915696263313
) O 0 0.0044082943350076675
, O 0 0.0028136749751865864
and O 0 0.0027603718917816877
, O 0 0.0028786940965801477
furthermore O 0 0.005905374884605408
, O 0 0.002976861782371998
it O 0 0.002814218169078231
was O 0 0.0037688137963414192
always O 0 0.00496649881824851
seen O 0 0.006908272858709097
in O 0 0.005205872468650341
conjunction O 0 0.016313446685671806
with O 0 0.012341569177806377
HLA O 1 0.9951791763305664
haplotypes O 1 0.9784437417984009
common O 0 0.025101441890001297
in O 0 0.009784809313714504
Caucasians O 1 0.6143972873687744
, O 0 0.007472672499716282
suggesting O 0 0.016784127801656723
that O 0 0.008080748841166496
845 O 1 0.8478451371192932
G O 1 0.567505955696106
- O 0 0.122315414249897
- O 0 0.16097059845924377
> O 0 0.2502530813217163
A O 0 0.008441335521638393
may O 0 0.007843604311347008
have O 0 0.004048306029289961
been O 0 0.0040085455402731895
introduced O 0 0.006264699622988701
into O 0 0.005674073472619057
these O 0 0.006925127934664488
populations O 0 0.02787795662879944
by O 0 0.016663704067468643
Caucasian O 1 0.8498303294181824
admixture O 1 0.9423043131828308
. O 0 0.04835914820432663

187 O 0 0.09884139150381088
C O 0 0.08286233246326447
- O 0 0.06867030262947083
- O 0 0.11268248409032822
> O 0 0.4793180227279663
G O 0 0.03796475753188133
was O 0 0.00763660715892911
present O 0 0.0072191390208899975
at O 0 0.0066753593273460865
an O 0 0.0072876145131886005
allele O 0 0.4066274166107178
frequency O 0 0.022247930988669395
of O 0 0.010822704061865807
2 O 0 0.02094024233520031
. O 0 0.0231354758143425

68 O 0 0.0392703041434288
% O 0 0.015772860497236252
in O 0 0.0060418471693992615
the O 0 0.005360796116292477
two O 0 0.006237220484763384
populations O 0 0.0280438382178545
analyzed O 0 0.017757471650838852
( O 0 0.010087552480399609
Australian O 0 0.01338029745966196
Aboriginal O 0 0.01921103522181511
and O 0 0.007266192231327295
Chinese O 0 0.01655418612062931
) O 0 0.01747598871588707
. O 0 0.020469972863793373

In O 0 0.015813099220395088
the O 0 0.011982650496065617
Australian O 0 0.017119478434324265
Aboriginal O 0 0.026853369548916817
samples O 0 0.020823847502470016
, O 0 0.009670201689004898
187 O 0 0.03203205019235611
C O 0 0.04926250874996185
- O 0 0.06478072702884674
- O 0 0.17461515963077545
> O 0 0.44212740659713745
G O 0 0.02909175306558609
was O 0 0.00587853230535984
found O 0 0.006211865693330765
to O 0 0.003381460439413786
be O 0 0.0039849719032645226
associated O 0 0.009306042455136776
with O 0 0.008311384357511997
HLA O 1 0.9951909780502319
haplotypes O 1 0.9869614839553833
common O 0 0.026252904906868935
in O 0 0.00865892507135868
Caucasians O 1 0.8697378039360046
, O 0 0.0057905507273972034
suggesting O 0 0.011364762671291828
that O 0 0.003904478158801794
it O 0 0.003700344590470195
was O 0 0.005808049812912941
introduced O 0 0.00963853020220995
by O 0 0.010663970373570919
recent O 0 0.025799646973609924
admixture O 1 0.69826740026474
. O 0 0.035679444670677185

In O 0 0.01511465571820736
the O 0 0.009387688711285591
Chinese O 0 0.012145870365202427
samples O 0 0.018139081075787544
analyzed O 0 0.016789628192782402
, O 0 0.008066709153354168
187 O 0 0.02318442612886429
C O 0 0.03253654018044472
- O 0 0.07021216303110123
- O 0 0.1679687798023224
> O 1 0.6776065826416016
G O 0 0.03619574010372162
was O 0 0.0051107024773955345
present O 0 0.00496083265170455
in O 0 0.004548272117972374
association O 0 0.008037653751671314
with O 0 0.004401928745210171
a O 0 0.006452509202063084
wide O 0 0.012385966256260872
variety O 0 0.010772813111543655
of O 0 0.01019242499023676
HLA O 1 0.9972612857818604
haplotypes O 1 0.9721340537071228
, O 0 0.008916270919144154
showing O 0 0.013968642801046371
this O 0 0.007379424292594194
mutation O 1 0.8274352550506592
to O 0 0.004555908031761646
be O 0 0.003715552156791091
widespread O 0 0.014051836915314198
and O 0 0.004374655429273844
likely O 0 0.008188924752175808
to O 0 0.0047180913388729095
predate O 0 0.026021219789981842
the O 0 0.005874100141227245
more O 0 0.00815572403371334
genetically O 0 0.05966198444366455
restricted O 0 0.03139656409621239
845 O 1 0.8225337266921997
G O 0 0.49447837471961975
- O 0 0.10777321457862854
- O 0 0.17841386795043945
> O 1 0.6196795105934143
A O 0 0.036698922514915466
mutation O 1 0.9303653836250305
. O 0 0.042843639850616455

Genotype O 1 0.9853384494781494
- O 1 0.9167803525924683
phenotype O 1 0.9937477111816406
correlations O 1 0.8145185112953186
in O 0 0.0817105770111084
attenuated B-Disease 1 0.995769739151001
adenomatous I-Disease 1 0.9997014403343201
polyposis I-Disease 1 0.9998005032539368
coli I-Disease 1 0.9986236095428467
. O 0 0.13092684745788574

Germ O 1 0.8787834048271179
- O 0 0.0980750024318695
line O 0 0.02881701849400997
mutations O 1 0.788912832736969
of O 0 0.011573242954909801
the O 0 0.018483983352780342
tumor B-Disease 1 0.9992438554763794
suppressor O 1 0.9968913197517395
APC O 1 0.9765243530273438
are O 0 0.016886873170733452
implicated O 1 0.82696533203125
in O 0 0.0895674005150795
attenuated B-Disease 1 0.9988911747932434
adenomatous I-Disease 1 0.9999322891235352
polyposis I-Disease 1 0.9999324083328247
coli I-Disease 1 0.9997573494911194
( O 1 0.7103707790374756
AAPC B-Disease 1 0.991975724697113
) O 0 0.020101398229599
, O 0 0.010932067409157753
a O 0 0.01682724989950657
variant O 1 0.7577100396156311
of O 0 0.059113796800374985
familial B-Disease 1 0.9997242093086243
adenomatous I-Disease 1 0.9999322891235352
polyposis I-Disease 1 0.9999092817306519
( O 1 0.9270291328430176
FAP B-Disease 1 0.9936849474906921
) O 0 0.05975595861673355
. O 0 0.04966828599572182

AAPC B-Disease 1 0.9027937650680542
is O 0 0.02371152676641941
recognized O 0 0.0180086437612772
by O 0 0.009712795726954937
the O 0 0.00870517734438181
occurrence O 0 0.037871379405260086
of O 0 0.011513162404298782
< O 1 0.7525263428688049
100 O 0 0.021886171773076057
colonic B-Disease 1 0.993624210357666
adenomas I-Disease 1 0.9921441078186035
and O 0 0.008892511017620564
a O 0 0.012758743949234486
later O 0 0.01928405649960041
onset O 1 0.9981670379638672
of O 0 0.32132890820503235
colorectal B-Disease 1 0.9999731779098511
cancer I-Disease 1 0.9998818635940552
( O 0 0.17870083451271057
age O 0 0.10841593891382217
> O 1 0.5511839389801025
40 O 0 0.021484700962901115
years O 0 0.019363457337021828
) O 0 0.02116299979388714
. O 0 0.025688374415040016

The O 0 0.015158437192440033
aim O 0 0.01882917247712612
of O 0 0.007077979389578104
this O 0 0.0068436055444180965
study O 0 0.010114883072674274
was O 0 0.00733132055029273
to O 0 0.009644895792007446
assess O 0 0.12548476457595825
genotype O 1 0.9899433851242065
- O 1 0.8262774348258972
phenotype O 1 0.9939489364624023
correlations O 0 0.4665532112121582
in O 0 0.03005831316113472
AAPC B-Disease 1 0.9844111204147339
families O 0 0.06019759178161621
. O 0 0.043768737465143204

By O 0 0.027953175827860832
protein O 0 0.07092097401618958
- O 0 0.07489513605833054
truncation O 0 0.32986459136009216
test O 0 0.02281331457197666
( O 0 0.015616620890796185
PTT O 0 0.03849224001169205
) O 0 0.011355952359735966
assay O 0 0.019366158172488213
, O 0 0.00518743135035038
the O 0 0.005711350589990616
entire O 0 0.012244844809174538
coding O 0 0.02722860686480999
region O 0 0.012784294784069061
of O 0 0.006121870595961809
the O 0 0.009126481600105762
APC B-Disease 1 0.908305287361145
gene O 1 0.5402017831802368
was O 0 0.011026408523321152
screened O 0 0.02451198734343052
in O 0 0.008896967396140099
affected O 0 0.029626596719026566
individuals O 0 0.015273966826498508
from O 0 0.011364135891199112
11 O 0 0.022092051804065704
AAPC B-Disease 1 0.9911308288574219
kindreds O 1 0.7690779566764832
, O 0 0.010206654667854309
and O 0 0.008433317765593529
their O 0 0.012580032460391521
phenotypic O 0 0.49124032258987427
differences O 0 0.027900969609618187
were O 0 0.013850714080035686
examined O 0 0.05715734139084816
. O 0 0.032907597720623016

Five O 0 0.033622484654188156
novel O 0 0.052428022027015686
germ O 1 0.8711351156234741
- O 0 0.13257701694965363
line O 0 0.03437242656946182
APC B-Disease 1 0.9670344591140747
mutations O 1 0.9277323484420776
were O 0 0.007838329300284386
identified O 0 0.014985248446464539
in O 0 0.008947860449552536
seven O 0 0.01849837601184845
kindreds O 1 0.5118241906166077
. O 0 0.0379682295024395

Mutations O 1 0.7177262902259827
were O 0 0.010817372240126133
located O 0 0.010090790688991547
in O 0 0.005238443613052368
three O 0 0.005206862930208445
different O 0 0.0052924384362995625
regions O 0 0.010255287401378155
of O 0 0.005337954498827457
the O 0 0.00810991320759058
APC B-Disease 1 0.8331776857376099
gene O 1 0.5912032723426819
( O 0 0.012596454471349716
1 O 0 0.009085848927497864
) O 0 0.005914140492677689
at O 0 0.004155558999627829
the O 0 0.004153103101998568
5 O 0 0.008104747161269188
end O 0 0.009041359648108482
spanning O 0 0.018840612843632698
exons O 0 0.03821209818124771
4 O 0 0.01040328573435545
and O 0 0.005155845079571009
5 O 0 0.007496706675738096
, O 0 0.0049540018662810326
( O 0 0.006653027143329382
2 O 0 0.006596454884856939
) O 0 0.006300735753029585
within O 0 0.007258171681314707
exon O 0 0.031040748581290245
9 O 0 0.010582784190773964
, O 0 0.005184580106288195
and O 0 0.004730954300612211
( O 0 0.007596157491207123
3 O 0 0.007849201560020447
) O 0 0.006113896612077951
at O 0 0.004803065210580826
the O 0 0.00612976960837841
3 O 0 0.014514325186610222
distal O 1 0.6234560012817383
end O 0 0.014391490258276463
of O 0 0.012177477590739727
the O 0 0.018946822732686996
gene O 0 0.26289376616477966
. O 0 0.04213198646903038

Variability O 0 0.08636026829481125
in O 0 0.0105979535728693
the O 0 0.008456284180283546
number O 0 0.009817564859986305
of O 0 0.01543576642870903
colorectal B-Disease 1 0.9999033212661743
adenomas I-Disease 1 0.9985463619232178
was O 0 0.010727204382419586
most O 0 0.008677753619849682
apparent O 0 0.03744254261255264
in O 0 0.005467041861265898
individuals O 0 0.00912264920771122
with O 0 0.0062939985655248165
mutations O 1 0.9274089932441711
in O 0 0.005696657579392195
region O 0 0.011383678764104843
1 O 0 0.007734678220003843
, O 0 0.005109640769660473
and O 0 0.005907873157411814
upper O 0 0.44462254643440247
- O 1 0.9309406876564026
gastrointestinal O 1 0.9996681213378906
manifestations O 1 0.9446981549263
were O 0 0.006611464079469442
more O 0 0.009275411255657673
severe O 1 0.9761921167373657
in O 0 0.008695726282894611
them O 0 0.012703937478363514
. O 0 0.02152181975543499

In O 0 0.016750261187553406
individuals O 0 0.017109397798776627
with O 0 0.010017234832048416
mutations O 1 0.8929151892662048
in O 0 0.006751743145287037
either O 0 0.007361374329775572
region O 0 0.012092777527868748
2 O 0 0.007795326411724091
or O 0 0.006004019640386105
region O 0 0.009427334181964397
3 O 0 0.006104365456849337
, O 0 0.003435831982642412
the O 0 0.0037678575608879328
average O 0 0.007056497968733311
number O 0 0.005894578993320465
of O 0 0.006238189991563559
adenomas B-Disease 1 0.9876012802124023
tended O 0 0.017832377925515175
to O 0 0.004178337287157774
be O 0 0.0033311236184090376
lower O 0 0.005877699237316847
than O 0 0.0035972686018794775
those O 0 0.0032925005070865154
in O 0 0.00351881911046803
individuals O 0 0.006733231246471405
with O 0 0.0062329391948878765
mutations O 1 0.907734215259552
in O 0 0.006313628982752562
region O 0 0.01264431606978178
1 O 0 0.008377636782824993
, O 0 0.0049460637383162975
although O 0 0.007635739631950855
age O 0 0.013934597373008728
at O 0 0.01218324713408947
diagnosis O 1 0.9665449857711792
was O 0 0.013786102645099163
similar O 0 0.024744810536503792
. O 0 0.02895214408636093

In O 0 0.025864997878670692
all O 0 0.02404751256108284
AAPC B-Disease 1 0.9723348617553711
kindreds O 1 0.7085326313972473
, O 0 0.013202710077166557
a O 0 0.013044692575931549
predominance O 0 0.07544730603694916
of O 0 0.011805797927081585
right O 0 0.07243752479553223
- O 1 0.8632820248603821
sided O 1 0.9888448119163513
colorectal B-Disease 1 0.9998865127563477
adenomas I-Disease 1 0.9988866448402405
and O 0 0.25351059436798096
rectal B-Disease 1 0.9989784955978394
polyp I-Disease 1 0.9990561604499817
sparing O 1 0.954319953918457
was O 0 0.03066633827984333
observed O 0 0.047166090458631516
. O 0 0.03275727108120918

No O 0 0.04622308537364006
desmoid B-Disease 1 0.9819332957267761
tumors I-Disease 1 0.9962018132209778
were O 0 0.010364677757024765
found O 0 0.012505383230745792
in O 0 0.010742319747805595
these O 0 0.015479219146072865
kindreds O 1 0.6395001411437988
. O 0 0.03818557411432266

Our O 0 0.021123288199305534
data O 0 0.01460430771112442
suggest O 0 0.012552523985505104
that O 0 0.0050263796001672745
, O 0 0.005317352246493101
in O 0 0.006820504553616047
AAPC B-Disease 1 0.9849486947059631
families O 0 0.010914402082562447
, O 0 0.004351263865828514
the O 0 0.004159499425441027
location O 0 0.005977014545351267
of O 0 0.004700315184891224
the O 0 0.009112074039876461
APC B-Disease 1 0.9693882465362549
mutation O 1 0.9932841062545776
may O 0 0.036214347928762436
partially O 0 0.29089680314064026
predict O 0 0.08704577386379242
specific O 0 0.027547402307391167
phenotypic O 1 0.8653362989425659
expression O 0 0.12009537220001221
. O 0 0.03092212788760662

This O 0 0.011337729170918465
should O 0 0.007330789230763912
help O 0 0.007538826670497656
in O 0 0.004779516719281673
the O 0 0.004452493507415056
design O 0 0.006990896072238684
of O 0 0.006238569039851427
tailored O 0 0.06829699873924255
clinical O 1 0.6611423492431641
- O 0 0.07418585568666458
management O 0 0.019779184833168983
protocols O 0 0.017514880746603012
in O 0 0.0063647255301475525
this O 0 0.007660696282982826
subset O 0 0.028681673109531403
of O 0 0.015738949179649353
FAP B-Disease 1 0.9984484910964966
patients O 1 0.996807336807251
. O 0 0.02098088338971138
. O 0 0.028812628239393234

Wilms B-Disease 1 0.9934383034706116
' I-Disease 1 0.7348634600639343
tumor I-Disease 1 0.9957321286201477
1 O 0 0.0246315598487854
and O 0 0.013191183097660542
Dax O 0 0.13383810222148895
- O 0 0.04040732607245445
1 O 0 0.02354959212243557
modulate O 0 0.0921446904540062
the O 0 0.015436692163348198
orphan O 1 0.8207029700279236
nuclear O 0 0.0399741530418396
receptor O 1 0.9494420289993286
SF O 1 0.9451592564582825
- O 0 0.033648744225502014
1 O 0 0.01498631201684475
in O 0 0.011378067545592785
sex O 0 0.02979884296655655
- O 0 0.04486005753278732
specific O 0 0.028725259006023407
gene O 1 0.677142858505249
expression O 0 0.1409088522195816
. O 0 0.04110129177570343

Products O 0 0.04309563338756561
of O 0 0.02584361657500267
steroidogenic O 1 0.9735029935836792
factor O 0 0.07911559194326401
1 O 0 0.021843966096639633
( O 0 0.019478125497698784
SF O 1 0.8858705163002014
- O 0 0.031040001660585403
1 O 0 0.013213131576776505
) O 0 0.01263914443552494
and O 0 0.012753627263009548
Wilms B-Disease 1 0.9988275170326233
tumor I-Disease 1 0.9986566305160522
1 O 0 0.02774050086736679
( O 0 0.03007674217224121
WT1 O 1 0.9809731841087341
) O 0 0.017025738954544067
genes O 0 0.0901571735739708
are O 0 0.006201523821800947
essential O 0 0.010824982076883316
for O 0 0.00917031243443489
mammalian O 1 0.7140368819236755
gonadogenesis O 1 0.6261206269264221
prior O 0 0.019180918112397194
to O 0 0.01134419720619917
sexual O 0 0.047932300716638565
differentiation O 0 0.2625945806503296
. O 0 0.03615778684616089

In O 0 0.02580743469297886
males O 0 0.0901176780462265
, O 0 0.016075555235147476
SF O 1 0.8998792767524719
- O 0 0.03430301323533058
1 O 0 0.014737709425389767
participates O 0 0.024623392149806023
in O 0 0.009202362969517708
sexual O 0 0.01859966292977333
development O 0 0.009618605487048626
by O 0 0.007976222783327103
regulating O 0 0.03420109301805496
expression O 0 0.019447797909379005
of O 0 0.008000587113201618
the O 0 0.015718692913651466
polypeptide O 1 0.9683641195297241
hormone O 1 0.995307981967926
Mullerian O 1 0.9934967756271362
inhibiting O 1 0.9780120849609375
substance O 1 0.7177672982215881
( O 0 0.06153610348701477
MIS O 1 0.9652978181838989
) O 0 0.041368234902620316
. O 0 0.03676094859838486

Here O 0 0.017931723967194557
, O 0 0.01094401441514492
we O 0 0.008314047940075397
show O 0 0.015885617583990097
that O 0 0.014131305739283562
WT1 O 1 0.9635151028633118
- O 0 0.362985759973526
KTS O 1 0.97868412733078
isoforms O 0 0.2006213366985321
associate O 0 0.024128159508109093
and O 0 0.012559624388813972
synergize O 1 0.7391138672828674
with O 0 0.016925731673836708
SF O 1 0.8805469274520874
- O 0 0.030598720535635948
1 O 0 0.013656591065227985
to O 0 0.009917625226080418
promote O 0 0.027431709691882133
MIS O 1 0.9469811320304871
expression O 0 0.09557327628135681
. O 0 0.03224555030465126

In O 0 0.03338456153869629
contrast O 0 0.042465049773454666
, O 0 0.02769685909152031
WT1 O 1 0.9958341121673584
missense O 1 0.9910659193992615
mutations O 1 0.991603434085846
, O 0 0.012395944446325302
associated O 0 0.01718614436686039
with O 0 0.010619102977216244
male B-Disease 0 0.16174925863742828
pseudohermaphroditism I-Disease 1 0.9264617562294006
in O 0 0.020090455189347267
Denys B-Disease 1 0.9911399483680725
- I-Disease 1 0.984616756439209
Drash I-Disease 1 0.9971411228179932
syndrome I-Disease 1 0.999843955039978
, O 0 0.019027570262551308
fail O 0 0.11831977963447571
to O 0 0.011571989394724369
synergize O 1 0.8949522972106934
with O 0 0.023161740973591805
SF O 1 0.9572760462760925
- O 0 0.062172312289476395
1 O 0 0.03527914360165596
. O 0 0.033923130482435226

Additionally O 0 0.036717213690280914
, O 0 0.011612622067332268
the O 0 0.010332521051168442
X O 0 0.05227907747030258
- O 0 0.026835769414901733
linked O 0 0.036171864718198776
, O 0 0.010237985290586948
candidate O 0 0.023343659937381744
dosage O 1 0.6791404485702515
- O 0 0.05812432989478111
sensitive O 0 0.030849386006593704
sex O 0 0.054067619144916534
- O 0 0.20431487262248993
reversal O 1 0.5585036277770996
gene O 1 0.7486270666122437
, O 0 0.009926722384989262
Dax O 0 0.12320725619792938
- O 0 0.02747146040201187
1 O 0 0.012908607721328735
, O 0 0.0101038608700037
antagonizes O 1 0.5959769487380981
synergy O 0 0.07398142665624619
between O 0 0.01630658470094204
SF O 1 0.9621333479881287
- O 0 0.03758865222334862
1 O 0 0.013476881198585033
and O 0 0.008539395406842232
WT1 O 1 0.9685288071632385
, O 0 0.006803893018513918
most O 0 0.005879306700080633
likely O 0 0.0076997047290205956
through O 0 0.005657077766954899
a O 0 0.006686586420983076
direct O 0 0.014125501736998558
interaction O 0 0.01882236637175083
with O 0 0.012543130666017532
SF O 1 0.8301955461502075
- O 0 0.044886503368616104
1 O 0 0.030813291668891907
. O 0 0.03151930868625641

We O 0 0.02297314815223217
propose O 0 0.03692615404725075
that O 0 0.01513594388961792
WT1 O 1 0.9302574992179871
and O 0 0.012044470757246017
Dax O 0 0.25605958700180054
- O 0 0.03693701699376106
1 O 0 0.016808737069368362
functionally O 0 0.042794663459062576
oppose O 0 0.014203437604010105
each O 0 0.0061706057749688625
other O 0 0.004882133565843105
in O 0 0.008315260522067547
testis O 1 0.7590330243110657
development O 0 0.014440244063735008
by O 0 0.014711338095366955
modulating O 1 0.9577769637107849
SF O 1 0.9658538699150085
- O 0 0.11831621825695038
1 O 0 0.027610186487436295
- O 0 0.2006690949201584
mediated O 1 0.8143026828765869
transactivation O 1 0.9212590456008911
. O 0 0.026976944878697395
. O 0 0.033744845539331436

A O 0 0.047998134046792984
mouse O 0 0.32967427372932434
model O 0 0.03404286131262779
for O 0 0.02448139525949955
Prader B-Disease 1 0.9978973865509033
- I-Disease 1 0.9904995560646057
Willi I-Disease 1 0.9993008375167847
syndrome I-Disease 1 0.9999372959136963
imprinting O 1 0.998051643371582
- O 1 0.9464397430419922
centre O 0 0.4459865093231201
mutations O 1 0.9794718027114868
. O 0 0.05823172256350517

Imprinting O 1 0.6312198638916016
in O 0 0.018428495153784752
the O 0 0.01582052931189537
15q11 O 1 0.5123538970947266
- O 0 0.09988141059875488
q13 O 0 0.40759745240211487
region O 0 0.030937688425183296
involves O 0 0.030335471034049988
an O 0 0.01354321651160717
imprinting O 1 0.9141314625740051
centre O 0 0.027052035555243492
( O 0 0.017421714961528778
IC O 0 0.17695081233978271
) O 0 0.009175061248242855
, O 0 0.0054259165190160275
mapping O 0 0.011763405054807663
in O 0 0.004750247113406658
part O 0 0.005554427392780781
to O 0 0.004546452313661575
the O 0 0.00766082713380456
promoter O 0 0.030377577990293503
and O 0 0.00790200475603342
first O 0 0.01171126402914524
exon O 0 0.050205688923597336
of O 0 0.01955367438495159
SNRPN O 1 0.6491671800613403
. O 0 0.04113144427537918

Deletion O 0 0.20503288507461548
of O 0 0.020644813776016235
this O 0 0.02088966779410839
IC O 1 0.6113086342811584
abolishes O 1 0.8529453277587891
local O 0 0.0321824848651886
paternally O 1 0.9100053906440735
derived O 0 0.04402831941843033
gene O 1 0.6371296048164368
expression O 0 0.03473392128944397
and O 0 0.009011750109493732
results O 0 0.021173814311623573
in O 0 0.020450688898563385
Prader B-Disease 1 0.9989848732948303
- I-Disease 1 0.9970705509185791
Willi I-Disease 1 0.9997310042381287
syndrome I-Disease 1 0.9999738931655884
( O 1 0.9167266488075256
PWS B-Disease 1 0.9954240918159485
) O 0 0.05256080627441406
. O 0 0.042536601424217224

We O 0 0.014770522713661194
have O 0 0.009727561846375465
created O 0 0.013597968965768814
two O 0 0.010742816142737865
deletion O 1 0.9199621677398682
mutations O 1 0.9821512699127197
in O 0 0.010857359506189823
mice O 1 0.9196491241455078
to O 0 0.008521964773535728
understand O 0 0.02226037159562111
PWS B-Disease 1 0.9808856844902039
and O 0 0.006976997014135122
the O 0 0.0065920911729335785
mechanism O 0 0.01853092946112156
of O 0 0.009748096577823162
this O 0 0.015166226774454117
IC O 0 0.33393165469169617
. O 0 0.03386414051055908

Mice O 1 0.9693500399589539
harbouring O 1 0.7492699027061462
an O 0 0.03233125060796738
intragenic O 1 0.6817126870155334
deletion O 1 0.5134230852127075
in O 0 0.018680788576602936
Snrpn O 0 0.42595353722572327
are O 0 0.014549915678799152
phenotypically O 1 0.7702675461769104
normal O 0 0.02815990336239338
, O 0 0.009095004759728909
suggesting O 0 0.016421183943748474
that O 0 0.008680502884089947
mutations O 1 0.8163810968399048
of O 0 0.008807003498077393
SNRPN O 1 0.7201902270317078
are O 0 0.006996674928814173
not O 0 0.007075467146933079
sufficient O 0 0.015026549808681011
to O 0 0.015583207830786705
induce O 1 0.8194581866264343
PWS B-Disease 1 0.9873992204666138
. O 0 0.057286106050014496

Mice O 1 0.7868059277534485
with O 0 0.01420508697628975
a O 0 0.014114734716713428
larger O 0 0.021558159962296486
deletion O 1 0.5271010994911194
involving O 0 0.021557800471782684
both O 0 0.011640418320894241
Snrpn O 0 0.22682586312294006
and O 0 0.007737595587968826
the O 0 0.010969541035592556
putative O 1 0.906639039516449
PWS O 1 0.9972889423370361
- O 0 0.45282143354415894
IC O 1 0.7082486748695374
lack O 0 0.026273738592863083
expression O 0 0.022570667788386345
of O 0 0.009109819307923317
the O 0 0.012997989542782307
imprinted O 1 0.961851179599762
genes O 1 0.9456238150596619
Zfp127 O 1 0.9356489181518555
( O 0 0.030358022078871727
mouse O 1 0.767301082611084
homologue O 1 0.5953816175460815
of O 0 0.015552195720374584
ZNF127 O 1 0.8111295104026794
) O 0 0.01732397824525833
, O 0 0.011248458176851273
Ndn O 1 0.8258095383644104
and O 0 0.011174832470715046
Ipw O 0 0.11762065440416336
, O 0 0.008231479674577713
and O 0 0.00776725122705102
manifest O 0 0.02727389521896839
several O 0 0.014042960479855537
phenotypes O 1 0.9054381251335144
common O 0 0.038366563618183136
to O 0 0.022664863616228104
PWS B-Disease 1 0.9968196153640747
infants O 1 0.9951459765434265
. O 0 0.05231599509716034

These O 0 0.011649798601865768
data O 0 0.009707129560410976
demonstrate O 0 0.008733296766877174
that O 0 0.002972855232656002
both O 0 0.0028355249669402838
the O 0 0.0031562410295009613
position O 0 0.003677027067169547
of O 0 0.0030769079457968473
the O 0 0.004264324903488159
IC O 0 0.029928354546427727
and O 0 0.003867044812068343
its O 0 0.004500285256654024
role O 0 0.00628853403031826
in O 0 0.003851600456982851
the O 0 0.00517202727496624
coordinate O 0 0.013760808855295181
expression O 0 0.014886385761201382
of O 0 0.005965229589492083
genes O 0 0.12294071167707443
is O 0 0.007018372416496277
conserved O 0 0.015823988243937492
between O 0 0.008513725362718105
mouse O 0 0.2814541459083557
and O 0 0.004700894933193922
human O 0 0.00885132048279047
, O 0 0.003880397416651249
and O 0 0.0035685638431459665
indicate O 0 0.006392772309482098
that O 0 0.0032987173181027174
the O 0 0.003959711641073227
mouse O 0 0.061416275799274445
is O 0 0.004384019877761602
a O 0 0.005094276275485754
suitable O 0 0.0076005831360816956
model O 0 0.006533143576234579
system O 0 0.006207045633345842
in O 0 0.00344240665435791
which O 0 0.0034280349500477314
to O 0 0.003244528779760003
investigate O 0 0.009495601989328861
the O 0 0.005541275721043348
molecular O 0 0.01698257215321064
mechanisms O 0 0.013893313705921173
of O 0 0.00645283330231905
imprinting O 0 0.33331429958343506
in O 0 0.005614834371954203
this O 0 0.004460640251636505
region O 0 0.010056815110147
of O 0 0.005356284789741039
the O 0 0.008504384197294712
genome O 0 0.08980019390583038
. O 0 0.016097744926810265
. O 0 0.02863730490207672

Mutations O 1 0.7868777513504028
of O 0 0.01560196653008461
the O 0 0.016948850825428963
ATM O 0 0.422716349363327
gene O 1 0.8864346742630005
detected O 0 0.24536967277526855
in O 0 0.013769399374723434
Japanese O 0 0.10491062700748444
ataxia B-Disease 1 0.9994801878929138
- I-Disease 1 0.9925162196159363
telangiectasia I-Disease 1 0.9997163414955139
patients O 1 0.9982820749282837
: O 0 0.019325701519846916
possible O 0 0.014640137553215027
preponderance O 0 0.07986894249916077
of O 0 0.006828577723354101
the O 0 0.007764322683215141
two O 0 0.010034148581326008
founder O 0 0.07102752476930618
mutations O 1 0.9892654418945312
4612del165 O 1 0.8873801827430725
and O 0 0.02483689971268177
7883del5 O 1 0.6657456755638123
. O 0 0.042042963206768036

The O 0 0.025574082508683205
ATM O 0 0.07483428716659546
( O 0 0.018522337079048157
A O 0 0.019483156502246857
- O 0 0.23728294670581818
T O 1 0.969086229801178
, O 0 0.017494339495897293
mutated O 1 0.9408603310585022
) O 0 0.01972651295363903
gene O 0 0.2267516851425171
on O 0 0.015567781403660774
human O 0 0.16054508090019226
chromosome O 1 0.9843626022338867
11q22 O 1 0.7427381277084351
. O 0 0.04703756794333458

3 O 0 0.02756388857960701
has O 0 0.01214701496064663
recently O 0 0.013807599432766438
been O 0 0.007035593036562204
identified O 0 0.010673880577087402
as O 0 0.005231583025306463
the O 0 0.00623466819524765
gene O 0 0.12673868238925934
responsible O 0 0.012630031444132328
for O 0 0.006817436311393976
the O 0 0.010912085883319378
human O 1 0.9087605476379395
recessive B-Disease 1 0.9999182224273682
disease I-Disease 1 0.9999626874923706
ataxia B-Disease 1 0.9999176263809204
- I-Disease 1 0.9966763257980347
telangiectasia I-Disease 1 0.9993926286697388
( O 0 0.23644967377185822
A B-Disease 0 0.1054704338312149
- I-Disease 1 0.8489771485328674
T I-Disease 1 0.9719060063362122
) O 0 0.03806886821985245
. O 0 0.03892960771918297

In O 0 0.015024686232209206
order O 0 0.009682480245828629
to O 0 0.006477471441030502
define O 0 0.010744786821305752
the O 0 0.005890716332942247
types O 0 0.012546597979962826
of O 0 0.009718094952404499
disease O 1 0.9998062252998352
- O 1 0.9557932019233704
causing O 1 0.9916039109230042
ATM O 1 0.9066667556762695
mutations O 1 0.9614062309265137
in O 0 0.00973651371896267
Japanese O 0 0.015052076429128647
A B-Disease 0 0.022993218153715134
- I-Disease 1 0.8213383555412292
T I-Disease 1 0.9935262203216553
patients O 1 0.9608715772628784
as O 0 0.0047812857665121555
well O 0 0.0044824653305113316
as O 0 0.003561451332643628
to O 0 0.003769831033423543
look O 0 0.007637401577085257
for O 0 0.005833168048411608
possible O 0 0.013067388907074928
mutational O 1 0.8907575607299805
hotspots O 0 0.37370389699935913
, O 0 0.009961005300283432
reverse O 0 0.03415399417281151
- O 0 0.04848422110080719
transcribed O 0 0.05018549785017967
RNA O 0 0.04071516543626785
derived O 0 0.013750530779361725
from O 0 0.007225720211863518
ten O 0 0.01055611576884985
patients O 1 0.7383838891983032
belonging O 0 0.013809501193463802
to O 0 0.005629862193018198
eight O 0 0.008755679242312908
unrelated O 0 0.02017189934849739
Japanese O 0 0.014323296956717968
A B-Disease 0 0.01698215678334236
- I-Disease 0 0.2587931156158447
T I-Disease 1 0.8862257599830627
families O 0 0.01672373153269291
was O 0 0.009730244986712933
analyzed O 0 0.018490329384803772
for O 0 0.009755386039614677
mutations O 1 0.6267204284667969
by O 0 0.011031773872673512
the O 0 0.012951609678566456
restriction O 0 0.04591865837574005
endonuclease O 1 0.875914990901947
fingerprinting O 0 0.06755641847848892
method O 0 0.04733620211482048
. O 0 0.03501652553677559

As O 0 0.014214552007615566
has O 0 0.010291079059243202
been O 0 0.00851610116660595
reported O 0 0.013834681361913681
by O 0 0.007102807983756065
others O 0 0.008659628219902515
, O 0 0.0072853523306548595
mutations O 1 0.6448094844818115
that O 0 0.005930512212216854
lead O 0 0.009931270033121109
to O 0 0.008165102452039719
exon O 0 0.09403207153081894
skipping O 0 0.04673730209469795
or O 0 0.017463065683841705
premature O 1 0.9538182020187378
protein O 0 0.12677013874053955
truncation O 0 0.12053746730089188
were O 0 0.005940120201557875
also O 0 0.006884865462779999
predominant O 0 0.017852433025836945
in O 0 0.008360233157873154
our O 0 0.015498320572078228
mutants O 0 0.19181334972381592
. O 0 0.032591186463832855

Six O 0 0.027598896995186806
different O 0 0.017546599730849266
mutations O 1 0.6629014611244202
were O 0 0.006743529811501503
identified O 0 0.009047210216522217
on O 0 0.004643484950065613
12 O 0 0.006792324595153332
of O 0 0.0046382169239223
the O 0 0.00807263795286417
16 O 0 0.02287987992167473
alleles O 1 0.9118277430534363
examined O 0 0.07474595308303833
. O 0 0.039189890027046204

Four O 0 0.02014562115073204
were O 0 0.01098867878317833
deletions O 0 0.04292890429496765
involving O 0 0.018526636064052582
a O 0 0.010172000154852867
loss O 0 0.015285031870007515
of O 0 0.005455304868519306
a O 0 0.008009766228497028
single O 0 0.015002347528934479
exon O 0 0.37262988090515137
exon O 0 0.2781880497932434
7 O 0 0.015823159366846085
, O 0 0.009078248403966427
exon O 0 0.04982489347457886
16 O 0 0.013648166321218014
, O 0 0.010442017577588558
exon O 0 0.06724251806735992
33 O 0 0.023106705397367477
or O 0 0.019699137657880783
exon O 0 0.1451965719461441
35 O 0 0.03802525997161865
. O 0 0.03111160546541214

The O 0 0.015555734746158123
others O 0 0.013589615002274513
were O 0 0.006869520526379347
minute O 0 0.015308388508856297
deletions O 0 0.07210102677345276
, O 0 0.009832032956182957
4649delA O 0 0.1216907724738121
in O 0 0.011227603070437908
exon O 0 0.08071089535951614
33 O 0 0.01912003755569458
and O 0 0.010326300747692585
7883del5 O 0 0.1475868821144104
in O 0 0.017435016110539436
exon O 0 0.1905035525560379
55 O 0 0.04534102976322174
. O 0 0.0329771488904953

The O 0 0.03545711189508438
mutations O 1 0.9865283966064453
4612del165 O 1 0.5849646329879761
and O 0 0.011379645206034184
7883del5 O 0 0.0743512287735939
were O 0 0.006122041027992964
found O 0 0.006040246691554785
in O 0 0.0038015497848391533
more O 0 0.0038493468891829252
than O 0 0.004170192871242762
two O 0 0.0044432044960558414
unrelated O 0 0.01566719077527523
families O 0 0.010379337705671787
; O 0 0.0074407970532774925
44 O 0 0.009910221211612225
% O 0 0.0075353533029556274
( O 0 0.006389491725713015
7 O 0 0.0056195673532783985
of O 0 0.0035322285257279873
16 O 0 0.006428793538361788
) O 0 0.004472983535379171
of O 0 0.003910441417247057
the O 0 0.007110179867595434
mutant O 1 0.6704403758049011
alleles O 0 0.4890851378440857
had O 0 0.008051547221839428
one O 0 0.0059527503326535225
of O 0 0.005075495690107346
the O 0 0.0072637987323105335
two O 0 0.012209294363856316
mutations O 1 0.9329894781112671
. O 0 0.030143577605485916

The O 0 0.03248659148812294
4612del165 O 1 0.6636329293251038
mutations O 1 0.6425421833992004
in O 0 0.008338436484336853
three O 0 0.0054155513644218445
different O 0 0.004787497688084841
families O 0 0.006686317268759012
were O 0 0.003067231737077236
all O 0 0.002969747642055154
ascribed O 0 0.009729752317070961
to O 0 0.0030753875616937876
the O 0 0.004051304887980223
same O 0 0.007205083034932613
T O 0 0.49407118558883667
- O 0 0.09891177713871002
- O 0 0.08415882289409637
> O 0 0.16243544220924377
A O 0 0.011896941810846329
substitution O 0 0.019471099600195885
at O 0 0.007832554168999195
the O 0 0.008511052466928959
splice O 0 0.4900159239768982
donor O 0 0.26448947191238403
site O 0 0.02049139328300953
in O 0 0.018152503296732903
intron O 1 0.8726895451545715
33 O 0 0.050868719816207886
. O 0 0.038881100714206696

Microsatellite O 1 0.9340380430221558
genotyping O 0 0.3677937388420105
around O 0 0.021555311977863312
the O 0 0.014972309581935406
ATM O 0 0.05065847188234329
locus O 0 0.44468021392822266
also O 0 0.009480477310717106
indicated O 0 0.013728031888604164
that O 0 0.005106133874505758
a O 0 0.0083765909075737
common O 0 0.015502971597015858
haplotype O 1 0.7343762516975403
was O 0 0.006715637631714344
shared O 0 0.00898469053208828
by O 0 0.006836314219981432
the O 0 0.009429384022951126
mutant O 1 0.7888919115066528
alleles O 1 0.8601313233375549
in O 0 0.01385662890970707
both O 0 0.020505571737885475
mutations O 1 0.9480817317962646
. O 0 0.03320702165365219

This O 0 0.017755674198269844
suggests O 0 0.020393041893839836
that O 0 0.005699186120182276
these O 0 0.005155390594154596
two O 0 0.005736985243856907
founder O 0 0.0585973784327507
mutations O 1 0.9716943502426147
may O 0 0.011655658483505249
be O 0 0.006157067138701677
predominant O 0 0.02300305850803852
among O 0 0.014682281762361526
Japanese O 0 0.02741440013051033
ATM O 0 0.48419272899627686
mutant O 1 0.954093337059021
alleles O 1 0.9660890102386475
. O 0 0.04692425578832626

W474C O 1 0.6918279528617859
amino O 0 0.10126190632581711
acid O 0 0.3286411464214325
substitution O 0 0.05069859325885773
affects O 1 0.5343842506408691
early O 0 0.013818119652569294
processing O 0 0.010663853026926517
of O 0 0.00524619547650218
the O 0 0.007072519976645708
alpha O 0 0.023345239460468292
- O 0 0.02531236968934536
subunit O 0 0.033302661031484604
of O 0 0.008929603733122349
beta O 0 0.033744435757398605
- O 0 0.0363653339445591
hexosaminidase O 0 0.23380832374095917
A O 0 0.009923722594976425
and O 0 0.005986663047224283
is O 0 0.007171423640102148
associated O 0 0.015827778726816177
with O 0 0.015582667663693428
subacute O 1 0.998002827167511
G B-Disease 1 0.876137375831604
( I-Disease 0 0.03979915380477905
M2 I-Disease 0 0.2961442768573761
) I-Disease 0 0.03614342585206032
gangliosidosis I-Disease 0 0.19457298517227173
. O 0 0.04378359764814377

Mutations O 1 0.9325965642929077
in O 0 0.025458769872784615
the O 0 0.02303364686667919
HEXA O 1 0.9883036613464355
gene O 1 0.5192248821258545
, O 0 0.010794006288051605
encoding O 0 0.022883592173457146
the O 0 0.008618609979748726
alpha O 0 0.02668777108192444
- O 0 0.02523416094481945
subunit O 0 0.035044290125370026
of O 0 0.009180421009659767
beta O 0 0.036629218608140945
- O 0 0.049024105072021484
hexosaminidase O 0 0.25733888149261475
A O 0 0.01220257394015789
( O 0 0.011924798600375652
Hex O 0 0.021806346252560616
A O 0 0.009040680713951588
) O 0 0.007226924411952496
, O 0 0.004355983342975378
that O 0 0.004881185945123434
abolish O 0 0.021014738827943802
Hex O 0 0.02602662518620491
A O 0 0.012968589551746845
enzyme O 0 0.2882865369319916
activity O 0 0.07022619247436523
cause O 1 0.9799481630325317
Tay B-Disease 1 0.9993133544921875
- I-Disease 1 0.9924830794334412
Sachs I-Disease 1 0.998677670955658
disease I-Disease 1 0.9998723268508911
( O 0 0.4438401758670807
TSD B-Disease 1 0.9943943023681641
) O 0 0.01633697934448719
, O 0 0.009555715136229992
the O 0 0.013564548455178738
fatal O 1 0.9975428581237793
infantile B-Disease 1 0.9983915686607361
form I-Disease 0 0.02858271449804306
of I-Disease 0 0.015630686655640602
G I-Disease 0 0.3852437734603882
( I-Disease 0 0.022120948880910873
M2 I-Disease 0 0.34683874249458313
) I-Disease 0 0.01888236217200756
gangliosidosis I-Disease 0 0.10678970813751221
, I-Disease 0 0.015589666552841663
Type I-Disease 0 0.03438480198383331
1 I-Disease 0 0.027943983674049377
. O 0 0.027372973039746284

Less O 0 0.1055564433336258
severe O 1 0.9848384857177734
, O 0 0.031057097017765045
subacute O 1 0.9972803592681885
( O 0 0.133376806974411
juvenile O 1 0.9883974194526672
- O 1 0.967203676700592
onset O 1 0.9988834261894226
) O 0 0.02248115837574005
and O 0 0.01931653916835785
chronic O 1 0.9996285438537598
( O 0 0.059473972767591476
adult O 1 0.6355302929878235
- O 1 0.8707388043403625
onset O 1 0.9986352324485779
) O 0 0.014105434529483318
variants O 0 0.033105336129665375
are O 0 0.0052703930996358395
characterized O 0 0.030381424352526665
by O 0 0.006026976741850376
a O 0 0.00794812012463808
broad O 0 0.023486293852329254
spectrum O 0 0.02342899888753891
of O 0 0.007356132380664349
clinical O 1 0.9005232453346252
manifestations O 0 0.4827701151371002
and O 0 0.0055219861678779125
are O 0 0.004948091227561235
associated O 0 0.009474622085690498
with O 0 0.0062484703958034515
residual O 0 0.13989031314849854
levels O 0 0.01499295886605978
of O 0 0.007695486769080162
Hex O 0 0.037641044706106186
A O 0 0.016872987151145935
enzyme O 0 0.09400888532400131
activity O 0 0.03864039480686188
. O 0 0.03198325261473656

We O 0 0.01690864935517311
identified O 0 0.02521301433444023
a O 0 0.018436001613736153
1422 O 1 0.9282931089401245
G O 1 0.5163021683692932
- O 0 0.29583385586738586
- O 0 0.30260512232780457
> O 1 0.7737581133842468
C O 0 0.04670724272727966
( O 0 0.016843317076563835
amino O 0 0.031011933460831642
acid O 0 0.1307477355003357
W474C O 0 0.27917394042015076
) O 0 0.010633410885930061
substitution O 0 0.013405267149209976
in O 0 0.004542664159089327
the O 0 0.0037797794211655855
first O 0 0.004183839075267315
position O 0 0.005868854001164436
of O 0 0.005293223541229963
exon O 0 0.034029409289360046
13 O 0 0.011262699961662292
of O 0 0.008649982511997223
HEXA O 1 0.8566170930862427
of O 0 0.009458244778215885
a O 0 0.012388410978019238
non O 0 0.018933946266770363
- O 0 0.03830915316939354
Jewish O 0 0.027798907831311226
proband O 1 0.7441393136978149
who O 0 0.018478820100426674
manifested O 0 0.45601895451545715
a O 0 0.023512814193964005
subacute O 1 0.9960830211639404
variant O 1 0.8006259202957153
of O 0 0.01773931458592415
G B-Disease 1 0.5071398019790649
( I-Disease 0 0.03127243369817734
M2 I-Disease 0 0.23246324062347412
) I-Disease 0 0.03104025311768055
gangliosidosis I-Disease 0 0.19042523205280304
. O 0 0.03718314692378044

On O 0 0.01631351001560688
the O 0 0.014200407080352306
second O 0 0.023894457146525383
maternally O 1 0.9122948050498962
inherited O 1 0.9713090658187866
allele O 1 0.9412946701049805
, O 0 0.009278487414121628
we O 0 0.007125468458980322
identified O 0 0.014065914787352085
the O 0 0.00998488999903202
common O 1 0.6522882580757141
infantile O 1 0.9997178912162781
disease O 1 0.9999072551727295
- O 1 0.9426295161247253
causing O 1 0.9702470898628235
4 O 0 0.029450798407197
- O 0 0.16958267986774445
bp O 0 0.09682822227478027
insertion O 0 0.42412880063056946
, O 0 0.017857616767287254
+ O 0 0.31740400195121765
TATC O 1 0.8298466205596924
1278 O 1 0.6834280490875244
, O 0 0.015341099351644516
in O 0 0.016268910840153694
exon O 0 0.11886849254369736
11 O 0 0.0353708490729332
. O 0 0.034135837107896805

Pulse O 0 0.29338449239730835
- O 0 0.07688181102275848
chase O 0 0.058447375893592834
analysis O 0 0.0279092900454998
using O 0 0.024328192695975304
proband O 1 0.5964977145195007
fibroblasts O 1 0.7984282374382019
revealed O 0 0.02130623161792755
that O 0 0.007074632681906223
the O 0 0.007944275625050068
W474C O 0 0.13981562852859497
- O 0 0.027379034087061882
containing O 0 0.019659997895359993
alpha O 0 0.03369322791695595
- O 0 0.038326673209667206
subunit O 0 0.05350108817219734
precursor O 0 0.030841078609228134
was O 0 0.00881718285381794
normally O 0 0.013929015956819057
synthesized O 0 0.020108472555875778
, O 0 0.005351549480110407
but O 0 0.004473478067666292
not O 0 0.005215806420892477
phosphorylated O 0 0.03257334604859352
or O 0 0.009246019646525383
secreted O 0 0.025811458006501198
, O 0 0.005393576808273792
and O 0 0.004865352995693684
the O 0 0.008323339745402336
mature O 0 0.2964622974395752
lysosomal O 1 0.9826219081878662
alpha O 0 0.07745134830474854
- O 0 0.09710575640201569
subunit O 0 0.06214268133044243
was O 0 0.01326457317918539
not O 0 0.012670585885643959
detected O 0 0.05896336957812309
. O 0 0.029275208711624146

When O 0 0.032071977853775024
the O 0 0.019635671749711037
W474C O 0 0.14424265921115875
- O 0 0.039204083383083344
containing O 0 0.025943037122488022
alpha O 0 0.04250016435980797
- O 0 0.04215937852859497
subunit O 0 0.050743475556373596
was O 0 0.013519525527954102
transiently O 0 0.40702763199806213
co O 0 0.02846395969390869
- O 0 0.02307010069489479
expressed O 0 0.012709352187812328
with O 0 0.006849734112620354
the O 0 0.00718657486140728
beta O 0 0.027666131034493446
- O 0 0.0242815800011158
subunit O 0 0.03150945529341698
to O 0 0.006967311259359121
produce O 0 0.012738433666527271
Hex O 0 0.025634951889514923
A O 0 0.012537042610347271
( O 0 0.013433650135993958
alphabeta O 0 0.17511336505413055
) O 0 0.01108960248529911
in O 0 0.009491504170000553
COS O 1 0.5856558680534363
- O 0 0.04012688249349594
7 O 0 0.016474563628435135
cells O 0 0.09785767644643784
, O 0 0.006682628765702248
the O 0 0.00794836413115263
mature O 0 0.055344101041555405
alpha O 0 0.03006647899746895
- O 0 0.027511363849043846
subunit O 0 0.028719644993543625
was O 0 0.006017398554831743
present O 0 0.00552892591804266
, O 0 0.0032965796999633312
but O 0 0.0031903120689094067
its O 0 0.0037465826608240604
level O 0 0.00524764833971858
was O 0 0.003904228564351797
much O 0 0.004866322968155146
lower O 0 0.007649952545762062
than O 0 0.004366507288068533
that O 0 0.004343348555266857
from O 0 0.007268338464200497
normal O 0 0.02014043927192688
alpha O 0 0.0299253948032856
- O 0 0.05534945800900459
subunit O 0 0.10155549645423889
transfections O 0 0.11346262693405151
, O 0 0.008002211339771748
although O 0 0.0068232170306146145
higher O 0 0.007112125866115093
than O 0 0.004384771455079317
in O 0 0.0042111510410904884
those O 0 0.006476154550909996
cells O 0 0.3569888770580292
transfected O 1 0.6981991529464722
with O 0 0.00832203309983015
an O 0 0.008983416482806206
alpha O 0 0.03255321830511093
- O 0 0.057435087859630585
subunit O 0 0.09665139019489288
associated O 0 0.02762731909751892
with O 0 0.027533922344446182
infantile O 1 0.9980884194374084
TSD B-Disease 1 0.9921844601631165
. O 0 0.059073179960250854

Furthermore O 0 0.03480691462755203
, O 0 0.010237348265945911
the O 0 0.008465000428259373
precursor O 0 0.019642407074570656
level O 0 0.008859355933964252
of O 0 0.005157937295734882
the O 0 0.007034001871943474
W474C O 0 0.32528626918792725
alpha O 0 0.033882129937410355
- O 0 0.03297002613544464
subunit O 0 0.032018523663282394
was O 0 0.006646215915679932
found O 0 0.007075158413499594
to O 0 0.005064161028712988
accumulate O 0 0.01839950680732727
in O 0 0.005131157580763102
comparison O 0 0.009903009049594402
to O 0 0.004425311926752329
the O 0 0.007263392675668001
normal O 0 0.024794861674308777
alpha O 0 0.042717691510915756
- O 0 0.05243079364299774
subunit O 0 0.1018759235739708
precursor O 0 0.06494569033384323
levels O 0 0.048065461218357086
. O 0 0.03754017874598503

We O 0 0.015282224863767624
conclude O 0 0.02155202440917492
that O 0 0.008528003469109535
the O 0 0.013509874232113361
1422 O 1 0.9532938003540039
G O 1 0.601020097732544
- O 0 0.17163723707199097
- O 0 0.3818567097187042
> O 1 0.8083480596542358
C O 0 0.18596291542053223
mutation O 1 0.8970597982406616
is O 0 0.009436329826712608
the O 0 0.008161203004419804
cause O 0 0.052570804953575134
of O 0 0.008781134150922298
Hex B-Disease 0 0.08482696115970612
A I-Disease 0 0.027174759656190872
enzyme I-Disease 1 0.9713294506072998
deficiency I-Disease 1 0.9990936517715454
in O 0 0.018633360043168068
the O 0 0.02175692841410637
proband O 0 0.49492526054382324
. O 0 0.04113616794347763

The O 0 0.02603609673678875
resulting O 0 0.07572267204523087
W474C O 1 0.5531337261199951
substitution O 0 0.039797376841306686
clearly O 0 0.019906656816601753
interferes O 0 0.08928476274013519
with O 0 0.010004937648773193
alpha O 0 0.03523699939250946
- O 0 0.03378324955701828
subunit O 0 0.03811384737491608
processing O 0 0.01135820709168911
, O 0 0.00476177129894495
but O 0 0.004720170516520739
because O 0 0.00506447721272707
the O 0 0.004625329747796059
base O 0 0.008676822297275066
substitution O 0 0.012987373396754265
falls O 0 0.013003685511648655
at O 0 0.004385504871606827
the O 0 0.004139830358326435
first O 0 0.004442831967025995
position O 0 0.005954040680080652
of O 0 0.0066667296923696995
exon O 0 0.07459795475006104
13 O 0 0.013776298612356186
, O 0 0.010489496402442455
aberrant O 0 0.4168108105659485
splicing O 0 0.1519109159708023
may O 0 0.013935867697000504
also O 0 0.0075335209257900715
contribute O 0 0.01631047949194908
to O 0 0.007636678870767355
Hex B-Disease 0 0.035668447613716125
A I-Disease 0 0.022526858374476433
deficiency I-Disease 1 0.9974330067634583
in O 0 0.010914777405560017
this O 0 0.01145444717258215
proband O 0 0.3728025257587433
. O 0 0.019320152699947357
. O 0 0.026938222348690033

Two O 0 0.046750281006097794
frequent O 0 0.23034554719924927
missense O 1 0.9618495106697083
mutations O 1 0.9829745888710022
in O 0 0.0636649802327156
Pendred B-Disease 1 0.9929528832435608
syndrome I-Disease 1 0.9997231364250183
. O 0 0.07738430052995682

Pendred B-Disease 1 0.9957350492477417
syndrome I-Disease 1 0.9997828602790833
is O 0 0.12488030642271042
an O 1 0.5856390595436096
autosomal B-Disease 1 0.9998968839645386
recessive I-Disease 1 0.9999735355377197
disorder I-Disease 1 0.999970555305481
characterized O 1 0.9929205775260925
by O 0 0.0409252755343914
early O 1 0.5660194158554077
childhood O 1 0.9983144998550415
deafness B-Disease 1 0.9996672868728638
and O 0 0.23691043257713318
goiter B-Disease 1 0.99880051612854
. O 0 0.07545340806245804

A O 0 0.02245032973587513
century O 0 0.0169991347938776
after O 0 0.011804290115833282
its O 0 0.007834306918084621
recognition O 0 0.013155619613826275
as O 0 0.007418496534228325
a O 0 0.018952704966068268
syndrome O 1 0.999705970287323
by O 0 0.014370978809893131
Vaughan O 1 0.7439283728599548
Pendred O 1 0.9010770916938782
, O 0 0.010439332574605942
the O 0 0.016218651086091995
disease O 1 0.9997597336769104
gene O 1 0.989861249923706
( O 0 0.0417429655790329
PDS O 1 0.9649859070777893
) O 0 0.011733337305486202
was O 0 0.008181693963706493
mapped O 0 0.024145444855093956
to O 0 0.013897894881665707
chromosome O 1 0.9570925235748291
7q22 O 1 0.8068074584007263
- O 0 0.2518109679222107
q31 O 1 0.5350826382637024
. O 0 0.04621078446507454

1 O 0 0.024824233725667
and O 0 0.009238379076123238
, O 0 0.006881127133965492
recently O 0 0.009569299407303333
, O 0 0.005078451242297888
found O 0 0.006445029750466347
to O 0 0.005640344228595495
encode O 0 0.019890140742063522
a O 0 0.01830935664474964
putative O 1 0.7462815642356873
sulfate O 1 0.9744009375572205
transporter O 1 0.9135028719902039
. O 0 0.04939020797610283

We O 0 0.023755202069878578
performed O 0 0.025949956849217415
mutation O 1 0.5655254125595093
analysis O 0 0.015288246795535088
of O 0 0.006944251712411642
the O 0 0.010845787823200226
PDS B-Disease 1 0.9764062762260437
gene O 1 0.9088653326034546
in O 0 0.01415836252272129
patients O 1 0.9865569472312927
from O 0 0.012033466249704361
14 O 0 0.01717609539628029
Pendred B-Disease 1 0.6569376587867737
families O 0 0.015162978321313858
originating O 0 0.01744030974805355
from O 0 0.00691298209130764
seven O 0 0.006977496203035116
countries O 0 0.006598035804927349
and O 0 0.0058822729624807835
identified O 0 0.014508746564388275
all O 0 0.011647317558526993
mutations O 1 0.8993594646453857
. O 0 0.02784070000052452

The O 0 0.024821728467941284
mutations O 1 0.699955940246582
include O 0 0.012828621082007885
three O 0 0.008869912475347519
single O 0 0.011222871020436287
base O 0 0.014181956648826599
deletions O 0 0.03603063151240349
, O 0 0.006815421860665083
one O 0 0.007708000484853983
splice O 0 0.20852088928222656
site O 0 0.019872384145855904
mutation O 1 0.8941388130187988
and O 0 0.01301583368331194
10 O 0 0.025680596008896828
missense O 1 0.9591217041015625
mutations O 1 0.9769397974014282
. O 0 0.0394752137362957

One O 0 0.04400815814733505
missense O 1 0.9792633652687073
mutation O 1 0.9824632406234741
( O 0 0.02761879935860634
L236P O 0 0.20153583586215973
) O 0 0.01229152549058199
was O 0 0.006400344893336296
found O 0 0.006348208989948034
in O 0 0.004362823441624641
a O 0 0.006951451301574707
homozygous O 0 0.08908913284540176
state O 0 0.00563478097319603
in O 0 0.005106747150421143
two O 0 0.00619334215298295
consanguineous O 0 0.45243605971336365
families O 0 0.010163141414523125
and O 0 0.004758712835609913
in O 0 0.005104373674839735
a O 0 0.007653869688510895
heterozygous O 0 0.04634180665016174
state O 0 0.006836945656687021
in O 0 0.005747898947447538
five O 0 0.007545980159193277
additional O 0 0.012971973977982998
non O 0 0.024198396131396294
- O 0 0.08437374979257584
consanguineous O 1 0.9000728726387024
families O 0 0.04683178663253784
. O 0 0.03946736827492714

Another O 0 0.06517258286476135
missense O 1 0.9708489775657654
mutation O 1 0.9871358275413513
( O 0 0.032955680042505264
T416P O 0 0.2836224138736725
) O 0 0.010525217279791832
was O 0 0.005702207796275616
found O 0 0.005722287110984325
in O 0 0.004206306301057339
a O 0 0.006787629798054695
homozygous O 0 0.13135391473770142
state O 0 0.0050162263214588165
in O 0 0.004051627591252327
one O 0 0.0044042025692760944
family O 0 0.007064681965857744
and O 0 0.004018754698336124
in O 0 0.004966982174664736
a O 0 0.008513040840625763
heterozygous O 0 0.06988672912120819
state O 0 0.007739465683698654
in O 0 0.00782974623143673
four O 0 0.012406397610902786
families O 0 0.02683677338063717
. O 0 0.02738138474524021

Pendred B-Disease 1 0.9720025062561035
patients O 1 0.9618495106697083
in O 0 0.014259502291679382
three O 0 0.011861584149301052
non O 0 0.02401256002485752
- O 0 0.12233559787273407
consanguineous O 1 0.9283449053764343
families O 0 0.015147598460316658
were O 0 0.005713584832847118
shown O 0 0.009486125782132149
to O 0 0.005301751662045717
be O 0 0.005600946024060249
compound O 0 0.019087325781583786
heterozygotes O 0 0.39546263217926025
for O 0 0.012509622611105442
L236P O 0 0.310212105512619
and O 0 0.017338749021291733
T416P O 1 0.5216879844665527
. O 0 0.03543420881032944

In O 0 0.0126767847687006
total O 0 0.009118108078837395
, O 0 0.004785508383065462
one O 0 0.0035950199235230684
or O 0 0.0038397791795432568
both O 0 0.0030401351395994425
of O 0 0.0032241970766335726
these O 0 0.004339544102549553
mutations O 1 0.6863196492195129
were O 0 0.003408433636650443
found O 0 0.0043462119065225124
in O 0 0.0032552178017795086
nine O 0 0.0043091666884720325
of O 0 0.0037363837473094463
the O 0 0.005479222629219294
14 O 0 0.011604398488998413
families O 0 0.01806306466460228
analyzed O 0 0.03740449622273445
. O 0 0.02770141139626503

The O 0 0.018123731017112732
identification O 0 0.023119989782571793
of O 0 0.008519652299582958
two O 0 0.010679096914827824
frequent O 0 0.12097063660621643
PDS B-Disease 1 0.9899359345436096
mutations O 1 0.9798957109451294
will O 0 0.010379567742347717
facilitate O 0 0.020873814821243286
the O 0 0.01414768397808075
molecular O 0 0.38928845524787903
diagnosis O 1 0.9951097369194031
of O 0 0.046692024916410446
Pendred B-Disease 1 0.997765064239502
syndrome I-Disease 1 0.999901294708252
. O 0 0.08850129693746567

Insertional O 1 0.9202370643615723
mutation O 1 0.9320042729377747
by O 0 0.027098365128040314
transposable O 1 0.5260836482048035
element O 0 0.025821996852755547
, O 0 0.011462733149528503
L1 O 0 0.12964951992034912
, O 0 0.008296767249703407
in O 0 0.008401700295507908
the O 0 0.012621859088540077
DMD B-Disease 1 0.9983580708503723
gene O 1 0.8792399764060974
results O 0 0.025438057258725166
in O 0 0.014294310472905636
X B-Disease 1 0.532932698726654
- I-Disease 1 0.6198148131370544
linked I-Disease 1 0.9649316072463989
dilated I-Disease 1 0.9969366788864136
cardiomyopathy I-Disease 1 0.9991875290870667
. O 0 0.06906919181346893

X B-Disease 1 0.685006856918335
- I-Disease 1 0.7135461568832397
linked I-Disease 1 0.9613194465637207
dilated I-Disease 1 0.9979338645935059
cardiomyopathy I-Disease 1 0.9997089505195618
( O 0 0.08014639467000961
XLDCM B-Disease 1 0.913135290145874
) O 0 0.014644023962318897
is O 0 0.00976896658539772
a O 0 0.013935749419033527
clinical O 1 0.9226173162460327
phenotype O 1 0.9914649128913879
of O 0 0.012822668068110943
dystrophinopathy B-Disease 1 0.5486735701560974
which O 0 0.008123724721372128
is O 0 0.009159117937088013
characterized O 0 0.08077630400657654
by O 0 0.013772618025541306
preferential O 1 0.7778619527816772
myocardial B-Disease 1 0.998883068561554
involvement I-Disease 0 0.14367921650409698
without O 0 0.013437309302389622
any O 0 0.014937885105609894
overt O 0 0.33085811138153076
clinical O 1 0.8131816387176514
signs O 0 0.23291675746440887
of O 0 0.03032737225294113
skeletal B-Disease 1 0.9982017278671265
myopathy I-Disease 1 0.9990900754928589
. O 0 0.07501982897520065

To O 0 0.014605812728404999
date O 0 0.01580309122800827
, O 0 0.009752501733601093
several O 0 0.010746602900326252
mutations O 1 0.8864595293998718
in O 0 0.012383406050503254
the O 0 0.03377758339047432
Duchenne B-Disease 1 0.9997909665107727
muscular I-Disease 1 0.9998300075531006
dystrophy I-Disease 1 0.9999138116836548
gene O 1 0.9979053735733032
, O 0 0.10662873834371567
DMD O 1 0.9993482232093811
, O 0 0.008952138014137745
have O 0 0.005490683019161224
been O 0 0.005800032056868076
identified O 0 0.009719806723296642
in O 0 0.006834255997091532
patients O 1 0.9622393250465393
with O 0 0.00736110657453537
XLDCM B-Disease 1 0.8307085633277893
, O 0 0.006044006906449795
but O 0 0.005674947984516621
a O 0 0.009215716272592545
pathogenic O 1 0.7677735090255737
correlation O 0 0.02198709174990654
of O 0 0.008067461661994457
these O 0 0.010416263714432716
cardiospecific O 1 0.9662675261497498
mutations O 1 0.9858647584915161
in O 0 0.01682996191084385
DMD O 1 0.9980886578559875
with O 0 0.011697274632751942
the O 0 0.014638184569776058
XLDCM B-Disease 1 0.9851133823394775
phenotype O 1 0.9924977421760559
has O 0 0.013289622031152248
remained O 0 0.013743315823376179
to O 0 0.008267697878181934
be O 0 0.011996087618172169
elucidated O 0 0.07022377103567123
. O 0 0.026853879913687706

We O 0 0.012874470092356205
report O 0 0.01168090384453535
here O 0 0.006148415617644787
the O 0 0.005210039671510458
identification O 0 0.008414246141910553
of O 0 0.004540256690233946
a O 0 0.007853355258703232
unique O 0 0.01355501264333725
de O 0 0.032029978930950165
novo O 0 0.15019714832305908
L1 O 1 0.6095435619354248
insertion O 0 0.06696801632642746
in O 0 0.010990461334586143
the O 0 0.014650708064436913
muscle O 1 0.9450116157531738
exon O 0 0.3442422151565552
1 O 0 0.019481152296066284
in O 0 0.013385530561208725
DMD O 1 0.9935682415962219
in O 0 0.011387372389435768
three O 0 0.013751682825386524
XLDCM B-Disease 1 0.9685186147689819
patients O 1 0.959977924823761
from O 0 0.009776582941412926
two O 0 0.009683088399469852
unrelated O 0 0.04140925779938698
Japanese O 0 0.02542286179959774
families O 0 0.034066326916217804
. O 0 0.03357214108109474

The O 0 0.02190287783741951
insertion O 0 0.05004454776644707
was O 0 0.010328191332519054
a O 0 0.00969182513654232
5 O 0 0.013249662704765797
- O 0 0.02050391025841236
truncated O 0 0.026264183223247528
form O 0 0.011004977859556675
of O 0 0.007654152344912291
human O 0 0.030613597482442856
L1 O 1 0.6756847500801086
inversely O 0 0.0717393159866333
integrated O 0 0.016118913888931274
in O 0 0.006558890920132399
the O 0 0.0067425938323140144
5 O 0 0.011552948504686356
- O 0 0.025379624217748642
untranslated O 0 0.12925586104393005
region O 0 0.015378081239759922
in O 0 0.006166171282529831
the O 0 0.008198061026632786
muscle O 1 0.9667889475822449
exon O 0 0.3127942979335785
1 O 0 0.010673027485609055
, O 0 0.005628802347928286
which O 0 0.005421538837254047
affected O 0 0.015398489311337471
the O 0 0.005225739907473326
transcription O 0 0.022741980850696564
or O 0 0.0055128438398242
the O 0 0.004027843941003084
stability O 0 0.008012751117348671
of O 0 0.004680515732616186
the O 0 0.006908344570547342
muscle O 1 0.9752124547958374
form O 0 0.011190181598067284
of O 0 0.007830408401787281
dystrophin O 1 0.9684190154075623
transcripts O 0 0.012303156778216362
but O 0 0.0045334044843912125
not O 0 0.0030296691693365574
that O 0 0.002878244034945965
of O 0 0.0033884013537317514
the O 0 0.006357370875775814
brain O 1 0.9966121315956116
or O 0 0.01651260443031788
Purkinje O 1 0.9926282167434692
cell O 0 0.3920007348060608
form O 0 0.012943736277520657
, O 0 0.005272437818348408
probably O 0 0.008282075636088848
due O 0 0.007101849187165499
to O 0 0.003580656135454774
its O 0 0.00485349353402853
unique O 0 0.007760116830468178
site O 0 0.008975096046924591
of O 0 0.007951749488711357
integration O 0 0.02545291557908058
. O 0 0.02409304678440094

We O 0 0.017926115542650223
speculate O 0 0.027336355298757553
that O 0 0.006090685725212097
this O 0 0.006447338964790106
insertion O 0 0.021611178293824196
of O 0 0.005973782856017351
an O 0 0.008756597526371479
L1 O 0 0.2752230167388916
sequence O 0 0.019132504239678383
in O 0 0.010327327996492386
DMD O 1 0.9977693557739258
is O 0 0.007802887819707394
responsible O 0 0.008374982513487339
for O 0 0.003558800555765629
some O 0 0.00366152822971344
of O 0 0.0032204126473516226
the O 0 0.003838461358100176
population O 0 0.008308467455208302
of O 0 0.006874246057122946
Japanese O 0 0.021569939330220222
patients O 1 0.9842618703842163
with O 0 0.015949394553899765
XLDCM B-Disease 1 0.9176086187362671
. O 0 0.019473407417535782
. O 0 0.03021898865699768

Severe O 1 0.9914025664329529
early O 0 0.12463878840208054
- O 1 0.9804595708847046
onset O 1 0.9992896318435669
obesity B-Disease 1 0.9993684887886047
, O 0 0.21592673659324646
adrenal B-Disease 1 0.9982300400733948
insufficiency I-Disease 1 0.9977922439575195
and O 0 0.03166323900222778
red O 1 0.8183197379112244
hair O 1 0.9959158301353455
pigmentation O 1 0.9990279674530029
caused O 1 0.9872999787330627
by O 0 0.09923279285430908
POMC O 1 0.9978770017623901
mutations O 1 0.9944359064102173
in O 0 0.027248991653323174
humans O 0 0.3540610671043396
. O 0 0.041178148239851

Sequential O 0 0.08651737868785858
cleavage O 0 0.1600613296031952
of O 0 0.012581607326865196
the O 0 0.012937524355947971
precursor O 0 0.045832309871912
protein O 0 0.04918057844042778
pre O 0 0.04403402656316757
- O 0 0.062142159789800644
pro O 0 0.049446117132902145
- O 0 0.20131425559520721
opiomelanocortin O 1 0.7253798246383667
( O 0 0.03689900040626526
POMC O 1 0.9726169109344482
) O 0 0.021464351564645767
generates O 0 0.03998507931828499
the O 0 0.023629354313015938
melanocortin O 1 0.9788309931755066
peptides O 1 0.6605006456375122
adrenocorticotrophin O 1 0.8557582497596741
( O 0 0.03923031687736511
ACTH O 1 0.9510501027107239
) O 0 0.019237183034420013
, O 0 0.016516005620360374
melanocyte O 1 0.9891323447227478
- O 1 0.6559596657752991
stimulating O 1 0.9793199896812439
hormones O 1 0.9889487028121948
( O 0 0.05590376630425453
MSH O 1 0.9921242594718933
) O 0 0.017418278381228447
alpha O 0 0.024359166622161865
, O 0 0.008127414621412754
beta O 0 0.018433088436722755
and O 0 0.005557386204600334
gamma O 0 0.018489034846425056
as O 0 0.00453995680436492
well O 0 0.0043450589291751385
as O 0 0.005141359753906727
the O 0 0.010094597935676575
opioid O 1 0.8466901183128357
- O 0 0.41356247663497925
receptor O 1 0.9554589986801147
ligand O 0 0.4550521671772003
beta O 0 0.3607929050922394
- O 0 0.4237157702445984
endorphin O 1 0.9470138549804688
. O 0 0.052810292690992355

While O 0 0.019015958532691002
a O 0 0.013990450650453568
few O 0 0.012476249597966671
cases O 0 0.019235383719205856
of O 0 0.013023314997553825
isolated O 1 0.9597084522247314
ACTH B-Disease 1 0.9985135197639465
deficiency I-Disease 1 0.9995735287666321
have O 0 0.01292410958558321
been O 0 0.011419803835451603
reported O 0 0.02900877594947815
( O 0 0.02973446622490883
OMIM O 1 0.9928763508796692
201400 O 1 0.6832011938095093
) O 0 0.013453780673444271
, O 0 0.008790203370153904
an O 0 0.011170812882483006
inherited O 1 0.9930853843688965
POMC O 1 0.9987016916275024
defect O 1 0.9781896471977234
has O 0 0.01095447689294815
not O 0 0.0061354138888418674
been O 0 0.007905526086688042
described O 0 0.013383564539253712
so O 0 0.009984871372580528
far O 0 0.017232194542884827
. O 0 0.023910298943519592

Recent O 0 0.037068720906972885
studies O 0 0.021464355289936066
in O 0 0.011656904593110085
animal O 0 0.02669638767838478
models O 0 0.01661152020096779
elucidated O 0 0.03295142948627472
a O 0 0.008127584122121334
central O 0 0.00861402414739132
role O 0 0.010013051331043243
of O 0 0.007873994298279285
alpha O 0 0.038849830627441406
- O 0 0.09570625424385071
MSH O 1 0.9644102454185486
in O 0 0.007761857938021421
the O 0 0.005976606160402298
regulation O 0 0.011775040067732334
of O 0 0.005566083826124668
food O 0 0.013557849451899529
intake O 0 0.05399426072835922
by O 0 0.008177407085895538
activation O 0 0.06875158101320267
of O 0 0.006533592473715544
the O 0 0.01181885413825512
brain O 1 0.9978293776512146
melanocortin O 1 0.994562566280365
- O 0 0.2377532571554184
4 O 0 0.026674341410398483
- O 0 0.2494017481803894
receptor O 1 0.8220620155334473
( O 0 0.028552403673529625
MC4 O 1 0.9815955758094788
- O 0 0.0968753919005394
R O 0 0.05890051648020744
; O 0 0.012710255570709705
refs O 0 0.03819873183965683
3 O 0 0.012447021901607513
- O 0 0.01620488427579403
5 O 0 0.009546675719320774
) O 0 0.00555050652474165
and O 0 0.003536479314789176
the O 0 0.005044037476181984
linkage O 0 0.024570366367697716
of O 0 0.008050110191106796
human O 0 0.32019612193107605
obesity B-Disease 1 0.9984650611877441
to O 0 0.010082659311592579
chromosome O 1 0.8795392513275146
2 O 0 0.009490543976426125
in O 0 0.00661079166457057
close O 0 0.010912199504673481
proximity O 0 0.013468732126057148
to O 0 0.006540064699947834
the O 0 0.010043958202004433
POMC O 1 0.9787302613258362
locus O 1 0.5241501331329346
, O 0 0.0062266187742352486
led O 0 0.007018206175416708
to O 0 0.003417074214667082
the O 0 0.003572616493329406
proposal O 0 0.0062912702560424805
of O 0 0.0038901909720152617
an O 0 0.00471174530684948
association O 0 0.0107553256675601
of O 0 0.00848420336842537
POMC O 1 0.9908360242843628
with O 0 0.019087553024291992
human O 1 0.6886112093925476
obesity B-Disease 1 0.9981308579444885
. O 0 0.04645998030900955

The O 0 0.019564589485526085
dual O 0 0.029453851282596588
role O 0 0.018842056393623352
of O 0 0.012228700332343578
alpha O 0 0.04701295122504234
- O 0 0.18029162287712097
MSH O 1 0.9678809642791748
in O 0 0.016255805268883705
regulating O 0 0.0814848467707634
food O 0 0.032998520880937576
intake O 0 0.30270659923553467
and O 0 0.010336216539144516
influencing O 1 0.7857168912887573
hair O 1 0.994016170501709
pigmentation O 1 0.9984685778617859
predicts O 0 0.4069913923740387
that O 0 0.007329554297029972
the O 0 0.009650850668549538
phenotype O 1 0.9853770136833191
associated O 0 0.01522083580493927
with O 0 0.007625441998243332
a O 0 0.01197130884975195
defect O 1 0.8730096220970154
in O 0 0.012195966206490993
POMC O 1 0.9910037517547607
function O 0 0.027082253247499466
would O 0 0.00949391070753336
include O 0 0.018196582794189453
obesity B-Disease 1 0.997503936290741
, O 0 0.01448806282132864
alteration O 1 0.7234612703323364
in O 0 0.02053600177168846
pigmentation O 1 0.9980562925338745
and O 0 0.12054427713155746
ACTH B-Disease 1 0.9964703321456909
deficiency I-Disease 1 0.9985790252685547
. O 0 0.06813924014568329

The O 0 0.01958427205681801
observation O 0 0.02448642998933792
of O 0 0.010286339558660984
these O 0 0.011249194853007793
symptoms O 1 0.9966021776199341
in O 0 0.0074693625792860985
two O 0 0.007312618661671877
probands O 1 0.5599668025970459
prompted O 0 0.028187787160277367
us O 0 0.010477249510586262
to O 0 0.005146197974681854
search O 0 0.012039771303534508
for O 0 0.008966359309852123
mutations O 1 0.8655285835266113
within O 0 0.015218191780149937
their O 0 0.021050136536359787
POMC O 1 0.9908913969993591
genes O 1 0.9077184200286865
. O 0 0.04641390219330788

Patient O 1 0.7802467942237854
1 O 0 0.020298926159739494
was O 0 0.008869501762092113
found O 0 0.007892596535384655
to O 0 0.00447355629876256
be O 0 0.00354936090297997
a O 0 0.006795227527618408
compound O 0 0.017701806500554085
heterozygote O 0 0.1326790302991867
for O 0 0.008223169483244419
two O 0 0.010447689332067966
mutations O 1 0.6316347122192383
in O 0 0.010943632572889328
exon O 0 0.2140403538942337
3 O 0 0.01754986308515072
( O 0 0.015753550454974174
G7013T O 0 0.13369512557983398
, O 0 0.00994833093136549
C7133delta O 0 0.23453880846500397
) O 0 0.010249322280287743
which O 0 0.006502326112240553
interfere O 0 0.014506892301142216
with O 0 0.007380891125649214
appropriate O 0 0.011690485291182995
synthesis O 0 0.021493518725037575
of O 0 0.009621352888643742
ACTH O 1 0.9106243848800659
and O 0 0.01477388758212328
alpha O 0 0.09489982575178146
- O 0 0.34374791383743286
MSH O 1 0.9842358827590942
. O 0 0.0511627122759819

Patient O 1 0.8770349621772766
2 O 0 0.02535918727517128
was O 0 0.014682531356811523
homozygous O 0 0.05743783712387085
for O 0 0.009695850312709808
a O 0 0.01225340086966753
mutation O 1 0.8921036720275879
in O 0 0.011968815699219704
exon O 0 0.26476284861564636
2 O 0 0.02178560197353363
( O 0 0.022294046357274055
C3804A O 0 0.23876336216926575
) O 0 0.021477576345205307
which O 0 0.0211917944252491
abolishes O 1 0.8117402195930481
POMC O 1 0.9580633044242859
translation O 0 0.06731157004833221
. O 0 0.03945327550172806

These O 0 0.014958743937313557
findings O 0 0.018362771719694138
represent O 0 0.008949332870543003
the O 0 0.005369065795093775
first O 0 0.005390781443566084
examples O 0 0.007331973407417536
of O 0 0.005507126450538635
a O 0 0.011997116729617119
genetic B-Disease 1 0.959572434425354
defect I-Disease 1 0.9767240285873413
within O 0 0.01301310770213604
the O 0 0.013350719586014748
POMC O 1 0.9956252574920654
gene O 1 0.6043297648429871
and O 0 0.008678741753101349
define O 0 0.01712900586426258
a O 0 0.013286496512591839
new O 0 0.02636679820716381
monogenic B-Disease 1 0.9988540410995483
endocrine I-Disease 1 0.9997510313987732
disorder I-Disease 1 0.9997925162315369
resulting O 1 0.7233323454856873
in O 0 0.01590428687632084
early O 0 0.14291808009147644
- O 1 0.9912682771682739
onset O 1 0.9997733235359192
obesity B-Disease 1 0.9998524188995361
, O 1 0.5115432143211365
adrenal B-Disease 1 0.9996572732925415
insufficiency I-Disease 1 0.9991497993469238
and O 0 0.03786207363009453
red O 1 0.9020133018493652
hair O 1 0.9943230152130127
pigmentation O 1 0.9969249367713928
. O 0 0.026106776669621468
. O 0 0.034259356558322906

A O 0 0.03448878228664398
European O 0 0.03592458739876747
multicenter O 1 0.7014695405960083
study O 0 0.03206585347652435
of O 0 0.024969201534986496
phenylalanine B-Disease 1 0.9603046774864197
hydroxylase I-Disease 1 0.9895662069320679
deficiency I-Disease 1 0.9994726777076721
: O 0 0.01930144988000393
classification O 0 0.023251546546816826
of O 0 0.0068886131048202515
105 O 0 0.024737732484936714
mutations O 1 0.8692535758018494
and O 0 0.0045712292194366455
a O 0 0.00627833092585206
general O 0 0.007262915838509798
system O 0 0.009175858460366726
for O 0 0.007805283181369305
genotype O 1 0.8109347820281982
- O 0 0.02621900662779808
based O 0 0.01567569002509117
prediction O 0 0.03286655992269516
of O 0 0.021603628993034363
metabolic O 1 0.9924733638763428
phenotype O 1 0.9902008175849915
. O 0 0.04980940371751785

Phenylketonuria B-Disease 1 0.9963678121566772
( O 0 0.395693838596344
PKU B-Disease 1 0.9944730401039124
) O 0 0.02901708334684372
and O 0 0.019008329138159752
mild B-Disease 1 0.9897140860557556
hyperphenylalaninemia I-Disease 1 0.9916533827781677
( O 0 0.1491652876138687
MHP B-Disease 1 0.9968876242637634
) O 0 0.023302551358938217
are O 0 0.015313327312469482
allelic B-Disease 1 0.994696855545044
disorders I-Disease 1 0.9997379183769226
caused O 1 0.9654221534729004
by O 0 0.017431030049920082
mutations O 1 0.9699934124946594
in O 0 0.01103158202022314
the O 0 0.013585221953690052
gene O 1 0.8435453176498413
encoding O 0 0.3451181948184967
phenylalanine O 1 0.9449141621589661
hydroxylase O 1 0.9635891318321228
( O 0 0.13970471918582916
PAH O 1 0.9949676394462585
) O 0 0.04446922615170479
. O 0 0.03586754947900772

Previous O 0 0.025510864332318306
studies O 0 0.018518580123782158
have O 0 0.008321895264089108
suggested O 0 0.010356909595429897
that O 0 0.005275750532746315
the O 0 0.006607550662010908
highly O 0 0.021294185891747475
variable O 0 0.38926005363464355
metabolic O 1 0.9954202771186829
phenotypes O 1 0.9933005571365356
of O 0 0.10203591734170914
PAH B-Disease 1 0.9996864795684814
deficiency I-Disease 1 0.9997833371162415
correlate O 1 0.961035966873169
with O 0 0.1617644727230072
PAH O 1 0.9982346296310425
genotypes O 1 0.9860787987709045
. O 0 0.05589861050248146

We O 0 0.02152521349489689
identified O 0 0.02892370894551277
both O 0 0.017195813357830048
causative O 1 0.9442684650421143
mutations O 1 0.989983081817627
in O 0 0.017713850364089012
686 O 1 0.9694501161575317
patients O 1 0.9864922165870667
from O 0 0.013866099528968334
seven O 0 0.013229736126959324
European O 0 0.021792100742459297
centers O 0 0.039860501885414124
. O 0 0.032978057861328125

On O 0 0.012095033191144466
the O 0 0.006643339991569519
basis O 0 0.006581164430826902
of O 0 0.006036140024662018
the O 0 0.00836978480219841
phenotypic O 0 0.4766792356967926
characteristics O 0 0.01951805129647255
of O 0 0.011433391831815243
297 O 1 0.710772693157196
functionally O 1 0.9583125710487366
hemizygous O 1 0.9865201711654663
patients O 1 0.9881324172019958
, O 0 0.007391683757305145
105 O 0 0.01220656931400299
of O 0 0.0055449241772294044
the O 0 0.0075038946233689785
mutations O 1 0.7510871887207031
were O 0 0.004063444212079048
assigned O 0 0.006193746812641621
to O 0 0.0031297423411160707
one O 0 0.003979560919106007
of O 0 0.005123806651681662
four O 0 0.008802039548754692
arbitrary O 0 0.023365568369627
phenotype O 1 0.9400152564048767
categories O 0 0.036589521914720535
. O 0 0.029339207336306572

We O 0 0.012650296092033386
proposed O 0 0.013814820908010006
and O 0 0.007404835429042578
tested O 0 0.017223330214619637
a O 0 0.00829368457198143
simple O 0 0.01042595598846674
model O 0 0.010677918791770935
for O 0 0.007372152991592884
correlation O 0 0.02836473099887371
between O 0 0.01834060624241829
genotype O 1 0.9236884713172913
and O 0 0.016847962513566017
phenotypic O 1 0.9045891761779785
outcome O 0 0.049763794988393784
. O 0 0.031931884586811066

The O 0 0.029459252953529358
observed O 0 0.05603402107954025
phenotype O 1 0.9779873490333557
matched O 0 0.034098606556653976
the O 0 0.013356266543269157
predicted O 0 0.03955037519335747
phenotype O 1 0.9520799517631531
in O 0 0.008489965461194515
79 O 0 0.01792842335999012
% O 0 0.007264166139066219
of O 0 0.003988832700997591
the O 0 0.004038861952722073
cases O 0 0.008506828919053078
, O 0 0.003004875499755144
and O 0 0.0024312909226864576
in O 0 0.002878163242712617
only O 0 0.003096159780398011
5 O 0 0.005498802289366722
of O 0 0.0047373357228934765
184 O 0 0.17328909039497375
patients O 1 0.9543119072914124
was O 0 0.00602096738293767
the O 0 0.006047748029232025
observed O 0 0.02121281623840332
phenotype O 1 0.879817545413971
more O 0 0.005314806010574102
than O 0 0.005908688064664602
one O 0 0.005084560252726078
category O 0 0.00958436168730259
away O 0 0.007138305809348822
from O 0 0.007564916275441647
that O 0 0.007644863799214363
expected O 0 0.017071492969989777
. O 0 0.02265886403620243

Among O 0 0.02067996934056282
the O 0 0.010958687402307987
seven O 0 0.010533369146287441
contributing O 0 0.020877420902252197
centers O 0 0.012561824172735214
, O 0 0.005732061807066202
the O 0 0.0055931066162884235
proportion O 0 0.012749006040394306
of O 0 0.006256209220737219
patients O 1 0.9244769811630249
for O 0 0.005546428728848696
whom O 0 0.010673205368220806
the O 0 0.007252855226397514
observed O 0 0.034017711877822876
phenotype O 1 0.9865388870239258
did O 0 0.007435720879584551
not O 0 0.004289930686354637
match O 0 0.006123025435954332
the O 0 0.005826789420098066
predicted O 0 0.01958955079317093
phenotype O 1 0.848085343837738
was O 0 0.008462355472147465
4 O 0 0.011139091104269028
% O 0 0.009982749819755554
- O 0 0.017381738871335983
23 O 0 0.014124809764325619
% O 0 0.013656461611390114
( O 0 0.01598331891000271
P O 0 0.1140189990401268
< O 0 0.2152179479598999
. O 0 0.011434831656515598
0001 O 1 0.6135321855545044
) O 0 0.00858788937330246
, O 0 0.005006653256714344
suggesting O 0 0.011150619946420193
that O 0 0.004045319743454456
differences O 0 0.008324386551976204
in O 0 0.0041836961172521114
methods O 0 0.006911394651979208
used O 0 0.005337827373296022
for O 0 0.006770023610442877
mutation O 1 0.9918165802955627
detection O 1 0.6455197334289551
or O 0 0.02123025804758072
phenotype O 1 0.9971272349357605
classification O 0 0.15016520023345947
may O 0 0.00901805516332388
account O 0 0.007535731419920921
for O 0 0.0044041648507118225
a O 0 0.006494983099400997
considerable O 0 0.015160187147557735
proportion O 0 0.020247023552656174
of O 0 0.013522731140255928
genotype O 1 0.9812707901000977
- O 1 0.767419159412384
phenotype O 1 0.9922829270362854
inconsistencies O 0 0.24599215388298035
. O 0 0.04208807274699211

Our O 0 0.019168153405189514
data O 0 0.015500265173614025
indicate O 0 0.015222366899251938
that O 0 0.007039639167487621
the O 0 0.01139636617153883
PAH O 1 0.9985070824623108
- O 1 0.8412293791770935
mutation O 1 0.995173990726471
genotype O 1 0.9264078140258789
is O 0 0.011203315109014511
the O 0 0.0078705670312047
main O 0 0.013846546411514282
determinant O 0 0.1299399733543396
of O 0 0.01661038026213646
metabolic O 1 0.9950929880142212
phenotype O 1 0.995899498462677
in O 0 0.0150983314961195
most O 0 0.020851731300354004
patients O 1 0.9944314360618591
with O 0 0.1605900526046753
PAH B-Disease 1 0.9995986819267273
deficiency I-Disease 1 0.9996190071105957
. O 0 0.07545159012079239

In O 0 0.01248763408511877
the O 0 0.008002698421478271
present O 0 0.008378654718399048
study O 0 0.008944445289671421
, O 0 0.005104191601276398
the O 0 0.005573723930865526
classification O 0 0.01619279570877552
of O 0 0.009084951132535934
105 O 0 0.1515960544347763
PAH O 1 0.9990949630737305
mutations O 1 0.9955530762672424
may O 0 0.01309690997004509
allow O 0 0.007565824780613184
the O 0 0.0046094805002212524
prediction O 0 0.01085476391017437
of O 0 0.004574949853122234
the O 0 0.0066415369510650635
biochemical O 0 0.41144225001335144
phenotype O 1 0.9839222431182861
in O 0 0.008688663132488728
> O 0 0.4851454198360443
10 O 0 0.008296603336930275
, O 0 0.0060778213664889336
000 O 0 0.06097608432173729
genotypes O 1 0.9062854647636414
, O 0 0.005152022000402212
which O 0 0.004129622597247362
may O 0 0.004986117128282785
be O 0 0.00282278866507113
useful O 0 0.004751692526042461
for O 0 0.002981250872835517
the O 0 0.00425601564347744
management O 0 0.011827128008008003
of O 0 0.010013174265623093
hyperphenylalaninemia B-Disease 1 0.9096704721450806
in O 0 0.020313777029514313
newborns O 1 0.9871050119400024
. O 0 0.040047381073236465

Somatic O 1 0.8277141451835632
instability O 0 0.2415509968996048
of O 0 0.017655881121754646
the O 0 0.01816573739051819
CTG O 1 0.7392605543136597
repeat O 0 0.08659530431032181
in O 0 0.015263541601598263
mice O 1 0.8951505422592163
transgenic O 0 0.1150207594037056
for O 0 0.01180366612970829
the O 0 0.02838905341923237
myotonic B-Disease 1 0.999681830406189
dystrophy I-Disease 1 0.9998403787612915
region O 0 0.22469347715377808
is O 0 0.01292143389582634
age O 0 0.01883234642446041
dependent O 0 0.01794075407087803
but O 0 0.00517750671133399
not O 0 0.004892820026725531
correlated O 0 0.019550565630197525
to O 0 0.005084374453872442
the O 0 0.00735995639115572
relative O 0 0.023456385359168053
intertissue O 1 0.7943101525306702
transcription O 0 0.37639230489730835
levels O 0 0.03928370401263237
and O 0 0.02030905894935131
proliferative O 1 0.9874864816665649
capacities O 0 0.08927690982818604
. O 0 0.036596283316612244

A O 0 0.03588508442044258
( O 0 0.03168577700853348
CTG O 1 0.5325291752815247
) O 0 0.01854720711708069
nexpansion O 0 0.058644454926252365
in O 0 0.007601202931255102
the O 0 0.007473511155694723
3 O 0 0.014504616148769855
- O 0 0.034120094031095505
untranslated O 0 0.16362567245960236
region O 0 0.025655420497059822
( O 0 0.01709279790520668
UTR O 0 0.21976518630981445
) O 0 0.00966084934771061
of O 0 0.009092435240745544
the O 0 0.014771190471947193
DM O 1 0.9957147240638733
protein O 1 0.7486111521720886
kinase O 1 0.979901909828186
gene O 1 0.8946645855903625
( O 0 0.023800093680620193
DMPK O 1 0.5602462887763977
) O 0 0.012907038442790508
is O 0 0.009900643490254879
responsible O 0 0.021312424913048744
for O 0 0.02050902135670185
causing O 1 0.9937432408332825
myotonic B-Disease 1 0.999711811542511
dystrophy I-Disease 1 0.9999250173568726
( O 1 0.9227924942970276
DM B-Disease 1 0.9975670576095581
) O 0 0.052786000072956085
. O 0 0.04601745307445526

Major O 0 0.037564024329185486
instability O 0 0.2586522400379181
, O 0 0.009494073688983917
with O 0 0.006474826019257307
very O 0 0.007400698494166136
large O 0 0.008736728690564632
expansions O 0 0.015616715885698795
between O 0 0.007227431517094374
generations O 0 0.010962926782667637
and O 0 0.004964821506291628
high O 0 0.008053523488342762
levels O 0 0.012638179585337639
of O 0 0.009086741134524345
somatic O 1 0.9666827321052551
mosaicism O 1 0.9852893948554993
, O 0 0.01052582822740078
is O 0 0.010543353855609894
observed O 0 0.023766135796904564
in O 0 0.01835242472589016
patients O 1 0.9713262915611267
. O 0 0.03601835295557976

There O 0 0.016202157363295555
is O 0 0.009556897915899754
a O 0 0.009205054491758347
good O 0 0.01045388262718916
correlation O 0 0.019182097166776657
between O 0 0.009803269989788532
repeat O 0 0.026239311322569847
size O 0 0.012454853393137455
( O 0 0.008243046700954437
at O 0 0.005688428413122892
least O 0 0.007560298778116703
in O 0 0.007744022645056248
leucocytes O 1 0.5017644762992859
) O 0 0.010744397528469563
, O 0 0.008554394356906414
clinical O 1 0.755120575428009
severity O 1 0.9054706692695618
and O 0 0.009304187260568142
age O 0 0.024062996730208397
of O 0 0.02062305435538292
onset O 1 0.9955922961235046
. O 0 0.04496484622359276

The O 0 0.0424896739423275
trinucleotide O 1 0.9705945253372192
repeat O 1 0.662459135055542
instability O 1 0.8907806873321533
mechanisms O 0 0.14737080037593842
involved O 0 0.0198680330067873
in O 0 0.012243415229022503
DM B-Disease 1 0.994965136051178
and O 0 0.009226380847394466
other O 0 0.008670901879668236
human O 1 0.6574588418006897
genetic B-Disease 1 0.9983910918235779
diseases I-Disease 1 0.9996856451034546
are O 0 0.017517991364002228
unknown O 0 0.04615931957960129
. O 0 0.034117016941308975

We O 0 0.0286821611225605
studied O 0 0.03429639711976051
somatic O 1 0.6569033861160278
instability O 0 0.3081478178501129
by O 0 0.013696891255676746
measuring O 0 0.02635077014565468
the O 0 0.012517758645117283
CTG O 1 0.6139381527900696
repeat O 0 0.082419753074646
length O 0 0.013392633758485317
at O 0 0.00682125985622406
several O 0 0.006444479804486036
ages O 0 0.014008788391947746
in O 0 0.0066855731420218945
various O 0 0.009169879369437695
tissues O 0 0.3204926550388336
of O 0 0.009789226576685905
transgenic O 1 0.6030045747756958
mice O 1 0.9232004284858704
carrying O 0 0.01679195836186409
a O 0 0.012695048935711384
( O 0 0.016074245795607567
CTG O 1 0.6749622821807861
) O 0 0.013895444571971893
55expansion O 0 0.17151221632957458
surrounded O 0 0.014622620306909084
by O 0 0.00871188286691904
45 O 0 0.011773591861128807
kb O 0 0.023500848561525345
of O 0 0.007632069289684296
the O 0 0.009555259719491005
human O 0 0.09266405552625656
DM B-Disease 1 0.9960456490516663
region O 0 0.024494342505931854
, O 0 0.008094368502497673
using O 0 0.010921130888164043
small O 0 0.013896254822611809
- O 0 0.04505541920661926
pool O 0 0.06106415018439293
PCR O 0 0.27000299096107483
. O 0 0.04012322798371315

These O 0 0.024699261412024498
mice O 1 0.7120379209518433
have O 0 0.008656044490635395
been O 0 0.007608392741531134
shown O 0 0.009962504729628563
to O 0 0.005665326490998268
reproduce O 0 0.01808110438287258
the O 0 0.007962348870933056
intergenerational O 0 0.11432463675737381
and O 0 0.009495978243649006
somatic O 1 0.5102658867835999
instability O 0 0.16218487918376923
of O 0 0.007346264086663723
the O 0 0.008599568158388138
55 O 0 0.02536482736468315
CTG O 1 0.9096468091011047
repeat O 0 0.19345799088478088
suggesting O 0 0.02004130743443966
that O 0 0.0066610537469387054
surrounding O 0 0.012775643728673458
sequences O 0 0.015548588708043098
and O 0 0.00536487577483058
the O 0 0.006260040681809187
chromatin O 0 0.030694225803017616
environment O 0 0.012016268447041512
are O 0 0.0061646695248782635
involved O 0 0.012532049790024757
in O 0 0.011372254230082035
instability O 1 0.6765528917312622
mechanisms O 0 0.09312526136636734
. O 0 0.032170191407203674

As O 0 0.01585615612566471
observed O 0 0.01827496849000454
in O 0 0.006171626038849354
some O 0 0.004164671525359154
of O 0 0.004626010078936815
the O 0 0.006056927610188723
tissues O 1 0.9262356758117676
of O 0 0.016409849748015404
DM B-Disease 1 0.9998119473457336
patients O 1 0.9975900650024414
, O 0 0.007250119466334581
there O 0 0.005079277791082859
is O 0 0.005428845528513193
a O 0 0.006863562855869532
tendency O 0 0.025539252907037735
for O 0 0.0064282794483006
repeat O 0 0.03380204737186432
length O 0 0.014191444963216782
and O 0 0.007868221960961819
somatic O 1 0.9005089402198792
mosaicism O 1 0.9704033136367798
to O 0 0.006967984605580568
increase O 0 0.00962496642023325
with O 0 0.004813846666365862
the O 0 0.005348534788936377
age O 0 0.010517456568777561
of O 0 0.008300825022161007
the O 0 0.012185703963041306
mouse O 0 0.46649208664894104
. O 0 0.03820836544036865

Furthermore O 0 0.03551910072565079
, O 0 0.010724623687565327
we O 0 0.007337322924286127
observed O 0 0.014738456346094608
no O 0 0.007327559404075146
correlation O 0 0.01819494366645813
between O 0 0.009628785774111748
the O 0 0.010919726453721523
somatic O 1 0.9214413166046143
mutation O 1 0.9908243417739868
rate O 0 0.0320734977722168
and O 0 0.015148203819990158
tissue O 1 0.9919375777244568
proliferation O 1 0.5532686710357666
capacity O 0 0.03642147779464722
. O 0 0.031042123213410378

The O 0 0.039551638066768646
somatic O 1 0.9124743938446045
mutation O 1 0.9464288949966431
rates O 0 0.028030648827552795
in O 0 0.011124761775135994
different O 0 0.0093391640111804
tissues O 0 0.2309991866350174
were O 0 0.0044059427455067635
also O 0 0.004100381396710873
not O 0 0.004070655908435583
correlated O 0 0.016023024916648865
to O 0 0.004199516959488392
the O 0 0.005474777892231941
relative O 0 0.013685679994523525
inter O 0 0.021032599732279778
- O 0 0.09695377200841904
tissue O 1 0.9113978743553162
difference O 0 0.012925545684993267
in O 0 0.007396372966468334
transcriptional O 0 0.05204407125711441
levels O 0 0.011326547712087631
of O 0 0.004556048661470413
the O 0 0.004912575241178274
three O 0 0.006441259756684303
genes O 0 0.27783140540122986
( O 0 0.015681907534599304
DMAHP O 1 0.6251009702682495
, O 0 0.009292238391935825
DMPK O 0 0.35828331112861633
and O 0 0.007869841530919075
59 O 0 0.015929831191897392
) O 0 0.008886176161468029
surrounding O 0 0.01348611619323492
the O 0 0.00934541318565607
repeat O 0 0.04727260395884514
. O 0 0.016187412664294243
. O 0 0.026189453899860382

A O 0 0.04807443171739578
novel O 0 0.07883469015359879
missense O 1 0.956917941570282
mutation O 1 0.979698896408081
in O 0 0.022330550476908684
patients O 1 0.9709238409996033
from O 0 0.015474643558263779
a O 0 0.020855054259300232
retinoblastoma B-Disease 1 0.9959112405776978
pedigree O 1 0.7819833159446716
showing O 0 0.03489936888217926
only O 0 0.011986923404037952
mild O 1 0.8998083472251892
expression O 0 0.05002463608980179
of O 0 0.011731323786079884
the O 0 0.02698785439133644
tumor B-Disease 1 0.9992964267730713
phenotype O 1 0.9967357516288757
. O 0 0.047186192125082016

We O 0 0.013572079129517078
have O 0 0.009079298935830593
used O 0 0.009317386895418167
single O 0 0.015538949519395828
strand O 0 0.04339791089296341
conformation O 0 0.09663471579551697
polymorphism O 0 0.05003099516034126
analysis O 0 0.013968773186206818
to O 0 0.005254034418612719
study O 0 0.008561871945858002
the O 0 0.005692583508789539
27 O 0 0.012204383499920368
exons O 0 0.025376642122864723
of O 0 0.007363890763372183
the O 0 0.0104967150837183
RB1 O 1 0.9922611117362976
gene O 1 0.5111038088798523
in O 0 0.006424336228519678
individuals O 0 0.008658875711262226
from O 0 0.006150650326162577
a O 0 0.007797679863870144
family O 0 0.01543489657342434
showing O 0 0.030274348333477974
mild O 1 0.9544258117675781
expression O 0 0.04560837522149086
of O 0 0.011587833054363728
the O 0 0.020952651277184486
retinoblastoma B-Disease 1 0.9976644515991211
phenotype O 1 0.9951320886611938
. O 0 0.05035855993628502

In O 0 0.01803629659116268
this O 0 0.011435020714998245
family O 0 0.027755916118621826
affected O 0 0.3694606423377991
individuals O 0 0.02766592800617218
developed O 0 0.1104419082403183
unilateral B-Disease 1 0.8777828216552734
tumors I-Disease 1 0.9985190033912659
and O 0 0.005146422889083624
, O 0 0.004082784987986088
as O 0 0.0036057918332517147
a O 0 0.0047006853856146336
result O 0 0.007197602652013302
of O 0 0.0054151504300534725
linkage O 0 0.15170708298683167
analysis O 0 0.01324467733502388
, O 0 0.010095478966832161
unaffected O 1 0.9357880353927612
mutation O 1 0.9954907298088074
carriers O 0 0.14129020273685455
were O 0 0.005552059970796108
also O 0 0.005776728969067335
identified O 0 0.010671422816812992
within O 0 0.009904645383358002
the O 0 0.01236006524413824
pedigree O 0 0.16075260937213898
. O 0 0.03029773384332657

A O 0 0.030271638184785843
single O 0 0.025131236761808395
band O 0 0.023188769817352295
shift O 0 0.02752223052084446
using O 0 0.014407054521143436
SSCP O 0 0.11818590760231018
was O 0 0.008592246100306511
identified O 0 0.011593436822295189
in O 0 0.007269043941050768
exon O 0 0.04893983528017998
21 O 0 0.01152070239186287
which O 0 0.006087263114750385
resulted O 0 0.012148297391831875
in O 0 0.006372371688485146
a O 0 0.012339598499238491
missense O 1 0.958111047744751
mutation O 1 0.9640383720397949
converting O 0 0.025705445557832718
a O 0 0.019262468442320824
cys O 1 0.9606600999832153
- O 0 0.3418944180011749
- O 0 0.4598214030265808
> O 1 0.7892937660217285
arg O 0 0.4305316209793091
at O 0 0.015328464098274708
nucleotide O 0 0.03683207929134369
position O 0 0.012233039364218712
28 O 0 0.013654219917953014
in O 0 0.009547136723995209
the O 0 0.013467807322740555
exon O 0 0.08657384663820267
. O 0 0.03635268658399582

The O 0 0.03676031157374382
mutation O 1 0.8825567364692688
destroyed O 0 0.03676033020019531
an O 0 0.020778311416506767
NdeI O 1 0.685947835445404
restriction O 0 0.07380428165197372
enzyme O 0 0.15626560151576996
site O 0 0.04089686647057533
. O 0 0.03562851622700691

Analysis O 0 0.026325561106204987
of O 0 0.007419121451675892
all O 0 0.00546745490282774
family O 0 0.00985079538077116
members O 0 0.0065877120941877365
demonstrated O 0 0.01105640921741724
that O 0 0.005524431820958853
the O 0 0.010433915071189404
missense O 1 0.9830516576766968
mutation O 1 0.9917804598808289
co O 0 0.10193108022212982
- O 0 0.14000017940998077
segregated O 0 0.09286372363567352
with O 0 0.012240849435329437
patients O 1 0.9982302784919739
with O 0 0.043227728456258774
tumors B-Disease 1 0.9992703795433044
or O 0 0.00899445079267025
who O 0 0.00534752057865262
, O 0 0.003501764265820384
as O 0 0.003100306959822774
a O 0 0.0045913089998066425
result O 0 0.007866045460104942
of O 0 0.004981981124728918
linkage O 0 0.040206484496593475
analysis O 0 0.01190310437232256
had O 0 0.006471654865890741
been O 0 0.0065530696883797646
predicted O 0 0.011781955137848854
to O 0 0.006503517273813486
carry O 0 0.014986474066972733
the O 0 0.017897939309477806
predisposing O 1 0.9300790429115295
mutation O 1 0.9840447902679443
. O 0 0.041415341198444366

These O 0 0.013519315980374813
observations O 0 0.016201945021748543
point O 0 0.007532864343374968
to O 0 0.004046966787427664
another O 0 0.007320175413042307
region O 0 0.009895723313093185
of O 0 0.006382469553500414
the O 0 0.010547717101871967
RB1 O 1 0.9954850673675537
gene O 1 0.861449122428894
where O 0 0.014060751534998417
mutations O 1 0.8989900350570679
only O 0 0.0058121453039348125
modify O 0 0.013497953303158283
the O 0 0.004882008768618107
function O 0 0.007085892837494612
of O 0 0.003766975598409772
the O 0 0.0050962623208761215
gene O 0 0.1653362661600113
and O 0 0.003871495835483074
raise O 0 0.00830860435962677
important O 0 0.005378597881644964
questions O 0 0.0073250108398497105
for O 0 0.00526634743437171
genetic O 1 0.6939659714698792
counseling O 0 0.4307532012462616
in O 0 0.006115015596151352
families O 0 0.01025163009762764
with O 0 0.00679177138954401
these O 0 0.007947109639644623
distinctive O 0 0.1518278270959854
phenotypes O 1 0.9714493751525879
. O 0 0.01855144463479519
. O 0 0.026519233360886574

Maternal B-Disease 1 0.9658915996551514
disomy I-Disease 1 0.9342207312583923
and O 0 0.04592354968190193
Prader B-Disease 1 0.99818354845047
- I-Disease 1 0.9897556900978088
Willi I-Disease 1 0.999453604221344
syndrome I-Disease 1 0.9999217987060547
consistent O 0 0.15941886603832245
with O 0 0.02296505495905876
gamete O 1 0.9737381339073181
complementation O 1 0.9378467798233032
in O 0 0.011552735231816769
a O 0 0.011411021463572979
case O 0 0.012640507891774178
of O 0 0.0119398208335042
familial O 1 0.9977027773857117
translocation O 1 0.9654337167739868
( O 0 0.019131669774651527
3 O 0 0.01413134578615427
; O 0 0.010024826973676682
15 O 0 0.011221141554415226
) O 0 0.011912317015230656
( O 0 0.013962876051664352
p25 O 0 0.45820367336273193
; O 0 0.01654680445790291
q11 O 0 0.12789268791675568
. O 0 0.011498834006488323
2 O 0 0.01728385128080845
) O 0 0.019064070656895638
. O 0 0.02302026003599167

Maternal B-Disease 1 0.9853523373603821
uniparental I-Disease 1 0.9937527775764465
disomy I-Disease 1 0.981642484664917
( I-Disease 0 0.08186826854944229
UPD I-Disease 1 0.9808043837547302
) I-Disease 0 0.016379907727241516
for I-Disease 0 0.0110769746825099
chromosome I-Disease 1 0.8410233855247498
15 I-Disease 0 0.01025481428951025
is O 0 0.0051039159297943115
responsible O 0 0.008551026694476604
for O 0 0.003997017629444599
an O 0 0.004835041239857674
estimated O 0 0.009939318522810936
30 O 0 0.007876161485910416
% O 0 0.00737963430583477
of O 0 0.006009454373270273
cases O 0 0.017586354166269302
of O 0 0.017843738198280334
Prader B-Disease 1 0.9991897940635681
- I-Disease 1 0.9967449903488159
Willi I-Disease 1 0.9998503923416138
syndrome I-Disease 1 0.9999700784683228
( O 1 0.9260838031768799
PWS B-Disease 1 0.997249186038971
) O 0 0.04834315925836563
. O 0 0.04346247389912605

We O 0 0.013249733485281467
report O 0 0.012328562326729298
on O 0 0.005831296555697918
an O 0 0.004923748318105936
unusual O 0 0.01006210595369339
case O 0 0.009412598796188831
of O 0 0.007592460140585899
maternal B-Disease 1 0.9774878025054932
disomy I-Disease 1 0.8547334671020508
15 I-Disease 0 0.012619838118553162
in O 0 0.008839529938995838
PWS B-Disease 1 0.9873104095458984
that O 0 0.005911472253501415
is O 0 0.005491411313414574
most O 0 0.004901794716715813
consistent O 0 0.007841304875910282
with O 0 0.005369966849684715
adjacent O 0 0.010073102079331875
- O 0 0.015317562967538834
1 O 0 0.00998756755143404
segregation O 0 0.016870928928256035
of O 0 0.0058263689279556274
a O 0 0.009662561118602753
paternal O 1 0.8155592083930969
t O 1 0.7626920938491821
( O 0 0.013688885606825352
3 O 0 0.009970871731638908
; O 0 0.007618797942996025
15 O 0 0.00931861437857151
) O 0 0.009133592247962952
( O 0 0.012599509209394455
p25 O 0 0.49626395106315613
; O 0 0.012260004878044128
q11 O 0 0.04874161630868912
. O 0 0.008082402870059013
2 O 0 0.010095140896737576
) O 0 0.008514356799423695
with O 0 0.00797158945351839
simultaneous O 0 0.03781511262059212
maternal O 1 0.9742826819419861
meiotic O 1 0.9908418655395508
nondisjunction O 1 0.9249497652053833
for O 0 0.024758292362093925
chromosome O 1 0.9549236297607422
15 O 0 0.037978675216436386
. O 0 0.036582931876182556

The O 0 0.026849012821912766
patient O 1 0.9607256650924683
( O 0 0.028674215078353882
J O 1 0.6113977432250977
. O 0 0.00959694478660822
B O 0 0.02225002646446228
. O 0 0.005207369569689035
) O 0 0.005779257044196129
, O 0 0.003741323249414563
a O 0 0.004913232754915953
17 O 0 0.008708198554813862
- O 0 0.014250698499381542
year O 0 0.008542565628886223
- O 0 0.01964706927537918
old O 0 0.013540725223720074
white O 0 0.017251789569854736
male O 0 0.04766437038779259
with O 0 0.008636302314698696
PWS B-Disease 1 0.9956024885177612
, O 0 0.00654453644528985
was O 0 0.004585186950862408
found O 0 0.005061066709458828
to O 0 0.0031498486641794443
have O 0 0.004512128885835409
47 O 0 0.011850390583276749
chromosomes O 0 0.024332432076334953
with O 0 0.005696214269846678
a O 0 0.009006219916045666
supernumerary O 1 0.5873451828956604
, O 0 0.010268247686326504
paternal O 1 0.7672956585884094
der O 0 0.10978467017412186
( O 0 0.011026985011994839
15 O 0 0.007753925863653421
) O 0 0.005825044121593237
consisting O 0 0.006632910575717688
of O 0 0.004002817440778017
the O 0 0.004768156912177801
short O 0 0.010869668796658516
arm O 0 0.023820720613002777
and O 0 0.005376162473112345
the O 0 0.009091810323297977
proximal O 1 0.9590878486633301
long O 0 0.024104487150907516
arm O 0 0.04590161517262459
of O 0 0.011712653562426567
chromosome O 1 0.9673223495483398
15 O 0 0.016967805102467537
, O 0 0.010976388119161129
and O 0 0.016047101467847824
distal O 1 0.9901337027549744
chromosome O 1 0.9876111149787903
arm O 1 0.7395411729812622
3p O 1 0.6947730183601379
. O 0 0.049082785844802856

The O 0 0.02851616032421589
t O 0 0.320148766040802
( O 0 0.015810366719961166
3 O 0 0.01045827753841877
; O 0 0.0067380862310528755
15 O 0 0.006867676042020321
) O 0 0.004867056384682655
was O 0 0.0035641479771584272
present O 0 0.0038689111825078726
in O 0 0.003273152047768235
the O 0 0.0035759012680500746
balanced O 0 0.008417665027081966
state O 0 0.005291288252919912
in O 0 0.005203956738114357
the O 0 0.007433820515871048
patients O 1 0.9639993906021118
father O 0 0.017831241711974144
and O 0 0.00928860530257225
a O 0 0.015620088204741478
sister O 0 0.04050907492637634
. O 0 0.032863616943359375

Fluorescent O 0 0.12772853672504425
in O 0 0.026845116168260574
situ O 0 0.18285925686359406
hybridization O 0 0.05718435347080231
analysis O 0 0.022630097344517708
demonstrated O 0 0.02129972167313099
that O 0 0.00807751901447773
the O 0 0.013100139796733856
PWS B-Disease 1 0.9819483757019043
critical O 0 0.03184365853667259
region O 0 0.021662136539816856
resided O 0 0.018449151888489723
on O 0 0.006155351642519236
the O 0 0.007824639789760113
derivative O 0 0.04068062826991081
chromosome O 1 0.781221330165863
3 O 0 0.009154416620731354
and O 0 0.0038334322161972523
that O 0 0.0031655787024646997
there O 0 0.003284318605437875
was O 0 0.004426476079970598
no O 0 0.006174296606332064
deletion O 0 0.05679739639163017
of O 0 0.006729545537382364
the O 0 0.009088056161999702
PWS B-Disease 1 0.9872103929519653
region O 0 0.01783006452023983
on O 0 0.0060673970729112625
the O 0 0.006834277417510748
normal O 0 0.017317499965429306
pair O 0 0.012536239810287952
of O 0 0.009719733148813248
15s O 0 0.23423321545124054
present O 0 0.017388492822647095
in O 0 0.01821875385940075
J O 1 0.7625304460525513
. O 0 0.033481571823358536

B O 0 0.16507448256015778
. O 0 0.06905603408813477

Methylation O 0 0.09509754925966263
analysis O 0 0.03704501688480377
at O 0 0.018596738576889038
exon O 0 0.05546649545431137
alpha O 0 0.026996498927474022
of O 0 0.006922687869518995
the O 0 0.0077482969500124454
small O 0 0.013507911935448647
nuclear O 0 0.020753005519509315
ribonucleoprotein O 0 0.49871835112571716
- O 0 0.04722565412521362
associated O 0 0.03318300470709801
polypeptide O 1 0.6662047505378723
N O 0 0.0515173077583313
( O 0 0.020548205822706223
SNRPN O 1 0.7161523699760437
) O 0 0.014187296852469444
gene O 0 0.11528300493955612
showed O 0 0.014697769656777382
a O 0 0.009932001121342182
pattern O 0 0.02130206674337387
characteristic O 0 0.017142225056886673
of O 0 0.005489975214004517
only O 0 0.005712143611162901
the O 0 0.009230164811015129
maternal O 1 0.9674181938171387
chromosome O 1 0.9796857237815857
15 O 0 0.021519703790545464
in O 0 0.018969925120472908
J O 1 0.7574529647827148
. O 0 0.032776426523923874

B O 0 0.16768573224544525
. O 0 0.07326709479093552

Maternal B-Disease 1 0.9720396399497986
disomy I-Disease 1 0.730322539806366
was O 0 0.019127806648612022
confirmed O 0 0.029287224635481834
by O 0 0.019059162586927414
polymerase O 1 0.5659458041191101
chain O 0 0.09458592534065247
reaction O 0 0.030482839792966843
analysis O 0 0.016229776665568352
of O 0 0.010931902565062046
microsatellite O 1 0.7450908422470093
repeats O 0 0.03715793788433075
at O 0 0.011413726024329662
the O 0 0.012135765515267849
gamma O 0 0.13081324100494385
- O 0 0.19514250755310059
aminobutyric O 1 0.8827898502349854
acid O 1 0.9248194098472595
receptor O 1 0.9730632305145264
beta3 O 1 0.9391379952430725
subunit O 1 0.5956896543502808
( O 0 0.042744580656290054
GABRB3 O 1 0.6258816719055176
) O 0 0.04320480301976204
locus O 1 0.7048559784889221
. O 0 0.050818320363759995

A O 0 0.03669619560241699
niece O 0 0.21854716539382935
( O 0 0.02554592862725258
B O 0 0.03427959606051445
. O 0 0.008793340064585209
B O 0 0.019422730430960655
. O 0 0.005194343160837889
) O 0 0.005172575358301401
with O 0 0.004272388760000467
45 O 0 0.007892932742834091
chromosomes O 0 0.020215779542922974
and O 0 0.004652534611523151
the O 0 0.005061702337116003
derivative O 0 0.015822051092982292
3 O 0 0.0074510169215500355
but O 0 0.004189498722553253
without O 0 0.005190773867070675
the O 0 0.005577314645051956
der O 0 0.03572911396622658
( O 0 0.009531776420772076
15 O 0 0.009135480970144272
) O 0 0.008936767466366291
demonstrated O 0 0.014461779035627842
a O 0 0.010354182682931423
phenotype O 1 0.9534844160079956
consistent O 0 0.014502081088721752
with O 0 0.00598306255415082
that O 0 0.005019671283662319
reported O 0 0.011792441830039024
for O 0 0.007117343135178089
haploinsufficiency O 0 0.2270207554101944
of O 0 0.01287917885929346
distal O 1 0.9885092377662659
3 O 0 0.03586919233202934
p O 0 0.07992400974035263
. O 0 0.03528900817036629

Uniparental B-Disease 1 0.9933634996414185
disomy I-Disease 1 0.9545353055000305
associated O 0 0.04185584560036659
with O 0 0.01540407259017229
unbalanced O 0 0.14948667585849762
segregation O 0 0.046340346336364746
of O 0 0.011202005669474602
non O 0 0.04606638103723526
- O 0 0.4548454284667969
Robertsonian O 1 0.9713014364242554
translocations O 1 0.8942691683769226
has O 0 0.01047319732606411
been O 0 0.007847299799323082
reported O 0 0.011097203008830547
previously O 0 0.00601879321038723
but O 0 0.0031291295308619738
has O 0 0.003077099798247218
not O 0 0.0023654960095882416
, O 0 0.002261561807245016
to O 0 0.0024010739289224148
our O 0 0.0033410340547561646
knowledge O 0 0.004638912156224251
, O 0 0.0032551498152315617
been O 0 0.004408231470733881
observed O 0 0.0086800092831254
in O 0 0.005207791458815336
a O 0 0.007474328391253948
case O 0 0.01366774644702673
of O 0 0.01780254952609539
PWS B-Disease 1 0.9906446933746338
. O 0 0.04423236474394798

Furthermore O 0 0.04287942126393318
, O 0 0.012069473043084145
our O 0 0.009368941187858582
findings O 0 0.014921355061233044
are O 0 0.005462741944938898
best O 0 0.009296748787164688
interpreted O 0 0.014335236512124538
as O 0 0.009349807165563107
true O 0 0.021522512659430504
gamete O 1 0.8956449627876282
complementation O 1 0.9834381937980652
resulting O 0 0.2657927870750427
in O 0 0.025161471217870712
maternal B-Disease 1 0.9836817979812622
UPD I-Disease 1 0.9906322956085205
15 I-Disease 0 0.057375285774469376
and O 0 0.045773111283779144
PWS B-Disease 1 0.9754258990287781

Schwartz B-Disease 1 0.8987752199172974
- I-Disease 1 0.932861328125
Jampel I-Disease 1 0.992679238319397
syndrome I-Disease 1 0.999755322933197
type I-Disease 0 0.43118172883987427
2 I-Disease 0 0.02285027503967285
and O 0 0.016478851437568665
Stuve B-Disease 1 0.989781379699707
- I-Disease 1 0.9871194362640381
Wiedemann I-Disease 1 0.9981635212898254
syndrome I-Disease 1 0.9998852014541626
: O 0 0.019230401143431664
a O 0 0.01175620686262846
case O 0 0.012581638060510159
for O 0 0.009994704276323318
" O 0 0.016356054693460464
lumping O 0 0.08875521272420883
" O 0 0.024218909442424774
. O 0 0.02737199142575264

Recent O 0 0.03710523247718811
studies O 0 0.021708838641643524
demonstrated O 0 0.016742466017603874
the O 0 0.00667624082416296
existence O 0 0.0100575415417552
of O 0 0.00528687285259366
a O 0 0.009155821986496449
genetically O 0 0.13284024596214294
distinct O 0 0.019942402839660645
, O 0 0.006933530792593956
usually O 0 0.011609654873609543
lethal O 0 0.09113668650388718
form O 0 0.009739824570715427
of O 0 0.006229540798813105
the O 0 0.00932532548904419
Schwartz B-Disease 1 0.783595621585846
- I-Disease 1 0.9618285894393921
Jampel I-Disease 1 0.9988844990730286
syndrome I-Disease 1 0.9999622106552124
( O 1 0.7151506543159485
SJS B-Disease 1 0.9987452030181885
) O 0 0.02325793169438839
of O 0 0.01724993623793125
myotonia B-Disease 1 0.999093770980835
and O 0 0.07442270219326019
skeletal B-Disease 1 0.998766303062439
dysplasia I-Disease 1 0.9996176958084106
, O 0 0.010491812601685524
which O 0 0.00864392425864935
we O 0 0.008965934626758099
called O 0 0.026959547773003578
SJS B-Disease 1 0.9957958459854126
type I-Disease 0 0.23557816445827484
2 I-Disease 0 0.03019954264163971
. O 0 0.03200116008520126

This O 0 0.031322408467531204
disorder O 1 0.9971529245376587
is O 0 0.014050344005227089
reminiscent O 0 0.029747670516371727
of O 0 0.009350000880658627
another O 0 0.014315038919448853
rare O 0 0.11282502114772797
condition O 0 0.1367347538471222
, O 0 0.009306482039391994
the O 0 0.01205543801188469
Stuve B-Disease 1 0.9884203672409058
- I-Disease 1 0.9790505766868591
Wiedemann I-Disease 1 0.9971951246261597
syndrome I-Disease 1 0.9999099969863892
( O 0 0.3071844279766083
SWS B-Disease 1 0.9924476146697998
) O 0 0.01419870462268591
, O 0 0.006535976193845272
which O 0 0.007063296623528004
comprises O 0 0.0151583943516016
campomelia B-Disease 0 0.29575443267822266
at O 0 0.01333291083574295
birth O 0 0.24817441403865814
with O 0 0.022075146436691284
skeletal B-Disease 1 0.9986214637756348
dysplasia I-Disease 1 0.9997602105140686
, O 0 0.03519474342465401
contractures B-Disease 1 0.9902024269104004
, O 0 0.012152653187513351
and O 0 0.010011992417275906
early B-Disease 0 0.0229779165238142
death I-Disease 0 0.051402073353528976
. O 0 0.03455987572669983

To O 0 0.014836401678621769
test O 0 0.015497572720050812
for O 0 0.007175716571509838
possible O 0 0.014310088008642197
nosologic O 0 0.09447596222162247
identity O 0 0.01879713498055935
between O 0 0.010422218590974808
these O 0 0.009361823089420795
disorders O 1 0.9978892207145691
, O 0 0.005270388443022966
we O 0 0.003491185838356614
reviewed O 0 0.0061130099929869175
the O 0 0.0032749322708696127
literature O 0 0.00499795051291585
and O 0 0.002746745478361845
obtained O 0 0.004222940653562546
a O 0 0.004073695745319128
follow O 0 0.006249160971492529
- O 0 0.008068220689892769
up O 0 0.003802632912993431
of O 0 0.002842878457158804
the O 0 0.0030748783610761166
only O 0 0.0032009570859372616
two O 0 0.004994567018002272
surviving O 0 0.04206491634249687
patients O 1 0.9419413805007935
, O 0 0.0055047147907316685
one O 0 0.0067058103159070015
with O 0 0.00979168713092804
SJS B-Disease 1 0.9978018403053284
type I-Disease 0 0.06187360733747482
2 I-Disease 0 0.00931682251393795
at O 0 0.006251710467040539
age O 0 0.008951765485107899
10 O 0 0.006595805287361145
years O 0 0.006095380522310734
and O 0 0.00383268715813756
another O 0 0.006871586199849844
with O 0 0.008129117079079151
SWS B-Disease 1 0.9511356949806213
at O 0 0.0115053066983819
age O 0 0.017407672479748726
7 O 0 0.016908705234527588
years O 0 0.016949566081166267
. O 0 0.024309592321515083

Patients O 1 0.9878930449485779
reported O 0 0.03486553579568863
as O 0 0.010932856239378452
having O 0 0.017438815906643867
either O 0 0.030815180391073227
neonatal O 1 0.9991926550865173
SJS B-Disease 1 0.9984539747238159
or O 0 0.034870631992816925
SWS B-Disease 1 0.9808692932128906
presented O 0 0.01269217487424612
a O 0 0.008510075509548187
combination O 0 0.017000174149870872
of O 0 0.008055606856942177
a O 0 0.015367548912763596
severe O 1 0.9968084692955017
, O 0 0.08191607147455215
prenatal O 1 0.9990206956863403
- O 1 0.9950849413871765
onset O 1 0.9998645782470703
neuromuscular B-Disease 1 0.9999358654022217
disorder I-Disease 1 0.9999228715896606
( O 1 0.7521073222160339
with O 1 0.512822687625885
congenital B-Disease 1 0.9999579191207886
joint I-Disease 1 0.9927505254745483
contractures I-Disease 1 0.9997474551200867
, O 1 0.5825015306472778
respiratory O 1 0.9998793601989746
and O 0 0.018797338008880615
feeding O 1 0.8347265720367432
difficulties O 0 0.3891463875770569
, O 0 0.010145403444766998
tendency O 0 0.4196629524230957
to O 0 0.008780532516539097
hyperthermia B-Disease 1 0.9894373416900635
, O 0 0.007117811590433121
and O 0 0.005993607919663191
frequent O 0 0.07312684506177902
death O 0 0.05171065032482147
in O 0 0.009771767072379589
infancy O 0 0.3988114595413208
) O 0 0.009380384348332882
with O 0 0.007765472866594791
a O 0 0.01253256294876337
distinct O 0 0.0368659533560276
campomelic B-Disease 1 0.9695595502853394
- I-Disease 1 0.9574886560440063
metaphyseal I-Disease 1 0.9927311539649963
skeletal I-Disease 1 0.9965633749961853
dysplasia I-Disease 1 0.9987502098083496
. O 0 0.06947023421525955

The O 0 0.01860836334526539
similarity O 0 0.022632881999015808
of O 0 0.006803521886467934
the O 0 0.008279318921267986
clinical O 0 0.2619246244430542
and O 0 0.007310272194445133
radiographic O 1 0.6843901872634888
findings O 0 0.015894586220383644
is O 0 0.005781589075922966
so O 0 0.005694796796888113
extensive O 0 0.009789097122848034
that O 0 0.004594572354108095
these O 0 0.006885469425469637
disorders O 1 0.9983457326889038
appear O 0 0.010175740346312523
to O 0 0.004462008364498615
be O 0 0.0042168013751506805
a O 0 0.008341961540281773
single O 0 0.01845073327422142
entity O 0 0.03562154993414879
. O 0 0.02733549475669861

The O 0 0.01769881695508957
follow O 0 0.01841210201382637
- O 0 0.02093449980020523
up O 0 0.00881282426416874
observation O 0 0.012407185509800911
of O 0 0.0047672889195382595
an O 0 0.00547110615298152
identical O 0 0.010344645008444786
and O 0 0.0051208180375397205
unique O 0 0.010802132077515125
pattern O 0 0.02774723991751671
of O 0 0.012792072258889675
progressive O 1 0.9948871731758118
bone B-Disease 1 0.9997676014900208
dysplasia I-Disease 1 0.999612033367157
in O 0 0.009206429123878479
the O 0 0.007641826290637255
two O 0 0.008846823126077652
patients O 1 0.9918362498283386
( O 0 0.010484879836440086
one O 0 0.006728324107825756
with O 0 0.009764750488102436
SJS B-Disease 1 0.9960766434669495
type I-Disease 0 0.053675465285778046
2 I-Disease 0 0.009488738141953945
, O 0 0.005358536262065172
one O 0 0.005567318294197321
with O 0 0.008496430702507496
SWS B-Disease 1 0.9647783637046814
) O 0 0.014150811359286308
surviving O 0 0.026031875982880592
beyond O 0 0.018172718584537506
infancy O 0 0.20171116292476654
adds O 0 0.015600738115608692
to O 0 0.004683509003371
the O 0 0.004660561680793762
evidence O 0 0.007003165781497955
in O 0 0.006544803269207478
favor O 0 0.012169551104307175
of O 0 0.00997829157859087
identity O 0 0.030060796067118645
. O 0 0.026122286915779114

The O 0 0.026153936982154846
hypothesis O 0 0.05746715888381004
that O 0 0.018056506291031837
SWS B-Disease 1 0.9865743517875671
and O 0 0.019311580806970596
SJS B-Disease 1 0.9954611659049988
type I-Disease 0 0.05011916160583496
2 I-Disease 0 0.010735374875366688
are O 0 0.004988932982087135
the O 0 0.005964929703623056
same O 0 0.011019145138561726
disorder O 1 0.998619794845581
should O 0 0.007388676051050425
be O 0 0.0058090765960514545
testable O 0 0.022719446569681168
by O 0 0.009889945387840271
molecular O 0 0.028391610831022263
methods O 0 0.015972750261425972
. O 0 0.013191387988626957
. O 0 0.021421846002340317

A O 0 0.04339813441038132
mouse O 0 0.40645235776901245
model O 0 0.031898144632577896
of O 0 0.024262523278594017
severe O 1 0.9991406202316284
von B-Disease 1 0.9990600943565369
Willebrand I-Disease 1 0.9999244213104248
disease I-Disease 1 0.9999264478683472
: O 1 0.6937620639801025
defects O 1 0.9978819489479065
in O 0 0.056123074144124985
hemostasis O 1 0.996404767036438
and O 0 0.1363663375377655
thrombosis B-Disease 1 0.9990227222442627
. O 0 0.06848234683275223

von B-Disease 1 0.9667491316795349
Willebrand I-Disease 1 0.997583270072937
factor I-Disease 1 0.8634794354438782
( I-Disease 0 0.29434823989868164
vWf I-Disease 1 0.9912903308868408
) I-Disease 1 0.6792591214179993
deficiency I-Disease 1 0.9997461438179016
causes O 1 0.9994984865188599
severe O 1 0.9997654557228088
von B-Disease 1 0.999110996723175
Willebrand I-Disease 1 0.9998890161514282
disease I-Disease 1 0.9998570680618286
in O 0 0.06029623746871948
humans O 1 0.7710385322570801
. O 0 0.04136237874627113

We O 0 0.017696691676974297
generated O 0 0.02604765258729458
a O 0 0.01644991897046566
mouse O 0 0.10174278169870377
model O 0 0.014706805348396301
for O 0 0.008731609210371971
this O 0 0.01143767312169075
disease O 1 0.996647298336029
by O 0 0.014016471803188324
using O 0 0.02082417905330658
gene O 1 0.6849966049194336
targeting O 0 0.061719052493572235
. O 0 0.03549044579267502

vWf B-Disease 1 0.9802488684654236
- I-Disease 1 0.8080440163612366
deficient I-Disease 1 0.9852403402328491
mice O 1 0.9652245044708252
appeared O 0 0.02383766695857048
normal O 0 0.022808995097875595
at O 0 0.009263386949896812
birth O 0 0.027608949691057205
; O 0 0.00660349614918232
they O 0 0.003964303061366081
were O 0 0.004543958697468042
viable O 0 0.017927180975675583
and O 0 0.010832030326128006
fertile O 0 0.1588761955499649
. O 0 0.0317244678735733

Neither O 0 0.12460342049598694
vWf O 1 0.937383770942688
nor O 0 0.14883430302143097
vWf O 1 0.9857003688812256
propolypeptide O 1 0.9624825119972229
( O 0 0.15772372484207153
von B-Disease 1 0.9682666063308716
Willebrand I-Disease 1 0.9990711212158203
antigen O 1 0.9945214986801147
II O 0 0.19862034916877747
) O 0 0.012567740865051746
were O 0 0.007643315475434065
detectable O 0 0.17045293748378754
in O 0 0.00933450274169445
plasma O 0 0.09170102328062057
, O 0 0.009518268518149853
platelets O 1 0.9748900532722473
, O 0 0.010569151490926743
or O 0 0.01528931688517332
endothelial O 1 0.9774980545043945
cells O 0 0.15295971930027008
of O 0 0.01024563331156969
the O 0 0.01719558797776699
homozygous O 1 0.9562373161315918
mutant O 1 0.9724985361099243
mice O 1 0.9465382099151611
. O 0 0.04765433445572853

The O 0 0.043470341712236404
mutant O 1 0.961060643196106
mice O 1 0.9834359288215637
exhibited O 1 0.5020274519920349
defects O 1 0.9908722043037415
in O 0 0.017231039702892303
hemostasis O 1 0.990348219871521
with O 0 0.012177878059446812
a O 0 0.01585662178695202
highly O 0 0.11203308403491974
prolonged O 1 0.9955664277076721
bleeding O 1 0.9993257522583008
time O 0 0.012654339894652367
and O 0 0.011591853573918343
spontaneous O 1 0.9475126266479492
bleeding O 1 0.9977397918701172
events O 0 0.014279516413807869
in O 0 0.007302552927285433
approximately O 0 0.012453898787498474
10 O 0 0.010511708445847034
% O 0 0.013060049153864384
of O 0 0.013729116879403591
neonates O 1 0.9394193291664124
. O 0 0.036349378526210785

As O 0 0.014187277294695377
in O 0 0.009251582436263561
the O 0 0.01090468280017376
human O 0 0.3058618903160095
disease O 1 0.9993195533752441
, O 0 0.0073250941932201385
the O 0 0.007411782164126635
factor O 0 0.11321146041154861
VIII O 1 0.5615308880805969
level O 0 0.010875934734940529
in O 0 0.006427874322980642
these O 0 0.006503139156848192
mice O 1 0.6772128939628601
was O 0 0.0074392203241586685
reduced O 0 0.013331462629139423
strongly O 0 0.00799285527318716
as O 0 0.004172120243310928
a O 0 0.005166174378246069
result O 0 0.006770689971745014
of O 0 0.00372019549831748
the O 0 0.00468473881483078
lack O 0 0.009779865853488445
of O 0 0.0069670178927481174
protection O 0 0.019144868478178978
provided O 0 0.01569310575723648
by O 0 0.02159993350505829
vWf O 1 0.9311161637306213
. O 0 0.04483691602945328

Defective O 1 0.993266224861145
thrombosis B-Disease 1 0.9992372989654541
in O 0 0.0351005420088768
mutant O 1 0.9853107929229736
mice O 1 0.9282023310661316
was O 0 0.010433057323098183
also O 0 0.007400158327072859
evident O 0 0.014925617724657059
in O 0 0.00611389335244894
an O 0 0.006351265590637922
in O 0 0.007980052381753922
vivo O 0 0.0916668251156807
model O 0 0.02156466618180275
of O 0 0.02112662047147751
vascular B-Disease 1 0.9986407160758972
injury I-Disease 1 0.9903370141983032
. O 0 0.04544122889637947

In O 0 0.01985473744571209
this O 0 0.011943776160478592
model O 0 0.015964657068252563
, O 0 0.008040775544941425
the O 0 0.010470381006598473
exteriorized O 1 0.644340991973877
mesentery O 1 0.9327347874641418
was O 0 0.018270067870616913
superfused O 1 0.6431015729904175
with O 0 0.016283784061670303
ferric O 1 0.9758156538009644
chloride O 0 0.2085740566253662
and O 0 0.008668247610330582
the O 0 0.0101633220911026
accumulation O 0 0.047965068370103836
of O 0 0.015363956801593304
fluorescently O 1 0.9178236722946167
labeled O 0 0.4671649932861328
platelets O 1 0.9688845276832581
was O 0 0.017188208177685738
observed O 0 0.027287308126688004
by O 0 0.019065741449594498
intravital O 0 0.45919421315193176
microscopy O 0 0.07895029336214066
. O 0 0.037621308118104935

We O 0 0.020012084394693375
conclude O 0 0.026284310966730118
that O 0 0.009010758250951767
these O 0 0.009904594160616398
mice O 1 0.7234036326408386
very O 0 0.015904704108834267
closely O 0 0.03444804251194
mimic O 1 0.9896500110626221
severe O 1 0.9987130165100098
human O 1 0.9780213832855225
von B-Disease 1 0.9987517595291138
Willebrand I-Disease 1 0.999931812286377
disease I-Disease 1 0.9999245405197144
and O 0 0.008261634036898613
will O 0 0.0053070527501404285
be O 0 0.003563648322597146
very O 0 0.005088648293167353
useful O 0 0.005961738061159849
for O 0 0.003452061675488949
investigating O 0 0.008951904252171516
the O 0 0.004973176866769791
role O 0 0.009063256904482841
of O 0 0.008340761996805668
vWf O 1 0.9477578997612
in O 0 0.010768736712634563
normal O 0 0.05022469535470009
physiology O 1 0.5237422585487366
and O 0 0.009671312756836414
in O 0 0.015742259100079536
disease O 1 0.9987573623657227
models O 0 0.036176711320877075
. O 0 0.020654283463954926
. O 0 0.028871679678559303

Oral O 0 0.4485512971878052
contraceptives O 0 0.34460514783859253
and O 0 0.013778247870504856
the O 0 0.01616428792476654
risk O 1 0.7954879999160767
of O 0 0.032153937965631485
hereditary B-Disease 1 0.9993280172348022
ovarian I-Disease 1 0.9999270439147949
cancer I-Disease 1 0.9996283054351807
. O 0 0.11035335808992386

Hereditary B-Disease 1 0.997406542301178
Ovarian I-Disease 1 0.9998550415039062
Cancer I-Disease 1 0.9996342658996582
Clinical O 1 0.9893634915351868
Study O 0 0.0796639546751976
Group O 0 0.053832896053791046
. O 0 0.050806574523448944

BACKGROUND O 0 0.05421273410320282
Women O 0 0.03159948065876961
with O 0 0.013354658149182796
mutations O 1 0.8182201385498047
in O 0 0.007591842208057642
either O 0 0.009324326179921627
the O 0 0.009429041296243668
BRCA1 O 1 0.9945791959762573
or O 0 0.0128916185349226
the O 0 0.013447408564388752
BRCA2 O 1 0.9983460903167725
gene O 1 0.831176221370697
have O 0 0.009522467851638794
a O 0 0.011709899641573429
high O 0 0.019821085035800934
lifetime O 0 0.24725262820720673
risk O 1 0.951653778553009
of O 0 0.21808987855911255
ovarian B-Disease 1 0.9999381303787231
cancer I-Disease 1 0.999736487865448
. O 0 0.0889391079545021

Oral O 1 0.9176969528198242
contraceptives O 1 0.9851698279380798
protect O 1 0.5548799633979797
against O 1 0.5213668942451477
ovarian B-Disease 1 0.9999275207519531
cancer I-Disease 1 0.9997668862342834
in O 0 0.01063766609877348
general O 0 0.009411375969648361
, O 0 0.004471864551305771
but O 0 0.003524285741150379
it O 0 0.0028318078257143497
is O 0 0.003007748397067189
not O 0 0.0024744041729718447
known O 0 0.004695810843259096
whether O 0 0.003913423512130976
they O 0 0.003141911467537284
also O 0 0.004183984361588955
protect O 0 0.01211513951420784
against O 0 0.011007661931216717
hereditary B-Disease 1 0.953546404838562
forms I-Disease 0 0.11396799236536026
of I-Disease 0 0.2453254610300064
ovarian I-Disease 1 0.9999449253082275
cancer I-Disease 1 0.9998157620429993
. O 0 0.07294473052024841

METHODS O 0 0.03863458335399628
We O 0 0.019181663170456886
enrolled O 0 0.039547424763441086
207 O 0 0.10673563927412033
women O 0 0.03724551573395729
with O 0 0.028447510674595833
hereditary B-Disease 1 0.9991160035133362
ovarian I-Disease 1 0.999969482421875
cancer I-Disease 1 0.999756395816803
and O 0 0.011329936794936657
161 O 0 0.020457571372389793
of O 0 0.005993337370455265
their O 0 0.005553081165999174
sisters O 0 0.011815875768661499
as O 0 0.005153302103281021
controls O 0 0.010013805702328682
in O 0 0.004887446295469999
a O 0 0.006650946568697691
case O 0 0.012266092002391815
- O 0 0.034739840775728226
control O 0 0.028696369379758835
study O 0 0.029504135251045227
. O 0 0.0269672479480505

All O 0 0.016341103240847588
the O 0 0.015634071081876755
patients O 1 0.9409294128417969
carried O 0 0.019463958218693733
a O 0 0.02138317935168743
pathogenic O 1 0.9739897847175598
mutation O 1 0.9721310138702393
in O 0 0.012262384407222271
either O 0 0.022927185520529747
BRCA1 O 1 0.9946774244308472
( O 0 0.020075520500540733
179 O 0 0.03953320533037186
women O 0 0.02001032419502735
) O 0 0.012819181196391582
or O 0 0.015725821256637573
BRCA2 O 1 0.9968903660774231
( O 0 0.018992219120264053
28 O 0 0.021955477073788643
women O 0 0.025710631161928177
) O 0 0.01929442398250103
. O 0 0.02281090058386326

The O 0 0.019863657653331757
control O 0 0.02224130742251873
women O 0 0.013528723269701004
were O 0 0.005715044680982828
enrolled O 0 0.01309925876557827
regardless O 0 0.009353110566735268
of O 0 0.003934243228286505
whether O 0 0.006596761755645275
or O 0 0.0053150709718465805
not O 0 0.003801338141784072
they O 0 0.004118811339139938
had O 0 0.007862254045903683
either O 0 0.015458987094461918
mutation O 1 0.931838870048523
. O 0 0.02914041094481945

Lifetime O 0 0.08175136893987656
histories O 0 0.05028211697936058
of O 0 0.015809714794158936
oral O 0 0.34880656003952026
- O 0 0.1369452029466629
contraceptive O 1 0.7901923060417175
use O 0 0.007531078066676855
were O 0 0.004473032429814339
obtained O 0 0.0060651544481515884
by O 0 0.005160068161785603
interview O 0 0.008147808723151684
or O 0 0.004900692496448755
by O 0 0.004335049074143171
written O 0 0.004761759657412767
questionnaire O 0 0.011788124218583107
and O 0 0.0034340997226536274
were O 0 0.0037329932674765587
compared O 0 0.009593627415597439
between O 0 0.00867287814617157
patients O 1 0.9771811962127686
and O 0 0.005121162626892328
control O 0 0.013663003221154213
women O 0 0.00911183375865221
, O 0 0.004177683033049107
after O 0 0.006646839901804924
adjustment O 0 0.010568822734057903
for O 0 0.00414179265499115
year O 0 0.006247330456972122
of O 0 0.00711324717849493
birth O 0 0.0503145232796669
and O 0 0.011871016584336758
parity O 0 0.05346803739666939
. O 0 0.02926112525165081

RESULTS O 0 0.04107634723186493
The O 0 0.017613478004932404
adjusted O 0 0.038612738251686096
odds O 0 0.20087037980556488
ratio O 0 0.11597005277872086
for O 0 0.03431791067123413
ovarian B-Disease 1 0.9999216794967651
cancer I-Disease 1 0.999832272529602
associated O 0 0.022486748173832893
with O 0 0.005851430352777243
any O 0 0.005434277933090925
past O 0 0.006758641451597214
use O 0 0.006233405787497759
of O 0 0.007072964683175087
oral O 0 0.3081081211566925
contraceptives O 1 0.7959549427032471
was O 0 0.01647079363465309
0 O 0 0.037781666964292526
. O 0 0.03141133114695549

5 O 0 0.03734537959098816
( O 0 0.018876397982239723
95 O 0 0.017006803303956985
percent O 0 0.013677958399057388
confidence O 0 0.015553347766399384
interval O 0 0.017945371568202972
, O 0 0.007083551492542028
0 O 0 0.011234682984650135
. O 0 0.005137146916240454
3 O 0 0.0072007388807833195
to O 0 0.005160207860171795
0 O 0 0.014978625811636448
. O 0 0.00833411980420351
8 O 0 0.016255388036370277
) O 0 0.018879231065511703
. O 0 0.022194642573595047

The O 0 0.031153377145528793
risk O 1 0.6264761090278625
decreased O 0 0.07213596254587173
with O 0 0.010116214863955975
increasing O 0 0.019011424854397774
duration O 0 0.017722057178616524
of O 0 0.005790424533188343
use O 0 0.00746046332642436
( O 0 0.009917419403791428
P O 0 0.02348780632019043
for O 0 0.007030917797237635
trend O 0 0.0188188087195158
, O 0 0.00921203289180994
< O 0 0.20677627623081207
0 O 0 0.015698963776230812
. O 0 0.0071075307205319405
001 O 0 0.09460138529539108
) O 0 0.006319710053503513
; O 0 0.004841429181396961
use O 0 0.0032947780564427376
for O 0 0.002628009533509612
six O 0 0.004059617407619953
or O 0 0.0036246872041374445
more O 0 0.0033617790322750807
years O 0 0.00430986238643527
was O 0 0.004065515473484993
associated O 0 0.006344780325889587
with O 0 0.0037664994597434998
a O 0 0.006373422220349312
60 O 0 0.010313189588487148
percent O 0 0.012133193202316761
reduction O 0 0.028208494186401367
in O 0 0.012658231891691685
risk O 1 0.5228018760681152
. O 0 0.03031570091843605

Oral O 0 0.3999175429344177
- O 0 0.30993396043777466
contraceptive O 1 0.9180846214294434
use O 0 0.01826702617108822
protected O 0 0.07043210417032242
against O 0 0.2180311679840088
ovarian B-Disease 1 0.9999314546585083
cancer I-Disease 1 0.9996175765991211
both O 0 0.009834852069616318
for O 0 0.007611878681927919
carriers O 0 0.0379185751080513
of O 0 0.007347112987190485
the O 0 0.014197155833244324
BRCA1 O 1 0.999200165271759
mutation O 1 0.9975903034210205
( O 0 0.02371073141694069
odds O 0 0.10628829151391983
ratio O 0 0.021593334153294563
, O 0 0.006491533946245909
0 O 0 0.010855178348720074
. O 0 0.004776342306286097
5 O 0 0.00735080661252141
; O 0 0.006004984024912119
95 O 0 0.009417405351996422
percent O 0 0.00945437140762806
confidence O 0 0.011272470466792583
interval O 0 0.015343323349952698
, O 0 0.005693133920431137
0 O 0 0.008863636292517185
. O 0 0.0039537278935313225
3 O 0 0.006070558447390795
to O 0 0.003852483816444874
0 O 0 0.009181457571685314
. O 0 0.004924369975924492
9 O 0 0.006970106158405542
) O 0 0.004812248051166534
and O 0 0.0029107786249369383
for O 0 0.004225519951432943
carriers O 0 0.017046740278601646
of O 0 0.006628435105085373
the O 0 0.013279221951961517
BRCA2 O 1 0.9986971020698547
mutation O 1 0.996013879776001
( O 0 0.025752028450369835
odds O 0 0.06346546858549118
ratio O 0 0.021167229861021042
, O 0 0.006672150455415249
0 O 0 0.011969390325248241
. O 0 0.004907808266580105
4 O 0 0.00792328454554081
; O 0 0.006088668014854193
95 O 0 0.009434680454432964
percent O 0 0.008665148168802261
confidence O 0 0.010973953641951084
interval O 0 0.014513690955936909
, O 0 0.005083595402538776
0 O 0 0.008859111927449703
. O 0 0.00399089464917779
2 O 0 0.0049784984439611435
to O 0 0.0035206989850848913
1 O 0 0.0069537353701889515
. O 0 0.0060288202948868275
1 O 0 0.012636794708669186
) O 0 0.01668420247733593
. O 0 0.022901197895407677

CONCLUSIONS O 0 0.06565047055482864
Oral O 0 0.32855939865112305
- O 0 0.36014747619628906
contraceptive O 1 0.8693961501121521
use O 0 0.014581598341464996
may O 0 0.012994522228837013
reduce O 0 0.021823113784193993
the O 0 0.009892279282212257
risk O 1 0.8946968913078308
of O 0 0.14178712666034698
ovarian B-Disease 1 0.9999724626541138
cancer I-Disease 1 0.9997815489768982
in O 0 0.014448597095906734
women O 0 0.06595908850431442
with O 0 0.017623713240027428
pathogenic O 1 0.996557354927063
mutations O 1 0.9892327785491943
in O 0 0.014385424554347992
the O 0 0.02191314287483692
BRCA1 O 1 0.9972208738327026
or O 0 0.20353244245052338
BRCA2 O 1 0.9957976341247559
gene O 1 0.9726472496986389

A O 0 0.02908475697040558
Japanese O 0 0.02629779279232025
family O 0 0.023541389033198357
with O 0 0.015967562794685364
adrenoleukodystrophy B-Disease 1 0.9960230588912964
with O 0 0.013284983113408089
a O 0 0.01656273566186428
codon O 0 0.3156864047050476
291 O 0 0.20612873136997223
deletion O 1 0.6114923357963562
: O 0 0.011812263168394566
a O 0 0.010067583061754704
clinical O 1 0.6152355074882507
, O 0 0.007636238355189562
biochemical O 0 0.15608935058116913
, O 0 0.007954894565045834
pathological O 1 0.6353610754013062
, O 0 0.007401227485388517
and O 0 0.008495423011481762
genetic O 0 0.4662109911441803
report O 0 0.026059389114379883
. O 0 0.02766456827521324

We O 0 0.016281569376587868
report O 0 0.018278827890753746
a O 0 0.01346944086253643
Japanese O 0 0.019686469808220863
family O 0 0.023625535890460014
with O 0 0.020107300952076912
adrenoleukodystrophy B-Disease 1 0.9992597699165344
( O 0 0.18116070330142975
ALD B-Disease 1 0.9981924891471863
) O 0 0.01049873698502779
with O 0 0.005924179684370756
a O 0 0.006395004689693451
three O 0 0.0058774566277861595
base O 0 0.012848013080656528
pair O 0 0.018823331221938133
deletion O 1 0.6903194785118103
( O 0 0.022404085844755173
delGAG O 1 0.7222520709037781
291 O 0 0.13126106560230255
) O 0 0.015134252607822418
in O 0 0.011088411323726177
the O 0 0.02005424164235592
ALD B-Disease 1 0.9960913062095642
gene O 1 0.9128067493438721
. O 0 0.053436581045389175

A O 0 0.02619238570332527
variety O 0 0.019769039005041122
of O 0 0.011405293829739094
phenotypes O 1 0.755858838558197
were O 0 0.0077302111312747
observed O 0 0.017738137394189835
within O 0 0.011052369140088558
this O 0 0.010667744092643261
family O 0 0.02698202058672905
. O 0 0.02861427329480648

While O 0 0.02065524272620678
the O 0 0.01809658110141754
proband O 1 0.6633738875389099
( O 0 0.0251590795814991
patient O 1 0.6117871999740601
1 O 0 0.01287532877177
) O 0 0.007903738878667355
was O 0 0.0049080136232078075
classified O 0 0.0078090885654091835
as O 0 0.0038834321312606335
having O 0 0.005698975175619125
a O 0 0.006171761080622673
rare O 0 0.018684078007936478
intermediate O 0 0.019815051928162575
type O 0 0.021206960082054138
of O 0 0.008783391676843166
adult O 1 0.6089572310447693
cerebral O 1 0.9981586337089539
and O 0 0.01968119665980339
cerebello O 1 0.9893339276313782
- O 1 0.972767174243927
brain O 1 0.9982702732086182
stem O 1 0.9041318893432617
forms O 0 0.022496623918414116
, O 0 0.008186880499124527
his O 0 0.008909039199352264
younger O 0 0.14087948203086853
brother O 0 0.03891519457101822
( O 0 0.018149491399526596
patient O 1 0.6957143545150757
2 O 0 0.011768738739192486
) O 0 0.008563361130654812
and O 0 0.006203905213624239
nephew O 0 0.10529852658510208
( O 0 0.01785035990178585
patient O 1 0.8219902515411377
3 O 0 0.012573327869176865
) O 0 0.011115203611552715
had O 0 0.011753834784030914
a O 0 0.020899293944239616
childhood O 1 0.9718129634857178
ALD B-Disease 1 0.9978616833686829
type O 0 0.48831459879875183
. O 0 0.05283995717763901

Another O 0 0.04200446605682373
nephew O 0 0.2931874692440033
( O 0 0.031195711344480515
patient O 1 0.7479766011238098
4 O 0 0.015599748119711876
) O 0 0.010163971222937107
of O 0 0.007316843140870333
patient O 0 0.40989404916763306
1 O 0 0.0094081936404109
was O 0 0.007302701938897371
classified O 0 0.012444823980331421
as O 0 0.006861499510705471
having O 0 0.011610590852797031
an O 0 0.011609540320932865
adolescent O 1 0.7829074859619141
form O 0 0.03490590676665306
. O 0 0.03337803855538368

The O 0 0.029925137758255005
tau O 0 0.09589129686355591
level O 0 0.01877930760383606
in O 0 0.011094299145042896
the O 0 0.013520009815692902
cerebrospinal O 1 0.9933702945709229
fluid O 1 0.9037384390830994
( O 0 0.030258608981966972
CSF O 1 0.9667122960090637
) O 0 0.013534842059016228
in O 0 0.009065951220691204
patient O 0 0.4750203788280487
1 O 0 0.008567912504076958
was O 0 0.004556963685899973
as O 0 0.004009523894637823
high O 0 0.005875484552234411
as O 0 0.003858389798551798
that O 0 0.004143958445638418
of O 0 0.007997484877705574
patients O 1 0.995236873626709
with O 0 0.2882501184940338
Alzheimers B-Disease 1 0.9999176263809204
disease I-Disease 1 0.9998706579208374
( O 0 0.283104807138443
AD B-Disease 0 0.3538123369216919
) O 0 0.03672143071889877
. O 0 0.030168743804097176

His O 0 0.04732611030340195
brain O 1 0.9848054051399231
magnetic O 0 0.08960878103971481
resonance O 0 0.1633153259754181
image O 0 0.054720427840948105
( O 0 0.026260847225785255
MRI O 1 0.7331337928771973
) O 0 0.014633123762905598
showed O 0 0.01956021599471569
abnormalities B-Disease 1 0.9741594791412354
in I-Disease 0 0.00716113718226552
the I-Disease 0 0.008972742594778538
bilateral I-Disease 0 0.06225375831127167
cerebellar I-Disease 1 0.9979962706565857
hemispheres I-Disease 1 0.988849937915802
and O 0 0.04390547797083855
brain O 1 0.998874843120575
stem O 1 0.9492615461349487
, O 0 0.006387676112353802
but O 0 0.0042022657580673695
not O 0 0.0032507835421711206
in O 0 0.004603060893714428
the O 0 0.00682816980406642
cerebral O 1 0.995579183101654
white O 0 0.01637650467455387
matter O 0 0.0073823481798172
, O 0 0.004655352793633938
where O 0 0.005819043610244989
marked O 0 0.011542660184204578
reductions O 0 0.013958564028143883
of O 0 0.006208357866853476
the O 0 0.011219422332942486
cerebral O 1 0.9987841248512268
blood O 1 0.9850110411643982
flow O 0 0.07559444010257721
and O 0 0.010619674809277058
oxygen O 0 0.23368564248085022
metabolism O 1 0.6449657678604126
were O 0 0.007368611637502909
clearly O 0 0.014184363186359406
demonstrated O 0 0.02254188247025013
by O 0 0.016919687390327454
positron O 1 0.9790562987327576
emission O 1 0.5134293437004089
tomography O 1 0.8918527960777283
( O 0 0.03511132672429085
PET O 0 0.356722891330719
) O 0 0.033200476318597794
. O 0 0.03156531602144241

In O 0 0.027384601533412933
patients O 1 0.8765146136283875
2 O 0 0.013447928242385387
and O 0 0.005950415041297674
3 O 0 0.008106308057904243
, O 0 0.004724707920104265
the O 0 0.006192635279148817
autopsy O 0 0.07061568647623062
findings O 0 0.020816903561353683
showed O 0 0.022002674639225006
massive O 0 0.3607295751571655
demyelination B-Disease 1 0.9920090436935425
of I-Disease 0 0.010608422569930553
the I-Disease 0 0.012653392739593983
cerebral I-Disease 1 0.9976669549942017
white I-Disease 0 0.02257305011153221
matter I-Disease 0 0.01010178029537201
with O 0 0.0064241113141179085
sparing O 0 0.029165180400013924
of O 0 0.005525783635675907
the O 0 0.008239518851041794
U O 0 0.0867311954498291
- O 0 0.09034673124551773
fibers O 0 0.3304871618747711
, O 0 0.006944103632122278
compatible O 0 0.010760287754237652
with O 0 0.0052208979614079
the O 0 0.006893831770867109
findings O 0 0.018393265083432198
of O 0 0.014222713187336922
childhood O 1 0.9821633696556091
ALD B-Disease 1 0.9988468885421753
. O 0 0.05673198401927948

Oleic O 1 0.7558130621910095
and O 0 0.033462703227996826
erucic O 1 0.9094432592391968
acids O 0 0.0874134823679924
( O 0 0.024506347253918648
Lorenzos O 0 0.12083735316991806
Oil O 0 0.01478845626115799
) O 0 0.007750826422125101
were O 0 0.005078058689832687
administered O 0 0.016057970002293587
to O 0 0.006643560249358416
patients O 1 0.7284088730812073
1 O 0 0.00820316281169653
and O 0 0.004286188632249832
4 O 0 0.006889148615300655
, O 0 0.00374907860532403
but O 0 0.004631504882127047
sufficient O 0 0.009451037272810936
effectiveness O 0 0.02109239622950554
was O 0 0.007585679180920124
not O 0 0.0067412215285003185
obtained O 0 0.016043126583099365
. O 0 0.020680854097008705

The O 0 0.01662416011095047
findings O 0 0.020018305629491806
in O 0 0.008042247965931892
this O 0 0.006445928011089563
family O 0 0.011876650154590607
suggest O 0 0.012988095171749592
that O 0 0.0064337849617004395
delGAG291 O 0 0.05943026393651962
is O 0 0.006968948058784008
part O 0 0.007126818411052227
of O 0 0.005612398497760296
the O 0 0.007369748782366514
cause O 0 0.05525849014520645
of O 0 0.011389970779418945
Japanese O 0 0.04395454749464989
ALD B-Disease 1 0.9963918328285217
with O 0 0.03055945597589016
phenotypic O 1 0.8856223821640015
variations O 0 0.07267946749925613
. O 0 0.04392044246196747

Moreover O 0 0.03569450229406357
, O 0 0.009682041592895985
although O 0 0.007856305688619614
the O 0 0.0051904963329434395
scale O 0 0.008924373425543308
of O 0 0.004009130410850048
the O 0 0.0038021779619157314
study O 0 0.006893354933708906
is O 0 0.004229992628097534
limited O 0 0.005782005842775106
, O 0 0.00299725029617548
there O 0 0.0028109445702284575
is O 0 0.0030684247612953186
a O 0 0.00483659328892827
possibility O 0 0.008678462356328964
that O 0 0.005674450192600489
PET O 1 0.568657398223877
can O 0 0.00990824680775404
detect O 0 0.05744880437850952
an O 0 0.010093226097524166
insidious B-Disease 1 0.9845882058143616
lesion I-Disease 1 0.9957349300384521
which O 0 0.009862024337053299
is O 0 0.010193781927227974
undetectable O 1 0.6081624031066895
by O 0 0.012348935008049011
computed O 0 0.13749852776527405
tomogram O 1 0.9293515682220459
( O 0 0.033016104251146317
CT O 1 0.9792945981025696
) O 0 0.01241556741297245
or O 0 0.010460755787789822
MRI O 0 0.16674365103244781
analysis O 0 0.009210719726979733
, O 0 0.003391815349459648
and O 0 0.002683744765818119
that O 0 0.0024870417546480894
the O 0 0.0033783651888370514
higher O 0 0.0054643042385578156
level O 0 0.006225952412933111
of O 0 0.0051938449032604694
tau O 0 0.07861092686653137
reflects O 0 0.012916537933051586
the O 0 0.006505921017378569
process O 0 0.010574309155344963
of O 0 0.015187201090157032
neuronal B-Disease 1 0.98908931016922
degeneration I-Disease 1 0.9989317059516907
in O 0 0.06789681315422058
ALD B-Disease 1 0.9975776076316833
. O 0 0.06193481758236885

Lorenzos O 0 0.33453771471977234
Oil O 0 0.0233940239995718
should O 0 0.010113302618265152
be O 0 0.00528201786801219
given O 0 0.00641552172601223
in O 0 0.00539118517190218
the O 0 0.005667093675583601
early O 0 0.012513210065662861
stage O 0 0.022370386868715286
. O 0 0.015088606625795364
. O 0 0.025801656767725945

Nonsense O 0 0.27780598402023315
mutation O 1 0.9464709758758545
in O 0 0.017442401498556137
exon O 0 0.0715460404753685
4 O 0 0.01675020530819893
of O 0 0.009200581349432468
human O 0 0.0261040348559618
complement O 0 0.11161342263221741
C9 O 1 0.9905266761779785
gene O 0 0.463913232088089
is O 0 0.010473586618900299
the O 0 0.008061419241130352
major O 0 0.017554551362991333
cause O 0 0.1216084286570549
of O 0 0.013228124007582664
Japanese O 0 0.03701954334974289
complement B-Disease 0 0.3118906617164612
C9 I-Disease 1 0.9930757284164429
deficiency I-Disease 1 0.9986384510993958
. O 0 0.061543166637420654

Deficiency B-Disease 1 0.9949648976325989
of I-Disease 0 0.014159081503748894
the I-Disease 0 0.011048032902181149
ninth I-Disease 0 0.02163638360798359
component I-Disease 0 0.018785299733281136
of I-Disease 0 0.007622208911925554
human I-Disease 0 0.019487155601382256
complement I-Disease 0 0.025926925241947174
( O 0 0.016740644350647926
C9 O 1 0.9248338341712952
) O 0 0.008450169116258621
is O 0 0.005421777255833149
the O 0 0.004322980530560017
most O 0 0.006108251865953207
common O 0 0.02050013095140457
complement B-Disease 0 0.4579301178455353
deficiency I-Disease 1 0.9995622038841248
in O 0 0.00733667379245162
Japan O 0 0.00809451099485159
but O 0 0.00464604003354907
is O 0 0.005163643043488264
rare O 0 0.011951128020882607
in O 0 0.0055725956335663795
other O 0 0.007677112240344286
countries O 0 0.015721658244729042
. O 0 0.02309527061879635

We O 0 0.01703653857111931
studied O 0 0.018587974831461906
the O 0 0.009954565204679966
molecular O 0 0.02623155526816845
basis O 0 0.011864027008414268
of O 0 0.014289721846580505
C9 B-Disease 1 0.9932823181152344
deficiency I-Disease 1 0.9982239603996277
in O 0 0.012388329952955246
four O 0 0.012358587235212326
Japanese O 0 0.040588878095149994
C9 B-Disease 1 0.996484637260437
- I-Disease 1 0.9761785864830017
deficient I-Disease 1 0.9956048727035522
patients O 1 0.9958691000938416
who O 0 0.022637536749243736
had O 0 0.027088867500424385
suffered O 1 0.9918738007545471
from O 0 0.25487005710601807
meningococcal B-Disease 1 0.9997015595436096
meningitis I-Disease 1 0.9996265172958374
. O 0 0.11927385628223419

Direct O 0 0.04963301867246628
sequencing O 0 0.06225791573524475
of O 0 0.022202936932444572
amplified O 0 0.17011627554893494
C9 O 1 0.9233967661857605
cDNA O 0 0.06492630392313004
and O 0 0.013533039018511772
DNA O 0 0.03221869841217995
revealed O 0 0.020110832527279854
a O 0 0.01220216415822506
nonsense O 0 0.02987784519791603
substitution O 0 0.03250529617071152
( O 0 0.019953183829784393
CGA O 0 0.05289206653833389
- O 0 0.09885328263044357
- O 0 0.28848668932914734
> O 1 0.7859039306640625
TGA O 1 0.9454157948493958
) O 0 0.014738926663994789
at O 0 0.011114757508039474
codon O 0 0.04049398750066757
95 O 0 0.014836185611784458
in O 0 0.008760480210185051
exon O 0 0.03653712943196297
4 O 0 0.01064904872328043
in O 0 0.006305801682174206
the O 0 0.008435032330453396
four O 0 0.015492145903408527
C9 B-Disease 1 0.9702428579330444
- I-Disease 0 0.4462771415710449
deficient I-Disease 1 0.9097643494606018
individuals O 0 0.04661134257912636
. O 0 0.036566585302352905

An O 0 0.040691740810871124
allele O 1 0.7094604969024658
- O 0 0.07154081761837006
specific O 0 0.03472624719142914
polymerase O 1 0.782900333404541
chain O 0 0.22299690544605255
reaction O 0 0.03206565976142883
system O 0 0.010659518651664257
designed O 0 0.007686537690460682
to O 0 0.00456555699929595
detect O 0 0.01519857905805111
exclusively O 0 0.00621052086353302
only O 0 0.0030468441545963287
one O 0 0.00279064429923892
of O 0 0.0026726422365754843
the O 0 0.003833798225969076
normal O 0 0.011938720010221004
and O 0 0.005153588484972715
mutant O 1 0.7956599593162537
alleles O 1 0.965319037437439
indicated O 0 0.009556085802614689
that O 0 0.00304298079572618
all O 0 0.0027714334428310394
the O 0 0.0033390801399946213
four O 0 0.005293612834066153
patients O 1 0.9274552464485168
were O 0 0.0047317203134298325
homozygous O 0 0.28373610973358154
for O 0 0.0055036176927387714
the O 0 0.007909143343567848
mutation O 1 0.8889356255531311
in O 0 0.008625653572380543
exon O 0 0.1789819747209549
4 O 0 0.008835307322442532
and O 0 0.0038922426756471395
that O 0 0.0034701512195169926
the O 0 0.00478780223056674
parents O 0 0.011474843136966228
of O 0 0.007610084488987923
patient O 1 0.7083306908607483
2 O 0 0.01470370963215828
were O 0 0.012902174144983292
heterozygous O 0 0.1721058338880539
. O 0 0.031890422105789185

The O 0 0.026472989469766617
common O 0 0.038072969764471054
mutation O 1 0.9090782999992371
at O 0 0.016524627804756165
codon O 0 0.08681440353393555
95 O 0 0.016830293461680412
in O 0 0.010008692741394043
exon O 0 0.06105916202068329
4 O 0 0.012920109555125237
might O 0 0.009155881591141224
be O 0 0.004935163073241711
responsible O 0 0.01069655828177929
for O 0 0.006262295413762331
most O 0 0.01274004764854908
Japanese O 0 0.0372687503695488
C9 B-Disease 1 0.9928021430969238
deficiency I-Disease 1 0.9985520243644714
. O 0 0.027916375547647476
. O 0 0.03572564944624901

BRCA1 O 1 0.978469729423523
required O 0 0.02867531217634678
for O 0 0.01631038635969162
transcription O 0 0.24739690124988556
- O 0 0.13662302494049072
coupled O 0 0.11521750688552856
repair O 1 0.5047625303268433
of O 0 0.020601488649845123
oxidative O 1 0.9848560690879822
DNA O 0 0.4878675639629364
damage O 1 0.6657174229621887
. O 0 0.04660923033952713

The O 0 0.07793889194726944
breast B-Disease 1 0.9989627599716187
and I-Disease 1 0.6003302335739136
ovarian I-Disease 1 0.9999135732650757
cancer I-Disease 1 0.9999052286148071
susceptibility O 1 0.9994469285011292
gene O 1 0.9958835244178772
BRCA1 O 1 0.9981421232223511
encodes O 1 0.743801474571228
a O 0 0.029164092615246773
zinc O 1 0.8730165958404541
finger O 1 0.8164901733398438
protein O 0 0.054376065731048584
of O 0 0.014013249427080154
unknown O 0 0.02990931272506714
function O 0 0.035889238119125366
. O 0 0.024604033678770065

Association O 0 0.03518334776163101
of O 0 0.013236709870398045
the O 0 0.015638025477528572
BRCA1 O 1 0.9912336468696594
protein O 0 0.04350559413433075
with O 0 0.00815024133771658
the O 0 0.008638744242489338
DNA O 0 0.18541473150253296
repair O 1 0.8335831165313721
protein O 0 0.42786040902137756
Rad51 O 1 0.9690424203872681
and O 0 0.006469259038567543
changes O 0 0.006798335816711187
in O 0 0.003639709437265992
the O 0 0.0042153457179665565
phosphorylation O 0 0.014291087165474892
and O 0 0.004846363794058561
cellular O 0 0.020293403416872025
localization O 0 0.016489753499627113
of O 0 0.004280947148799896
the O 0 0.005594347603619099
protein O 0 0.02436652220785618
after O 0 0.010071191005408764
exposure O 0 0.3432196080684662
to O 0 0.006680040620267391
DNA O 0 0.06609773635864258
- O 0 0.07923320680856705
damaging O 0 0.18474844098091125
agents O 0 0.012142758816480637
are O 0 0.0047627948224544525
consistent O 0 0.009359779767692089
with O 0 0.005082008894532919
a O 0 0.008044392801821232
role O 0 0.013470537029206753
for O 0 0.01186449732631445
BRCA1 O 1 0.9901540875434875
in O 0 0.018066387623548508
DNA O 0 0.2182677537202835
repair O 1 0.6545835137367249
. O 0 0.036538105458021164

Here O 0 0.01598617061972618
, O 0 0.007608558051288128
it O 0 0.005248547066003084
is O 0 0.006190455053001642
shown O 0 0.01118621975183487
that O 0 0.008295277133584023
mouse O 1 0.9163591265678406
embryonic O 1 0.9750447273254395
stem O 1 0.986179769039154
cells O 1 0.9841167330741882
deficient B-Disease 1 0.9655072689056396
in I-Disease 0 0.014840771444141865
BRCA1 I-Disease 1 0.9973359704017639
are O 0 0.008629108779132366
defective O 1 0.5799482464790344
in O 0 0.005204914603382349
the O 0 0.00442364439368248
ability O 0 0.008061316795647144
to O 0 0.003528872039169073
carry O 0 0.006764716003090143
out O 0 0.006870964542031288
transcription O 0 0.0872778370976448
- O 0 0.08043410629034042
coupled O 0 0.07594610750675201
repair O 0 0.34833335876464844
of O 0 0.012064498849213123
oxidative O 1 0.9812785387039185
DNA O 0 0.46644893288612366
damage O 0 0.3013777434825897
, O 0 0.007260553538799286
and O 0 0.005552275106310844
are O 0 0.007097301539033651
hypersensitive O 1 0.7224323153495789
to O 0 0.013386033475399017
ionizing O 1 0.9411235451698303
radiation O 1 0.8103693723678589
and O 0 0.01608293317258358
hydrogen O 0 0.0536438524723053
peroxide O 0 0.35576948523521423
. O 0 0.04448236897587776

These O 0 0.017019513994455338
results O 0 0.021147269755601883
suggest O 0 0.016904884949326515
that O 0 0.009711201302707195
BRCA1 O 1 0.9946209192276001
participates O 0 0.034261446446180344
, O 0 0.006193265318870544
directly O 0 0.008673319593071938
or O 0 0.00665555102750659
indirectly O 0 0.016200721263885498
, O 0 0.005942848976701498
in O 0 0.0078012957237660885
transcription O 0 0.2926863133907318
- O 0 0.08057507127523422
coupled O 0 0.1331034153699875
repair O 1 0.5508663654327393
of O 0 0.018446389585733414
oxidative O 1 0.991074800491333
DNA O 1 0.5899897813796997
damage O 1 0.6446350812911987
. O 0 0.02247028984129429
. O 0 0.029010970145463943

Truncation O 1 0.9094659090042114
mutations O 1 0.9251295924186707
in O 0 0.01736386865377426
the O 0 0.016128314658999443
transactivation O 1 0.6797668933868408
region O 0 0.029212720692157745
of O 0 0.014498033560812473
PAX6 O 1 0.9871318340301514
result O 0 0.02911658026278019
in O 0 0.014924930408596992
dominant O 0 0.0881320908665657
- O 0 0.1538044959306717
negative O 0 0.16593234241008759
mutants O 0 0.4550001323223114
. O 0 0.04026079922914505

PAX6 O 1 0.8990785479545593
is O 0 0.02087041363120079
a O 0 0.017117273062467575
transcription O 0 0.056877586990594864
factor O 0 0.021549781784415245
with O 0 0.006385711953043938
two O 0 0.006890564691275358
DNA O 0 0.03151864558458328
- O 0 0.0304279625415802
binding O 0 0.023010635748505592
domains O 0 0.028421703726053238
( O 0 0.012968091294169426
paired O 0 0.02189645729959011
box O 0 0.016980772837996483
and O 0 0.008345749229192734
homeobox O 1 0.957707941532135
) O 0 0.010267841629683971
and O 0 0.006290849763900042
a O 0 0.01217604149132967
proline O 0 0.12563669681549072
- O 0 0.049661748111248016
serine O 0 0.17174874246120453
- O 0 0.06961842626333237
threonine O 0 0.27616891264915466
( O 0 0.02904072217643261
PST O 0 0.40484076738357544
) O 0 0.021813606843352318
- O 0 0.04940526559948921
rich O 0 0.05644695460796356
transactivation O 1 0.752504825592041
domain O 0 0.06751061230897903
. O 0 0.03809012100100517

PAX6 O 1 0.9884793162345886
regulates O 1 0.9312758445739746
eye O 1 0.9230909943580627
development O 0 0.021920200437307358
in O 0 0.011509988456964493
animals O 0 0.023800736293196678
ranging O 0 0.01900031976401806
from O 0 0.013831870630383492
jellyfish O 0 0.28427770733833313
to O 0 0.01330028846859932
Drosophila O 0 0.06893680989742279
to O 0 0.01655680313706398
humans O 0 0.07816587388515472
. O 0 0.032185591757297516

Heterozygous O 1 0.9502933621406555
mutations O 1 0.9113791584968567
in O 0 0.016493821516633034
the O 0 0.012528982013463974
human O 0 0.09569275379180908
PAX6 O 1 0.9935590624809265
gene O 1 0.9067805409431458
result O 0 0.01770712248980999
in O 0 0.007931890897452831
various O 0 0.009327678009867668
phenotypes O 1 0.8853603601455688
, O 0 0.00881404522806406
including O 0 0.01174224354326725
aniridia B-Disease 1 0.9637761116027832
, O 0 0.01453206967562437
Peters B-Disease 1 0.8994660973548889
anomaly I-Disease 1 0.9862050414085388
, O 0 0.07138556241989136
autosomal B-Disease 1 0.9994494318962097
dominant I-Disease 1 0.9850843548774719
keratitis I-Disease 1 0.9989293217658997
, O 0 0.03297819197177887
and O 0 0.03560035675764084
familial B-Disease 1 0.9988141059875488
foveal I-Disease 1 0.9945281147956848
dysplasia I-Disease 1 0.998892605304718
. O 0 0.08310304582118988

It O 0 0.014435508288443089
is O 0 0.009715676307678223
believed O 0 0.012366020120680332
that O 0 0.006417589262127876
the O 0 0.010365386493504047
mutated O 1 0.9732838273048401
allele O 1 0.849507749080658
of O 0 0.014867329970002174
PAX6 O 1 0.9896077513694763
produces O 0 0.05988451838493347
an O 0 0.013223357498645782
inactive O 0 0.05302867293357849
protein O 0 0.037001144140958786
and O 0 0.008922656066715717
aniridia B-Disease 1 0.8849584460258484
is O 0 0.011803749948740005
caused O 1 0.5414057970046997
due O 0 0.019141843542456627
to O 0 0.013656146824359894
genetic O 1 0.8530581593513489
haploinsufficiency O 1 0.8885349631309509
. O 0 0.03571518883109093

However O 0 0.020352978259325027
, O 0 0.010319652035832405
several O 0 0.01127554289996624
truncation O 1 0.8385541439056396
mutations O 1 0.9681283831596375
have O 0 0.005720154847949743
been O 0 0.004945715889334679
found O 0 0.005147692747414112
to O 0 0.0036826215218752623
occur O 0 0.007359817624092102
in O 0 0.0030938570853322744
the O 0 0.004467773251235485
C O 0 0.021968858316540718
- O 0 0.022809378802776337
terminal O 0 0.022334497421979904
half O 0 0.00930706225335598
of O 0 0.007910037413239479
PAX6 O 1 0.9896887540817261
in O 0 0.01366270612925291
patients O 1 0.9863181114196777
with O 0 0.011880556121468544
Aniridia B-Disease 1 0.9666591286659241
resulting O 0 0.14009718596935272
in O 0 0.010028598830103874
mutant O 1 0.6742583513259888
proteins O 0 0.02098280005156994
that O 0 0.005445738323032856
retain O 0 0.009802802465856075
the O 0 0.00521465390920639
DNA O 0 0.03666059672832489
- O 0 0.03822312131524086
binding O 0 0.01650136522948742
domains O 0 0.015798019245266914
but O 0 0.004444419872015715
have O 0 0.00435887323692441
lost O 0 0.007198611740022898
most O 0 0.00505036860704422
of O 0 0.00543095963075757
the O 0 0.01098161842674017
transactivation O 1 0.8272174000740051
domain O 0 0.05614089593291283
. O 0 0.03386624529957771

It O 0 0.014833703637123108
is O 0 0.008754457347095013
not O 0 0.00562768941745162
clear O 0 0.00798818375915289
whether O 0 0.006973704788833857
such O 0 0.006598255131393671
mutants O 0 0.18464821577072144
really O 0 0.012193483300507069
behave O 0 0.01844407245516777
as O 0 0.005608951207250357
loss O 0 0.019477350637316704
- O 0 0.01735003851354122
of O 0 0.007840167731046677
- O 0 0.041428495198488235
function O 0 0.029258055612444878
mutants O 0 0.19004704058170319
as O 0 0.010580897331237793
predicted O 0 0.023472754284739494
by O 0 0.016991624608635902
haploinsufficiency O 0 0.3166032135486603
. O 0 0.032873645424842834

Contrary O 0 0.02215328998863697
to O 0 0.006859287153929472
this O 0 0.0047376081347465515
theory O 0 0.007831879891455173
, O 0 0.003909579943865538
our O 0 0.004603540059179068
data O 0 0.004966909531503916
showed O 0 0.006235066335648298
that O 0 0.003317285794764757
these O 0 0.004265246447175741
mutants O 0 0.051045339554548264
are O 0 0.0056531126610934734
dominant O 0 0.043740905821323395
- O 0 0.04294571653008461
negative O 0 0.032645005732774734
in O 0 0.011813659220933914
transient O 1 0.8594656586647034
transfection O 1 0.9351487755775452
assays O 0 0.06089877709746361
when O 0 0.008768493309617043
they O 0 0.005398918408900499
are O 0 0.006823550909757614
coexpressed O 0 0.1221795454621315
with O 0 0.01264892052859068
wild O 0 0.0398067831993103
- O 0 0.2837039828300476
type O 0 0.27565836906433105
PAX6 O 1 0.9617913961410522
. O 0 0.0470111146569252

We O 0 0.01361321285367012
found O 0 0.010178225114941597
that O 0 0.005772668402642012
the O 0 0.007715612184256315
dominant O 0 0.05182575806975365
- O 0 0.2070429027080536
negative O 0 0.1365841031074524
effects O 0 0.2207639217376709
result O 0 0.013565007597208023
from O 0 0.007779714651405811
the O 0 0.007887632586061954
enhanced O 0 0.03110615350306034
DNA O 0 0.03328506276011467
binding O 0 0.021083777770400047
ability O 0 0.01775612309575081
of O 0 0.009555480442941189
these O 0 0.013616505078971386
mutants O 0 0.17261475324630737
. O 0 0.03443917632102966

Kinetic O 0 0.04975661635398865
studies O 0 0.022131895646452904
of O 0 0.010639142245054245
binding O 0 0.018259456381201744
and O 0 0.007920757867395878
dissociation O 0 0.12913522124290466
revealed O 0 0.014452653005719185
that O 0 0.005336680915206671
various O 0 0.007172198034822941
truncation O 0 0.20211461186408997
mutants O 0 0.11202813684940338
have O 0 0.006162368226796389
3 O 0 0.008766327984631062
- O 0 0.017634904012084007
5 O 0 0.01120225340127945
- O 0 0.0192322488874197
fold O 0 0.022498665377497673
higher O 0 0.010610220022499561
affinity O 0 0.016584355384111404
to O 0 0.00483937980607152
various O 0 0.006950009148567915
DNA O 0 0.021858515217900276
- O 0 0.021409323439002037
binding O 0 0.013914063572883606
sites O 0 0.008694171905517578
when O 0 0.0065169548615813255
compared O 0 0.010617394931614399
with O 0 0.005400185473263264
the O 0 0.007982729002833366
wild O 0 0.02908484637737274
- O 0 0.20354899764060974
type O 0 0.31749388575553894
PAX6 O 1 0.9696877598762512
. O 0 0.04661066457629204

These O 0 0.01573171280324459
results O 0 0.01593230478465557
provide O 0 0.00909231137484312
a O 0 0.007543595507740974
new O 0 0.005984724964946508
insight O 0 0.014289583079516888
into O 0 0.007441924884915352
the O 0 0.0064050015062093735
role O 0 0.011339113116264343
of O 0 0.010621543042361736
mutant O 1 0.9276546835899353
PAX6 O 1 0.9846723675727844
in O 0 0.025839798152446747
causing O 1 0.8783888220787048
aniridia B-Disease 1 0.9324702024459839
. O 0 0.02733781561255455
. O 0 0.03599958121776581

Reversal O 1 0.5860188603401184
of O 0 0.05536596477031708
severe O 1 0.9989240765571594
hypertrophic B-Disease 1 0.9997633099555969
cardiomyopathy I-Disease 1 0.9996951818466187
and O 0 0.018941882997751236
excellent O 0 0.030932065099477768
neuropsychologic O 1 0.7878441214561462
outcome O 0 0.019026992842555046
in O 0 0.008115660399198532
very B-Disease 0 0.009447429329156876
- I-Disease 0 0.0674322247505188
long I-Disease 0 0.028300203382968903
- I-Disease 0 0.22478991746902466
chain I-Disease 1 0.6482529044151306
acyl I-Disease 1 0.968132734298706
- I-Disease 1 0.6214569807052612
coenzyme I-Disease 1 0.9561693072319031
A I-Disease 0 0.16965556144714355
dehydrogenase I-Disease 1 0.9928483963012695
deficiency I-Disease 1 0.9976291060447693
. O 0 0.0653538629412651

Very B-Disease 0 0.03916788846254349
- I-Disease 0 0.06092589348554611
long I-Disease 0 0.03911551460623741
- I-Disease 0 0.1803685426712036
chain I-Disease 0 0.41850635409355164
acyl I-Disease 1 0.8903417587280273
- I-Disease 0 0.42366328835487366
coenzyme I-Disease 1 0.926118791103363
A I-Disease 0 0.05426613613963127
dehydrogenase I-Disease 1 0.9903841018676758
( I-Disease 0 0.04464091360569
VLCAD I-Disease 1 0.9622248411178589
) I-Disease 0 0.03891550377011299
deficiency I-Disease 1 0.9987577199935913
is O 0 0.015034280717372894
a O 0 0.02218271791934967
disorder O 1 0.9988307356834412
of O 0 0.020986467599868774
fatty O 1 0.9929420948028564
acid O 1 0.9582211375236511
beta O 1 0.5565429329872131
oxidation O 0 0.27457544207572937
that O 0 0.00640471326187253
reportedly O 0 0.013820500113070011
has O 0 0.00722457142546773
high O 0 0.009462014771997929
rates O 0 0.014770397916436195
of O 0 0.01141379214823246
morbidity O 1 0.9823490977287292
and O 0 0.021323006600141525
mortality O 1 0.9293325543403625
. O 0 0.039818890392780304

We O 0 0.012634563259780407
describe O 0 0.01669243723154068
the O 0 0.006924564018845558
outcome O 0 0.010392188094556332
of O 0 0.00465404475107789
a O 0 0.006067208014428616
5 O 0 0.009362379088997841
- O 0 0.016001328825950623
year O 0 0.009676959365606308
- O 0 0.02945234440267086
old O 0 0.017870167270302773
girl O 0 0.15744824707508087
with O 0 0.018366249278187752
VLCAD B-Disease 1 0.9980072379112244
deficiency I-Disease 1 0.9997196793556213
who O 0 0.011807388626039028
was O 0 0.006574723869562149
first O 0 0.005522305145859718
seen O 0 0.009271709248423576
at O 0 0.006443680264055729
5 O 0 0.008508004248142242
months O 0 0.011083271354436874
of O 0 0.008698496036231518
age O 0 0.024497685953974724
with O 0 0.02500021830201149
severe O 1 0.9995419979095459
hypertrophic B-Disease 1 0.9999343156814575
cardiomyopathy I-Disease 1 0.9999622106552124
, O 1 0.6912068128585815
hepatomegaly B-Disease 1 0.9996271133422852
, O 0 0.4647344648838043
encephalopathy B-Disease 1 0.99980229139328
, O 0 0.023806238546967506
and O 0 0.025004832074046135
hypotonia B-Disease 1 0.9917879700660706
. O 0 0.044086162000894547

Biochemical O 0 0.4825293719768524
studies O 0 0.06835397332906723
indicated O 0 0.4437105059623718
VLCAD B-Disease 1 0.998085618019104
deficiency I-Disease 1 0.9997844099998474
caused O 1 0.949402391910553
by O 0 0.01585465297102928
a O 0 0.017845243215560913
stable O 0 0.09891891479492188
yet O 0 0.0281678494066
inactive O 0 0.15524977445602417
enzyme O 0 0.18360766768455505
. O 0 0.035454802215099335

Molecular O 0 0.1410163789987564
genetic O 0 0.288819819688797
analysis O 0 0.02275760844349861
of O 0 0.01288638822734356
her O 0 0.0260308925062418
VLCAD O 1 0.9718338251113892
gene O 1 0.9026660919189453
revealed O 0 0.035256706178188324
a O 0 0.019856330007314682
T1372C O 1 0.609028160572052
( O 0 0.02979039028286934
F458L O 1 0.6192660927772522
) O 0 0.027657371014356613
missense O 1 0.9511542916297913
mutation O 1 0.9626918435096741
and O 0 0.015850568190217018
a O 0 0.027411678805947304
1668 O 1 0.9418314099311829
ACAG O 1 0.9660530686378479
1669 O 1 0.9429754614830017
splice O 1 0.8933772444725037
site O 0 0.06760556250810623
mutation O 1 0.9401528835296631
. O 0 0.052017729729413986

After O 0 0.04185683652758598
initial O 0 0.04583889991044998
treatment O 0 0.43169140815734863
with O 0 0.01682562381029129
intravenous O 1 0.9724025130271912
glucose O 1 0.8488298058509827
and O 0 0.012242266908288002
carnitine O 1 0.9903709292411804
, O 0 0.008539319038391113
the O 0 0.008553237654268742
patient O 1 0.8735672831535339
has O 0 0.009419464506208897
thrived O 0 0.025066029280424118
on O 0 0.006486579310148954
a O 0 0.01099642924964428
low O 0 0.021594224497675896
- O 0 0.07307086884975433
fat O 0 0.31833091378211975
diet O 0 0.21813784539699554
supplemented O 0 0.022014005109667778
with O 0 0.009275530464947224
medium O 0 0.022079257294535637
- O 0 0.05195913836359978
chain O 0 0.1021718978881836
triglyceride O 0 0.2609183192253113
oil O 0 0.020906656980514526
and O 0 0.014677854254841805
carnitine O 1 0.9131559729576111
and O 0 0.015514175407588482
avoidance O 0 0.274504154920578
of O 0 0.020588194951415062
fasting O 1 0.5797116160392761
. O 0 0.03822023421525955

Her O 0 0.3561708927154541
ventricular O 1 0.9968022108078003
hypertrophy O 1 0.9951470494270325
resolved O 0 0.05545885115861893
significantly O 0 0.028420081362128258
over O 0 0.009416773915290833
1 O 0 0.009059756994247437
year O 0 0.0064231399446725845
, O 0 0.00448505999520421
and O 0 0.0051382798701524734
cognitively O 0 0.38989078998565674
, O 0 0.004408608190715313
she O 0 0.00417928583920002
is O 0 0.0032579933758825064
in O 0 0.003959280904382467
the O 0 0.00522723700851202
superior O 0 0.013560924679040909
range O 0 0.010732680559158325
for O 0 0.008342289365828037
age O 0 0.024229172617197037
. O 0 0.024525273591279984

Clinical O 1 0.627764105796814
recognition O 0 0.046877969056367874
of O 0 0.02408575639128685
VLCAD B-Disease 1 0.9980660080909729
deficiency I-Disease 1 0.9996300935745239
is O 0 0.008541342802345753
important O 0 0.005696128122508526
because O 0 0.005441057495772839
it O 0 0.0026905036065727472
is O 0 0.002904759254306555
one O 0 0.0031168998684734106
of O 0 0.003396667307242751
the O 0 0.004730716813355684
few O 0 0.009229636751115322
directly O 0 0.02266717702150345
treatable O 1 0.998887836933136
causes O 1 0.9889963865280151
of O 0 0.02152356691658497
cardiomyopathy B-Disease 1 0.9994574189186096
in O 0 0.017614180222153664
children O 0 0.06306012719869614
. O 0 0.020957214757800102
. O 0 0.028049571439623833

Cloning O 0 0.05464344844222069
of O 0 0.010962140746414661
a O 0 0.011581935919821262
novel O 0 0.016744324937462807
member O 0 0.00942887645214796
of O 0 0.006225208751857281
the O 0 0.008534916676580906
low O 0 0.0326305627822876
- O 0 0.2535971999168396
density O 0 0.41259416937828064
lipoprotein O 1 0.9935734868049622
receptor O 1 0.9591599702835083
family O 0 0.05483098700642586
. O 0 0.0395868644118309

A O 0 0.03781434893608093
gene O 0 0.21477261185646057
encoding O 0 0.03633895888924599
a O 0 0.014331545680761337
novel O 0 0.029102247208356857
transmembrane O 0 0.44595906138420105
protein O 0 0.035613466054201126
was O 0 0.008712949231266975
identified O 0 0.011832200922071934
by O 0 0.007888388819992542
DNA O 0 0.021229460835456848
sequence O 0 0.017408913001418114
analysis O 0 0.010476828552782536
within O 0 0.008141465485095978
the O 0 0.009992783889174461
insulin B-Disease 1 0.9856270551681519
- I-Disease 1 0.7914855480194092
dependent I-Disease 1 0.9821052551269531
diabetes I-Disease 1 0.9999223947525024
mellitus I-Disease 1 0.9996753931045532
( O 0 0.284556120634079
IDDM B-Disease 1 0.9770656824111938
) O 0 0.0349576435983181
locus O 1 0.9609205722808838
IDDM4 O 1 0.8960524201393127
on O 0 0.030606431886553764
chromosome O 1 0.9753494262695312
11q13 O 1 0.6775301098823547
. O 0 0.05265380069613457

Based O 0 0.02127857133746147
on O 0 0.010793400928378105
its O 0 0.011822436936199665
chromosomal O 0 0.4979306161403656
position O 0 0.009657388553023338
, O 0 0.006185642443597317
this O 0 0.006454771384596825
gene O 0 0.04467029497027397
is O 0 0.007156321778893471
a O 0 0.008833199739456177
candidate O 0 0.017015160992741585
for O 0 0.011307562701404095
conferring O 0 0.37842005491256714
susceptibility O 1 0.9955659508705139
to O 0 0.033995870500802994
diabetes B-Disease 1 0.9987683892250061
. O 0 0.05213578790426254

The O 0 0.02556305192410946
gene O 0 0.4341064989566803
, O 0 0.014138981699943542
termed O 0 0.058858297765254974
low O 0 0.03529118746519089
- O 0 0.13011592626571655
density O 0 0.12023143470287323
lipoprotein O 1 0.9933213591575623
receptor O 1 0.9294127225875854
related O 0 0.030635317787528038
protein O 0 0.07833907008171082
5 O 0 0.01569346897304058
( O 0 0.01460065133869648
LRP5 O 0 0.24946922063827515
) O 0 0.008741160854697227
, O 0 0.007056744769215584
encodes O 0 0.0221564881503582
a O 0 0.01014370284974575
protein O 0 0.02149030566215515
of O 0 0.008730234578251839
1615 O 0 0.06434500217437744
amino O 0 0.02516159974038601
acids O 0 0.017671993002295494
that O 0 0.004694473464041948
contains O 0 0.007769457064568996
conserved O 0 0.011524427682161331
modules O 0 0.00869410764425993
which O 0 0.003824687097221613
are O 0 0.0033080680295825005
characteristic O 0 0.008588074706494808
of O 0 0.004181056283414364
the O 0 0.006512276828289032
low O 0 0.021365856751799583
- O 0 0.19664235413074493
density O 0 0.29238811135292053
lipoprotein O 1 0.9930434226989746
( O 0 0.1520203799009323
LDL O 1 0.9966375827789307
) O 0 0.03857678547501564
receptor O 1 0.724655270576477
family O 0 0.04769277572631836
. O 0 0.03476450964808464

These O 0 0.01972084864974022
modules O 0 0.024894339963793755
include O 0 0.013118387199938297
a O 0 0.01402257289737463
putative O 0 0.06821384280920029
signal O 0 0.027561435475945473
peptide O 0 0.040411368012428284
for O 0 0.008977683261036873
protein O 0 0.022123979404568672
export O 0 0.009892730042338371
, O 0 0.00603127246722579
four O 0 0.009766816161572933
epidermal O 1 0.9051169753074646
growth O 0 0.03375563025474548
factor O 0 0.13236203789710999
( O 0 0.02061736397445202
EGF O 1 0.9237316846847534
) O 0 0.014326724223792553
repeats O 0 0.026824109256267548
with O 0 0.009368570521473885
associated O 0 0.01832372322678566
spacer O 0 0.35066893696784973
domains O 0 0.031866442412137985
, O 0 0.010269274935126305
three O 0 0.014680689200758934
LDL O 1 0.9935507774353027
- O 1 0.536238431930542
receptor O 1 0.916420578956604
( O 0 0.027701448649168015
LDLR O 1 0.5184131264686584
) O 0 0.014449575915932655
repeats O 0 0.022384561598300934
, O 0 0.006306321360170841
a O 0 0.007749425247311592
single O 0 0.01225698459893465
transmembrane O 0 0.10192466527223587
spanning O 0 0.02362174540758133
domain O 0 0.01605529710650444
, O 0 0.006119584199041128
and O 0 0.006059287115931511
a O 0 0.011158936657011509
cytoplasmic O 0 0.17123083770275116
domain O 0 0.04348139092326164
. O 0 0.03078554943203926

The O 0 0.0210240688174963
encoded O 0 0.03379841148853302
protein O 0 0.027941659092903137
has O 0 0.006868086289614439
a O 0 0.006674565374851227
unique O 0 0.008587952703237534
organization O 0 0.009748263284564018
of O 0 0.007132998201996088
EGF O 1 0.9849264621734619
and O 0 0.010945186018943787
LDLR O 1 0.8895488977432251
repeats O 0 0.18326184153556824
; O 0 0.01057247444987297
therefore O 0 0.009521729312837124
, O 0 0.006663764826953411
LRP5 O 1 0.5002752542495728
likely O 0 0.012177682481706142
represents O 0 0.01056129764765501
a O 0 0.006920049898326397
new O 0 0.0072890701703727245
category O 0 0.011932279914617538
of O 0 0.006693773437291384
the O 0 0.01263730600476265
LDLR O 1 0.798856794834137
family O 0 0.04157612472772598
. O 0 0.03193921223282814

Both O 0 0.022774243727326393
human O 0 0.02676921710371971
and O 0 0.014184569008648396
mouse O 1 0.9345192909240723
LRP5 O 1 0.9715296626091003
cDNAs O 1 0.6757615804672241
have O 0 0.008974548429250717
been O 0 0.008110967464745045
isolated O 0 0.0199214369058609
and O 0 0.004534943029284477
the O 0 0.005403454415500164
encoded O 0 0.015049031935632229
mature O 0 0.027020087465643883
proteins O 0 0.014849788509309292
are O 0 0.00457145506516099
95 O 0 0.009024286642670631
% O 0 0.007194799371063709
identical O 0 0.0089151281863451
, O 0 0.004609362222254276
indicating O 0 0.01066889613866806
a O 0 0.006332221440970898
high O 0 0.00819596741348505
degree O 0 0.010481060482561588
of O 0 0.008863975293934345
evolutionary O 0 0.029010869562625885
conservation O 0 0.024097852408885956
. O 0 0.015235395170748234
. O 0 0.02659894898533821

The O 0 0.037081047892570496
APC B-Disease 1 0.6927081942558289
variants O 0 0.11998779326677322
I1307K O 0 0.2181074470281601
and O 0 0.01494950708001852
E1317Q O 0 0.2916282117366791
are O 0 0.011089340783655643
associated O 0 0.02678348496556282
with O 0 0.11475178599357605
colorectal B-Disease 1 0.9999701976776123
tumors I-Disease 1 0.9998223185539246
, O 0 0.00691887317225337
but O 0 0.004642955958843231
not O 0 0.0033391753677278757
always O 0 0.005436943378299475
with O 0 0.004980180412530899
a O 0 0.00850304588675499
family O 0 0.019783973693847656
history O 0 0.023894956335425377
. O 0 0.027678614482283592

Classical O 0 0.4794585406780243
familial B-Disease 1 0.9985600113868713
adenomatous I-Disease 1 0.9997568726539612
polyposis I-Disease 1 0.9998001456260681
( O 1 0.6067020893096924
FAP B-Disease 1 0.9916403293609619
) O 0 0.02172885835170746
is O 0 0.010641410015523434
a O 0 0.012681250460445881
high O 0 0.022113464772701263
- O 1 0.8534939289093018
penetrance O 1 0.9976032376289368
autosomal B-Disease 1 0.9997790455818176
dominant I-Disease 1 0.9956412315368652
disease I-Disease 1 0.999646782875061
that O 0 0.019324904307723045
predisposes O 1 0.9854602217674255
to O 0 0.008493606932461262
hundreds O 0 0.013615273870527744
or O 0 0.009794886223971844
thousands O 0 0.02124520018696785
of O 0 0.028777441009879112
colorectal B-Disease 1 0.9999372959136963
adenomas I-Disease 1 0.9996053576469421
and I-Disease 0 0.09685054421424866
carcinoma I-Disease 1 0.9996017813682556
and O 0 0.007662022951990366
that O 0 0.006213145796209574
results O 0 0.014322386123239994
from O 0 0.011547552421689034
truncating O 1 0.9736166596412659
mutations O 1 0.9843770265579224
in O 0 0.014529058709740639
the O 0 0.020180711522698402
APC B-Disease 1 0.9190138578414917
gene O 1 0.8931173086166382
. O 0 0.04261191934347153

A O 0 0.04616812616586685
variant O 0 0.35687845945358276
of O 0 0.02976340986788273
FAP B-Disease 1 0.9966630339622498
is O 0 0.33625471591949463
attenuated B-Disease 1 0.9987025260925293
adenomatous I-Disease 1 0.9999282360076904
polyposis I-Disease 1 0.9999476671218872
coli I-Disease 1 0.9994779229164124
, O 0 0.015522153116762638
which O 0 0.008501997217535973
results O 0 0.012748501263558865
from O 0 0.009568016976118088
germ O 1 0.7934027314186096
- O 0 0.11152317374944687
line O 0 0.017389746382832527
mutations O 1 0.5492118000984192
in O 0 0.0055019427090883255
the O 0 0.005512916948646307
5 O 0 0.007162866182625294
and O 0 0.0041610547341406345
3 O 0 0.008741783909499645
regions O 0 0.014566759578883648
of O 0 0.008307925425469875
the O 0 0.014945190399885178
APC B-Disease 1 0.8813692331314087
gene O 1 0.809760332107544
. O 0 0.044568877667188644

Attenuated B-Disease 1 0.9970880150794983
adenomatous I-Disease 1 0.9997889399528503
polyposis I-Disease 1 0.9999057054519653
coli I-Disease 1 0.9997314810752869
patients O 1 0.9981997013092041
have O 0 0.019849449396133423
" O 0 0.02037692815065384
multiple O 0 0.179578498005867
" O 0 0.20742295682430267
colorectal B-Disease 1 0.9998738765716553
adenomas I-Disease 1 0.9989965558052063
( O 0 0.0290348082780838
typically O 0 0.019895626232028008
fewer O 0 0.015223659574985504
than O 0 0.007695275358855724
100 O 0 0.008611040189862251
) O 0 0.008254190906882286
without O 0 0.008402340114116669
the O 0 0.010206923820078373
florid O 1 0.6790237426757812
phenotype O 1 0.9660521745681763
of O 0 0.017942557111382484
classical O 0 0.04405391216278076
FAP B-Disease 1 0.9881249666213989
. O 0 0.04652585834264755

Another O 0 0.02863827347755432
group O 0 0.019466064870357513
of O 0 0.012848728336393833
patients O 1 0.9493014812469482
with O 0 0.01123475655913353
multiple O 0 0.35374996066093445
adenomas B-Disease 1 0.9958394765853882
has O 0 0.010225960984826088
no O 0 0.009073145687580109
mutations O 1 0.8364428877830505
in O 0 0.00661809416487813
the O 0 0.007893948815762997
APC B-Disease 1 0.9190212488174438
gene O 0 0.4364675283432007
, O 0 0.005899656098335981
and O 0 0.004884258843958378
their O 0 0.007155630737543106
phenotype O 1 0.9800395965576172
probably O 0 0.012069359421730042
results O 0 0.01192542351782322
from O 0 0.007472141645848751
variation O 0 0.015530738048255444
at O 0 0.006123779341578484
a O 0 0.008241027593612671
locus O 0 0.3997344970703125
, O 0 0.007745753042399883
or O 0 0.010621507652103901
loci O 0 0.4422837197780609
, O 0 0.00786605291068554
elsewhere O 0 0.013649926520884037
in O 0 0.008531575091183186
the O 0 0.012711391784250736
genome O 0 0.1367400586605072
. O 0 0.032517027109861374

Recently O 0 0.033582475036382675
, O 0 0.012106024660170078
however O 0 0.00958248320966959
, O 0 0.007516597863286734
a O 0 0.013870872557163239
missense O 1 0.8194048404693604
variant O 1 0.5040830373764038
of O 0 0.013994312845170498
APC B-Disease 1 0.9018850922584534
( O 0 0.019454600289463997
I1307K O 0 0.3225198984146118
) O 0 0.009855889715254307
was O 0 0.0057860370725393295
described O 0 0.00897105410695076
that O 0 0.005054846405982971
confers O 0 0.0922980010509491
an O 0 0.007750115357339382
increased O 0 0.05048055946826935
risk O 1 0.942259669303894
of O 0 0.1211857944726944
colorectal B-Disease 1 0.9999749660491943
tumors I-Disease 1 0.9997971653938293
, O 0 0.015230774879455566
including O 0 0.014429917559027672
multiple O 0 0.3256677985191345
adenomas B-Disease 1 0.9947184324264526
, O 0 0.01402546837925911
in O 0 0.016503438353538513
Ashkenazim O 1 0.8061740398406982
. O 0 0.03717559576034546

We O 0 0.01223051082342863
have O 0 0.008241233415901661
studied O 0 0.00994021911174059
a O 0 0.006659505423158407
set O 0 0.0065422519110143185
of O 0 0.007912185043096542
164 O 0 0.11166417598724365
patients O 1 0.9829658269882202
with O 0 0.02020328864455223
multiple O 1 0.961864709854126
colorectal B-Disease 1 0.9999409914016724
adenomas I-Disease 1 0.999393105506897
and I-Disease 0 0.02522953785955906
/ I-Disease 1 0.8473861813545227
or I-Disease 0 0.040999989956617355
carcinoma I-Disease 1 0.9993792772293091
and O 0 0.015409902669489384
analyzed O 0 0.05514755845069885
codons O 1 0.5352778434753418
1263 O 1 0.958498477935791
- O 1 0.5700847506523132
1377 O 1 0.9481434226036072
( O 0 0.031020091846585274
exon O 1 0.6678991317749023
15G O 1 0.5779454112052917
) O 0 0.013071793131530285
of O 0 0.007801451254636049
the O 0 0.009952131658792496
APC B-Disease 1 0.8400070071220398
gene O 1 0.6655040383338928
for O 0 0.012801108881831169
germ O 1 0.7247724533081055
- O 0 0.0880565494298935
line O 0 0.032194532454013824
variants O 0 0.06599191576242447
. O 0 0.03355289250612259

Three O 0 0.025684764608740807
patients O 1 0.8865569233894348
with O 0 0.01139803696423769
the O 0 0.011866402812302113
I1307K O 1 0.8843321204185486
allele O 1 0.8772962093353271
were O 0 0.009053466841578484
detected O 0 0.029786663129925728
, O 0 0.005901893600821495
each O 0 0.006858134642243385
of O 0 0.01074159611016512
Ashkenazi O 1 0.5289134979248047
descent O 0 0.06287462264299393
. O 0 0.03810475766658783

Four O 0 0.03149202838540077
patients O 1 0.8052567839622498
had O 0 0.015859652310609818
a O 0 0.016921496018767357
germ O 1 0.8063259720802307
- O 0 0.07113193720579147
line O 0 0.028891514986753464
E1317Q O 1 0.9014664888381958
missense O 1 0.9476982355117798
variant O 0 0.4477110207080841
of O 0 0.010526876896619797
APC O 1 0.5022822618484497
that O 0 0.0051473332569003105
was O 0 0.00450686551630497
not O 0 0.003302426775917411
present O 0 0.004042720887809992
in O 0 0.0036288730334490538
controls O 0 0.007719476241618395
; O 0 0.003876990871503949
one O 0 0.0026114413049072027
of O 0 0.003065967932343483
these O 0 0.002974316943436861
individuals O 0 0.006246963050216436
had O 0 0.004334484227001667
an O 0 0.0049790493212640285
unusually O 0 0.015656180679798126
large O 0 0.007873532362282276
number O 0 0.006477704271674156
of O 0 0.008058620616793633
metaplastic B-Disease 1 0.9493991732597351
polyps I-Disease 1 0.9913932085037231
of I-Disease 0 0.011272082105278969
the I-Disease 0 0.017051421105861664
colorectum I-Disease 1 0.7480705976486206
. O 0 0.03641640394926071

There O 0 0.019536908715963364
is O 0 0.011077534407377243
increasing O 0 0.015610947273671627
evidence O 0 0.009032913483679295
that O 0 0.004664504900574684
there O 0 0.00551212765276432
exist O 0 0.010293200612068176
germ O 0 0.3501666784286499
- O 0 0.020754484459757805
line O 0 0.012461588717997074
variants O 0 0.015417449176311493
of O 0 0.005576915107667446
the O 0 0.008429331704974174
APC B-Disease 1 0.9268812537193298
gene O 1 0.7788051962852478
that O 0 0.00794378574937582
predispose O 0 0.387984961271286
to O 0 0.0048577263951301575
the O 0 0.00577025581151247
development O 0 0.01036552432924509
of O 0 0.013166924007236958
multiple O 1 0.9420867562294006
colorectal B-Disease 1 0.999941349029541
adenomas I-Disease 1 0.999603807926178
and I-Disease 0 0.18430933356285095
carcinoma I-Disease 1 0.9997687935829163
, O 0 0.01050850935280323
but O 0 0.007050065789371729
without O 0 0.009304370731115341
the O 0 0.009335445240139961
florid O 1 0.8944907188415527
phenotype O 1 0.9871254563331604
of O 0 0.010691981762647629
classical O 0 0.018240224570035934
FAP B-Disease 1 0.989090621471405
, O 0 0.008308782242238522
and O 0 0.005846883170306683
possibly O 0 0.013609180226922035
with O 0 0.007097927387803793
importance O 0 0.01767236925661564
for O 0 0.08626712113618851
colorectal B-Disease 1 0.9999703168869019
cancer I-Disease 1 0.9999392032623291
risk O 1 0.9744967222213745
in O 0 0.009178495034575462
the O 0 0.007571731694042683
general O 0 0.012761836871504784
population O 0 0.019404839724302292
. O 0 0.014472099021077156
. O 0 0.024657685309648514

Genomic O 0 0.26945310831069946
structure O 0 0.027079632505774498
of O 0 0.014415419660508633
the O 0 0.018144376575946808
human O 1 0.9683849215507507
congenital B-Disease 1 0.9999350309371948
chloride I-Disease 1 0.998028576374054
diarrhea I-Disease 1 0.9999104738235474
( O 1 0.7818836569786072
CLD B-Disease 1 0.994705855846405
) O 0 0.06911222636699677
gene O 1 0.7936155200004578
. O 0 0.049011532217264175

Congenital B-Disease 1 0.9998410940170288
chloride I-Disease 1 0.9981024861335754
diarrhea I-Disease 1 0.9999092817306519
( O 1 0.5833818316459656
CLD B-Disease 1 0.9960289001464844
) O 0 0.02271323651075363
is O 0 0.013072051107883453
caused O 0 0.28496024012565613
by O 0 0.010642929933965206
mutations O 1 0.9103826284408569
in O 0 0.007783569861203432
a O 0 0.011513064615428448
gene O 0 0.3757626712322235
which O 0 0.012385966256260872
encodes O 0 0.10962077975273132
an O 0 0.02664964459836483
intestinal O 1 0.9992319345474243
anion O 1 0.9740557670593262
transporter O 1 0.9358923435211182
. O 0 0.051572658121585846

We O 0 0.013538374565541744
report O 0 0.012161127291619778
here O 0 0.007916761562228203
the O 0 0.00603323383256793
complete O 0 0.012048675678670406
genomic O 0 0.0670868456363678
organization O 0 0.011434018611907959
of O 0 0.006432645488530397
the O 0 0.008771070279181004
human O 0 0.08249523490667343
CLD B-Disease 1 0.9954118132591248
gene O 1 0.8256174921989441
which O 0 0.014725099317729473
spans O 0 0.06356969475746155
approximately O 0 0.020327288657426834
39kb O 0 0.15118443965911865
, O 0 0.008771376684308052
and O 0 0.009385472163558006
comprises O 0 0.02116900309920311
21 O 0 0.031044557690620422
exons O 0 0.10616078227758408
. O 0 0.03998110815882683

All O 0 0.032653823494911194
exon O 0 0.4317399263381958
/ O 0 0.28302574157714844
intron O 0 0.4087331295013428
boundaries O 0 0.018112225458025932
conform O 0 0.021746724843978882
to O 0 0.009050028398633003
the O 0 0.012773598544299603
GT O 1 0.550768256187439
/ O 1 0.656768262386322
AG O 1 0.7906665205955505
rule O 0 0.05551721528172493
. O 0 0.04005415737628937

An O 0 0.017382990568876266
analysis O 0 0.0195621270686388
of O 0 0.00957828015089035
the O 0 0.011258299462497234
putative O 0 0.10353109985589981
promoter O 0 0.16574357450008392
region O 0 0.022287525236606598
sequence O 0 0.020363999530673027
shows O 0 0.01491771824657917
a O 0 0.01277978252619505
putative O 0 0.13956694304943085
TATA O 0 0.27914297580718994
box O 0 0.024490542709827423
and O 0 0.00924185011535883
predicts O 0 0.05206986516714096
multiple O 0 0.03639157488942146
transcription O 0 0.3393154442310333
factor O 0 0.05073627084493637
binding O 0 0.030217409133911133
sites O 0 0.026274992153048515
. O 0 0.026715697720646858

The O 0 0.021986179053783417
genomic O 0 0.13009455800056458
structure O 0 0.016714787110686302
was O 0 0.006974417716264725
determined O 0 0.009584949351847172
using O 0 0.006766458507627249
DNA O 0 0.01219942420721054
from O 0 0.00553024560213089
several O 0 0.004869325086474419
sources O 0 0.00694392342120409
including O 0 0.005864798557013273
multiple O 0 0.01290954276919365
large O 0 0.011382176540791988
- O 0 0.04794875159859657
insert O 0 0.31200334429740906
libaries O 1 0.5292147397994995
and O 0 0.01273829024285078
genomic O 0 0.3096812963485718
DNA O 0 0.050783123821020126
from O 0 0.02045181579887867
Finnish O 0 0.39991113543510437
CLD B-Disease 1 0.9967827796936035
patients O 1 0.9925426244735718
and O 0 0.0206990297883749
controls O 0 0.059414658695459366
. O 0 0.0392739400267601

Exon O 0 0.4837248623371124
- O 0 0.06214624270796776
specific O 0 0.023738481104373932
primers O 0 0.04860153794288635
developed O 0 0.014495893381536007
in O 0 0.005546450149267912
this O 0 0.00437895068898797
study O 0 0.00834940280765295
will O 0 0.005759869702160358
facilitate O 0 0.02563953585922718
mutation O 1 0.9872652292251587
screening O 0 0.25734540820121765
studies O 0 0.015053349547088146
of O 0 0.009984117932617664
patients O 1 0.9673495888710022
with O 0 0.010431955568492413
the O 0 0.02052321471273899
disease O 1 0.9991952776908875
. O 0 0.04303138330578804

Genomic O 0 0.2487042099237442
sequencing O 0 0.05970148369669914
of O 0 0.01527654193341732
a O 0 0.023295411840081215
BAC O 1 0.9828402996063232
clone O 1 0.978617250919342
H O 1 0.887900710105896
_ O 0 0.028365112841129303
RG364P16 O 0 0.3329336941242218
revealed O 0 0.01949148252606392
the O 0 0.00670394254848361
presence O 0 0.00933646410703659
of O 0 0.005064112134277821
another O 0 0.007796956226229668
, O 0 0.006239206995815039
highly O 0 0.015337402932345867
homologous O 0 0.47095733880996704
gene O 0 0.3039739429950714
3 O 0 0.011968505568802357
of O 0 0.007507411763072014
the O 0 0.010688971728086472
CLD B-Disease 1 0.9949835538864136
gene O 1 0.5060094594955444
, O 0 0.0071853469125926495
with O 0 0.005876615177839994
a O 0 0.008438948541879654
similar O 0 0.012583100236952305
genomic O 0 0.09984904527664185
structure O 0 0.011724692769348621
, O 0 0.006228217855095863
recently O 0 0.010749523527920246
identified O 0 0.012160278856754303
as O 0 0.006928358227014542
the O 0 0.01654387079179287
Pendred B-Disease 1 0.9976805448532104
syndrome I-Disease 1 0.9999682903289795
gene O 1 0.9950963854789734
( O 0 0.12965236604213715
PDS B-Disease 1 0.9566003084182739
) O 0 0.02531025931239128
. O 0 0.019697220996022224
. O 0 0.02852914109826088

The O 0 0.04051792994141579
APCI1307K O 1 0.9556366205215454
allele O 1 0.9754078388214111
and O 0 0.027492182329297066
cancer B-Disease 1 0.9992146492004395
risk O 1 0.7234473824501038
in O 0 0.008026164956390858
a O 0 0.00885902438312769
community O 0 0.010773838497698307
- O 0 0.018647227436304092
based O 0 0.009678339585661888
study O 0 0.013703313656151295
of O 0 0.012156006880104542
Ashkenazi O 0 0.46387019753456116
Jews O 0 0.03464854136109352
. O 0 0.03017038106918335

Mutations O 1 0.9577707052230835
in O 0 0.02487022802233696
APC O 1 0.7916597723960876
are O 0 0.014703398570418358
classically O 1 0.7560349106788635
associated O 0 0.06505618244409561
with O 0 0.06229932978749275
familial B-Disease 1 0.9997137188911438
adenomatous I-Disease 1 0.9999592304229736
polyposis I-Disease 1 0.9999246597290039
( O 1 0.916387677192688
FAP B-Disease 1 0.998034656047821
) O 0 0.02073131501674652
, O 0 0.010202488861978054
a O 0 0.017960969358682632
highly O 0 0.14686766266822815
penetrant O 1 0.9979866743087769
autosomal B-Disease 1 0.999786913394928
dominant I-Disease 1 0.9967867136001587
disorder I-Disease 1 0.9999239444732666
characterized O 1 0.9905416369438171
by O 0 0.12368809431791306
multiple O 1 0.9925129413604736
intestinal O 1 0.9999315738677979
polyps B-Disease 1 0.9991683959960938
and O 0 0.010282563045620918
, O 0 0.009373589418828487
without O 0 0.014400064013898373
surgical O 1 0.9603263139724731
intervention O 0 0.13304822146892548
, O 0 0.006531580816954374
the O 0 0.00770532013848424
development O 0 0.015363380312919617
of O 0 0.042400334030389786
colorectal B-Disease 1 0.9999371767044067
cancer I-Disease 1 0.9998249411582947
( O 0 0.26979002356529236
CRC B-Disease 1 0.9333656430244446
) O 0 0.03797624632716179
. O 0 0.03539746627211571

APC B-Disease 1 0.7362747192382812
is O 0 0.03038422204554081
a O 0 0.03736673668026924
tumour O 1 0.9976536631584167
- O 1 0.8411329388618469
suppressor O 1 0.9944009184837341
gene O 1 0.928583025932312
, O 0 0.015014387667179108
and O 0 0.014475520700216293
somatic O 1 0.8649747371673584
loss O 0 0.3137604594230652
occurs O 0 0.3394595682621002
in O 0 0.030147075653076172
tumours B-Disease 1 0.994186282157898
. O 0 0.04305778071284294

The O 0 0.0381869375705719
germline O 1 0.9851003289222717
T O 1 0.8901461362838745
- O 0 0.036406535655260086
to O 0 0.009329449385404587
- O 0 0.02151082456111908
A O 0 0.01427848357707262
transversion O 0 0.1667955219745636
responsible O 0 0.01733965054154396
for O 0 0.008312114514410496
the O 0 0.01274736039340496
APC O 1 0.8705434203147888
I1307K O 1 0.7871689796447754
allele O 1 0.729977548122406
converts O 0 0.024533754214644432
the O 0 0.010692505165934563
wild O 0 0.021759195253252983
- O 0 0.03181248903274536
type O 0 0.024400876834988594
sequence O 0 0.016636760905385017
to O 0 0.006692260969430208
a O 0 0.012918478809297085
homopolymer O 1 0.9419273138046265
tract O 1 0.9927387833595276
( O 0 0.02686476893723011
A8 O 1 0.6803576350212097
) O 0 0.010980259627103806
that O 0 0.005803805775940418
is O 0 0.00900233443826437
genetically O 0 0.4388216733932495
unstable O 1 0.6535663604736328
and O 0 0.01181957870721817
prone O 1 0.6647006869316101
to O 0 0.017388785257935524
somatic O 1 0.965825080871582
mutation O 1 0.9800441861152649
. O 0 0.04477034881711006

The O 0 0.038817085325717926
I1307K O 1 0.6881101131439209
allele O 1 0.7710131406784058
was O 0 0.016557298600673676
found O 0 0.01393822766840458
in O 0 0.01202448084950447
6 O 0 0.02741413563489914
. O 0 0.027631480246782303

1 O 0 0.03352782875299454
% O 0 0.02338293567299843
of O 0 0.01622534729540348
unselected O 0 0.42361947894096375
Ashkenazi O 1 0.5271403789520264
Jews O 0 0.01766929402947426
and O 0 0.008800355717539787
higher O 0 0.01552226860076189
proportions O 0 0.07372231036424637
of O 0 0.009361647069454193
Ashkenazim O 1 0.5160924792289734
with O 0 0.008978324010968208
family O 0 0.014272673986852169
or O 0 0.008966311812400818
personal O 0 0.015059877187013626
histories O 0 0.03409022092819214
of O 0 0.013486426323652267
CRC B-Disease 1 0.9340201616287231
( O 0 0.028927123174071312
ref O 0 0.3894881010055542
. O 0 0.013793534599244595
2 O 0 0.020022178068757057
) O 0 0.022391168400645256
. O 0 0.025502866134047508

To O 0 0.01792941242456436
evaluate O 0 0.026965999975800514
the O 0 0.009884643368422985
role O 0 0.014134719967842102
of O 0 0.009033574722707272
I1307K O 1 0.6442477107048035
in O 0 0.01428958959877491
cancer B-Disease 1 0.9980011582374573
, O 0 0.009636550210416317
we O 0 0.007185993250459433
genotyped O 0 0.2595839202404022
5 O 0 0.015806829556822777
, O 0 0.01121256873011589
081 O 1 0.9653856158256531
Ashkenazi O 1 0.6107254028320312
volunteers O 0 0.01969001442193985
in O 0 0.008744664490222931
a O 0 0.01149781420826912
community O 0 0.02348273992538452
survey O 0 0.03457941114902496
. O 0 0.02903015911579132

Risk O 1 0.7845865488052368
of O 0 0.023667462170124054
developing O 1 0.9360858798027039
colorectal B-Disease 1 0.9998127818107605
, I-Disease 0 0.08118891716003418
breast I-Disease 1 0.9990081191062927
and I-Disease 0 0.010229667648673058
other I-Disease 0 0.01106637716293335
cancers I-Disease 1 0.9977201819419861
were O 0 0.008486826904118061
compared O 0 0.01568884402513504
between O 0 0.014413399621844292
genotyped O 1 0.8452770709991455
I1307K O 1 0.8231780529022217
carriers O 0 0.07481121271848679
and O 0 0.007676552981138229
non O 0 0.017797045409679413
- O 0 0.04148535802960396
carriers O 0 0.02546059712767601
and O 0 0.0053143855184316635
their O 0 0.004873428959399462
first O 0 0.007616390008479357
- O 0 0.028394576162099838
degree O 0 0.023209525272250175
relatives O 0 0.042892761528491974
. O 0 0.034530311822891235

Sperm O 0 0.27137118577957153
DNA O 0 0.05768447741866112
analysis O 0 0.024820012971758842
in O 0 0.014187255874276161
a O 0 0.03022490069270134
Friedreich B-Disease 1 0.9937921166419983
ataxia I-Disease 1 0.9990255832672119
premutation O 1 0.9864461421966553
carrier O 1 0.5404713153839111
suggests O 0 0.035575322806835175
both O 0 0.015560446307063103
meiotic O 1 0.8363083600997925
and O 0 0.013029475696384907
mitotic O 0 0.1622086614370346
expansion O 0 0.02301880158483982
in O 0 0.012089661322534084
the O 0 0.018399827182292938
FRDA B-Disease 1 0.8559160232543945
gene O 1 0.6954512596130371
. O 0 0.044320497661828995

Friedreich B-Disease 1 0.9931759238243103
ataxia I-Disease 1 0.9957119226455688
is O 0 0.0228628721088171
usually O 0 0.021047178655862808
caused O 0 0.06781795620918274
by O 0 0.007442793808877468
an O 0 0.00593578303232789
expansion O 0 0.010420717298984528
of O 0 0.0063535594381392
a O 0 0.011032174341380596
GAA O 0 0.05584842711687088
trinucleotide O 1 0.9632678031921387
repeat O 0 0.061026692390441895
in O 0 0.014516602270305157
intron O 0 0.47416985034942627
1 O 0 0.016664056107401848
of O 0 0.01002628542482853
the O 0 0.017873521894216537
FRDA B-Disease 1 0.9003773927688599
gene O 1 0.7490676641464233
. O 0 0.04217054694890976

Occasionally O 0 0.03866739943623543
, O 0 0.011677656322717667
a O 0 0.010233377106487751
fully O 0 0.014246038161218166
expanded O 0 0.015261177904903889
allele O 0 0.4527791738510132
has O 0 0.007030178792774677
been O 0 0.005885098595172167
found O 0 0.007004110142588615
to O 0 0.004785705823451281
arise O 0 0.01370177324861288
from O 0 0.0065511055290699005
a O 0 0.008913983590900898
premutation O 0 0.044738318771123886
of O 0 0.008278844878077507
100 O 0 0.010922661982476711
or O 0 0.012011175975203514
less O 0 0.022813845425844193
triplet O 1 0.7434456944465637
repeats O 0 0.111470527946949
. O 0 0.03847578540444374

We O 0 0.01648045890033245
have O 0 0.011264330707490444
examined O 0 0.021815812215209007
the O 0 0.010285514406859875
sperm O 0 0.043872393667697906
DNA O 0 0.03150423988699913
of O 0 0.011397446505725384
a O 0 0.02118808589875698
premutation O 1 0.6917389035224915
carrier O 0 0.13220076262950897
. O 0 0.03830725699663162

This O 0 0.028779469430446625
mans O 0 0.08845533430576324
leucocyte O 0 0.4953002333641052
DNA O 0 0.05448174476623535
showed O 0 0.02197747305035591
one O 0 0.01198625098913908
normal O 0 0.026233024895191193
allele O 0 0.3383881449699402
and O 0 0.007258996367454529
one O 0 0.009193520992994308
allele O 0 0.09344109147787094
of O 0 0.009598957374691963
approximately O 0 0.019083907827734947
100 O 0 0.021013250574469566
repeats O 0 0.054695989936590195
. O 0 0.02993994578719139

His O 0 0.02868036739528179
sperm O 0 0.06780458986759186
showed O 0 0.02544477768242359
an O 0 0.008986757136881351
expanded O 0 0.01744200848042965
allele O 0 0.10369835793972015
in O 0 0.00701563386246562
a O 0 0.008103716187179089
tight O 0 0.013751914724707603
range O 0 0.009797115810215473
centering O 0 0.01685679331421852
on O 0 0.005638619419187307
a O 0 0.007648066151887178
size O 0 0.011265212669968605
of O 0 0.0075491731986403465
approximately O 0 0.021082373335957527
320 O 0 0.06527478992938995
trinucleotide O 1 0.9334741830825806
repeats O 0 0.1759031116962433
. O 0 0.049461737275123596

His O 0 0.037463635206222534
affected O 0 0.1125655397772789
son O 0 0.04226509481668472
has O 0 0.01550733856856823
repeat O 0 0.04406510666012764
sizes O 0 0.024260373786091805
of O 0 0.013193773105740547
1040 O 0 0.3242560029029846
and O 0 0.017996428534388542
540 O 0 0.07465548813343048
. O 0 0.040898289531469345

These O 0 0.013307029381394386
data O 0 0.013975381851196289
suggest O 0 0.013471062295138836
that O 0 0.006019954103976488
expansion O 0 0.011123297736048698
occurs O 0 0.0132336700335145
in O 0 0.003955576103180647
two O 0 0.004191078711301088
stages O 0 0.01104676816612482
, O 0 0.00452566659078002
the O 0 0.004550628364086151
first O 0 0.006528673227876425
during O 0 0.011135715059936047
meiosis O 0 0.21636821329593658
followed O 0 0.011435047723352909
by O 0 0.008239214308559895
a O 0 0.010308665223419666
second O 0 0.017041465267539024
mitotic O 0 0.14256365597248077
expansion O 0 0.04371268302202225
. O 0 0.034406628459692

We O 0 0.010956041514873505
also O 0 0.007079682778567076
show O 0 0.007242010440677404
that O 0 0.003227143781259656
in O 0 0.0036584592889994383
all O 0 0.004176401533186436
informative O 0 0.013982816599309444
carrier O 0 0.02203099988400936
father O 0 0.011459345929324627
to O 0 0.005751023534685373
affected O 0 0.1636914312839508
child O 0 0.13742072880268097
transmissions O 0 0.028996862471103668
, O 0 0.0049006203189492226
with O 0 0.004270454403012991
the O 0 0.004758220631629229
notable O 0 0.007878689095377922
exception O 0 0.008534656837582588
of O 0 0.005118806380778551
the O 0 0.007429797202348709
premutation O 0 0.4100320339202881
carrier O 0 0.025003887712955475
, O 0 0.006375355180352926
the O 0 0.007194908335804939
expansion O 0 0.016903087496757507
size O 0 0.019624579697847366
decreases O 0 0.06304007023572922
. O 0 0.015107310377061367
. O 0 0.022234957665205002

The O 0 0.03297259286046028
R496H O 1 0.7206801772117615
mutation O 1 0.9418749809265137
of O 0 0.013600599020719528
arylsulfatase O 1 0.73403400182724
A O 0 0.01511608250439167
does O 0 0.0152137978002429
not O 0 0.013198571279644966
cause O 1 0.9167190194129944
metachromatic B-Disease 1 0.9913642406463623
leukodystrophy I-Disease 1 0.997529923915863
. O 0 0.06310202181339264

Deficiency B-Disease 1 0.9962759017944336
of I-Disease 0 0.026869036257267
arylsulfatase I-Disease 1 0.8287420272827148
A I-Disease 0 0.0339723639190197
( O 0 0.03819707781076431
ARSA O 1 0.9816797971725464
) O 0 0.040006123483181
enzyme O 0 0.4467843472957611
activity O 0 0.09676708281040192
causes O 1 0.9891968369483948
metachromatic B-Disease 1 0.9906554818153381
leukodystrophy I-Disease 1 0.9985777139663696
( O 0 0.32289615273475647
MLD B-Disease 1 0.9832005500793457
) O 0 0.059130750596523285
. O 0 0.05164254084229469

A O 0 0.026938239112496376
number O 0 0.02017311006784439
of O 0 0.02039279229938984
ARSA O 1 0.9953908920288086
gene O 1 0.9923978447914124
mutations O 1 0.9949393272399902
responsible O 0 0.0371338352560997
for O 0 0.013790836557745934
MLD B-Disease 1 0.9883280396461487
have O 0 0.011434955522418022
been O 0 0.014176703058183193
identified O 0 0.029737643897533417
. O 0 0.027270061895251274

Recently O 0 0.03974023833870888
, O 0 0.015575523488223553
the O 0 0.01594178006052971
R496H O 1 0.7289785742759705
mutation O 1 0.9479359984397888
of O 0 0.014709762297570705
ARSA O 1 0.9465730786323547
was O 0 0.00981827825307846
proposed O 0 0.011171171441674232
to O 0 0.004700401797890663
be O 0 0.0047833421267569065
a O 0 0.008068579249083996
cause O 0 0.05431108549237251
of O 0 0.014445598237216473
MLD B-Disease 1 0.9933847784996033
( O 0 0.037963710725307465
Draghia O 1 0.7956174612045288
et O 0 0.08972389250993729
al O 0 0.0315043106675148
. O 0 0.011226601898670197
, O 0 0.010588206350803375
1997 O 0 0.023629389703273773
) O 0 0.02097472734749317
. O 0 0.02278100699186325

We O 0 0.014873099513351917
have O 0 0.010935083962976933
investigated O 0 0.02288028597831726
the O 0 0.011895339004695415
R496H O 1 0.863655686378479
mutation O 1 0.951068103313446
and O 0 0.007364828139543533
found O 0 0.00965910218656063
this O 0 0.006788128521293402
mutation O 1 0.6909931302070618
at O 0 0.007046321406960487
a O 0 0.007592747453600168
relatively O 0 0.01071091741323471
high O 0 0.008921263739466667
frequency O 0 0.012285570614039898
in O 0 0.004751784726977348
an O 0 0.005178165156394243
African O 0 0.013584078289568424
American O 0 0.01099990401417017
population O 0 0.014808764681220055
( O 0 0.014855781570076942
f O 0 0.02481081336736679
= O 0 0.02783578261733055
0 O 0 0.016797123476862907
. O 0 0.007782823406159878
09 O 0 0.026665078476071358
, O 0 0.010877391323447227
n O 0 0.02984977699816227
= O 0 0.04016118496656418
61 O 0 0.03216928616166115
subjects O 0 0.02772429957985878
) O 0 0.01975441724061966
. O 0 0.0244029201567173

The O 0 0.042014848440885544
ARSA O 1 0.9582004547119141
enzyme O 0 0.1688319593667984
activity O 0 0.020319366827607155
in O 0 0.007455926854163408
subjects O 0 0.00993655901402235
with O 0 0.004643595777451992
and O 0 0.0037145831156522036
without O 0 0.006387222092598677
the O 0 0.006686915177851915
R496H O 1 0.9094749093055725
mutation O 1 0.9789888858795166
was O 0 0.0067186313681304455
determined O 0 0.008610389195382595
and O 0 0.004175160080194473
found O 0 0.005905898753553629
to O 0 0.004657381679862738
be O 0 0.0069806226529181
normal O 0 0.026157069951295853
. O 0 0.023571515455842018

It O 0 0.014658543281257153
is O 0 0.010279380716383457
therefore O 0 0.011276387609541416
concluded O 0 0.012619268149137497
that O 0 0.005463861394673586
the O 0 0.008056379854679108
R496H O 1 0.7776884436607361
mutation O 1 0.9653121829032898
of O 0 0.013270964846014977
ARSA O 1 0.987800121307373
does O 0 0.013900757767260075
not O 0 0.00853284914046526
negatively O 0 0.022016819566488266
influence O 0 0.011317312717437744
the O 0 0.00649998476728797
activity O 0 0.013441963121294975
of O 0 0.008188900537788868
ARSA O 1 0.9034419059753418
and O 0 0.0076752095483243465
is O 0 0.00798098836094141
not O 0 0.00786808505654335
a O 0 0.0143196489661932
cause O 0 0.09481596946716309
of O 0 0.0315777026116848
MLD B-Disease 1 0.9761571884155273

Down O 0 0.04370773956179619
- O 0 0.05567287653684616
regulation O 0 0.03828022629022598
of O 0 0.019695576280355453
transmembrane O 1 0.9560292363166809
carbonic O 1 0.9861350655555725
anhydrases O 1 0.9768224954605103
in O 0 0.16279034316539764
renal B-Disease 1 0.9999184608459473
cell I-Disease 1 0.9972320199012756
carcinoma I-Disease 1 0.9998600482940674
cell O 1 0.8484647274017334
lines O 0 0.028833674266934395
by O 0 0.015655415132641792
wild O 0 0.04863077402114868
- O 1 0.5101864337921143
type O 0 0.47071096301078796
von B-Disease 1 0.92851322889328
Hippel I-Disease 1 0.9915482401847839
- I-Disease 1 0.8655421733856201
Lindau I-Disease 1 0.9769313931465149
transgenes O 1 0.9222107529640198
. O 0 0.07052537798881531

To O 0 0.027483439072966576
discover O 0 0.06470662355422974
genes O 0 0.14648744463920593
involved O 0 0.02945002354681492
in O 0 0.02183358557522297
von B-Disease 1 0.6961991786956787
Hippel I-Disease 1 0.9913321733474731
- I-Disease 1 0.9034788608551025
Lindau I-Disease 1 0.9925050735473633
( O 0 0.07805796712636948
VHL B-Disease 1 0.9925398230552673
) O 0 0.026910612359642982
- O 0 0.2939245402812958
mediated O 1 0.9104002118110657
carcinogenesis O 1 0.9904173612594604
, O 0 0.012921451590955257
we O 0 0.010349689051508904
used O 0 0.02408875897526741
renal B-Disease 1 0.9998279809951782
cell I-Disease 1 0.9939543604850769
carcinoma I-Disease 1 0.999752938747406
cell O 1 0.9425124526023865
lines O 0 0.10512244701385498
stably O 1 0.7819923162460327
transfected O 1 0.9165711998939514
with O 0 0.021059798076748848
wild O 0 0.06950657814741135
- O 0 0.282977819442749
type O 1 0.5171176791191101
VHL O 1 0.9904705286026001
- O 1 0.544826090335846
expressing O 0 0.2504267990589142
transgenes O 1 0.7992258071899414
. O 0 0.06025099754333496

Large O 0 0.04735978692770004
- O 0 0.061460427939891815
scale O 0 0.04303910955786705
RNA O 0 0.05444036424160004
differential O 0 0.030777031555771828
display O 0 0.012742249295115471
technology O 0 0.00990209262818098
applied O 0 0.007655887398868799
to O 0 0.004197022877633572
these O 0 0.00486947363242507
cell O 0 0.02003142237663269
lines O 0 0.01544533483684063
identified O 0 0.012857911176979542
several O 0 0.008936114609241486
differentially O 0 0.16476400196552277
expressed O 0 0.01840813457965851
genes O 0 0.12317710369825363
, O 0 0.007224297616630793
including O 0 0.008615825325250626
an O 0 0.014309448190033436
alpha O 0 0.09252382814884186
carbonic O 1 0.9765074253082275
anhydrase O 1 0.9883335828781128
gene O 1 0.9003239274024963
, O 0 0.02960110828280449
termed O 0 0.37186744809150696
CA12 O 1 0.8647748231887817
. O 0 0.05426637828350067

The O 0 0.02203228510916233
deduced O 0 0.044661782681941986
protein O 0 0.03466668725013733
sequence O 0 0.016838684678077698
was O 0 0.006246383301913738
classified O 0 0.00940107274800539
as O 0 0.004543997347354889
a O 0 0.005248417612165213
one O 0 0.005903290119022131
- O 0 0.02315433695912361
pass O 0 0.01798226870596409
transmembrane O 0 0.34739598631858826
CA O 0 0.02316693402826786
possessing O 0 0.017333419993519783
an O 0 0.008994655683636665
apparently O 0 0.020802289247512817
intact O 0 0.03315948322415352
catalytic O 0 0.060740843415260315
domain O 0 0.022010216489434242
in O 0 0.008318398147821426
the O 0 0.010581445880234241
extracellular O 0 0.05152301490306854
CA O 0 0.04042097553610802
module O 0 0.05100392922759056
. O 0 0.032106753438711166

Reintroduced O 0 0.19494472444057465
wild O 0 0.0874052420258522
- O 0 0.23447927832603455
type O 0 0.38826021552085876
VHL B-Disease 1 0.984975278377533
strongly O 0 0.04058841988444328
inhibited O 0 0.3793255686759949
the O 0 0.013807332143187523
overexpression O 0 0.3907412886619568
of O 0 0.009874054230749607
the O 0 0.012810747139155865
CA12 O 1 0.9235755801200867
gene O 0 0.48413148522377014
in O 0 0.01435750164091587
the O 0 0.021068383008241653
parental O 1 0.9879283308982849
renal B-Disease 1 0.9998424053192139
cell I-Disease 1 0.9958478212356567
carcinoma I-Disease 1 0.999783456325531
cell O 1 0.9216400384902954
lines O 0 0.07723439484834671
. O 0 0.04518815502524376

Similar O 0 0.028440769761800766
results O 0 0.0195686724036932
were O 0 0.007656308356672525
obtained O 0 0.011258149519562721
with O 0 0.01072547398507595
CA9 O 1 0.9244049787521362
, O 0 0.01189352385699749
encoding O 0 0.033863529562950134
another O 0 0.01811607927083969
transmembrane O 0 0.2593255341053009
CA O 0 0.02277402952313423
with O 0 0.01119380071759224
an O 0 0.012978043407201767
intact O 0 0.043952133506536484
catalytic O 0 0.1854594349861145
domain O 0 0.05096179619431496
. O 0 0.03212673217058182

Although O 0 0.02316136658191681
both O 0 0.012047182768583298
domains O 0 0.023383168503642082
of O 0 0.007667213212698698
the O 0 0.012887607328593731
VHL B-Disease 1 0.992929995059967
protein O 0 0.15371590852737427
contribute O 0 0.019811388105154037
to O 0 0.006870942190289497
regulation O 0 0.015602274797856808
of O 0 0.008435585536062717
CA12 O 1 0.6956691145896912
expression O 0 0.026493575423955917
, O 0 0.006806351710110903
the O 0 0.008218029513955116
elongin O 1 0.5720396041870117
binding O 0 0.025632161647081375
domain O 0 0.023683035746216774
alone O 0 0.01738768443465233
could O 0 0.014156065881252289
effectively O 0 0.04649907723069191
regulate O 0 0.4354029893875122
CA9 O 1 0.9812191128730774
expression O 0 0.1488504856824875
. O 0 0.04404092952609062

We O 0 0.029763810336589813
mapped O 0 0.06254075467586517
CA12 O 1 0.5358222723007202
and O 0 0.03073243796825409
CA9 O 1 0.9854769110679626
loci O 1 0.892819881439209
to O 0 0.030061647295951843
chromosome O 1 0.9612699747085571
bands O 0 0.05942165106534958
15q22 O 0 0.440716028213501
and O 0 0.026149729266762733
17q21 O 0 0.30434131622314453
. O 0 0.04750008508563042

2 O 0 0.027813812717795372
respectively O 0 0.018751969560980797
, O 0 0.01199508085846901
regions O 0 0.02761027403175831
prone O 0 0.19659629464149475
to O 0 0.008585009723901749
amplification O 0 0.05225026234984398
in O 0 0.009792721830308437
some O 0 0.013479932211339474
human O 0 0.30589476227760315
cancers B-Disease 1 0.9985411167144775
. O 0 0.03824744373559952

Additional O 0 0.028417911380529404
experiments O 0 0.022948168218135834
are O 0 0.006476163864135742
needed O 0 0.008192961104214191
to O 0 0.004285539500415325
define O 0 0.009183800779283047
the O 0 0.004826337564736605
role O 0 0.008018754422664642
of O 0 0.006569288205355406
CA O 0 0.05818617343902588
IX O 1 0.5797669291496277
and O 0 0.007402461022138596
CA O 0 0.09956970810890198
XII O 1 0.6159732341766357
enzymes O 0 0.025634877383708954
in O 0 0.004879310727119446
the O 0 0.004496364388614893
regulation O 0 0.010179963894188404
of O 0 0.006096215452998877
pH O 0 0.3080084025859833
in O 0 0.007070363033562899
the O 0 0.008692673407495022
extracellular O 0 0.06987025588750839
microenvironment O 1 0.8101967573165894
and O 0 0.007265404332429171
its O 0 0.008977618999779224
potential O 0 0.02020798996090889
impact O 0 0.03214046359062195
on O 0 0.016938352957367897
cancer B-Disease 1 0.9984930753707886
cell O 0 0.44355878233909607
growth O 0 0.054595187306404114
. O 0 0.036233093589544296

A O 0 0.04501354321837425
gene O 0 0.17842677235603333
encoding O 0 0.045577023178339005
a O 0 0.020571794360876083
transmembrane O 0 0.45447707176208496
protein O 0 0.10646575689315796
is O 0 0.013800165615975857
mutated O 1 0.9830028414726257
in O 0 0.019979283213615417
patients O 1 0.9973854422569275
with O 0 0.40302154421806335
diabetes B-Disease 1 0.9999662637710571
mellitus I-Disease 1 0.9997466206550598
and O 1 0.6689470410346985
optic B-Disease 1 0.999472439289093
atrophy I-Disease 1 0.9997764229774475
( O 1 0.9788359999656677
Wolfram B-Disease 1 0.9988617897033691
syndrome I-Disease 1 0.9999165534973145
) O 0 0.07881611585617065
. O 0 0.04484836012125015

Wolfram B-Disease 1 0.9968569278717041
syndrome I-Disease 1 0.9998917579650879
( O 1 0.5603019595146179
WFS B-Disease 1 0.9950053095817566
; O 0 0.17909514904022217
OMIM O 1 0.9942118525505066
222300 O 1 0.8277071714401245
) O 0 0.023659272119402885
is O 0 0.016717897728085518
an O 0 0.04465465992689133
autosomal B-Disease 1 0.999774158000946
recessive I-Disease 1 0.9999558925628662
neurodegenerative I-Disease 1 0.9999488592147827
disorder I-Disease 1 0.9998843669891357
defined O 0 0.33197450637817383
by O 0 0.02149892970919609
young O 0 0.4402294456958771
- O 1 0.9316307306289673
onset O 1 0.9991023540496826
non O 1 0.6686383485794067
- O 1 0.9857327938079834
immune O 1 0.9993409514427185
insulin B-Disease 1 0.9987820982933044
- I-Disease 1 0.9867358803749084
dependent I-Disease 1 0.9909456968307495
diabetes I-Disease 1 0.9999349117279053
mellitus I-Disease 1 0.9995399713516235
and O 0 0.20755015313625336
progressive O 1 0.9925866723060608
optic B-Disease 1 0.9989913105964661
atrophy I-Disease 1 0.9973101615905762
. O 0 0.07115019112825394

Linkage O 0 0.08518096059560776
to O 0 0.017953306436538696
markers O 0 0.04186328127980232
on O 0 0.01747032254934311
chromosome O 1 0.9728824496269226
4p O 1 0.8639904856681824
was O 0 0.015339680016040802
confirmed O 0 0.019308527931571007
in O 0 0.009795621037483215
five O 0 0.013303598389029503
families O 0 0.02684633806347847
. O 0 0.027085933834314346

On O 0 0.01383365411311388
the O 0 0.009556577540934086
basis O 0 0.01134035736322403
of O 0 0.012221099808812141
meiotic O 1 0.9788091778755188
recombinants O 1 0.9757274389266968
and O 0 0.027423430234193802
disease O 1 0.9994588494300842
- O 1 0.5861042141914368
associated O 0 0.10842132568359375
haplotypes O 1 0.9445473551750183
, O 0 0.011385000310838223
the O 0 0.014233090914785862
WFS B-Disease 1 0.9925134778022766
gene O 1 0.8692392110824585
was O 0 0.01438898779451847
localized O 0 0.48092323541641235
to O 0 0.008623680099844933
a O 0 0.014568743295967579
BAC O 1 0.9813308119773865
/ O 1 0.7865114808082581
P1 O 1 0.5189554691314697
contig O 0 0.14441652595996857
of O 0 0.01039051078259945
less O 0 0.014551542699337006
than O 0 0.013688306324183941
250 O 0 0.03043520264327526
kb O 0 0.09146095812320709
. O 0 0.043070316314697266

Mutations O 1 0.9224275946617126
in O 0 0.01649644412100315
a O 0 0.019128357991576195
novel O 0 0.04399193823337555
gene O 1 0.7346546053886414
( O 0 0.024937910959124565
WFS1 O 1 0.6094387173652649
) O 0 0.01558084599673748
encoding O 0 0.028588706627488136
a O 0 0.014431124553084373
putative O 0 0.4066745340824127
transmembrane O 0 0.43839049339294434
protein O 0 0.025042284280061722
were O 0 0.004122560378164053
found O 0 0.005701964721083641
in O 0 0.004133781883865595
all O 0 0.004214394837617874
affected O 0 0.02107483707368374
individuals O 0 0.008488340303301811
in O 0 0.006189105566591024
six O 0 0.009631873108446598
WFS B-Disease 1 0.9219045639038086
families O 0 0.012201798148453236
, O 0 0.0054939547553658485
and O 0 0.004733809269964695
these O 0 0.006649932824075222
mutations O 1 0.9161940813064575
were O 0 0.005820091813802719
associated O 0 0.01192425936460495
with O 0 0.009439819492399693
the O 0 0.020376771688461304
disease O 1 0.9994058609008789
phenotype O 1 0.9969684481620789
. O 0 0.04776269197463989

WFS1 O 1 0.586410403251648
appears O 0 0.03597274422645569
to O 0 0.011070683598518372
function O 0 0.017367247492074966
in O 0 0.009675486944615841
survival O 0 0.06272000074386597
of O 0 0.013839300721883774
islet O 1 0.9244511127471924
beta O 0 0.40097156167030334
- O 0 0.32520079612731934
cells O 0 0.4973496198654175
and O 0 0.018072178587317467
neurons O 0 0.2891847789287567
. O 0 0.019023029133677483
. O 0 0.030535688623785973

Stable O 0 0.05792120844125748
interaction O 0 0.030462708324193954
between O 0 0.011315791867673397
the O 0 0.007268466055393219
products O 0 0.01116175763309002
of O 0 0.0066770692355930805
the O 0 0.011588051915168762
BRCA1 O 1 0.9977026581764221
and O 0 0.11294686049222946
BRCA2 O 1 0.9996390342712402
tumor B-Disease 1 0.9997300505638123
suppressor O 1 0.9984149932861328
genes O 1 0.9548842906951904
in O 0 0.021274451166391373
mitotic O 1 0.811162531375885
and O 0 0.023546144366264343
meiotic O 1 0.9793961048126221
cells O 1 0.8480151295661926
. O 0 0.04664523899555206

BRCA1 O 1 0.9899482727050781
and O 0 0.022915568202733994
BRCA2 O 1 0.9888656735420227
account O 0 0.017829006537795067
for O 0 0.007702054921537638
most O 0 0.00738653214648366
cases O 0 0.015598627738654613
of O 0 0.008315318264067173
familial O 1 0.9971634745597839
, O 0 0.01565595529973507
early O 0 0.24842806160449982
onset O 1 0.9997496008872986
breast B-Disease 1 0.9998290538787842
and I-Disease 0 0.08499310910701752
/ I-Disease 1 0.9826547503471375
or I-Disease 1 0.6496481895446777
ovarian I-Disease 1 0.9999462366104126
cancer I-Disease 1 0.9997650980949402
and O 0 0.010799543000757694
encode O 0 0.023759420961141586
products O 0 0.011729744262993336
that O 0 0.006193128414452076
each O 0 0.009427298791706562
interact O 0 0.026088451966643333
with O 0 0.015185103751718998
hRAD51 O 0 0.23596301674842834
. O 0 0.037386808544397354

Results O 0 0.03317265957593918
presented O 0 0.016482029110193253
here O 0 0.008613776415586472
show O 0 0.011979742906987667
that O 0 0.009328542277216911
BRCA1 O 1 0.996567964553833
and O 0 0.01558071468025446
BRCA2 O 1 0.9984361529350281
coexist O 0 0.09717326611280441
in O 0 0.008249811828136444
a O 0 0.010942203924059868
biochemical O 0 0.05869583040475845
complex O 0 0.014527569524943829
and O 0 0.00795484147965908
colocalize O 0 0.22779661417007446
in O 0 0.013002277351915836
subnuclear O 1 0.6953025460243225
foci O 1 0.5624967813491821
in O 0 0.013560337945818901
somatic O 1 0.9231192469596863
cells O 0 0.32110291719436646
and O 0 0.007195933721959591
on O 0 0.006117308046668768
the O 0 0.007292453199625015
axial O 0 0.04256928712129593
elements O 0 0.013666531071066856
of O 0 0.011517146602272987
developing O 0 0.06319761276245117
synaptonemal O 1 0.7642364501953125
complexes O 0 0.14405576884746552
. O 0 0.03891218081116676

Like O 0 0.07995480298995972
BRCA1 O 1 0.9867527484893799
and O 0 0.03355642035603523
RAD51 O 1 0.9865642786026001
, O 0 0.033733297139406204
BRCA2 O 1 0.9960097074508667
relocates O 1 0.5880072116851807
to O 0 0.023887455463409424
PCNA O 1 0.9782107472419739
+ O 0 0.3231683373451233
replication O 0 0.29734286665916443
sites O 0 0.01720157451927662
following O 0 0.017139475792646408
exposure O 0 0.3026779294013977
of O 0 0.010117804631590843
S O 0 0.30012354254722595
phase O 0 0.10454785078763962
cells O 0 0.3701273500919342
to O 0 0.017792535945773125
hydroxyurea O 1 0.9733245372772217
or O 0 0.0449608713388443
UV O 1 0.9785090088844299
irradiation O 1 0.5771399736404419
. O 0 0.044889211654663086

Thus O 0 0.04046604037284851
, O 0 0.02352776750922203
BRCA1 O 1 0.9890666007995605
and O 0 0.015550246462225914
BRCA2 O 1 0.996292769908905
participate O 0 0.013845562003552914
, O 0 0.0058297812938690186
together O 0 0.005346870515495539
, O 0 0.004380487371236086
in O 0 0.005202310625463724
a O 0 0.008988987654447556
pathway O 0 0.050768475979566574
( O 0 0.012626482173800468
s O 0 0.0209120512008667
) O 0 0.007620391435921192
associated O 0 0.008875449188053608
with O 0 0.004036585800349712
the O 0 0.004619047045707703
activation O 0 0.020377498120069504
of O 0 0.005129480734467506
double O 0 0.015194985084235668
- O 0 0.08706382662057877
strand O 0 0.09500355273485184
break O 0 0.024850882589817047
repair O 0 0.30491629242897034
and O 0 0.011148113757371902
/ O 0 0.08914689719676971
or O 0 0.024693628773093224
homologous O 1 0.681728184223175
recombination O 1 0.6665429472923279
. O 0 0.04046279937028885

Dysfunction O 1 0.9850179553031921
of O 0 0.014195362105965614
this O 0 0.0120948925614357
pathway O 0 0.14164647459983826
may O 0 0.010604535229504108
be O 0 0.004106721840798855
a O 0 0.005380782298743725
general O 0 0.00836858619004488
phenomenon O 0 0.0166157353669405
in O 0 0.004380493890494108
the O 0 0.004421945195645094
majority O 0 0.007145254407078028
of O 0 0.005544430110603571
cases O 0 0.021586092188954353
of O 0 0.011630871333181858
hereditary B-Disease 1 0.99905925989151
breast I-Disease 1 0.9997547268867493
and I-Disease 0 0.07392441481351852
/ I-Disease 1 0.9889673590660095
or I-Disease 1 0.87298983335495
ovarian I-Disease 1 0.9999511241912842
cancer I-Disease 1 0.9997691512107849
. O 0 0.03603107109665871
. O 0 0.04101436212658882

A O 0 0.03975174203515053
novel O 0 0.06540349870920181
Arg362Ser O 1 0.9055081009864807
mutation O 1 0.8914147019386292
in O 0 0.01254170760512352
the O 0 0.01336007472127676
sterol O 1 0.5683425068855286
27 O 0 0.03557054325938225
- O 0 0.22829696536064148
hydroxylase O 1 0.9539437294006348
gene O 1 0.8361120223999023
( O 0 0.02418028935790062
CYP27 O 1 0.6891081929206848
) O 0 0.012712888419628143
: O 0 0.009284096769988537
its O 0 0.008106998167932034
effects O 0 0.021372945979237556
on O 0 0.007840489968657494
pre O 0 0.029750000685453415
- O 0 0.04169035702943802
mRNA O 0 0.052162352949380875
splicing O 0 0.06638412922620773
and O 0 0.017555883154273033
enzyme O 0 0.07680395990610123
activity O 0 0.04225536435842514
. O 0 0.0371166430413723

A O 0 0.029709000140428543
novel O 0 0.030904604122042656
C O 0 0.027063675224781036
to O 0 0.007527063135057688
A O 0 0.013443759642541409
mutation O 0 0.493977427482605
in O 0 0.008249768055975437
the O 0 0.010337403044104576
sterol O 0 0.40695932507514954
27 O 0 0.028269730508327484
- O 0 0.31085166335105896
hydroxylase O 1 0.9530563950538635
gene O 1 0.880158007144928
( O 0 0.022257113829255104
CYP27 O 1 0.5116850733757019
) O 0 0.011174152605235577
was O 0 0.00715603306889534
identified O 0 0.012680450454354286
by O 0 0.010100188665091991
sequencing O 0 0.04727303981781006
amplified O 0 0.2532028555870056
CYP27 O 1 0.9399535655975342
gene O 0 0.4031147360801697
products O 0 0.01568594202399254
from O 0 0.009967389516532421
a O 0 0.013791524805128574
patient O 1 0.7747154235839844
with O 0 0.02013518288731575
cerebrotendinous B-Disease 1 0.976829469203949
xanthomatosis I-Disease 1 0.9753581881523132
( O 0 0.05124199390411377
CTX B-Disease 1 0.9694672226905823
) O 0 0.03832302615046501
. O 0 0.036931950598955154

The O 0 0.0353117398917675
mutation O 1 0.8953986763954163
changed O 0 0.027712451294064522
the O 0 0.016433503478765488
adrenodoxin O 0 0.45006635785102844
cofactor O 0 0.2892407476902008
binding O 0 0.04948941618204117
residue O 0 0.08077716827392578
362Arg O 0 0.3199516534805298
to O 0 0.018310146406292915
362Ser O 1 0.581295371055603
( O 0 0.029610823839902878
CGT O 1 0.92913419008255
362Arg O 1 0.6917722821235657
to O 0 0.020765289664268494
AGT O 1 0.9944068193435669
362Ser O 1 0.7480587363243103
) O 0 0.011755906976759434
, O 0 0.00571074103936553
and O 0 0.004377745091915131
was O 0 0.005171600729227066
responsible O 0 0.0109297726303339
for O 0 0.0076063331216573715
deficiency O 1 0.9972223043441772
in O 0 0.007889696396887302
the O 0 0.00893455184996128
sterol O 1 0.6977169513702393
27 O 0 0.021515050902962685
- O 0 0.060419075191020966
hydroxylase O 0 0.33002251386642456
activity O 0 0.017410967499017715
, O 0 0.005738255102187395
as O 0 0.004897505044937134
confirmed O 0 0.00849137082695961
by O 0 0.005824071820825338
expression O 0 0.01691962406039238
of O 0 0.009678288362920284
mutant O 0 0.3292113244533539
cDNA O 0 0.05484412983059883
into O 0 0.018390577286481857
COS O 1 0.6367340087890625
- O 0 0.05263959988951683
1 O 0 0.02899990603327751
cells O 0 0.20085608959197998
. O 0 0.029376139864325523

Quantitative O 0 0.059401173144578934
analysis O 0 0.0256620142608881
showed O 0 0.01587204821407795
that O 0 0.005957673769444227
the O 0 0.006696249824017286
expression O 0 0.015167351812124252
of O 0 0.008909333497285843
CYP27 O 1 0.9472445249557495
gene O 1 0.7179276347160339
mRNA O 0 0.03440653160214424
in O 0 0.009888040833175182
the O 0 0.010526959784328938
patient O 1 0.6700705885887146
represented O 0 0.02326956018805504
52 O 0 0.04120699688792229
. O 0 0.034478120505809784

5 O 0 0.026471586897969246
% O 0 0.013817633502185345
of O 0 0.008410181850194931
the O 0 0.009448657743632793
normal O 0 0.025871090590953827
level O 0 0.023043375462293625
. O 0 0.02794223465025425

As O 0 0.018897462636232376
the O 0 0.01782301999628544
mutation O 1 0.7691870927810669
occurred O 0 0.024001404643058777
at O 0 0.008658311329782009
the O 0 0.008636302314698696
penultimate O 0 0.038412872701883316
nucleotide O 0 0.03421419486403465
of O 0 0.009425407275557518
exon O 0 0.07216238230466843
6 O 0 0.015252388082444668
( O 0 0.010725665837526321
- O 0 0.016808390617370605
2 O 0 0.008844916708767414
position O 0 0.007379735354334116
of O 0 0.007769978139549494
exon O 0 0.07117488980293274
6 O 0 0.021710803732275963
- O 0 0.058170974254608154
intron O 1 0.8770151734352112
6 O 0 0.022898094728589058
splice O 0 0.10172033309936523
site O 0 0.012446440756320953
) O 0 0.007019741460680962
of O 0 0.004685617052018642
the O 0 0.005195814650505781
gene O 0 0.08291858434677124
, O 0 0.005124220158904791
we O 0 0.004682858008891344
hypothesized O 0 0.021087735891342163
that O 0 0.005061623640358448
the O 0 0.007174307014793158
mutation O 1 0.9651925563812256
may O 0 0.01538259256631136
partially O 0 0.025626888498663902
affect O 0 0.01711852476000786
the O 0 0.0072197094559669495
normal O 0 0.019434083253145218
splicing O 0 0.04785251244902611
efficiency O 0 0.017356574535369873
in O 0 0.00841248407959938
exon O 0 0.12444910407066345
6 O 0 0.013559521175920963
and O 0 0.007761013228446245
cause O 0 0.1723744124174118
alternative O 0 0.018430015072226524
splicing O 0 0.07619955390691757
elsewhere O 0 0.013581624254584312
, O 0 0.005786176770925522
which O 0 0.0057523297145962715
resulted O 0 0.014499688521027565
in O 0 0.008328068070113659
decreased O 0 0.06697656214237213
transcript O 0 0.020286792889237404
in O 0 0.008240926079452038
the O 0 0.012532521970570087
patient O 1 0.6361078023910522
. O 0 0.03318537026643753

Transfection O 1 0.526949942111969
of O 0 0.019706403836607933
constructed O 0 0.02225053310394287
minigenes O 0 0.10968444496393204
, O 0 0.007726016920059919
with O 0 0.006313072517514229
or O 0 0.006537062581628561
without O 0 0.007206874433904886
the O 0 0.006388405803591013
mutation O 1 0.7212490439414978
, O 0 0.006856893189251423
into O 0 0.011098673567175865
COS O 1 0.7776021361351013
- O 0 0.03402220085263252
1 O 0 0.01424633152782917
cells O 0 0.1458343267440796
confirmed O 0 0.011275839991867542
that O 0 0.004815016407519579
the O 0 0.006477587390691042
mutant O 1 0.7054906487464905
minigene O 0 0.23480159044265747
was O 0 0.007640068884938955
responsible O 0 0.011536508798599243
for O 0 0.006358473561704159
a O 0 0.01101592369377613
mRNA O 0 0.030113741755485535
species O 0 0.018426943570375443
alternatively O 0 0.025235015898942947
spliced O 0 0.037408068776130676
at O 0 0.010061227716505527
an O 0 0.011473074555397034
activated O 0 0.08316081762313843
cryptic O 0 0.06607494503259659
5 O 0 0.017548909410834312
splice O 0 0.21932487189769745
site O 0 0.014761983416974545
88 O 0 0.0216594897210598
bp O 0 0.026777831837534904
upstream O 0 0.018142731860280037
from O 0 0.007252927403897047
the O 0 0.006430822890251875
3 O 0 0.01024883333593607
end O 0 0.011848234571516514
of O 0 0.012284581549465656
exon O 0 0.11537099629640579
6 O 0 0.03958294913172722
. O 0 0.03217964991927147

Our O 0 0.020640665665268898
data O 0 0.01443581935018301
suggest O 0 0.014281478710472584
that O 0 0.005210239905864
the O 0 0.005571631249040365
C O 0 0.01480755303055048
to O 0 0.004451202228665352
A O 0 0.008933605626225471
mutation O 0 0.46888163685798645
at O 0 0.00806361623108387
the O 0 0.006906954105943441
penultimate O 0 0.03757370263338089
nucleotide O 0 0.0300709567964077
of O 0 0.00847428198903799
exon O 0 0.04495110735297203
6 O 0 0.011934349313378334
of O 0 0.006252489518374205
the O 0 0.00872438121587038
CYP27 O 1 0.8890195488929749
gene O 1 0.5000751614570618
not O 0 0.006567085161805153
only O 0 0.0077353366650640965
causes O 1 0.6042493581771851
the O 0 0.01169846672564745
deficiency B-Disease 1 0.9981052875518799
in I-Disease 0 0.009789051488041878
the I-Disease 0 0.010404082015156746
sterol I-Disease 1 0.6732582449913025
27 I-Disease 0 0.02464359626173973
- I-Disease 0 0.12576425075531006
hydroxylase I-Disease 1 0.6654163002967834
activity I-Disease 0 0.018184563145041466
, O 0 0.006279467139393091
but O 0 0.005252000875771046
also O 0 0.005136233288794756
partially O 0 0.016138797625899315
leads O 0 0.012443598359823227
to O 0 0.006200636737048626
alternative O 0 0.016154328361153603
pre O 0 0.033848464488983154
- O 0 0.04123406112194061
mRNA O 0 0.04609181731939316
splicing O 0 0.04691937565803528
of O 0 0.012823797762393951
the O 0 0.018530171364545822
gene O 0 0.3268651068210602
. O 0 0.0297970212996006

To O 0 0.010665232315659523
our O 0 0.00827895849943161
knowledge O 0 0.00736599275842309
, O 0 0.003932590130716562
this O 0 0.002815019804984331
is O 0 0.002892277669161558
the O 0 0.0028378060087561607
first O 0 0.003379977773874998
report O 0 0.005410973913967609
regarding O 0 0.007936079986393452
effects O 0 0.019807765260338783
on O 0 0.005394354462623596
pre O 0 0.019590072333812714
- O 0 0.025523608550429344
mRNA O 0 0.026235533878207207
splicing O 0 0.02698702923953533
of O 0 0.006726129446178675
a O 0 0.009143522940576077
mutation O 0 0.39652112126350403
at O 0 0.00535530736669898
the O 0 0.005269947927445173
- O 0 0.012125845067203045
2 O 0 0.0070310975424945354
position O 0 0.005083995871245861
of O 0 0.004442829638719559
a O 0 0.00979500263929367
5 O 0 0.017479004338383675
splice O 0 0.13660310208797455
site O 0 0.03273627161979675
. O 0 0.030185997486114502

ATM O 1 0.7403597235679626
germline O 1 0.9820241332054138
mutations O 1 0.9529427289962769
in O 0 0.030482318252325058
classical O 0 0.07339544594287872
ataxia B-Disease 1 0.9992188215255737
- I-Disease 1 0.9941950440406799
telangiectasia I-Disease 1 0.9995251893997192
patients O 1 0.9946617484092712
in O 0 0.014134746976196766
the O 0 0.014020595699548721
Dutch O 0 0.036889199167490005
population O 0 0.040038853883743286
. O 0 0.030488451942801476

Germline O 1 0.977637529373169
mutations O 1 0.9460791945457458
in O 0 0.014274577610194683
the O 0 0.013421673327684402
ATM O 0 0.16512084007263184
gene O 0 0.17707125842571259
are O 0 0.007799395825713873
responsible O 0 0.016526153311133385
for O 0 0.011132490821182728
the O 0 0.052896711975336075
autosomal B-Disease 1 0.9999357461929321
recessive I-Disease 1 0.999983549118042
disorder I-Disease 1 0.9999915361404419
ataxia B-Disease 1 0.9999562501907349
- I-Disease 1 0.9981935620307922
telangiectasia I-Disease 1 0.9997486472129822
( O 0 0.30681467056274414
A B-Disease 0 0.1855040341615677
- I-Disease 1 0.8995364308357239
T I-Disease 1 0.9836238622665405
) O 0 0.03290892019867897
. O 0 0.03436940908432007

In O 0 0.016690609976649284
our O 0 0.012022712267935276
study O 0 0.01166107039898634
, O 0 0.0054981037974357605
we O 0 0.00460947398096323
have O 0 0.00494685024023056
determined O 0 0.00849257130175829
the O 0 0.007139590103179216
ATM O 0 0.08704004436731339
mutation O 1 0.9299997687339783
spectrum O 0 0.025514766573905945
in O 0 0.006942818406969309
19 O 0 0.010052600875496864
classical O 0 0.009544449858367443
A B-Disease 0 0.015467132441699505
- I-Disease 1 0.8479176759719849
T I-Disease 1 0.9964313507080078
patients O 1 0.9866944551467896
, O 0 0.005763251334428787
including O 0 0.0062036109156906605
some O 0 0.005968168377876282
immigrant O 0 0.03201922029256821
populations O 0 0.06510370969772339
, O 0 0.004201254341751337
as O 0 0.003746691159904003
well O 0 0.003721277229487896
as O 0 0.004022627137601376
12 O 0 0.006346576381474733
of O 0 0.007039342075586319
Dutch O 0 0.023422202095389366
ethnic O 0 0.026547832414507866
origin O 0 0.03184857591986656
. O 0 0.028031544759869576

Both O 0 0.018922006711363792
the O 0 0.015424703247845173
protein O 0 0.04782229661941528
truncation O 0 0.19071052968502045
test O 0 0.020029494538903236
( O 0 0.013318642042577267
PTT O 0 0.02714656852185726
) O 0 0.008354248479008675
and O 0 0.004595224745571613
the O 0 0.007984905503690243
restriction O 0 0.030446430668234825
endonuclease O 1 0.9088125824928284
fingerprinting O 0 0.11268880218267441
( O 0 0.018849419429898262
REF O 0 0.3664650321006775
) O 0 0.008160886354744434
method O 0 0.007851616479456425
were O 0 0.0037649362348020077
used O 0 0.004093931056559086
and O 0 0.0036931089125573635
compared O 0 0.007151834201067686
for O 0 0.004079860169440508
their O 0 0.0050475094467401505
detection O 0 0.020387237891554832
efficiency O 0 0.013675635680556297
, O 0 0.00673132436349988
identifying O 0 0.01737518236041069
76 O 0 0.017780931666493416
% O 0 0.00821935199201107
and O 0 0.003956570290029049
60 O 0 0.007614677771925926
% O 0 0.0068330056965351105
of O 0 0.005123155657202005
the O 0 0.009350663982331753
mutations O 1 0.8590942025184631
, O 0 0.012998881749808788
respectively O 0 0.024975519627332687
. O 0 0.026314612478017807

Most O 0 0.03079530969262123
patients O 1 0.9029921293258667
were O 0 0.009070119820535183
found O 0 0.01062982901930809
to O 0 0.007111897226423025
be O 0 0.009154794737696648
compound O 0 0.04039153456687927
heterozygote O 1 0.618019163608551
. O 0 0.044523898512125015

Seventeen O 0 0.07444173842668533
mutations O 1 0.7906826734542847
were O 0 0.009592725895345211
distinct O 0 0.013021605089306831
, O 0 0.004149836953729391
of O 0 0.0033793540205806494
which O 0 0.003500316757708788
10 O 0 0.00519716227427125
were O 0 0.0034802870359271765
not O 0 0.004466123413294554
reported O 0 0.014800626784563065
previously O 0 0.019232964143157005
. O 0 0.023530056700110435

Mutations O 1 0.8836889266967773
are O 0 0.016036257147789
small O 0 0.019737252965569496
deletions O 0 0.15079376101493835
or O 0 0.015689104795455933
point O 0 0.01830412447452545
mutations O 1 0.9826195240020752
frequently O 0 0.04685807228088379
affecting O 1 0.6032059788703918
splice O 1 0.6579219698905945
sites O 0 0.03995382413268089
. O 0 0.03507910296320915

Moreover O 0 0.05608261004090309
, O 0 0.019718538969755173
a O 0 0.02259732410311699
16 O 0 0.03154044598340988
. O 0 0.03388211503624916

7 O 0 0.04885923117399216
- O 0 0.08260132372379303
kb O 0 0.40301522612571716
genomic O 1 0.5220404267311096
deletion O 0 0.15865004062652588
of O 0 0.006622970569878817
the O 0 0.005704919807612896
3 O 0 0.007019302807748318
end O 0 0.00609959103167057
of O 0 0.0037121945060789585
the O 0 0.005090649705380201
gene O 0 0.08675248920917511
, O 0 0.0045633683912456036
most O 0 0.005035038106143475
likely O 0 0.006132288370281458
a O 0 0.004869270138442516
result O 0 0.007179009262472391
of O 0 0.005237688776105642
recombination O 0 0.05225106328725815
between O 0 0.006743960548192263
two O 0 0.0043615493923425674
LINE O 0 0.008874236606061459
elements O 0 0.007180585991591215
, O 0 0.005795931443572044
was O 0 0.008868183009326458
identified O 0 0.02246745303273201
. O 0 0.02117096446454525

The O 0 0.019173122942447662
most O 0 0.01409590058028698
frequently O 0 0.017232857644557953
found O 0 0.013582468964159489
mutation O 1 0.8813244104385376
, O 0 0.006583063863217831
identified O 0 0.010135471820831299
in O 0 0.00486000906676054
three O 0 0.005183834582567215
unrelated O 0 0.01887236163020134
Turkish O 0 0.016129270195961
A B-Disease 0 0.014867337420582771
- I-Disease 0 0.34366393089294434
T I-Disease 1 0.9679424166679382
individuals O 0 0.01238278765231371
, O 0 0.005272143520414829
was O 0 0.004658922553062439
previously O 0 0.006724562030285597
described O 0 0.007779122330248356
to O 0 0.003184978850185871
be O 0 0.0036585896741598845
a O 0 0.00650408212095499
Turkish O 0 0.01583048142492771
A B-Disease 0 0.019094979390501976
- I-Disease 0 0.39317578077316284
T I-Disease 1 0.9471576809883118
founder O 0 0.16682745516300201
mutation O 1 0.9644724130630493
. O 0 0.041599638760089874

The O 0 0.01905548758804798
presence O 0 0.017440898343920708
of O 0 0.008444265462458134
a O 0 0.012913141399621964
founder O 0 0.045088112354278564
mutation O 1 0.9297385811805725
among O 0 0.012865407392382622
relatively O 0 0.013418447226285934
small O 0 0.009041880257427692
ethnic O 0 0.01303466409444809
population O 0 0.01199356559664011
groups O 0 0.008175531402230263
in O 0 0.005390204023569822
Western O 0 0.00831744633615017
Europe O 0 0.00884536188095808
could O 0 0.006477943155914545
indicate O 0 0.010122486390173435
a O 0 0.0070183915086090565
high O 0 0.011111021041870117
carrier O 0 0.02752784639596939
frequency O 0 0.020006496459245682
in O 0 0.008840549737215042
such O 0 0.010436504147946835
communities O 0 0.02738916128873825
. O 0 0.024217478930950165

In O 0 0.02720888890326023
patients O 1 0.84401935338974
of O 0 0.010384226217865944
Dutch O 0 0.023462187498807907
ethnic O 0 0.01722070947289467
origin O 0 0.012281452305614948
, O 0 0.00582575099542737
however O 0 0.005868007894605398
, O 0 0.004397951066493988
no O 0 0.006484425161033869
significant O 0 0.010525857098400593
founder O 0 0.01652444899082184
effect O 0 0.015565699897706509
could O 0 0.008521207608282566
be O 0 0.007716105319559574
identified O 0 0.0258630383759737
. O 0 0.022478964179754257

The O 0 0.027677293866872787
observed O 0 0.04244846850633621
genetic O 0 0.3862396776676178
heterogeneity O 0 0.1739300638437271
including O 0 0.007987083867192268
the O 0 0.006658783182501793
relative O 0 0.012846296653151512
high O 0 0.009152663871645927
percentage O 0 0.012549764476716518
of O 0 0.00770984310656786
splice O 0 0.42581331729888916
- O 0 0.04838041588664055
site O 0 0.021046457812190056
mutations O 1 0.7470573782920837
had O 0 0.007952937856316566
no O 0 0.007802846375852823
reflection O 0 0.018748153001070023
on O 0 0.009342614561319351
the O 0 0.015159033238887787
phenotype O 1 0.9556700587272644
. O 0 0.03527900576591492

All O 0 0.027900459244847298
patients O 1 0.973844051361084
manifested O 0 0.19338099658489227
classical O 0 0.020463181659579277
A B-Disease 0 0.021529339253902435
- I-Disease 0 0.292998343706131
T I-Disease 1 0.9132807850837708
and O 0 0.012882023118436337
increased O 0 0.03400268033146858
cellular O 0 0.30147847533226013
radioresistant O 1 0.8317983150482178
DNA O 0 0.16087953746318817
synthesis O 0 0.0777871161699295
. O 0 0.04268837720155716

Determination O 0 0.031643811613321304
of O 0 0.01060849241912365
the O 0 0.010313098318874836
genomic O 0 0.050881512463092804
structure O 0 0.012102368287742138
of O 0 0.006141659803688526
the O 0 0.009632064960896969
COL4A4 O 1 0.9113330841064453
gene O 0 0.4186565577983856
and O 0 0.008338754065334797
of O 0 0.010163981467485428
novel O 1 0.5569280385971069
mutations O 1 0.9988675117492676
causing O 1 0.998641312122345
autosomal B-Disease 1 0.9999277591705322
recessive I-Disease 1 0.99994957447052
Alport I-Disease 1 0.9999005794525146
syndrome I-Disease 1 0.9999325275421143
. O 0 0.3101736307144165

Autosomal B-Disease 1 0.9997074007987976
recessive I-Disease 1 0.9998770952224731
Alport I-Disease 1 0.9998249411582947
syndrome I-Disease 1 0.9999233484268188
is O 0 0.0567406490445137
a O 0 0.04856494069099426
progressive O 1 0.9868882298469543
hematuric B-Disease 1 0.9953237175941467
glomerulonephritis I-Disease 1 0.9992116689682007
characterized O 1 0.9637953639030457
by O 0 0.04207035154104233
glomerular B-Disease 1 0.9972026348114014
basement I-Disease 1 0.8106337189674377
membrane I-Disease 1 0.9463270306587219
abnormalities I-Disease 1 0.9939906597137451
and O 0 0.009459675289690495
associated O 0 0.01598580926656723
with O 0 0.00873707514256239
mutations O 1 0.90666264295578
in O 0 0.006394407246261835
either O 0 0.007403886411339045
the O 0 0.006821508519351482
COL4A3 O 0 0.29408884048461914
or O 0 0.009669307619333267
the O 0 0.009869590401649475
COL4A4 O 1 0.9395936131477356
gene O 0 0.4246795177459717
, O 0 0.007917262613773346
which O 0 0.006951840128749609
encode O 0 0.019503699615597725
the O 0 0.009573912248015404
alpha3 O 0 0.21927429735660553
and O 0 0.015446901321411133
alpha4 O 1 0.9270082712173462
type O 1 0.7419149875640869
IV O 1 0.9885116815567017
collagen O 1 0.9949461817741394
chains O 0 0.18778572976589203
, O 0 0.01996631920337677
respectively O 0 0.031834814697504044
. O 0 0.03304389864206314

To O 0 0.01651579700410366
date O 0 0.017897656187415123
, O 0 0.01144487876445055
mutation O 1 0.9058030843734741
screening O 0 0.023328915238380432
in O 0 0.004636671859771013
the O 0 0.004228543024510145
two O 0 0.0043113743886351585
genes O 0 0.10914432257413864
has O 0 0.006196190137416124
been O 0 0.005706594791263342
hampered O 0 0.09976787120103836
by O 0 0.005645186640322208
the O 0 0.005585161503404379
lack O 0 0.01102603878825903
of O 0 0.0079480716958642
genomic O 0 0.31324371695518494
structure O 0 0.020084593445062637
information O 0 0.016486605629324913
. O 0 0.022994834929704666

We O 0 0.013694629073143005
report O 0 0.010328683070838451
here O 0 0.006312079261988401
the O 0 0.005225734785199165
complete O 0 0.00808507576584816
characterization O 0 0.012651368044316769
of O 0 0.005476053804159164
the O 0 0.005363647360354662
48 O 0 0.011553432792425156
exons O 0 0.025388944894075394
of O 0 0.005867199040949345
the O 0 0.008922752924263477
COL4A4 O 1 0.8773912787437439
gene O 0 0.27539122104644775
, O 0 0.0070207747630774975
a O 0 0.009677095338702202
comprehensive O 0 0.027123186737298965
gene O 1 0.5031681656837463
screen O 0 0.014925701543688774
, O 0 0.004312037490308285
and O 0 0.0034706362057477236
the O 0 0.003948019351810217
subsequent O 0 0.010384775698184967
detection O 0 0.016718337312340736
of O 0 0.0057114772498607635
10 O 0 0.00965028628706932
novel O 0 0.02865232527256012
mutations O 1 0.9578058123588562
in O 0 0.011341330595314503
eight O 0 0.07153590768575668
patients O 1 0.9995255470275879
diagnosed O 1 0.9998871088027954
with O 1 0.8910570740699768
autosomal B-Disease 1 0.9999203681945801
recessive I-Disease 1 0.9999314546585083
Alport I-Disease 1 0.9998888969421387
syndrome I-Disease 1 0.9999533891677856
. O 0 0.43280869722366333

Furthermore O 0 0.03606225550174713
, O 0 0.010450933128595352
we O 0 0.007116939406841993
identified O 0 0.012373232282698154
a O 0 0.008139277808368206
glycine O 0 0.02514318749308586
to O 0 0.007355839945375919
alanine O 0 0.03904389962553978
substitution O 0 0.019683580845594406
in O 0 0.007386221084743738
the O 0 0.00884439516812563
collagenous O 1 0.8473431468009949
domain O 0 0.019494343549013138
that O 0 0.005681675858795643
is O 0 0.006585280876606703
apparently O 0 0.014488832093775272
silent O 0 0.01946433074772358
in O 0 0.007483580149710178
the O 0 0.009758178144693375
heterozygous O 1 0.6439833045005798
carriers O 0 0.08249934017658234
, O 0 0.009521622210741043
in O 0 0.010610169731080532
11 O 0 0.0215779859572649
. O 0 0.02686731144785881

5 O 0 0.025771720334887505
% O 0 0.011480756103992462
of O 0 0.005705913063138723
all O 0 0.004980327095836401
control O 0 0.010519194416701794
individuals O 0 0.007853521034121513
, O 0 0.0034546898677945137
and O 0 0.0032271791715174913
in O 0 0.003908559214323759
one O 0 0.004908467642962933
control O 0 0.012786961160600185
individual O 0 0.010810541920363903
homozygous O 0 0.14006377756595612
for O 0 0.009334328584372997
this O 0 0.01230549719184637
glycine O 0 0.06681890040636063
substitution O 0 0.054640691727399826
. O 0 0.032475631684064865

There O 0 0.014129593037068844
has O 0 0.009777991101145744
been O 0 0.0069546764716506
no O 0 0.005523111205548048
previous O 0 0.006414928939193487
finding O 0 0.007824509404599667
of O 0 0.004481262993067503
a O 0 0.007353667635470629
glycine O 0 0.026754414662718773
substitution O 0 0.014774436131119728
that O 0 0.004416010808199644
is O 0 0.004445645492523909
not O 0 0.0038678308483213186
associated O 0 0.007991138845682144
with O 0 0.005952378734946251
any O 0 0.008971733041107655
obvious O 0 0.04039335623383522
phenotype O 1 0.9891603589057922
in O 0 0.01736156828701496
homozygous O 1 0.8919090628623962
individuals O 0 0.04069630429148674
. O 0 0.033867549151182175

Founder O 0 0.4601747393608093
BRCA1 O 1 0.9960349202156067
and O 0 0.045550327748060226
BRCA2 O 1 0.9988760352134705
mutations O 1 0.9919997453689575
in O 0 0.018972452729940414
French O 0 0.0856543481349945
Canadian O 1 0.7239698171615601
breast B-Disease 1 0.9997990727424622
and I-Disease 1 0.8749567866325378
ovarian I-Disease 1 0.9999603033065796
cancer I-Disease 1 0.9998243451118469
families O 0 0.43110451102256775
. O 0 0.04968684911727905

We O 0 0.013644956052303314
have O 0 0.009020684286952019
identified O 0 0.0139496810734272
four O 0 0.009047412313520908
mutations O 0 0.2828720211982727
in O 0 0.0054303002543747425
each O 0 0.005250708200037479
of O 0 0.006455845199525356
the O 0 0.019871298223733902
breast B-Disease 1 0.9998138546943665
cancer I-Disease 1 0.9998024106025696
- O 1 0.986412525177002
susceptibility O 1 0.9987528324127197
genes O 1 0.989084780216217
, O 0 0.02682933770120144
BRCA1 O 1 0.9980255365371704
and O 0 0.017260506749153137
BRCA2 O 1 0.9968845248222351
, O 0 0.01094811875373125
in O 0 0.010845031589269638
French O 0 0.10226526856422424
Canadian O 1 0.8032073974609375
breast B-Disease 1 0.9998388290405273
cancer I-Disease 1 0.9998409748077393
and O 1 0.7533106803894043
breast B-Disease 1 0.9999303817749023
/ I-Disease 1 0.9993133544921875
ovarian I-Disease 1 0.9999744892120361
cancer I-Disease 1 0.999900221824646
families O 0 0.37709274888038635
from O 0 0.030521975830197334
Quebec O 0 0.4486928880214691
. O 0 0.044278912246227264

To O 0 0.02293561026453972
identify O 0 0.035103458911180496
founder O 0 0.0399429053068161
effects O 0 0.04507160931825638
, O 0 0.008667606860399246
we O 0 0.00735503202304244
examined O 0 0.02270883321762085
independently O 0 0.019237443804740906
ascertained O 0 0.08763100951910019
French O 0 0.032034989446401596
Canadian O 0 0.18756628036499023
cancer B-Disease 1 0.9978729486465454
families O 0 0.013830466195940971
for O 0 0.005756975617259741
the O 0 0.00591790396720171
distribution O 0 0.009830914437770844
of O 0 0.005517792422324419
these O 0 0.007674413733184338
eight O 0 0.01715201325714588
mutations O 1 0.9638591408729553
. O 0 0.0315975621342659

Mutations O 1 0.8757671117782593
were O 0 0.012807364575564861
found O 0 0.013924864120781422
in O 0 0.009920626878738403
41 O 0 0.01797497831285
of O 0 0.012019269168376923
97 O 0 0.03274184837937355
families O 0 0.03295690566301346
. O 0 0.03410396724939346

Six O 0 0.018834367394447327
of O 0 0.009852410294115543
eight O 0 0.014488579705357552
mutations O 1 0.7758316993713379
were O 0 0.007092239800840616
observed O 0 0.016993949189782143
at O 0 0.009146391414105892
least O 0 0.015916351228952408
twice O 0 0.02650468610227108
. O 0 0.025608528405427933

The O 0 0.04951602220535278
BRCA1 O 1 0.9956561326980591
C4446T O 1 0.9734563231468201
mutation O 1 0.9471800327301025
was O 0 0.010079469531774521
the O 0 0.006992843467742205
most O 0 0.007213621400296688
common O 0 0.022572077810764313
mutation O 1 0.9506229758262634
found O 0 0.009033869951963425
, O 0 0.006190800573676825
followed O 0 0.010150504298508167
by O 0 0.009791242890059948
the O 0 0.01738475263118744
BRCA2 O 1 0.9976836442947388
8765delAG O 1 0.9906264543533325
mutation O 1 0.9931766986846924
. O 0 0.04604145511984825

Together O 0 0.02070821262896061
, O 0 0.010098248720169067
these O 0 0.008829108439385891
mutations O 0 0.40291622281074524
were O 0 0.004396076314151287
found O 0 0.005497274920344353
in O 0 0.004227767698466778
28 O 0 0.007382987532764673
of O 0 0.004608114715665579
41 O 0 0.011377482675015926
families O 0 0.00970403105020523
identified O 0 0.011331833899021149
to O 0 0.0060090734623372555
have O 0 0.007710732985287905
a O 0 0.017187047749757767
mutation O 1 0.8873274922370911
. O 0 0.03208785131573677

The O 0 0.01715497113764286
odds O 0 0.02814389392733574
of O 0 0.008287916891276836
detection O 0 0.017502209171652794
of O 0 0.004933360032737255
any O 0 0.0045229061506688595
of O 0 0.004231376573443413
the O 0 0.006648344453424215
four O 0 0.015130500309169292
BRCA1 O 1 0.9974663257598877
mutations O 1 0.9821650385856628
was O 0 0.01672591082751751
18 O 0 0.023459982126951218
. O 0 0.026025379076600075

7x O 1 0.7542968988418579
greater O 0 0.022672193124890327
if O 0 0.00947190634906292
one O 0 0.0062455665320158005
or O 0 0.007134911138564348
more O 0 0.006356645375490189
cases O 0 0.025870639830827713
of O 0 0.02880905009806156
ovarian B-Disease 1 0.9999493360519409
cancer I-Disease 1 0.9997538924217224
were O 0 0.00741254398599267
also O 0 0.005971814971417189
present O 0 0.007172062061727047
in O 0 0.0059896972961723804
the O 0 0.009012346155941486
family O 0 0.02599499747157097
. O 0 0.023468345403671265

The O 0 0.01776309311389923
odds O 0 0.02869918756186962
of O 0 0.008815616369247437
detection O 0 0.018671438097953796
of O 0 0.004655962809920311
any O 0 0.004308103118091822
of O 0 0.0046361698769032955
the O 0 0.0066770887933671474
four O 0 0.013975021429359913
BRCA2 O 1 0.9972822666168213
mutations O 1 0.9809600114822388
was O 0 0.019336802884936333
5 O 0 0.030473560094833374
. O 0 0.033867351710796356

3x O 0 0.3818170130252838
greater O 0 0.02243976667523384
if O 0 0.008913927711546421
there O 0 0.005306043196469545
were O 0 0.003586322534829378
at O 0 0.005132915452122688
least O 0 0.007188599556684494
five O 0 0.007559841498732567
cases O 0 0.019592413678765297
of O 0 0.019771579653024673
breast B-Disease 1 0.9997883439064026
cancer I-Disease 1 0.9989854693412781
in O 0 0.01595993898808956
the O 0 0.017801955342292786
family O 0 0.03995862603187561
. O 0 0.037308815866708755

Interestingly O 0 0.05954334884881973
, O 0 0.013250287622213364
the O 0 0.009043521247804165
presence O 0 0.014592284336686134
of O 0 0.009617333300411701
a O 0 0.06652528792619705
breast B-Disease 1 0.9997956156730652
cancer I-Disease 1 0.9995793700218201
case O 0 0.14845937490463257
< O 1 0.8498338460922241
36 O 0 0.013146448880434036
years O 0 0.007330272812396288
of O 0 0.005454104393720627
age O 0 0.010099153965711594
was O 0 0.0063834041357040405
strongly O 0 0.010683314874768257
predictive O 0 0.020370708778500557
of O 0 0.004229518584907055
the O 0 0.004118594340980053
presence O 0 0.0069326674565672874
of O 0 0.00393451564013958
any O 0 0.003871707711368799
of O 0 0.004808593541383743
the O 0 0.0074562313966453075
eight O 0 0.018594441935420036
mutations O 1 0.9786173105239868
screened O 0 0.12116903811693192
. O 0 0.03738393634557724

Carriers O 0 0.05670759826898575
of O 0 0.010813295841217041
the O 0 0.010386019945144653
same O 0 0.012396153062582016
mutation O 1 0.8209797143936157
, O 0 0.005856964271515608
from O 0 0.005313883535563946
different O 0 0.0055399308912456036
families O 0 0.008464476093649864
, O 0 0.005601583980023861
shared O 0 0.009751231409609318
similar O 0 0.013871980831027031
haplotypes O 1 0.8295670747756958
, O 0 0.006696789525449276
indicating O 0 0.013710526749491692
that O 0 0.004790563602000475
the O 0 0.007527126930654049
mutant O 1 0.6809212565422058
alleles O 1 0.8131744265556335
were O 0 0.004985164385288954
likely O 0 0.007649336941540241
to O 0 0.003189092967659235
be O 0 0.002996161812916398
identical O 0 0.006802774034440517
by O 0 0.004980043508112431
descent O 0 0.012313184328377247
for O 0 0.005240913946181536
a O 0 0.010819519869983196
mutation O 1 0.6278424263000488
in O 0 0.008095288649201393
the O 0 0.009507444687187672
founder O 0 0.03531637042760849
population O 0 0.03224525228142738
. O 0 0.03177259489893913

The O 0 0.015686234459280968
identification O 0 0.022217143326997757
of O 0 0.01027048658579588
common O 0 0.13888011872768402
BRCA1 O 1 0.9988806843757629
and O 0 0.05212040990591049
BRCA2 O 1 0.999295711517334
mutations O 1 0.9922977089881897
will O 0 0.010951056145131588
facilitate O 0 0.025272835046052933
carrier O 0 0.05888824164867401
detection O 0 0.037884727120399475
in O 0 0.011168711818754673
French O 0 0.11849388480186462
Canadian O 1 0.8772597908973694
breast B-Disease 1 0.9998995065689087
cancer I-Disease 1 0.9998751878738403
and O 1 0.781971275806427
breast B-Disease 1 0.9999178647994995
/ I-Disease 1 0.9994049072265625
ovarian I-Disease 1 0.9999781847000122
cancer I-Disease 1 0.9998584985733032
families O 0 0.4773983061313629
. O 0 0.048802219331264496

Are O 0 0.02929859794676304
Dp71 O 1 0.7812239527702332
and O 0 0.030072230845689774
Dp140 O 1 0.9770503044128418
brain O 1 0.996382474899292
dystrophin O 1 0.9902087450027466
isoforms O 1 0.5386647582054138
related O 0 0.04965218901634216
to O 0 0.01871155947446823
cognitive B-Disease 1 0.9641088843345642
impairment I-Disease 1 0.9941502213478088
in O 0 0.4091617166996002
Duchenne B-Disease 1 0.9997686743736267
muscular I-Disease 1 0.9996763467788696
dystrophy I-Disease 1 0.9997996687889099
? O 1 0.9318511486053467

Molecular O 0 0.07667092233896255
study O 0 0.02700597047805786
and O 0 0.012446095235645771
neuropsychological O 0 0.1706855148077011
analysis O 0 0.013932342641055584
were O 0 0.005708477925509214
performed O 0 0.010021846741437912
concurrently O 0 0.01177038624882698
on O 0 0.007690077647566795
49 O 0 0.0353693813085556
patients O 1 0.9918081164360046
with O 0 0.2839077413082123
Duchenne B-Disease 1 0.9998726844787598
muscular I-Disease 1 0.999902606010437
dystrophy I-Disease 1 0.9999510049819946
( O 1 0.9461982846260071
DMD B-Disease 1 0.999298095703125
) O 0 0.013217147439718246
in O 0 0.00591245898976922
order O 0 0.005528714507818222
to O 0 0.0038107051514089108
find O 0 0.007432515732944012
a O 0 0.006963416002690792
molecular O 0 0.01709604263305664
explanation O 0 0.011066658422350883
for O 0 0.0058101569302380085
the O 0 0.009233484044671059
cognitive B-Disease 1 0.8001531362533569
impairment I-Disease 1 0.9878567457199097
observed O 0 0.039015524089336395
in O 0 0.01520590391010046
most O 0 0.04920368269085884
DMD B-Disease 1 0.9994640946388245
patients O 1 0.9967792630195618
. O 0 0.05169251933693886

Complete O 0 0.030857793986797333
analysis O 0 0.0194193534553051
of O 0 0.009651013650000095
the O 0 0.013628249056637287
dystrophin O 1 0.9827802181243896
gene O 1 0.7662354707717896
was O 0 0.00881396234035492
performed O 0 0.009734104387462139
to O 0 0.004295074846595526
define O 0 0.009085290133953094
the O 0 0.004602036904543638
localization O 0 0.016605360433459282
of O 0 0.00574160274118185
deletions O 0 0.05984095484018326
and O 0 0.005889130290597677
duplications O 0 0.13452255725860596
in O 0 0.006108275149017572
relation O 0 0.011911855079233646
to O 0 0.006108367815613747
the O 0 0.010905144736170769
different O 0 0.02339891716837883
DMD B-Disease 1 0.9931125044822693
promoters O 0 0.4274614155292511
. O 0 0.05463108420372009

Qualitative O 0 0.0485706701874733
analysis O 0 0.023540867492556572
of O 0 0.010205725207924843
the O 0 0.010830681771039963
Dp71 O 0 0.23962533473968506
transcript O 0 0.01924954727292061
and O 0 0.006020587403327227
testing O 0 0.010967385023832321
for O 0 0.004061726853251457
the O 0 0.004112422466278076
specific O 0 0.0070727234706282616
first O 0 0.00646998081356287
exon O 0 0.029627762734889984
of O 0 0.006845352239906788
Dp140 O 0 0.08996761590242386
were O 0 0.005665245931595564
also O 0 0.006005382630974054
carried O 0 0.013133094646036625
out O 0 0.012992197647690773
. O 0 0.024063002318143845

Neuropsychological O 1 0.6370925903320312
analysis O 0 0.04319431632757187
assessed O 0 0.042198773473501205
verbal O 0 0.047487325966358185
and O 0 0.015643399208784103
visuospatial O 1 0.9104948043823242
intelligence O 0 0.02435728907585144
, O 0 0.011206220835447311
verbal O 0 0.038876909762620926
memory O 0 0.031818147748708725
, O 0 0.006975051946938038
and O 0 0.0068800984881818295
reading O 0 0.018680116161704063
skills O 0 0.0322430245578289
. O 0 0.029821280390024185

Comparison O 0 0.037585947662591934
of O 0 0.01380062010139227
molecular O 0 0.03228126838803291
and O 0 0.009623116813600063
psychometric O 0 0.14393620193004608
findings O 0 0.019019927829504013
demonstrated O 0 0.014671014621853828
that O 0 0.006840446498245001
deletions O 0 0.058781955391168594
and O 0 0.005545245483517647
duplications O 0 0.15376606583595276
that O 0 0.004489869344979525
were O 0 0.004482580348849297
localized O 0 0.13609254360198975
in O 0 0.005680544767528772
the O 0 0.006784422323107719
distal O 1 0.6424602270126343
part O 0 0.00806288793683052
of O 0 0.006032518111169338
the O 0 0.007893746718764305
gene O 0 0.2505805194377899
seemed O 0 0.013791796751320362
to O 0 0.006626322399824858
be O 0 0.007536811754107475
preferentially O 0 0.04478893056511879
associated O 0 0.019889771938323975
with O 0 0.015487760305404663
cognitive B-Disease 1 0.812030017375946
impairment I-Disease 1 0.969927966594696
. O 0 0.04544917494058609

Two O 0 0.02706388756632805
altered O 0 0.05329824611544609
Dp71 O 0 0.1509702503681183
transcripts O 0 0.02068786509335041
and O 0 0.007558306213468313
two O 0 0.008733714930713177
deleted O 0 0.02861756831407547
Dp140 O 0 0.38635164499282837
DNA O 0 0.03318074718117714
sequences O 0 0.017589090391993523
were O 0 0.0046605393290519714
found O 0 0.00655711954459548
in O 0 0.006520306225866079
four O 0 0.011116371490061283
patients O 1 0.9914202690124512
with O 0 0.05110633745789528
severe O 1 0.999157190322876
cerebral B-Disease 1 0.9994327425956726
dysfunction I-Disease 1 0.9984342455863953
. O 0 0.08434879779815674

These O 0 0.017233114689588547
findings O 0 0.021474847570061684
suggest O 0 0.013812084682285786
that O 0 0.004888081457465887
some O 0 0.0059493123553693295
sequences O 0 0.013559947721660137
located O 0 0.006977000739425421
in O 0 0.004334001801908016
the O 0 0.006272757891565561
distal O 1 0.7141084671020508
part O 0 0.007568619213998318
of O 0 0.005093120504170656
the O 0 0.005464476067572832
gene O 0 0.08794759958982468
and O 0 0.0039209164679050446
, O 0 0.003912169020622969
in O 0 0.004321641754359007
particular O 0 0.008015678264200687
, O 0 0.005820329766720533
some O 0 0.008986740373075008
DMD B-Disease 1 0.9985974431037903
isoforms O 0 0.4994256794452667
expressed O 0 0.013279796577990055
in O 0 0.00706422608345747
the O 0 0.008328923024237156
brain O 1 0.9953742623329163
may O 0 0.008954320102930069
be O 0 0.00395236536860466
related O 0 0.008451891131699085
to O 0 0.0045142993330955505
the O 0 0.008356220088899136
cognitive B-Disease 1 0.9014737606048584
impairment I-Disease 1 0.9905822277069092
associated O 0 0.06381116807460785
with O 0 0.02798476070165634
DMD B-Disease 1 0.9976045489311218
. O 0 0.02453063800930977
. O 0 0.03539134934544563

I1307K O 1 0.7995558977127075
APC O 1 0.7580446004867554
and O 0 0.021190447732806206
hMLH1 O 1 0.8625765442848206
mutations O 1 0.8407801985740662
in O 0 0.010046306066215038
a O 0 0.009674051776528358
non O 0 0.017355231568217278
- O 0 0.0318978987634182
Jewish O 0 0.020124761387705803
family O 0 0.020553724840283394
with O 0 0.01755620166659355
hereditary B-Disease 1 0.9889538288116455
non I-Disease 1 0.8424385786056519
- I-Disease 1 0.9936727285385132
polyposis I-Disease 1 0.9999171495437622
colorectal I-Disease 1 0.9999605417251587
cancer I-Disease 1 0.9996498823165894
. O 0 0.19423320889472961

We O 0 0.02187904715538025
describe O 0 0.025766996666789055
a O 0 0.015378260053694248
French O 0 0.028566787019371986
Canadian O 0 0.06496121734380722
hereditary B-Disease 1 0.9945737719535828
non I-Disease 1 0.9548674821853638
- I-Disease 1 0.997144877910614
polyposis I-Disease 1 0.9999449253082275
colorectal I-Disease 1 0.9999860525131226
cancer I-Disease 1 0.9999254941940308
( O 1 0.9209295511245728
HNPCC B-Disease 1 0.9984872341156006
) O 0 0.03196669742465019
kindred O 1 0.7998260855674744
which O 0 0.01122983731329441
carries O 0 0.01976442150771618
a O 0 0.015476240776479244
novel O 0 0.04437646269798279
truncating O 1 0.9520820379257202
mutation O 1 0.9855408072471619
in O 0 0.029805121943354607
hMLH1 O 1 0.7776312232017517
. O 0 0.04249589145183563

Interestingly O 0 0.07487580180168152
, O 0 0.01944359764456749
the O 0 0.019528791308403015
I1307K O 1 0.8110201954841614
APC O 1 0.954749345779419
polymorphism O 0 0.3524739146232605
, O 0 0.00967503059655428
associated O 0 0.011247852817177773
with O 0 0.0059617916122078896
an O 0 0.006673778407275677
increased O 0 0.04111683368682861
risk O 1 0.9545827507972717
of O 0 0.19409075379371643
colorectal B-Disease 1 0.9999825954437256
cancer I-Disease 1 0.999915599822998
, O 0 0.009587160311639309
is O 0 0.006431980524212122
also O 0 0.004557351116091013
present O 0 0.006899629253894091
in O 0 0.005857980344444513
this O 0 0.00897388719022274
family O 0 0.027068939059972763
. O 0 0.027236223220825195

The O 0 0.026690399274230003
I1307K O 1 0.6447004079818726
polymorphism O 0 0.12778036296367645
has O 0 0.009314975701272488
previously O 0 0.007651320658624172
only O 0 0.0038197506219148636
been O 0 0.004383934661746025
identified O 0 0.006997633259743452
in O 0 0.00397923169657588
individuals O 0 0.007330536376684904
of O 0 0.006367069203406572
self O 0 0.03859446942806244
- O 0 0.10687533766031265
reported O 0 0.046526264399290085
Ashkenazi O 1 0.6141838431358337
Jewish O 0 0.046981390565633774
origins O 0 0.07380684465169907
. O 0 0.04184522107243538

In O 0 0.015671854838728905
addition O 0 0.012102973647415638
, O 0 0.005945914890617132
in O 0 0.004860755987465382
this O 0 0.004129832144826651
family O 0 0.007626884616911411
, O 0 0.003797526704147458
there O 0 0.00427175173535943
appears O 0 0.007315610535442829
to O 0 0.0028999405913054943
be O 0 0.002597193466499448
no O 0 0.0035412649158388376
relationship O 0 0.008663150481879711
between O 0 0.006131803151220083
the O 0 0.006994857452809811
I1307K O 0 0.28008052706718445
polymorphism O 0 0.15296463668346405
and O 0 0.005438990890979767
the O 0 0.005865707993507385
presence O 0 0.012762532569468021
or O 0 0.009810720570385456
absence O 0 0.0221332348883152
of O 0 0.01465708389878273
cancer B-Disease 1 0.998201847076416
. O 0 0.020574301481246948
. O 0 0.0275237038731575

Identification O 0 0.030400624498724937
of O 0 0.010982436127960682
a O 0 0.012776028364896774
novel O 0 0.02475922740995884
mutation O 1 0.7828640937805176
of O 0 0.008336223661899567
the O 0 0.010812409222126007
CPO O 0 0.11962248384952545
gene O 0 0.1054493859410286
in O 0 0.010733941569924355
a O 0 0.01390006486326456
Japanese O 0 0.03150652348995209
hereditary B-Disease 1 0.947677493095398
coproporphyria I-Disease 1 0.9355807900428772
family O 0 0.07186606526374817
. O 0 0.04916953295469284

Hereditary B-Disease 1 0.9816451072692871
coproporphyria I-Disease 1 0.943030595779419
( O 0 0.05921448394656181
HCP B-Disease 1 0.9170814156532288
) O 0 0.018738865852355957
is O 0 0.012241650372743607
an O 0 0.015345687977969646
autosomal B-Disease 1 0.9992788434028625
dominant I-Disease 1 0.9942224621772766
disease I-Disease 1 0.9998294115066528
characterized O 1 0.9335203170776367
by O 0 0.016751637682318687
a O 0 0.027000844478607178
deficiency B-Disease 1 0.9988677501678467
of I-Disease 0 0.022178202867507935
coproporphyrinogen I-Disease 1 0.9926275610923767
oxidase I-Disease 1 0.9907671213150024
( O 0 0.03266504034399986
CPO O 0 0.20031951367855072
) O 0 0.013718764297664165
caused O 0 0.05769412964582443
by O 0 0.008143767714500427
a O 0 0.011106986552476883
mutation O 1 0.7888952493667603
in O 0 0.010593928396701813
the O 0 0.01436320599168539
CPO O 0 0.154827281832695
gene O 0 0.43913665413856506
. O 0 0.03727119788527489

Only O 0 0.018719563260674477
11 O 0 0.023902425542473793
mutations O 0 0.3469969630241394
of O 0 0.008133521303534508
the O 0 0.009236777201294899
gene O 0 0.3943580389022827
have O 0 0.007616022136062384
been O 0 0.01052421797066927
reported O 0 0.02326500415802002
in O 0 0.017998626455664635
HCP B-Disease 1 0.9934583306312561
patients O 1 0.9924691319465637
. O 0 0.03940899297595024

We O 0 0.016662858426570892
report O 0 0.0160038061439991
another O 0 0.019862806424498558
mutation O 1 0.7454447746276855
in O 0 0.009892536327242851
a O 0 0.012327348813414574
Japanese O 0 0.022032586857676506
family O 0 0.031605228781700134
. O 0 0.032212741672992706

Polymerase O 1 0.8660968542098999
chain O 0 0.31790292263031006
reaction O 0 0.06181710585951805
- O 0 0.04321034997701645
single O 0 0.026455378159880638
strand O 0 0.14083026349544525
conformational O 0 0.47266682982444763
polymorphism O 0 0.11488711088895798
and O 0 0.006764870136976242
direct O 0 0.01177405845373869
sequence O 0 0.01632346771657467
analyses O 0 0.014065505936741829
demonstrated O 0 0.01318247802555561
a O 0 0.008455535396933556
C O 0 0.018362829461693764
to O 0 0.006649192422628403
T O 0 0.18938839435577393
substitution O 0 0.0183107927441597
in O 0 0.008276797831058502
exon O 0 0.03612204268574715
1 O 0 0.009936928749084473
of O 0 0.005574408452957869
the O 0 0.00869689416140318
CPO O 0 0.0470912903547287
gene O 0 0.08054651319980621
at O 0 0.010354524478316307
nucleotide O 0 0.026652775704860687
position O 0 0.008456967771053314
85 O 0 0.011295792646706104
, O 0 0.00467146560549736
which O 0 0.004557116888463497
lies O 0 0.009341657161712646
in O 0 0.00531254755333066
the O 0 0.007541467901319265
putative O 0 0.12262677401304245
presequence O 0 0.21881692111492157
for O 0 0.010680049657821655
targeting O 0 0.02609468623995781
to O 0 0.018282826989889145
mitochondria O 0 0.16631698608398438
. O 0 0.037641093134880066

This O 0 0.0286953654140234
mutation O 1 0.6714115738868713
changes O 0 0.019220786169171333
the O 0 0.010748245753347874
codon O 0 0.04553590714931488
for O 0 0.008528124541044235
glutamine O 0 0.03164418786764145
to O 0 0.007555378135293722
a O 0 0.013383407145738602
termination O 0 0.19361083209514618
codon O 0 0.07714683562517166
at O 0 0.017546311020851135
amino O 0 0.03707381337881088
acid O 0 0.05697115883231163
position O 0 0.019772525876760483
29 O 0 0.03274792060256004
. O 0 0.02546313777565956

MaeI O 1 0.5716664791107178
restriction O 0 0.05202077329158783
analysis O 0 0.023494143038988113
showed O 0 0.01719832792878151
two O 0 0.0070655373856425285
other O 0 0.0071290116757154465
carriers O 0 0.022111907601356506
in O 0 0.008455120027065277
the O 0 0.010636567138135433
family O 0 0.024724718183279037
. O 0 0.024382663890719414

The O 0 0.031394872814416885
C O 0 0.16283905506134033
- O 0 0.35241085290908813
T O 1 0.9561722278594971
mutation O 1 0.966340959072113
is O 0 0.010747069492936134
located O 0 0.012683195993304253
within O 0 0.009691757149994373
a O 0 0.009980347938835621
recently O 0 0.015681231394410133
proposed O 0 0.017231935635209084
putative O 0 0.052897002547979355
alternative O 0 0.021873727440834045
translation O 0 0.02239963598549366
initiation O 0 0.07496289908885956
codon O 0 0.3999767303466797
( O 0 0.022393902763724327
TIC O 1 0.8199392557144165
- O 0 0.026875849813222885
1 O 0 0.01225372962653637
) O 0 0.00844842754304409
, O 0 0.004991506692022085
supporting O 0 0.011183439753949642
that O 0 0.007522925268858671
TIC O 1 0.8561458587646484
- O 0 0.023272622376680374
1 O 0 0.009827986359596252
is O 0 0.006066638510674238
the O 0 0.006934496108442545
real O 0 0.016408419236540794
TIC O 1 0.7221198678016663
rather O 0 0.014958294108510017
than O 0 0.015347273088991642
TIC O 1 0.9249248504638672
- O 0 0.046683769673109055
2 O 0 0.02548670582473278
. O 0 0.01787661388516426
. O 0 0.026587307453155518

Human B-Disease 0 0.0925917997956276
complement I-Disease 0 0.11177003383636475
factor I-Disease 1 0.8637575507164001
H I-Disease 1 0.9904194474220276
deficiency I-Disease 1 0.9994945526123047
associated O 1 0.8050591349601746
with O 1 0.752533495426178
hemolytic B-Disease 1 0.9999475479125977
uremic I-Disease 1 0.9999713897705078
syndrome I-Disease 1 0.99994957447052
. O 0 0.36606210470199585

This O 0 0.016353728249669075
study O 0 0.018068140372633934
reports O 0 0.012135765515267849
on O 0 0.006688347086310387
six O 0 0.009116035886108875
cases O 0 0.016774743795394897
of O 0 0.009623215533792973
deficiency B-Disease 1 0.9985176920890808
in I-Disease 0 0.008472295477986336
the I-Disease 0 0.00836244598031044
human I-Disease 0 0.023225704208016396
complement I-Disease 0 0.032235417515039444
regulatory I-Disease 0 0.1771269142627716
protein I-Disease 0 0.3128412365913391
Factor I-Disease 0 0.4035640060901642
H I-Disease 1 0.8415476679801941
( O 0 0.021618373692035675
FH O 1 0.9611203074455261
) O 0 0.00887144822627306
in O 0 0.005495121702551842
the O 0 0.005071632564067841
context O 0 0.01279906090348959
of O 0 0.01017092913389206
an O 0 0.04850659891963005
acute B-Disease 1 0.9997679591178894
renal I-Disease 1 0.999976634979248
disease I-Disease 1 0.9999290704727173
. O 0 0.2873590290546417

Five O 0 0.014215321280062199
of O 0 0.008730297908186913
the O 0 0.007738419342786074
cases O 0 0.013813268393278122
were O 0 0.0053107040002942085
observed O 0 0.013059545308351517
in O 0 0.007562983315438032
children O 0 0.020057227462530136
presenting O 0 0.0893356055021286
with O 0 0.4585607051849365
idiopathic O 1 0.999864935874939
hemolytic B-Disease 1 0.9999843835830688
uremic I-Disease 1 0.9999876022338867
syndrome I-Disease 1 0.999977707862854
( O 1 0.9640553593635559
HUS B-Disease 1 0.9980849027633667
) O 0 0.06359507143497467
. O 0 0.0519929863512516

Two O 0 0.012321862392127514
of O 0 0.008110426366329193
the O 0 0.009023911319673061
children O 0 0.01782660000026226
exhibited O 0 0.02785314992070198
a O 0 0.020836686715483665
homozygous O 1 0.9954087138175964
deficiency O 1 0.9996839761734009
characterized O 1 0.5090904235839844
by O 0 0.006956521887332201
the O 0 0.005392768885940313
absence O 0 0.00990199949592352
of O 0 0.004605530761182308
the O 0 0.005355967674404383
150 O 0 0.011648442596197128
- O 0 0.030234389007091522
kD O 0 0.31503599882125854
form O 0 0.01278302539139986
of O 0 0.007397217210382223
Factor O 0 0.09113739430904388
H O 0 0.11874620616436005
and O 0 0.00478798383846879
the O 0 0.00468867551535368
presence O 0 0.009228355251252651
, O 0 0.004756509326398373
upon O 0 0.007073949556797743
immunoblotting O 0 0.04636085778474808
, O 0 0.004479764029383659
of O 0 0.004327917005866766
the O 0 0.006302429363131523
42 O 0 0.01763155870139599
- O 0 0.11606640368700027
kD O 1 0.7814569473266602
Factor O 0 0.2526934742927551
H O 0 0.3924088478088379
- O 0 0.030950728803873062
like O 0 0.014933016151189804
protein O 0 0.03304673731327057
1 O 0 0.014612524770200253
( O 0 0.016390550881624222
FHL O 1 0.8576794266700745
- O 0 0.027795223519206047
1 O 0 0.01181307528167963
) O 0 0.006906967144459486
and O 0 0.005602550692856312
other O 0 0.007435080129653215
FH O 1 0.9802597165107727
- O 0 0.1367679089307785
related O 0 0.0407833568751812
protein O 0 0.16832973062992096
( O 0 0.02519485354423523
FHR O 1 0.8012303113937378
) O 0 0.023045681416988373
bands O 0 0.03965514153242111
. O 0 0.030078398063778877

Southern O 0 0.05237305909395218
blot O 0 0.12920451164245605
and O 0 0.0144471051171422
PCR O 0 0.04613454267382622
analysis O 0 0.0134633993729949
of O 0 0.006487242877483368
DNA O 0 0.016254091635346413
of O 0 0.005250969901680946
one O 0 0.007504739798605442
patient O 1 0.7971031665802002
with O 0 0.013486605137586594
homozygous O 1 0.9959740042686462
deficiency O 1 0.9996219873428345
ruled O 0 0.034031305462121964
out O 0 0.0058210683055222034
the O 0 0.004973271396011114
presence O 0 0.008089463226497173
of O 0 0.0038253774400800467
a O 0 0.006134576164186001
large O 0 0.008124747313559055
deletion O 0 0.17029038071632385
of O 0 0.006600171327590942
the O 0 0.010429469868540764
FH O 1 0.9940823912620544
gene O 0 0.4498063027858734
as O 0 0.007132698781788349
the O 0 0.008242624811828136
underlying O 0 0.0710926502943039
defect O 1 0.8251506090164185
for O 0 0.01373420562595129
the O 0 0.0230476725846529
deficiency O 1 0.9983811378479004
. O 0 0.04269770160317421

The O 0 0.014419091865420341
other O 0 0.008399594575166702
four O 0 0.007920953445136547
children O 0 0.012186386622488499
presented O 0 0.011089036241173744
with O 0 0.01180627103894949
heterozygous O 1 0.9657456874847412
deficiency O 1 0.9987010955810547
and O 0 0.009736265055835247
exhibited O 0 0.020724453032016754
a O 0 0.011196091771125793
normal O 0 0.04379085823893547
immunoblotting O 1 0.6619681119918823
pattern O 0 0.028940534219145775
of O 0 0.008523424156010151
proteins O 0 0.019616592675447464
of O 0 0.009631176479160786
the O 0 0.016725990921258926
FH O 1 0.9863176345825195
family O 0 0.0550849512219429
. O 0 0.03870120272040367

Factor B-Disease 1 0.7482527494430542
H I-Disease 1 0.9710423946380615
deficiency I-Disease 1 0.9971566200256348
is O 0 0.014543368481099606
the O 0 0.010770175606012344
only O 0 0.012879645451903343
complement B-Disease 1 0.6600962281227112
deficiency I-Disease 1 0.9995300769805908
associated O 0 0.10659392178058624
with O 0 0.0321013443171978
HUS B-Disease 1 0.9943445920944214
. O 0 0.0484592579305172

These O 0 0.01771354302763939
observations O 0 0.021033398807048798
suggest O 0 0.015182316303253174
a O 0 0.008572272025048733
role O 0 0.011111435480415821
for O 0 0.008560380898416042
FH O 1 0.9856487512588501
and O 0 0.011560197919607162
/ O 0 0.37510159611701965
or O 0 0.022226499393582344
FH O 1 0.995367169380188
receptors O 1 0.5902621746063232
in O 0 0.013384195044636726
the O 0 0.016563760116696358
pathogenesis O 1 0.9899352192878723
of O 0 0.043892402201890945
idiopathic O 1 0.9996225833892822
HUS B-Disease 1 0.9981853365898132
. O 0 0.03671551123261452
. O 0 0.03700405731797218

Further O 0 0.019420500844717026
evidence O 0 0.012041064910590649
for O 0 0.006833397317677736
a O 0 0.010327542200684547
major O 0 0.015813322737812996
ancient O 0 0.02355262264609337
mutation O 1 0.99379563331604
underlying O 1 0.9800298810005188
myotonic B-Disease 1 0.9997627139091492
dystrophy I-Disease 1 0.9998607635498047
from O 0 0.055822424590587616
linkage O 1 0.927457869052887
disequilibrium O 1 0.9632962346076965
studies O 0 0.021973742172122
in O 0 0.010113618336617947
the O 0 0.010766766965389252
Japanese O 0 0.022040413692593575
population O 0 0.032540708780288696
. O 0 0.031109562143683434

The O 0 0.15376386046409607
myotonic B-Disease 1 0.9994906187057495
dystrophy I-Disease 1 0.9997960925102234
( O 1 0.8501800894737244
DM B-Disease 1 0.9981271624565125
) O 0 0.039180826395750046
mutation O 1 0.9761185050010681
is O 0 0.013715841807425022
an O 0 0.011884985491633415
unstable O 1 0.7434950470924377
( O 0 0.024221641942858696
CTG O 1 0.7227016687393188
) O 0 0.015088960528373718
n O 0 0.017944633960723877
repeat O 0 0.018385836854577065
, O 0 0.005050443112850189
present O 0 0.005470177158713341
at O 0 0.004191783256828785
a O 0 0.004870830103754997
copy O 0 0.008572871796786785
number O 0 0.004802042152732611
of O 0 0.0047624362632632256
5 O 0 0.009271004237234592
- O 0 0.017070278525352478
37 O 0 0.016155729070305824
repeats O 0 0.021387482061982155
on O 0 0.007442033849656582
normal O 0 0.017940692603588104
chromosomes O 0 0.03564397618174553
but O 0 0.006975224241614342
amplified O 0 0.02104322798550129
to O 0 0.006846355274319649
50 O 0 0.012772356159985065
- O 0 0.023989399895071983
3000 O 0 0.03626551851630211
copies O 0 0.01856154389679432
on O 0 0.019218746572732925
DM B-Disease 1 0.9899174571037292
chromosomes O 1 0.6549873948097229
. O 0 0.047590434551239014

Previous O 0 0.035529740154743195
findings O 0 0.03243228420615196
in O 0 0.016884619370102882
Caucasian O 0 0.3556864857673645
populations O 0 0.040472362190485
of O 0 0.012162983417510986
a O 0 0.02246985211968422
DM B-Disease 1 0.9972276091575623
founder O 0 0.3103272020816803
chromosome O 1 0.9801256060600281
raise O 0 0.019401540979743004
a O 0 0.009530531242489815
question O 0 0.00950661301612854
about O 0 0.006752245593816042
the O 0 0.006794093642383814
molecular O 0 0.01808149367570877
events O 0 0.009883647784590721
involved O 0 0.011585605330765247
in O 0 0.007783669978380203
the O 0 0.011972373351454735
expansion O 0 0.03743279352784157
mutation O 1 0.9363650679588318
. O 0 0.03949690982699394

To O 0 0.017570488154888153
investigate O 0 0.026507612317800522
whether O 0 0.014244952239096165
a O 0 0.01164906844496727
founder O 0 0.03293435648083687
chromosome O 1 0.7042364478111267
for O 0 0.01015429012477398
the O 0 0.01520463451743126
DM B-Disease 1 0.9984191656112671
mutation O 1 0.9813787937164307
exists O 0 0.016856707632541656
in O 0 0.006882509216666222
the O 0 0.006054820958524942
Japanese O 0 0.010643216781318188
population O 0 0.010182463563978672
, O 0 0.005750494077801704
we O 0 0.0062911780551075935
genotyped O 0 0.11959236115217209
families O 0 0.014574768953025341
using O 0 0.013496770523488522
polymorphic O 1 0.7841335535049438
markers O 0 0.03459320589900017
near O 0 0.013370777480304241
the O 0 0.00971271377056837
( O 0 0.01625766046345234
CTG O 0 0.42415758967399597
) O 0 0.013886860571801662
n O 0 0.02580655738711357
repeat O 0 0.03313693404197693
region O 0 0.020099690183997154
and O 0 0.012573682703077793
constructed O 0 0.027440018951892853
haplotypes O 1 0.7656736969947815
. O 0 0.035333722829818726

Six O 0 0.022287629544734955
different O 0 0.014900890178978443
haplotypes O 1 0.5636401772499084
were O 0 0.006854445673525333
found O 0 0.01128483284264803
and O 0 0.012635212391614914
DM B-Disease 1 0.997878909111023
alleles O 1 0.9850234985351562
were O 0 0.01592080481350422
always O 0 0.02397943288087845
haplotype O 1 0.8602660894393921
A O 0 0.03644472360610962
. O 0 0.03678284212946892

To O 0 0.014204259030520916
find O 0 0.01301670353859663
an O 0 0.0072938608936965466
origin O 0 0.009565414860844612
of O 0 0.00501388031989336
the O 0 0.007312480825930834
( O 0 0.014816738665103912
CTG O 0 0.493507444858551
) O 0 0.013423025608062744
n O 0 0.026213834062218666
repeat O 0 0.12859822809696198
mutation O 1 0.5581908822059631
and O 0 0.004710410721600056
to O 0 0.004050767980515957
investigate O 0 0.009258740581572056
the O 0 0.004439680837094784
mechanism O 0 0.010721690021455288
of O 0 0.00452139088883996
the O 0 0.005421785172075033
expansion O 0 0.013621604070067406
mutation O 1 0.7319416403770447
in O 0 0.004946814384311438
the O 0 0.0047910092398524284
Japanese O 0 0.0084792235866189
population O 0 0.008632898330688477
we O 0 0.004057897720485926
have O 0 0.004711490590125322
studied O 0 0.009945222176611423
90 O 0 0.013911357149481773
Japanese O 0 0.022475797683000565
DM B-Disease 1 0.9934412240982056
families O 0 0.026926029473543167
comprising O 0 0.023647412657737732
190 O 0 0.032584160566329956
affected O 0 0.045695409178733826
and O 0 0.013312363997101784
130 O 0 0.03449927642941475
unaffected O 0 0.16377043724060059
members O 0 0.025020157918334007
. O 0 0.03174987807869911

The O 0 0.016915660351514816
results O 0 0.018135279417037964
suggest O 0 0.013223330490291119
that O 0 0.004936701152473688
a O 0 0.006855607498437166
few O 0 0.0075500598177313805
common O 0 0.013461612164974213
ancestral O 0 0.1868516206741333
mutations O 1 0.9512749314308167
in O 0 0.007406213786453009
both O 0 0.007171149365603924
Caucasian O 0 0.08319739997386932
and O 0 0.00579731585457921
Japanese O 0 0.01018028985708952
populations O 0 0.02375619113445282
have O 0 0.005143396556377411
originated O 0 0.011327886953949928
by O 0 0.005582503508776426
expansion O 0 0.007708241231739521
of O 0 0.0040025548078119755
an O 0 0.005986594595015049
ancestral O 0 0.03177106752991676
n O 0 0.02981719560921192
= O 0 0.02849743328988552
5 O 0 0.011139096692204475
repeat O 0 0.02039550617337227
to O 0 0.007484891451895237
n O 0 0.023009875789284706
= O 0 0.03016042150557041
19 O 0 0.01859511435031891
- O 0 0.028910674154758453
37 O 0 0.026254545897245407
copies O 0 0.03092576004564762
. O 0 0.02946980483829975

These O 0 0.018958626314997673
data O 0 0.01775035262107849
support O 0 0.01755361445248127
multistep O 0 0.06677628308534622
models O 0 0.017936956137418747
of O 0 0.010179641656577587
triplet O 1 0.798888087272644
repeat O 0 0.0455569252371788
expansion O 0 0.0130471121519804
that O 0 0.005059933289885521
have O 0 0.0042958310805261135
been O 0 0.00439058942720294
proposed O 0 0.007214871700853109
for O 0 0.005645887926220894
both O 0 0.010163526050746441
DM B-Disease 1 0.9948093891143799
and O 0 0.018420055508613586
Friedreichs B-Disease 1 0.9901185631752014
ataxia I-Disease 1 0.9980692267417908
. O 0 0.028188874945044518
. O 0 0.03340383619070053

The O 0 0.02606409229338169
molecular O 0 0.03996476158499718
basis O 0 0.01787370815873146
of O 0 0.018381567671895027
C6 B-Disease 1 0.9977444410324097
deficiency I-Disease 1 0.9992879033088684
in O 0 0.01030485238879919
the O 0 0.008832268416881561
western O 0 0.015659384429454803
Cape O 0 0.03520404174923897
, O 0 0.010573391802608967
South O 0 0.017526570707559586
Africa O 0 0.031001484021544456
. O 0 0.03026026487350464

Deficiency B-Disease 1 0.9949209094047546
of I-Disease 0 0.012325751595199108
the I-Disease 0 0.009578343480825424
sixth I-Disease 0 0.017579294741153717
component I-Disease 0 0.015848856419324875
of I-Disease 0 0.0069739618338644505
human I-Disease 0 0.018100108951330185
complement I-Disease 0 0.023458605632185936
( O 0 0.014951509423553944
C6 O 1 0.9027817249298096
) O 0 0.007431541103869677
has O 0 0.004882073029875755
been O 0 0.004806624259799719
reported O 0 0.0068574873730540276
in O 0 0.0031222354155033827
a O 0 0.003843735670670867
number O 0 0.003623146563768387
of O 0 0.003179234452545643
families O 0 0.006694905459880829
from O 0 0.005052276886999607
the O 0 0.005645023193210363
western O 0 0.012196476571261883
Cape O 0 0.02428639866411686
, O 0 0.009204298257827759
South O 0 0.019328998401761055
Africa O 0 0.034821461886167526
. O 0 0.03461027517914772

Meningococcal B-Disease 1 0.9992202520370483
disease I-Disease 1 0.9994879961013794
is O 0 0.023292457684874535
endemic O 1 0.5457776784896851
in O 0 0.007823414169251919
the O 0 0.006639775354415178
Cape O 0 0.016497239470481873
and O 0 0.005041635595262051
almost O 0 0.005990125704556704
all O 0 0.005610767751932144
pedigrees O 0 0.035516656935214996
of O 0 0.009562479332089424
total O 0 0.030565833672881126
C6 B-Disease 1 0.9988436698913574
deficiency I-Disease 1 0.9997524619102478
( O 0 0.05294474959373474
C6Q0 O 1 0.8757637143135071
) O 0 0.012556314468383789
have O 0 0.0074640060774981976
been O 0 0.008169327862560749
ascertained O 0 0.038553595542907715
because O 0 0.015196832828223705
of O 0 0.018525155261158943
recurrent O 1 0.998156726360321
disease O 1 0.9992823004722595
. O 0 0.05409173294901848

We O 0 0.016629287973046303
have O 0 0.012129656970500946
sequenced O 0 0.031185638159513474
the O 0 0.008930059149861336
expressed O 0 0.013725662603974342
exons O 0 0.03268814831972122
of O 0 0.007526742294430733
the O 0 0.010472157970070839
C6 O 1 0.970624566078186
gene O 0 0.4030842185020447
from O 0 0.007055362220853567
selected O 0 0.007050586398690939
cases O 0 0.008433368988335133
and O 0 0.003438339103013277
have O 0 0.00392973842099309
found O 0 0.0055635240860283375
three O 0 0.006266064941883087
molecular O 0 0.18446731567382812
defects O 1 0.9511420726776123
leading O 0 0.012112611904740334
to O 0 0.0075505697168409824
total O 0 0.019577601924538612
deficiency O 1 0.999462902545929
879delG O 1 0.7449424862861633
, O 0 0.006497438531368971
which O 0 0.004495208151638508
is O 0 0.0049375444650650024
the O 0 0.004853173159062862
common O 0 0.013547459617257118
defect O 1 0.6579157710075378
in O 0 0.005110135301947594
the O 0 0.005753079429268837
Cape O 0 0.01881490834057331
and O 0 0.006704011932015419
hitherto O 0 0.03728032484650612
unreported O 0 0.038196172565221786
, O 0 0.006599214859306812
and O 0 0.0066656433045864105
1195delC O 0 0.12758424878120422
and O 0 0.006292757578194141
1936delG O 0 0.12537874281406403
, O 0 0.0045438227243721485
which O 0 0.003952541388571262
have O 0 0.0035652618389576674
been O 0 0.004381204955279827
previously O 0 0.006851190701127052
reported O 0 0.010258735157549381
in O 0 0.007828330621123314
African O 0 0.02379418909549713
- O 0 0.07417302578687668
Americans O 0 0.03796914592385292
. O 0 0.03065529651939869

We O 0 0.01343700010329485
also O 0 0.008322855457663536
show O 0 0.010041886940598488
that O 0 0.004816694185137749
the O 0 0.006829340476542711
879delG O 0 0.09835225343704224
and O 0 0.008994808420538902
1195delC O 1 0.9088271260261536
defects O 1 0.9860646724700928
are O 0 0.006321033462882042
associated O 0 0.01318714302033186
with O 0 0.009920332580804825
characteristic O 1 0.7295055985450745
C6 O 1 0.9971120357513428
/ O 1 0.9598878622055054
C7 O 1 0.991356372833252
region O 0 0.10098043829202652
DNA O 0 0.29012531042099
marker O 0 0.34786394238471985
haplotypes O 1 0.8814440965652466
, O 0 0.009956356137990952
although O 0 0.009877792559564114
small O 0 0.011128229089081287
variations O 0 0.018269719555974007
were O 0 0.008754204958677292
observed O 0 0.027277665212750435
. O 0 0.02248299866914749

The O 0 0.036372050642967224
1936delG O 1 0.825236976146698
defect O 1 0.855424702167511
was O 0 0.012638580054044724
observed O 0 0.01417371816933155
only O 0 0.005011420696973801
once O 0 0.005588074680417776
in O 0 0.004493279382586479
the O 0 0.005385047290474176
Cape O 0 0.014492024667561054
, O 0 0.004441715776920319
but O 0 0.0041600982658565044
its O 0 0.006890838034451008
associated O 0 0.01742720976471901
haplotype O 1 0.8393325209617615
could O 0 0.01127704605460167
be O 0 0.010489403270184994
deduced O 0 0.04429856687784195
. O 0 0.02757483348250389

The O 0 0.014805495738983154
data O 0 0.013488685712218285
from O 0 0.008795085363090038
the O 0 0.00899550598114729
haplotypes O 1 0.5489381551742554
indicate O 0 0.012461465783417225
that O 0 0.004568187985569239
these O 0 0.004640286322683096
three O 0 0.006594059057533741
molecular O 0 0.07495450228452682
defects O 1 0.9118582606315613
account O 0 0.008319656364619732
for O 0 0.004508671350777149
the O 0 0.006362041924148798
defects O 1 0.603819727897644
in O 0 0.00480640958994627
all O 0 0.0037801293656229973
the O 0 0.006127933971583843
38 O 0 0.01665961928665638
unrelated O 0 0.06678400188684464
C6Q0 O 1 0.8592396378517151
individuals O 0 0.012190509587526321
we O 0 0.00504947267472744
have O 0 0.005667803343385458
studied O 0 0.010566324926912785
from O 0 0.009372924454510212
the O 0 0.012008719146251678
Cape O 0 0.04793960973620415
. O 0 0.03080114722251892

We O 0 0.016704795882105827
have O 0 0.009098495356738567
also O 0 0.008058926090598106
observed O 0 0.01634012721478939
the O 0 0.010371076874434948
879delG O 1 0.5918025374412537
defect O 0 0.42485490441322327
in O 0 0.009117982350289822
two O 0 0.011180064640939236
Dutch O 0 0.10196445137262344
C6 B-Disease 1 0.9941926598548889
- I-Disease 1 0.6539415121078491
deficient I-Disease 1 0.9843412041664124
kindreds O 1 0.8471742868423462
, O 0 0.0071224430575966835
but O 0 0.006395179778337479
the O 0 0.0074262418784201145
879delG O 1 0.791966438293457
defect O 1 0.8663086891174316
in O 0 0.006422632373869419
the O 0 0.006256888620555401
Cape O 0 0.02292947843670845
probably O 0 0.009576077573001385
did O 0 0.0047228834591805935
not O 0 0.003531652968376875
come O 0 0.005589350126683712
from O 0 0.0056886570528149605
The O 0 0.006891673896461725
Netherlands O 0 0.020750364288687706
. O 0 0.015317002311348915
. O 0 0.022538689896464348

Complement B-Disease 1 0.8349441885948181
C7 I-Disease 1 0.9973174929618835
deficiency I-Disease 1 0.9991188645362854
: O 0 0.025434060022234917
seven O 0 0.016799455508589745
further O 0 0.019409462809562683
molecular O 0 0.21901550889015198
defects O 1 0.9497453570365906
and O 0 0.009597397409379482
their O 0 0.011554347351193428
associated O 0 0.03218349814414978
marker O 0 0.27555546164512634
haplotypes O 1 0.9430674910545349
. O 0 0.043809596449136734

Seven O 0 0.03172560781240463
further O 0 0.027601731941103935
molecular O 0 0.04301870986819267
bases O 0 0.030345454812049866
of O 0 0.026775503531098366
C7 B-Disease 1 0.995895504951477
deficiency I-Disease 1 0.9991565942764282
are O 0 0.029040269553661346
described O 0 0.05070500448346138
. O 0 0.037278708070516586

All O 0 0.013120677322149277
these O 0 0.010433214716613293
new O 0 0.012548140250146389
molecular O 0 0.09233545511960983
defects O 1 0.9327623844146729
involve O 0 0.02481440082192421
single O 0 0.017597248777747154
- O 0 0.02975979633629322
nucleotide O 0 0.034495580941438675
events O 0 0.012370488606393337
, O 0 0.00646232021972537
deletions O 0 0.026655199006199837
and O 0 0.004768822807818651
substitutions O 0 0.011016557924449444
, O 0 0.003939974121749401
some O 0 0.0038413924630731344
of O 0 0.004354233853518963
which O 0 0.0067525142803788185
alter O 0 0.047104138880968094
splice O 0 0.12948355078697205
sites O 0 0.010983141139149666
, O 0 0.006695060525089502
and O 0 0.007498627062886953
others O 0 0.018387772142887115
codons O 0 0.12676700949668884
. O 0 0.03450685739517212

They O 0 0.012136456556618214
are O 0 0.007635992951691151
distributed O 0 0.012837694026529789
along O 0 0.010541627183556557
the O 0 0.011903534643352032
C7 O 1 0.9493329524993896
gene O 0 0.3496710956096649
, O 0 0.008777955546975136
but O 0 0.008145554922521114
predominantly O 0 0.013432386331260204
towards O 0 0.010372430086135864
the O 0 0.009728982113301754
3 O 0 0.019584687426686287
end O 0 0.024490585550665855
. O 0 0.030385147780179977

All O 0 0.015528764575719833
were O 0 0.01070655882358551
found O 0 0.013177621178328991
in O 0 0.012135125696659088
compound O 0 0.03775500878691673
heterozygous O 1 0.5378470420837402
individuals O 0 0.0375639982521534
. O 0 0.035596150904893875

The O 0 0.058173928409814835
C6 O 1 0.9816141128540039
/ O 1 0.9201775193214417
C7 O 1 0.9848788380622864
marker O 1 0.5416229963302612
haplotypes O 1 0.9636897444725037
associated O 0 0.025257939472794533
with O 0 0.013533217832446098
most O 0 0.019153859466314316
C7 B-Disease 1 0.994724452495575
defects I-Disease 1 0.9919458031654358
are O 0 0.014751702547073364
tabulated O 0 0.02844025380909443
. O 0 0.017161067575216293
. O 0 0.02718837559223175

A O 0 0.03917275741696358
genome O 0 0.19993190467357635
- O 0 0.04586387425661087
wide O 0 0.02676975727081299
search O 0 0.020113538950681686
for O 0 0.015019064769148827
chromosomal O 1 0.9936457872390747
loci O 1 0.9786473512649536
linked O 0 0.48848891258239746
to O 0 0.013383137062191963
mental O 1 0.9838501214981079
health O 1 0.9128493666648865
wellness O 1 0.8068798184394836
in O 0 0.01053751539438963
relatives O 0 0.027177728712558746
at O 0 0.010846825316548347
high O 0 0.02124002017080784
risk O 1 0.9234155416488647
for O 0 0.04831179603934288
bipolar B-Disease 1 0.9998390674591064
affective I-Disease 1 0.999643087387085
disorder I-Disease 1 0.9996916055679321
among O 0 0.02656123973429203
the O 0 0.012704679742455482
Old O 0 0.024558141827583313
Order O 0 0.023335615172982216
Amish O 0 0.08968526870012283
. O 0 0.03428806737065315

Bipolar B-Disease 1 0.9995855689048767
affective I-Disease 1 0.99928218126297
disorder I-Disease 1 0.9998512268066406
( O 1 0.8666012287139893
BPAD B-Disease 1 0.9975919723510742
; O 1 0.7976139783859253
manic B-Disease 1 0.9994233846664429
- I-Disease 1 0.9938579201698303
depressive I-Disease 1 0.9997100234031677
illness I-Disease 1 0.9989880919456482
) O 0 0.021341849118471146
is O 0 0.010845138691365719
characterized O 0 0.04947374761104584
by O 0 0.009573478251695633
episodes O 0 0.019721614196896553
of O 0 0.009615185670554638
mania B-Disease 1 0.9912473559379578
and O 0 0.013064966537058353
/ O 0 0.4625306725502014
or O 0 0.02232557162642479
hypomania B-Disease 1 0.9940124154090881
interspersed O 0 0.04853876680135727
with O 0 0.013502340763807297
periods O 0 0.029280077666044235
of O 0 0.018709776923060417
depression B-Disease 1 0.9934317469596863
. O 0 0.0457274504005909

Compelling O 0 0.03810170665383339
evidence O 0 0.019486799836158752
supports O 0 0.021628353744745255
a O 0 0.011330006644129753
significant O 0 0.015598238445818424
genetic O 0 0.3700503706932068
component O 0 0.0191863551735878
in O 0 0.007887684740126133
the O 0 0.009286188520491123
susceptibility O 1 0.9803935289382935
to O 0 0.012270084582269192
develop O 0 0.2014746516942978
BPAD B-Disease 1 0.9714833498001099
. O 0 0.04188842698931694

To O 0 0.01323077455163002
date O 0 0.013773965649306774
, O 0 0.007237709127366543
however O 0 0.0066193328239023685
, O 0 0.005592080298811197
linkage O 0 0.03465407341718674
studies O 0 0.008457615040242672
have O 0 0.004401801154017448
attempted O 0 0.007994813844561577
only O 0 0.0038563597481697798
to O 0 0.004760741256177425
identify O 0 0.027107631787657738
chromosomal O 1 0.994592010974884
loci O 1 0.9740766882896423
that O 0 0.009036919102072716
cause O 1 0.6113302111625671
or O 0 0.009389551356434822
increase O 0 0.012744142673909664
the O 0 0.008488576859235764
risk O 0 0.21969088912010193
of O 0 0.016028087586164474
developing O 0 0.10889291018247604
BPAD B-Disease 1 0.947459876537323
. O 0 0.050125639885663986

To O 0 0.015865733847022057
determine O 0 0.018263021484017372
whether O 0 0.009848438203334808
there O 0 0.005980953574180603
could O 0 0.006793958600610495
be O 0 0.00700544286519289
protective O 0 0.47362902760505676
alleles O 1 0.8611191511154175
that O 0 0.007703297771513462
prevent O 0 0.037770044058561325
or O 0 0.008669865317642689
reduce O 0 0.020098650828003883
the O 0 0.007730078883469105
risk O 0 0.2886196970939636
of O 0 0.007894843816757202
developing O 0 0.039171282202005386
BPAD B-Disease 1 0.910478413105011
, O 0 0.005934359505772591
similar O 0 0.007117289584130049
to O 0 0.0034252663608640432
what O 0 0.004287495743483305
is O 0 0.004878048785030842
observed O 0 0.008701273240149021
in O 0 0.005423495080322027
other O 0 0.007018278818577528
genetic B-Disease 1 0.9939941763877869
disorders I-Disease 1 0.9997895359992981
, O 0 0.007494415622204542
we O 0 0.005145726725459099
used O 0 0.009238078258931637
mental O 1 0.9872066974639893
health O 1 0.9254244565963745
wellness O 1 0.9699346423149109
( O 0 0.013175750151276588
absence O 0 0.015168107114732265
of O 0 0.007214844226837158
any O 0 0.015420620329678059
psychiatric B-Disease 1 0.9986442923545837
disorder I-Disease 1 0.9997449517250061
) O 0 0.010114787146449089
as O 0 0.0059518166817724705
the O 0 0.007433830760419369
phenotype O 1 0.9140174388885498
in O 0 0.00717171560972929
our O 0 0.009854577481746674
genome O 0 0.2153676301240921
- O 0 0.03702342510223389
wide O 0 0.022419244050979614
linkage O 0 0.12329240888357162
scan O 0 0.04378548637032509
of O 0 0.0057909488677978516
several O 0 0.006787980441004038
large O 0 0.01137849222868681
multigeneration O 0 0.2718922793865204
Old O 0 0.01751963421702385
Order O 0 0.016411174088716507
Amish O 0 0.064628005027771
pedigrees O 0 0.3956369161605835
exhibiting O 0 0.093923419713974
an O 0 0.015248076058924198
extremely O 0 0.03607269749045372
high O 0 0.024976035580039024
incidence O 1 0.9787952303886414
of O 0 0.024111811071634293
BPAD B-Disease 1 0.9753063321113586
. O 0 0.044847872108221054

We O 0 0.012528698891401291
have O 0 0.007766542490571737
found O 0 0.009123167023062706
strong O 0 0.009360709227621555
evidence O 0 0.007377301342785358
for O 0 0.004910624586045742
a O 0 0.009096029214560986
locus O 0 0.4851894974708557
on O 0 0.014073090627789497
chromosome O 1 0.9724441766738892
4p O 1 0.8982857465744019
at O 0 0.017270084470510483
D4S2949 O 0 0.45869770646095276
( O 0 0.018609648570418358
maximum O 0 0.020776735618710518
GENEHUNTER O 1 0.5317502617835999
- O 0 0.040079664438962936
PLUS O 0 0.03307856246829033
nonparametric O 0 0.08131389319896698
linkage O 0 0.04832529276609421
score O 0 0.017836671322584152
= O 0 0.029394879937171936
4 O 0 0.01296063419431448
. O 0 0.007747512310743332
05 O 0 0.027509469538927078
, O 0 0.01018186192959547
P O 0 0.03414742276072502
= O 0 0.022659258916974068
5 O 0 0.008444732055068016
. O 0 0.005758165847510099
22 O 0 0.009455992840230465
x O 0 0.016453223302960396
10 O 0 0.00880491454154253
( O 0 0.00890347734093666
- O 0 0.015838922932744026
4 O 0 0.01175984088331461
) O 0 0.009675020352005959
; O 0 0.011673969216644764
SIBPAL O 0 0.2746582329273224
Pempirical O 0 0.2117566615343094
value O 0 0.01814359985291958
< O 0 0.0934254601597786
3 O 0 0.01443762332201004
x O 0 0.02034640870988369
10 O 0 0.00859904382377863
( O 0 0.009790021926164627
- O 0 0.014119830913841724
5 O 0 0.008979341946542263
) O 0 0.006176719907671213
) O 0 0.005257659126073122
and O 0 0.004269721917808056
suggestive O 0 0.018742799758911133
evidence O 0 0.007084162440150976
for O 0 0.0053993407636880875
a O 0 0.010128863155841827
locus O 1 0.5550286769866943
on O 0 0.017642447724938393
chromosome O 1 0.9881475567817688
4q O 1 0.976223886013031
at O 0 0.021781155839562416
D4S397 O 0 0.40354424715042114
( O 0 0.02034514956176281
maximum O 0 0.02754346653819084
GENEHUNTER O 0 0.30730512738227844
- O 0 0.04130852222442627
PLUS O 0 0.03327943757176399
nonparametric O 0 0.07761526852846146
linkage O 0 0.04798277094960213
score O 0 0.018044915050268173
= O 0 0.028169289231300354
3 O 0 0.011372185312211514
. O 0 0.005896802060306072
29 O 0 0.010470716282725334
, O 0 0.007211197633296251
P O 0 0.031191479414701462
= O 0 0.020624639466404915
2 O 0 0.00993469636887312
. O 0 0.006489560008049011
57 O 0 0.016346367076039314
x O 0 0.020359067246317863
10 O 0 0.009897315874695778
( O 0 0.01008264534175396
- O 0 0.0183416698127985
3 O 0 0.013712713494896889
) O 0 0.011244051158428192
; O 0 0.0121657345443964
SIBPAL O 0 0.4771552085876465
Pempirical O 0 0.24439777433872223
value O 0 0.01683451607823372
< O 0 0.10204365849494934
1 O 0 0.013367216102778912
x O 0 0.01801285892724991
10 O 0 0.008370224386453629
( O 0 0.008887927047908306
- O 0 0.015076693147420883
3 O 0 0.009622902609407902
) O 0 0.0067535885609686375
) O 0 0.00540768401697278
that O 0 0.0037279215175658464
are O 0 0.004866615869104862
linked O 0 0.02655111625790596
to O 0 0.0118594104424119
mental O 1 0.9611608386039734
health O 1 0.9176809787750244
wellness O 1 0.9024441242218018
. O 0 0.043719157576560974

These O 0 0.01571122743189335
findings O 0 0.01819770783185959
are O 0 0.005524573381990194
consistent O 0 0.009700717404484749
with O 0 0.004249610472470522
the O 0 0.004874314181506634
hypothesis O 0 0.014716439880430698
that O 0 0.004718481097370386
certain O 0 0.008876663632690907
alleles O 1 0.8740176558494568
could O 0 0.00774493208155036
prevent O 0 0.027067318558692932
or O 0 0.008259110152721405
modify O 0 0.02218114584684372
the O 0 0.007625322788953781
clinical O 1 0.5535139441490173
manifestations O 0 0.46929532289505005
of O 0 0.010709751397371292
BPAD B-Disease 1 0.9826717376708984
and O 0 0.009565518237650394
perhaps O 0 0.018938226625323296
other O 0 0.012983584776520729
related O 0 0.35190126299858093
affective B-Disease 1 0.996945321559906
disorders I-Disease 1 0.9994303584098816
. O 0 0.05580958351492882

Segregation O 1 0.6184431314468384
distortion O 1 0.7632307410240173
in O 0 0.0781814381480217
myotonic B-Disease 1 0.9986276626586914
dystrophy I-Disease 1 0.9991164803504944
. O 0 0.10106927901506424

Myotonic B-Disease 1 0.9990891218185425
dystrophy I-Disease 1 0.9996048808097839
( O 1 0.7666040658950806
DM B-Disease 1 0.9960950016975403
) O 0 0.025640567764639854
is O 0 0.014015989378094673
an O 0 0.018659789115190506
autosomal B-Disease 1 0.9993178844451904
dominant I-Disease 1 0.988970160484314
disease I-Disease 1 0.9996922016143799
which O 0 0.007821710780262947
, O 0 0.005216773599386215
in O 0 0.004548149183392525
the O 0 0.006055027712136507
typical O 0 0.018943579867482185
pedigree O 0 0.11787399649620056
, O 0 0.0060846698470413685
shows O 0 0.008612427860498428
a O 0 0.00755987036973238
three O 0 0.00992476288229227
generation O 0 0.029970142990350723
anticipation O 0 0.04498805105686188
cascade O 0 0.12007427215576172
. O 0 0.039476171135902405

This O 0 0.024464255198836327
results O 0 0.033113814890384674
in O 0 0.025372838601469994
infertility B-Disease 1 0.9991746544837952
and O 1 0.640134871006012
congenital B-Disease 1 0.999981164932251
myotonic I-Disease 1 0.999966025352478
dystrophy I-Disease 1 0.999944806098938
( O 0 0.437324196100235
CDM B-Disease 1 0.9624074697494507
) O 0 0.013253305107355118
with O 0 0.006923812907189131
the O 0 0.00794136244803667
disappearance O 0 0.0315665602684021
of O 0 0.012362189590930939
DM B-Disease 1 0.9951807260513306
in O 0 0.013654800131917
that O 0 0.01427127793431282
pedigree O 0 0.3354026675224304
. O 0 0.035870179533958435

The O 0 0.017980432137846947
concept O 0 0.01802881807088852
of O 0 0.010651360265910625
segregation O 0 0.04119425639510155
distortion O 0 0.05384841561317444
, O 0 0.0063978200778365135
where O 0 0.006180930882692337
there O 0 0.004573974292725325
is O 0 0.004724679049104452
preferential O 0 0.019267646595835686
transmission O 0 0.023391004651784897
of O 0 0.004975022282451391
the O 0 0.006507896818220615
larger O 0 0.015716664493083954
allele O 1 0.704795241355896
at O 0 0.009103057906031609
the O 0 0.010279816575348377
DM B-Disease 1 0.9984575510025024
locus O 1 0.944669246673584
, O 0 0.006336170248687267
has O 0 0.004947037436068058
been O 0 0.003973860759288073
put O 0 0.005799364298582077
forward O 0 0.006411170586943626
to O 0 0.004520093090832233
explain O 0 0.010792077518999577
partially O 0 0.015609211288392544
the O 0 0.006526211276650429
maintenance O 0 0.01587255485355854
of O 0 0.010417423211038113
DM B-Disease 1 0.9927113056182861
in O 0 0.012064174748957157
the O 0 0.013196081854403019
population O 0 0.035850536078214645
. O 0 0.029246283695101738

In O 0 0.015062332153320312
a O 0 0.013883132487535477
survey O 0 0.01975875347852707
of O 0 0.011157389730215073
DM B-Disease 1 0.9838826656341553
in O 0 0.010752550326287746
Northern O 0 0.016497278586030006
Ireland O 0 0.015802230685949326
, O 0 0.009787305258214474
59 O 0 0.028071243315935135
pedigrees O 0 0.17872567474842072
were O 0 0.015193643048405647
ascertained O 0 0.08362735062837601
. O 0 0.036868542432785034

Sibships O 0 0.2241744101047516
where O 0 0.012086394242942333
the O 0 0.005597387906163931
status O 0 0.006392729002982378
of O 0 0.0031391149386763573
all O 0 0.0025032986886799335
the O 0 0.002985838335007429
members O 0 0.004084660205990076
had O 0 0.0043264832347631454
been O 0 0.00442850636318326
identified O 0 0.006904210429638624
were O 0 0.0034235690254718065
examined O 0 0.009806649759411812
to O 0 0.004260962828993797
determine O 0 0.00668300548568368
the O 0 0.004922585096210241
transmission O 0 0.01937171071767807
of O 0 0.006467937026172876
the O 0 0.009207351133227348
DM B-Disease 1 0.9925088286399841
expansion O 0 0.02286258526146412
from O 0 0.012935690581798553
affected O 0 0.12153440713882446
parents O 0 0.018691301345825195
to O 0 0.00952054187655449
their O 0 0.016408279538154602
offspring O 0 0.18169331550598145
. O 0 0.03728012368083

Where O 0 0.028261657804250717
the O 0 0.020727142691612244
transmitting O 0 0.07633291184902191
parent O 0 0.06225832924246788
was O 0 0.019618960097432137
male O 0 0.04086228832602501
, O 0 0.01986756920814514
58 O 0 0.04442061856389046
. O 0 0.033520832657814026

3 O 0 0.02266000583767891
% O 0 0.011485838331282139
of O 0 0.0060494630597531796
the O 0 0.007111671380698681
offspring O 0 0.09310517460107803
were O 0 0.004720792640000582
affected O 0 0.01832641288638115
, O 0 0.003474677447229624
and O 0 0.0026946135330945253
in O 0 0.0032279142178595066
the O 0 0.0033985255286097527
case O 0 0.005722167436033487
of O 0 0.005134947132319212
a O 0 0.008855566382408142
female O 0 0.027821123600006104
transmitting O 0 0.20942717790603638
parent O 0 0.14210739731788635
, O 0 0.015851398929953575
68 O 0 0.04196703061461449
. O 0 0.03237567096948624

7 O 0 0.04656585678458214
% O 0 0.027174096554517746
were O 0 0.018461788073182106
affected O 0 0.056643202900886536
. O 0 0.03771701827645302

Studies O 0 0.04007740318775177
on O 0 0.01981951668858528
meiotic O 1 0.5304878354072571
drive O 0 0.029490334913134575
in O 0 0.014383147470653057
DM B-Disease 1 0.9896145462989807
have O 0 0.009090038947761059
shown O 0 0.012527808547019958
increased O 0 0.01392410509288311
transmission O 0 0.02271241694688797
of O 0 0.0051234420388937
the O 0 0.0060951062478125095
larger O 0 0.015988795086741447
allele O 0 0.4155348837375641
at O 0 0.010274908505380154
the O 0 0.01348506286740303
DM B-Disease 1 0.996701180934906
locus O 1 0.8710300326347351
in O 0 0.018818583339452744
non O 0 0.0731915608048439
- O 1 0.8092434406280518
DM O 1 0.9967395663261414
heterozygotes O 1 0.971778392791748
for O 0 0.033554185181856155
CTGn O 1 0.6958493590354919
. O 0 0.050456978380680084

This O 0 0.01887364313006401
study O 0 0.02090274915099144
provides O 0 0.015657320618629456
further O 0 0.009600752033293247
evidence O 0 0.00889456644654274
that O 0 0.006644677370786667
the O 0 0.010298574343323708
DM B-Disease 1 0.9941248297691345
expansion O 0 0.025994624942541122
tends O 0 0.029643340036273003
to O 0 0.009545079432427883
be O 0 0.013756313361227512
transmitted O 0 0.4204358458518982
preferentially O 0 0.1342945694923401
. O 0 0.03866918757557869

Diagnosis O 1 0.9876375198364258
of O 0 0.06921057403087616
hemochromatosis B-Disease 1 0.9949924349784851
. O 0 0.07211992889642715

If O 0 0.04700583592057228
untreated O 1 0.9955645799636841
, O 0 0.09950050711631775
hemochromatosis B-Disease 1 0.9996652603149414
can O 0 0.1744529902935028
cause O 1 0.9858871102333069
serious O 1 0.9775571823120117
illness O 1 0.9985756874084473
and O 0 0.009219774045050144
early B-Disease 0 0.013905066065490246
death I-Disease 0 0.0937405526638031
, O 0 0.005268703680485487
but O 0 0.00582644110545516
the O 0 0.009054985828697681
disease O 1 0.9987439513206482
is O 0 0.008847585879266262
still O 0 0.011615741066634655
substantially O 0 0.05422484502196312
under O 0 0.019068758934736252
- O 1 0.8458624482154846
diagnosed O 1 0.9986918568611145
. O 0 0.04806836321949959

The O 0 0.018196122720837593
cornerstone O 0 0.027840957045555115
of O 0 0.010118139907717705
screening O 0 0.029712112620472908
and O 0 0.007093358319252729
case O 0 0.012073395773768425
detection O 0 0.019660480320453644
is O 0 0.005297420080751181
the O 0 0.00545392045751214
measurement O 0 0.01768946647644043
of O 0 0.009870100766420364
serum O 1 0.9642750024795532
transferrin O 1 0.9508816003799438
saturation O 0 0.33218443393707275
and O 0 0.010714116506278515
the O 0 0.01445616502314806
serum O 1 0.8846532702445984
ferritin O 1 0.8431454300880432
level O 0 0.03805116191506386
. O 0 0.03604673594236374

Once O 0 0.03008708544075489
the O 0 0.016757473349571228
diagnosis O 1 0.9814697504043579
is O 0 0.010532256215810776
suspected O 0 0.02633756585419178
, O 0 0.00924768391996622
physicians O 0 0.24493308365345
must O 0 0.010182463563978672
use O 0 0.012715468183159828
serum O 1 0.9200659990310669
ferritin O 1 0.9539495706558228
levels O 0 0.06247003376483917
and O 0 0.014241144061088562
hepatic O 1 0.9983264803886414
iron O 0 0.36981287598609924
stores O 0 0.0258167814463377
on O 0 0.017124246805906296
liver O 1 0.9996669292449951
biopsy O 1 0.9961942434310913
specimens O 0 0.13448046147823334
to O 0 0.00962795875966549
assess O 0 0.25998273491859436
patients O 1 0.9550596475601196
for O 0 0.005661762785166502
the O 0 0.007648127619177103
presence O 0 0.015864981338381767
of O 0 0.010786805301904678
iron B-Disease 0 0.3080429434776306
overload I-Disease 1 0.9393132328987122
. O 0 0.03637785091996193

Liver O 1 0.9990301132202148
biopsy O 1 0.9896181225776672
is O 0 0.011368056759238243
also O 0 0.005789970979094505
used O 0 0.0056928605772554874
to O 0 0.004055820871144533
establish O 0 0.007593199610710144
the O 0 0.004607949405908585
presence O 0 0.009933960624039173
or O 0 0.006414081435650587
absence O 0 0.015186409465968609
of O 0 0.008553165011107922
cirrhosis B-Disease 1 0.999299168586731
, O 0 0.008450939320027828
which O 0 0.00875234417617321
can O 0 0.011642733588814735
affect O 0 0.12626396119594574
prognosis O 1 0.9891291856765747
and O 0 0.015279526822268963
management O 0 0.040210992097854614
. O 0 0.03452510014176369

A O 0 0.03199806064367294
DNA O 0 0.04753946512937546
- O 0 0.02846582792699337
based O 0 0.011916660703718662
test O 0 0.012165315449237823
for O 0 0.007062049582600594
the O 0 0.010360716842114925
HFE O 1 0.9678103923797607
gene O 0 0.32349488139152527
is O 0 0.007414733525365591
commercially O 0 0.009662511758506298
available O 0 0.00501619279384613
, O 0 0.0034400078002363443
but O 0 0.0032674307003617287
its O 0 0.003226375440135598
place O 0 0.003728987881913781
in O 0 0.004126286134123802
the O 0 0.007660192903131247
diagnosis O 1 0.9923604130744934
of O 0 0.014600452966988087
hemochromatosis B-Disease 1 0.9991108775138855
is O 0 0.014415210112929344
still O 0 0.013701329007744789
being O 0 0.016629962250590324
evaluated O 0 0.04686766490340233
. O 0 0.031329408288002014

Currently O 0 0.01888899877667427
, O 0 0.00810321420431137
the O 0 0.005104000214487314
most O 0 0.004970940761268139
useful O 0 0.0057335589081048965
role O 0 0.0055686915293335915
for O 0 0.003125953720882535
this O 0 0.0031385496258735657
test O 0 0.00565499160438776
is O 0 0.003501662751659751
in O 0 0.00373371341265738
the O 0 0.004958206322044134
detection O 0 0.02229301445186138
of O 0 0.007607736624777317
hemochromatosis B-Disease 1 0.9985973238945007
in O 0 0.007521842606365681
the O 0 0.006896498613059521
family O 0 0.01014732290059328
members O 0 0.006579438224434853
of O 0 0.006782283075153828
patients O 1 0.9379158020019531
with O 0 0.0065661147236824036
a O 0 0.009189842268824577
proven O 0 0.02093600481748581
case O 0 0.01284020859748125
of O 0 0.010015678592026234
the O 0 0.019726883620023727
disease O 1 0.9984292387962341
. O 0 0.042770639061927795

It O 0 0.01742069609463215
is O 0 0.014149333350360394
crucial O 0 0.02415877766907215
to O 0 0.022312846034765244
diagnose O 1 0.9988067150115967
hemochromatosis B-Disease 1 0.9994726777076721
before O 1 0.6226148009300232
hepatic B-Disease 1 0.9998140931129456
cirrhosis I-Disease 1 0.9998494386672974
develops O 1 0.9943133592605591
because O 0 0.4590427875518799
phlebotomy O 1 0.9980302453041077
therapy O 1 0.9970046877861023
can O 0 0.3999740481376648
avert O 1 0.9983844757080078
serious O 1 0.9990800619125366
chronic O 1 0.999971866607666
disease O 1 0.9998681545257568
and O 0 0.0121228639036417
can O 0 0.008057652972638607
even O 0 0.006408319342881441
lead O 0 0.009197465144097805
to O 0 0.006226185243576765
normal O 0 0.019225535914301872
life O 0 0.018764974549412727
expectancy O 0 0.27137523889541626
. O 0 0.01507255807518959
. O 0 0.02346058003604412

Prevalence O 1 0.7949078679084778
of O 0 0.019578546285629272
the O 0 0.019601130858063698
I1307K O 1 0.957509458065033
APC B-Disease 1 0.9872283935546875
gene O 1 0.9679232835769653
variant O 1 0.6402817368507385
in O 0 0.009047385305166245
Israeli O 0 0.013177726417779922
Jews O 0 0.011610881425440311
of O 0 0.0077621969394385815
differing O 0 0.0175319816917181
ethnic O 0 0.017036715522408485
origin O 0 0.017152301967144012
and O 0 0.013232581317424774
risk O 1 0.9633495211601257
for O 0 0.23342308402061462
colorectal B-Disease 1 0.9999295473098755
cancer I-Disease 1 0.9996139407157898
. O 0 0.07039094716310501

BACKGROUND O 0 0.06108558923006058
& O 0 0.039541423320770264
AIMS O 0 0.03613055869936943
Israeli O 0 0.01878735050559044
Jews O 0 0.013482125476002693
of O 0 0.007159144151955843
European O 0 0.012872833758592606
birth O 0 0.03055821917951107
, O 0 0.0063558961264789104
i O 0 0.006504666991531849
. O 0 0.00553502794355154
e O 0 0.013410785235464573
. O 0 0.004992328584194183
, O 0 0.005955939646810293
Ashkenazim O 0 0.1954265683889389
, O 0 0.006716633215546608
have O 0 0.006982037331908941
the O 0 0.010945040732622147
highest O 1 0.7628504633903503
colorectal B-Disease 1 0.9999628067016602
cancer I-Disease 1 0.9999421834945679
incidence O 1 0.9977834820747375
of O 0 0.012524829246103764
any O 0 0.013399012386798859
Israeli O 0 0.021971222013235092
ethnic O 0 0.029888270422816277
group O 0 0.02962397411465645
. O 0 0.03478473424911499

The O 0 0.04729621857404709
I1307K O 1 0.9027937650680542
APC B-Disease 1 0.9519187808036804
gene O 1 0.9091808199882507
variant O 0 0.42938920855522156
was O 0 0.015721332281827927
found O 0 0.01771506853401661
in O 0 0.015659091994166374
6 O 0 0.030355513095855713
. O 0 0.027406366541981697

1 O 0 0.028796659782528877
% O 0 0.015963302925229073
of O 0 0.007357288617640734
American O 0 0.01124078594148159
Jews O 0 0.01065217424184084
, O 0 0.005863770376890898
28 O 0 0.009623348712921143
% O 0 0.007729212753474712
of O 0 0.006789281964302063
their O 0 0.03498394042253494
familial O 1 0.9998524188995361
colorectal B-Disease 1 0.9999905824661255
cancer I-Disease 1 0.9999557733535767
cases O 1 0.7408448457717896
, O 0 0.008591031655669212
but O 0 0.0061454614624381065
not O 0 0.005449607968330383
in O 0 0.007513172924518585
non O 0 0.0209522545337677
- O 0 0.04052489995956421
Jews O 0 0.03404344245791435
. O 0 0.03357144072651863

We O 0 0.022283358499407768
assessed O 0 0.03597250208258629
the O 0 0.016563061624765396
I1307K O 1 0.7344191074371338
prevalence O 1 0.8904887437820435
in O 0 0.010026072151958942
Israeli O 0 0.013990003615617752
Jews O 0 0.011791697703301907
of O 0 0.007598096039146185
differing O 0 0.01739303022623062
ethnic O 0 0.017460545524954796
origin O 0 0.016914207488298416
and O 0 0.01172755565494299
risk O 1 0.9455716013908386
for O 0 0.2346406877040863
colorectal B-Disease 1 0.9998952150344849
cancer I-Disease 1 0.9995895028114319
. O 0 0.07410480827093124

METHODS O 0 0.04055716469883919
DNA O 0 0.03984394669532776
samples O 0 0.024582698941230774
from O 0 0.011227375827729702
500 O 0 0.013133483938872814
unrelated O 0 0.018759334459900856
Jews O 0 0.00803616363555193
of O 0 0.0048993416130542755
European O 0 0.007945443503558636
or O 0 0.00598580576479435
non O 0 0.012056384235620499
- O 0 0.013711887411773205
European O 0 0.007596836891025305
origin O 0 0.007089613936841488
, O 0 0.003401938360184431
with O 0 0.003286112565547228
or O 0 0.0040657431818544865
without O 0 0.0045578572899103165
a O 0 0.004658861085772514
personal O 0 0.006939850281924009
and O 0 0.0048693157732486725
/ O 0 0.038320332765579224
or O 0 0.005824060644954443
family O 0 0.009179709479212761
history O 0 0.008403858169913292
of O 0 0.008337261155247688
neoplasia B-Disease 1 0.9905374646186829
, O 0 0.00616209302097559
were O 0 0.0045963614247739315
examined O 0 0.01410435326397419
for O 0 0.004924879875034094
the O 0 0.0077926418744027615
I1307K O 0 0.2738312780857086
variant O 0 0.10688598453998566
by O 0 0.009988845326006413
the O 0 0.012204710394144058
allele O 1 0.6623523831367493
- O 0 0.06012434884905815
specific O 0 0.027651499956846237
oligonucleotide O 1 0.5856339335441589
( O 0 0.027655519545078278
ASO O 0 0.4887210726737976
) O 0 0.022078925743699074
method O 0 0.03522172197699547
. O 0 0.028676293790340424

RESULTS O 0 0.03215303272008896
In O 0 0.011919834651052952
persons O 0 0.016145363450050354
at O 0 0.011316501535475254
average O 0 0.03363178297877312
risk O 1 0.9733686447143555
for O 0 0.11818985641002655
colorectal B-Disease 1 0.9999454021453857
cancer I-Disease 1 0.999821126461029
, O 0 0.023669499903917313
I1307K O 1 0.7950294613838196
was O 0 0.011535215191543102
found O 0 0.013153226114809513
in O 0 0.011480296961963177
5 O 0 0.023663688451051712
. O 0 0.026697639375925064

0 O 0 0.04414627328515053
% O 0 0.0194544717669487
of O 0 0.009429944679141045
120 O 0 0.015065813437104225
European O 0 0.012600434944033623
and O 0 0.009836792014539242
1 O 0 0.02166355773806572
. O 0 0.027501512318849564

6 O 0 0.032814595848321915
% O 0 0.016174346208572388
of O 0 0.009162697941064835
188 O 0 0.02446133829653263
non O 0 0.018354931846261024
- O 0 0.022335657849907875
European O 0 0.014592064544558525
Jews O 0 0.020988892763853073
( O 0 0.019345926120877266
P O 0 0.07350265979766846
= O 0 0.0392003208398819
0 O 0 0.023744730278849602
. O 0 0.013335797935724258
08 O 0 0.04329841956496239
) O 0 0.02348334714770317
. O 0 0.027747657150030136

It O 0 0.026578033342957497
occurred O 0 0.04070926085114479
in O 0 0.019122282043099403
15 O 0 0.031205276027321815
. O 0 0.03274922072887421

4 O 0 0.029034607112407684
% O 0 0.01934519037604332
of O 0 0.011316485702991486
52 O 0 0.0277919452637434
Ashkenazi O 1 0.5178942084312439
Israelis O 0 0.04244862496852875
with O 0 0.022677648812532425
familial O 1 0.9992781281471252
cancer B-Disease 1 0.9996716976165771
( O 0 0.09036201238632202
P O 1 0.6875360608100891
= O 0 0.06721897423267365
0 O 0 0.021278556436300278
. O 0 0.00843798741698265
02 O 0 0.04959196597337723
) O 0 0.007226679008454084
and O 0 0.004194180015474558
was O 0 0.004945042543113232
not O 0 0.004508091136813164
detected O 0 0.01764281839132309
in O 0 0.005779558792710304
51 O 0 0.014904124662280083
non O 0 0.01593462936580181
- O 0 0.021734341979026794
European O 0 0.012069830670952797
Jews O 0 0.016015667468309402
at O 0 0.016199488192796707
increased O 0 0.3905716836452484
cancer B-Disease 1 0.9987664222717285
risk O 1 0.9597080945968628
. O 0 0.036048706620931625

Colorectal B-Disease 1 0.9993317723274231
neoplasia I-Disease 1 0.9959734082221985
occurred O 0 0.08674237132072449
personally O 0 0.026693418622016907
or O 0 0.009595159441232681
in O 0 0.005201917607337236
the O 0 0.004904632922261953
families O 0 0.006637297570705414
of O 0 0.004292936529964209
13 O 0 0.007514485158026218
of O 0 0.005241550970822573
20 O 0 0.011091411113739014
Ashkenazi O 1 0.82181715965271
I1307K O 1 0.9087927937507629
carriers O 0 0.08816754072904587
, O 0 0.005634228233247995
8 O 0 0.006391587667167187
of O 0 0.0043104044161736965
whom O 0 0.0077302479185163975
also O 0 0.004141537006944418
had O 0 0.004747308325022459
a O 0 0.006165601313114166
personal O 0 0.009644221514463425
or O 0 0.00909333024173975
family O 0 0.014318753965198994
history O 0 0.014084945432841778
of O 0 0.017993692308664322
noncolonic O 1 0.971592128276825
neoplasia B-Disease 1 0.9919856786727905
. O 0 0.05144062265753746

CONCLUSIONS O 0 0.04549787938594818
The O 0 0.022026829421520233
I1307K O 1 0.9423441290855408
APC O 1 0.9754957556724548
variant O 1 0.7416387796401978
may O 0 0.021038301289081573
represent O 0 0.015485209412872791
a O 0 0.015541634522378445
susceptibility O 1 0.9967495203018188
gene O 1 0.9241031408309937
for O 0 0.015903735533356667
colorectal B-Disease 1 0.9994872808456421
, I-Disease 0 0.0076134093105793
or I-Disease 0 0.007127610966563225
other I-Disease 0 0.005156273487955332
, I-Disease 0 0.0074696773663163185
cancers I-Disease 1 0.9960318207740784
in O 0 0.007159822154790163
Ashkenazi O 1 0.5983445048332214
Jews O 0 0.01048814132809639
, O 0 0.005182239692658186
and O 0 0.0058547272346913815
partially O 0 0.028022179380059242
explains O 0 0.01859244890511036
the O 0 0.008781624026596546
higher O 0 0.026183445006608963
incidence O 1 0.9964324235916138
of O 0 0.15946759283542633
colorectal B-Disease 1 0.9999690055847168
cancer I-Disease 1 0.9998243451118469
in O 0 0.01910940371453762
European O 0 0.027533311396837234
Israelis O 0 0.07506939768791199
. O 0 0.03258118778467178

Systematic O 0 0.0746157169342041
analysis O 0 0.04284097999334335
of O 0 0.024430306628346443
coproporphyrinogen O 1 0.9595335721969604
oxidase O 1 0.9891467094421387
gene O 1 0.9885584115982056
defects O 1 0.9962977766990662
in O 0 0.02254830300807953
hereditary B-Disease 1 0.9897664189338684
coproporphyria I-Disease 1 0.9502736330032349
and O 0 0.023840930312871933
mutation O 1 0.990954577922821
update O 0 0.15654994547367096
. O 0 0.039599522948265076

Hereditary B-Disease 1 0.9858226180076599
coproporphyria I-Disease 1 0.9356725215911865
( O 0 0.04402530938386917
HC B-Disease 1 0.5339606404304504
) O 0 0.01719803735613823
is O 0 0.01278164703398943
an O 0 0.023729758337140083
acute O 1 0.9996246099472046
hepatic B-Disease 1 0.9998517036437988
porphyria I-Disease 1 0.9998754262924194
with O 0 0.4970351755619049
autosomal O 1 0.9996641874313354
dominant O 1 0.986441969871521
inheritance O 1 0.9936991930007935
caused O 1 0.9614878296852112
by O 0 0.021283794194459915
deficient B-Disease 1 0.922386884689331
activity I-Disease 0 0.028126878663897514
of I-Disease 0 0.01809012144804001
coproporphyrinogen I-Disease 1 0.9463857412338257
III I-Disease 1 0.8131170868873596
oxidase I-Disease 1 0.9685025215148926
( O 0 0.03899695351719856
CPO O 0 0.09161800891160965
) O 0 0.03458791598677635
. O 0 0.03287063539028168

Clinical O 1 0.8861197829246521
manifestations O 0 0.3079041838645935
of O 0 0.012225020676851273
the O 0 0.015714040026068687
disease O 1 0.9992701411247253
are O 0 0.013859247788786888
characterized O 1 0.8909141421318054
by O 0 0.028968220576643944
acute O 1 0.99921715259552
attacks O 1 0.5545961260795593
of O 0 0.0865410789847374
neurological B-Disease 1 0.9998564720153809
dysfunction I-Disease 1 0.999718964099884
often O 0 0.2958522140979767
precipitated O 1 0.9800517559051514
by O 0 0.015321345068514347
drugs O 0 0.38590115308761597
, O 0 0.01121627539396286
fasting O 1 0.7819446921348572
, O 0 0.01846097595989704
cyclical O 1 0.9928914308547974
hormonal O 1 0.9961509704589844
changes O 0 0.033850930631160736
, O 0 0.014320584014058113
or O 0 0.06847906857728958
infectious B-Disease 1 0.9992307424545288
diseases I-Disease 1 0.9992932081222534
. O 0 0.05125156044960022

Skin O 1 0.9981271624565125
photosensitivity O 1 0.9951399564743042
may O 0 0.031326957046985626
also O 0 0.011512048542499542
be O 0 0.010654832236468792
present O 0 0.01938333734869957
. O 0 0.02662200853228569

The O 0 0.020752746611833572
seven O 0 0.01742836833000183
exons O 0 0.044675327837467194
, O 0 0.009676436893641949
the O 0 0.011685836128890514
exon O 0 0.4690339267253876
/ O 0 0.2666933536529541
intron O 0 0.38679707050323486
boundaries O 0 0.010613974183797836
and O 0 0.005072894040495157
part O 0 0.006004227790981531
of O 0 0.005927901715040207
3 O 0 0.011578607372939587
noncoding O 0 0.1321837455034256
sequence O 0 0.013238159939646721
of O 0 0.006032632663846016
the O 0 0.007728707976639271
CPO O 0 0.08043345808982849
gene O 0 0.11493205279111862
were O 0 0.006838853005319834
systematically O 0 0.01825445145368576
analyzed O 0 0.014581619761884212
by O 0 0.0070083895698189735
an O 0 0.00872481893748045
exon O 0 0.08542690426111221
- O 0 0.031148985028266907
by O 0 0.01439584605395794
- O 0 0.0900464728474617
exon O 1 0.6473261713981628
denaturing O 1 0.9655516147613525
gradient O 1 0.7123772501945496
gel O 1 0.9503703117370605
electrophoresis O 1 0.7638328671455383
( O 0 0.027987314388155937
DGGE O 1 0.6307392716407776
) O 0 0.013723035342991352
strategy O 0 0.016387054696679115
followed O 0 0.010184269398450851
by O 0 0.007686865050345659
direct O 0 0.01379203051328659
sequencing O 0 0.025029756128787994
in O 0 0.009049742482602596
seven O 0 0.01402256079018116
unrelated O 0 0.1833207607269287
heterozygous O 1 0.9679784774780273
HC B-Disease 1 0.9912426471710205
patients O 1 0.9909623265266418
from O 0 0.013761851005256176
France O 0 0.022905489429831505
, O 0 0.00910145416855812
Holland O 0 0.020409589633345604
, O 0 0.007471031975001097
and O 0 0.008326878771185875
Czech O 0 0.027371548116207123
Republic O 0 0.030819030478596687
. O 0 0.03033444844186306

Seven O 0 0.033474456518888474
novel O 0 0.04655703902244568
mutations O 1 0.7304766178131104
and O 0 0.009399144910275936
two O 0 0.009278163313865662
new O 0 0.01551998220384121
polymorphisms O 1 0.5573871731758118
were O 0 0.01710306480526924
detected O 0 0.08635836094617844
. O 0 0.030577652156352997

Among O 0 0.02978898584842682
these O 0 0.01585881970822811
mutations O 1 0.7345523238182068
two O 0 0.008998380042612553
are O 0 0.00891382247209549
missense O 1 0.844509482383728
( O 0 0.020563196390867233
G197W O 0 0.4719092845916748
, O 0 0.010393894277513027
W427R O 0 0.21393023431301117
) O 0 0.008621863089501858
, O 0 0.005232054740190506
two O 0 0.0044763037003576756
are O 0 0.005275660194456577
nonsense O 0 0.019703185185790062
( O 0 0.01238546334207058
Q306X O 0 0.3129011392593384
, O 0 0.008562563918530941
Q385X O 0 0.15453143417835236
) O 0 0.0066238706931471825
, O 0 0.0037420487497001886
two O 0 0.003350268816575408
are O 0 0.004473261535167694
small O 0 0.00939127616584301
deletions O 0 0.11116475611925125
( O 0 0.015922849997878075
662de14bp O 0 0.43424129486083984
; O 0 0.014657014049589634
1168del3bp O 0 0.22143243253231049
removing O 0 0.023331398144364357
a O 0 0.010498988442122936
glycine O 0 0.028885945677757263
at O 0 0.007666683290153742
position O 0 0.009027459658682346
390 O 0 0.016264118254184723
) O 0 0.0064209806732833385
, O 0 0.003491501323878765
and O 0 0.0029112505726516247
one O 0 0.0036403355188667774
is O 0 0.0056581804528832436
a O 0 0.010832900181412697
splicing O 0 0.2609243094921112
mutation O 1 0.9552568197250366
( O 0 0.025782385841012
IVS1 O 1 0.788729190826416
- O 0 0.20458224415779114
15c O 1 0.8883022665977478
- O 0 0.16508430242538452
- O 0 0.2652819752693176
> O 1 0.6219861507415771
g O 0 0.044753506779670715
) O 0 0.01023884117603302
which O 0 0.007039259187877178
creates O 0 0.019198935478925705
a O 0 0.011644275858998299
new O 0 0.01512157078832388
acceptor O 0 0.2704154849052429
splice O 0 0.30804166197776794
site O 0 0.041385065764188766
. O 0 0.03449147939682007

The O 0 0.02254560776054859
pathological O 0 0.1658075749874115
significance O 0 0.014461057260632515
of O 0 0.006465936545282602
the O 0 0.007597031537443399
point O 0 0.013022628612816334
mutations O 1 0.9807924628257751
G197W O 1 0.6023250222206116
, O 0 0.009769026190042496
W427R O 0 0.08529248088598251
, O 0 0.005403948947787285
and O 0 0.003823068691417575
the O 0 0.00377993518486619
in O 0 0.005581229459494352
- O 0 0.022893136367201805
frame O 0 0.024963784962892532
deletion O 1 0.8132935166358948
390delGly O 0 0.2764611840248108
were O 0 0.006615304388105869
assessed O 0 0.012165075168013573
by O 0 0.005531247239559889
their O 0 0.005022356286644936
respective O 0 0.009355917572975159
expression O 0 0.012343201786279678
in O 0 0.005176892504096031
a O 0 0.0073418631218373775
prokaryotic O 0 0.04128143936395645
system O 0 0.012370913289487362
using O 0 0.010922146961092949
site O 0 0.017083147540688515
- O 0 0.03594067692756653
directed O 0 0.03474254161119461
mutagenesis O 0 0.31650975346565247
. O 0 0.04252740368247032

These O 0 0.024603454396128654
mutations O 1 0.9573981761932373
resulted O 0 0.024998769164085388
in O 0 0.007374362088739872
the O 0 0.006989010144025087
absence O 0 0.012749028392136097
or O 0 0.008291003294289112
a O 0 0.009417908266186714
dramatic O 0 0.024606827646493912
decrease O 0 0.0420873649418354
of O 0 0.014976968057453632
CPO O 0 0.09866919368505478
activity O 0 0.04417872056365013
. O 0 0.03098694607615471

The O 0 0.020298311486840248
two O 0 0.017062317579984665
polymorphisms O 0 0.41788849234580994
were O 0 0.011666379868984222
localized O 0 0.30137208104133606
in O 0 0.009639986790716648
noncoding O 0 0.10531160235404968
part O 0 0.007488908711820841
of O 0 0.0058901640586555
the O 0 0.007966915145516396
gene O 0 0.1554711014032364
1 O 0 0.011444732546806335
) O 0 0.008411857299506664
a O 0 0.009736702777445316
C O 0 0.04535588622093201
/ O 0 0.18862678110599518
G O 0 0.17419636249542236
polymorphism O 0 0.07342002540826797
in O 0 0.00755592156201601
the O 0 0.009201825596392155
promotor O 1 0.6988013982772827
region O 0 0.02227538637816906
, O 0 0.010190761648118496
142 O 0 0.02713867463171482
bp O 0 0.032390840351581573
upstream O 0 0.0222769808024168
from O 0 0.00924178771674633
the O 0 0.009179726243019104
transcriptional O 0 0.05811358243227005
initiation O 0 0.03617757186293602
site O 0 0.018271641805768013
( O 0 0.016175802797079086
- O 0 0.0822797566652298
142C O 1 0.9001652002334595
/ O 0 0.4266929626464844
G O 0 0.07415634393692017
) O 0 0.008575615473091602
, O 0 0.004470472224056721
and O 0 0.0040038228034973145
2 O 0 0.007136491127312183
) O 0 0.00673277210444212
a O 0 0.007577062118798494
6 O 0 0.014511814340949059
bp O 0 0.037082601338624954
deletion O 0 0.4827142655849457
polymorphism O 0 0.048473089933395386
in O 0 0.007748677860945463
the O 0 0.007449613884091377
3 O 0 0.01320849359035492
noncoding O 0 0.048169367015361786
part O 0 0.008126846514642239
of O 0 0.005695336498320103
the O 0 0.007992704398930073
CPO O 0 0.22978514432907104
gene O 0 0.33370500802993774
, O 0 0.01020326092839241
574 O 0 0.14675472676753998
bp O 0 0.029923418536782265
downstream O 0 0.01977674849331379
of O 0 0.004990024492144585
the O 0 0.005012609530240297
last O 0 0.0070143816992640495
base O 0 0.007964624091982841
of O 0 0.005919480696320534
the O 0 0.009347222745418549
normal O 0 0.03333984315395355
termination O 1 0.6415088772773743
codon O 0 0.45629823207855225
( O 0 0.04059787467122078
+ O 0 0.260306179523468
574 O 1 0.7007361650466919
delATTCTT O 1 0.7788400650024414
) O 0 0.034955237060785294
. O 0 0.032687898725271225

Five O 0 0.040300946682691574
intragenic O 1 0.6700212359428406
dimorphisms O 0 0.2682228982448578
are O 0 0.00930755864828825
now O 0 0.00935590360313654
well O 0 0.006630400195717812
characterized O 0 0.01769965887069702
and O 0 0.0038395514711737633
the O 0 0.00439219456166029
high O 0 0.007755515165627003
degree O 0 0.009182905778288841
of O 0 0.00941686425358057
allelic O 1 0.8686262965202332
heterogeneity O 0 0.4923783540725708
in O 0 0.011955239810049534
HC B-Disease 0 0.18215100467205048
is O 0 0.008258102461695671
demonstrated O 0 0.010817633010447025
with O 0 0.004849966615438461
seven O 0 0.005618315190076828
new O 0 0.005837925709784031
different O 0 0.006806973833590746
mutations O 0 0.31249159574508667
making O 0 0.005650882609188557
a O 0 0.005336741916835308
total O 0 0.006787288933992386
of O 0 0.007054574321955442
nineteen O 0 0.06303631514310837
CPO O 1 0.8194960355758667
gene B-Disease 1 0.9810614585876465
defects I-Disease 1 0.9912989735603333
reported O 0 0.030911827459931374
so O 0 0.010513583198189735
far O 0 0.014480996876955032
. O 0 0.013401748612523079
. O 0 0.0243846382945776

Coincidence O 0 0.0438663512468338
of O 0 0.01141933910548687
two O 0 0.00971237476915121
novel O 0 0.023217763751745224
arylsulfatase O 0 0.4457051753997803
A O 0 0.01851525716483593
alleles O 1 0.9681265950202942
and O 0 0.015709636732935905
mutation O 1 0.9918614625930786
459 O 1 0.9341235756874084
+ O 1 0.901951014995575
1G O 1 0.9826112389564514
> O 0 0.4631481468677521
A O 0 0.009904534555971622
within O 0 0.008469628170132637
a O 0 0.009152858518064022
family O 0 0.01585119217634201
with O 0 0.015725363045930862
metachromatic B-Disease 1 0.9872663617134094
leukodystrophy I-Disease 1 0.9969679713249207
: O 0 0.025512345135211945
molecular O 0 0.037528134882450104
basis O 0 0.015404883772134781
of O 0 0.020732082426548004
phenotypic O 1 0.9438089728355408
heterogeneity O 1 0.8593020439147949
. O 0 0.04867244511842728

In O 0 0.016880962997674942
a O 0 0.012648199684917927
family O 0 0.015176016837358475
with O 0 0.00822080485522747
three O 0 0.007967204786837101
siblings O 0 0.026417335495352745
, O 0 0.006527225486934185
one O 0 0.00693639786913991
developed O 0 0.016341280192136765
classical O 0 0.020310888066887856
late O 0 0.04242513328790665
infantile O 1 0.9988083839416504
metachromatic B-Disease 1 0.9980289340019226
leukodystrophy I-Disease 1 0.999496579170227
( O 0 0.41569289565086365
MLD B-Disease 1 0.995061457157135
) O 0 0.021304428577423096
, O 0 0.012553676962852478
fatal O 1 0.9752680063247681
at O 0 0.009529279544949532
age O 0 0.011644178070127964
5 O 0 0.008228639140725136
years O 0 0.006346100941300392
, O 0 0.005702824331820011
with O 0 0.009485309943556786
deficient O 1 0.820476233959198
arylsulfatase O 1 0.6920475959777832
A O 0 0.02061832696199417
( O 0 0.02737165428698063
ARSA O 1 0.9663601517677307
) O 0 0.014273243956267834
activity O 0 0.017118532210588455
and O 0 0.009351192973554134
increased O 0 0.026068734005093575
galactosylsulfatide O 1 0.6513285636901855
( O 0 0.0346231646835804
GS O 1 0.8875452280044556
) O 0 0.03257148340344429
excretion O 1 0.7091057896614075
. O 0 0.03940131515264511

The O 0 0.01432266365736723
two O 0 0.008757300674915314
other O 0 0.008225486613810062
siblings O 0 0.03708793222904205
, O 0 0.008488420397043228
apparently O 0 0.018247002735733986
healthy O 0 0.12031712383031845
at O 0 0.008531608618795872
12 O 0 0.010451426729559898
( O 0 0.00940734799951315
1 O 0 0.010093926452100277
/ O 0 0.019262870773673058
2 O 0 0.007622757460922003
) O 0 0.004581890534609556
and O 0 0.002865623915567994
15 O 0 0.004550696816295385
years O 0 0.003933536820113659
, O 0 0.0029538720846176147
respectively O 0 0.004744920879602432
, O 0 0.002754315733909607
and O 0 0.002700591692700982
their O 0 0.004125876352190971
father O 0 0.009492269717156887
, O 0 0.005515872035175562
apparently O 0 0.013506500981748104
healthy O 0 0.05090747028589249
as O 0 0.005529999267309904
well O 0 0.005642440635710955
, O 0 0.006308524403721094
presented O 0 0.012754186056554317
ARSA O 1 0.9382224082946777
and O 0 0.009849144145846367
GS O 0 0.44597429037094116
values O 0 0.01248085219413042
within O 0 0.010204420424997807
the O 0 0.008493050001561642
range O 0 0.018357273191213608
of O 0 0.02161763422191143
MLD B-Disease 1 0.9922897219657898
patients O 1 0.9915488958358765
. O 0 0.04785853996872902

Mutation O 1 0.9711705446243286
screening O 0 0.07400503009557724
and O 0 0.012022746726870537
sequence O 0 0.02215082198381424
analysis O 0 0.013615978881716728
disclosed O 0 0.014313127845525742
the O 0 0.005829895380884409
involvement O 0 0.01358458399772644
of O 0 0.005608351901173592
three O 0 0.007295436225831509
different O 0 0.011695443652570248
ARSA O 1 0.9905694723129272
mutations O 1 0.9709572792053223
being O 0 0.008291997946798801
the O 0 0.00789195392280817
molecular O 0 0.021455781534314156
basis O 0 0.00976530835032463
of O 0 0.01512956153601408
intrafamilial O 1 0.9430705904960632
phenotypic O 1 0.9666641354560852
heterogeneity O 1 0.891060471534729
. O 0 0.0519196018576622

The O 0 0.03707289695739746
late O 0 0.07430814206600189
infantile O 1 0.9977850914001465
patient O 1 0.9932492971420288
inherited O 1 0.8819319605827332
from O 0 0.013463321141898632
his O 0 0.011152382008731365
mother O 0 0.025687815621495247
the O 0 0.009519063867628574
frequent O 0 0.03985298052430153
0 O 0 0.032523855566978455
- O 0 0.218998521566391
type O 0 0.3410947024822235
mutation O 1 0.9883221983909607
459 O 1 0.8645524382591248
+ O 1 0.7708587050437927
1G O 1 0.9716021418571472
> O 0 0.27473095059394836
A O 0 0.0073896897956728935
, O 0 0.0037525068037211895
and O 0 0.002922317013144493
from O 0 0.003884314326569438
his O 0 0.004830390680581331
father O 0 0.010075104422867298
a O 0 0.006863224785774946
novel O 0 0.012919500470161438
, O 0 0.0078519806265831
single O 0 0.014244376681745052
basepair O 0 0.42774584889411926
microdeletion O 0 0.10907595604658127
of O 0 0.010193334892392159
guanine O 0 0.034541916102170944
at O 0 0.012510742992162704
nucleotide O 0 0.03415635973215103
7 O 0 0.015136179514229298
in O 0 0.01066967099905014
exon O 0 0.06945805251598358
1 O 0 0.021765435114502907
( O 0 0.0238246638327837
7delG O 0 0.19979307055473328
) O 0 0.032313719391822815
. O 0 0.032187893986701965

The O 0 0.028088387101888657
two O 0 0.02385164238512516
clinically O 1 0.8684138655662537
unaffected O 1 0.8061732053756714
siblings O 0 0.13643795251846313
carried O 0 0.024667659774422646
the O 0 0.018478751182556152
maternal O 1 0.9750508069992065
mutation O 1 0.9947143197059631
459 O 1 0.9455811977386475
+ O 1 0.8112688064575195
1G O 1 0.9575114250183105
> O 0 0.1836734265089035
A O 0 0.010996459051966667
and O 0 0.005590009968727827
, O 0 0.004612566437572241
on O 0 0.004698128905147314
their O 0 0.0072663952596485615
paternal O 0 0.4038434326648712
allele O 1 0.7812709212303162
, O 0 0.007446624804288149
a O 0 0.009780919179320335
novel O 0 0.02236238867044449
cytosine O 0 0.05268588289618492
to O 0 0.011714905500411987
thymidine O 0 0.1632513701915741
transition O 0 0.02913489192724228
at O 0 0.01566985435783863
nucleotide O 0 0.05638715252280235
2435 O 1 0.6546098589897156
in O 0 0.013390536420047283
exon O 0 0.07634623348712921
8 O 0 0.015725385397672653
, O 0 0.007771033328026533
resulting O 0 0.017027301713824272
in O 0 0.007603303529322147
substitution O 0 0.022369863465428352
of O 0 0.011579458601772785
alanine O 0 0.2016531229019165
464 O 0 0.28532305359840393
by O 0 0.018950842320919037
valine O 1 0.6074752807617188
( O 0 0.031244587153196335
A464V O 0 0.33791282773017883
) O 0 0.029466690495610237
. O 0 0.02930631674826145

The O 0 0.035843733698129654
fathers O 0 0.13479086756706238
genotype O 1 0.8802462816238403
thus O 0 0.03540533781051636
was O 0 0.03060639090836048
7delG O 1 0.8302905559539795
/ O 1 0.6267783045768738
A464V O 1 0.6067194938659668
. O 0 0.056747324764728546

Mutation O 1 0.975298285484314
A464V O 0 0.30895906686782837
was O 0 0.016105247661471367
not O 0 0.007793099153786898
found O 0 0.008890834636986256
in O 0 0.007951862178742886
18 O 0 0.01750640757381916
unrelated O 0 0.4145907759666443
MLD B-Disease 1 0.9975619316101074
patients O 1 0.9925980567932129
and O 0 0.012882702052593231
50 O 0 0.022367585450410843
controls O 0 0.03994479775428772
. O 0 0.030425649136304855

A464V O 0 0.2995379567146301
, O 0 0.02331835776567459
although O 0 0.0234946571290493
clearly O 0 0.02848188579082489
modifying O 0 0.3416132628917694
ARSA O 1 0.9770349264144897
and O 0 0.016756571829319
GS O 1 0.960889995098114
levels O 0 0.024354731664061546
, O 0 0.008418213576078415
apparently O 0 0.016336221247911453
bears O 0 0.017612474039196968
little O 0 0.01088574156165123
significance O 0 0.01209066528826952
for O 0 0.00820458959788084
clinical O 1 0.5907843708992004
manifestation O 1 0.5288337469100952
of O 0 0.01389703806489706
MLD B-Disease 1 0.9944325089454651
, O 0 0.016837697476148605
mimicking O 0 0.3280577063560486
the O 0 0.024463484063744545
frequent O 1 0.5778714418411255
ARSA O 1 0.9893388152122498
pseudodeficiency O 1 0.9663031101226807
allele O 1 0.952357828617096
. O 0 0.0688336044549942

Our O 0 0.019156645983457565
results O 0 0.01823749765753746
demonstrate O 0 0.012266149744391441
that O 0 0.005047796294093132
in O 0 0.006009477656334639
certain O 0 0.010234314948320389
genetic O 1 0.897219181060791
conditions O 0 0.27409863471984863
MLD B-Disease 1 0.9955839514732361
- O 0 0.31786975264549255
like O 0 0.021940603852272034
ARSA O 1 0.9857912063598633
and O 0 0.011498725041747093
GS O 1 0.7363333106040955
values O 0 0.009928634390234947
need O 0 0.007230514660477638
not O 0 0.004670955706387758
be O 0 0.004730956628918648
paralleled O 0 0.032469697296619415
by O 0 0.011357837356626987
clinical O 1 0.9782232642173767
disease O 1 0.99937504529953
, O 0 0.007535331882536411
a O 0 0.008486654609441757
finding O 0 0.012969964183866978
with O 0 0.008930710144340992
serious O 1 0.667350709438324
diagnostic O 1 0.6720554232597351
and O 0 0.017095427960157394
prognostic O 1 0.9807299375534058
implications O 1 0.5452423691749573
. O 0 0.042029641568660736

Moreover O 0 0.05366778373718262
, O 0 0.021178292110562325
further O 0 0.03213018178939819
ARSA O 1 0.9928960204124451
alleles O 1 0.9885097146034241
functionally O 1 0.6066656708717346
similar O 0 0.01665640063583851
to O 0 0.007816888391971588
A464V O 0 0.16545557975769043
might O 0 0.010816606692969799
exist O 0 0.006751985754817724
which O 0 0.0038265404291450977
, O 0 0.0036346169654279947
together O 0 0.004733020905405283
with O 0 0.005588424392044544
0 O 0 0.017312349751591682
- O 0 0.11885608732700348
type O 0 0.18325959146022797
mutations O 1 0.9760881662368774
, O 0 0.01155705377459526
may O 0 0.027913393452763557
cause O 1 0.9422004818916321
pathological O 1 0.9941871166229248
ARSA O 1 0.9965206384658813
and O 0 0.013971881940960884
GS O 1 0.9829899072647095
levels O 0 0.023097893223166466
, O 0 0.006592731457203627
but O 0 0.0068172551691532135
not O 0 0.008494691923260689
clinical O 1 0.8303254842758179
outbreak O 1 0.9944502115249634
of O 0 0.01166756171733141
the O 0 0.02235475182533264
disease O 1 0.9993129968643188
. O 0 0.02240457572042942
. O 0 0.030033476650714874

Human O 1 0.9386739134788513
MLH1 O 1 0.9974539875984192
deficiency O 1 0.9995205402374268
predisposes O 1 0.9946635961532593
to O 0 0.05891234800219536
hematological B-Disease 1 0.9958498477935791
malignancy I-Disease 1 0.9981057643890381
and O 0 0.07184354215860367
neurofibromatosis B-Disease 1 0.9983435869216919
type I-Disease 0 0.37227970361709595
1 I-Disease 0 0.03397674858570099
. O 0 0.035398196429014206

Heterozygous O 1 0.9520758390426636
germ O 1 0.9486773014068604
- O 0 0.18326948583126068
line O 0 0.03126690536737442
mutations O 1 0.6496227383613586
in O 0 0.009291624650359154
the O 0 0.011842899024486542
DNA O 0 0.1337500661611557
mismatch O 1 0.9514649510383606
repair O 1 0.8796372413635254
genes O 1 0.8555620312690735
lead O 0 0.03657050058245659
to O 0 0.024756353348493576
hereditary B-Disease 1 0.9962368011474609
nonpolyposis I-Disease 1 0.9986711740493774
colorectal I-Disease 1 0.9999504089355469
cancer I-Disease 1 0.9996410608291626
. O 0 0.12821592390537262

The O 0 0.05203784257173538
disease O 1 0.999313473701477
susceptibility O 1 0.9925594329833984
of O 0 0.01202118955552578
individuals O 0 0.022371506318449974
who O 0 0.011081081815063953
constitutionally O 0 0.029925918206572533
lack O 0 0.017364734783768654
both O 0 0.009709683246910572
wild O 0 0.04975331574678421
- O 0 0.2416151612997055
type O 0 0.25189417600631714
alleles O 1 0.9231953620910645
is O 0 0.018332745879888535
unknown O 0 0.03820067271590233
. O 0 0.02889665961265564

We O 0 0.015100033953785896
have O 0 0.010497258976101875
identified O 0 0.015541977249085903
three O 0 0.010640531778335571
offspring O 0 0.10676532983779907
in O 0 0.010500791482627392
a O 0 0.023703549057245255
hereditary B-Disease 1 0.997996985912323
nonpolyposis I-Disease 1 0.9993212223052979
colorectal I-Disease 1 0.9999779462814331
cancer I-Disease 1 0.9999028444290161
family O 1 0.6850676536560059
who O 0 0.04405488446354866
developed O 1 0.5852421522140503
hematological B-Disease 1 0.9984571933746338
malignancy I-Disease 1 0.9981998205184937
at O 0 0.01077196840196848
a O 0 0.008289645425975323
very O 0 0.007319662719964981
early O 0 0.00832237210124731
age O 0 0.008160601370036602
, O 0 0.003146909410133958
and O 0 0.002622112864628434
at O 0 0.0032799681648612022
least O 0 0.003917863126844168
two O 0 0.0024199639447033405
of O 0 0.0026710766833275557
them O 0 0.003751188050955534
displayed O 0 0.009147381410002708
signs O 0 0.01950768753886223
of O 0 0.011703666299581528
neurofibromatosis B-Disease 1 0.9991781115531921
type I-Disease 0 0.41308969259262085
1 I-Disease 0 0.026778921484947205
( O 0 0.03194693475961685
NF1 B-Disease 1 0.9655005931854248
) O 0 0.032339684665203094
. O 0 0.03396717831492424

DNA O 0 0.05771655961871147
sequence O 0 0.030612559989094734
analysis O 0 0.01775309629738331
and O 0 0.00869697518646717
allele O 1 0.6036176085472107
- O 0 0.03141540661454201
specific O 0 0.013730177655816078
amplification O 0 0.029216406866908073
in O 0 0.006242572795599699
two O 0 0.007401010487228632
siblings O 0 0.06377407908439636
revealed O 0 0.025733795017004013
a O 0 0.022639822214841843
homozygous O 1 0.9857894778251648
MLH1 O 1 0.9961140155792236
mutation O 1 0.9921603798866272
( O 0 0.0518820695579052
C676T O 1 0.8635252118110657
- O 0 0.39017531275749207
- O 0 0.3898676931858063
> O 1 0.8478541374206543
Arg226Stop O 1 0.8400055766105652
) O 0 0.04181944578886032
. O 0 0.04107028990983963

Thus O 0 0.030842909589409828
, O 0 0.014814302325248718
a O 0 0.02096005156636238
homozygous O 1 0.9253395199775696
germ O 1 0.952102541923523
- O 0 0.4101019501686096
line O 0 0.05073106288909912
MLH1 O 1 0.9940128922462463
mutation O 1 0.9895188212394714
and O 0 0.023352691903710365
consequent O 1 0.9851969480514526
mismatch O 1 0.9969248175621033
repair O 1 0.9950811862945557
deficiency O 1 0.9993359446525574
results O 0 0.041597019881010056
in O 0 0.014109665527939796
a O 0 0.02600347436964512
mutator O 1 0.9958095550537109
phenotype O 1 0.998267412185669
characterized O 1 0.9322351217269897
by O 0 0.0713343545794487
leukemia B-Disease 1 0.9997079968452454
and O 0 0.026298167183995247
/ O 1 0.9683139324188232
or O 0 0.3691224753856659
lymphoma B-Disease 1 0.9998886585235596
associated O 0 0.1749887466430664
with O 0 0.05446380004286766
neurofibromatosis B-Disease 1 0.9994139671325684
type I-Disease 0 0.3490438461303711
1 I-Disease 0 0.023338129743933678
. O 0 0.017461437731981277
. O 0 0.026027334854006767

Missense O 1 0.9680279493331909
mutations O 1 0.7898608446121216
in O 0 0.00997073482722044
the O 0 0.007940675131976604
most O 0 0.0064886752516031265
ancient O 0 0.009397129528224468
residues O 0 0.012379287742078304
of O 0 0.00537967961281538
the O 0 0.008689850568771362
PAX6 O 1 0.9873815178871155
paired O 0 0.13282805681228638
domain O 0 0.04146480932831764
underlie O 1 0.5093249678611755
a O 0 0.014574344269931316
spectrum O 0 0.07122376561164856
of O 0 0.01702834665775299
human O 1 0.9772021174430847
congenital B-Disease 1 0.999941349029541
eye I-Disease 1 0.9989081621170044
malformations I-Disease 1 0.998727023601532
. O 0 0.06905705481767654

Mutations O 1 0.8384555578231812
of O 0 0.018086599186062813
the O 0 0.018607093021273613
human O 0 0.38796013593673706
PAX6 O 1 0.9957572817802429
gene O 1 0.9938545227050781
underlie O 1 0.99566251039505
aniridia B-Disease 1 0.9956451654434204
( O 0 0.3154957592487335
congenital B-Disease 1 0.9995822310447693
absence I-Disease 0 0.05062707141041756
of I-Disease 0 0.007861970923841
the I-Disease 0 0.009494073688983917
iris I-Disease 1 0.8443840742111206
) O 0 0.010082962922751904
, O 0 0.006193873472511768
a O 0 0.00959252193570137
rare O 0 0.09883412718772888
dominant O 1 0.513721764087677
malformation B-Disease 1 0.9957055449485779
of I-Disease 0 0.011621392332017422
the I-Disease 0 0.017529215663671494
eye I-Disease 1 0.9621285200119019
. O 0 0.036221884191036224

The O 0 0.024267535656690598
spectrum O 0 0.05496669560670853
of O 0 0.022179801017045975
PAX6 O 1 0.9935498833656311
mutations O 1 0.9935563206672668
in O 0 0.02321632020175457
aniridia B-Disease 1 0.9961093068122864
patients O 1 0.9951716065406799
is O 0 0.011375637724995613
highly O 0 0.014910074882209301
biased O 0 0.0157755259424448
, O 0 0.005494751036167145
with O 0 0.005308941006660461
92 O 0 0.011765893548727036
% O 0 0.006443509366363287
of O 0 0.003914447966963053
all O 0 0.004717356525361538
reported O 0 0.01874707080423832
mutations O 1 0.9465946555137634
leading O 0 0.01271036360412836
to O 0 0.007183622103184462
premature O 1 0.6601970791816711
truncation O 0 0.1150922030210495
of O 0 0.00634248461574316
the O 0 0.006691082380712032
protein O 0 0.03511715680360794
( O 0 0.009925943799316883
nonsense O 0 0.016453508287668228
, O 0 0.0072357975877821445
splicing O 0 0.0561557337641716
, O 0 0.007828016765415668
insertions O 0 0.0809517428278923
and O 0 0.006830194033682346
deletions O 0 0.0351107195019722
) O 0 0.005767690017819405
and O 0 0.0033319832291454077
just O 0 0.004574637394398451
2 O 0 0.005681559909135103
% O 0 0.005567646585404873
leading O 0 0.005483244080096483
to O 0 0.0035146246664226055
substitution O 0 0.009672729298472404
of O 0 0.00479087745770812
one O 0 0.006383552681654692
amino O 0 0.022245753556489944
acid O 0 0.037579573690891266
by O 0 0.010745893232524395
another O 0 0.01640949584543705
( O 0 0.023242099210619926
missense O 1 0.7754145860671997
) O 0 0.0269035454839468
. O 0 0.029309144243597984

The O 0 0.020805085077881813
extraordinary O 0 0.02685808576643467
conservation O 0 0.018951334059238434
of O 0 0.01038801483809948
the O 0 0.01407600287348032
PAX6 O 1 0.9662118554115295
protein O 0 0.04359354451298714
at O 0 0.009968651458621025
the O 0 0.010283058509230614
amino O 0 0.026027973741292953
acid O 0 0.04972239211201668
level O 0 0.013471976853907108
amongst O 0 0.021770738065242767
vertebrates O 0 0.23972705006599426
predicts O 0 0.0919085294008255
that O 0 0.012275501154363155
pathological O 1 0.9900687336921692
missense O 1 0.9935716390609741
mutations O 1 0.9851790070533752
should O 0 0.008679153397679329
in O 0 0.005429509561508894
fact O 0 0.006509197875857353
be O 0 0.003345463890582323
common O 0 0.006297963205724955
even O 0 0.004892227705568075
though O 0 0.004626199137419462
they O 0 0.00314635899849236
are O 0 0.004137403331696987
hardly O 0 0.012704302556812763
ever O 0 0.01036200299859047
seen O 0 0.013997018337249756
in O 0 0.015516798011958599
aniridia B-Disease 1 0.9854602217674255
patients O 1 0.9923388957977295
. O 0 0.04202934354543686

This O 0 0.016139063984155655
indicates O 0 0.018343396484851837
that O 0 0.006286540534347296
there O 0 0.005340073723345995
is O 0 0.005098473746329546
a O 0 0.0076040844433009624
heavy O 0 0.02387254498898983
ascertainment O 1 0.7286733984947205
bias O 0 0.027131032198667526
in O 0 0.005656600464135408
the O 0 0.005201177671551704
selection O 0 0.008774454705417156
of O 0 0.007160340901464224
patients O 1 0.9799636006355286
for O 0 0.011330513283610344
PAX6 O 1 0.9974313378334045
mutation O 1 0.9891015887260437
analysis O 0 0.01205730065703392
and O 0 0.004736915230751038
that O 0 0.00462379353120923
the O 0 0.008054600097239017
missing O 0 0.10937026888132095
PAX6 O 1 0.996661901473999
missense O 1 0.9946139454841614
mutations O 1 0.9940640330314636
frequently O 0 0.07871232181787491
may O 0 0.06868048757314682
underlie O 1 0.9623219966888428
phenotypes O 1 0.9764704704284668
distinct O 0 0.05269235745072365
from O 0 0.026025814935564995
textbook O 0 0.2756572961807251
aniridia B-Disease 1 0.9061657190322876
. O 0 0.044858574867248535

Here O 0 0.019427629187703133
we O 0 0.009980172850191593
present O 0 0.011197268962860107
four O 0 0.011396253481507301
novel O 0 0.04473396763205528
PAX6 O 1 0.9947251677513123
missense O 1 0.9868491888046265
mutations O 1 0.9509645700454712
, O 0 0.00933513231575489
two O 0 0.006980192847549915
in O 0 0.008222702890634537
association O 0 0.018472526222467422
with O 0 0.01557038351893425
atypical O 1 0.9939435124397278
phenotypes O 1 0.9967081546783447
ectopia B-Disease 1 0.9931986927986145
pupillae I-Disease 1 0.9839903116226196
( O 0 0.038784902542829514
displaced B-Disease 1 0.5264624357223511
pupils I-Disease 0 0.05907557159662247
) O 0 0.019294483587145805
and O 0 0.02840995602309704
congenital B-Disease 1 0.9998936653137207
nystagmus I-Disease 1 0.9987576007843018
( O 0 0.02888721413910389
searching B-Disease 0 0.029958071187138557
gaze I-Disease 0 0.10869165509939194
) O 0 0.009098203852772713
, O 0 0.004463209770619869
and O 0 0.0034355116076767445
two O 0 0.0034868521615862846
in O 0 0.00468897819519043
association O 0 0.01172473095357418
with O 0 0.008215916343033314
more O 0 0.014324704185128212
recognizable O 0 0.38246989250183105
aniridia B-Disease 1 0.9788796305656433
phenotypes O 1 0.9786970615386963
. O 0 0.0494500957429409

Strikingly O 0 0.05727468430995941
, O 0 0.01149752177298069
all O 0 0.005866330582648516
four O 0 0.009521604515612125
mutations O 1 0.5023926496505737
are O 0 0.005739980842918158
located O 0 0.00863251555711031
within O 0 0.007877727970480919
the O 0 0.0101116131991148
PAX6 O 1 0.9670587778091431
paired O 0 0.033368516713380814
domain O 0 0.019913410767912865
and O 0 0.0072998711839318275
affect O 0 0.022692859172821045
amino O 0 0.023097684606909752
acids O 0 0.017423788085579872
which O 0 0.00464113662019372
are O 0 0.0036874043289572
highly O 0 0.008476573042571545
conserved O 0 0.010905583389103413
in O 0 0.004490660969167948
all O 0 0.004574845544993877
known O 0 0.0128870140761137
paired O 0 0.03467303887009621
domain O 0 0.038454290479421616
proteins O 0 0.04898521676659584
. O 0 0.026687586680054665

Our O 0 0.019011329859495163
results O 0 0.016072601079940796
support O 0 0.009383978322148323
the O 0 0.005159074906259775
hypothesis O 0 0.011815442703664303
that O 0 0.0032525439746677876
the O 0 0.0032804326619952917
under O 0 0.004847398959100246
- O 0 0.012223328463733196
representation O 0 0.009453308768570423
of O 0 0.009273049421608448
missense O 1 0.9878050088882446
mutations O 1 0.9936317801475525
is O 0 0.012008295394480228
caused O 1 0.5238170027732849
by O 0 0.00986578781157732
ascertainment O 1 0.9682062864303589
bias O 0 0.15947668254375458
and O 0 0.00626458041369915
suggest O 0 0.01190172415226698
that O 0 0.005365543067455292
a O 0 0.007744126487523317
substantial O 0 0.017732828855514526
burden O 0 0.17699244618415833
of O 0 0.01309196837246418
PAX6 B-Disease 1 0.9974899291992188
- I-Disease 1 0.8889577388763428
related I-Disease 1 0.8037286996841431
disease I-Disease 1 0.9995118379592896
remains O 0 0.023979222401976585
to O 0 0.007740939036011696
be O 0 0.009000472724437714
uncovered O 0 0.02865580841898918
. O 0 0.016702134162187576
. O 0 0.02820703759789467

The O 0 0.03104662522673607
chromosomal O 1 0.5840540528297424
order O 0 0.01468202006071806
of O 0 0.010881587862968445
genes O 0 0.4674341678619385
controlling O 0 0.12624375522136688
the O 0 0.012678074650466442
major O 0 0.037578582763671875
histocompatibility O 1 0.9908520579338074
complex O 0 0.023420238867402077
, O 0 0.011682598851621151
properdin O 1 0.7891671061515808
factor O 0 0.12608975172042847
B O 0 0.08795046806335449
, O 0 0.007968991063535213
and O 0 0.007778798695653677
deficiency B-Disease 1 0.9961114525794983
of I-Disease 0 0.006270805839449167
the I-Disease 0 0.005824817810207605
second I-Disease 0 0.00962674431502819
component I-Disease 0 0.018369169905781746
of I-Disease 0 0.01246977224946022
complement I-Disease 0 0.038480162620544434
. O 0 0.02919618971645832

The O 0 0.01950164884328842
relationship O 0 0.02166000008583069
of O 0 0.008267335593700409
the O 0 0.010226096026599407
genes O 0 0.34327980875968933
coding O 0 0.10614660382270813
for O 0 0.008930409327149391
HLA O 1 0.9497814178466797
to O 0 0.006243839394301176
those O 0 0.007201126776635647
coding O 0 0.03240503743290901
for O 0 0.009072900749742985
properdin O 1 0.7183982133865356
Factor O 0 0.10905681550502777
B O 0 0.16221413016319275
allotypes O 0 0.2803749740123749
and O 0 0.006689231377094984
for O 0 0.007272431626915932
deficiency B-Disease 1 0.9967228770256042
of I-Disease 0 0.005213904194533825
the I-Disease 0 0.004992987494915724
second I-Disease 0 0.007224188186228275
component I-Disease 0 0.013548377901315689
of I-Disease 0 0.00714923394843936
complement I-Disease 0 0.02041415497660637
( O 0 0.015363343060016632
C2 O 1 0.6297817826271057
) O 0 0.008421813137829304
was O 0 0.006019897293299437
studied O 0 0.008668463677167892
in O 0 0.00667679775506258
families O 0 0.012193776667118073
of O 0 0.011766298674046993
patients O 1 0.9948403239250183
with O 0 0.11414027959108353
connective O 1 0.9996596574783325
tissue O 1 0.9996070265769958
disorders O 1 0.999537467956543
. O 0 0.08294480293989182

Patients O 1 0.966525673866272
were O 0 0.010601223446428776
selected O 0 0.010264817625284195
because O 0 0.0070739928632974625
they O 0 0.0048354752361774445
were O 0 0.006101615261286497
heterozygous O 0 0.12351828813552856
or O 0 0.018010148778557777
homozygous O 1 0.8883458375930786
for O 0 0.03203437849879265
C2 B-Disease 1 0.9973340034484863
deficiency I-Disease 1 0.9990898370742798
. O 0 0.05704517662525177

12 O 0 0.033297277987003326
families O 0 0.027188589796423912
with O 0 0.014712097123265266
15 O 0 0.023010775446891785
matings O 0 0.36639532446861267
informative O 0 0.04303145036101341
for O 0 0.027061274275183678
C2 B-Disease 1 0.9962795376777649
deficiency I-Disease 1 0.999043881893158
were O 0 0.020323103293776512
found O 0 0.03326334431767464
. O 0 0.03422076255083084

Of O 0 0.02174551598727703
57 O 0 0.03648516535758972
informative O 0 0.03388427942991257
meioses O 0 0.1013232171535492
, O 0 0.00883957277983427
two O 0 0.007087923586368561
crossovers O 0 0.020751411095261574
were O 0 0.006073519587516785
noted O 0 0.010144708678126335
between O 0 0.010358748026192188
the O 0 0.01593485288321972
C2 B-Disease 1 0.9972566962242126
deficiency I-Disease 1 0.9995737671852112
gene O 1 0.8292192220687866
and O 0 0.010994111187756062
the O 0 0.01402671355754137
HLA O 1 0.993057131767273
- O 1 0.5920119285583496
B O 1 0.5121966600418091
gene O 0 0.2596617341041565
, O 0 0.007943090982735157
with O 0 0.00800487119704485
a O 0 0.013059348799288273
recombinant O 0 0.14268195629119873
fraction O 0 0.03259454295039177
of O 0 0.018504900857806206
0 O 0 0.04546027258038521
. O 0 0.03435734286904335

035 O 1 0.762112021446228
. O 0 0.1124730110168457

A O 0 0.02990955486893654
lod O 0 0.05590234696865082
score O 0 0.012371824122965336
of O 0 0.005804344546049833
13 O 0 0.00826269295066595
was O 0 0.005473861936479807
calculated O 0 0.011414005421102047
for O 0 0.006784653291106224
linkage O 0 0.11316857486963272
between O 0 0.03226159140467644
C2 B-Disease 1 0.9971615076065063
deficiency I-Disease 1 0.9995507597923279
and O 0 0.024029608815908432
HLA O 1 0.997092604637146
- O 0 0.19029293954372406
B O 0 0.06261758506298065
at O 0 0.007811120245605707
a O 0 0.007156361360102892
maximum O 0 0.010430444031953812
likelihood O 0 0.014458713121712208
value O 0 0.006525181233882904
of O 0 0.005046810023486614
the O 0 0.008675793185830116
recombinant O 0 0.12383557111024857
fraction O 0 0.025500796735286713
of O 0 0.015055336058139801
0 O 0 0.04127353057265282
. O 0 0.029510963708162308

04 O 0 0.25339797139167786
. O 0 0.09003295749425888

18 O 0 0.03081364557147026
families O 0 0.023260416463017464
with O 0 0.012249419465661049
21 O 0 0.019227631390094757
informative O 0 0.029268182814121246
matings O 0 0.0956534668803215
for O 0 0.008992723189294338
both O 0 0.011229487136006355
properdin O 0 0.4036252200603485
Factor O 0 0.07406648993492126
B O 0 0.16282911598682404
allotype O 1 0.60066819190979
and O 0 0.01816459558904171
HLA O 1 0.9889014959335327
- O 0 0.15469330549240112
B O 0 0.056775279343128204
were O 0 0.013941536657512188
found O 0 0.024623479694128036
. O 0 0.025569044053554535

Of O 0 0.024560626596212387
72 O 0 0.036660682410001755
informative O 0 0.037121765315532684
meioses O 0 0.08705025911331177
, O 0 0.008246098645031452
three O 0 0.007081311196088791
recombinants O 0 0.05422582849860191
were O 0 0.005095619708299637
found O 0 0.007063026074320078
, O 0 0.005166622810065746
giving O 0 0.010680291801691055
a O 0 0.011498421430587769
recombinant O 0 0.1161062940955162
fraction O 0 0.03221123665571213
of O 0 0.015131324529647827
0 O 0 0.03825119137763977
. O 0 0.025230353698134422

042 O 0 0.4866262376308441
. O 0 0.08778263628482819

A O 0 0.031232019886374474
lod O 0 0.06034579500555992
score O 0 0.012567616067826748
of O 0 0.00780796492472291
16 O 0 0.015751931816339493
between O 0 0.015824805945158005
HLA O 1 0.9818603992462158
- O 0 0.09719448536634445
B O 0 0.04971596971154213
and O 0 0.010307574644684792
Factor O 0 0.06469343602657318
B O 0 0.12148814648389816
allotypes O 0 0.1240905299782753
was O 0 0.008402871899306774
calculated O 0 0.010990927927196026
at O 0 0.0057374718599021435
a O 0 0.006227787584066391
maximum O 0 0.010744119063019753
likelihood O 0 0.01380893588066101
value O 0 0.005892106797546148
of O 0 0.004961119964718819
the O 0 0.007171668577939272
recombinant O 0 0.060721505433321
fraction O 0 0.024385999888181686
of O 0 0.01312195509672165
0 O 0 0.03199213743209839
. O 0 0.02695266716182232

04 O 0 0.22116750478744507
. O 0 0.08142679184675217

A O 0 0.02725541964173317
crossover O 0 0.035041265189647675
was O 0 0.01028828602284193
shown O 0 0.009610038250684738
to O 0 0.004577482584863901
have O 0 0.00527518754824996
occurred O 0 0.011809073388576508
between O 0 0.007536530029028654
genes O 0 0.05743587762117386
for O 0 0.005481918342411518
Factor O 0 0.06577477604150772
B O 0 0.07294187694787979
and O 0 0.009276852943003178
HLA O 1 0.9972562193870544
- O 0 0.4945833384990692
D O 0 0.1813526302576065
, O 0 0.00835499633103609
in O 0 0.007522654253989458
which O 0 0.011404410935938358
HLA O 1 0.9894659519195557
- O 1 0.6001226305961609
D O 1 0.728282630443573
segregared O 1 0.657106876373291
with O 0 0.018657958135008812
HLA O 1 0.9909186363220215
- O 0 0.04634374380111694
A O 0 0.021022550761699677
and O 0 0.016046861186623573
B O 0 0.05966075509786606
. O 0 0.02812878228724003

These O 0 0.019157877191901207
studies O 0 0.0193471796810627
suggest O 0 0.013510613702237606
that O 0 0.005336951930075884
the O 0 0.0064817131496965885
genes O 0 0.07572318613529205
for O 0 0.008478573523461819
Factor O 0 0.10552699863910675
B O 0 0.10735306888818741
and O 0 0.013659828342497349
C2 B-Disease 1 0.9978681802749634
deficiency I-Disease 1 0.9994472861289978
are O 0 0.00855539832264185
located O 0 0.008259457536041737
outside O 0 0.005828214809298515
those O 0 0.0041397614404559135
for O 0 0.005008459556847811
HLA O 1 0.9466599225997925
, O 0 0.004001980647444725
that O 0 0.0027920042630285025
the O 0 0.0037499479949474335
order O 0 0.004867712501436472
of O 0 0.006056324578821659
genese O 0 0.3478093147277832
is O 0 0.011484761722385883
HLA O 1 0.9885542988777161
- O 0 0.028277402743697166
A O 0 0.009294644929468632
, O 0 0.007125117816030979
- O 0 0.04493574798107147
B O 0 0.05276809632778168
, O 0 0.009056723676621914
- O 0 0.03749203681945801
D O 0 0.07912158221006393
, O 0 0.011346736922860146
Factor O 0 0.061922237277030945
B O 0 0.2798822224140167
allotype O 1 0.8773062229156494
, O 0 0.02713741548359394
C2 B-Disease 1 0.9968999624252319
deficiency I-Disease 1 0.9992953538894653
, O 0 0.009307066909968853
that O 0 0.006204152014106512
the O 0 0.007791890762746334
genes O 0 0.40992820262908936
coding O 0 0.3981003165245056
for O 0 0.01876022480428219
C2 B-Disease 1 0.9990071654319763
deficiency I-Disease 1 0.9996440410614014
and O 0 0.012858371250331402
Factor O 0 0.24760191142559052
B O 0 0.16294240951538086
allotypes O 0 0.2574487626552582
are O 0 0.006066695787012577
approximately O 0 0.010606717318296432
3 O 0 0.010345547460019588
- O 0 0.019948860630393028
- O 0 0.021122215315699577
5 O 0 0.014462633989751339
centimorgans O 0 0.0365939736366272
from O 0 0.00842637475579977
the O 0 0.008918697014451027
HLA O 1 0.9685041904449463
- O 0 0.02803528867661953
A O 0 0.012616880238056183
and O 0 0.011258119717240334
HLA O 1 0.9937478303909302
- O 0 0.4962924122810364
B O 0 0.3318662643432617
loci O 1 0.5308037996292114
, O 0 0.007050980348140001
and O 0 0.003930988721549511
that O 0 0.004161558113992214
the O 0 0.005281830206513405
apparent O 0 0.01638656295835972
lack O 0 0.010556583292782307
of O 0 0.00595342181622982
recombinants O 0 0.20384617149829865
between O 0 0.009029003791511059
the O 0 0.007767169736325741
Factor O 0 0.22026647627353668
B O 0 0.499621719121933
gene O 1 0.9277994632720947
and O 0 0.028803205117583275
C2 B-Disease 1 0.9989112615585327
deficiency I-Disease 1 0.9998354911804199
gene O 1 0.9818207621574402
suggests O 0 0.02728867530822754
that O 0 0.005432360805571079
these O 0 0.004668061621487141
two O 0 0.005451009143143892
genes O 0 0.04714798182249069
lie O 0 0.011153523810207844
in O 0 0.006244619842618704
close O 0 0.00963972695171833
proximity O 0 0.013994214124977589
to O 0 0.006867617834359407
one O 0 0.010502065531909466
another O 0 0.02182781882584095
. O 0 0.027806667611002922

Distribution O 0 0.04114232584834099
of O 0 0.018481114879250526
emerin O 0 0.263325959444046
and O 0 0.012508738785982132
lamins O 0 0.4884195923805237
in O 0 0.009692873805761337
the O 0 0.009499559178948402
heart O 1 0.646457850933075
and O 0 0.009814765304327011
implications O 0 0.05038450285792351
for O 0 0.014810002408921719
Emery B-Disease 1 0.9387221336364746
- I-Disease 1 0.9855307340621948
Dreifuss I-Disease 1 0.9984672665596008
muscular I-Disease 1 0.9994240999221802
dystrophy I-Disease 1 0.999496579170227
. O 0 0.0932689756155014

Emerin O 0 0.38871338963508606
is O 0 0.016969887539744377
a O 0 0.014889296144247055
nuclear O 0 0.018947120755910873
membrane O 0 0.034806836396455765
protein O 0 0.019725147634744644
which O 0 0.0054215360432863235
is O 0 0.005896040704101324
missing O 0 0.014376570470631123
or O 0 0.011806253343820572
defective O 1 0.509702205657959
in O 0 0.013632313348352909
Emery B-Disease 1 0.9287043213844299
- I-Disease 1 0.9754456281661987
Dreifuss I-Disease 1 0.9992108345031738
muscular I-Disease 1 0.9995484948158264
dystrophy I-Disease 1 0.9997928738594055
( O 1 0.651910662651062
EDMD B-Disease 1 0.9839714169502258
) O 0 0.047028783708810806
. O 0 0.0368107371032238

It O 0 0.011942223645746708
is O 0 0.008014813996851444
one O 0 0.0051423669792711735
member O 0 0.005934410262852907
of O 0 0.004349264781922102
a O 0 0.007214226294308901
family O 0 0.012607021257281303
of O 0 0.008986159227788448
lamina O 1 0.9638803005218506
- O 0 0.20006641745567322
associated O 0 0.022852057591080666
proteins O 0 0.022719303146004677
which O 0 0.008205044083297253
includes O 0 0.015731211751699448
LAP1 O 1 0.5127635598182678
, O 0 0.01428886316716671
LAP2 O 1 0.7591409087181091
and O 0 0.02232719585299492
lamin O 1 0.9815528988838196
B O 1 0.853904664516449
receptor O 1 0.9616027474403381
( O 0 0.05716834217309952
LBR O 1 0.9587101936340332
) O 0 0.0397300124168396
. O 0 0.03724074736237526

A O 0 0.030697928741574287
panel O 0 0.026638496667146683
of O 0 0.012800204567611217
16 O 0 0.028388697654008865
monoclonal O 1 0.9743282794952393
antibodies O 1 0.9801822900772095
( O 0 0.034216295927762985
mAbs O 1 0.7926439642906189
) O 0 0.010204507037997246
has O 0 0.006181718781590462
been O 0 0.005213681608438492
mapped O 0 0.010380424559116364
to O 0 0.003898468567058444
six O 0 0.00597616471350193
specific O 0 0.007712367922067642
sites O 0 0.008373633027076721
throughout O 0 0.009106314741075039
the O 0 0.008306818082928658
emerin O 0 0.17137062549591064
molecule O 0 0.031087003648281097
using O 0 0.016493171453475952
phage O 1 0.8403403759002686
- O 0 0.04691318795084953
displayed O 0 0.019075367599725723
peptide O 0 0.044816162437200546
libraries O 0 0.009449688717722893
and O 0 0.003871126100420952
has O 0 0.0042887800373137
been O 0 0.0035508873406797647
used O 0 0.004191671963781118
to O 0 0.005515851080417633
localize O 0 0.3518978953361511
emerin O 1 0.5081222057342529
in O 0 0.010238179005682468
human O 0 0.025439249351620674
and O 0 0.014164253138005733
rabbit O 1 0.9815865159034729
heart O 1 0.9848500490188599
. O 0 0.04839760810136795

Several O 0 0.03770631551742554
mAbs O 1 0.5310941934585571
against O 0 0.020660951733589172
different O 0 0.01625734753906727
emerin O 1 0.8130378127098083
epitopes O 1 0.6810482740402222
did O 0 0.011073623783886433
not O 0 0.007999898865818977
recognize O 0 0.021119723096489906
intercalated O 0 0.18387751281261444
discs O 0 0.015856824815273285
in O 0 0.005908513441681862
the O 0 0.006821800023317337
heart O 1 0.7209423780441284
, O 0 0.0058782873675227165
though O 0 0.00745580717921257
they O 0 0.005744788330048323
recognized O 0 0.015116955153644085
cardiomyocyte O 0 0.396696537733078
nuclei O 0 0.04214772954583168
strongly O 0 0.012084690853953362
, O 0 0.004892332013696432
both O 0 0.0045472318306565285
at O 0 0.004960938822478056
the O 0 0.005530570633709431
rim O 0 0.016682256013154984
and O 0 0.006369962356984615
in O 0 0.009917925111949444
intranuclear O 0 0.2105255424976349
spots O 0 0.03839229419827461
or O 0 0.022137729451060295
channels O 0 0.04386672377586365
. O 0 0.03209402412176132

A O 0 0.08289166539907455
polyclonal O 1 0.9761376976966858
rabbit O 1 0.9717337489128113
antiserum O 1 0.9565205574035645
against O 0 0.032025065273046494
emerin O 0 0.37687695026397705
did O 0 0.014960836619138718
recognize O 0 0.019617360085248947
both O 0 0.008224165067076683
nuclear O 0 0.014831461012363434
membrane O 0 0.02621830813586712
and O 0 0.006512566935271025
intercalated O 0 0.07265416532754898
discs O 0 0.015980543568730354
but O 0 0.005869599524885416
, O 0 0.005166079383343458
after O 0 0.0092899976298213
affinity O 0 0.020109685137867928
purification O 0 0.017364611849188805
against O 0 0.0068910084664821625
a O 0 0.007738144602626562
pure O 0 0.014611585065722466
- O 0 0.033057473599910736
emerin O 0 0.2760034203529358
band O 0 0.01233940664678812
on O 0 0.005677566863596439
a O 0 0.0073178960010409355
western O 0 0.01008213683962822
blot O 0 0.07856067270040512
, O 0 0.006200549192726612
it O 0 0.006203023251146078
stained O 0 0.037169791758060455
only O 0 0.006693700794130564
the O 0 0.009465520270168781
nuclear O 0 0.023187199607491493
membrane O 0 0.05340438708662987
. O 0 0.030944205820560455

These O 0 0.013463861308991909
results O 0 0.014523869380354881
would O 0 0.005408459343016148
not O 0 0.003987741190940142
be O 0 0.0035107573494315147
expected O 0 0.006483820267021656
if O 0 0.00738420058041811
immunostaining O 0 0.07293049246072769
at O 0 0.009050366468727589
intercalated O 0 0.14564354717731476
discs O 0 0.015776636078953743
were O 0 0.004800062160938978
due O 0 0.007388668600469828
to O 0 0.003696738975122571
a O 0 0.004420417360961437
product O 0 0.006303979083895683
of O 0 0.003954156301915646
the O 0 0.006564323790371418
emerin O 1 0.7334932684898376
gene O 0 0.3034956753253937
and O 0 0.0051748305559158325
, O 0 0.004652750678360462
therefore O 0 0.005600343458354473
, O 0 0.003913659602403641
cast O 0 0.007090222090482712
some O 0 0.0049459319561719894
doubt O 0 0.009364410303533077
upon O 0 0.007233739830553532
the O 0 0.006812723819166422
hypothesis O 0 0.06422903388738632
that O 0 0.013677775859832764
cardiac B-Disease 1 0.9990703463554382
defects I-Disease 1 0.9962964653968811
in O 0 0.013922455720603466
EDMD B-Disease 1 0.9763090014457703
are O 0 0.01022177841514349
caused O 0 0.17240072786808014
by O 0 0.010061250068247318
absence O 0 0.019239971414208412
of O 0 0.010538669303059578
emerin O 1 0.5548132061958313
from O 0 0.019454989582300186
intercalated O 0 0.40007272362709045
discs O 0 0.06625101715326309
. O 0 0.03779568150639534

Although O 0 0.03605196997523308
emerin O 0 0.14578977227210999
was O 0 0.011317211203277111
abundant O 0 0.01568613201379776
in O 0 0.00654904218390584
the O 0 0.008167358115315437
membranes O 0 0.16130006313323975
of O 0 0.009175763465464115
cardiomyocyte O 1 0.8258472681045532
nuclei O 0 0.03267967700958252
, O 0 0.006731933448463678
it O 0 0.004783173557370901
was O 0 0.006629596464335918
absent O 0 0.014835153706371784
from O 0 0.006012190133333206
many O 0 0.00759352371096611
non O 0 0.020374439656734467
- O 0 0.3546154797077179
myocyte O 1 0.9890720844268799
cells O 1 0.6068477630615234
in O 0 0.011789497919380665
the O 0 0.017029298469424248
heart O 1 0.9057444930076599
. O 0 0.03823356702923775

This O 0 0.01751643419265747
distribution O 0 0.02026689052581787
of O 0 0.009785793721675873
emerin O 0 0.10384376347064972
was O 0 0.007425426971167326
similar O 0 0.007649879902601242
to O 0 0.0037532488349825144
that O 0 0.004128900822252035
of O 0 0.006065793335437775
lamin O 1 0.5426775217056274
A O 0 0.009102310054004192
, O 0 0.006454520858824253
a O 0 0.008716368116438389
candidate O 0 0.01817791350185871
gene O 0 0.1340753734111786
for O 0 0.009823203086853027
an O 0 0.014846921898424625
autosomal O 1 0.9946250319480896
form O 0 0.030248410999774933
of O 0 0.023151589557528496
EDMD B-Disease 1 0.9570682048797607
. O 0 0.04540688544511795

In O 0 0.026892205700278282
contrast O 0 0.037969302386045456
, O 0 0.0217297300696373
lamin O 1 0.9698579907417297
B1 O 1 0.9641420841217041
was O 0 0.016904687508940697
absent O 0 0.03848663717508316
from O 0 0.016476958990097046
cardiomyocyte O 1 0.598040759563446
nuclei O 0 0.04277011752128601
, O 0 0.009924125857651234
showing O 0 0.020018022507429123
that O 0 0.01111559197306633
lamin O 1 0.965621829032898
B1 O 1 0.8284924626350403
is O 0 0.008254912681877613
not O 0 0.005096166394650936
essential O 0 0.007953019812703133
for O 0 0.0057741738855838776
localization O 0 0.01909806951880455
of O 0 0.0071998052299022675
emerin O 0 0.07029309868812561
to O 0 0.008681540377438068
the O 0 0.011811167001724243
nuclear O 0 0.031075919046998024
lamina O 1 0.647412121295929
. O 0 0.03861156851053238

Lamin O 1 0.9783493280410767
B1 O 1 0.9178628325462341
is O 0 0.015967892482876778
also O 0 0.010283179581165314
almost O 0 0.0149679658934474
completely O 0 0.02232298068702221
absent O 0 0.050598692148923874
from O 0 0.023852050304412842
skeletal O 1 0.9905202388763428
muscle O 1 0.9923205971717834
nuclei O 0 0.3751235604286194
. O 0 0.042323336005210876

In O 0 0.026173461228609085
EDMD B-Disease 1 0.5400612950325012
, O 0 0.010265041142702103
the O 0 0.008019838482141495
additional O 0 0.011513943783938885
absence O 0 0.018767422065138817
of O 0 0.01168970949947834
lamin O 1 0.9901553392410278
B1 O 1 0.9796441793441772
from O 0 0.018859202042222023
heart O 1 0.9810084104537964
and O 0 0.018945451825857162
skeletal O 1 0.9968106150627136
muscle O 1 0.9966302514076233
nuclei O 0 0.1773323118686676
which O 0 0.00887986272573471
already O 0 0.013964150100946426
lack O 0 0.031383879482746124
emerin O 1 0.7863861918449402
may O 0 0.010947023518383503
offer O 0 0.007004793733358383
an O 0 0.004699633922427893
alternative O 0 0.008750291541218758
explanation O 0 0.008115922100841999
of O 0 0.005194964352995157
why O 0 0.00979121495038271
these O 0 0.006443643942475319
tissues O 1 0.8044272661209106
are O 0 0.007804578170180321
particularly O 0 0.020371656864881516
affected O 0 0.08341732621192932
. O 0 0.013280966319143772
. O 0 0.021403634920716286

Genetic O 0 0.22407685220241547
mapping O 0 0.04205990210175514
of O 0 0.013518406078219414
the O 0 0.01636623963713646
copper B-Disease 0 0.06779557466506958
toxicosis I-Disease 1 0.9853217601776123
locus O 1 0.8778761625289917
in O 0 0.020316990092396736
Bedlington O 1 0.951362669467926
terriers O 1 0.8147293329238892
to O 0 0.014822322875261307
dog O 1 0.8131192922592163
chromosome O 1 0.9461289048194885
10 O 0 0.009846178814768791
, O 0 0.005745539907366037
in O 0 0.005600630771368742
a O 0 0.008587836287915707
region O 0 0.01961023546755314
syntenic O 0 0.20926395058631897
to O 0 0.011349792592227459
human O 0 0.041798900812864304
chromosome O 1 0.9814536571502686
region O 0 0.1312054693698883
2p13 O 1 0.9375975131988525
- O 1 0.633526086807251
p16 O 1 0.9627144932746887
. O 0 0.0562392957508564

Abnormal O 1 0.9940963983535767
hepatic B-Disease 1 0.9981378316879272
copper I-Disease 0 0.24578821659088135
accumulation I-Disease 0 0.3617689311504364
is O 0 0.014303808100521564
recognized O 0 0.01548698265105486
as O 0 0.00799788162112236
an O 0 0.012681674212217331
inherited B-Disease 1 0.9977924823760986
disorder I-Disease 1 0.9996801614761353
in O 0 0.012810607440769672
man O 0 0.02409643866121769
, O 0 0.011759723536670208
mouse O 1 0.7673333883285522
, O 0 0.015742110088467598
rat O 1 0.9032082557678223
and O 0 0.020301349461078644
dog O 0 0.42236945033073425
. O 0 0.03530944883823395

The O 0 0.019797036424279213
major O 0 0.026390286162495613
cause O 0 0.2147812396287918
of O 0 0.015452711842954159
hepatic B-Disease 1 0.9981153011322021
copper I-Disease 0 0.11512985825538635
accumulation I-Disease 0 0.35554730892181396
in O 0 0.011244715191423893
man O 0 0.01602407917380333
is O 0 0.010160067118704319
a O 0 0.016585273668169975
dysfunctional O 1 0.9798524379730225
ATP7B O 1 0.9843822121620178
gene O 1 0.965858519077301
, O 0 0.02959134243428707
causing O 1 0.9822090864181519
Wilson B-Disease 1 0.9703722596168518
disease I-Disease 1 0.9996322393417358
( O 1 0.5057814121246338
WD B-Disease 1 0.9936898946762085
) O 0 0.04353366047143936
. O 0 0.039119962602853775

Mutations O 1 0.8515541553497314
in O 0 0.016269797459244728
the O 0 0.014292551204562187
ATP7B O 1 0.9169530272483826
genes O 0 0.35175806283950806
have O 0 0.007887744344770908
also O 0 0.005810337606817484
been O 0 0.007497624959796667
demonstrated O 0 0.018602440133690834
in O 0 0.011548560112714767
mouse O 0 0.4800634980201721
and O 0 0.018728084862232208
rat O 1 0.8160873055458069
. O 0 0.038902319967746735

The O 0 0.037997741252183914
ATP7B O 1 0.919269859790802
gene O 1 0.5454308986663818
has O 0 0.011935270391404629
been O 0 0.007791116368025541
excluded O 0 0.013429612852633
in O 0 0.005245816893875599
the O 0 0.006657861638814211
much O 0 0.012074942700564861
rarer O 1 0.8839055299758911
human O 0 0.22526313364505768
copper B-Disease 1 0.6343357563018799
overload I-Disease 1 0.9966225624084473
disease O 1 0.9995506405830383
non B-Disease 0 0.2922079563140869
- I-Disease 0 0.39254412055015564
Indian I-Disease 0 0.10085075348615646
childhood I-Disease 1 0.9917678833007812
cirrhosis I-Disease 1 0.9989591836929321
, O 0 0.027854377403855324
indicating O 0 0.2997116446495056
genetic O 1 0.9753191471099854
heterogeneity O 1 0.9177860021591187
. O 0 0.052008356899023056

By O 0 0.030089927837252617
investigating O 0 0.04374152421951294
the O 0 0.021972300484776497
common O 0 0.3988090753555298
autosomal O 1 0.9994926452636719
recessive O 1 0.9997001886367798
copper B-Disease 1 0.984459638595581
toxicosis I-Disease 1 0.9983530044555664
( O 0 0.21075643599033356
CT B-Disease 1 0.9812129139900208
) O 0 0.017024613916873932
in O 0 0.012477065436542034
Bedlington O 1 0.8557687997817993
terriers O 1 0.5502920746803284
, O 0 0.00692011509090662
we O 0 0.004467539954930544
have O 0 0.005164545029401779
identified O 0 0.00944134034216404
a O 0 0.007824983447790146
new O 0 0.009462837129831314
locus O 1 0.8240631222724915
involved O 0 0.02562006004154682
in O 0 0.024521881714463234
progressive O 1 0.9916302561759949
liver B-Disease 1 0.9998757839202881
disease I-Disease 1 0.9997636675834656
. O 0 0.10424605011940002

We O 0 0.021762678399682045
examined O 0 0.038127169013023376
whether O 0 0.019788239151239395
the O 0 0.017872022464871407
WD B-Disease 1 0.9911423921585083
gene O 1 0.9623740911483765
ATP7B O 1 0.8234159350395203
was O 0 0.010719717480242252
also O 0 0.00804105307906866
causative O 0 0.4115883409976959
for O 0 0.008794886991381645
CT B-Disease 1 0.8404042720794678
by O 0 0.007947169244289398
investigating O 0 0.017710838466882706
the O 0 0.009103282354772091
chromosomal O 1 0.990860104560852
co O 0 0.10366170853376389
- O 0 0.07217857986688614
localization O 0 0.03506153076887131
of O 0 0.009361752308905125
ATP7B O 1 0.7257416248321533
and O 0 0.008666803129017353
C04107 O 0 0.23232463002204895
, O 0 0.008984788320958614
using O 0 0.012095234356820583
fluorescence O 0 0.048361893743276596
in O 0 0.014335683546960354
situ O 0 0.4531266987323761
hybridization O 0 0.15724952518939972
( O 0 0.025117240846157074
FISH O 0 0.03171611204743385
) O 0 0.025859804823994637
. O 0 0.028963258489966393

C04107 O 0 0.2514900267124176
is O 0 0.020471135154366493
an O 0 0.016686441376805305
anonymous O 0 0.04114830866456032
microsatellite O 1 0.7907170653343201
marker O 0 0.07649791240692139
closely O 0 0.030263599008321762
linked O 0 0.06862509995698929
to O 0 0.02336127683520317
CT B-Disease 1 0.8968287706375122
. O 0 0.03956106677651405

However O 0 0.03209681063890457
, O 0 0.02483539469540119
BAC O 1 0.8799960613250732
clones O 1 0.6168323755264282
containing O 0 0.03449731320142746
ATP7B O 1 0.5250274538993835
and O 0 0.012984611093997955
C04107 O 0 0.14573316276073456
mapped O 0 0.022076360881328583
to O 0 0.008619344793260098
the O 0 0.014955399557948112
canine O 1 0.9797022938728333
chromosome O 1 0.9889577031135559
regions O 0 0.13600046932697296
CFA22q11 O 1 0.7492634057998657
and O 0 0.01219003926962614
CFA10q26 O 1 0.5049982666969299
, O 0 0.009889029897749424
respectively O 0 0.011868310160934925
, O 0 0.007998430170118809
demonstrating O 0 0.01666826754808426
that O 0 0.009939059615135193
WD B-Disease 1 0.9828751087188721
cannot O 0 0.01494469866156578
be O 0 0.009687429293990135
homologous O 0 0.12772731482982635
to O 0 0.01705441065132618
CT B-Disease 1 0.8676005005836487
. O 0 0.03222125768661499

The O 0 0.030274732038378716
copper O 0 0.04248908907175064
transport O 0 0.03169079124927521
genes O 1 0.5168430209159851
CTR1 O 1 0.781944751739502
and O 0 0.010746155865490437
CTR2 O 0 0.23134279251098633
were O 0 0.006078524515032768
also O 0 0.0056794616393744946
excluded O 0 0.013484681956470013
as O 0 0.006107117515057325
candidate O 0 0.013909675180912018
genes O 0 0.09025777876377106
for O 0 0.007937001995742321
CT B-Disease 1 0.9024662375450134
since O 0 0.009695740416646004
they O 0 0.004815270192921162
both O 0 0.006693922448903322
mapped O 0 0.020938970148563385
to O 0 0.014637199230492115
canine O 1 0.976982831954956
chromosome O 1 0.9801771640777588
region O 0 0.08218169957399368
CFA11q22 O 1 0.7939274311065674
. O 0 0.04539504647254944

2 O 0 0.057095907628536224
- O 0 0.0706501454114914
22 O 0 0.05185989663004875
. O 0 0.03953319787979126

5 O 0 0.08625809848308563
. O 0 0.07047467678785324

A O 0 0.031397152692079544
transcribed O 0 0.03902159631252289
sequence O 0 0.0230345968157053
identified O 0 0.013657012954354286
from O 0 0.007737002335488796
the O 0 0.007950772531330585
C04107 O 0 0.2761073112487793
- O 0 0.03264312073588371
containing O 0 0.016890238970518112
BAC O 1 0.5948081016540527
was O 0 0.007047415245324373
found O 0 0.00636484008282423
to O 0 0.0035427240654826164
be O 0 0.004181922413408756
homologous O 0 0.025683052837848663
to O 0 0.0043008169159293175
a O 0 0.008863388560712337
gene O 0 0.2861943244934082
expressed O 0 0.013284096494317055
from O 0 0.011351948603987694
human O 0 0.1577300727367401
chromosome O 1 0.9959742426872253
2p13 O 1 0.9325404763221741
- O 0 0.3231622874736786
p16 O 1 0.9246845841407776
, O 0 0.009671559557318687
a O 0 0.009405642747879028
region O 0 0.015923431143164635
devoid O 0 0.02126746065914631
of O 0 0.00753815658390522
any O 0 0.010425016283988953
positional O 0 0.047307681292295456
candidate O 0 0.04160039871931076
genes O 1 0.5148130655288696
. O 0 0.032966576516628265

Molecular O 0 0.061005327850580215
analysis O 0 0.021961191669106483
of O 0 0.010796151123940945
the O 0 0.013466007076203823
APC B-Disease 1 0.6875192523002625
gene O 0 0.2099291831254959
in O 0 0.012123345397412777
205 O 0 0.035176973789930344
families O 0 0.02322816476225853
: O 0 0.018629388883709908
extended O 0 0.030992917716503143
genotype O 1 0.9817072749137878
- O 1 0.7577915191650391
phenotype O 1 0.9913010001182556
correlations O 0 0.16565349698066711
in O 0 0.012376893311738968
FAP B-Disease 1 0.9816989898681641
and O 0 0.006658127065747976
evidence O 0 0.008122691884636879
for O 0 0.0045958091504871845
the O 0 0.004633941221982241
role O 0 0.009449089877307415
of O 0 0.009203976951539516
APC B-Disease 1 0.9067871570587158
amino O 0 0.09712885320186615
acid O 1 0.7251089811325073
changes O 0 0.10323122888803482
in O 0 0.20787407457828522
colorectal B-Disease 1 0.9999263286590576
cancer I-Disease 1 0.9998793601989746
predisposition O 1 0.9982068538665771
. O 0 0.06682080030441284

BACKGROUND O 0 0.06573960930109024
/ O 0 0.08510999381542206
AIMS O 0 0.02926652319729328
The O 0 0.012263238430023193
development O 0 0.017487594857811928
of O 0 0.024781526997685432
colorectal B-Disease 1 0.9998898506164551
cancer I-Disease 1 0.9995524287223816
and O 0 0.00970939826220274
a O 0 0.012293900363147259
variable O 0 0.031058967113494873
range O 0 0.014127073809504509
of O 0 0.01125762052834034
extracolonic O 1 0.9602279663085938
manifestations O 1 0.9669801592826843
in O 0 0.1655712127685547
familial B-Disease 1 0.9998408555984497
adenomatous I-Disease 1 0.9999446868896484
polyposis I-Disease 1 0.999937891960144
( O 1 0.9076579809188843
FAP B-Disease 1 0.9960989952087402
) O 0 0.017428040504455566
is O 0 0.007789113558828831
the O 0 0.006648232229053974
result O 0 0.009581582620739937
of O 0 0.006624181754887104
the O 0 0.009870092384517193
dominant O 0 0.08345627039670944
inheritance O 1 0.8238211274147034
of O 0 0.17790769040584564
adenomatous B-Disease 1 0.9998921155929565
polyposis I-Disease 1 0.9998975992202759
coli I-Disease 1 0.9996602535247803
( O 1 0.7640376091003418
APC B-Disease 1 0.9920450448989868
) O 0 0.0818328857421875
gene O 1 0.9634352922439575
mutations O 1 0.9770700931549072
. O 0 0.04642704129219055

In O 0 0.016788456588983536
this O 0 0.010700378566980362
study O 0 0.014333068393170834
, O 0 0.008199655450880527
direct O 0 0.01420914102345705
mutation O 1 0.8326911330223083
analysis O 0 0.010337688960134983
of O 0 0.00553890410810709
the O 0 0.008174418471753597
APC B-Disease 1 0.9394150376319885
gene O 0 0.40110549330711365
was O 0 0.007580009754747152
performed O 0 0.010439143516123295
to O 0 0.006978778168559074
determine O 0 0.01979302056133747
genotype O 1 0.9561437964439392
- O 0 0.4688231348991394
phenotype O 1 0.984613299369812
correlations O 0 0.0446951687335968
for O 0 0.009710200130939484
nine O 0 0.013069111853837967
extracolonic O 1 0.6410707831382751
manifestations O 0 0.18005980551242828
and O 0 0.0056982459500432014
to O 0 0.005937949754297733
investigate O 0 0.01461050659418106
the O 0 0.009399083442986012
incidence O 1 0.9576712250709534
of O 0 0.01455176156014204
APC B-Disease 1 0.9844016432762146
mutations O 1 0.9889812469482422
in O 0 0.022548504173755646
non O 0 0.41636934876441956
- O 1 0.984906792640686
FAP O 1 0.9992695450782776
colorectal B-Disease 1 0.999894380569458
cancer I-Disease 1 0.9996204376220703
. O 0 0.09612777829170227

METHODS O 0 0.050590503960847855
The O 0 0.027089999988675117
APC B-Disease 1 0.7755758166313171
gene O 0 0.2858305871486664
was O 0 0.014317232184112072
analysed O 0 0.026857703924179077
in O 0 0.012655801139771938
190 O 0 0.03408190980553627
unrelated O 0 0.14501145482063293
FAP B-Disease 1 0.9821935892105103
and O 0 0.015075510367751122
15 O 0 0.026201700791716576
non O 0 0.18921105563640594
- O 1 0.9864696264266968
FAP O 1 0.9997265934944153
colorectal B-Disease 1 0.9999765157699585
cancer I-Disease 1 0.9999027252197266
patients O 1 0.9979113936424255
using O 0 0.04666658490896225
denaturing O 1 0.9849975109100342
gradient O 1 0.8930369019508362
gel O 1 0.9457479119300842
electrophoresis O 0 0.3768343925476074
, O 0 0.010130144655704498
the O 0 0.010353239253163338
protein O 0 0.037744056433439255
truncation O 0 0.14723458886146545
test O 0 0.015236941166222095
, O 0 0.0070965965278446674
and O 0 0.007992086932063103
direct O 0 0.022934429347515106
sequencing O 0 0.058815307915210724
. O 0 0.029099080711603165

RESULTS O 0 0.056213848292827606
Chain O 0 0.17819975316524506
terminating O 0 0.06895452737808228
signals O 0 0.020313868299126625
were O 0 0.005712029989808798
only O 0 0.005463716108351946
identified O 0 0.010022016242146492
in O 0 0.007789199706166983
patients O 1 0.9482497572898865
belonging O 0 0.01494740042835474
to O 0 0.0073454296216368675
the O 0 0.011651478707790375
FAP B-Disease 1 0.990263819694519
group O 0 0.02294367365539074
( O 0 0.022061321884393692
105 O 0 0.04739503189921379
patients O 1 0.9594064950942993
) O 0 0.02953432686626911
. O 0 0.030591601505875587

Amino O 0 0.08537321537733078
acid O 0 0.10504049807786942
changes O 0 0.01618664525449276
were O 0 0.006114157382398844
identified O 0 0.01079264935106039
in O 0 0.005244254134595394
four O 0 0.006790404673665762
patients O 1 0.8304993510246277
, O 0 0.004098712466657162
three O 0 0.0037034577690064907
of O 0 0.004226744174957275
whom O 0 0.010399467311799526
belonged O 0 0.01077224314212799
to O 0 0.004379310645163059
the O 0 0.006513806991279125
non O 0 0.021083040162920952
- O 0 0.39279666543006897
FAP O 1 0.9944144487380981
group O 0 0.0553482361137867
of O 0 0.21706585586071014
colorectal B-Disease 1 0.9999347925186157
cancer I-Disease 1 0.9998698234558105
patients O 1 0.9973219037055969
. O 0 0.059894923120737076

Genotype O 1 0.9863057136535645
- O 1 0.8466094136238098
phenotype O 1 0.9956641793251038
correlations O 0 0.4117942154407501
identified O 0 0.026962842792272568
significant O 0 0.014463620260357857
differences O 0 0.013802165165543556
in O 0 0.005514634773135185
the O 0 0.0050126719288527966
nature O 0 0.009675797075033188
of O 0 0.006692162714898586
certain O 0 0.014262988232076168
extracolonic O 1 0.8744618892669678
manifestations O 1 0.8908208012580872
in O 0 0.025251999497413635
FAP B-Disease 1 0.9989157915115356
patients O 1 0.9947808384895325
belonging O 0 0.025381483137607574
to O 0 0.010930174961686134
three O 0 0.016366884112358093
mutation O 1 0.9725058674812317
subgroups O 0 0.23085275292396545
. O 0 0.03387077525258064

CONCLUSIONS O 0 0.06740749627351761
Extended O 0 0.06440961360931396
genotype O 1 0.9862339496612549
- O 1 0.6111843585968018
phenotype O 1 0.9876794219017029
correlations O 0 0.061328500509262085
made O 0 0.005376806948333979
in O 0 0.004696314688771963
this O 0 0.003917470574378967
study O 0 0.007802267093211412
may O 0 0.005755054764449596
have O 0 0.0032986777368932962
the O 0 0.0035368171520531178
potential O 0 0.007317587733268738
to O 0 0.0036975261755287647
determine O 0 0.006125482730567455
the O 0 0.004618371836841106
most O 0 0.0053629400208592415
appropriate O 0 0.009492135606706142
surveillance O 0 0.015813574194908142
and O 0 0.008761553093791008
prophylactic O 1 0.9807164072990417
treatment O 1 0.9833072423934937
regimens O 1 0.950643002986908
for O 0 0.009206412360072136
those O 0 0.013477637432515621
patients O 1 0.9930809140205383
with O 0 0.013920091092586517
mutations O 1 0.9946553707122803
associated O 0 0.025860989466309547
with O 0 0.010275683365762234
life O 0 0.03981401026248932
threatening O 1 0.8391606211662292
conditions O 0 0.12033893913030624
. O 0 0.0322878323495388

This O 0 0.014462273567914963
study O 0 0.015315276570618153
also O 0 0.005991335492581129
provided O 0 0.006590289995074272
evidence O 0 0.0059556858614087105
for O 0 0.004297522362321615
the O 0 0.005522855091840029
pathological O 0 0.23325368762016296
nature O 0 0.010654098354279995
of O 0 0.007699238136410713
amino O 0 0.02669593319296837
acid O 0 0.12141093611717224
changes O 0 0.01333326194435358
in O 0 0.008981829509139061
APC O 1 0.6659154891967773
associated O 0 0.015411821193993092
with O 0 0.00740285636857152
both O 0 0.011053661815822124
FAP B-Disease 1 0.9919195175170898
and O 0 0.013992036692798138
non O 1 0.5515050292015076
- O 1 0.9940038323402405
FAP O 1 0.9997884631156921
colorectal B-Disease 1 0.9999881982803345
cancer I-Disease 1 0.9999638795852661
patients O 1 0.9982688426971436
. O 0 0.03739228844642639
. O 0 0.04282774403691292

Inherited B-Disease 1 0.9987347722053528
colorectal I-Disease 1 0.9999051094055176
polyposis I-Disease 1 0.999816358089447
and O 0 0.371151328086853
cancer B-Disease 1 0.9994146823883057
risk O 1 0.8896426558494568
of O 0 0.017222652211785316
the O 0 0.026519740000367165
APC O 1 0.9720548391342163
I1307K O 1 0.9468721151351929
polymorphism O 1 0.7279883027076721
. O 0 0.052325669676065445

Germ O 1 0.7517200112342834
- O 0 0.06321526318788528
line O 0 0.03080671839416027
and O 0 0.01702607236802578
somatic O 1 0.9142496585845947
truncating O 1 0.9716176986694336
mutations O 1 0.9587691426277161
of O 0 0.013764958828687668
the O 0 0.01531467866152525
APC B-Disease 1 0.9189736843109131
gene O 1 0.5033376812934875
are O 0 0.008990861475467682
thought O 0 0.015770625323057175
to O 0 0.013321161270141602
initiate O 1 0.9602804780006409
colorectal B-Disease 1 0.9998674392700195
tumor I-Disease 1 0.9997017979621887
formation O 1 0.9490085244178772
in O 0 0.32385125756263733
familial B-Disease 1 0.9997829794883728
adenomatous I-Disease 1 0.9999449253082275
polyposis I-Disease 1 0.9999839067459106
syndrome I-Disease 1 0.9999697208404541
and O 1 0.7174930572509766
sporadic O 1 0.9967659711837769
colorectal O 1 0.9998457431793213
carcinogenesis O 1 0.9951955676078796
, O 0 0.0343148335814476
respectively O 0 0.04453246295452118
. O 0 0.04778062924742699

Recently O 0 0.037831861525774
, O 0 0.014942719601094723
an O 0 0.014185563661158085
isoleucine O 0 0.4697413146495819
- O 0 0.1058598980307579
- O 0 0.3311508297920227
> O 1 0.7666999101638794
lysine O 1 0.5811390280723572
polymorphism O 0 0.39079776406288147
at O 0 0.025547483935952187
codon O 0 0.3151322901248932
1307 O 1 0.7994518280029297
( O 0 0.025024158880114555
I1307K O 0 0.08288589864969254
) O 0 0.010551673360168934
of O 0 0.006754509638994932
the O 0 0.009052162058651447
APC B-Disease 1 0.7729837894439697
gene O 0 0.38054296374320984
has O 0 0.006639835890382528
been O 0 0.005410416051745415
identified O 0 0.0074794408865273
in O 0 0.004978387150913477
6 O 0 0.007289816625416279
% O 0 0.007181646768003702
- O 0 0.014226806350052357
7 O 0 0.009400966577231884
% O 0 0.00662577897310257
of O 0 0.005067986436188221
the O 0 0.009124896489083767
Ashkenazi O 0 0.25590381026268005
Jewish O 0 0.030225735157728195
population O 0 0.038139816373586655
. O 0 0.029800012707710266

To O 0 0.018470022827386856
assess O 0 0.031427208334207535
the O 0 0.011096099391579628
risk O 0 0.04643773287534714
of O 0 0.008245092816650867
this O 0 0.00971497967839241
common O 0 0.04387790337204933
APC B-Disease 1 0.9897409677505493
allelic O 1 0.9902528524398804
variant O 1 0.98597252368927
in O 0 0.06220800802111626
colorectal O 1 0.99989914894104
carcinogenesis O 1 0.9969567060470581
, O 0 0.009038429707288742
we O 0 0.005083078984171152
have O 0 0.005026940256357193
analyzed O 0 0.012515468522906303
a O 0 0.007740173023194075
large O 0 0.010527421720325947
cohort O 0 0.04500972107052803
of O 0 0.012259623035788536
unselected O 1 0.6048763394355774
Ashkenazi O 1 0.6848402619361877
Jewish O 0 0.03411233052611351
subjects O 0 0.049038052558898926
with O 0 0.05741792544722557
adenomatous B-Disease 1 0.9997233748435974
polyps I-Disease 1 0.9990205764770508
and O 0 0.016108699142932892
. O 0 0.0205050278455019
or O 1 0.5880359411239624
colorectal B-Disease 1 0.9999487400054932
cancer I-Disease 1 0.9997541308403015
, I-Disease 0 0.012092230841517448
for O 0 0.01024885755032301
the O 0 0.01699673756957054
APC O 1 0.9690431356430054
I1307K O 1 0.9172798991203308
polymorphism O 1 0.759211540222168
. O 0 0.04611979424953461

The O 0 0.04076658561825752
APC O 1 0.9168565273284912
I1307K O 1 0.8142728805541992
allele O 1 0.7517666816711426
was O 0 0.012014858424663544
identified O 0 0.013474511913955212
in O 0 0.006840968504548073
48 O 0 0.011990256607532501
( O 0 0.008745705708861351
10 O 0 0.007591353729367256
. O 0 0.005591670051217079
1 O 0 0.009532812982797623
% O 0 0.009725173003971577
) O 0 0.009304639883339405
of O 0 0.011007942259311676
476 O 1 0.7100614905357361
patients O 1 0.9847961664199829
. O 0 0.04106665775179863

Compared O 0 0.028071744367480278
with O 0 0.009932009503245354
the O 0 0.0076212892308831215
frequency O 0 0.01282487716525793
in O 0 0.004485232289880514
two O 0 0.0046617514453828335
separate O 0 0.0081509193405509
population O 0 0.010861263610422611
control O 0 0.011662410572171211
groups O 0 0.010311885736882687
, O 0 0.006700428668409586
the O 0 0.009026325307786465
APC O 1 0.8930676579475403
I1307K O 1 0.9240808486938477
allele O 1 0.8757600784301758
is O 0 0.010036873631179333
associated O 0 0.012870433740317822
with O 0 0.0051227351650595665
an O 0 0.006213693879544735
estimated O 0 0.014560353010892868
relative O 0 0.020636379718780518
risk O 0 0.17372511327266693
of O 0 0.01182799693197012
1 O 0 0.02511165849864483
. O 0 0.02713373675942421

5 O 0 0.060973625630140305
- O 0 0.07098527997732162
1 O 0 0.053644053637981415
. O 0 0.04477403685450554

7 O 0 0.05946614220738411
for O 0 0.044229257851839066
colorectal B-Disease 1 0.9992771744728088
neoplasia I-Disease 1 0.9945224523544312
( O 0 0.02930055931210518
both O 0 0.01570698991417885
P O 0 0.13700982928276062
= O 0 0.057682447135448456
. O 0 0.015472201630473137
01 O 0 0.4563705027103424
) O 0 0.027773287147283554
. O 0 0.030662111937999725

Furthermore O 0 0.04304610937833786
, O 0 0.013958938419818878
compared O 0 0.01901411823928356
with O 0 0.011066251434385777
noncarriers O 1 0.700530469417572
, O 0 0.016891583800315857
APC O 1 0.9607654213905334
I1307K O 1 0.8613190650939941
carriers O 0 0.1961764097213745
had O 0 0.011448397301137447
increased O 0 0.015937816351652145
numbers O 0 0.013135974295437336
of O 0 0.010862636379897594
adenomas B-Disease 1 0.9978750944137573
and O 0 0.08754999190568924
colorectal B-Disease 1 0.9999102354049683
cancers I-Disease 1 0.99972003698349
per O 0 0.03244785591959953
patient O 1 0.9792588949203491
( O 0 0.02960325963795185
P O 0 0.4414035677909851
= O 0 0.03895653784275055
. O 0 0.007864686660468578
03 O 0 0.059231050312519073
) O 0 0.007024815306067467
, O 0 0.0040769800543785095
as O 0 0.0031030362006276846
well O 0 0.0034692150074988604
as O 0 0.0036876897793263197
a O 0 0.0072317225858569145
younger O 0 0.03910781070590019
age O 0 0.024326980113983154
at O 0 0.02136724628508091
diagnosis O 1 0.9857335090637207
. O 0 0.03667518123984337

We O 0 0.01561751589179039
conclude O 0 0.0220604557543993
that O 0 0.0084729278460145
the O 0 0.012067005038261414
APC O 1 0.8635960817337036
I1307K O 1 0.8848831057548523
variant O 1 0.7089614868164062
leads O 0 0.02837582491338253
to O 0 0.009856462478637695
increased O 0 0.04482925683259964
adenoma B-Disease 1 0.9963674545288086
formation O 0 0.0313146747648716
and O 0 0.005538181401789188
directly O 0 0.009088948369026184
contributes O 0 0.018602536991238594
to O 0 0.005186464171856642
3 O 0 0.00883613433688879
% O 0 0.008100930601358414
- O 0 0.013794762082397938
4 O 0 0.010080650448799133
% O 0 0.00870366208255291
of O 0 0.0073525127954781055
all O 0 0.010566809214651585
Ashkenazi O 1 0.9322587847709656
Jewish O 1 0.8580197095870972
colorectal B-Disease 1 0.999848484992981
cancer I-Disease 1 0.9996023774147034
. O 0 0.0794883742928505

The O 0 0.021943427622318268
estimated O 0 0.029705040156841278
relative O 0 0.02869781292974949
risk O 1 0.571337878704071
for O 0 0.009109740145504475
carriers O 0 0.274203896522522
may O 0 0.01283655222505331
justify O 0 0.019824795424938202
specific O 0 0.014581171795725822
clinical O 1 0.5487852096557617
screening O 0 0.024049289524555206
for O 0 0.005182789638638496
the O 0 0.005015688017010689
360 O 0 0.01285765040665865
, O 0 0.005517174955457449
000 O 0 0.016058437526226044
Americans O 0 0.010361886583268642
expected O 0 0.006919240579009056
to O 0 0.005369063466787338
harbor O 0 0.0136234937235713
this O 0 0.006378116551786661
allele O 0 0.45063793659210205
, O 0 0.005599997937679291
and O 0 0.004847819916903973
genetic O 0 0.12623313069343567
testing O 0 0.010241755284368992
in O 0 0.003854759270325303
the O 0 0.003399433335289359
setting O 0 0.006608692463487387
of O 0 0.005187832284718752
long O 0 0.011679582297801971
- O 0 0.026249030604958534
term O 0 0.0174726415425539
- O 0 0.03212209418416023
outcome O 0 0.02059822902083397
studies O 0 0.017609667032957077
may O 0 0.019788673147559166
impact O 0 0.04011360555887222
significantly O 0 0.21550880372524261
on O 0 0.06307642161846161
colorectal B-Disease 1 0.999942421913147
cancer I-Disease 1 0.9998911619186401
prevention O 1 0.9864158034324646
in O 0 0.01634247414767742
this O 0 0.015496685169637203
population O 0 0.03555329516530037
. O 0 0.030773727223277092

Localization O 0 0.06314890086650848
of O 0 0.017132923007011414
human O 0 0.13822992146015167
BRCA1 O 1 0.9955838322639465
and O 0 0.007604656741023064
its O 0 0.008227832615375519
loss O 0 0.0161847285926342
in O 0 0.006357467267662287
high O 0 0.009095917455852032
- O 0 0.02352830395102501
grade O 0 0.017374573275446892
, O 0 0.009858346544206142
non B-Disease 0 0.03786599636077881
- I-Disease 1 0.8204331994056702
inherited I-Disease 1 0.9963621497154236
breast I-Disease 1 0.9997400641441345
carcinomas I-Disease 1 0.998096764087677
. O 0 0.061988845467567444

Although O 0 0.021751808002591133
the O 0 0.01168622262775898
link O 0 0.027485864236950874
between O 0 0.016497155651450157
the O 0 0.020478716120123863
BRCA1 O 1 0.9995934367179871
tumour B-Disease 1 0.9997547268867493
- O 1 0.9884445667266846
suppressor O 1 0.9987754225730896
gene O 1 0.9937140345573425
and O 0 0.08441245555877686
hereditary B-Disease 1 0.9992101192474365
breast I-Disease 1 0.9999135732650757
and I-Disease 1 0.9044963121414185
ovarian I-Disease 1 0.999984622001648
cancer I-Disease 1 0.9998849630355835
is O 0 0.013640079647302628
established O 0 0.008836114779114723
, O 0 0.004216497298330069
the O 0 0.0036826215218752623
role O 0 0.005713655147701502
, O 0 0.003038596361875534
if O 0 0.0032842315267771482
any O 0 0.0034111947752535343
, O 0 0.003823796985670924
of O 0 0.006136454641819
BRCA1 O 1 0.9927813410758972
in O 0 0.010319611057639122
non B-Disease 0 0.1873365193605423
- I-Disease 1 0.9585902690887451
familial I-Disease 1 0.9995535016059875
cancers I-Disease 1 0.9996328353881836
is O 0 0.024695346131920815
unclear O 0 0.045051492750644684
. O 0 0.03237096965312958

BRCA1 O 1 0.9970558881759644
mutations O 1 0.9898104667663574
are O 0 0.015072147361934185
rare O 0 0.03789312392473221
in O 0 0.012471557594835758
sporadic B-Disease 1 0.9141041040420532
cancers I-Disease 1 0.998967170715332
, O 0 0.008247876539826393
but O 0 0.00645992998033762
loss O 0 0.02478843927383423
of O 0 0.00968062411993742
BRCA1 O 1 0.9992313385009766
resulting O 0 0.2321052849292755
from O 0 0.010508104227483273
reduced O 0 0.026297373697161674
expression O 0 0.024359704926609993
or O 0 0.01051255501806736
incorrect O 0 0.022660216316580772
subcellular O 0 0.0509389266371727
localization O 0 0.02903381548821926
is O 0 0.00783503707498312
postulated O 0 0.017440246418118477
to O 0 0.004232917912304401
be O 0 0.0036337124183773994
important O 0 0.005708761978894472
in O 0 0.006747561972588301
non B-Disease 0 0.03205104172229767
- I-Disease 1 0.8567280173301697
familial I-Disease 1 0.9994877576828003
breast I-Disease 1 0.9997873902320862
and I-Disease 1 0.87353515625
ovarian I-Disease 1 0.999947190284729
cancers I-Disease 1 0.9996684789657593
. O 0 0.07212890684604645

Epigenetic O 1 0.9107373952865601
loss O 0 0.060623250901699066
, O 0 0.009079252369701862
however O 0 0.007606250699609518
, O 0 0.005408048629760742
has O 0 0.005111143924295902
not O 0 0.003934511914849281
received O 0 0.007853555493056774
general O 0 0.008236082270741463
acceptance O 0 0.017965376377105713
due O 0 0.009546446613967419
to O 0 0.005111027508974075
controversy O 0 0.013765295967459679
regarding O 0 0.010500569827854633
the O 0 0.007940191775560379
subcellular O 0 0.039224814623594284
localization O 0 0.0322975255548954
of O 0 0.011948386207222939
BRCA1 O 1 0.9951122403144836
proteins O 0 0.04410402476787567
, O 0 0.005858599673956633
reports O 0 0.006834439933300018
of O 0 0.0042192330583930016
which O 0 0.00445979367941618
have O 0 0.004313190467655659
ranged O 0 0.011570080183446407
from O 0 0.005675822496414185
exclusively O 0 0.00815234612673521
nuclear O 0 0.008280469104647636
, O 0 0.003972041420638561
to O 0 0.004170034546405077
conditionally O 0 0.015853840857744217
nuclear O 0 0.007741517387330532
, O 0 0.0038244908209890127
to O 0 0.004225094802677631
the O 0 0.008053678087890148
ER O 1 0.8269032835960388
/ O 0 0.2197563648223877
golgi O 0 0.2645418047904968
, O 0 0.011111759580671787
to O 0 0.01041119359433651
cytoplasmic O 0 0.17572246491909027
invaginations O 0 0.08756036311388016
into O 0 0.018540002405643463
the O 0 0.019717920571565628
nucleus O 0 0.07598522305488586
. O 0 0.039418309926986694

In O 0 0.015450206585228443
an O 0 0.01014898531138897
attempt O 0 0.013854758813977242
to O 0 0.0062639424577355385
resolve O 0 0.012017417699098587
this O 0 0.005720166023820639
issue O 0 0.007936792448163033
, O 0 0.005336296278983355
we O 0 0.005030420143157244
have O 0 0.007039555814117193
comprehensively O 0 0.08029963076114655
characterized O 0 0.23408569395542145
19 O 0 0.03333081677556038
anti O 0 0.3477858006954193
- O 1 0.9062783122062683
BRCA1 O 1 0.9983134269714355
antibodies O 1 0.9772071242332458
. O 0 0.05664824694395065

These O 0 0.02864937111735344
reagents O 0 0.0741470605134964
detect O 0 0.05099399387836456
a O 0 0.017935089766979218
220 O 0 0.03220396861433983
- O 0 0.09833554923534393
kD O 1 0.7569410800933838
protein O 0 0.20504498481750488
localized O 0 0.24404507875442505
in O 0 0.01071837916970253
discrete O 0 0.023967735469341278
nuclear O 0 0.01565486565232277
foci O 0 0.050669535994529724
in O 0 0.008657943457365036
all O 0 0.007987967692315578
epithelial O 1 0.9745293259620667
cell O 0 0.15037377178668976
lines O 0 0.013335696421563625
, O 0 0.005243542604148388
including O 0 0.0065358891151845455
those O 0 0.007835703901946545
derived O 0 0.025509381666779518
from O 0 0.03221765533089638
breast B-Disease 1 0.9992262125015259
malignancies I-Disease 1 0.9941725134849548
. O 0 0.05121619999408722

Immunohistochemical O 1 0.9467326402664185
staining O 1 0.7997424602508545
of O 0 0.028129417449235916
human O 1 0.7937572002410889
breast O 1 0.9986433386802673
specimens O 0 0.19022130966186523
also O 0 0.014293470419943333
revealed O 0 0.2345712035894394
BRCA1 O 1 0.9963870048522949
nuclear O 0 0.034588877111673355
foci O 1 0.8901684880256653
in O 0 0.03056318499147892
benign O 1 0.9992433786392212
breast O 1 0.9998041987419128
, O 1 0.5340508818626404
invasive B-Disease 1 0.9997473359107971
lobular I-Disease 1 0.9998772144317627
cancers I-Disease 1 0.9997001886367798
and O 0 0.021426670253276825
low B-Disease 0 0.2203947901725769
- I-Disease 1 0.556190013885498
grade I-Disease 1 0.5613145232200623
ductal I-Disease 1 0.9982013702392578
carcinomas I-Disease 1 0.9966893196105957
. O 0 0.06701899319887161

Conversely O 0 0.27799880504608154
, O 0 0.026546742767095566
BRCA1 O 1 0.9950727820396423
expression O 0 0.06633581966161728
was O 0 0.011422376148402691
reduced O 0 0.020522112026810646
or O 0 0.010323874652385712
undetectable O 0 0.10307586938142776
in O 0 0.00596908712759614
the O 0 0.004905736539512873
majority O 0 0.007706629578024149
of O 0 0.005317884963005781
high O 0 0.009940411895513535
- O 0 0.026953505352139473
grade O 0 0.026858435943722725
, O 0 0.01993737183511257
ductal B-Disease 1 0.9994308352470398
carcinomas I-Disease 1 0.9989198446273804
, O 0 0.010692289099097252
suggesting O 0 0.018354589119553566
that O 0 0.005848918110132217
absence O 0 0.016155123710632324
of O 0 0.008618481457233429
BRCA1 O 1 0.9985650181770325
may O 0 0.019318562000989914
contribute O 0 0.014206234365701675
to O 0 0.004557779524475336
the O 0 0.006287476513534784
pathogenesis O 0 0.4880918860435486
of O 0 0.005596730392426252
a O 0 0.008750482462346554
significant O 0 0.013400651514530182
percentage O 0 0.01961595192551613
of O 0 0.014058364555239677
sporadic B-Disease 1 0.9855875968933105
breast I-Disease 1 0.9998582601547241
cancers I-Disease 1 0.9993988275527954
. O 0 0.026607541367411613
. O 0 0.030961424112319946

